id	sid	tid	token	lemma	pos
dpc-4547	1	1	dermatology	dermatology	NOUN
dpc-4547	1	2	:	:	PUNCT
dpc-4547	1	3	practical	practical	ADJ
dpc-4547	1	4	and	and	CCONJ
dpc-4547	1	5	conceptual	conceptual	ADJ
dpc-4547	1	6	review	review	NOUN
dpc-4547	1	7	|	|	ADV
dpc-4547	1	8	dermatol	dermatol	ADJ
dpc-4547	1	9	pract	pract	NOUN
dpc-4547	1	10	concept	concept	NOUN
dpc-4547	1	11	.	.	PUNCT
dpc-4547	2	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	2	2	:	:	PUNCT
dpc-4547	2	3	e2024146s	e2024146s	ADV
dpc-4547	2	4	1	1	NUM
dpc-4547	2	5	epidemiology	epidemiology	NOUN
dpc-4547	2	6	and	and	CCONJ
dpc-4547	2	7	risk	risk	NOUN
dpc-4547	2	8	factors	factor	NOUN
dpc-4547	2	9	of	of	ADP
dpc-4547	2	10	actinic	actinic	ADJ
dpc-4547	2	11	keratosis	keratosis	NOUN
dpc-4547	2	12	.	.	PUNCT
dpc-4547	3	1	what	what	PRON
dpc-4547	3	2	is	be	AUX
dpc-4547	3	3	new	new	ADJ
dpc-4547	3	4	for	for	ADP
dpc-4547	3	5	the	the	DET
dpc-4547	3	6	management	management	NOUN
dpc-4547	3	7	for	for	ADP
dpc-4547	3	8	sun	sun	NOUN
dpc-4547	3	9	-	-	PUNCT
dpc-4547	3	10	damaged	damage	VERB
dpc-4547	3	11	skin	skin	NOUN
dpc-4547	3	12	janis	janis	PROPN
dpc-4547	3	13	raphael	raphael	PROPN
dpc-4547	3	14	thamm1	thamm1	PROPN
dpc-4547	3	15	,	,	PUNCT
dpc-4547	3	16	sandra	sandra	PROPN
dpc-4547	3	17	schuh1	schuh1	PROPN
dpc-4547	3	18	,	,	PUNCT
dpc-4547	3	19	julia	julia	PROPN
dpc-4547	3	20	welzel1	welzel1	PROPN
dpc-4547	3	21	1	1	NUM
dpc-4547	3	22	department	department	NOUN
dpc-4547	3	23	of	of	ADP
dpc-4547	3	24	dermatology	dermatology	NOUN
dpc-4547	3	25	and	and	CCONJ
dpc-4547	3	26	allergology	allergology	NOUN
dpc-4547	3	27	,	,	PUNCT
dpc-4547	3	28	university	university	NOUN
dpc-4547	3	29	hospital	hospital	NOUN
dpc-4547	3	30	augsburg	augsburg	PROPN
dpc-4547	3	31	,	,	PUNCT
dpc-4547	3	32	germany	germany	PROPN
dpc-4547	3	33	key	key	ADJ
dpc-4547	3	34	words	word	NOUN
dpc-4547	3	35	:	:	PUNCT
dpc-4547	3	36	actinic	actinic	ADJ
dpc-4547	3	37	keratosis	keratosis	NOUN
dpc-4547	3	38	,	,	PUNCT
dpc-4547	3	39	skin	skin	NOUN
dpc-4547	3	40	cancer	cancer	NOUN
dpc-4547	3	41	,	,	PUNCT
dpc-4547	3	42	prevention	prevention	NOUN
dpc-4547	3	43	,	,	PUNCT
dpc-4547	3	44	non	non	ADJ
dpc-4547	3	45	-	-	ADJ
dpc-4547	3	46	invasive	invasive	ADJ
dpc-4547	3	47	imaging	imaging	NOUN
dpc-4547	3	48	,	,	PUNCT
dpc-4547	3	49	pro	pro	X
dpc-4547	3	50	score	score	NOUN
dpc-4547	3	51	citation	citation	NOUN
dpc-4547	3	52	:	:	PUNCT
dpc-4547	3	53	thamm	thamm	PROPN
dpc-4547	3	54	jr	jr	PROPN
dpc-4547	3	55	,	,	PUNCT
dpc-4547	3	56	schuh	schuh	PROPN
dpc-4547	3	57	s	s	PROPN
dpc-4547	3	58	,	,	PUNCT
dpc-4547	3	59	welzel	welzel	ADJ
dpc-4547	3	60	j	j	PROPN
dpc-4547	3	61	epidemiology	epidemiology	NOUN
dpc-4547	3	62	and	and	CCONJ
dpc-4547	3	63	risk	risk	NOUN
dpc-4547	3	64	factors	factor	NOUN
dpc-4547	3	65	of	of	ADP
dpc-4547	3	66	actinic	actinic	ADJ
dpc-4547	3	67	keratosis	keratosis	NOUN
dpc-4547	3	68	.	.	PUNCT
dpc-4547	4	1	what	what	PRON
dpc-4547	4	2	is	be	AUX
dpc-4547	4	3	new	new	ADJ
dpc-4547	4	4	for	for	ADP
dpc-4547	4	5	the	the	DET
dpc-4547	4	6	management	management	NOUN
dpc-4547	4	7	for	for	ADP
dpc-4547	4	8	sun	sun	NOUN
dpc-4547	4	9	-	-	PUNCT
dpc-4547	4	10	damaged	damage	VERB
dpc-4547	4	11	skin	skin	NOUN
dpc-4547	4	12	.	.	PUNCT
dpc-4547	5	1	dermatol	dermatol	NOUN
dpc-4547	5	2	pract	pract	PROPN
dpc-4547	5	3	concept	concept	NOUN
dpc-4547	5	4	.	.	PUNCT
dpc-4547	6	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	6	2	:	:	PUNCT
dpc-4547	6	3	e2024146s	e2024146s	X
dpc-4547	6	4	.	.	PUNCT
dpc-4547	7	1	doi	doi	NOUN
dpc-4547	7	2	:	:	PUNCT
dpc-4547	7	3	https://doi.org/10.5826/dpc.1403s1a146s	https://doi.org/10.5826/dpc.1403s1a146s	PUNCT
dpc-4547	7	4	accepted	accept	VERB
dpc-4547	7	5	:	:	PUNCT
dpc-4547	7	6	july	july	PROPN
dpc-4547	7	7	12	12	NUM
dpc-4547	7	8	,	,	PUNCT
dpc-4547	7	9	2024	2024	NUM
dpc-4547	7	10	;	;	PUNCT
dpc-4547	7	11	published	publish	VERB
dpc-4547	7	12	:	:	PUNCT
dpc-4547	8	1	september	september	PROPN
dpc-4547	8	2	2024	2024	NUM
dpc-4547	8	3	copyright	copyright	NOUN
dpc-4547	8	4	:	:	PUNCT
dpc-4547	8	5	©	©	PROPN
dpc-4547	8	6	2024	2024	NUM
dpc-4547	8	7	thamm	thamm	PROPN
dpc-4547	8	8	et	et	PROPN
dpc-4547	8	9	al	al	PROPN
dpc-4547	8	10	.	.	PUNCT
dpc-4547	9	1	this	this	PRON
dpc-4547	9	2	is	be	AUX
dpc-4547	9	3	an	an	DET
dpc-4547	9	4	open	open	ADJ
dpc-4547	9	5	-	-	PUNCT
dpc-4547	9	6	access	access	NOUN
dpc-4547	9	7	article	article	NOUN
dpc-4547	9	8	distributed	distribute	VERB
dpc-4547	9	9	under	under	ADP
dpc-4547	9	10	the	the	DET
dpc-4547	9	11	terms	term	NOUN
dpc-4547	9	12	of	of	ADP
dpc-4547	9	13	the	the	DET
dpc-4547	9	14	creative	creative	ADJ
dpc-4547	9	15	commons	common	NOUN
dpc-4547	9	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4547	9	17	license	license	NOUN
dpc-4547	9	18	(	(	PUNCT
dpc-4547	9	19	by	by	ADP
dpc-4547	9	20	-	-	PUNCT
dpc-4547	9	21	nc-4.0	nc-4.0	NOUN
dpc-4547	9	22	)	)	PUNCT
dpc-4547	9	23	,	,	PUNCT
dpc-4547	9	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4547	9	25	,	,	PUNCT
dpc-4547	9	26	which	which	PRON
dpc-4547	9	27	permits	permit	VERB
dpc-4547	9	28	unrestricted	unrestricted	ADJ
dpc-4547	9	29	noncommercial	noncommercial	ADJ
dpc-4547	9	30	use	use	NOUN
dpc-4547	9	31	,	,	PUNCT
dpc-4547	9	32	distribution	distribution	NOUN
dpc-4547	9	33	,	,	PUNCT
dpc-4547	9	34	and	and	CCONJ
dpc-4547	9	35	reproduction	reproduction	NOUN
dpc-4547	9	36	in	in	ADP
dpc-4547	9	37	any	any	DET
dpc-4547	9	38	medium	medium	NOUN
dpc-4547	9	39	,	,	PUNCT
dpc-4547	9	40	provided	provide	VERB
dpc-4547	9	41	the	the	DET
dpc-4547	9	42	original	original	ADJ
dpc-4547	9	43	authors	author	NOUN
dpc-4547	9	44	and	and	CCONJ
dpc-4547	9	45	source	source	NOUN
dpc-4547	9	46	are	be	AUX
dpc-4547	9	47	credited	credit	VERB
dpc-4547	9	48	.	.	PUNCT
dpc-4547	10	1	funding	funding	NOUN
dpc-4547	10	2	:	:	PUNCT
dpc-4547	10	3	none	none	NOUN
dpc-4547	10	4	.	.	PUNCT
dpc-4547	11	1	competing	compete	VERB
dpc-4547	11	2	interests	interest	NOUN
dpc-4547	11	3	:	:	PUNCT
dpc-4547	11	4	julia	julia	PROPN
dpc-4547	11	5	welzel	welzel	PROPN
dpc-4547	11	6	:	:	PUNCT
dpc-4547	11	7	consulting	consult	VERB
dpc-4547	11	8	fees	fee	NOUN
dpc-4547	11	9	from	from	ADP
dpc-4547	11	10	almirall	almirall	ADJ
dpc-4547	11	11	,	,	PUNCT
dpc-4547	11	12	janssen	janssen	PROPN
dpc-4547	11	13	,	,	PUNCT
dpc-4547	11	14	lecture	lecture	NOUN
dpc-4547	11	15	fees	fee	NOUN
dpc-4547	11	16	from	from	ADP
dpc-4547	11	17	almirall	almirall	ADJ
dpc-4547	11	18	,	,	PUNCT
dpc-4547	11	19	novartis	novartis	PROPN
dpc-4547	11	20	,	,	PUNCT
dpc-4547	11	21	janssen	janssen	PROPN
dpc-4547	11	22	,	,	PUNCT
dpc-4547	11	23	leo	leo	PROPN
dpc-4547	11	24	,	,	PUNCT
dpc-4547	11	25	boehringer	boehringer	PROPN
dpc-4547	11	26	ingelheim	ingelheim	PROPN
dpc-4547	11	27	,	,	PUNCT
dpc-4547	11	28	bms	bms	PROPN
dpc-4547	11	29	,	,	PUNCT
dpc-4547	11	30	travel	travel	NOUN
dpc-4547	11	31	grant	grant	NOUN
dpc-4547	11	32	from	from	ADP
dpc-4547	11	33	janssen	janssen	PROPN
dpc-4547	11	34	,	,	PUNCT
dpc-4547	11	35	president	president	NOUN
dpc-4547	11	36	of	of	ADP
dpc-4547	11	37	the	the	DET
dpc-4547	11	38	german	german	ADJ
dpc-4547	11	39	dermatological	dermatological	ADJ
dpc-4547	11	40	society	society	NOUN
dpc-4547	11	41	.	.	PUNCT
dpc-4547	12	1	authorship	authorship	NOUN
dpc-4547	12	2	:	:	PUNCT
dpc-4547	12	3	all	all	DET
dpc-4547	12	4	authors	author	NOUN
dpc-4547	12	5	have	have	AUX
dpc-4547	12	6	contributed	contribute	VERB
dpc-4547	12	7	significantly	significantly	ADV
dpc-4547	12	8	to	to	ADP
dpc-4547	12	9	this	this	DET
dpc-4547	12	10	publication	publication	NOUN
dpc-4547	12	11	.	.	PUNCT
dpc-4547	13	1	corresponding	correspond	VERB
dpc-4547	13	2	author	author	NOUN
dpc-4547	13	3	:	:	PUNCT
dpc-4547	13	4	janis	janis	PROPN
dpc-4547	13	5	thamm	thamm	PROPN
dpc-4547	13	6	,	,	PUNCT
dpc-4547	13	7	md	md	PROPN
dpc-4547	13	8	,	,	PUNCT
dpc-4547	13	9	department	department	NOUN
dpc-4547	13	10	of	of	ADP
dpc-4547	13	11	dermatology	dermatology	NOUN
dpc-4547	13	12	and	and	CCONJ
dpc-4547	13	13	allergology	allergology	NOUN
dpc-4547	13	14	,	,	PUNCT
dpc-4547	13	15	university	university	NOUN
dpc-4547	13	16	hospital	hospital	NOUN
dpc-4547	13	17	augsburg	augsburg	PROPN
dpc-4547	13	18	,	,	PUNCT
dpc-4547	13	19	sauerbruchstr	sauerbruchstr	NOUN
dpc-4547	13	20	.	.	PROPN
dpc-4547	14	1	6	6	NUM
dpc-4547	14	2	,	,	PUNCT
dpc-4547	14	3	86179	86179	NUM
dpc-4547	14	4	augsburg	augsburg	PROPN
dpc-4547	14	5	,	,	PUNCT
dpc-4547	14	6	germany	germany	PROPN
dpc-4547	14	7	.	.	PUNCT
dpc-4547	15	1	phone	phone	NOUN
dpc-4547	15	2	:	:	PUNCT
dpc-4547	15	3	+498214007401	+498214007401	NUM
dpc-4547	15	4	fax	fax	NOUN
dpc-4547	15	5	:	:	PUNCT
dpc-4547	15	6	+49821400177401	+49821400177401	NUM
dpc-4547	15	7	e	e	NOUN
dpc-4547	15	8	-	-	NOUN
dpc-4547	15	9	mail	mail	NOUN
dpc-4547	15	10	:	:	PUNCT
dpc-4547	15	11	janis.thamm@uk-augsburg.de	janis.thamm@uk-augsburg.de	PROPN
dpc-4547	15	12	actinic	actinic	ADJ
dpc-4547	15	13	keratosis	keratosis	NOUN
dpc-4547	15	14	(	(	PUNCT
dpc-4547	15	15	ak	ak	PROPN
dpc-4547	15	16	)	)	PUNCT
dpc-4547	15	17	is	be	AUX
dpc-4547	15	18	considered	consider	VERB
dpc-4547	15	19	a	a	DET
dpc-4547	15	20	chronic	chronic	ADJ
dpc-4547	15	21	skin	skin	NOUN
dpc-4547	15	22	disease	disease	NOUN
dpc-4547	15	23	mostly	mostly	ADV
dpc-4547	15	24	caused	cause	VERB
dpc-4547	15	25	by	by	ADP
dpc-4547	15	26	long	long	ADJ
dpc-4547	15	27	-	-	PUNCT
dpc-4547	15	28	term	term	NOUN
dpc-4547	15	29	exposure	exposure	NOUN
dpc-4547	15	30	to	to	ADP
dpc-4547	15	31	uv	uv	NOUN
dpc-4547	15	32	radiation	radiation	NOUN
dpc-4547	15	33	and	and	CCONJ
dpc-4547	15	34	other	other	ADJ
dpc-4547	15	35	risk	risk	NOUN
dpc-4547	15	36	factors	factor	NOUN
dpc-4547	15	37	such	such	ADJ
dpc-4547	15	38	as	as	ADP
dpc-4547	15	39	immunosuppression	immunosuppression	NOUN
dpc-4547	15	40	,	,	PUNCT
dpc-4547	15	41	leading	lead	VERB
dpc-4547	15	42	to	to	ADP
dpc-4547	15	43	an	an	DET
dpc-4547	15	44	individual	individual	ADJ
dpc-4547	15	45	susceptibility	susceptibility	NOUN
dpc-4547	15	46	for	for	ADP
dpc-4547	15	47	skin	skin	NOUN
dpc-4547	15	48	cancer	cancer	NOUN
dpc-4547	15	49	manifestation	manifestation	NOUN
dpc-4547	15	50	.	.	PUNCT
dpc-4547	16	1	the	the	DET
dpc-4547	16	2	treatment	treatment	NOUN
dpc-4547	16	3	of	of	ADP
dpc-4547	16	4	ak	ak	PROPN
dpc-4547	16	5	is	be	AUX
dpc-4547	16	6	laborious	laborious	ADJ
dpc-4547	16	7	and	and	CCONJ
dpc-4547	16	8	costly	costly	ADJ
dpc-4547	16	9	,	,	PUNCT
dpc-4547	16	10	and	and	CCONJ
dpc-4547	16	11	the	the	DET
dpc-4547	16	12	incidence	incidence	NOUN
dpc-4547	16	13	of	of	ADP
dpc-4547	16	14	skin	skin	NOUN
dpc-4547	16	15	cancer	cancer	NOUN
dpc-4547	16	16	is	be	AUX
dpc-4547	16	17	forecasted	forecast	VERB
dpc-4547	16	18	to	to	PART
dpc-4547	16	19	double	double	VERB
dpc-4547	16	20	until	until	ADP
dpc-4547	16	21	the	the	DET
dpc-4547	16	22	year	year	NOUN
dpc-4547	16	23	2030	2030	NUM
dpc-4547	16	24	in	in	ADP
dpc-4547	16	25	an	an	DET
dpc-4547	16	26	aging	age	VERB
dpc-4547	16	27	society	society	NOUN
dpc-4547	16	28	.	.	PUNCT
dpc-4547	17	1	risk	risk	NOUN
dpc-4547	17	2	factors	factor	NOUN
dpc-4547	17	3	in	in	ADP
dpc-4547	17	4	ak	ak	PROPN
dpc-4547	17	5	for	for	ADP
dpc-4547	17	6	malignant	malignant	ADJ
dpc-4547	17	7	transformation	transformation	NOUN
dpc-4547	17	8	in	in	ADP
dpc-4547	17	9	cutaneous	cutaneous	ADJ
dpc-4547	17	10	squamous	squamous	ADJ
dpc-4547	17	11	cell	cell	NOUN
dpc-4547	17	12	carcinoma	carcinoma	NOUN
dpc-4547	17	13	(	(	PUNCT
dpc-4547	17	14	cscc	cscc	ADJ
dpc-4547	17	15	)	)	PUNCT
dpc-4547	17	16	are	be	AUX
dpc-4547	17	17	not	not	PART
dpc-4547	17	18	fully	fully	ADV
dpc-4547	17	19	understood	understand	VERB
dpc-4547	17	20	,	,	PUNCT
dpc-4547	17	21	but	but	CCONJ
dpc-4547	17	22	studies	study	NOUN
dpc-4547	17	23	suggest	suggest	VERB
dpc-4547	17	24	that	that	SCONJ
dpc-4547	17	25	histological	histological	ADJ
dpc-4547	17	26	features	feature	NOUN
dpc-4547	17	27	,	,	PUNCT
dpc-4547	17	28	such	such	ADJ
dpc-4547	17	29	as	as	ADP
dpc-4547	17	30	atypia	atypia	PROPN
dpc-4547	17	31	in	in	ADP
dpc-4547	17	32	the	the	DET
dpc-4547	17	33	basal	basal	ADJ
dpc-4547	17	34	epidermal	epidermal	ADJ
dpc-4547	17	35	third	third	ADJ
dpc-4547	17	36	and	and	CCONJ
dpc-4547	17	37	basal	basal	ADJ
dpc-4547	17	38	proliferation	proliferation	NOUN
dpc-4547	17	39	(	(	PUNCT
dpc-4547	17	40	pro	pro	ADJ
dpc-4547	17	41	score	score	NOUN
dpc-4547	17	42	)	)	PUNCT
dpc-4547	17	43	in	in	ADP
dpc-4547	17	44	ak	ak	PROPN
dpc-4547	17	45	play	play	VERB
dpc-4547	17	46	a	a	DET
dpc-4547	17	47	pivotal	pivotal	ADJ
dpc-4547	17	48	role	role	NOUN
dpc-4547	17	49	for	for	ADP
dpc-4547	17	50	development	development	NOUN
dpc-4547	17	51	of	of	ADP
dpc-4547	17	52	malignancy	malignancy	NOUN
dpc-4547	17	53	.	.	PUNCT
dpc-4547	18	1	as	as	SCONJ
dpc-4547	18	2	the	the	DET
dpc-4547	18	3	clinical	clinical	ADJ
dpc-4547	18	4	appearance	appearance	NOUN
dpc-4547	18	5	of	of	ADP
dpc-4547	18	6	ak	ak	PROPN
dpc-4547	18	7	does	do	AUX
dpc-4547	18	8	not	not	PART
dpc-4547	18	9	correlate	correlate	VERB
dpc-4547	18	10	with	with	ADP
dpc-4547	18	11	the	the	DET
dpc-4547	18	12	risk	risk	NOUN
dpc-4547	18	13	for	for	ADP
dpc-4547	18	14	malignancy	malignancy	NOUN
dpc-4547	18	15	,	,	PUNCT
dpc-4547	18	16	guidelines	guideline	NOUN
dpc-4547	18	17	suggest	suggest	AUX
dpc-4547	18	18	treating	treat	VERB
dpc-4547	18	19	every	every	DET
dpc-4547	18	20	single	single	ADJ
dpc-4547	18	21	ak	ak	NOUN
dpc-4547	18	22	lesion	lesion	NOUN
dpc-4547	18	23	upon	upon	SCONJ
dpc-4547	18	24	diagnosis	diagnosis	NOUN
dpc-4547	18	25	.	.	PUNCT
dpc-4547	19	1	skin	skin	NOUN
dpc-4547	19	2	imaging	imaging	NOUN
dpc-4547	19	3	techniques	technique	NOUN
dpc-4547	19	4	,	,	PUNCT
dpc-4547	19	5	such	such	ADJ
dpc-4547	19	6	as	as	ADP
dpc-4547	19	7	line	line	NOUN
dpc-4547	19	8	-	-	PUNCT
dpc-4547	19	9	field	field	NOUN
dpc-4547	19	10	confocal	confocal	ADJ
dpc-4547	19	11	optical	optical	ADJ
dpc-4547	19	12	coherence	coherence	NOUN
dpc-4547	19	13	tomography	tomography	NOUN
dpc-4547	19	14	(	(	PUNCT
dpc-4547	19	15	lc	lc	PROPN
dpc-4547	19	16	-	-	PUNCT
dpc-4547	19	17	oct	oct	NOUN
dpc-4547	19	18	)	)	PUNCT
dpc-4547	19	19	can	can	AUX
dpc-4547	19	20	help	help	VERB
dpc-4547	19	21	to	to	PART
dpc-4547	19	22	provide	provide	VERB
dpc-4547	19	23	an	an	DET
dpc-4547	19	24	individual	individual	ADJ
dpc-4547	19	25	holistic	holistic	ADJ
dpc-4547	19	26	follow	follow	NOUN
dpc-4547	19	27	-	-	PUNCT
dpc-4547	19	28	up	up	NOUN
dpc-4547	19	29	for	for	ADP
dpc-4547	19	30	ak	ak	PROPN
dpc-4547	19	31	lesions	lesion	NOUN
dpc-4547	19	32	by	by	ADP
dpc-4547	19	33	non	non	ADJ
dpc-4547	19	34	-	-	ADJ
dpc-4547	19	35	invasive	invasive	ADJ
dpc-4547	19	36	visualization	visualization	NOUN
dpc-4547	19	37	of	of	ADP
dpc-4547	19	38	atypia	atypia	PROPN
dpc-4547	19	39	and	and	CCONJ
dpc-4547	19	40	basal	basal	PROPN
dpc-4547	19	41	proliferation	proliferation	NOUN
dpc-4547	19	42	.	.	PUNCT
dpc-4547	20	1	a	a	DET
dpc-4547	20	2	follow	follow	NOUN
dpc-4547	20	3	-	-	PUNCT
dpc-4547	20	4	up	up	NOUN
dpc-4547	20	5	for	for	ADP
dpc-4547	20	6	patients	patient	NOUN
dpc-4547	20	7	with	with	ADP
dpc-4547	20	8	ak	ak	PROPN
dpc-4547	20	9	may	may	AUX
dpc-4547	20	10	be	be	AUX
dpc-4547	20	11	critical	critical	ADJ
dpc-4547	20	12	for	for	ADP
dpc-4547	20	13	treatment	treatment	NOUN
dpc-4547	20	14	success	success	NOUN
dpc-4547	20	15	in	in	ADP
dpc-4547	20	16	terms	term	NOUN
dpc-4547	20	17	of	of	ADP
dpc-4547	20	18	strengthening	strengthen	VERB
dpc-4547	20	19	therapy	therapy	NOUN
dpc-4547	20	20	adherence	adherence	NOUN
dpc-4547	20	21	.	.	PUNCT
dpc-4547	21	1	when	when	SCONJ
dpc-4547	21	2	ak	ak	PROPN
dpc-4547	21	3	presents	present	VERB
dpc-4547	21	4	therapy	therapy	NOUN
dpc-4547	21	5	refractory	refractory	NOUN
dpc-4547	21	6	,	,	PUNCT
dpc-4547	21	7	cscc	cscc	ADJ
dpc-4547	21	8	manifests	manifest	NOUN
dpc-4547	21	9	in	in	ADP
dpc-4547	21	10	nearly	nearly	ADV
dpc-4547	21	11	30	30	NUM
dpc-4547	21	12	%	%	NOUN
dpc-4547	21	13	of	of	ADP
dpc-4547	21	14	the	the	DET
dpc-4547	21	15	cases	case	NOUN
dpc-4547	21	16	after	after	ADP
dpc-4547	21	17	several	several	ADJ
dpc-4547	21	18	years	year	NOUN
dpc-4547	21	19	.	.	PUNCT
dpc-4547	22	1	patients	patient	NOUN
dpc-4547	22	2	with	with	ADP
dpc-4547	22	3	ak	ak	PROPN
dpc-4547	22	4	suffering	suffering	NOUN
dpc-4547	22	5	from	from	ADP
dpc-4547	22	6	field	field	NOUN
dpc-4547	22	7	cancerization	cancerization	NOUN
dpc-4547	22	8	and	and	CCONJ
dpc-4547	22	9	immunosuppression	immunosuppression	NOUN
dpc-4547	22	10	are	be	AUX
dpc-4547	22	11	susceptible	susceptible	ADJ
dpc-4547	22	12	for	for	ADP
dpc-4547	22	13	a	a	DET
dpc-4547	22	14	severe	severe	ADJ
dpc-4547	22	15	course	course	NOUN
dpc-4547	22	16	of	of	ADP
dpc-4547	22	17	disease	disease	NOUN
dpc-4547	22	18	including	include	VERB
dpc-4547	22	19	metastasis	metastasis	NOUN
dpc-4547	22	20	and	and	CCONJ
dpc-4547	22	21	high	high	ADJ
dpc-4547	22	22	mortality	mortality	NOUN
dpc-4547	22	23	rates	rate	NOUN
dpc-4547	22	24	.	.	PUNCT
dpc-4547	23	1	those	those	DET
dpc-4547	23	2	vulnerable	vulnerable	ADJ
dpc-4547	23	3	subgroups	subgroup	NOUN
dpc-4547	23	4	benefit	benefit	VERB
dpc-4547	23	5	from	from	ADP
dpc-4547	23	6	close	close	ADJ
dpc-4547	23	7	skin	skin	NOUN
dpc-4547	23	8	cancer	cancer	NOUN
dpc-4547	23	9	screening	screening	NOUN
dpc-4547	23	10	,	,	PUNCT
dpc-4547	23	11	early	early	ADV
dpc-4547	23	12	adequate	adequate	ADJ
dpc-4547	23	13	treatment	treatment	NOUN
dpc-4547	23	14	and	and	CCONJ
dpc-4547	23	15	chemoprevention	chemoprevention	NOUN
dpc-4547	23	16	,	,	PUNCT
dpc-4547	23	17	such	such	ADJ
dpc-4547	23	18	as	as	ADP
dpc-4547	23	19	niacinamide	niacinamide	NOUN
dpc-4547	23	20	or	or	CCONJ
dpc-4547	23	21	acitretin	acitretin	NOUN
dpc-4547	23	22	.	.	PUNCT
dpc-4547	24	1	skin	skin	NOUN
dpc-4547	24	2	cancer	cancer	NOUN
dpc-4547	24	3	prevention	prevention	NOUN
dpc-4547	24	4	is	be	AUX
dpc-4547	24	5	substantial	substantial	ADJ
dpc-4547	24	6	.	.	PUNCT
dpc-4547	25	1	primary	primary	ADJ
dpc-4547	25	2	prevention	prevention	NOUN
dpc-4547	25	3	should	should	AUX
dpc-4547	25	4	include	include	VERB
dpc-4547	25	5	chemical	chemical	NOUN
dpc-4547	25	6	and	and	CCONJ
dpc-4547	25	7	physical	physical	ADJ
dpc-4547	25	8	uv	uv	NOUN
dpc-4547	25	9	-	-	PUNCT
dpc-4547	25	10	light	light	NOUN
dpc-4547	25	11	protection	protection	NOUN
dpc-4547	25	12	and	and	CCONJ
dpc-4547	25	13	avoidance	avoidance	NOUN
dpc-4547	25	14	of	of	ADP
dpc-4547	25	15	indoor	indoor	ADJ
dpc-4547	25	16	tanning	tanning	NOUN
dpc-4547	25	17	.	.	PUNCT
dpc-4547	26	1	secondary	secondary	ADJ
dpc-4547	26	2	prevention	prevention	NOUN
dpc-4547	26	3	is	be	AUX
dpc-4547	26	4	essential	essential	ADJ
dpc-4547	26	5	in	in	ADP
dpc-4547	26	6	high	high	ADJ
dpc-4547	26	7	-	-	PUNCT
dpc-4547	26	8	risk	risk	NOUN
dpc-4547	26	9	populations	population	NOUN
dpc-4547	26	10	,	,	PUNCT
dpc-4547	26	11	such	such	ADJ
dpc-4547	26	12	as	as	ADP
dpc-4547	26	13	fair	fair	ADJ
dpc-4547	26	14	skin	skin	NOUN
dpc-4547	26	15	type	type	NOUN
dpc-4547	26	16	elderly	elderly	ADJ
dpc-4547	26	17	men	man	NOUN
dpc-4547	26	18	and	and	CCONJ
dpc-4547	26	19	stors	stor	NOUN
dpc-4547	26	20	.	.	PUNCT
dpc-4547	27	1	tertiary	tertiary	ADJ
dpc-4547	27	2	prevention	prevention	NOUN
dpc-4547	27	3	should	should	AUX
dpc-4547	27	4	comprise	comprise	VERB
dpc-4547	27	5	adequate	adequate	ADJ
dpc-4547	27	6	treatment	treatment	NOUN
dpc-4547	27	7	strategies	strategy	NOUN
dpc-4547	27	8	to	to	PART
dpc-4547	27	9	prevent	prevent	VERB
dpc-4547	27	10	therapy	therapy	NOUN
dpc-4547	27	11	resistance	resistance	NOUN
dpc-4547	27	12	,	,	PUNCT
dpc-4547	27	13	reoccurrence	reoccurrence	NOUN
dpc-4547	27	14	and	and	CCONJ
dpc-4547	27	15	cscc	cscc	ADJ
dpc-4547	27	16	,	,	PUNCT
dpc-4547	27	17	especially	especially	ADV
dpc-4547	27	18	when	when	SCONJ
dpc-4547	27	19	field	field	NOUN
dpc-4547	27	20	cancerization	cancerization	NOUN
dpc-4547	27	21	and	and	CCONJ
dpc-4547	27	22	immunosuppression	immunosuppression	NOUN
dpc-4547	27	23	are	be	AUX
dpc-4547	27	24	present	present	ADJ
dpc-4547	27	25	.	.	PUNCT
dpc-4547	28	1	abstract	abstract	ADJ
dpc-4547	28	2	2	2	NUM
dpc-4547	28	3	review	review	NOUN
dpc-4547	28	4	|	|	ADV
dpc-4547	28	5	dermatol	dermatol	ADJ
dpc-4547	28	6	pract	pract	NOUN
dpc-4547	28	7	concept	concept	NOUN
dpc-4547	28	8	.	.	PUNCT
dpc-4547	29	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	29	2	:	:	PUNCT
dpc-4547	29	3	e2024146s	e2024146s	ADV
dpc-4547	29	4	introduction	introduction	NOUN
dpc-4547	29	5	–	–	PUNCT
dpc-4547	29	6	epidemiology	epidemiology	NOUN
dpc-4547	29	7	actinic	actinic	ADJ
dpc-4547	29	8	keratosis	keratosis	NOUN
dpc-4547	29	9	(	(	PUNCT
dpc-4547	29	10	ak	ak	PROPN
dpc-4547	29	11	)	)	PUNCT
dpc-4547	29	12	is	be	AUX
dpc-4547	29	13	characterized	characterize	VERB
dpc-4547	29	14	by	by	ADP
dpc-4547	29	15	the	the	DET
dpc-4547	29	16	presence	presence	NOUN
dpc-4547	29	17	of	of	ADP
dpc-4547	29	18	atypical	atypical	ADJ
dpc-4547	29	19	keratinocytes	keratinocyte	NOUN
dpc-4547	29	20	within	within	ADP
dpc-4547	29	21	the	the	DET
dpc-4547	29	22	epidermal	epidermal	ADJ
dpc-4547	29	23	skin	skin	NOUN
dpc-4547	29	24	layer	layer	NOUN
dpc-4547	29	25	and	and	CCONJ
dpc-4547	29	26	is	be	AUX
dpc-4547	29	27	considered	consider	VERB
dpc-4547	29	28	an	an	DET
dpc-4547	29	29	in	in	ADP
dpc-4547	29	30	-	-	PUNCT
dpc-4547	29	31	situ	situ	ADJ
dpc-4547	29	32	neoplasia	neoplasia	NOUN
dpc-4547	29	33	of	of	ADP
dpc-4547	29	34	the	the	DET
dpc-4547	29	35	skin	skin	NOUN
dpc-4547	29	36	and	and	CCONJ
dpc-4547	29	37	a	a	DET
dpc-4547	29	38	progenitor	progenitor	NOUN
dpc-4547	29	39	of	of	ADP
dpc-4547	29	40	cutaneous	cutaneous	ADJ
dpc-4547	29	41	squamous	squamous	ADJ
dpc-4547	29	42	cell	cell	NOUN
dpc-4547	29	43	cancer	cancer	NOUN
dpc-4547	29	44	(	(	PUNCT
dpc-4547	29	45	cscc	cscc	ADJ
dpc-4547	29	46	)	)	PUNCT
dpc-4547	30	1	[	[	X
dpc-4547	30	2	1	1	NUM
dpc-4547	30	3	]	]	PUNCT
dpc-4547	30	4	.	.	PUNCT
dpc-4547	31	1	ak	ak	PROPN
dpc-4547	31	2	usually	usually	ADV
dpc-4547	31	3	manifest	manifest	VERB
dpc-4547	31	4	on	on	ADP
dpc-4547	31	5	body	body	NOUN
dpc-4547	31	6	areas	area	NOUN
dpc-4547	31	7	,	,	PUNCT
dpc-4547	31	8	such	such	ADJ
dpc-4547	31	9	as	as	ADP
dpc-4547	31	10	the	the	DET
dpc-4547	31	11	face	face	NOUN
dpc-4547	31	12	,	,	PUNCT
dpc-4547	31	13	scalp	scalp	NOUN
dpc-4547	31	14	,	,	PUNCT
dpc-4547	31	15	head	head	NOUN
dpc-4547	31	16	and	and	CCONJ
dpc-4547	31	17	neck	neck	NOUN
dpc-4547	31	18	area	area	NOUN
dpc-4547	31	19	,	,	PUNCT
dpc-4547	31	20	hands	hand	NOUN
dpc-4547	31	21	,	,	PUNCT
dpc-4547	31	22	and	and	CCONJ
dpc-4547	31	23	forearms	forearm	NOUN
dpc-4547	31	24	,	,	PUNCT
dpc-4547	31	25	being	be	AUX
dpc-4547	31	26	exposed	expose	VERB
dpc-4547	31	27	to	to	ADP
dpc-4547	31	28	long	long	ADJ
dpc-4547	31	29	-	-	PUNCT
dpc-4547	31	30	term	term	NOUN
dpc-4547	31	31	ultraviolet	ultraviolet	NOUN
dpc-4547	31	32	(	(	PUNCT
dpc-4547	31	33	uv	uv	NOUN
dpc-4547	31	34	)	)	PUNCT
dpc-4547	31	35	radiation	radiation	NOUN
dpc-4547	31	36	(	(	PUNCT
dpc-4547	31	37	uvr	uvr	NOUN
dpc-4547	31	38	)	)	PUNCT
dpc-4547	31	39	over	over	ADP
dpc-4547	31	40	several	several	ADJ
dpc-4547	31	41	years	year	NOUN
dpc-4547	31	42	,	,	PUNCT
dpc-4547	31	43	usually	usually	ADV
dpc-4547	31	44	decades	decade	NOUN
dpc-4547	31	45	.	.	PUNCT
dpc-4547	32	1	uvr	uvr	VERB
dpc-4547	32	2	and	and	CCONJ
dpc-4547	32	3	especially	especially	ADV
dpc-4547	32	4	uv	uv	NOUN
dpc-4547	32	5	-	-	PUNCT
dpc-4547	32	6	b	b	NOUN
dpc-4547	32	7	radiation	radiation	NOUN
dpc-4547	32	8	(	(	PUNCT
dpc-4547	32	9	uvbr	uvbr	NOUN
dpc-4547	32	10	)	)	PUNCT
dpc-4547	32	11	causes	cause	VERB
dpc-4547	32	12	damage	damage	NOUN
dpc-4547	32	13	to	to	ADP
dpc-4547	32	14	the	the	DET
dpc-4547	32	15	skin	skin	NOUN
dpc-4547	32	16	and	and	CCONJ
dpc-4547	32	17	its	its	PRON
dpc-4547	32	18	keratinocytes	keratinocyte	NOUN
dpc-4547	32	19	at	at	ADP
dpc-4547	32	20	several	several	ADJ
dpc-4547	32	21	stages	stage	NOUN
dpc-4547	32	22	of	of	ADP
dpc-4547	32	23	cell	cell	NOUN
dpc-4547	32	24	regulation	regulation	NOUN
dpc-4547	32	25	and	and	CCONJ
dpc-4547	32	26	homeostasis	homeostasis	NOUN
dpc-4547	32	27	,	,	PUNCT
dpc-4547	32	28	underlined	underline	VERB
dpc-4547	32	29	by	by	ADP
dpc-4547	32	30	a	a	DET
dpc-4547	32	31	complex	complex	ADJ
dpc-4547	32	32	interplay	interplay	NOUN
dpc-4547	32	33	of	of	ADP
dpc-4547	32	34	local	local	ADJ
dpc-4547	32	35	immunosuppression	immunosuppression	NOUN
dpc-4547	32	36	,	,	PUNCT
dpc-4547	32	37	skin	skin	NOUN
dpc-4547	32	38	inflammation	inflammation	NOUN
dpc-4547	32	39	,	,	PUNCT
dpc-4547	32	40	oxidative	oxidative	ADJ
dpc-4547	32	41	stress	stress	NOUN
dpc-4547	32	42	and	and	CCONJ
dpc-4547	32	43	dna	dna	PROPN
dpc-4547	32	44	alteration	alteration	NOUN
dpc-4547	32	45	.	.	PUNCT
dpc-4547	33	1	clinically	clinically	ADV
dpc-4547	33	2	,	,	PUNCT
dpc-4547	33	3	ak	ak	PROPN
dpc-4547	33	4	is	be	AUX
dpc-4547	33	5	characterized	characterize	VERB
dpc-4547	33	6	by	by	ADP
dpc-4547	33	7	erythema	erythema	NOUN
dpc-4547	33	8	and	and	CCONJ
dpc-4547	33	9	scaling	scaling	NOUN
dpc-4547	33	10	.	.	PUNCT
dpc-4547	34	1	ak	ak	PROPN
dpc-4547	34	2	may	may	AUX
dpc-4547	34	3	appear	appear	VERB
dpc-4547	34	4	erosive	erosive	VERB
dpc-4547	34	5	or	or	CCONJ
dpc-4547	34	6	may	may	AUX
dpc-4547	34	7	be	be	AUX
dpc-4547	34	8	accompanied	accompany	VERB
dpc-4547	34	9	by	by	ADP
dpc-4547	34	10	itching	itching	NOUN
dpc-4547	34	11	,	,	PUNCT
dpc-4547	34	12	but	but	CCONJ
dpc-4547	34	13	usually	usually	ADV
dpc-4547	34	14	elderly	elderly	ADJ
dpc-4547	34	15	patients	patient	NOUN
dpc-4547	34	16	do	do	AUX
dpc-4547	34	17	not	not	PART
dpc-4547	34	18	consider	consider	VERB
dpc-4547	34	19	these	these	DET
dpc-4547	34	20	lesions	lesion	NOUN
dpc-4547	34	21	as	as	ADP
dpc-4547	34	22	harmful	harmful	ADJ
dpc-4547	34	23	,	,	PUNCT
dpc-4547	34	24	as	as	ADP
dpc-4547	34	25	ak	ak	PROPN
dpc-4547	34	26	progress	progress	NOUN
dpc-4547	34	27	or	or	CCONJ
dpc-4547	34	28	even	even	ADV
dpc-4547	34	29	regress	regress	NOUN
dpc-4547	34	30	slowly	slowly	ADV
dpc-4547	34	31	over	over	ADP
dpc-4547	34	32	time	time	NOUN
dpc-4547	34	33	.	.	PUNCT
dpc-4547	35	1	the	the	DET
dpc-4547	35	2	estimated	estimate	VERB
dpc-4547	35	3	prevalence	prevalence	NOUN
dpc-4547	35	4	of	of	ADP
dpc-4547	35	5	ak	ak	PROPN
dpc-4547	35	6	in	in	ADP
dpc-4547	35	7	the	the	DET
dpc-4547	35	8	group	group	NOUN
dpc-4547	35	9	of	of	ADP
dpc-4547	35	10	individuals	individual	NOUN
dpc-4547	35	11	being	be	AUX
dpc-4547	35	12	60	60	NUM
dpc-4547	35	13	years	year	NOUN
dpc-4547	35	14	of	of	ADP
dpc-4547	35	15	age	age	NOUN
dpc-4547	35	16	and	and	CCONJ
dpc-4547	35	17	older	old	ADJ
dpc-4547	35	18	is	be	AUX
dpc-4547	35	19	4.6	4.6	NUM
dpc-4547	35	20	-	-	SYM
dpc-4547	35	21	14.57	14.57	NUM
dpc-4547	35	22	%	%	NOUN
dpc-4547	35	23	[	[	X
dpc-4547	35	24	2	2	NUM
dpc-4547	35	25	]	]	PUNCT
dpc-4547	35	26	.	.	PUNCT
dpc-4547	36	1	moreover	moreover	ADV
dpc-4547	36	2	,	,	PUNCT
dpc-4547	36	3	the	the	DET
dpc-4547	36	4	male	male	ADJ
dpc-4547	36	5	population	population	NOUN
dpc-4547	36	6	is	be	AUX
dpc-4547	36	7	affected	affect	VERB
dpc-4547	36	8	at	at	ADP
dpc-4547	36	9	a	a	DET
dpc-4547	36	10	higher	high	ADJ
dpc-4547	36	11	rate	rate	NOUN
dpc-4547	36	12	of	of	ADP
dpc-4547	36	13	3.5	3.5	NUM
dpc-4547	36	14	%	%	NOUN
dpc-4547	36	15	compared	compare	VERB
dpc-4547	36	16	to	to	ADP
dpc-4547	36	17	females	female	NOUN
dpc-4547	36	18	(	(	PUNCT
dpc-4547	36	19	1.5	1.5	NUM
dpc-4547	36	20	%	%	NOUN
dpc-4547	36	21	)	)	PUNCT
dpc-4547	37	1	[	[	X
dpc-4547	37	2	3	3	NUM
dpc-4547	37	3	]	]	PUNCT
dpc-4547	37	4	.	.	PUNCT
dpc-4547	38	1	patients	patient	NOUN
dpc-4547	38	2	suffering	suffer	VERB
dpc-4547	38	3	from	from	ADP
dpc-4547	38	4	multiple	multiple	ADJ
dpc-4547	38	5	ak	ak	PROPN
dpc-4547	38	6	,	,	PUNCT
dpc-4547	38	7	face	face	VERB
dpc-4547	38	8	a	a	DET
dpc-4547	38	9	cumulative	cumulative	ADJ
dpc-4547	38	10	lifetime	lifetime	NOUN
dpc-4547	38	11	risk	risk	NOUN
dpc-4547	38	12	of	of	ADP
dpc-4547	38	13	6	6	NUM
dpc-4547	38	14	-	-	SYM
dpc-4547	38	15	10	10	NUM
dpc-4547	38	16	%	%	NOUN
dpc-4547	38	17	for	for	ADP
dpc-4547	38	18	malignant	malignant	ADJ
dpc-4547	38	19	transformation	transformation	NOUN
dpc-4547	38	20	into	into	ADP
dpc-4547	38	21	cscc	cscc	PROPN
dpc-4547	38	22	and	and	CCONJ
dpc-4547	38	23	the	the	DET
dpc-4547	38	24	annual	annual	ADJ
dpc-4547	38	25	risk	risk	NOUN
dpc-4547	38	26	for	for	ADP
dpc-4547	38	27	malignant	malignant	ADJ
dpc-4547	38	28	development	development	NOUN
dpc-4547	38	29	for	for	ADP
dpc-4547	38	30	a	a	DET
dpc-4547	38	31	single	single	ADJ
dpc-4547	38	32	ak	ak	PROPN
dpc-4547	38	33	lesion	lesion	NOUN
dpc-4547	38	34	ranges	range	VERB
dpc-4547	38	35	from	from	ADP
dpc-4547	38	36	0.03	0.03	NUM
dpc-4547	38	37	-	-	SYM
dpc-4547	38	38	20	20	NUM
dpc-4547	38	39	%	%	NOUN
dpc-4547	39	1	[	[	X
dpc-4547	39	2	4	4	NUM
dpc-4547	39	3	-	-	SYM
dpc-4547	39	4	6	6	NUM
dpc-4547	39	5	]	]	PUNCT
dpc-4547	39	6	.	.	PUNCT
dpc-4547	40	1	furthermore	furthermore	ADV
dpc-4547	40	2	,	,	PUNCT
dpc-4547	40	3	in	in	ADP
dpc-4547	40	4	up	up	ADP
dpc-4547	40	5	to	to	PART
dpc-4547	40	6	85	85	NUM
dpc-4547	40	7	%	%	NOUN
dpc-4547	40	8	of	of	ADP
dpc-4547	40	9	cases	case	NOUN
dpc-4547	40	10	of	of	ADP
dpc-4547	40	11	treated	treat	VERB
dpc-4547	40	12	ak	ak	PROPN
dpc-4547	40	13	,	,	PUNCT
dpc-4547	40	14	recurrence	recurrence	NOUN
dpc-4547	40	15	or	or	CCONJ
dpc-4547	40	16	manifestation	manifestation	NOUN
dpc-4547	40	17	of	of	ADP
dpc-4547	40	18	new	new	ADJ
dpc-4547	40	19	lesions	lesion	NOUN
dpc-4547	40	20	can	can	AUX
dpc-4547	40	21	be	be	AUX
dpc-4547	40	22	observed	observe	VERB
dpc-4547	40	23	after	after	ADP
dpc-4547	40	24	a	a	DET
dpc-4547	40	25	one	one	NUM
dpc-4547	40	26	-	-	PUNCT
dpc-4547	40	27	year	year	NOUN
dpc-4547	40	28	follow	follow	NOUN
dpc-4547	40	29	up	up	ADP
dpc-4547	40	30	,	,	PUNCT
dpc-4547	40	31	making	make	VERB
dpc-4547	40	32	ak	ak	PROPN
dpc-4547	40	33	a	a	DET
dpc-4547	40	34	chronic	chronic	ADJ
dpc-4547	40	35	and	and	CCONJ
dpc-4547	40	36	recurring	recur	VERB
dpc-4547	40	37	disease	disease	NOUN
dpc-4547	40	38	[	[	X
dpc-4547	40	39	7	7	NUM
dpc-4547	40	40	]	]	PUNCT
dpc-4547	40	41	.	.	PUNCT
dpc-4547	41	1	the	the	DET
dpc-4547	41	2	aging	age	VERB
dpc-4547	41	3	society	society	NOUN
dpc-4547	41	4	and	and	CCONJ
dpc-4547	41	5	the	the	DET
dpc-4547	41	6	high	high	ADJ
dpc-4547	41	7	rate	rate	NOUN
dpc-4547	41	8	of	of	ADP
dpc-4547	41	9	recurrence	recurrence	NOUN
dpc-4547	41	10	may	may	AUX
dpc-4547	41	11	partly	partly	ADV
dpc-4547	41	12	explain	explain	VERB
dpc-4547	41	13	,	,	PUNCT
dpc-4547	41	14	why	why	SCONJ
dpc-4547	41	15	the	the	DET
dpc-4547	41	16	treatment	treatment	NOUN
dpc-4547	41	17	of	of	ADP
dpc-4547	41	18	ak	ak	PROPN
dpc-4547	41	19	is	be	AUX
dpc-4547	41	20	considered	consider	VERB
dpc-4547	41	21	a	a	DET
dpc-4547	41	22	laborious	laborious	ADJ
dpc-4547	41	23	and	and	CCONJ
dpc-4547	41	24	costly	costly	ADJ
dpc-4547	41	25	task	task	NOUN
dpc-4547	41	26	,	,	PUNCT
dpc-4547	41	27	placing	place	VERB
dpc-4547	41	28	an	an	DET
dpc-4547	41	29	estimated	estimate	VERB
dpc-4547	41	30	financial	financial	ADJ
dpc-4547	41	31	burden	burden	NOUN
dpc-4547	41	32	on	on	ADP
dpc-4547	41	33	the	the	DET
dpc-4547	41	34	us	us	PROPN
dpc-4547	41	35	healthcare	healthcare	NOUN
dpc-4547	41	36	system	system	NOUN
dpc-4547	41	37	of	of	ADP
dpc-4547	41	38	nearly	nearly	ADV
dpc-4547	41	39	$	$	SYM
dpc-4547	41	40	1	1	NUM
dpc-4547	41	41	-	-	SYM
dpc-4547	41	42	1.68	1.68	NUM
dpc-4547	41	43	billion	billion	NUM
dpc-4547	41	44	annually	annually	ADV
dpc-4547	41	45	[	[	X
dpc-4547	41	46	8	8	NUM
dpc-4547	41	47	,	,	PUNCT
dpc-4547	41	48	9	9	NUM
dpc-4547	41	49	]	]	PUNCT
dpc-4547	41	50	.	.	PUNCT
dpc-4547	42	1	these	these	DET
dpc-4547	42	2	spendings	spending	NOUN
dpc-4547	42	3	cover	cover	VERB
dpc-4547	42	4	the	the	DET
dpc-4547	42	5	evaluation	evaluation	NOUN
dpc-4547	42	6	of	of	ADP
dpc-4547	42	7	almost	almost	ADV
dpc-4547	42	8	10	10	NUM
dpc-4547	42	9	million	million	NUM
dpc-4547	42	10	patients	patient	NOUN
dpc-4547	42	11	for	for	ADP
dpc-4547	42	12	actinic	actinic	ADJ
dpc-4547	42	13	skin	skin	NOUN
dpc-4547	42	14	damaged	damage	VERB
dpc-4547	42	15	,	,	PUNCT
dpc-4547	42	16	annually	annually	ADV
dpc-4547	42	17	[	[	X
dpc-4547	42	18	8	8	NUM
dpc-4547	42	19	]	]	X
dpc-4547	42	20	.	.	PUNCT
dpc-4547	43	1	respectively	respectively	ADV
dpc-4547	43	2	,	,	PUNCT
dpc-4547	43	3	the	the	DET
dpc-4547	43	4	costs	cost	NOUN
dpc-4547	43	5	for	for	ADP
dpc-4547	43	6	treatment	treatment	NOUN
dpc-4547	43	7	of	of	ADP
dpc-4547	43	8	ak	ak	PROPN
dpc-4547	43	9	and	and	CCONJ
dpc-4547	43	10	cscc	cscc	PROPN
dpc-4547	43	11	reached	reach	VERB
dpc-4547	43	12	an	an	DET
dpc-4547	43	13	enormous	enormous	ADJ
dpc-4547	43	14	amount	amount	NOUN
dpc-4547	43	15	of	of	ADP
dpc-4547	43	16	$	$	SYM
dpc-4547	43	17	4.59	4.59	NUM
dpc-4547	43	18	billion	billion	NUM
dpc-4547	43	19	for	for	ADP
dpc-4547	43	20	the	the	DET
dpc-4547	43	21	year	year	NOUN
dpc-4547	43	22	2013	2013	NUM
dpc-4547	43	23	and	and	CCONJ
dpc-4547	43	24	accounted	account	VERB
dpc-4547	43	25	for	for	ADP
dpc-4547	43	26	more	more	ADJ
dpc-4547	43	27	than	than	ADP
dpc-4547	43	28	15	15	NUM
dpc-4547	43	29	%	%	NOUN
dpc-4547	43	30	of	of	ADP
dpc-4547	43	31	health	health	NOUN
dpc-4547	43	32	care	care	NOUN
dpc-4547	43	33	spendings	spending	NOUN
dpc-4547	43	34	related	relate	VERB
dpc-4547	43	35	to	to	ADP
dpc-4547	43	36	skin	skin	NOUN
dpc-4547	43	37	disease	disease	NOUN
dpc-4547	43	38	treatment	treatment	NOUN
dpc-4547	43	39	[	[	X
dpc-4547	43	40	8	8	NUM
dpc-4547	43	41	]	]	PUNCT
dpc-4547	43	42	.	.	PUNCT
dpc-4547	44	1	however	however	ADV
dpc-4547	44	2	,	,	PUNCT
dpc-4547	44	3	treatment	treatment	NOUN
dpc-4547	44	4	of	of	ADP
dpc-4547	44	5	cscc	cscc	PROPN
dpc-4547	44	6	remains	remain	VERB
dpc-4547	44	7	significantly	significantly	ADV
dpc-4547	44	8	more	more	ADV
dpc-4547	44	9	costly	costly	ADJ
dpc-4547	44	10	per	per	ADP
dpc-4547	44	11	year	year	NOUN
dpc-4547	44	12	than	than	ADP
dpc-4547	44	13	treatment	treatment	NOUN
dpc-4547	44	14	of	of	ADP
dpc-4547	44	15	ak	ak	PROPN
dpc-4547	44	16	(	(	PUNCT
dpc-4547	44	17	$	$	SYM
dpc-4547	44	18	791	791	NUM
dpc-4547	44	19	vs.	vs.	ADP
dpc-4547	44	20	$	$	SYM
dpc-4547	44	21	143	143	NUM
dpc-4547	44	22	)	)	PUNCT
dpc-4547	45	1	[	[	X
dpc-4547	45	2	10	10	NUM
dpc-4547	45	3	]	]	PUNCT
dpc-4547	45	4	.	.	PUNCT
dpc-4547	46	1	this	this	DET
dpc-4547	46	2	burden	burden	NOUN
dpc-4547	46	3	may	may	AUX
dpc-4547	46	4	increase	increase	VERB
dpc-4547	46	5	in	in	ADP
dpc-4547	46	6	an	an	DET
dpc-4547	46	7	aging	age	VERB
dpc-4547	46	8	society	society	NOUN
dpc-4547	46	9	and	and	CCONJ
dpc-4547	46	10	is	be	AUX
dpc-4547	46	11	supported	support	VERB
dpc-4547	46	12	by	by	ADP
dpc-4547	46	13	the	the	DET
dpc-4547	46	14	fact	fact	NOUN
dpc-4547	46	15	that	that	SCONJ
dpc-4547	46	16	the	the	DET
dpc-4547	46	17	incidence	incidence	NOUN
dpc-4547	46	18	of	of	ADP
dpc-4547	46	19	cscc	cscc	PROPN
dpc-4547	46	20	has	have	AUX
dpc-4547	46	21	partly	partly	ADV
dpc-4547	46	22	quadrupled	quadruple	VERB
dpc-4547	46	23	in	in	ADP
dpc-4547	46	24	the	the	DET
dpc-4547	46	25	last	last	ADJ
dpc-4547	46	26	30	30	NUM
dpc-4547	46	27	years	year	NOUN
dpc-4547	46	28	among	among	ADP
dpc-4547	46	29	the	the	DET
dpc-4547	46	30	population	population	NOUN
dpc-4547	46	31	in	in	ADP
dpc-4547	46	32	germany	germany	PROPN
dpc-4547	47	1	[	[	X
dpc-4547	47	2	11	11	NUM
dpc-4547	47	3	]	]	PUNCT
dpc-4547	47	4	.	.	PUNCT
dpc-4547	48	1	moreover	moreover	ADV
dpc-4547	48	2	,	,	PUNCT
dpc-4547	48	3	for	for	ADP
dpc-4547	48	4	the	the	DET
dpc-4547	48	5	year	year	NOUN
dpc-4547	48	6	2030	2030	NUM
dpc-4547	48	7	,	,	PUNCT
dpc-4547	48	8	leiter	leiter	PROPN
dpc-4547	48	9	et	et	PROPN
dpc-4547	48	10	al	al	PROPN
dpc-4547	48	11	.	.	PROPN
dpc-4547	48	12	predict	predict	VERB
dpc-4547	48	13	that	that	SCONJ
dpc-4547	48	14	,	,	PUNCT
dpc-4547	48	15	the	the	DET
dpc-4547	48	16	incidence	incidence	NOUN
dpc-4547	48	17	rate	rate	NOUN
dpc-4547	48	18	of	of	ADP
dpc-4547	48	19	nmsc	nmsc	NOUN
dpc-4547	48	20	will	will	AUX
dpc-4547	48	21	double	double	VERB
dpc-4547	48	22	again	again	ADV
dpc-4547	48	23	,	,	PUNCT
dpc-4547	48	24	with	with	ADP
dpc-4547	48	25	a	a	DET
dpc-4547	48	26	continuous	continuous	ADJ
dpc-4547	48	27	long	long	ADJ
dpc-4547	48	28	-	-	PUNCT
dpc-4547	48	29	term	term	NOUN
dpc-4547	48	30	trend	trend	NOUN
dpc-4547	48	31	in	in	ADP
dpc-4547	48	32	increasing	increase	VERB
dpc-4547	48	33	incidence	incidence	NOUN
dpc-4547	48	34	[	[	X
dpc-4547	48	35	12	12	NUM
dpc-4547	48	36	]	]	PUNCT
dpc-4547	48	37	.	.	PUNCT
dpc-4547	49	1	the	the	DET
dpc-4547	49	2	estimated	estimate	VERB
dpc-4547	49	3	age	age	NOUN
dpc-4547	49	4	-	-	PUNCT
dpc-4547	49	5	standardized	standardize	VERB
dpc-4547	49	6	incidence	incidence	NOUN
dpc-4547	49	7	rates	rate	NOUN
dpc-4547	49	8	are	be	AUX
dpc-4547	49	9	230	230	NUM
dpc-4547	49	10	for	for	ADP
dpc-4547	49	11	males	male	NOUN
dpc-4547	49	12	and	and	CCONJ
dpc-4547	49	13	180	180	NUM
dpc-4547	49	14	-	-	PUNCT
dpc-4547	49	15	200/100.000	200/100.000	NUM
dpc-4547	49	16	cases	case	NOUN
dpc-4547	49	17	for	for	ADP
dpc-4547	49	18	females	female	NOUN
dpc-4547	49	19	per	per	ADP
dpc-4547	49	20	annum	annum	NOUN
dpc-4547	49	21	in	in	ADP
dpc-4547	49	22	the	the	DET
dpc-4547	49	23	year	year	NOUN
dpc-4547	49	24	2030	2030	NUM
dpc-4547	50	1	[	[	X
dpc-4547	50	2	12	12	NUM
dpc-4547	50	3	]	]	PUNCT
dpc-4547	50	4	.	.	PUNCT
dpc-4547	51	1	the	the	DET
dpc-4547	51	2	chronic	chronic	ADJ
dpc-4547	51	3	course	course	NOUN
dpc-4547	51	4	of	of	ADP
dpc-4547	51	5	ak	ak	PROPN
dpc-4547	51	6	disease	disease	NOUN
dpc-4547	51	7	,	,	PUNCT
dpc-4547	51	8	including	include	VERB
dpc-4547	51	9	spontaneous	spontaneous	ADJ
dpc-4547	51	10	regression	regression	NOUN
dpc-4547	51	11	,	,	PUNCT
dpc-4547	51	12	but	but	CCONJ
dpc-4547	51	13	also	also	ADV
dpc-4547	51	14	progression	progression	NOUN
dpc-4547	51	15	from	from	ADP
dpc-4547	51	16	sun	sun	NOUN
dpc-4547	51	17	damaged	damage	VERB
dpc-4547	51	18	actinic	actinic	ADJ
dpc-4547	51	19	skin	skin	NOUN
dpc-4547	51	20	,	,	PUNCT
dpc-4547	51	21	has	have	VERB
dpc-4547	51	22	influence	influence	NOUN
dpc-4547	51	23	on	on	ADP
dpc-4547	51	24	the	the	DET
dpc-4547	51	25	quality	quality	NOUN
dpc-4547	51	26	of	of	ADP
dpc-4547	51	27	life	life	NOUN
dpc-4547	51	28	(	(	PUNCT
dpc-4547	51	29	qol	qol	NOUN
dpc-4547	51	30	)	)	PUNCT
dpc-4547	51	31	in	in	ADP
dpc-4547	51	32	several	several	ADJ
dpc-4547	51	33	aspects	aspect	NOUN
dpc-4547	51	34	,	,	PUNCT
dpc-4547	51	35	including	include	VERB
dpc-4547	51	36	fear	fear	NOUN
dpc-4547	51	37	about	about	ADP
dpc-4547	51	38	cscc	cscc	ADJ
dpc-4547	51	39	manifestation	manifestation	NOUN
dpc-4547	51	40	,	,	PUNCT
dpc-4547	51	41	cosmesis	cosmesis	NOUN
dpc-4547	51	42	and	and	CCONJ
dpc-4547	51	43	clinical	clinical	ADJ
dpc-4547	51	44	symptoms	symptom	NOUN
dpc-4547	51	45	[	[	X
dpc-4547	51	46	13	13	NUM
dpc-4547	51	47	]	]	PUNCT
dpc-4547	51	48	.	.	PUNCT
dpc-4547	52	1	as	as	SCONJ
dpc-4547	52	2	ak	ak	PROPN
dpc-4547	52	3	is	be	AUX
dpc-4547	52	4	considered	consider	VERB
dpc-4547	52	5	a	a	DET
dpc-4547	52	6	chronic	chronic	ADJ
dpc-4547	52	7	disease	disease	NOUN
dpc-4547	52	8	,	,	PUNCT
dpc-4547	52	9	qol	qol	PROPN
dpc-4547	52	10	scores	score	NOUN
dpc-4547	52	11	of	of	ADP
dpc-4547	52	12	those	those	DET
dpc-4547	52	13	patients	patient	NOUN
dpc-4547	52	14	are	be	AUX
dpc-4547	52	15	comparable	comparable	ADJ
dpc-4547	52	16	to	to	ADP
dpc-4547	52	17	scores	score	NOUN
dpc-4547	52	18	of	of	ADP
dpc-4547	52	19	patients	patient	NOUN
dpc-4547	52	20	suffering	suffer	VERB
dpc-4547	52	21	from	from	ADP
dpc-4547	52	22	other	other	ADJ
dpc-4547	52	23	chronic	chronic	ADJ
dpc-4547	52	24	skin	skin	NOUN
dpc-4547	52	25	conditions	condition	NOUN
dpc-4547	52	26	,	,	PUNCT
dpc-4547	52	27	such	such	ADJ
dpc-4547	52	28	as	as	ADP
dpc-4547	52	29	atopic	atopic	NOUN
dpc-4547	52	30	dermatitis	dermatitis	NOUN
dpc-4547	52	31	and	and	CCONJ
dpc-4547	52	32	psoriasis	psoriasis	NOUN
dpc-4547	52	33	and	and	CCONJ
dpc-4547	52	34	are	be	AUX
dpc-4547	52	35	remarkably	remarkably	ADV
dpc-4547	52	36	lower	low	ADJ
dpc-4547	52	37	compared	compare	VERB
dpc-4547	52	38	to	to	ADP
dpc-4547	52	39	patients	patient	NOUN
dpc-4547	52	40	without	without	ADP
dpc-4547	52	41	ak	ak	PROPN
dpc-4547	52	42	[	[	X
dpc-4547	52	43	13	13	NUM
dpc-4547	52	44	-	-	SYM
dpc-4547	52	45	15	15	NUM
dpc-4547	52	46	]	]	PUNCT
dpc-4547	52	47	.	.	PUNCT
dpc-4547	53	1	interestingly	interestingly	ADV
dpc-4547	53	2	,	,	PUNCT
dpc-4547	53	3	the	the	DET
dpc-4547	53	4	number	number	NOUN
dpc-4547	53	5	of	of	ADP
dpc-4547	53	6	ak	ak	PROPN
dpc-4547	53	7	correlates	correlate	VERB
dpc-4547	53	8	inversely	inversely	ADV
dpc-4547	53	9	with	with	ADP
dpc-4547	53	10	the	the	DET
dpc-4547	53	11	qol	qol	PROPN
dpc-4547	53	12	scores	score	NOUN
dpc-4547	53	13	of	of	ADP
dpc-4547	53	14	patients	patient	NOUN
dpc-4547	53	15	and	and	CCONJ
dpc-4547	53	16	may	may	AUX
dpc-4547	53	17	cause	cause	VERB
dpc-4547	53	18	a	a	DET
dpc-4547	53	19	high	high	ADJ
dpc-4547	53	20	sense	sense	NOUN
dpc-4547	53	21	of	of	ADP
dpc-4547	53	22	affliction	affliction	NOUN
dpc-4547	53	23	in	in	ADP
dpc-4547	53	24	patients	patient	NOUN
dpc-4547	53	25	with	with	ADP
dpc-4547	53	26	multiple	multiple	ADJ
dpc-4547	53	27	ak	ak	PROPN
dpc-4547	53	28	,	,	PUNCT
dpc-4547	53	29	field	field	NOUN
dpc-4547	53	30	cancerization	cancerization	NOUN
dpc-4547	53	31	(	(	PUNCT
dpc-4547	53	32	fc	fc	INTJ
dpc-4547	53	33	)	)	PUNCT
dpc-4547	53	34	or	or	CCONJ
dpc-4547	53	35	recurring	recur	VERB
dpc-4547	53	36	disease	disease	NOUN
dpc-4547	53	37	[	[	X
dpc-4547	53	38	13	13	NUM
dpc-4547	53	39	,	,	PUNCT
dpc-4547	53	40	14	14	NUM
dpc-4547	53	41	,	,	PUNCT
dpc-4547	53	42	16	16	NUM
dpc-4547	53	43	,	,	PUNCT
dpc-4547	53	44	17	17	NUM
dpc-4547	53	45	]	]	PUNCT
dpc-4547	53	46	.	.	PUNCT
dpc-4547	54	1	moreover	moreover	ADV
dpc-4547	54	2	,	,	PUNCT
dpc-4547	54	3	disease	disease	NOUN
dpc-4547	54	4	burden	burden	NOUN
dpc-4547	54	5	regarding	regard	VERB
dpc-4547	54	6	lower	low	ADJ
dpc-4547	54	7	qol	qol	PROPN
dpc-4547	54	8	scores	score	NOUN
dpc-4547	54	9	is	be	AUX
dpc-4547	54	10	significantly	significantly	ADV
dpc-4547	54	11	higher	high	ADJ
dpc-4547	54	12	in	in	ADP
dpc-4547	54	13	female	female	ADJ
dpc-4547	54	14	patients	patient	NOUN
dpc-4547	54	15	and	and	CCONJ
dpc-4547	54	16	patients	patient	NOUN
dpc-4547	54	17	younger	young	ADJ
dpc-4547	54	18	than	than	ADP
dpc-4547	54	19	60	60	NUM
dpc-4547	54	20	years	year	NOUN
dpc-4547	54	21	of	of	ADP
dpc-4547	54	22	age	age	NOUN
dpc-4547	54	23	[	[	X
dpc-4547	54	24	18	18	NUM
dpc-4547	54	25	,	,	PUNCT
dpc-4547	54	26	19	19	NUM
dpc-4547	54	27	]	]	PUNCT
dpc-4547	54	28	.	.	PUNCT
dpc-4547	55	1	for	for	ADP
dpc-4547	55	2	the	the	DET
dpc-4547	55	3	reasons	reason	NOUN
dpc-4547	55	4	named	name	VERB
dpc-4547	55	5	,	,	PUNCT
dpc-4547	55	6	the	the	DET
dpc-4547	55	7	complex	complex	ADJ
dpc-4547	55	8	management	management	NOUN
dpc-4547	55	9	of	of	ADP
dpc-4547	55	10	ak	ak	PROPN
dpc-4547	55	11	,	,	PUNCT
dpc-4547	55	12	placing	place	VERB
dpc-4547	55	13	an	an	DET
dpc-4547	55	14	immense	immense	ADJ
dpc-4547	55	15	financial	financial	ADJ
dpc-4547	55	16	burden	burden	NOUN
dpc-4547	55	17	on	on	ADP
dpc-4547	55	18	health	health	NOUN
dpc-4547	55	19	care	care	NOUN
dpc-4547	55	20	providers	provider	NOUN
dpc-4547	55	21	and	and	CCONJ
dpc-4547	55	22	psychological	psychological	ADJ
dpc-4547	55	23	stress	stress	NOUN
dpc-4547	55	24	on	on	ADP
dpc-4547	55	25	diseased	diseased	ADJ
dpc-4547	55	26	individuals	individual	NOUN
dpc-4547	55	27	,	,	PUNCT
dpc-4547	55	28	requires	require	VERB
dpc-4547	55	29	improved	improved	ADJ
dpc-4547	55	30	strategies	strategy	NOUN
dpc-4547	55	31	for	for	ADP
dpc-4547	55	32	ak	ak	PROPN
dpc-4547	55	33	and	and	CCONJ
dpc-4547	55	34	cscc	cscc	ADJ
dpc-4547	55	35	prevention	prevention	NOUN
dpc-4547	55	36	as	as	ADV
dpc-4547	55	37	well	well	ADV
dpc-4547	55	38	as	as	ADP
dpc-4547	55	39	adequate	adequate	ADJ
dpc-4547	55	40	treatment	treatment	NOUN
dpc-4547	55	41	strategies	strategy	NOUN
dpc-4547	55	42	.	.	PUNCT
dpc-4547	56	1	this	this	DET
dpc-4547	56	2	section	section	NOUN
dpc-4547	56	3	will	will	AUX
dpc-4547	56	4	discuss	discuss	VERB
dpc-4547	56	5	the	the	DET
dpc-4547	56	6	identification	identification	NOUN
dpc-4547	56	7	of	of	ADP
dpc-4547	56	8	possible	possible	ADJ
dpc-4547	56	9	risk	risk	NOUN
dpc-4547	56	10	factors	factor	NOUN
dpc-4547	56	11	in	in	ADP
dpc-4547	56	12	ak	ak	PROPN
dpc-4547	56	13	for	for	ADP
dpc-4547	56	14	early	early	ADJ
dpc-4547	56	15	adequate	adequate	ADJ
dpc-4547	56	16	therapy	therapy	NOUN
dpc-4547	56	17	referral	referral	NOUN
dpc-4547	56	18	,	,	PUNCT
dpc-4547	56	19	as	as	ADV
dpc-4547	56	20	well	well	ADV
dpc-4547	56	21	as	as	ADP
dpc-4547	56	22	insights	insight	NOUN
dpc-4547	56	23	into	into	ADP
dpc-4547	56	24	recent	recent	ADJ
dpc-4547	56	25	approaches	approach	NOUN
dpc-4547	56	26	for	for	ADP
dpc-4547	56	27	therapy	therapy	NOUN
dpc-4547	56	28	monitoring	monitoring	NOUN
dpc-4547	56	29	.	.	PUNCT
dpc-4547	57	1	especially	especially	ADV
dpc-4547	57	2	the	the	DET
dpc-4547	57	3	quantification	quantification	NOUN
dpc-4547	57	4	of	of	ADP
dpc-4547	57	5	objectifiable	objectifiable	ADJ
dpc-4547	57	6	treatment	treatment	NOUN
dpc-4547	57	7	response	response	NOUN
dpc-4547	57	8	parameters	parameter	NOUN
dpc-4547	57	9	may	may	AUX
dpc-4547	57	10	become	become	VERB
dpc-4547	57	11	substantial	substantial	ADJ
dpc-4547	57	12	,	,	PUNCT
dpc-4547	57	13	as	as	SCONJ
dpc-4547	57	14	detection	detection	NOUN
dpc-4547	57	15	of	of	ADP
dpc-4547	57	16	non	non	ADJ
dpc-4547	57	17	-	-	ADJ
dpc-4547	57	18	responding	respond	VERB
dpc-4547	57	19	lesions	lesion	NOUN
dpc-4547	57	20	and	and	CCONJ
dpc-4547	57	21	reduction	reduction	NOUN
dpc-4547	57	22	of	of	ADP
dpc-4547	57	23	malignant	malignant	ADJ
dpc-4547	57	24	transformation	transformation	NOUN
dpc-4547	57	25	in	in	ADP
dpc-4547	57	26	ak	ak	PROPN
dpc-4547	57	27	should	should	AUX
dpc-4547	57	28	remain	remain	VERB
dpc-4547	57	29	primary	primary	ADJ
dpc-4547	57	30	goals	goal	NOUN
dpc-4547	57	31	in	in	ADP
dpc-4547	57	32	the	the	DET
dpc-4547	57	33	handling	handling	NOUN
dpc-4547	57	34	of	of	ADP
dpc-4547	57	35	ak	ak	PROPN
dpc-4547	57	36	.	.	PROPN
dpc-4547	57	37	pathogenesis	pathogenesis	PROPN
dpc-4547	57	38	of	of	ADP
dpc-4547	57	39	ak	ak	PROPN
dpc-4547	57	40	and	and	CCONJ
dpc-4547	57	41	histological	histological	ADJ
dpc-4547	57	42	risk	risk	NOUN
dpc-4547	57	43	factors	factor	NOUN
dpc-4547	57	44	for	for	ADP
dpc-4547	57	45	development	development	NOUN
dpc-4547	57	46	of	of	ADP
dpc-4547	57	47	cscc	cscc	ADJ
dpc-4547	57	48	the	the	DET
dpc-4547	57	49	development	development	NOUN
dpc-4547	57	50	of	of	ADP
dpc-4547	57	51	ak	ak	PROPN
dpc-4547	57	52	and	and	CCONJ
dpc-4547	57	53	the	the	DET
dpc-4547	57	54	progression	progression	NOUN
dpc-4547	57	55	into	into	ADP
dpc-4547	57	56	invasive	invasive	ADJ
dpc-4547	57	57	cscc	cscc	NOUN
dpc-4547	57	58	is	be	AUX
dpc-4547	57	59	multifactorial	multifactorial	ADJ
dpc-4547	57	60	and	and	CCONJ
dpc-4547	57	61	is	be	AUX
dpc-4547	57	62	driven	drive	VERB
dpc-4547	57	63	by	by	ADP
dpc-4547	57	64	a	a	DET
dpc-4547	57	65	variety	variety	NOUN
dpc-4547	57	66	of	of	ADP
dpc-4547	57	67	endogenous	endogenous	ADJ
dpc-4547	57	68	and	and	CCONJ
dpc-4547	57	69	exogenous	exogenous	ADJ
dpc-4547	57	70	factors	factor	NOUN
dpc-4547	57	71	.	.	PUNCT
dpc-4547	58	1	sunlight	sunlight	NOUN
dpc-4547	58	2	,	,	PUNCT
dpc-4547	58	3	and	and	CCONJ
dpc-4547	58	4	especially	especially	ADV
dpc-4547	58	5	uvrb	uvrb	NOUN
dpc-4547	58	6	,	,	PUNCT
dpc-4547	58	7	was	be	AUX
dpc-4547	58	8	identified	identify	VERB
dpc-4547	58	9	as	as	ADP
dpc-4547	58	10	a	a	DET
dpc-4547	58	11	carcinogen	carcinogen	NOUN
dpc-4547	58	12	for	for	ADP
dpc-4547	58	13	its	its	PRON
dpc-4547	58	14	ability	ability	NOUN
dpc-4547	58	15	to	to	PART
dpc-4547	58	16	mutate	mutate	VERB
dpc-4547	58	17	tp53	tp53	PROPN
dpc-4547	58	18	[	[	X
dpc-4547	58	19	20	20	NUM
dpc-4547	58	20	,	,	PUNCT
dpc-4547	58	21	21	21	NUM
dpc-4547	58	22	]	]	PUNCT
dpc-4547	58	23	.	.	PUNCT
dpc-4547	59	1	on	on	ADP
dpc-4547	59	2	gene	gene	NOUN
dpc-4547	59	3	level	level	NOUN
dpc-4547	59	4	,	,	PUNCT
dpc-4547	59	5	tp53	tp53	PROPN
dpc-4547	59	6	functions	function	NOUN
dpc-4547	59	7	as	as	ADP
dpc-4547	59	8	a	a	DET
dpc-4547	59	9	tumor	tumor	NOUN
dpc-4547	59	10	suppressor	suppressor	NOUN
dpc-4547	59	11	gene	gene	NOUN
dpc-4547	59	12	in	in	ADP
dpc-4547	59	13	the	the	DET
dpc-4547	59	14	human	human	ADJ
dpc-4547	59	15	genome	genome	NOUN
dpc-4547	59	16	,	,	PUNCT
dpc-4547	59	17	which	which	PRON
dpc-4547	59	18	controls	control	VERB
dpc-4547	59	19	various	various	ADJ
dpc-4547	59	20	cell	cell	NOUN
dpc-4547	59	21	cycle	cycle	NOUN
dpc-4547	59	22	mechanisms	mechanism	NOUN
dpc-4547	59	23	and	and	CCONJ
dpc-4547	59	24	is	be	AUX
dpc-4547	59	25	of	of	ADP
dpc-4547	59	26	importance	importance	NOUN
dpc-4547	59	27	in	in	ADP
dpc-4547	59	28	the	the	DET
dpc-4547	59	29	regulation	regulation	NOUN
dpc-4547	59	30	of	of	ADP
dpc-4547	59	31	cell	cell	NOUN
dpc-4547	59	32	proliferation	proliferation	NOUN
dpc-4547	59	33	and	and	CCONJ
dpc-4547	59	34	induction	induction	NOUN
dpc-4547	59	35	of	of	ADP
dpc-4547	59	36	apoptosis	apoptosis	NOUN
dpc-4547	59	37	in	in	ADP
dpc-4547	59	38	mutated	mutate	VERB
dpc-4547	59	39	cells	cell	NOUN
dpc-4547	59	40	[	[	X
dpc-4547	59	41	21	21	NUM
dpc-4547	59	42	,	,	PUNCT
dpc-4547	59	43	22	22	NUM
dpc-4547	59	44	]	]	PUNCT
dpc-4547	59	45	.	.	PUNCT
dpc-4547	60	1	additionally	additionally	ADV
dpc-4547	60	2	,	,	PUNCT
dpc-4547	60	3	uvb	uvb	ADJ
dpc-4547	60	4	irradiation	irradiation	NOUN
dpc-4547	60	5	of	of	ADP
dpc-4547	60	6	the	the	DET
dpc-4547	60	7	skin	skin	NOUN
dpc-4547	60	8	initiates	initiate	VERB
dpc-4547	60	9	production	production	NOUN
dpc-4547	60	10	of	of	ADP
dpc-4547	60	11	pro	pro	ADJ
dpc-4547	60	12	-	-	ADJ
dpc-4547	60	13	inflammatory	inflammatory	ADJ
dpc-4547	60	14	cytokines	cytokine	NOUN
dpc-4547	60	15	in	in	ADP
dpc-4547	60	16	keratinocytes	keratinocyte	NOUN
dpc-4547	60	17	,	,	PUNCT
dpc-4547	60	18	those	those	PRON
dpc-4547	60	19	include	include	VERB
dpc-4547	60	20	il-1	il-1	NOUN
dpc-4547	60	21	,	,	PUNCT
dpc-4547	60	22	il-6	il-6	NUM
dpc-4547	60	23	,	,	PUNCT
dpc-4547	60	24	il-8	il-8	NOUN
dpc-4547	60	25	,	,	PUNCT
dpc-4547	60	26	interferon	interferon	ADJ
dpc-4547	60	27	gamma	gamma	NOUN
dpc-4547	60	28	(	(	PUNCT
dpc-4547	60	29	ifn	ifn	PROPN
dpc-4547	60	30	-	-	PUNCT
dpc-4547	60	31	γ	γ	NOUN
dpc-4547	60	32	)	)	PUNCT
dpc-4547	60	33	,	,	PUNCT
dpc-4547	60	34	granulocyte	granulocyte	ADJ
dpc-4547	60	35	colony	colony	NOUN
dpc-4547	60	36	-	-	PUNCT
dpc-4547	60	37	stimulating	stimulate	VERB
dpc-4547	60	38	factor	factor	NOUN
dpc-4547	60	39	(	(	PUNCT
dpc-4547	60	40	c	c	NOUN
dpc-4547	60	41	-	-	PUNCT
dpc-4547	60	42	gsf	gsf	NOUN
dpc-4547	60	43	)	)	PUNCT
dpc-4547	60	44	,	,	PUNCT
dpc-4547	60	45	macrophage	macrophage	ADJ
dpc-4547	60	46	inflammatory	inflammatory	ADJ
dpc-4547	60	47	protein	protein	NOUN
dpc-4547	60	48	(	(	PUNCT
dpc-4547	60	49	mip	mip	NOUN
dpc-4547	60	50	-	-	PUNCT
dpc-4547	60	51	β	β	NOUN
dpc-4547	60	52	)	)	PUNCT
dpc-4547	60	53	and	and	CCONJ
dpc-4547	60	54	tumor	tumor	NOUN
dpc-4547	60	55	necrosis	necrosis	NOUN
dpc-4547	60	56	factor	factor	NOUN
dpc-4547	60	57	alpha	alpha	NOUN
dpc-4547	60	58	(	(	PUNCT
dpc-4547	60	59	tnf	tnf	PROPN
dpc-4547	60	60	-	-	PUNCT
dpc-4547	60	61	α	α	NOUN
dpc-4547	60	62	)	)	PUNCT
dpc-4547	61	1	[	[	X
dpc-4547	61	2	23	23	NUM
dpc-4547	61	3	]	]	PUNCT
dpc-4547	61	4	.	.	PUNCT
dpc-4547	62	1	together	together	ADV
dpc-4547	62	2	with	with	ADP
dpc-4547	62	3	other	other	ADJ
dpc-4547	62	4	neuroand	neuroand	ADJ
dpc-4547	62	5	vasoactive	vasoactive	ADJ
dpc-4547	62	6	mediators	mediator	NOUN
dpc-4547	62	7	this	this	DET
dpc-4547	62	8	inflammation	inflammation	NOUN
dpc-4547	62	9	causes	cause	VERB
dpc-4547	62	10	“	"	PUNCT
dpc-4547	62	11	sunburn	sunburn	NOUN
dpc-4547	62	12	”	"	PUNCT
dpc-4547	62	13	within	within	ADP
dpc-4547	62	14	24	24	NUM
dpc-4547	62	15	hours	hour	NOUN
dpc-4547	62	16	of	of	ADP
dpc-4547	62	17	exposure	exposure	NOUN
dpc-4547	62	18	[	[	X
dpc-4547	62	19	24	24	NUM
dpc-4547	62	20	]	]	PUNCT
dpc-4547	62	21	.	.	PUNCT
dpc-4547	63	1	uvr	uvr	PROPN
dpc-4547	63	2	is	be	AUX
dpc-4547	63	3	reported	report	VERB
dpc-4547	63	4	to	to	PART
dpc-4547	63	5	cause	cause	VERB
dpc-4547	63	6	formation	formation	NOUN
dpc-4547	63	7	of	of	ADP
dpc-4547	63	8	reactive	reactive	ADJ
dpc-4547	63	9	oxygen	oxygen	NOUN
dpc-4547	63	10	species	specie	NOUN
dpc-4547	63	11	(	(	PUNCT
dpc-4547	63	12	ros	ros	PROPN
dpc-4547	63	13	)	)	PUNCT
dpc-4547	63	14	in	in	ADP
dpc-4547	63	15	the	the	DET
dpc-4547	63	16	skin	skin	NOUN
dpc-4547	63	17	,	,	PUNCT
dpc-4547	63	18	such	such	ADJ
dpc-4547	63	19	as	as	ADP
dpc-4547	63	20	hydroxide	hydroxide	ADJ
dpc-4547	63	21	peroxide	peroxide	NOUN
dpc-4547	63	22	and	and	CCONJ
dpc-4547	63	23	other	other	ADJ
dpc-4547	63	24	hydroxyl	hydroxyl	NOUN
dpc-4547	63	25	radicals	radical	NOUN
dpc-4547	63	26	[	[	X
dpc-4547	63	27	25	25	NUM
dpc-4547	63	28	]	]	PUNCT
dpc-4547	63	29	.	.	PUNCT
dpc-4547	64	1	as	as	SCONJ
dpc-4547	64	2	dna	dna	PROPN
dpc-4547	64	3	nucleotides	nucleotide	NOUN
dpc-4547	64	4	targeted	target	VERB
dpc-4547	64	5	by	by	ADP
dpc-4547	64	6	ros	ros	PROPN
dpc-4547	64	7	are	be	AUX
dpc-4547	64	8	highly	highly	ADV
dpc-4547	64	9	susceptible	susceptible	ADJ
dpc-4547	64	10	to	to	ADP
dpc-4547	64	11	mutagenesis	mutagenesis	NOUN
dpc-4547	64	12	,	,	PUNCT
dpc-4547	64	13	a	a	DET
dpc-4547	64	14	well	well	ADV
dpc-4547	64	15	-	-	PUNCT
dpc-4547	64	16	characterized	characterize	VERB
dpc-4547	64	17	nucleotide	nucleotide	NOUN
dpc-4547	64	18	mispairing	mispairing	NOUN
dpc-4547	64	19	found	find	VERB
dpc-4547	64	20	in	in	ADP
dpc-4547	64	21	dna	dna	NOUN
dpc-4547	64	22	of	of	ADP
dpc-4547	64	23	sun	sun	NOUN
dpc-4547	64	24	damaged	damage	VERB
dpc-4547	64	25	skin	skin	NOUN
dpc-4547	64	26	is	be	AUX
dpc-4547	64	27	the	the	DET
dpc-4547	64	28	change	change	NOUN
dpc-4547	64	29	of	of	ADP
dpc-4547	64	30	g	g	PROPN
dpc-4547	64	31	/	/	SYM
dpc-4547	64	32	c	c	NOUN
dpc-4547	64	33	pair	pair	NOUN
dpc-4547	64	34	into	into	ADP
dpc-4547	64	35	an	an	DET
dpc-4547	64	36	a	a	NOUN
dpc-4547	64	37	/	/	SYM
dpc-4547	64	38	t	t	NOUN
dpc-4547	64	39	pair	pair	NOUN
dpc-4547	65	1	[	[	X
dpc-4547	65	2	26	26	NUM
dpc-4547	65	3	]	]	PUNCT
dpc-4547	65	4	.	.	PUNCT
dpc-4547	66	1	nadph	nadph	ADJ
dpc-4547	66	2	-	-	PUNCT
dpc-4547	66	3	dependent	dependent	ADJ
dpc-4547	66	4	dna	dna	PROPN
dpc-4547	66	5	repair	repair	NOUN
dpc-4547	66	6	mechanism	mechanism	NOUN
dpc-4547	66	7	play	play	VERB
dpc-4547	66	8	a	a	DET
dpc-4547	66	9	pivotal	pivotal	ADJ
dpc-4547	66	10	role	role	NOUN
dpc-4547	66	11	in	in	ADP
dpc-4547	66	12	keratinocytes	keratinocyte	NOUN
dpc-4547	66	13	to	to	PART
dpc-4547	66	14	reverse	reverse	VERB
dpc-4547	66	15	free	free	ADJ
dpc-4547	66	16	radical	radical	ADJ
dpc-4547	66	17	damage	damage	NOUN
dpc-4547	66	18	in	in	ADP
dpc-4547	66	19	dna	dna	PROPN
dpc-4547	66	20	to	to	PART
dpc-4547	66	21	avoid	avoid	VERB
dpc-4547	66	22	oxidative	oxidative	ADJ
dpc-4547	66	23	mutagenesis	mutagenesis	NOUN
dpc-4547	66	24	eventually	eventually	ADV
dpc-4547	66	25	.	.	PUNCT
dpc-4547	67	1	typically	typically	ADV
dpc-4547	67	2	,	,	PUNCT
dpc-4547	67	3	mutations	mutation	NOUN
dpc-4547	67	4	of	of	ADP
dpc-4547	67	5	tp53	tp53	PROPN
dpc-4547	67	6	are	be	AUX
dpc-4547	67	7	predominantly	predominantly	ADV
dpc-4547	67	8	found	find	VERB
dpc-4547	67	9	in	in	ADP
dpc-4547	67	10	human	human	ADJ
dpc-4547	67	11	cancer	cancer	NOUN
dpc-4547	67	12	tissue	tissue	NOUN
dpc-4547	67	13	,	,	PUNCT
dpc-4547	67	14	including	include	VERB
dpc-4547	67	15	cscc	cscc	VERB
dpc-4547	67	16	,	,	PUNCT
dpc-4547	67	17	where	where	SCONJ
dpc-4547	67	18	mutations	mutation	NOUN
dpc-4547	67	19	of	of	ADP
dpc-4547	67	20	review	review	NOUN
dpc-4547	67	21	|	|	ADV
dpc-4547	67	22	dermatol	dermatol	ADJ
dpc-4547	67	23	pract	pract	NOUN
dpc-4547	67	24	concept	concept	NOUN
dpc-4547	67	25	.	.	PUNCT
dpc-4547	68	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	68	2	:	:	PUNCT
dpc-4547	68	3	e2024146s	e2024146s	ADV
dpc-4547	68	4	3	3	NUM
dpc-4547	68	5	tp53	tp53	PROPN
dpc-4547	68	6	are	be	AUX
dpc-4547	68	7	found	find	VERB
dpc-4547	68	8	in	in	ADP
dpc-4547	68	9	approximately	approximately	ADV
dpc-4547	68	10	50	50	NUM
dpc-4547	68	11	%	%	NOUN
dpc-4547	68	12	of	of	ADP
dpc-4547	68	13	the	the	DET
dpc-4547	68	14	cases	case	NOUN
dpc-4547	68	15	[	[	X
dpc-4547	68	16	21	21	NUM
dpc-4547	68	17	,	,	PUNCT
dpc-4547	68	18	27	27	NUM
dpc-4547	68	19	,	,	PUNCT
dpc-4547	68	20	28	28	NUM
dpc-4547	68	21	]	]	PUNCT
dpc-4547	68	22	.	.	PUNCT
dpc-4547	69	1	when	when	SCONJ
dpc-4547	69	2	the	the	DET
dpc-4547	69	3	mechanism	mechanism	NOUN
dpc-4547	69	4	of	of	ADP
dpc-4547	69	5	dna	dna	PROPN
dpc-4547	69	6	repair	repair	NOUN
dpc-4547	69	7	is	be	AUX
dpc-4547	69	8	absent	absent	ADJ
dpc-4547	69	9	due	due	ADP
dpc-4547	69	10	to	to	ADP
dpc-4547	69	11	mutation	mutation	NOUN
dpc-4547	69	12	,	,	PUNCT
dpc-4547	69	13	the	the	DET
dpc-4547	69	14	immunosuppressive	immunosuppressive	ADJ
dpc-4547	69	15	mechanism	mechanism	NOUN
dpc-4547	69	16	of	of	ADP
dpc-4547	69	17	action	action	NOUN
dpc-4547	69	18	of	of	ADP
dpc-4547	69	19	uvr	uvr	NOUN
dpc-4547	69	20	,	,	PUNCT
dpc-4547	69	21	and	and	CCONJ
dpc-4547	69	22	especially	especially	ADV
dpc-4547	69	23	uvar	uvar	PROPN
dpc-4547	69	24	,	,	PUNCT
dpc-4547	69	25	which	which	PRON
dpc-4547	69	26	already	already	ADV
dpc-4547	69	27	comes	come	VERB
dpc-4547	69	28	into	into	ADP
dpc-4547	69	29	play	play	NOUN
dpc-4547	69	30	after	after	ADP
dpc-4547	69	31	the	the	DET
dpc-4547	69	32	first	first	ADJ
dpc-4547	69	33	ten	ten	NUM
dpc-4547	69	34	days	day	NOUN
dpc-4547	69	35	of	of	ADP
dpc-4547	69	36	sun	sun	NOUN
dpc-4547	69	37	exposure	exposure	NOUN
dpc-4547	69	38	,	,	PUNCT
dpc-4547	69	39	mediated	mediate	VERB
dpc-4547	69	40	through	through	ADP
dpc-4547	69	41	dna	dna	PROPN
dpc-4547	69	42	damage	damage	NOUN
dpc-4547	69	43	in	in	ADP
dpc-4547	69	44	the	the	DET
dpc-4547	69	45	form	form	NOUN
dpc-4547	69	46	of	of	ADP
dpc-4547	69	47	cyclobutene	cyclobutene	ADJ
dpc-4547	69	48	pyrimidine	pyrimidine	NOUN
dpc-4547	69	49	dimers	dimer	NOUN
dpc-4547	69	50	(	(	PUNCT
dpc-4547	69	51	cpds	cpd	NOUN
dpc-4547	69	52	)	)	PUNCT
dpc-4547	69	53	,	,	PUNCT
dpc-4547	69	54	leads	lead	VERB
dpc-4547	69	55	the	the	DET
dpc-4547	69	56	sequel	sequel	NOUN
dpc-4547	69	57	ak	ak	PROPN
dpc-4547	69	58	development	development	NOUN
dpc-4547	69	59	and	and	CCONJ
dpc-4547	69	60	progression	progression	NOUN
dpc-4547	69	61	to	to	PART
dpc-4547	69	62	cscc	cscc	VERB
dpc-4547	69	63	[	[	X
dpc-4547	69	64	24	24	NUM
dpc-4547	69	65	,	,	PUNCT
dpc-4547	69	66	29	29	NUM
dpc-4547	69	67	,	,	PUNCT
dpc-4547	69	68	30	30	NUM
dpc-4547	69	69	]	]	PUNCT
dpc-4547	69	70	.	.	PUNCT
dpc-4547	70	1	tp53	tp53	PROPN
dpc-4547	70	2	mutations	mutation	NOUN
dpc-4547	70	3	found	find	VERB
dpc-4547	70	4	in	in	ADP
dpc-4547	70	5	uvb	uvb	ADJ
dpc-4547	70	6	-	-	ADJ
dpc-4547	70	7	induced	induced	ADJ
dpc-4547	70	8	skin	skin	NOUN
dpc-4547	70	9	patches	patch	NOUN
dpc-4547	70	10	of	of	ADP
dpc-4547	70	11	mice	mouse	NOUN
dpc-4547	70	12	were	be	AUX
dpc-4547	70	13	like	like	ADP
dpc-4547	70	14	mutations	mutation	NOUN
dpc-4547	70	15	in	in	ADP
dpc-4547	70	16	cscc	cscc	NOUN
dpc-4547	70	17	,	,	PUNCT
dpc-4547	70	18	suggesting	suggest	VERB
dpc-4547	70	19	that	that	SCONJ
dpc-4547	70	20	these	these	DET
dpc-4547	70	21	patch	patch	ADJ
dpc-4547	70	22	lesions	lesion	NOUN
dpc-4547	70	23	are	be	AUX
dpc-4547	70	24	precursors	precursor	NOUN
dpc-4547	70	25	of	of	ADP
dpc-4547	70	26	cscc	cscc	NOUN
dpc-4547	70	27	[	[	X
dpc-4547	70	28	31	31	NUM
dpc-4547	70	29	]	]	PUNCT
dpc-4547	70	30	.	.	PUNCT
dpc-4547	71	1	a	a	DET
dpc-4547	71	2	characteristic	characteristic	ADJ
dpc-4547	71	3	uvbr	uvbr	NOUN
dpc-4547	71	4	induced	induce	VERB
dpc-4547	71	5	mutation	mutation	NOUN
dpc-4547	71	6	in	in	ADP
dpc-4547	71	7	the	the	DET
dpc-4547	71	8	tp53	tp53	PROPN
dpc-4547	71	9	gene	gene	NOUN
dpc-4547	71	10	is	be	AUX
dpc-4547	71	11	the	the	DET
dpc-4547	71	12	transition	transition	NOUN
dpc-4547	71	13	of	of	ADP
dpc-4547	71	14	cytidine	cytidine	NOUN
dpc-4547	71	15	to	to	ADP
dpc-4547	71	16	thymidine	thymidine	NOUN
dpc-4547	71	17	,	,	PUNCT
dpc-4547	71	18	leading	lead	VERB
dpc-4547	71	19	to	to	ADP
dpc-4547	71	20	a	a	DET
dpc-4547	71	21	loss	loss	NOUN
dpc-4547	71	22	of	of	ADP
dpc-4547	71	23	function	function	NOUN
dpc-4547	71	24	of	of	ADP
dpc-4547	71	25	the	the	DET
dpc-4547	71	26	tp53	tp53	PROPN
dpc-4547	71	27	gene	gene	NOUN
dpc-4547	71	28	product	product	NOUN
dpc-4547	71	29	[	[	X
dpc-4547	71	30	32	32	NUM
dpc-4547	71	31	]	]	PUNCT
dpc-4547	71	32	.	.	PUNCT
dpc-4547	72	1	beside	beside	ADP
dpc-4547	72	2	tp53	tp53	PROPN
dpc-4547	72	3	,	,	PUNCT
dpc-4547	72	4	other	other	ADJ
dpc-4547	72	5	additional	additional	ADJ
dpc-4547	72	6	mutations	mutation	NOUN
dpc-4547	72	7	in	in	ADP
dpc-4547	72	8	the	the	DET
dpc-4547	72	9	genome	genome	NOUN
dpc-4547	72	10	are	be	AUX
dpc-4547	72	11	considered	consider	VERB
dpc-4547	72	12	to	to	PART
dpc-4547	72	13	increase	increase	VERB
dpc-4547	72	14	the	the	DET
dpc-4547	72	15	risk	risk	NOUN
dpc-4547	72	16	of	of	ADP
dpc-4547	72	17	atypia	atypia	PROPN
dpc-4547	72	18	in	in	ADP
dpc-4547	72	19	cscc	cscc	ADJ
dpc-4547	72	20	or	or	CCONJ
dpc-4547	72	21	stimulate	stimulate	VERB
dpc-4547	72	22	uncontrolled	uncontrolled	ADJ
dpc-4547	72	23	cell	cell	NOUN
dpc-4547	72	24	proliferation	proliferation	NOUN
dpc-4547	72	25	.	.	PUNCT
dpc-4547	73	1	mutations	mutation	NOUN
dpc-4547	73	2	in	in	ADP
dpc-4547	73	3	the	the	DET
dpc-4547	73	4	knstrn	knstrn	ADJ
dpc-4547	73	5	oncogene	oncogene	NOUN
dpc-4547	73	6	are	be	AUX
dpc-4547	73	7	reported	report	VERB
dpc-4547	73	8	to	to	PART
dpc-4547	73	9	drive	drive	VERB
dpc-4547	73	10	progression	progression	NOUN
dpc-4547	73	11	towards	towards	ADP
dpc-4547	73	12	cell	cell	NOUN
dpc-4547	73	13	atypia	atypia	PROPN
dpc-4547	74	1	[	[	X
dpc-4547	74	2	33	33	NUM
dpc-4547	74	3	]	]	PUNCT
dpc-4547	74	4	.	.	PUNCT
dpc-4547	75	1	on	on	ADP
dpc-4547	75	2	protein	protein	NOUN
dpc-4547	75	3	level	level	NOUN
dpc-4547	75	4	,	,	PUNCT
dpc-4547	75	5	knstrn	knstrn	PROPN
dpc-4547	75	6	translates	translate	VERB
dpc-4547	75	7	into	into	ADP
dpc-4547	75	8	a	a	DET
dpc-4547	75	9	kinetochore	kinetochore	NOUN
dpc-4547	75	10	-	-	PUNCT
dpc-4547	75	11	associated	associate	VERB
dpc-4547	75	12	protein	protein	NOUN
dpc-4547	75	13	responsible	responsible	ADJ
dpc-4547	75	14	for	for	ADP
dpc-4547	75	15	mitotic	mitotic	ADJ
dpc-4547	75	16	chromosome	chromosome	NOUN
dpc-4547	75	17	segregation	segregation	NOUN
dpc-4547	75	18	during	during	ADP
dpc-4547	75	19	anaphase	anaphase	NOUN
dpc-4547	75	20	in	in	ADP
dpc-4547	75	21	the	the	DET
dpc-4547	75	22	cell	cell	NOUN
dpc-4547	75	23	cycle	cycle	NOUN
dpc-4547	75	24	.	.	PUNCT
dpc-4547	76	1	mutations	mutation	NOUN
dpc-4547	76	2	in	in	ADP
dpc-4547	76	3	this	this	DET
dpc-4547	76	4	gene	gene	NOUN
dpc-4547	76	5	,	,	PUNCT
dpc-4547	76	6	caused	cause	VERB
dpc-4547	76	7	by	by	ADP
dpc-4547	76	8	substitution	substitution	NOUN
dpc-4547	76	9	of	of	ADP
dpc-4547	76	10	the	the	DET
dpc-4547	76	11	genome	genome	NOUN
dpc-4547	76	12	bases	basis	NOUN
dpc-4547	76	13	cytosine	cytosine	VERB
dpc-4547	76	14	for	for	ADP
dpc-4547	76	15	adenine	adenine	NOUN
dpc-4547	76	16	and	and	CCONJ
dpc-4547	76	17	induced	induce	VERB
dpc-4547	76	18	by	by	ADP
dpc-4547	76	19	uvr	uvr	NOUN
dpc-4547	76	20	,	,	PUNCT
dpc-4547	76	21	lead	lead	VERB
dpc-4547	76	22	to	to	ADP
dpc-4547	76	23	cell	cell	NOUN
dpc-4547	76	24	aneuploidy	aneuploidy	ADJ
dpc-4547	76	25	and	and	CCONJ
dpc-4547	76	26	enhanced	enhance	VERB
dpc-4547	76	27	tumor	tumor	NOUN
dpc-4547	76	28	genesis	genesis	NOUN
dpc-4547	76	29	[	[	X
dpc-4547	76	30	32	32	NUM
dpc-4547	76	31	,	,	PUNCT
dpc-4547	76	32	33	33	NUM
dpc-4547	76	33	]	]	PUNCT
dpc-4547	76	34	.	.	PUNCT
dpc-4547	77	1	the	the	DET
dpc-4547	77	2	mutation	mutation	NOUN
dpc-4547	77	3	was	be	AUX
dpc-4547	77	4	observed	observe	VERB
dpc-4547	77	5	in	in	ADP
dpc-4547	77	6	19	19	NUM
dpc-4547	77	7	%	%	NOUN
dpc-4547	77	8	of	of	ADP
dpc-4547	77	9	cscc	cscc	NOUN
dpc-4547	77	10	and	and	CCONJ
dpc-4547	77	11	in	in	ADP
dpc-4547	77	12	13	13	NUM
dpc-4547	77	13	%	%	NOUN
dpc-4547	77	14	of	of	ADP
dpc-4547	77	15	ak	ak	PROPN
dpc-4547	77	16	,	,	PUNCT
dpc-4547	77	17	contrary	contrary	VERB
dpc-4547	77	18	this	this	DET
dpc-4547	77	19	mutation	mutation	NOUN
dpc-4547	77	20	was	be	AUX
dpc-4547	77	21	never	never	ADV
dpc-4547	77	22	found	find	VERB
dpc-4547	77	23	in	in	ADP
dpc-4547	77	24	healthy	healthy	ADJ
dpc-4547	77	25	skin	skin	NOUN
dpc-4547	77	26	[	[	X
dpc-4547	77	27	32	32	NUM
dpc-4547	77	28	]	]	PUNCT
dpc-4547	77	29	.	.	PUNCT
dpc-4547	78	1	the	the	DET
dpc-4547	78	2	resulting	result	VERB
dpc-4547	78	3	uncontrolled	uncontrolled	ADJ
dpc-4547	78	4	cell	cell	NOUN
dpc-4547	78	5	cycle	cycle	NOUN
dpc-4547	78	6	finally	finally	ADV
dpc-4547	78	7	leads	lead	VERB
dpc-4547	78	8	to	to	ADP
dpc-4547	78	9	keratinocyte	keratinocyte	NOUN
dpc-4547	78	10	cell	cell	NOUN
dpc-4547	78	11	atypia	atypia	PROPN
dpc-4547	78	12	and	and	CCONJ
dpc-4547	78	13	dysplasia	dysplasia	NOUN
dpc-4547	78	14	,	,	PUNCT
dpc-4547	78	15	which	which	PRON
dpc-4547	78	16	can	can	AUX
dpc-4547	78	17	initially	initially	ADV
dpc-4547	78	18	be	be	AUX
dpc-4547	78	19	observed	observe	VERB
dpc-4547	78	20	in	in	ADP
dpc-4547	78	21	the	the	DET
dpc-4547	78	22	basal	basal	ADJ
dpc-4547	78	23	layers	layer	NOUN
dpc-4547	78	24	of	of	ADP
dpc-4547	78	25	the	the	DET
dpc-4547	78	26	epidermis	epidermis	NOUN
dpc-4547	79	1	[	[	X
dpc-4547	79	2	34	34	NUM
dpc-4547	79	3	]	]	PUNCT
dpc-4547	79	4	.	.	PUNCT
dpc-4547	80	1	beside	beside	ADP
dpc-4547	80	2	genomic	genomic	ADJ
dpc-4547	80	3	mutations	mutation	NOUN
dpc-4547	80	4	found	find	VERB
dpc-4547	80	5	in	in	ADP
dpc-4547	80	6	ak	ak	PROPN
dpc-4547	80	7	,	,	PUNCT
dpc-4547	80	8	other	other	ADJ
dpc-4547	80	9	co	co	NOUN
dpc-4547	80	10	-	-	NOUN
dpc-4547	80	11	factors	factor	NOUN
dpc-4547	80	12	seem	seem	VERB
dpc-4547	80	13	to	to	PART
dpc-4547	80	14	stimulate	stimulate	VERB
dpc-4547	80	15	the	the	DET
dpc-4547	80	16	malignant	malignant	ADJ
dpc-4547	80	17	transformation	transformation	NOUN
dpc-4547	80	18	of	of	ADP
dpc-4547	80	19	ak	ak	PROPN
dpc-4547	80	20	.	.	PUNCT
dpc-4547	81	1	it	it	PRON
dpc-4547	81	2	is	be	AUX
dpc-4547	81	3	estimated	estimate	VERB
dpc-4547	81	4	that	that	SCONJ
dpc-4547	81	5	in	in	ADP
dpc-4547	81	6	up	up	ADP
dpc-4547	81	7	to	to	PART
dpc-4547	81	8	35	35	NUM
dpc-4547	81	9	%	%	NOUN
dpc-4547	81	10	of	of	ADP
dpc-4547	81	11	the	the	DET
dpc-4547	81	12	cases	case	NOUN
dpc-4547	81	13	of	of	ADP
dpc-4547	81	14	cancer	cancer	NOUN
dpc-4547	81	15	manifestation	manifestation	NOUN
dpc-4547	81	16	,	,	PUNCT
dpc-4547	81	17	viral	viral	ADJ
dpc-4547	81	18	infections	infection	NOUN
dpc-4547	81	19	play	play	VERB
dpc-4547	81	20	a	a	DET
dpc-4547	81	21	co	co	ADJ
dpc-4547	81	22	-	-	ADJ
dpc-4547	81	23	stimulatory	stimulatory	ADJ
dpc-4547	81	24	role	role	NOUN
dpc-4547	81	25	in	in	ADP
dpc-4547	81	26	carcinogenesis	carcinogenesis	NOUN
dpc-4547	81	27	of	of	ADP
dpc-4547	81	28	cscc	cscc	NOUN
dpc-4547	81	29	[	[	X
dpc-4547	81	30	35	35	NUM
dpc-4547	81	31	]	]	PUNCT
dpc-4547	81	32	.	.	PUNCT
dpc-4547	82	1	for	for	ADP
dpc-4547	82	2	the	the	DET
dpc-4547	82	3	skin	skin	NOUN
dpc-4547	82	4	,	,	PUNCT
dpc-4547	82	5	hpv	hpv	PROPN
dpc-4547	82	6	dna	dna	PROPN
dpc-4547	82	7	is	be	AUX
dpc-4547	82	8	found	find	VERB
dpc-4547	82	9	in	in	ADP
dpc-4547	82	10	forms	form	NOUN
dpc-4547	82	11	of	of	ADP
dpc-4547	82	12	non	non	ADJ
dpc-4547	82	13	-	-	ADJ
dpc-4547	82	14	melanoma	melanoma	ADJ
dpc-4547	82	15	skin	skin	NOUN
dpc-4547	82	16	cancer	cancer	NOUN
dpc-4547	82	17	(	(	PUNCT
dpc-4547	82	18	nmsc	nmsc	NOUN
dpc-4547	82	19	)	)	PUNCT
dpc-4547	82	20	,	,	PUNCT
dpc-4547	82	21	such	such	ADJ
dpc-4547	82	22	as	as	ADP
dpc-4547	82	23	basal	basal	ADJ
dpc-4547	82	24	cell	cell	NOUN
dpc-4547	82	25	carcinoma	carcinoma	NOUN
dpc-4547	82	26	(	(	PUNCT
dpc-4547	82	27	bcc	bcc	PROPN
dpc-4547	82	28	)	)	PUNCT
dpc-4547	82	29	and	and	CCONJ
dpc-4547	82	30	cscc	cscc	ADJ
dpc-4547	82	31	,	,	PUNCT
dpc-4547	82	32	but	but	CCONJ
dpc-4547	82	33	also	also	ADV
dpc-4547	82	34	in	in	ADP
dpc-4547	82	35	ak	ak	PROPN
dpc-4547	82	36	and	and	CCONJ
dpc-4547	82	37	healthy	healthy	ADJ
dpc-4547	82	38	skin	skin	NOUN
dpc-4547	82	39	.	.	PUNCT
dpc-4547	83	1	for	for	ADP
dpc-4547	83	2	people	people	NOUN
dpc-4547	83	3	under	under	ADP
dpc-4547	83	4	immunosuppression	immunosuppression	NOUN
dpc-4547	83	5	hpv	hpv	X
dpc-4547	83	6	dna	dna	PROPN
dpc-4547	83	7	is	be	AUX
dpc-4547	83	8	found	find	VERB
dpc-4547	83	9	in	in	ADP
dpc-4547	83	10	80	80	NUM
dpc-4547	83	11	%	%	NOUN
dpc-4547	83	12	of	of	ADP
dpc-4547	83	13	nmsc	nmsc	NOUN
dpc-4547	83	14	.	.	PUNCT
dpc-4547	84	1	still	still	ADV
dpc-4547	84	2	,	,	PUNCT
dpc-4547	84	3	its	its	PRON
dpc-4547	84	4	causal	causal	ADJ
dpc-4547	84	5	role	role	NOUN
dpc-4547	84	6	in	in	ADP
dpc-4547	84	7	the	the	DET
dpc-4547	84	8	pathogenesis	pathogenesis	NOUN
dpc-4547	84	9	for	for	ADP
dpc-4547	84	10	nmsc	nmsc	NOUN
dpc-4547	84	11	is	be	AUX
dpc-4547	84	12	poorly	poorly	ADV
dpc-4547	84	13	understood	understand	VERB
dpc-4547	84	14	.	.	PUNCT
dpc-4547	85	1	it	it	PRON
dpc-4547	85	2	is	be	AUX
dpc-4547	85	3	assumed	assume	VERB
dpc-4547	85	4	that	that	SCONJ
dpc-4547	85	5	hpv	hpv	PROPN
dpc-4547	85	6	skin	skin	NOUN
dpc-4547	85	7	infection	infection	NOUN
dpc-4547	85	8	acts	act	VERB
dpc-4547	85	9	co	co	NOUN
dpc-4547	85	10	-	-	NOUN
dpc-4547	85	11	stimulatory	stimulatory	ADJ
dpc-4547	85	12	in	in	ADP
dpc-4547	85	13	the	the	DET
dpc-4547	85	14	pathogeneses	pathogenese	NOUN
dpc-4547	85	15	of	of	ADP
dpc-4547	85	16	ak	ak	NOUN
dpc-4547	85	17	,	,	PUNCT
dpc-4547	85	18	but	but	CCONJ
dpc-4547	85	19	it	it	PRON
dpc-4547	85	20	is	be	AUX
dpc-4547	85	21	not	not	PART
dpc-4547	85	22	considered	consider	VERB
dpc-4547	85	23	to	to	PART
dpc-4547	85	24	be	be	AUX
dpc-4547	85	25	a	a	DET
dpc-4547	85	26	co	co	NOUN
dpc-4547	85	27	-	-	NOUN
dpc-4547	85	28	carcinogen	carcinogen	NOUN
dpc-4547	85	29	for	for	ADP
dpc-4547	85	30	malignant	malignant	ADJ
dpc-4547	85	31	transformation	transformation	NOUN
dpc-4547	85	32	into	into	ADP
dpc-4547	85	33	nmsc	nmsc	NOUN
dpc-4547	85	34	[	[	X
dpc-4547	85	35	32	32	NUM
dpc-4547	85	36	]	]	PUNCT
dpc-4547	85	37	.	.	PUNCT
dpc-4547	86	1	since	since	SCONJ
dpc-4547	86	2	ak	ak	PROPN
dpc-4547	86	3	is	be	AUX
dpc-4547	86	4	considered	consider	VERB
dpc-4547	86	5	an	an	DET
dpc-4547	86	6	insitu	insitu	ADJ
dpc-4547	86	7	scc	scc	NOUN
dpc-4547	86	8	,	,	PUNCT
dpc-4547	86	9	the	the	DET
dpc-4547	86	10	proliferation	proliferation	NOUN
dpc-4547	86	11	of	of	ADP
dpc-4547	86	12	atypic	atypic	NOUN
dpc-4547	86	13	keratinocytes	keratinocyte	NOUN
dpc-4547	86	14	is	be	AUX
dpc-4547	86	15	limited	limit	VERB
dpc-4547	86	16	to	to	ADP
dpc-4547	86	17	the	the	DET
dpc-4547	86	18	epidermis	epidermis	NOUN
dpc-4547	86	19	,	,	PUNCT
dpc-4547	86	20	while	while	SCONJ
dpc-4547	86	21	the	the	DET
dpc-4547	86	22	dermo	dermo	NOUN
dpc-4547	86	23	-	-	PUNCT
dpc-4547	86	24	epidermal	epidermal	ADJ
dpc-4547	86	25	junction	junction	NOUN
dpc-4547	86	26	(	(	PUNCT
dpc-4547	86	27	dej	dej	NOUN
dpc-4547	86	28	)	)	PUNCT
dpc-4547	86	29	remains	remain	VERB
dpc-4547	86	30	intact	intact	ADJ
dpc-4547	86	31	.	.	PUNCT
dpc-4547	87	1	from	from	ADP
dpc-4547	87	2	the	the	DET
dpc-4547	87	3	evaluation	evaluation	NOUN
dpc-4547	87	4	of	of	ADP
dpc-4547	87	5	histological	histological	ADJ
dpc-4547	87	6	specimen	speciman	NOUN
dpc-4547	87	7	of	of	ADP
dpc-4547	87	8	cscc	cscc	ADJ
dpc-4547	87	9	and	and	CCONJ
dpc-4547	87	10	adjacent	adjacent	ADJ
dpc-4547	87	11	ak	ak	PROPN
dpc-4547	87	12	tissue	tissue	NOUN
dpc-4547	87	13	,	,	PUNCT
dpc-4547	87	14	fernandez	fernandez	NOUN
dpc-4547	87	15	-	-	PUNCT
dpc-4547	87	16	figueras	figueras	PROPN
dpc-4547	87	17	et	et	PROPN
dpc-4547	87	18	al	al	PROPN
dpc-4547	87	19	.	.	PROPN
dpc-4547	87	20	suggested	suggest	VERB
dpc-4547	87	21	two	two	NUM
dpc-4547	87	22	major	major	ADJ
dpc-4547	87	23	pathways	pathway	NOUN
dpc-4547	87	24	of	of	ADP
dpc-4547	87	25	malignant	malignant	ADJ
dpc-4547	87	26	transformation	transformation	NOUN
dpc-4547	87	27	from	from	ADP
dpc-4547	87	28	ak	ak	PROPN
dpc-4547	87	29	to	to	PART
dpc-4547	87	30	cscc	cscc	VERB
dpc-4547	87	31	[	[	X
dpc-4547	87	32	36	36	NUM
dpc-4547	87	33	]	]	PUNCT
dpc-4547	87	34	.	.	PUNCT
dpc-4547	88	1	the	the	DET
dpc-4547	88	2	classic	classic	ADJ
dpc-4547	88	3	pathway	pathway	NOUN
dpc-4547	88	4	describes	describe	VERB
dpc-4547	88	5	the	the	DET
dpc-4547	88	6	stepwise	stepwise	ADJ
dpc-4547	88	7	evolution	evolution	NOUN
dpc-4547	88	8	of	of	ADP
dpc-4547	88	9	cscc	cscc	PROPN
dpc-4547	88	10	rom	rom	PROPN
dpc-4547	88	11	atypia	atypia	PROPN
dpc-4547	88	12	in	in	ADP
dpc-4547	88	13	the	the	DET
dpc-4547	88	14	lowest	low	ADJ
dpc-4547	88	15	third	third	NOUN
dpc-4547	88	16	of	of	ADP
dpc-4547	88	17	the	the	DET
dpc-4547	88	18	epidermis	epidermis	NOUN
dpc-4547	88	19	(	(	PUNCT
dpc-4547	88	20	ak	ak	PROPN
dpc-4547	88	21	i	i	PROPN
dpc-4547	88	22	)	)	PUNCT
dpc-4547	88	23	evolving	evolve	VERB
dpc-4547	88	24	to	to	ADP
dpc-4547	88	25	atypia	atypia	PROPN
dpc-4547	88	26	in	in	ADP
dpc-4547	88	27	the	the	DET
dpc-4547	88	28	middle	middle	NOUN
dpc-4547	88	29	(	(	PUNCT
dpc-4547	88	30	ak	ak	PROPN
dpc-4547	88	31	ii	ii	PROPN
dpc-4547	88	32	)	)	PUNCT
dpc-4547	88	33	and	and	CCONJ
dpc-4547	88	34	finally	finally	ADV
dpc-4547	88	35	upper	upper	ADJ
dpc-4547	88	36	third	third	NOUN
dpc-4547	88	37	of	of	ADP
dpc-4547	88	38	the	the	DET
dpc-4547	88	39	epidermis	epidermis	NOUN
dpc-4547	88	40	(	(	PUNCT
dpc-4547	88	41	ak	ak	PROPN
dpc-4547	88	42	iii	iii	PROPN
dpc-4547	88	43	)	)	PUNCT
dpc-4547	88	44	,	,	PUNCT
dpc-4547	88	45	according	accord	VERB
dpc-4547	88	46	to	to	ADP
dpc-4547	88	47	the	the	DET
dpc-4547	88	48	previously	previously	ADV
dpc-4547	88	49	proposed	propose	VERB
dpc-4547	88	50	atypia	atypia	PROPN
dpc-4547	88	51	grading	grade	VERB
dpc-4547	88	52	by	by	ADP
dpc-4547	88	53	röwert	röwert	PROPN
dpc-4547	88	54	-	-	PROPN
dpc-4547	88	55	huber	huber	PROPN
dpc-4547	89	1	[	[	X
dpc-4547	89	2	34	34	NUM
dpc-4547	89	3	,	,	PUNCT
dpc-4547	89	4	36	36	NUM
dpc-4547	89	5	]	]	PUNCT
dpc-4547	89	6	.	.	PUNCT
dpc-4547	90	1	at	at	ADP
dpc-4547	90	2	the	the	DET
dpc-4547	90	3	final	final	ADJ
dpc-4547	90	4	stage	stage	NOUN
dpc-4547	90	5	of	of	ADP
dpc-4547	90	6	the	the	DET
dpc-4547	90	7	disease	disease	NOUN
dpc-4547	90	8	,	,	PUNCT
dpc-4547	90	9	invasive	invasive	ADJ
dpc-4547	90	10	proliferation	proliferation	NOUN
dpc-4547	90	11	is	be	AUX
dpc-4547	90	12	defined	define	VERB
dpc-4547	90	13	by	by	ADP
dpc-4547	90	14	loss	loss	NOUN
dpc-4547	90	15	of	of	ADP
dpc-4547	90	16	dej	dej	PROPN
dpc-4547	90	17	integrity	integrity	NOUN
dpc-4547	90	18	and	and	CCONJ
dpc-4547	90	19	invasive	invasive	ADJ
dpc-4547	90	20	infiltration	infiltration	NOUN
dpc-4547	90	21	of	of	ADP
dpc-4547	90	22	atypical	atypical	ADJ
dpc-4547	90	23	keratinocytes	keratinocyte	NOUN
dpc-4547	90	24	into	into	ADP
dpc-4547	90	25	the	the	DET
dpc-4547	90	26	dermis	dermis	NOUN
dpc-4547	90	27	.	.	PUNCT
dpc-4547	91	1	beside	beside	ADP
dpc-4547	91	2	the	the	DET
dpc-4547	91	3	classic	classic	ADJ
dpc-4547	91	4	pathway	pathway	NOUN
dpc-4547	91	5	,	,	PUNCT
dpc-4547	91	6	it	it	PRON
dpc-4547	91	7	was	be	AUX
dpc-4547	91	8	found	find	VERB
dpc-4547	91	9	that	that	SCONJ
dpc-4547	91	10	ak	ak	PROPN
dpc-4547	91	11	i	i	PRON
dpc-4547	91	12	can	can	AUX
dpc-4547	91	13	even	even	ADV
dpc-4547	91	14	directly	directly	ADV
dpc-4547	91	15	progress	progress	VERB
dpc-4547	91	16	into	into	ADP
dpc-4547	91	17	cscc	cscc	PROPN
dpc-4547	91	18	,	,	PUNCT
dpc-4547	91	19	without	without	ADP
dpc-4547	91	20	stagewise	stagewise	NOUN
dpc-4547	91	21	atypia	atypia	PROPN
dpc-4547	91	22	evolvement	evolvement	NOUN
dpc-4547	91	23	,	,	PUNCT
dpc-4547	91	24	especially	especially	ADV
dpc-4547	91	25	when	when	SCONJ
dpc-4547	91	26	ak	ak	PROPN
dpc-4547	91	27	i	i	PRON
dpc-4547	91	28	grows	grow	VERB
dpc-4547	91	29	in	in	ADP
dpc-4547	91	30	close	close	ADJ
dpc-4547	91	31	contact	contact	NOUN
dpc-4547	91	32	to	to	PART
dpc-4547	91	33	adnexal	adnexal	VERB
dpc-4547	91	34	tissue	tissue	NOUN
dpc-4547	92	1	[	[	X
dpc-4547	92	2	36	36	NUM
dpc-4547	92	3	]	]	PUNCT
dpc-4547	92	4	.	.	PUNCT
dpc-4547	93	1	beside	beside	ADP
dpc-4547	93	2	atypia	atypia	PROPN
dpc-4547	93	3	,	,	PUNCT
dpc-4547	93	4	schmitz	schmitz	PROPN
dpc-4547	93	5	et	et	PROPN
dpc-4547	93	6	al	al	PROPN
dpc-4547	93	7	.	.	PUNCT
dpc-4547	94	1	[	[	X
dpc-4547	94	2	37	37	NUM
dpc-4547	94	3	]	]	PUNCT
dpc-4547	94	4	identified	identify	VERB
dpc-4547	94	5	distinct	distinct	ADJ
dpc-4547	94	6	basal	basal	ADJ
dpc-4547	94	7	growth	growth	NOUN
dpc-4547	94	8	patterns	pattern	NOUN
dpc-4547	94	9	in	in	ADP
dpc-4547	94	10	ak	ak	PROPN
dpc-4547	94	11	to	to	PART
dpc-4547	94	12	be	be	AUX
dpc-4547	94	13	suggestive	suggestive	ADJ
dpc-4547	94	14	for	for	ADP
dpc-4547	94	15	cscc	cscc	ADJ
dpc-4547	94	16	development	development	NOUN
dpc-4547	94	17	.	.	PUNCT
dpc-4547	95	1	those	those	DET
dpc-4547	95	2	basal	basal	ADJ
dpc-4547	95	3	growth	growth	NOUN
dpc-4547	95	4	patterns	pattern	NOUN
dpc-4547	95	5	,	,	PUNCT
dpc-4547	95	6	found	find	VERB
dpc-4547	95	7	in	in	ADP
dpc-4547	95	8	histological	histological	ADJ
dpc-4547	95	9	sections	section	NOUN
dpc-4547	95	10	,	,	PUNCT
dpc-4547	95	11	can	can	AUX
dpc-4547	95	12	be	be	AUX
dpc-4547	95	13	subsumed	subsume	VERB
dpc-4547	95	14	under	under	ADP
dpc-4547	95	15	the	the	DET
dpc-4547	95	16	so	so	ADV
dpc-4547	95	17	-	-	PUNCT
dpc-4547	95	18	called	call	VERB
dpc-4547	95	19	pro	pro	ADJ
dpc-4547	95	20	score	score	NOUN
dpc-4547	95	21	,	,	PUNCT
dpc-4547	95	22	which	which	PRON
dpc-4547	95	23	grades	grade	VERB
dpc-4547	95	24	the	the	DET
dpc-4547	95	25	basal	basal	ADJ
dpc-4547	95	26	growth	growth	NOUN
dpc-4547	95	27	pattern	pattern	NOUN
dpc-4547	95	28	in	in	ADP
dpc-4547	95	29	ak	ak	PROPN
dpc-4547	95	30	on	on	ADP
dpc-4547	95	31	a	a	DET
dpc-4547	95	32	tier	tier	NOUN
dpc-4547	95	33	grading	grade	VERB
dpc-4547	95	34	system	system	NOUN
dpc-4547	95	35	(	(	PUNCT
dpc-4547	95	36	pro	pro	X
dpc-4547	95	37	i	i	PROPN
dpc-4547	95	38	-	-	PUNCT
dpc-4547	95	39	iii	iii	NOUN
dpc-4547	95	40	)	)	PUNCT
dpc-4547	96	1	[	[	X
dpc-4547	96	2	37	37	NUM
dpc-4547	96	3	]	]	PUNCT
dpc-4547	96	4	.	.	PUNCT
dpc-4547	97	1	for	for	ADP
dpc-4547	97	2	pro	pro	ADJ
dpc-4547	97	3	i	i	PROPN
dpc-4547	97	4	,	,	PUNCT
dpc-4547	97	5	the	the	DET
dpc-4547	97	6	epidermal	epidermal	ADJ
dpc-4547	97	7	layer	layer	NOUN
dpc-4547	97	8	is	be	AUX
dpc-4547	97	9	flat	flat	ADJ
dpc-4547	97	10	and	and	CCONJ
dpc-4547	97	11	no	no	DET
dpc-4547	97	12	protrusions	protrusion	NOUN
dpc-4547	97	13	in	in	ADP
dpc-4547	97	14	the	the	DET
dpc-4547	97	15	dermis	dermis	NOUN
dpc-4547	97	16	can	can	AUX
dpc-4547	97	17	be	be	AUX
dpc-4547	97	18	observed	observe	VERB
dpc-4547	97	19	.	.	PUNCT
dpc-4547	98	1	for	for	ADP
dpc-4547	98	2	pro	pro	PROPN
dpc-4547	98	3	ii	ii	PROPN
dpc-4547	98	4	,	,	PUNCT
dpc-4547	98	5	the	the	DET
dpc-4547	98	6	dej	dej	PROPN
dpc-4547	98	7	appears	appear	VERB
dpc-4547	98	8	undulated	undulated	ADJ
dpc-4547	98	9	and	and	CCONJ
dpc-4547	98	10	slight	slight	ADJ
dpc-4547	98	11	protrusion	protrusion	NOUN
dpc-4547	98	12	into	into	ADP
dpc-4547	98	13	the	the	DET
dpc-4547	98	14	dermis	dermis	NOUN
dpc-4547	98	15	can	can	AUX
dpc-4547	98	16	be	be	AUX
dpc-4547	98	17	appreciated	appreciate	VERB
dpc-4547	98	18	.	.	PUNCT
dpc-4547	99	1	pro	pro	X
dpc-4547	99	2	iii	iii	PROPN
dpc-4547	99	3	ak	ak	PROPN
dpc-4547	99	4	lesions	lesion	NOUN
dpc-4547	99	5	are	be	AUX
dpc-4547	99	6	considered	consider	VERB
dpc-4547	99	7	to	to	PART
dpc-4547	99	8	be	be	AUX
dpc-4547	99	9	high	high	ADJ
dpc-4547	99	10	proliferative	proliferative	ADJ
dpc-4547	99	11	,	,	PUNCT
dpc-4547	99	12	as	as	SCONJ
dpc-4547	99	13	protrusions	protrusion	NOUN
dpc-4547	99	14	found	find	VERB
dpc-4547	99	15	in	in	ADP
dpc-4547	99	16	those	those	DET
dpc-4547	99	17	lesions	lesion	NOUN
dpc-4547	99	18	reach	reach	VERB
dpc-4547	99	19	a	a	DET
dpc-4547	99	20	deep	deep	ADJ
dpc-4547	99	21	,	,	PUNCT
dpc-4547	99	22	cone	cone	NOUN
dpc-4547	99	23	-	-	PUNCT
dpc-4547	99	24	like	like	ADJ
dpc-4547	99	25	penetration	penetration	NOUN
dpc-4547	99	26	into	into	ADP
dpc-4547	99	27	the	the	DET
dpc-4547	99	28	dermis	dermis	NOUN
dpc-4547	99	29	.	.	PUNCT
dpc-4547	100	1	the	the	DET
dpc-4547	100	2	dej	dej	PROPN
dpc-4547	100	3	remains	remain	VERB
dpc-4547	100	4	still	still	ADV
dpc-4547	100	5	intact	intact	ADJ
dpc-4547	100	6	[	[	X
dpc-4547	100	7	37	37	NUM
dpc-4547	100	8	]	]	PUNCT
dpc-4547	100	9	.	.	PUNCT
dpc-4547	101	1	in	in	ADP
dpc-4547	101	2	2019	2019	NUM
dpc-4547	101	3	,	,	PUNCT
dpc-4547	101	4	schmitz	schmitz	PROPN
dpc-4547	101	5	et	et	PROPN
dpc-4547	101	6	al	al	PROPN
dpc-4547	101	7	.	.	PROPN
dpc-4547	101	8	histologically	histologically	PROPN
dpc-4547	101	9	investigated	investigate	VERB
dpc-4547	101	10	the	the	DET
dpc-4547	101	11	epidermis	epidermis	NOUN
dpc-4547	101	12	adjacent	adjacent	ADJ
dpc-4547	101	13	to	to	ADP
dpc-4547	101	14	samples	sample	NOUN
dpc-4547	101	15	of	of	ADP
dpc-4547	101	16	cscc	cscc	NOUN
dpc-4547	101	17	[	[	X
dpc-4547	101	18	38	38	NUM
dpc-4547	101	19	]	]	PUNCT
dpc-4547	101	20	.	.	PUNCT
dpc-4547	102	1	the	the	DET
dpc-4547	102	2	epidermal	epidermal	ADJ
dpc-4547	102	3	layers	layer	NOUN
dpc-4547	102	4	were	be	AUX
dpc-4547	102	5	assessed	assess	VERB
dpc-4547	102	6	for	for	ADP
dpc-4547	102	7	keratinocyte	keratinocyte	NOUN
dpc-4547	102	8	atypia	atypia	PROPN
dpc-4547	102	9	(	(	PUNCT
dpc-4547	102	10	röwert	röwert	PROPN
dpc-4547	102	11	-	-	PUNCT
dpc-4547	102	12	huber	huber	PROPN
dpc-4547	102	13	,	,	PUNCT
dpc-4547	102	14	ak	ak	PROPN
dpc-4547	102	15	i	i	PROPN
dpc-4547	102	16	-	-	PUNCT
dpc-4547	102	17	iii	iii	PROPN
dpc-4547	102	18	)	)	PUNCT
dpc-4547	102	19	and	and	CCONJ
dpc-4547	102	20	the	the	DET
dpc-4547	102	21	basal	basal	ADJ
dpc-4547	102	22	growth	growth	NOUN
dpc-4547	102	23	pattern	pattern	NOUN
dpc-4547	102	24	(	(	PUNCT
dpc-4547	102	25	pro	pro	X
dpc-4547	102	26	i	i	PROPN
dpc-4547	102	27	-	-	PUNCT
dpc-4547	102	28	iii	iii	NOUN
dpc-4547	102	29	)	)	PUNCT
dpc-4547	102	30	.	.	PUNCT
dpc-4547	103	1	the	the	DET
dpc-4547	103	2	majority	majority	NOUN
dpc-4547	103	3	(	(	PUNCT
dpc-4547	103	4	39.4	39.4	NUM
dpc-4547	103	5	%	%	NOUN
dpc-4547	103	6	)	)	PUNCT
dpc-4547	103	7	of	of	ADP
dpc-4547	103	8	cscc	cscc	PROPN
dpc-4547	103	9	harbored	harbor	VERB
dpc-4547	103	10	pro	pro	X
dpc-4547	103	11	iii	iii	X
dpc-4547	103	12	in	in	ADP
dpc-4547	103	13	the	the	DET
dpc-4547	103	14	adjacent	adjacent	ADJ
dpc-4547	103	15	epidermis	epidermis	NOUN
dpc-4547	103	16	,	,	PUNCT
dpc-4547	103	17	followed	follow	VERB
dpc-4547	103	18	by	by	ADP
dpc-4547	103	19	pro	pro	PROPN
dpc-4547	103	20	ii	ii	PROPN
dpc-4547	103	21	(	(	PUNCT
dpc-4547	103	22	31.9	31.9	NUM
dpc-4547	103	23	%	%	NOUN
dpc-4547	103	24	)	)	PUNCT
dpc-4547	103	25	and	and	CCONJ
dpc-4547	103	26	pro	pro	X
dpc-4547	103	27	i	i	NOUN
dpc-4547	103	28	(	(	PUNCT
dpc-4547	103	29	25.7	25.7	NUM
dpc-4547	103	30	%	%	NOUN
dpc-4547	103	31	)	)	PUNCT
dpc-4547	104	1	[	[	X
dpc-4547	104	2	38	38	NUM
dpc-4547	104	3	]	]	PUNCT
dpc-4547	104	4	.	.	PUNCT
dpc-4547	105	1	also	also	ADV
dpc-4547	105	2	,	,	PUNCT
dpc-4547	105	3	basal	basal	ADJ
dpc-4547	105	4	proliferation	proliferation	NOUN
dpc-4547	105	5	of	of	ADP
dpc-4547	105	6	atypical	atypical	ADJ
dpc-4547	105	7	keratinocytes	keratinocyte	NOUN
dpc-4547	105	8	(	(	PUNCT
dpc-4547	105	9	ak	ak	PROPN
dpc-4547	105	10	i	i	PROPN
dpc-4547	105	11	)	)	PUNCT
dpc-4547	105	12	was	be	AUX
dpc-4547	105	13	found	find	VERB
dpc-4547	105	14	in	in	ADP
dpc-4547	105	15	more	more	ADJ
dpc-4547	105	16	than	than	ADP
dpc-4547	105	17	50	50	NUM
dpc-4547	105	18	%	%	NOUN
dpc-4547	105	19	of	of	ADP
dpc-4547	105	20	the	the	DET
dpc-4547	105	21	evaluated	evaluate	VERB
dpc-4547	105	22	adjacent	adjacent	ADJ
dpc-4547	105	23	ak	ak	PROPN
dpc-4547	105	24	lesions	lesion	NOUN
dpc-4547	105	25	[	[	X
dpc-4547	105	26	38	38	NUM
dpc-4547	105	27	]	]	PUNCT
dpc-4547	105	28	.	.	PUNCT
dpc-4547	106	1	the	the	DET
dpc-4547	106	2	finding	finding	NOUN
dpc-4547	106	3	of	of	ADP
dpc-4547	106	4	ak	ak	PROPN
dpc-4547	106	5	i	i	PROPN
dpc-4547	106	6	,	,	PUNCT
dpc-4547	106	7	being	be	AUX
dpc-4547	106	8	predominantly	predominantly	ADV
dpc-4547	106	9	associated	associate	VERB
dpc-4547	106	10	with	with	ADP
dpc-4547	106	11	cscc	cscc	PROPN
dpc-4547	106	12	was	be	AUX
dpc-4547	106	13	determined	determine	VERB
dpc-4547	106	14	in	in	ADP
dpc-4547	106	15	accordance	accordance	NOUN
dpc-4547	106	16	with	with	ADP
dpc-4547	106	17	the	the	DET
dpc-4547	106	18	study	study	NOUN
dpc-4547	106	19	of	of	ADP
dpc-4547	106	20	fernandez	fernandez	PROPN
dpc-4547	106	21	-	-	PUNCT
dpc-4547	106	22	figueras	figueras	PROPN
dpc-4547	106	23	et	et	PROPN
dpc-4547	106	24	al	al	PROPN
dpc-4547	106	25	.	.	PROPN
dpc-4547	106	26	,	,	PUNCT
dpc-4547	106	27	who	who	PRON
dpc-4547	106	28	reported	report	VERB
dpc-4547	106	29	that	that	SCONJ
dpc-4547	106	30	cscc	cscc	PROPN
dpc-4547	106	31	often	often	ADV
dpc-4547	106	32	emerges	emerge	VERB
dpc-4547	106	33	from	from	ADP
dpc-4547	106	34	atypia	atypia	PROPN
dpc-4547	106	35	(	(	PUNCT
dpc-4547	106	36	ak	ak	PROPN
dpc-4547	106	37	i	i	PROPN
dpc-4547	106	38	)	)	PUNCT
dpc-4547	106	39	in	in	ADP
dpc-4547	106	40	the	the	DET
dpc-4547	106	41	lower	low	ADJ
dpc-4547	106	42	third	third	NOUN
dpc-4547	106	43	of	of	ADP
dpc-4547	106	44	the	the	DET
dpc-4547	106	45	epidermis	epidermis	NOUN
dpc-4547	107	1	[	[	X
dpc-4547	107	2	36	36	NUM
dpc-4547	107	3	,	,	PUNCT
dpc-4547	107	4	38	38	NUM
dpc-4547	107	5	]	]	PUNCT
dpc-4547	107	6	.	.	PUNCT
dpc-4547	108	1	when	when	SCONJ
dpc-4547	108	2	ak	ak	PROPN
dpc-4547	108	3	i	i	PROPN
dpc-4547	108	4	advances	advance	VERB
dpc-4547	108	5	along	along	ADP
dpc-4547	108	6	adnexal	adnexal	PROPN
dpc-4547	108	7	structures	structure	NOUN
dpc-4547	108	8	this	this	PRON
dpc-4547	108	9	might	might	AUX
dpc-4547	108	10	even	even	ADV
dpc-4547	108	11	further	far	ADV
dpc-4547	108	12	facilitate	facilitate	VERB
dpc-4547	108	13	the	the	DET
dpc-4547	108	14	development	development	NOUN
dpc-4547	108	15	of	of	ADP
dpc-4547	108	16	cscc	cscc	PROPN
dpc-4547	108	17	from	from	ADP
dpc-4547	108	18	ak	ak	PROPN
dpc-4547	108	19	i	i	PROPN
dpc-4547	108	20	lesions	lesion	NOUN
dpc-4547	108	21	[	[	X
dpc-4547	108	22	36	36	NUM
dpc-4547	108	23	]	]	PUNCT
dpc-4547	108	24	.	.	PUNCT
dpc-4547	109	1	the	the	DET
dpc-4547	109	2	clinical	clinical	ADJ
dpc-4547	109	3	olsen	olsen	NOUN
dpc-4547	109	4	classification	classification	NOUN
dpc-4547	109	5	,	,	PUNCT
dpc-4547	109	6	and	and	CCONJ
dpc-4547	109	7	both	both	DET
dpc-4547	109	8	histological	histological	ADJ
dpc-4547	109	9	classifications	classification	NOUN
dpc-4547	109	10	(	(	PUNCT
dpc-4547	109	11	pro	pro	X
dpc-4547	109	12	score	score	NOUN
dpc-4547	109	13	and	and	CCONJ
dpc-4547	109	14	röwert	röwert	PROPN
dpc-4547	109	15	-	-	PUNCT
dpc-4547	109	16	huber	huber	PROPN
dpc-4547	109	17	)	)	PUNCT
dpc-4547	109	18	have	have	VERB
dpc-4547	109	19	in	in	ADP
dpc-4547	109	20	common	common	ADJ
dpc-4547	109	21	to	to	PART
dpc-4547	109	22	provide	provide	VERB
dpc-4547	109	23	a	a	DET
dpc-4547	109	24	possible	possible	ADJ
dpc-4547	109	25	grading	grading	NOUN
dpc-4547	109	26	to	to	ADP
dpc-4547	109	27	the	the	DET
dpc-4547	109	28	malignant	malignant	ADJ
dpc-4547	109	29	potential	potential	NOUN
dpc-4547	109	30	of	of	ADP
dpc-4547	109	31	ak	ak	PROPN
dpc-4547	109	32	.	.	PROPN
dpc-4547	109	33	however	however	ADV
dpc-4547	109	34	,	,	PUNCT
dpc-4547	109	35	the	the	DET
dpc-4547	109	36	clinical	clinical	ADJ
dpc-4547	109	37	value	value	NOUN
dpc-4547	109	38	of	of	ADP
dpc-4547	109	39	these	these	DET
dpc-4547	109	40	classifications	classification	NOUN
dpc-4547	109	41	is	be	AUX
dpc-4547	109	42	debated	debate	VERB
dpc-4547	109	43	and	and	CCONJ
dpc-4547	109	44	critically	critically	ADV
dpc-4547	109	45	discussed	discuss	VERB
dpc-4547	109	46	in	in	ADP
dpc-4547	109	47	the	the	DET
dpc-4547	109	48	literature	literature	NOUN
dpc-4547	109	49	.	.	PUNCT
dpc-4547	110	1	recent	recent	ADJ
dpc-4547	110	2	studies	study	NOUN
dpc-4547	110	3	imply	imply	VERB
dpc-4547	110	4	that	that	SCONJ
dpc-4547	110	5	the	the	DET
dpc-4547	110	6	clinical	clinical	ADJ
dpc-4547	110	7	olsen	olsen	NOUN
dpc-4547	110	8	score	score	NOUN
dpc-4547	110	9	is	be	AUX
dpc-4547	110	10	not	not	PART
dpc-4547	110	11	sufficient	sufficient	ADJ
dpc-4547	110	12	to	to	PART
dpc-4547	110	13	predict	predict	VERB
dpc-4547	110	14	the	the	DET
dpc-4547	110	15	potential	potential	NOUN
dpc-4547	110	16	of	of	ADP
dpc-4547	110	17	malignant	malignant	ADJ
dpc-4547	110	18	transformation	transformation	NOUN
dpc-4547	110	19	alone	alone	ADV
dpc-4547	111	1	[	[	X
dpc-4547	111	2	11	11	NUM
dpc-4547	111	3	,	,	PUNCT
dpc-4547	111	4	36	36	NUM
dpc-4547	111	5	,	,	PUNCT
dpc-4547	111	6	39	39	NUM
dpc-4547	111	7	]	]	PUNCT
dpc-4547	111	8	.	.	PUNCT
dpc-4547	112	1	in	in	ADP
dpc-4547	112	2	a	a	DET
dpc-4547	112	3	study	study	NOUN
dpc-4547	112	4	conducted	conduct	VERB
dpc-4547	112	5	by	by	ADP
dpc-4547	112	6	schmitz	schmitz	PROPN
dpc-4547	112	7	et	et	PROPN
dpc-4547	112	8	al	al	PROPN
dpc-4547	112	9	.	.	PROPN
dpc-4547	113	1	in	in	ADP
dpc-4547	113	2	2016	2016	NUM
dpc-4547	113	3	,	,	PUNCT
dpc-4547	113	4	it	it	PRON
dpc-4547	113	5	was	be	AUX
dpc-4547	113	6	proven	prove	VERB
dpc-4547	113	7	that	that	SCONJ
dpc-4547	113	8	the	the	DET
dpc-4547	113	9	clinical	clinical	ADJ
dpc-4547	113	10	appearance	appearance	NOUN
dpc-4547	113	11	of	of	ADP
dpc-4547	113	12	ak	ak	PROPN
dpc-4547	113	13	,	,	PUNCT
dpc-4547	113	14	graded	grade	VERB
dpc-4547	113	15	by	by	ADP
dpc-4547	113	16	the	the	DET
dpc-4547	113	17	olsen	olsen	NOUN
dpc-4547	113	18	scale	scale	NOUN
dpc-4547	113	19	,	,	PUNCT
dpc-4547	113	20	did	do	AUX
dpc-4547	113	21	not	not	PART
dpc-4547	113	22	correlate	correlate	VERB
dpc-4547	113	23	with	with	ADP
dpc-4547	113	24	the	the	DET
dpc-4547	113	25	extent	extent	NOUN
dpc-4547	113	26	of	of	ADP
dpc-4547	113	27	keratinocyte	keratinocyte	NOUN
dpc-4547	113	28	atypia	atypia	PROPN
dpc-4547	113	29	underneath	underneath	PROPN
dpc-4547	113	30	,	,	PUNCT
dpc-4547	113	31	measured	measure	VERB
dpc-4547	113	32	using	use	VERB
dpc-4547	113	33	the	the	DET
dpc-4547	113	34	röwert	röwert	PROPN
dpc-4547	113	35	-	-	PUNCT
dpc-4547	113	36	huber	huber	PROPN
dpc-4547	113	37	scale	scale	NOUN
dpc-4547	113	38	[	[	X
dpc-4547	113	39	39	39	NUM
dpc-4547	113	40	]	]	PUNCT
dpc-4547	113	41	.	.	PUNCT
dpc-4547	114	1	only	only	ADV
dpc-4547	114	2	in	in	ADP
dpc-4547	114	3	53.8	53.8	NUM
dpc-4547	114	4	%	%	NOUN
dpc-4547	114	5	lesions	lesion	NOUN
dpc-4547	114	6	,	,	PUNCT
dpc-4547	114	7	a	a	DET
dpc-4547	114	8	matching	matching	NOUN
dpc-4547	114	9	clinical	clinical	ADJ
dpc-4547	114	10	and	and	CCONJ
dpc-4547	114	11	histological	histological	ADJ
dpc-4547	114	12	classification	classification	NOUN
dpc-4547	114	13	was	be	AUX
dpc-4547	114	14	found	find	VERB
dpc-4547	114	15	,	,	PUNCT
dpc-4547	114	16	with	with	ADP
dpc-4547	114	17	the	the	DET
dpc-4547	114	18	majority	majority	NOUN
dpc-4547	114	19	(	(	PUNCT
dpc-4547	114	20	83.1	83.1	NUM
dpc-4547	114	21	%	%	NOUN
dpc-4547	114	22	)	)	PUNCT
dpc-4547	114	23	being	be	AUX
dpc-4547	114	24	olsen	olsen	PROPN
dpc-4547	114	25	ii	ii	PROPN
dpc-4547	114	26	and	and	CCONJ
dpc-4547	114	27	ak	ak	PROPN
dpc-4547	114	28	ii	ii	PROPN
dpc-4547	115	1	[	[	X
dpc-4547	115	2	39	39	NUM
dpc-4547	115	3	]	]	PUNCT
dpc-4547	115	4	.	.	PUNCT
dpc-4547	116	1	another	another	DET
dpc-4547	116	2	study	study	NOUN
dpc-4547	116	3	found	find	VERB
dpc-4547	116	4	that	that	SCONJ
dpc-4547	116	5	the	the	DET
dpc-4547	116	6	expression	expression	NOUN
dpc-4547	116	7	of	of	ADP
dpc-4547	116	8	the	the	DET
dpc-4547	116	9	mutated	mutate	VERB
dpc-4547	116	10	tp53	tp53	PROPN
dpc-4547	116	11	gene	gene	NOUN
dpc-4547	116	12	in	in	ADP
dpc-4547	116	13	ak	ak	PROPN
dpc-4547	116	14	,	,	PUNCT
dpc-4547	116	15	tended	tend	VERB
dpc-4547	116	16	to	to	PART
dpc-4547	116	17	increase	increase	VERB
dpc-4547	116	18	with	with	ADP
dpc-4547	116	19	a	a	DET
dpc-4547	116	20	higher	high	ADJ
dpc-4547	116	21	rate	rate	NOUN
dpc-4547	116	22	of	of	ADP
dpc-4547	116	23	keratinocyte	keratinocyte	NOUN
dpc-4547	116	24	dysplasia	dysplasia	NOUN
dpc-4547	116	25	,	,	PUNCT
dpc-4547	116	26	but	but	CCONJ
dpc-4547	116	27	no	no	DET
dpc-4547	116	28	significant	significant	ADJ
dpc-4547	116	29	level	level	NOUN
dpc-4547	116	30	was	be	AUX
dpc-4547	116	31	reached	reach	VERB
dpc-4547	116	32	[	[	X
dpc-4547	116	33	28	28	NUM
dpc-4547	116	34	]	]	PUNCT
dpc-4547	116	35	.	.	PUNCT
dpc-4547	117	1	moreover	moreover	ADV
dpc-4547	117	2	,	,	PUNCT
dpc-4547	117	3	in	in	ADP
dpc-4547	117	4	ak	ak	PROPN
dpc-4547	117	5	no	no	DET
dpc-4547	117	6	significant	significant	ADJ
dpc-4547	117	7	correlation	correlation	NOUN
dpc-4547	117	8	was	be	AUX
dpc-4547	117	9	found	find	VERB
dpc-4547	117	10	between	between	ADP
dpc-4547	117	11	tp53	tp53	PROPN
dpc-4547	117	12	expression	expression	NOUN
dpc-4547	117	13	,	,	PUNCT
dpc-4547	117	14	the	the	DET
dpc-4547	117	15	extent	extent	NOUN
dpc-4547	117	16	of	of	ADP
dpc-4547	117	17	dysplasia	dysplasia	NOUN
dpc-4547	117	18	in	in	ADP
dpc-4547	117	19	the	the	DET
dpc-4547	117	20	epidermis	epidermis	NOUN
dpc-4547	117	21	and	and	CCONJ
dpc-4547	117	22	the	the	DET
dpc-4547	117	23	clinical	clinical	ADJ
dpc-4547	117	24	thickness	thickness	NOUN
dpc-4547	117	25	as	as	ADV
dpc-4547	117	26	well	well	ADV
dpc-4547	117	27	as	as	ADP
dpc-4547	117	28	thickness	thickness	NOUN
dpc-4547	117	29	of	of	ADP
dpc-4547	117	30	the	the	DET
dpc-4547	117	31	stratum	stratum	NOUN
dpc-4547	117	32	corneum	corneum	NOUN
dpc-4547	117	33	(	(	PUNCT
dpc-4547	117	34	sc	sc	PROPN
dpc-4547	117	35	)	)	PUNCT
dpc-4547	118	1	[	[	X
dpc-4547	118	2	28	28	NUM
dpc-4547	118	3	]	]	PUNCT
dpc-4547	118	4	.	.	PUNCT
dpc-4547	119	1	from	from	ADP
dpc-4547	119	2	these	these	DET
dpc-4547	119	3	findings	finding	NOUN
dpc-4547	119	4	,	,	PUNCT
dpc-4547	119	5	heerfordt	heerfordt	ADJ
dpc-4547	119	6	et	et	NOUN
dpc-4547	119	7	al.[28	al.[28	PROPN
dpc-4547	119	8	]	]	PUNCT
dpc-4547	119	9	supported	support	VERB
dpc-4547	119	10	the	the	DET
dpc-4547	119	11	suggestion	suggestion	NOUN
dpc-4547	119	12	4	4	NUM
dpc-4547	119	13	review	review	NOUN
dpc-4547	119	14	|	|	ADV
dpc-4547	119	15	dermatol	dermatol	ADJ
dpc-4547	119	16	pract	pract	NOUN
dpc-4547	119	17	concept	concept	NOUN
dpc-4547	119	18	.	.	PUNCT
dpc-4547	120	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	120	2	:	:	PUNCT
dpc-4547	120	3	e2024146s	e2024146s	ADV
dpc-4547	120	4	during	during	ADP
dpc-4547	120	5	their	their	PRON
dpc-4547	120	6	lifetime	lifetime	NOUN
dpc-4547	120	7	.	.	PUNCT
dpc-4547	121	1	80	80	NUM
dpc-4547	121	2	%	%	NOUN
dpc-4547	121	3	of	of	ADP
dpc-4547	121	4	transplant	transplant	NOUN
dpc-4547	121	5	recipient	recipient	NOUN
dpc-4547	121	6	develop	develop	VERB
dpc-4547	121	7	ak	ak	PROPN
dpc-4547	121	8	during	during	ADP
dpc-4547	121	9	their	their	PRON
dpc-4547	121	10	lifetime	lifetime	NOUN
dpc-4547	121	11	,	,	PUNCT
dpc-4547	121	12	with	with	ADP
dpc-4547	121	13	up	up	ADP
dpc-4547	121	14	to	to	PART
dpc-4547	121	15	30	30	NUM
dpc-4547	121	16	%	%	NOUN
dpc-4547	121	17	of	of	ADP
dpc-4547	121	18	them	they	PRON
dpc-4547	121	19	suffering	suffer	VERB
dpc-4547	121	20	from	from	ADP
dpc-4547	121	21	more	more	ADJ
dpc-4547	121	22	than	than	ADP
dpc-4547	121	23	five	five	NUM
dpc-4547	121	24	ak	ak	PROPN
dpc-4547	121	25	lesions	lesion	NOUN
dpc-4547	121	26	[	[	X
dpc-4547	121	27	44	44	NUM
dpc-4547	121	28	,	,	PUNCT
dpc-4547	121	29	45	45	NUM
dpc-4547	121	30	]	]	PUNCT
dpc-4547	121	31	.	.	PUNCT
dpc-4547	122	1	although	although	SCONJ
dpc-4547	122	2	,	,	PUNCT
dpc-4547	122	3	immunosuppression	immunosuppression	NOUN
dpc-4547	122	4	is	be	AUX
dpc-4547	122	5	associated	associate	VERB
dpc-4547	122	6	with	with	ADP
dpc-4547	122	7	the	the	DET
dpc-4547	122	8	likelihood	likelihood	NOUN
dpc-4547	122	9	of	of	ADP
dpc-4547	122	10	hpv	hpv	NOUN
dpc-4547	122	11	colonization	colonization	NOUN
dpc-4547	122	12	,	,	PUNCT
dpc-4547	122	13	immunosuppression	immunosuppression	NOUN
dpc-4547	122	14	alone	alone	ADV
dpc-4547	122	15	,	,	PUNCT
dpc-4547	122	16	significantly	significantly	ADV
dpc-4547	122	17	correlates	correlate	VERB
dpc-4547	122	18	with	with	ADP
dpc-4547	122	19	the	the	DET
dpc-4547	122	20	development	development	NOUN
dpc-4547	122	21	nmsc	nmsc	NOUN
dpc-4547	122	22	,	,	PUNCT
dpc-4547	122	23	depending	depend	VERB
dpc-4547	122	24	on	on	ADP
dpc-4547	122	25	its	its	PRON
dpc-4547	122	26	prescription	prescription	NOUN
dpc-4547	122	27	duration	duration	NOUN
dpc-4547	122	28	[	[	X
dpc-4547	122	29	32	32	NUM
dpc-4547	122	30	]	]	PUNCT
dpc-4547	122	31	.	.	PUNCT
dpc-4547	123	1	while	while	SCONJ
dpc-4547	123	2	for	for	ADP
dpc-4547	123	3	a	a	DET
dpc-4547	123	4	period	period	NOUN
dpc-4547	123	5	of	of	ADP
dpc-4547	123	6	two	two	NUM
dpc-4547	123	7	years	year	NOUN
dpc-4547	123	8	under	under	ADP
dpc-4547	123	9	immunosuppression	immunosuppression	NOUN
dpc-4547	123	10	,	,	PUNCT
dpc-4547	123	11	the	the	DET
dpc-4547	123	12	reported	report	VERB
dpc-4547	123	13	incidence	incidence	NOUN
dpc-4547	123	14	of	of	ADP
dpc-4547	123	15	nmsc	nmsc	NOUN
dpc-4547	123	16	is	be	AUX
dpc-4547	123	17	5	5	NUM
dpc-4547	123	18	%	%	NOUN
dpc-4547	123	19	,	,	PUNCT
dpc-4547	123	20	it	it	PRON
dpc-4547	123	21	significantly	significantly	ADV
dpc-4547	123	22	increases	increase	VERB
dpc-4547	123	23	over	over	ADP
dpc-4547	123	24	time	time	NOUN
dpc-4547	123	25	and	and	CCONJ
dpc-4547	123	26	reaches	reach	VERB
dpc-4547	123	27	up	up	ADV
dpc-4547	123	28	to	to	PART
dpc-4547	123	29	60	60	NUM
dpc-4547	123	30	%	%	NOUN
dpc-4547	123	31	in	in	ADP
dpc-4547	123	32	patients	patient	NOUN
dpc-4547	123	33	,	,	PUNCT
dpc-4547	123	34	being	be	AUX
dpc-4547	123	35	under	under	ADP
dpc-4547	123	36	immunosuppression	immunosuppression	NOUN
dpc-4547	123	37	for	for	ADP
dpc-4547	123	38	a	a	DET
dpc-4547	123	39	period	period	NOUN
dpc-4547	123	40	of	of	ADP
dpc-4547	123	41	at	at	ADV
dpc-4547	123	42	least	least	ADV
dpc-4547	123	43	20	20	NUM
dpc-4547	123	44	years	year	NOUN
dpc-4547	123	45	[	[	X
dpc-4547	123	46	32	32	NUM
dpc-4547	123	47	]	]	PUNCT
dpc-4547	123	48	.	.	PUNCT
dpc-4547	124	1	studies	study	NOUN
dpc-4547	124	2	report	report	VERB
dpc-4547	124	3	a	a	DET
dpc-4547	124	4	median	median	NOUN
dpc-4547	124	5	of	of	ADP
dpc-4547	124	6	eight	eight	NUM
dpc-4547	124	7	years	year	NOUN
dpc-4547	124	8	after	after	ADP
dpc-4547	124	9	transplantation	transplantation	NOUN
dpc-4547	124	10	for	for	ADP
dpc-4547	124	11	nmsc	nmsc	NOUN
dpc-4547	124	12	to	to	PART
dpc-4547	124	13	manifest	manifest	VERB
dpc-4547	124	14	,	,	PUNCT
dpc-4547	124	15	while	while	SCONJ
dpc-4547	124	16	transplant	transplant	NOUN
dpc-4547	124	17	recipients	recipient	NOUN
dpc-4547	124	18	older	old	ADJ
dpc-4547	124	19	than	than	ADP
dpc-4547	124	20	60	60	NUM
dpc-4547	124	21	years	year	NOUN
dpc-4547	124	22	of	of	ADP
dpc-4547	124	23	age	age	NOUN
dpc-4547	124	24	seem	seem	VERB
dpc-4547	124	25	to	to	PART
dpc-4547	124	26	develop	develop	VERB
dpc-4547	124	27	nmsc	nmsc	NOUN
dpc-4547	124	28	already	already	ADV
dpc-4547	124	29	after	after	ADP
dpc-4547	124	30	three	three	NUM
dpc-4547	124	31	to	to	PART
dpc-4547	124	32	five	five	NUM
dpc-4547	124	33	years	year	NOUN
dpc-4547	124	34	of	of	ADP
dpc-4547	124	35	transplantation	transplantation	NOUN
dpc-4547	124	36	[	[	X
dpc-4547	124	37	46	46	NUM
dpc-4547	124	38	,	,	PUNCT
dpc-4547	124	39	47	47	NUM
dpc-4547	124	40	]	]	PUNCT
dpc-4547	124	41	.	.	PUNCT
dpc-4547	125	1	patients	patient	NOUN
dpc-4547	125	2	under	under	ADP
dpc-4547	125	3	immunosuppression	immunosuppression	NOUN
dpc-4547	125	4	also	also	ADV
dpc-4547	125	5	face	face	VERB
dpc-4547	125	6	a	a	DET
dpc-4547	125	7	ten	ten	NUM
dpc-4547	125	8	times	time	NOUN
dpc-4547	125	9	increased	increase	VERB
dpc-4547	125	10	risk	risk	NOUN
dpc-4547	125	11	to	to	PART
dpc-4547	125	12	develop	develop	VERB
dpc-4547	125	13	a	a	DET
dpc-4547	125	14	second	second	ADJ
dpc-4547	125	15	cscc	cscc	NOUN
dpc-4547	125	16	when	when	SCONJ
dpc-4547	125	17	field	field	NOUN
dpc-4547	125	18	cancerization	cancerization	NOUN
dpc-4547	125	19	(	(	PUNCT
dpc-4547	125	20	fc	fc	INTJ
dpc-4547	125	21	)	)	PUNCT
dpc-4547	125	22	is	be	AUX
dpc-4547	125	23	present	present	ADJ
dpc-4547	126	1	[	[	X
dpc-4547	126	2	48	48	NUM
dpc-4547	126	3	,	,	PUNCT
dpc-4547	126	4	49	49	NUM
dpc-4547	126	5	]	]	PUNCT
dpc-4547	126	6	.	.	PUNCT
dpc-4547	127	1	in	in	ADP
dpc-4547	127	2	a	a	DET
dpc-4547	127	3	renal	renal	ADJ
dpc-4547	127	4	transplant	transplant	NOUN
dpc-4547	127	5	cohort	cohort	NOUN
dpc-4547	127	6	,	,	PUNCT
dpc-4547	127	7	7	7	NUM
dpc-4547	127	8	%	%	NOUN
dpc-4547	127	9	of	of	ADP
dpc-4547	127	10	recipients	recipient	NOUN
dpc-4547	127	11	with	with	ADP
dpc-4547	127	12	ak	ak	PROPN
dpc-4547	127	13	developed	develop	VERB
dpc-4547	127	14	cscc	cscc	VERB
dpc-4547	127	15	,	,	PUNCT
dpc-4547	127	16	while	while	SCONJ
dpc-4547	127	17	recipients	recipient	NOUN
dpc-4547	127	18	with	with	ADP
dpc-4547	127	19	fc	fc	PROPN
dpc-4547	127	20	developed	develop	VERB
dpc-4547	127	21	cscc	cscc	ADV
dpc-4547	127	22	in	in	ADP
dpc-4547	127	23	15	15	NUM
dpc-4547	127	24	%	%	NOUN
dpc-4547	127	25	of	of	ADP
dpc-4547	127	26	the	the	DET
dpc-4547	127	27	cases	case	NOUN
dpc-4547	127	28	.	.	PUNCT
dpc-4547	128	1	the	the	DET
dpc-4547	128	2	authors	author	NOUN
dpc-4547	128	3	concluded	conclude	VERB
dpc-4547	128	4	a	a	DET
dpc-4547	128	5	correlation	correlation	NOUN
dpc-4547	128	6	between	between	ADP
dpc-4547	128	7	risk	risk	NOUN
dpc-4547	128	8	of	of	ADP
dpc-4547	128	9	scc	scc	NOUN
dpc-4547	128	10	development	development	NOUN
dpc-4547	128	11	and	and	CCONJ
dpc-4547	128	12	the	the	DET
dpc-4547	128	13	skin	skin	NOUN
dpc-4547	128	14	area	area	NOUN
dpc-4547	128	15	suffering	suffer	VERB
dpc-4547	128	16	from	from	ADP
dpc-4547	128	17	ak	ak	PROPN
dpc-4547	128	18	,	,	PUNCT
dpc-4547	128	19	such	such	ADJ
dpc-4547	128	20	as	as	ADP
dpc-4547	128	21	fc	fc	PROPN
dpc-4547	128	22	[	[	X
dpc-4547	128	23	50	50	NUM
dpc-4547	128	24	]	]	PUNCT
dpc-4547	128	25	.	.	PUNCT
dpc-4547	129	1	studies	study	NOUN
dpc-4547	129	2	found	find	VERB
dpc-4547	129	3	that	that	SCONJ
dpc-4547	129	4	,	,	PUNCT
dpc-4547	129	5	manifestation	manifestation	NOUN
dpc-4547	129	6	of	of	ADP
dpc-4547	129	7	bcc	bcc	PROPN
dpc-4547	129	8	is	be	AUX
dpc-4547	129	9	predominantly	predominantly	ADV
dpc-4547	129	10	observed	observe	VERB
dpc-4547	129	11	after	after	ADP
dpc-4547	129	12	initiation	initiation	NOUN
dpc-4547	129	13	of	of	ADP
dpc-4547	129	14	immunosuppression	immunosuppression	NOUN
dpc-4547	129	15	and	and	CCONJ
dpc-4547	129	16	the	the	DET
dpc-4547	129	17	risk	risk	NOUN
dpc-4547	129	18	follows	follow	VERB
dpc-4547	129	19	a	a	DET
dpc-4547	129	20	linear	linear	ADJ
dpc-4547	129	21	trend	trend	NOUN
dpc-4547	129	22	,	,	PUNCT
dpc-4547	129	23	but	but	CCONJ
dpc-4547	129	24	for	for	ADP
dpc-4547	129	25	cscc	cscc	ADJ
dpc-4547	129	26	the	the	DET
dpc-4547	129	27	risk	risk	NOUN
dpc-4547	129	28	even	even	ADV
dpc-4547	129	29	develops	develop	VERB
dpc-4547	129	30	exponentially	exponentially	ADV
dpc-4547	129	31	[	[	X
dpc-4547	129	32	51	51	NUM
dpc-4547	129	33	]	]	PUNCT
dpc-4547	129	34	.	.	PUNCT
dpc-4547	130	1	for	for	ADP
dpc-4547	130	2	immunosuppressed	immunosuppressed	ADJ
dpc-4547	130	3	patients	patient	NOUN
dpc-4547	130	4	,	,	PUNCT
dpc-4547	130	5	the	the	DET
dpc-4547	130	6	ratio	ratio	NOUN
dpc-4547	130	7	of	of	ADP
dpc-4547	130	8	cscc	cscc	PROPN
dpc-4547	130	9	vs.	vs.	X
dpc-4547	130	10	bcc	bcc	PROPN
dpc-4547	130	11	occurrence	occurrence	NOUN
dpc-4547	130	12	is	be	AUX
dpc-4547	130	13	4:1	4:1	NUM
dpc-4547	130	14	and	and	CCONJ
dpc-4547	130	15	therefore	therefore	ADV
dpc-4547	130	16	inverse	inverse	NOUN
dpc-4547	130	17	proportionally	proportionally	ADV
dpc-4547	130	18	to	to	ADP
dpc-4547	130	19	the	the	DET
dpc-4547	130	20	ratio	ratio	NOUN
dpc-4547	130	21	observed	observe	VERB
dpc-4547	130	22	in	in	ADP
dpc-4547	130	23	immunocompetent	immunocompetent	ADJ
dpc-4547	130	24	patients	patient	NOUN
dpc-4547	130	25	[	[	X
dpc-4547	130	26	32	32	NUM
dpc-4547	130	27	]	]	PUNCT
dpc-4547	130	28	.	.	PUNCT
dpc-4547	131	1	according	accord	VERB
dpc-4547	131	2	to	to	ADP
dpc-4547	131	3	schmitz	schmitz	PROPN
dpc-4547	131	4	et	et	PROPN
dpc-4547	131	5	al	al	PROPN
dpc-4547	131	6	.	.	PUNCT
dpc-4547	132	1	this	this	PRON
dpc-4547	132	2	may	may	AUX
dpc-4547	132	3	partly	partly	ADV
dpc-4547	132	4	be	be	AUX
dpc-4547	132	5	explained	explain	VERB
dpc-4547	132	6	by	by	ADP
dpc-4547	132	7	the	the	DET
dpc-4547	132	8	higher	high	ADJ
dpc-4547	132	9	observed	observed	ADJ
dpc-4547	132	10	progression	progression	NOUN
dpc-4547	132	11	rate	rate	NOUN
dpc-4547	132	12	of	of	ADP
dpc-4547	132	13	up	up	ADP
dpc-4547	132	14	to	to	PART
dpc-4547	132	15	30	30	NUM
dpc-4547	132	16	%	%	NOUN
dpc-4547	132	17	from	from	ADP
dpc-4547	132	18	ak	ak	PROPN
dpc-4547	132	19	to	to	ADP
dpc-4547	132	20	scc	scc	PROPN
dpc-4547	132	21	in	in	ADP
dpc-4547	132	22	immunodeficient	immunodeficient	NOUN
dpc-4547	132	23	patients	patient	NOUN
dpc-4547	132	24	[	[	X
dpc-4547	132	25	32	32	NUM
dpc-4547	132	26	]	]	PUNCT
dpc-4547	132	27	.	.	PUNCT
dpc-4547	133	1	recent	recent	ADJ
dpc-4547	133	2	follow	follow	VERB
dpc-4547	133	3	-	-	PUNCT
dpc-4547	133	4	up	up	ADP
dpc-4547	133	5	data	datum	NOUN
dpc-4547	133	6	from	from	ADP
dpc-4547	133	7	the	the	DET
dpc-4547	133	8	year	year	NOUN
dpc-4547	133	9	2022	2022	NUM
dpc-4547	133	10	for	for	ADP
dpc-4547	133	11	a	a	DET
dpc-4547	133	12	finnish	finnish	ADJ
dpc-4547	133	13	cohort	cohort	NOUN
dpc-4547	133	14	of	of	ADP
dpc-4547	133	15	organ	organ	NOUN
dpc-4547	133	16	-	-	PUNCT
dpc-4547	133	17	transplanted	transplant	VERB
dpc-4547	133	18	patients	patient	NOUN
dpc-4547	133	19	,	,	PUNCT
dpc-4547	133	20	who	who	PRON
dpc-4547	133	21	were	be	AUX
dpc-4547	133	22	retrospectively	retrospectively	ADV
dpc-4547	133	23	evaluated	evaluate	VERB
dpc-4547	133	24	for	for	ADP
dpc-4547	133	25	the	the	DET
dpc-4547	133	26	last	last	ADJ
dpc-4547	133	27	30	30	NUM
dpc-4547	133	28	years	year	NOUN
dpc-4547	133	29	,	,	PUNCT
dpc-4547	133	30	revealed	reveal	VERB
dpc-4547	133	31	that	that	SCONJ
dpc-4547	133	32	nmsc	nmsc	NOUN
dpc-4547	133	33	was	be	AUX
dpc-4547	133	34	found	find	VERB
dpc-4547	133	35	predominately	predominately	ADV
dpc-4547	133	36	in	in	ADP
dpc-4547	133	37	53	53	NUM
dpc-4547	133	38	%	%	NOUN
dpc-4547	133	39	of	of	ADP
dpc-4547	133	40	all	all	DET
dpc-4547	133	41	observed	observed	ADJ
dpc-4547	133	42	cancer	cancer	NOUN
dpc-4547	133	43	manifestations	manifestation	NOUN
dpc-4547	134	1	[	[	X
dpc-4547	134	2	52	52	NUM
dpc-4547	134	3	]	]	PUNCT
dpc-4547	134	4	.	.	PUNCT
dpc-4547	135	1	moreover	moreover	ADV
dpc-4547	135	2	,	,	PUNCT
dpc-4547	135	3	nsmc	nsmc	NOUN
dpc-4547	135	4	was	be	AUX
dpc-4547	135	5	found	find	VERB
dpc-4547	135	6	to	to	PART
dpc-4547	135	7	be	be	AUX
dpc-4547	135	8	the	the	DET
dpc-4547	135	9	leading	lead	VERB
dpc-4547	135	10	cause	cause	NOUN
dpc-4547	135	11	for	for	ADP
dpc-4547	135	12	tumor	tumor	NOUN
dpc-4547	135	13	-	-	PUNCT
dpc-4547	135	14	associated	associate	VERB
dpc-4547	135	15	mortality	mortality	NOUN
dpc-4547	135	16	in	in	ADP
dpc-4547	135	17	kidney	kidney	NOUN
dpc-4547	135	18	transplanted	transplant	VERB
dpc-4547	135	19	patients	patient	NOUN
dpc-4547	135	20	in	in	ADP
dpc-4547	135	21	the	the	DET
dpc-4547	135	22	australian	australian	ADJ
dpc-4547	135	23	and	and	CCONJ
dpc-4547	135	24	new	new	PROPN
dpc-4547	135	25	zealand	zealand	PROPN
dpc-4547	135	26	based	base	VERB
dpc-4547	135	27	population	population	NOUN
dpc-4547	136	1	[	[	X
dpc-4547	136	2	53	53	NUM
dpc-4547	136	3	]	]	PUNCT
dpc-4547	136	4	.	.	PUNCT
dpc-4547	137	1	in	in	ADP
dpc-4547	137	2	general	general	ADJ
dpc-4547	137	3	,	,	PUNCT
dpc-4547	137	4	patients	patient	NOUN
dpc-4547	137	5	under	under	ADP
dpc-4547	137	6	immunosuppression	immunosuppression	NOUN
dpc-4547	137	7	are	be	AUX
dpc-4547	137	8	reported	report	VERB
dpc-4547	137	9	to	to	PART
dpc-4547	137	10	suffer	suffer	VERB
dpc-4547	137	11	from	from	ADP
dpc-4547	137	12	a	a	DET
dpc-4547	137	13	more	more	ADV
dpc-4547	137	14	aggressive	aggressive	ADJ
dpc-4547	137	15	course	course	NOUN
dpc-4547	137	16	of	of	ADP
dpc-4547	137	17	disease	disease	NOUN
dpc-4547	137	18	,	,	PUNCT
dpc-4547	137	19	coming	come	VERB
dpc-4547	137	20	along	along	ADV
dpc-4547	137	21	with	with	ADP
dpc-4547	137	22	higher	high	ADJ
dpc-4547	137	23	rates	rate	NOUN
dpc-4547	137	24	of	of	ADP
dpc-4547	137	25	malignant	malignant	ADJ
dpc-4547	137	26	infiltration	infiltration	NOUN
dpc-4547	137	27	,	,	PUNCT
dpc-4547	137	28	such	such	ADJ
dpc-4547	137	29	as	as	ADP
dpc-4547	137	30	perineural	perineural	ADJ
dpc-4547	137	31	spreading	spreading	NOUN
dpc-4547	137	32	,	,	PUNCT
dpc-4547	137	33	high	high	ADJ
dpc-4547	137	34	risk	risk	NOUN
dpc-4547	137	35	of	of	ADP
dpc-4547	137	36	recurrence	recurrence	NOUN
dpc-4547	137	37	(	(	PUNCT
dpc-4547	137	38	up	up	ADP
dpc-4547	137	39	to	to	ADP
dpc-4547	137	40	13,4	13,4	NUM
dpc-4547	137	41	%	%	NOUN
dpc-4547	137	42	)	)	PUNCT
dpc-4547	137	43	,	,	PUNCT
dpc-4547	137	44	metastasis	metastasis	NOUN
dpc-4547	137	45	(	(	PUNCT
dpc-4547	137	46	5	5	NUM
dpc-4547	137	47	-	-	SYM
dpc-4547	137	48	8	8	NUM
dpc-4547	137	49	%	%	NOUN
dpc-4547	137	50	)	)	PUNCT
dpc-4547	137	51	and	and	CCONJ
dpc-4547	137	52	higher	high	ADJ
dpc-4547	137	53	rates	rate	NOUN
dpc-4547	137	54	of	of	ADP
dpc-4547	137	55	mortality	mortality	NOUN
dpc-4547	137	56	[	[	X
dpc-4547	137	57	49	49	NUM
dpc-4547	137	58	,	,	PUNCT
dpc-4547	137	59	54	54	NUM
dpc-4547	137	60	-	-	SYM
dpc-4547	137	61	57	57	NUM
dpc-4547	137	62	]	]	PUNCT
dpc-4547	137	63	.	.	PUNCT
dpc-4547	138	1	moreover	moreover	ADV
dpc-4547	138	2	,	,	PUNCT
dpc-4547	138	3	nmsc	nmsc	NOUN
dpc-4547	138	4	manifests	manifest	VERB
dpc-4547	138	5	multifocal	multifocal	ADJ
dpc-4547	138	6	and	and	CCONJ
dpc-4547	138	7	eruptive	eruptive	ADJ
dpc-4547	138	8	.	.	PUNCT
dpc-4547	139	1	similarly	similarly	ADV
dpc-4547	139	2	,	,	PUNCT
dpc-4547	139	3	patients	patient	NOUN
dpc-4547	139	4	with	with	ADP
dpc-4547	139	5	chronic	chronic	ADJ
dpc-4547	139	6	lymphatic	lymphatic	ADJ
dpc-4547	139	7	leukemia	leukemia	NOUN
dpc-4547	139	8	have	have	VERB
dpc-4547	139	9	a	a	DET
dpc-4547	139	10	5to	5to	ADJ
dpc-4547	139	11	8.6	8.6	NUM
dpc-4547	139	12	-	-	ADJ
dpc-4547	139	13	fold	fold	ADJ
dpc-4547	139	14	higher	high	ADJ
dpc-4547	139	15	risk	risk	NOUN
dpc-4547	139	16	to	to	PART
dpc-4547	139	17	suffer	suffer	VERB
dpc-4547	139	18	from	from	ADP
dpc-4547	139	19	cscc	cscc	ADJ
dpc-4547	139	20	,	,	PUNCT
dpc-4547	139	21	compared	compare	VERB
dpc-4547	139	22	to	to	ADP
dpc-4547	139	23	immunocompetent	immunocompetent	ADJ
dpc-4547	139	24	patients	patient	NOUN
dpc-4547	139	25	[	[	X
dpc-4547	139	26	58	58	NUM
dpc-4547	139	27	-	-	SYM
dpc-4547	139	28	60	60	NUM
dpc-4547	139	29	]	]	PUNCT
dpc-4547	139	30	.	.	PUNCT
dpc-4547	140	1	in	in	ADP
dpc-4547	140	2	this	this	DET
dpc-4547	140	3	patient	patient	ADJ
dpc-4547	140	4	population	population	NOUN
dpc-4547	140	5	,	,	PUNCT
dpc-4547	140	6	cscc	cscc	PROPN
dpc-4547	140	7	occurs	occur	VERB
dpc-4547	140	8	with	with	ADP
dpc-4547	140	9	significantly	significantly	ADV
dpc-4547	140	10	higher	high	ADJ
dpc-4547	140	11	rates	rate	NOUN
dpc-4547	140	12	of	of	ADP
dpc-4547	140	13	poor	poor	ADJ
dpc-4547	140	14	outcome	outcome	NOUN
dpc-4547	140	15	such	such	ADJ
dpc-4547	140	16	as	as	ADP
dpc-4547	140	17	metastasis	metastasis	NOUN
dpc-4547	140	18	,	,	PUNCT
dpc-4547	140	19	recurrence	recurrence	NOUN
dpc-4547	140	20	,	,	PUNCT
dpc-4547	140	21	or	or	CCONJ
dpc-4547	140	22	tumor	tumor	NOUN
dpc-4547	140	23	related	relate	VERB
dpc-4547	140	24	death	death	NOUN
dpc-4547	140	25	[	[	X
dpc-4547	140	26	61	61	NUM
dpc-4547	140	27	-	-	SYM
dpc-4547	140	28	64	64	NUM
dpc-4547	140	29	]	]	PUNCT
dpc-4547	140	30	.	.	PUNCT
dpc-4547	141	1	for	for	ADP
dpc-4547	141	2	the	the	DET
dpc-4547	141	3	reasons	reason	NOUN
dpc-4547	141	4	named	name	VERB
dpc-4547	141	5	,	,	PUNCT
dpc-4547	141	6	stors	stor	NOUN
dpc-4547	141	7	profit	profit	VERB
dpc-4547	141	8	from	from	ADP
dpc-4547	141	9	close	close	ADJ
dpc-4547	141	10	therapy	therapy	NOUN
dpc-4547	141	11	monitoring	monitoring	NOUN
dpc-4547	141	12	and	and	CCONJ
dpc-4547	141	13	disease	disease	NOUN
dpc-4547	141	14	management	management	NOUN
dpc-4547	141	15	to	to	PART
dpc-4547	141	16	control	control	VERB
dpc-4547	141	17	and	and	CCONJ
dpc-4547	141	18	prevent	prevent	VERB
dpc-4547	141	19	development	development	NOUN
dpc-4547	141	20	of	of	ADP
dpc-4547	141	21	nmsc	nmsc	NOUN
dpc-4547	141	22	in	in	ADP
dpc-4547	141	23	the	the	DET
dpc-4547	141	24	first	first	ADJ
dpc-4547	141	25	place	place	NOUN
dpc-4547	141	26	,	,	PUNCT
dpc-4547	141	27	or	or	CCONJ
dpc-4547	141	28	to	to	PART
dpc-4547	141	29	by	by	ADP
dpc-4547	141	30	schmitz	schmitz	PROPN
dpc-4547	141	31	et	et	PROPN
dpc-4547	141	32	al.[39	al.[39	PROPN
dpc-4547	141	33	]	]	PUNCT
dpc-4547	141	34	that	that	SCONJ
dpc-4547	141	35	the	the	DET
dpc-4547	141	36	clinical	clinical	ADJ
dpc-4547	141	37	appearance	appearance	NOUN
dpc-4547	141	38	of	of	ADP
dpc-4547	141	39	ak	ak	PROPN
dpc-4547	141	40	is	be	AUX
dpc-4547	141	41	not	not	PART
dpc-4547	141	42	a	a	DET
dpc-4547	141	43	sufficient	sufficient	ADJ
dpc-4547	141	44	and	and	CCONJ
dpc-4547	141	45	reliable	reliable	ADJ
dpc-4547	141	46	predictor	predictor	NOUN
dpc-4547	141	47	of	of	ADP
dpc-4547	141	48	malignant	malignant	ADJ
dpc-4547	141	49	transformation	transformation	NOUN
dpc-4547	141	50	in	in	ADP
dpc-4547	141	51	ak	ak	PROPN
dpc-4547	141	52	.	.	PROPN
dpc-4547	142	1	in	in	ADP
dpc-4547	142	2	contrast	contrast	NOUN
dpc-4547	142	3	,	,	PUNCT
dpc-4547	142	4	bakshi	bakshi	PROPN
dpc-4547	142	5	et	et	PROPN
dpc-4547	142	6	al	al	PROPN
dpc-4547	142	7	.	.	PROPN
dpc-4547	142	8	were	be	AUX
dpc-4547	142	9	able	able	ADJ
dpc-4547	142	10	to	to	PART
dpc-4547	142	11	show	show	VERB
dpc-4547	142	12	that	that	SCONJ
dpc-4547	142	13	the	the	DET
dpc-4547	142	14	mutational	mutational	ADJ
dpc-4547	142	15	status	status	NOUN
dpc-4547	142	16	of	of	ADP
dpc-4547	142	17	tp53	tp53	PROPN
dpc-4547	142	18	and	and	CCONJ
dpc-4547	142	19	its	its	PRON
dpc-4547	142	20	increased	increase	VERB
dpc-4547	142	21	level	level	NOUN
dpc-4547	142	22	of	of	ADP
dpc-4547	142	23	protein	protein	NOUN
dpc-4547	142	24	expression	expression	NOUN
dpc-4547	142	25	was	be	AUX
dpc-4547	142	26	found	find	VERB
dpc-4547	142	27	in	in	ADP
dpc-4547	142	28	clinical	clinical	ADJ
dpc-4547	142	29	apparent	apparent	ADJ
dpc-4547	142	30	ak	ak	PROPN
dpc-4547	142	31	,	,	PUNCT
dpc-4547	142	32	sun	sun	NOUN
dpc-4547	142	33	-	-	PUNCT
dpc-4547	142	34	exposed	expose	VERB
dpc-4547	142	35	skin	skin	NOUN
dpc-4547	142	36	,	,	PUNCT
dpc-4547	142	37	cscc	cscc	ADJ
dpc-4547	142	38	and	and	CCONJ
dpc-4547	142	39	bcc	bcc	PROPN
dpc-4547	142	40	,	,	PUNCT
dpc-4547	142	41	while	while	SCONJ
dpc-4547	142	42	significantly	significantly	ADV
dpc-4547	142	43	lower	low	ADJ
dpc-4547	142	44	levels	level	NOUN
dpc-4547	142	45	were	be	AUX
dpc-4547	142	46	found	find	VERB
dpc-4547	142	47	in	in	ADP
dpc-4547	142	48	regressive	regressive	ADJ
dpc-4547	142	49	ak	ak	PROPN
dpc-4547	143	1	[	[	X
dpc-4547	143	2	40	40	NUM
dpc-4547	143	3	]	]	PUNCT
dpc-4547	143	4	.	.	PUNCT
dpc-4547	144	1	it	it	PRON
dpc-4547	144	2	was	be	AUX
dpc-4547	144	3	found	find	VERB
dpc-4547	144	4	that	that	SCONJ
dpc-4547	144	5	a	a	DET
dpc-4547	144	6	progressive	progressive	ADJ
dpc-4547	144	7	increase	increase	NOUN
dpc-4547	144	8	in	in	ADP
dpc-4547	144	9	nuclear	nuclear	ADJ
dpc-4547	144	10	tp53	tp53	PROPN
dpc-4547	144	11	staining	stain	VERB
dpc-4547	144	12	was	be	AUX
dpc-4547	144	13	associated	associate	VERB
dpc-4547	144	14	with	with	ADP
dpc-4547	144	15	a	a	DET
dpc-4547	144	16	progress	progress	NOUN
dpc-4547	144	17	from	from	ADP
dpc-4547	144	18	actinically	actinically	ADV
dpc-4547	144	19	damaged	damage	VERB
dpc-4547	144	20	skin	skin	NOUN
dpc-4547	144	21	to	to	ADP
dpc-4547	144	22	ak	ak	PROPN
dpc-4547	144	23	to	to	PART
dpc-4547	144	24	cscc	cscc	VERB
dpc-4547	144	25	eventually	eventually	ADV
dpc-4547	144	26	[	[	X
dpc-4547	144	27	40	40	NUM
dpc-4547	144	28	]	]	PUNCT
dpc-4547	144	29	.	.	PUNCT
dpc-4547	145	1	from	from	ADP
dpc-4547	145	2	these	these	DET
dpc-4547	145	3	findings	finding	NOUN
dpc-4547	145	4	they	they	PRON
dpc-4547	145	5	concluded	conclude	VERB
dpc-4547	145	6	that	that	SCONJ
dpc-4547	145	7	tp53	tp53	PROPN
dpc-4547	145	8	may	may	AUX
dpc-4547	145	9	be	be	AUX
dpc-4547	145	10	a	a	DET
dpc-4547	145	11	good	good	ADJ
dpc-4547	145	12	biomarker	biomarker	NOUN
dpc-4547	145	13	of	of	ADP
dpc-4547	145	14	ak	ak	PROPN
dpc-4547	145	15	progression	progression	NOUN
dpc-4547	145	16	towards	towards	ADP
dpc-4547	145	17	invasiveness	invasiveness	NOUN
dpc-4547	145	18	[	[	X
dpc-4547	145	19	40	40	NUM
dpc-4547	145	20	]	]	PUNCT
dpc-4547	145	21	.	.	PUNCT
dpc-4547	146	1	the	the	DET
dpc-4547	146	2	progression	progression	NOUN
dpc-4547	146	3	from	from	ADP
dpc-4547	146	4	ak	ak	PROPN
dpc-4547	146	5	to	to	ADP
dpc-4547	146	6	cscc	cscc	PROPN
dpc-4547	146	7	appears	appear	VERB
dpc-4547	146	8	to	to	PART
dpc-4547	146	9	be	be	AUX
dpc-4547	146	10	a	a	DET
dpc-4547	146	11	complex	complex	ADJ
dpc-4547	146	12	process	process	NOUN
dpc-4547	146	13	of	of	ADP
dpc-4547	146	14	interactions	interaction	NOUN
dpc-4547	146	15	between	between	ADP
dpc-4547	146	16	the	the	DET
dpc-4547	146	17	named	name	VERB
dpc-4547	146	18	co	co	NOUN
dpc-4547	146	19	-	-	ADJ
dpc-4547	146	20	carcinogenic	carcinogenic	ADJ
dpc-4547	146	21	factors	factor	NOUN
dpc-4547	146	22	.	.	PUNCT
dpc-4547	147	1	their	their	PRON
dpc-4547	147	2	underlying	underlying	ADJ
dpc-4547	147	3	mechanism	mechanism	NOUN
dpc-4547	147	4	are	be	AUX
dpc-4547	147	5	still	still	ADV
dpc-4547	147	6	insufficiently	insufficiently	ADV
dpc-4547	147	7	understood	understand	VERB
dpc-4547	147	8	and	and	CCONJ
dpc-4547	147	9	thus	thus	ADV
dpc-4547	147	10	subject	subject	ADJ
dpc-4547	147	11	to	to	ADP
dpc-4547	147	12	controversially	controversially	ADV
dpc-4547	147	13	discussion	discussion	NOUN
dpc-4547	147	14	in	in	ADP
dpc-4547	147	15	the	the	DET
dpc-4547	147	16	available	available	ADJ
dpc-4547	147	17	literature	literature	NOUN
dpc-4547	147	18	.	.	PUNCT
dpc-4547	148	1	with	with	ADP
dpc-4547	148	2	these	these	DET
dpc-4547	148	3	assumptions	assumption	NOUN
dpc-4547	148	4	,	,	PUNCT
dpc-4547	148	5	schmitz	schmitz	PROPN
dpc-4547	148	6	et	et	PROPN
dpc-4547	148	7	al	al	PROPN
dpc-4547	148	8	.	.	PROPN
dpc-4547	148	9	suggest	suggest	VERB
dpc-4547	148	10	to	to	PART
dpc-4547	148	11	use	use	VERB
dpc-4547	148	12	clinical	clinical	ADJ
dpc-4547	148	13	and	and	CCONJ
dpc-4547	148	14	histological	histological	ADJ
dpc-4547	148	15	features	feature	NOUN
dpc-4547	148	16	,	,	PUNCT
dpc-4547	148	17	found	find	VERB
dpc-4547	148	18	in	in	ADP
dpc-4547	148	19	ak	ak	PROPN
dpc-4547	148	20	lesions	lesion	NOUN
dpc-4547	148	21	,	,	PUNCT
dpc-4547	148	22	to	to	PART
dpc-4547	148	23	predict	predict	VERB
dpc-4547	148	24	the	the	DET
dpc-4547	148	25	risk	risk	NOUN
dpc-4547	148	26	of	of	ADP
dpc-4547	148	27	malignant	malignant	ADJ
dpc-4547	148	28	transformation	transformation	NOUN
dpc-4547	148	29	in	in	ADP
dpc-4547	148	30	ak	ak	PROPN
dpc-4547	148	31	[	[	X
dpc-4547	148	32	32	32	NUM
dpc-4547	148	33	]	]	PUNCT
dpc-4547	148	34	.	.	PUNCT
dpc-4547	149	1	from	from	ADP
dpc-4547	149	2	these	these	DET
dpc-4547	149	3	controversies	controversy	NOUN
dpc-4547	149	4	,	,	PUNCT
dpc-4547	149	5	the	the	DET
dpc-4547	149	6	latest	late	ADJ
dpc-4547	149	7	s3	s3	NOUN
dpc-4547	149	8	-	-	NOUN
dpc-4547	149	9	guideline	guideline	NOUN
dpc-4547	149	10	for	for	ADP
dpc-4547	149	11	ak	ak	PROPN
dpc-4547	149	12	and	and	CCONJ
dpc-4547	149	13	scc	scc	PROPN
dpc-4547	149	14	does	do	AUX
dpc-4547	149	15	not	not	PART
dpc-4547	149	16	give	give	VERB
dpc-4547	149	17	any	any	DET
dpc-4547	149	18	advice	advice	NOUN
dpc-4547	149	19	on	on	ADP
dpc-4547	149	20	risk	risk	NOUN
dpc-4547	149	21	factors	factor	NOUN
dpc-4547	149	22	for	for	ADP
dpc-4547	149	23	malignancy	malignancy	NOUN
dpc-4547	149	24	in	in	ADP
dpc-4547	149	25	ak	ak	PROPN
dpc-4547	149	26	[	[	X
dpc-4547	149	27	11	11	NUM
dpc-4547	149	28	]	]	PUNCT
dpc-4547	149	29	.	.	PUNCT
dpc-4547	150	1	moreover	moreover	ADV
dpc-4547	150	2	,	,	PUNCT
dpc-4547	150	3	no	no	DET
dpc-4547	150	4	predictive	predictive	ADJ
dpc-4547	150	5	value	value	NOUN
dpc-4547	150	6	for	for	ADP
dpc-4547	150	7	the	the	DET
dpc-4547	150	8	risk	risk	NOUN
dpc-4547	150	9	of	of	ADP
dpc-4547	150	10	malignant	malignant	ADJ
dpc-4547	150	11	transformation	transformation	NOUN
dpc-4547	150	12	can	can	AUX
dpc-4547	150	13	be	be	AUX
dpc-4547	150	14	assumed	assume	VERB
dpc-4547	150	15	by	by	ADP
dpc-4547	150	16	the	the	DET
dpc-4547	150	17	clinical	clinical	ADJ
dpc-4547	150	18	appearance	appearance	NOUN
dpc-4547	150	19	of	of	ADP
dpc-4547	150	20	ak	ak	PROPN
dpc-4547	151	1	[	[	X
dpc-4547	151	2	11	11	NUM
dpc-4547	151	3	]	]	PUNCT
dpc-4547	151	4	.	.	PUNCT
dpc-4547	152	1	still	still	ADV
dpc-4547	152	2	,	,	PUNCT
dpc-4547	152	3	the	the	DET
dpc-4547	152	4	reported	report	VERB
dpc-4547	152	5	findings	finding	NOUN
dpc-4547	152	6	imply	imply	VERB
dpc-4547	152	7	that	that	SCONJ
dpc-4547	152	8	the	the	DET
dpc-4547	152	9	downward	downward	ADJ
dpc-4547	152	10	proliferation	proliferation	NOUN
dpc-4547	152	11	and	and	CCONJ
dpc-4547	152	12	basal	basal	NOUN
dpc-4547	152	13	atypia	atypia	PROPN
dpc-4547	152	14	in	in	ADP
dpc-4547	152	15	ak	ak	PROPN
dpc-4547	152	16	are	be	AUX
dpc-4547	152	17	two	two	NUM
dpc-4547	152	18	major	major	ADJ
dpc-4547	152	19	factors	factor	NOUN
dpc-4547	152	20	for	for	ADP
dpc-4547	152	21	discrimination	discrimination	NOUN
dpc-4547	152	22	of	of	ADP
dpc-4547	152	23	high	high	ADJ
dpc-4547	152	24	-	-	PUNCT
dpc-4547	152	25	risk	risk	NOUN
dpc-4547	152	26	ak	ak	PROPN
dpc-4547	152	27	.	.	PUNCT
dpc-4547	153	1	unfortunately	unfortunately	ADV
dpc-4547	153	2	,	,	PUNCT
dpc-4547	153	3	they	they	PRON
dpc-4547	153	4	can	can	AUX
dpc-4547	153	5	not	not	PART
dpc-4547	153	6	be	be	AUX
dpc-4547	153	7	assessed	assess	VERB
dpc-4547	153	8	by	by	ADP
dpc-4547	153	9	clinical	clinical	ADJ
dpc-4547	153	10	appearance	appearance	NOUN
dpc-4547	153	11	and	and	CCONJ
dpc-4547	153	12	are	be	AUX
dpc-4547	153	13	not	not	PART
dpc-4547	153	14	routinely	routinely	ADV
dpc-4547	153	15	evaluated	evaluate	VERB
dpc-4547	153	16	in	in	ADP
dpc-4547	153	17	the	the	DET
dpc-4547	153	18	follow	follow	NOUN
dpc-4547	153	19	-	-	PUNCT
dpc-4547	153	20	up	up	NOUN
dpc-4547	153	21	of	of	ADP
dpc-4547	153	22	ak	ak	NOUN
dpc-4547	153	23	,	,	PUNCT
dpc-4547	153	24	due	due	ADP
dpc-4547	153	25	to	to	PART
dpc-4547	153	26	invasiveness	invasiveness	NOUN
dpc-4547	153	27	of	of	ADP
dpc-4547	153	28	skin	skin	NOUN
dpc-4547	153	29	biopsy	biopsy	NOUN
dpc-4547	154	1	[	[	X
dpc-4547	154	2	36	36	NUM
dpc-4547	154	3	,	,	PUNCT
dpc-4547	154	4	39	39	NUM
dpc-4547	154	5	]	]	PUNCT
dpc-4547	154	6	.	.	PUNCT
dpc-4547	155	1	hence	hence	ADV
dpc-4547	155	2	,	,	PUNCT
dpc-4547	155	3	no	no	DET
dpc-4547	155	4	long	long	ADJ
dpc-4547	155	5	-	-	PUNCT
dpc-4547	155	6	term	term	NOUN
dpc-4547	155	7	follow	follow	NOUN
dpc-4547	155	8	-	-	PUNCT
dpc-4547	155	9	up	up	ADP
dpc-4547	155	10	data	datum	NOUN
dpc-4547	155	11	of	of	ADP
dpc-4547	155	12	ak	ak	PROPN
dpc-4547	155	13	exists	exist	NOUN
dpc-4547	155	14	,	,	PUNCT
dpc-4547	155	15	reporting	report	VERB
dpc-4547	155	16	and	and	CCONJ
dpc-4547	155	17	documenting	document	VERB
dpc-4547	155	18	distinct	distinct	ADJ
dpc-4547	155	19	ongoing	ongoing	ADJ
dpc-4547	155	20	changes	change	NOUN
dpc-4547	155	21	in	in	ADP
dpc-4547	155	22	cellular	cellular	ADJ
dpc-4547	155	23	morphology	morphology	NOUN
dpc-4547	155	24	and	and	CCONJ
dpc-4547	155	25	epidermal	epidermal	ADJ
dpc-4547	155	26	architecture	architecture	NOUN
dpc-4547	155	27	in	in	ADP
dpc-4547	155	28	the	the	DET
dpc-4547	155	29	pathway	pathway	NOUN
dpc-4547	155	30	of	of	ADP
dpc-4547	155	31	malignant	malignant	ADJ
dpc-4547	155	32	transformation	transformation	NOUN
dpc-4547	155	33	.	.	PUNCT
dpc-4547	156	1	beside	beside	ADP
dpc-4547	156	2	these	these	DET
dpc-4547	156	3	histopathological	histopathological	ADJ
dpc-4547	156	4	features	feature	NOUN
dpc-4547	156	5	in	in	ADP
dpc-4547	156	6	ak	ak	PROPN
dpc-4547	156	7	,	,	PUNCT
dpc-4547	156	8	which	which	PRON
dpc-4547	156	9	may	may	AUX
dpc-4547	156	10	contribute	contribute	VERB
dpc-4547	156	11	to	to	ADP
dpc-4547	156	12	malignant	malignant	ADJ
dpc-4547	156	13	transformation	transformation	NOUN
dpc-4547	156	14	,	,	PUNCT
dpc-4547	156	15	schmitz	schmitz	PROPN
dpc-4547	156	16	et	et	PROPN
dpc-4547	156	17	al	al	PROPN
dpc-4547	156	18	.	.	PUNCT
dpc-4547	157	1	[	[	X
dpc-4547	157	2	41	41	NUM
dpc-4547	157	3	]	]	PUNCT
dpc-4547	157	4	identified	identify	VERB
dpc-4547	157	5	painfulness	painfulness	NOUN
dpc-4547	157	6	and	and	CCONJ
dpc-4547	157	7	refractory	refractory	NOUN
dpc-4547	157	8	of	of	ADP
dpc-4547	157	9	therapy	therapy	NOUN
dpc-4547	157	10	in	in	ADP
dpc-4547	157	11	ak	ak	PROPN
dpc-4547	157	12	as	as	ADP
dpc-4547	157	13	clinical	clinical	ADJ
dpc-4547	157	14	warning	warning	NOUN
dpc-4547	157	15	sign	sign	NOUN
dpc-4547	157	16	for	for	ADP
dpc-4547	157	17	malignant	malignant	ADJ
dpc-4547	157	18	transformation	transformation	NOUN
dpc-4547	157	19	,	,	PUNCT
dpc-4547	157	20	as	as	SCONJ
dpc-4547	157	21	those	those	DET
dpc-4547	157	22	therapy	therapy	NOUN
dpc-4547	157	23	-	-	PUNCT
dpc-4547	157	24	resistant	resistant	ADJ
dpc-4547	157	25	ak	ak	PROPN
dpc-4547	157	26	have	have	VERB
dpc-4547	157	27	an	an	DET
dpc-4547	157	28	underlying	underlie	VERB
dpc-4547	157	29	histology	histology	NOUN
dpc-4547	157	30	of	of	ADP
dpc-4547	157	31	highgrade	highgrade	NOUN
dpc-4547	157	32	atypia	atypia	PROPN
dpc-4547	157	33	(	(	PUNCT
dpc-4547	157	34	ak	ak	PROPN
dpc-4547	157	35	iii	iii	PROPN
dpc-4547	157	36	)	)	PUNCT
dpc-4547	157	37	and	and	CCONJ
dpc-4547	157	38	high	high	ADJ
dpc-4547	157	39	basal	basal	NOUN
dpc-4547	157	40	proliferation	proliferation	NOUN
dpc-4547	157	41	rates	rate	NOUN
dpc-4547	157	42	(	(	PUNCT
dpc-4547	157	43	pro	pro	X
dpc-4547	157	44	iii	iii	NOUN
dpc-4547	157	45	)	)	PUNCT
dpc-4547	157	46	.	.	PUNCT
dpc-4547	158	1	beside	beside	ADP
dpc-4547	158	2	intrinsic	intrinsic	ADJ
dpc-4547	158	3	risk	risk	NOUN
dpc-4547	158	4	factors	factor	NOUN
dpc-4547	158	5	for	for	ADP
dpc-4547	158	6	the	the	DET
dpc-4547	158	7	development	development	NOUN
dpc-4547	158	8	of	of	ADP
dpc-4547	158	9	ak	ak	PROPN
dpc-4547	158	10	,	,	PUNCT
dpc-4547	158	11	extrinsic	extrinsic	ADJ
dpc-4547	158	12	factors	factor	NOUN
dpc-4547	158	13	such	such	ADJ
dpc-4547	158	14	as	as	ADP
dpc-4547	158	15	intake	intake	NOUN
dpc-4547	158	16	of	of	ADP
dpc-4547	158	17	photosensitizing	photosensitize	VERB
dpc-4547	158	18	cardiovascular	cardiovascular	ADJ
dpc-4547	158	19	drugs	drug	NOUN
dpc-4547	158	20	seem	seem	VERB
dpc-4547	158	21	to	to	PART
dpc-4547	158	22	affect	affect	VERB
dpc-4547	158	23	the	the	DET
dpc-4547	158	24	likeliness	likeliness	NOUN
dpc-4547	158	25	of	of	ADP
dpc-4547	158	26	ak	ak	PROPN
dpc-4547	158	27	development	development	NOUN
dpc-4547	158	28	.	.	PUNCT
dpc-4547	159	1	studies	study	NOUN
dpc-4547	159	2	report	report	VERB
dpc-4547	159	3	exposure	exposure	NOUN
dpc-4547	159	4	to	to	ADP
dpc-4547	159	5	angiotensin	angiotensin	PROPN
dpc-4547	159	6	ii	ii	PROPN
dpc-4547	159	7	receptor	receptor	NOUN
dpc-4547	159	8	blockers	blocker	NOUN
dpc-4547	159	9	,	,	PUNCT
dpc-4547	159	10	angiotensin	angiotensin	NOUN
dpc-4547	159	11	-	-	PUNCT
dpc-4547	159	12	converting	convert	VERB
dpc-4547	159	13	enzyme	enzyme	NOUN
dpc-4547	159	14	inhibitors	inhibitor	NOUN
dpc-4547	159	15	and	and	CCONJ
dpc-4547	159	16	calcium	calcium	NOUN
dpc-4547	159	17	channel	channel	NOUN
dpc-4547	159	18	blockers	blocker	NOUN
dpc-4547	159	19	[	[	X
dpc-4547	159	20	42	42	NUM
dpc-4547	159	21	]	]	PUNCT
dpc-4547	159	22	.	.	PUNCT
dpc-4547	160	1	moreover	moreover	ADV
dpc-4547	160	2	,	,	PUNCT
dpc-4547	160	3	the	the	DET
dpc-4547	160	4	intake	intake	NOUN
dpc-4547	160	5	of	of	ADP
dpc-4547	160	6	antiplatelet	antiplatelet	NOUN
dpc-4547	160	7	agents	agent	NOUN
dpc-4547	160	8	was	be	AUX
dpc-4547	160	9	identified	identify	VERB
dpc-4547	160	10	as	as	ADP
dpc-4547	160	11	an	an	DET
dpc-4547	160	12	independent	independent	ADJ
dpc-4547	160	13	risk	risk	NOUN
dpc-4547	160	14	factor	factor	NOUN
dpc-4547	160	15	for	for	ADP
dpc-4547	160	16	ak	ak	PROPN
dpc-4547	160	17	development	development	PROPN
dpc-4547	160	18	[	[	X
dpc-4547	160	19	43	43	NUM
dpc-4547	160	20	]	]	PUNCT
dpc-4547	160	21	.	.	PUNCT
dpc-4547	161	1	risk	risk	NOUN
dpc-4547	161	2	factors	factor	NOUN
dpc-4547	161	3	for	for	ADP
dpc-4547	161	4	development	development	NOUN
dpc-4547	161	5	of	of	ADP
dpc-4547	161	6	ak	ak	PROPN
dpc-4547	161	7	and	and	CCONJ
dpc-4547	161	8	cscc	cscc	ADJ
dpc-4547	161	9	–	–	PUNCT
dpc-4547	161	10	immunosuppression	immunosuppression	NOUN
dpc-4547	161	11	solid	solid	ADJ
dpc-4547	161	12	organ	organ	NOUN
dpc-4547	161	13	transplant	transplant	NOUN
dpc-4547	161	14	recipients	recipient	NOUN
dpc-4547	161	15	(	(	PUNCT
dpc-4547	161	16	stors	stor	NOUN
dpc-4547	161	17	)	)	PUNCT
dpc-4547	161	18	under	under	ADP
dpc-4547	161	19	immunosuppression	immunosuppression	NOUN
dpc-4547	161	20	face	face	NOUN
dpc-4547	161	21	a	a	DET
dpc-4547	161	22	significant	significant	ADJ
dpc-4547	161	23	risk	risk	NOUN
dpc-4547	161	24	of	of	ADP
dpc-4547	161	25	developing	develop	VERB
dpc-4547	161	26	nmsc	nmsc	NOUN
dpc-4547	161	27	review	review	NOUN
dpc-4547	161	28	|	|	ADV
dpc-4547	161	29	dermatol	dermatol	ADJ
dpc-4547	161	30	pract	pract	NOUN
dpc-4547	161	31	concept	concept	NOUN
dpc-4547	161	32	.	.	PUNCT
dpc-4547	162	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	162	2	:	:	PUNCT
dpc-4547	162	3	e2024146s	e2024146s	ADV
dpc-4547	162	4	5	5	NUM
dpc-4547	162	5	cellular	cellular	ADJ
dpc-4547	162	6	level	level	NOUN
dpc-4547	162	7	,	,	PUNCT
dpc-4547	162	8	fc	fc	PROPN
dpc-4547	162	9	correlates	correlate	VERB
dpc-4547	162	10	with	with	ADP
dpc-4547	162	11	the	the	DET
dpc-4547	162	12	clonal	clonal	ADJ
dpc-4547	162	13	expansion	expansion	NOUN
dpc-4547	162	14	of	of	ADP
dpc-4547	162	15	a	a	DET
dpc-4547	162	16	mutant	mutant	ADJ
dpc-4547	162	17	cell	cell	NOUN
dpc-4547	162	18	clone	clone	NOUN
dpc-4547	162	19	,	,	PUNCT
dpc-4547	162	20	spreading	spread	VERB
dpc-4547	162	21	in	in	ADP
dpc-4547	162	22	tumor	tumor	NOUN
dpc-4547	162	23	adjacent	adjacent	ADJ
dpc-4547	162	24	tissue	tissue	NOUN
dpc-4547	162	25	and	and	CCONJ
dpc-4547	162	26	being	be	AUX
dpc-4547	162	27	susceptible	susceptible	ADJ
dpc-4547	162	28	for	for	ADP
dpc-4547	162	29	malignant	malignant	ADJ
dpc-4547	162	30	transformation	transformation	NOUN
dpc-4547	162	31	[	[	X
dpc-4547	162	32	79	79	NUM
dpc-4547	162	33	]	]	PUNCT
dpc-4547	162	34	.	.	PUNCT
dpc-4547	163	1	while	while	SCONJ
dpc-4547	163	2	fc	fc	PROPN
dpc-4547	163	3	was	be	AUX
dpc-4547	163	4	found	find	VERB
dpc-4547	163	5	in	in	ADP
dpc-4547	163	6	several	several	ADJ
dpc-4547	163	7	tumor	tumor	NOUN
dpc-4547	163	8	types	type	NOUN
dpc-4547	163	9	,	,	PUNCT
dpc-4547	163	10	such	such	ADJ
dpc-4547	163	11	as	as	ADP
dpc-4547	163	12	head	head	NOUN
dpc-4547	163	13	and	and	CCONJ
dpc-4547	163	14	neck	neck	NOUN
dpc-4547	163	15	,	,	PUNCT
dpc-4547	163	16	breast	breast	NOUN
dpc-4547	163	17	and	and	CCONJ
dpc-4547	163	18	cervix	cervix	NOUN
dpc-4547	163	19	,	,	PUNCT
dpc-4547	163	20	skin	skin	NOUN
dpc-4547	163	21	tissue	tissue	NOUN
dpc-4547	163	22	is	be	AUX
dpc-4547	163	23	especially	especially	ADV
dpc-4547	163	24	vulnerable	vulnerable	ADJ
dpc-4547	163	25	to	to	PART
dpc-4547	163	26	develop	develop	VERB
dpc-4547	163	27	cell	cell	NOUN
dpc-4547	163	28	atypia	atypia	NOUN
dpc-4547	163	29	,	,	PUNCT
dpc-4547	163	30	due	due	ADP
dpc-4547	163	31	to	to	ADP
dpc-4547	163	32	a	a	DET
dpc-4547	163	33	chronic	chronic	ADJ
dpc-4547	163	34	uvr	uvr	NOUN
dpc-4547	163	35	stimulus	stimulus	NOUN
dpc-4547	163	36	on	on	ADP
dpc-4547	163	37	sun	sun	NOUN
dpc-4547	163	38	-	-	PUNCT
dpc-4547	163	39	exposed	expose	VERB
dpc-4547	163	40	body	body	NOUN
dpc-4547	163	41	areas	area	NOUN
dpc-4547	163	42	such	such	ADJ
dpc-4547	163	43	as	as	ADP
dpc-4547	163	44	scalp	scalp	NOUN
dpc-4547	163	45	,	,	PUNCT
dpc-4547	163	46	forearms	forearm	NOUN
dpc-4547	163	47	,	,	PUNCT
dpc-4547	163	48	and	and	CCONJ
dpc-4547	163	49	dorsum	dorsum	NOUN
dpc-4547	163	50	of	of	ADP
dpc-4547	163	51	the	the	DET
dpc-4547	163	52	hand	hand	NOUN
dpc-4547	163	53	[	[	X
dpc-4547	163	54	79	79	NUM
dpc-4547	163	55	]	]	PUNCT
dpc-4547	163	56	.	.	PUNCT
dpc-4547	164	1	still	still	ADV
dpc-4547	164	2	,	,	PUNCT
dpc-4547	164	3	there	there	PRON
dpc-4547	164	4	is	be	VERB
dpc-4547	164	5	no	no	DET
dpc-4547	164	6	standardized	standardized	ADJ
dpc-4547	164	7	definition	definition	NOUN
dpc-4547	164	8	of	of	ADP
dpc-4547	164	9	fc	fc	PROPN
dpc-4547	164	10	implemented	implement	VERB
dpc-4547	164	11	to	to	ADP
dpc-4547	164	12	this	this	DET
dpc-4547	164	13	date	date	NOUN
dpc-4547	164	14	.	.	PUNCT
dpc-4547	165	1	vague	vague	ADJ
dpc-4547	165	2	definition	definition	NOUN
dpc-4547	165	3	describes	describe	VERB
dpc-4547	165	4	fc	fc	PROPN
dpc-4547	165	5	as	as	ADP
dpc-4547	165	6	an	an	DET
dpc-4547	165	7	anatomical	anatomical	ADJ
dpc-4547	165	8	area	area	NOUN
dpc-4547	165	9	suffering	suffer	VERB
dpc-4547	165	10	from	from	ADP
dpc-4547	165	11	ak	ak	PROPN
dpc-4547	165	12	or	or	CCONJ
dpc-4547	165	13	skin	skin	NOUN
dpc-4547	165	14	adjacent	adjacent	ADJ
dpc-4547	165	15	to	to	ADP
dpc-4547	165	16	ak	ak	PROPN
dpc-4547	165	17	showing	show	VERB
dpc-4547	165	18	at	at	ADP
dpc-4547	165	19	least	least	ADV
dpc-4547	165	20	two	two	NUM
dpc-4547	165	21	clinical	clinical	ADJ
dpc-4547	165	22	markers	marker	NOUN
dpc-4547	165	23	of	of	ADP
dpc-4547	165	24	chronic	chronic	ADJ
dpc-4547	165	25	actinic	actinic	ADJ
dpc-4547	165	26	sun	sun	NOUN
dpc-4547	165	27	exposure	exposure	NOUN
dpc-4547	165	28	,	,	PUNCT
dpc-4547	165	29	such	such	ADJ
dpc-4547	165	30	as	as	ADP
dpc-4547	165	31	telangiectasia	telangiectasia	NOUN
dpc-4547	165	32	,	,	PUNCT
dpc-4547	165	33	skin	skin	NOUN
dpc-4547	165	34	atrophy	atrophy	NOUN
dpc-4547	165	35	,	,	PUNCT
dpc-4547	165	36	pigmentation	pigmentation	NOUN
dpc-4547	165	37	disorder	disorder	NOUN
dpc-4547	165	38	or	or	CCONJ
dpc-4547	165	39	hyperkeratosis	hyperkeratosis	NOUN
dpc-4547	165	40	[	[	X
dpc-4547	165	41	80	80	NUM
dpc-4547	165	42	]	]	PUNCT
dpc-4547	165	43	.	.	PUNCT
dpc-4547	166	1	it	it	PRON
dpc-4547	166	2	remains	remain	VERB
dpc-4547	166	3	unclear	unclear	ADJ
dpc-4547	166	4	,	,	PUNCT
dpc-4547	166	5	whether	whether	SCONJ
dpc-4547	166	6	fc	fc	PROPN
dpc-4547	166	7	can	can	AUX
dpc-4547	166	8	be	be	AUX
dpc-4547	166	9	assumed	assume	VERB
dpc-4547	166	10	without	without	ADP
dpc-4547	166	11	clinical	clinical	ADJ
dpc-4547	166	12	appearance	appearance	NOUN
dpc-4547	166	13	of	of	ADP
dpc-4547	166	14	ak	ak	PROPN
dpc-4547	166	15	,	,	PUNCT
dpc-4547	166	16	or	or	CCONJ
dpc-4547	166	17	not	not	PART
dpc-4547	166	18	[	[	X
dpc-4547	166	19	80	80	NUM
dpc-4547	166	20	]	]	PUNCT
dpc-4547	166	21	.	.	PUNCT
dpc-4547	167	1	while	while	SCONJ
dpc-4547	167	2	,	,	PUNCT
dpc-4547	167	3	ak	ak	PROPN
dpc-4547	167	4	and	and	CCONJ
dpc-4547	167	5	fc	fc	PROPN
dpc-4547	167	6	are	be	AUX
dpc-4547	167	7	currently	currently	ADV
dpc-4547	167	8	not	not	PART
dpc-4547	167	9	considered	consider	VERB
dpc-4547	167	10	distinct	distinct	ADJ
dpc-4547	167	11	diagnosis	diagnosis	NOUN
dpc-4547	167	12	from	from	ADP
dpc-4547	167	13	each	each	DET
dpc-4547	167	14	other	other	ADJ
dpc-4547	167	15	,	,	PUNCT
dpc-4547	167	16	presence	presence	NOUN
dpc-4547	167	17	of	of	ADP
dpc-4547	167	18	fc	fc	PROPN
dpc-4547	167	19	is	be	AUX
dpc-4547	167	20	associated	associate	VERB
dpc-4547	167	21	with	with	ADP
dpc-4547	167	22	development	development	NOUN
dpc-4547	167	23	of	of	ADP
dpc-4547	167	24	a	a	DET
dpc-4547	167	25	poor	poor	ADJ
dpc-4547	167	26	disease	disease	NOUN
dpc-4547	167	27	-	-	PUNCT
dpc-4547	167	28	related	relate	VERB
dpc-4547	167	29	outcome	outcome	NOUN
dpc-4547	167	30	compared	compare	VERB
dpc-4547	167	31	to	to	ADP
dpc-4547	167	32	presence	presence	NOUN
dpc-4547	167	33	of	of	ADP
dpc-4547	167	34	several	several	ADJ
dpc-4547	167	35	discrete	discrete	NOUN
dpc-4547	167	36	ak	ak	PROPN
dpc-4547	168	1	[	[	X
dpc-4547	168	2	81	81	NUM
dpc-4547	168	3	]	]	PUNCT
dpc-4547	168	4	.	.	PUNCT
dpc-4547	169	1	the	the	DET
dpc-4547	169	2	lack	lack	NOUN
dpc-4547	169	3	of	of	ADP
dpc-4547	169	4	understanding	understanding	NOUN
dpc-4547	169	5	fc	fc	INTJ
dpc-4547	169	6	correctly	correctly	ADV
dpc-4547	169	7	and	and	CCONJ
dpc-4547	169	8	treating	treat	VERB
dpc-4547	169	9	fc	fc	PROPN
dpc-4547	169	10	and	and	CCONJ
dpc-4547	169	11	multiple	multiple	PROPN
dpc-4547	169	12	ak	ak	PROPN
dpc-4547	169	13	equally	equally	ADV
dpc-4547	169	14	,	,	PUNCT
dpc-4547	169	15	may	may	AUX
dpc-4547	169	16	lead	lead	VERB
dpc-4547	169	17	to	to	ADP
dpc-4547	169	18	undertreatment	undertreatment	NOUN
dpc-4547	169	19	of	of	ADP
dpc-4547	169	20	fc	fc	PROPN
dpc-4547	169	21	patients	patient	NOUN
dpc-4547	169	22	and	and	CCONJ
dpc-4547	169	23	poor	poor	ADJ
dpc-4547	169	24	outcomes	outcome	NOUN
dpc-4547	169	25	eventually	eventually	ADV
dpc-4547	169	26	[	[	X
dpc-4547	169	27	81	81	NUM
dpc-4547	169	28	]	]	PUNCT
dpc-4547	169	29	.	.	PUNCT
dpc-4547	170	1	studies	study	NOUN
dpc-4547	170	2	found	find	VERB
dpc-4547	170	3	that	that	SCONJ
dpc-4547	170	4	the	the	DET
dpc-4547	170	5	risk	risk	NOUN
dpc-4547	170	6	for	for	ADP
dpc-4547	170	7	development	development	NOUN
dpc-4547	170	8	of	of	ADP
dpc-4547	170	9	cscc	cscc	PROPN
dpc-4547	170	10	correlates	correlate	VERB
dpc-4547	170	11	with	with	ADP
dpc-4547	170	12	the	the	DET
dpc-4547	170	13	number	number	NOUN
dpc-4547	170	14	of	of	ADP
dpc-4547	170	15	ak	ak	PROPN
dpc-4547	170	16	present	present	NOUN
dpc-4547	170	17	.	.	PUNCT
dpc-4547	171	1	even	even	ADV
dpc-4547	171	2	immunocompetent	immunocompetent	ADJ
dpc-4547	171	3	patients	patient	NOUN
dpc-4547	171	4	have	have	VERB
dpc-4547	171	5	a	a	DET
dpc-4547	171	6	5.7	5.7	NUM
dpc-4547	171	7	-	-	ADJ
dpc-4547	171	8	fold	fold	ADJ
dpc-4547	171	9	increased	increased	ADJ
dpc-4547	171	10	risk	risk	NOUN
dpc-4547	171	11	for	for	ADP
dpc-4547	171	12	cscc	cscc	ADJ
dpc-4547	171	13	manifestation	manifestation	NOUN
dpc-4547	171	14	,	,	PUNCT
dpc-4547	171	15	when	when	SCONJ
dpc-4547	171	16	more	more	ADJ
dpc-4547	171	17	than	than	ADP
dpc-4547	171	18	15	15	NUM
dpc-4547	171	19	aks	ak	NOUN
dpc-4547	171	20	are	be	AUX
dpc-4547	171	21	present	present	ADJ
dpc-4547	171	22	on	on	ADP
dpc-4547	171	23	the	the	DET
dpc-4547	171	24	head	head	NOUN
dpc-4547	171	25	and	and	CCONJ
dpc-4547	171	26	neck	neck	NOUN
dpc-4547	171	27	area	area	NOUN
dpc-4547	172	1	[	[	X
dpc-4547	172	2	82	82	NUM
dpc-4547	172	3	]	]	PUNCT
dpc-4547	172	4	.	.	PUNCT
dpc-4547	173	1	willenbrink	willenbrink	PROPN
dpc-4547	173	2	et	et	PROPN
dpc-4547	173	3	al	al	PROPN
dpc-4547	173	4	.	.	PUNCT
dpc-4547	174	1	[	[	X
dpc-4547	174	2	81	81	NUM
dpc-4547	174	3	]	]	PUNCT
dpc-4547	174	4	presume	presume	VERB
dpc-4547	174	5	,	,	PUNCT
dpc-4547	174	6	that	that	SCONJ
dpc-4547	174	7	regarding	regard	VERB
dpc-4547	174	8	fc	fc	PROPN
dpc-4547	174	9	,	,	PUNCT
dpc-4547	174	10	patients	patient	NOUN
dpc-4547	174	11	face	face	VERB
dpc-4547	174	12	an	an	DET
dpc-4547	174	13	even	even	ADV
dpc-4547	174	14	higher	high	ADJ
dpc-4547	174	15	risk	risk	NOUN
dpc-4547	174	16	,	,	PUNCT
dpc-4547	174	17	due	due	ADP
dpc-4547	174	18	to	to	ADP
dpc-4547	174	19	the	the	DET
dpc-4547	174	20	confluent	confluent	ADJ
dpc-4547	174	21	nature	nature	NOUN
dpc-4547	174	22	of	of	ADP
dpc-4547	174	23	ak	ak	PROPN
dpc-4547	174	24	and	and	CCONJ
dpc-4547	174	25	the	the	DET
dpc-4547	174	26	wide	wide	ADJ
dpc-4547	174	27	field	field	NOUN
dpc-4547	174	28	of	of	ADP
dpc-4547	174	29	premalignant	premalignant	ADJ
dpc-4547	174	30	atypical	atypical	ADJ
dpc-4547	174	31	keratinocytes	keratinocyte	NOUN
dpc-4547	174	32	,	,	PUNCT
dpc-4547	174	33	prone	prone	ADJ
dpc-4547	174	34	to	to	ADP
dpc-4547	174	35	malignant	malignant	ADJ
dpc-4547	174	36	transformation	transformation	NOUN
dpc-4547	174	37	.	.	PUNCT
dpc-4547	175	1	risk	risk	NOUN
dpc-4547	175	2	factors	factor	NOUN
dpc-4547	175	3	for	for	ADP
dpc-4547	175	4	developing	develop	VERB
dpc-4547	175	5	fc	fc	PROPN
dpc-4547	175	6	are	be	AUX
dpc-4547	175	7	similar	similar	ADJ
dpc-4547	175	8	to	to	ADP
dpc-4547	175	9	those	those	PRON
dpc-4547	175	10	of	of	ADP
dpc-4547	175	11	ak	ak	PROPN
dpc-4547	175	12	and	and	CCONJ
dpc-4547	175	13	cscc	cscc	VERB
dpc-4547	175	14	and	and	CCONJ
dpc-4547	175	15	can	can	AUX
dpc-4547	175	16	be	be	AUX
dpc-4547	175	17	narrowed	narrow	VERB
dpc-4547	175	18	down	down	ADP
dpc-4547	175	19	to	to	ADP
dpc-4547	175	20	duration	duration	NOUN
dpc-4547	175	21	of	of	ADP
dpc-4547	175	22	uvr	uvr	ADJ
dpc-4547	175	23	exposure	exposure	NOUN
dpc-4547	175	24	,	,	PUNCT
dpc-4547	175	25	age	age	NOUN
dpc-4547	175	26	,	,	PUNCT
dpc-4547	175	27	fair	fair	ADJ
dpc-4547	175	28	skin	skin	NOUN
dpc-4547	175	29	type	type	NOUN
dpc-4547	175	30	,	,	PUNCT
dpc-4547	175	31	male	male	ADJ
dpc-4547	175	32	sex	sex	NOUN
dpc-4547	175	33	and	and	CCONJ
dpc-4547	175	34	immunosuppression	immunosuppression	NOUN
dpc-4547	175	35	[	[	X
dpc-4547	175	36	81	81	NUM
dpc-4547	175	37	]	]	PUNCT
dpc-4547	175	38	.	.	PUNCT
dpc-4547	176	1	for	for	ADP
dpc-4547	176	2	age	age	NOUN
dpc-4547	176	3	,	,	PUNCT
dpc-4547	176	4	a	a	DET
dpc-4547	176	5	4	4	NUM
dpc-4547	176	6	-	-	ADJ
dpc-4547	176	7	fold	fold	ADJ
dpc-4547	176	8	increased	increased	ADJ
dpc-4547	176	9	risk	risk	NOUN
dpc-4547	176	10	of	of	ADP
dpc-4547	176	11	ak	ak	PROPN
dpc-4547	176	12	development	development	NOUN
dpc-4547	176	13	is	be	AUX
dpc-4547	176	14	reported	report	VERB
dpc-4547	176	15	for	for	ADP
dpc-4547	176	16	the	the	DET
dpc-4547	176	17	age	age	NOUN
dpc-4547	176	18	group	group	NOUN
dpc-4547	176	19	of	of	ADP
dpc-4547	176	20	61	61	NUM
dpc-4547	176	21	to	to	PART
dpc-4547	176	22	70	70	NUM
dpc-4547	176	23	year	year	NOUN
dpc-4547	176	24	of	of	ADP
dpc-4547	176	25	age	age	NOUN
dpc-4547	176	26	.	.	PUNCT
dpc-4547	177	1	the	the	DET
dpc-4547	177	2	same	same	ADJ
dpc-4547	177	3	increased	increase	VERB
dpc-4547	177	4	risk	risk	NOUN
dpc-4547	177	5	is	be	AUX
dpc-4547	177	6	reported	report	VERB
dpc-4547	177	7	for	for	ADP
dpc-4547	177	8	male	male	ADJ
dpc-4547	177	9	sex	sex	NOUN
dpc-4547	177	10	in	in	ADP
dpc-4547	177	11	the	the	DET
dpc-4547	177	12	german	german	ADJ
dpc-4547	177	13	population	population	NOUN
dpc-4547	178	1	[	[	X
dpc-4547	178	2	83	83	NUM
dpc-4547	178	3	,	,	PUNCT
dpc-4547	178	4	84	84	NUM
dpc-4547	178	5	]	]	PUNCT
dpc-4547	178	6	.	.	PUNCT
dpc-4547	179	1	in	in	ADP
dpc-4547	179	2	males	male	NOUN
dpc-4547	179	3	the	the	DET
dpc-4547	179	4	prevalence	prevalence	NOUN
dpc-4547	179	5	of	of	ADP
dpc-4547	179	6	extensive	extensive	ADJ
dpc-4547	179	7	sun	sun	NOUN
dpc-4547	179	8	damage	damage	NOUN
dpc-4547	179	9	(	(	PUNCT
dpc-4547	179	10	minimum	minimum	NOUN
dpc-4547	179	11	of	of	ADP
dpc-4547	179	12	ten	ten	NUM
dpc-4547	179	13	ak	ak	NOUN
dpc-4547	179	14	)	)	PUNCT
dpc-4547	179	15	is	be	AUX
dpc-4547	179	16	three	three	NUM
dpc-4547	179	17	times	time	NOUN
dpc-4547	179	18	more	more	ADV
dpc-4547	179	19	present	present	ADJ
dpc-4547	179	20	compared	compare	VERB
dpc-4547	179	21	to	to	ADP
dpc-4547	179	22	females	female	NOUN
dpc-4547	179	23	[	[	X
dpc-4547	179	24	85	85	NUM
dpc-4547	179	25	]	]	PUNCT
dpc-4547	179	26	.	.	PUNCT
dpc-4547	180	1	in	in	ADP
dpc-4547	180	2	terms	term	NOUN
dpc-4547	180	3	of	of	ADP
dpc-4547	180	4	body	body	NOUN
dpc-4547	180	5	site	site	NOUN
dpc-4547	180	6	,	,	PUNCT
dpc-4547	180	7	the	the	DET
dpc-4547	180	8	single	single	ADJ
dpc-4547	180	9	strongest	strong	ADJ
dpc-4547	180	10	risk	risk	NOUN
dpc-4547	180	11	factor	factor	NOUN
dpc-4547	180	12	for	for	ADP
dpc-4547	180	13	development	development	NOUN
dpc-4547	180	14	of	of	ADP
dpc-4547	180	15	ten	ten	NUM
dpc-4547	180	16	ak	ak	PROPN
dpc-4547	180	17	is	be	AUX
dpc-4547	180	18	reported	report	VERB
dpc-4547	180	19	to	to	PART
dpc-4547	180	20	be	be	AUX
dpc-4547	180	21	scalp	scalp	NOUN
dpc-4547	180	22	baldness	baldness	NOUN
dpc-4547	180	23	in	in	ADP
dpc-4547	180	24	males	male	NOUN
dpc-4547	180	25	[	[	X
dpc-4547	180	26	85	85	NUM
dpc-4547	180	27	]	]	PUNCT
dpc-4547	180	28	.	.	PUNCT
dpc-4547	181	1	willenbrink	willenbrink	PROPN
dpc-4547	181	2	et	et	PROPN
dpc-4547	181	3	al.[81	al.[81	PROPN
dpc-4547	181	4	]	]	PUNCT
dpc-4547	181	5	experienced	experience	VERB
dpc-4547	181	6	the	the	DET
dpc-4547	181	7	highest	high	ADJ
dpc-4547	181	8	risk	risk	NOUN
dpc-4547	181	9	for	for	ADP
dpc-4547	181	10	the	the	DET
dpc-4547	181	11	occurrence	occurrence	NOUN
dpc-4547	181	12	of	of	ADP
dpc-4547	181	13	fc	fc	PROPN
dpc-4547	181	14	in	in	ADP
dpc-4547	181	15	immunosuppressed	immunosuppressed	ADJ
dpc-4547	181	16	patients	patient	NOUN
dpc-4547	181	17	,	,	PUNCT
dpc-4547	181	18	such	such	ADJ
dpc-4547	181	19	as	as	ADP
dpc-4547	181	20	stors	stor	NOUN
dpc-4547	181	21	.	.	PUNCT
dpc-4547	182	1	this	this	DET
dpc-4547	182	2	assumption	assumption	NOUN
dpc-4547	182	3	is	be	AUX
dpc-4547	182	4	backed	back	VERB
dpc-4547	182	5	by	by	ADP
dpc-4547	182	6	evidence	evidence	NOUN
dpc-4547	182	7	reporting	report	VERB
dpc-4547	182	8	a	a	DET
dpc-4547	182	9	prevalence	prevalence	NOUN
dpc-4547	182	10	of	of	ADP
dpc-4547	182	11	17	17	NUM
dpc-4547	182	12	%	%	NOUN
dpc-4547	182	13	of	of	ADP
dpc-4547	182	14	fc	fc	PROPN
dpc-4547	182	15	in	in	ADP
dpc-4547	182	16	stor	stor	PROPN
dpc-4547	182	17	cohorts	cohort	NOUN
dpc-4547	182	18	[	[	X
dpc-4547	182	19	81	81	NUM
dpc-4547	182	20	]	]	PUNCT
dpc-4547	182	21	.	.	PUNCT
dpc-4547	183	1	as	as	SCONJ
dpc-4547	183	2	patients	patient	NOUN
dpc-4547	183	3	suffering	suffer	VERB
dpc-4547	183	4	from	from	ADP
dpc-4547	183	5	fc	fc	PROPN
dpc-4547	183	6	may	may	AUX
dpc-4547	183	7	develop	develop	VERB
dpc-4547	183	8	cscc	cscc	ADJ
dpc-4547	183	9	more	more	ADV
dpc-4547	183	10	likely	likely	ADJ
dpc-4547	183	11	,	,	PUNCT
dpc-4547	183	12	the	the	DET
dpc-4547	183	13	development	development	NOUN
dpc-4547	183	14	of	of	ADP
dpc-4547	183	15	multiple	multiple	ADJ
dpc-4547	183	16	cscc	cscc	ADJ
dpc-4547	183	17	during	during	ADP
dpc-4547	183	18	a	a	DET
dpc-4547	183	19	patient	patient	NOUN
dpc-4547	183	20	’s	’s	PART
dpc-4547	183	21	lifetime	lifetime	NOUN
dpc-4547	183	22	is	be	AUX
dpc-4547	183	23	clearly	clearly	ADV
dpc-4547	183	24	associated	associate	VERB
dpc-4547	183	25	with	with	ADP
dpc-4547	183	26	a	a	DET
dpc-4547	183	27	significant	significant	ADJ
dpc-4547	183	28	worsening	worsening	NOUN
dpc-4547	183	29	of	of	ADP
dpc-4547	183	30	disease	disease	NOUN
dpc-4547	183	31	burden	burden	NOUN
dpc-4547	183	32	in	in	ADP
dpc-4547	183	33	terms	term	NOUN
dpc-4547	183	34	of	of	ADP
dpc-4547	183	35	aggressive	aggressive	ADJ
dpc-4547	183	36	disease	disease	NOUN
dpc-4547	183	37	progress	progress	NOUN
dpc-4547	183	38	.	.	PUNCT
dpc-4547	184	1	it	it	PRON
dpc-4547	184	2	is	be	AUX
dpc-4547	184	3	reported	report	VERB
dpc-4547	184	4	that	that	SCONJ
dpc-4547	184	5	patients	patient	NOUN
dpc-4547	184	6	suffering	suffer	VERB
dpc-4547	184	7	from	from	ADP
dpc-4547	184	8	more	more	ADJ
dpc-4547	184	9	than	than	ADP
dpc-4547	184	10	ten	ten	NUM
dpc-4547	184	11	cscc	cscc	NOUN
dpc-4547	184	12	have	have	VERB
dpc-4547	184	13	a	a	DET
dpc-4547	184	14	3.8	3.8	NUM
dpc-4547	184	15	-	-	SYM
dpc-4547	184	16	4.2	4.2	NUM
dpc-4547	184	17	times	time	NOUN
dpc-4547	184	18	increased	increase	VERB
dpc-4547	184	19	risk	risk	NOUN
dpc-4547	184	20	for	for	ADP
dpc-4547	184	21	nodal	nodal	NOUN
dpc-4547	184	22	metastasis	metastasis	NOUN
dpc-4547	184	23	and	and	CCONJ
dpc-4547	184	24	diseases	disease	NOUN
dpc-4547	184	25	recurrence	recurrence	NOUN
dpc-4547	184	26	,	,	PUNCT
dpc-4547	184	27	compared	compare	VERB
dpc-4547	184	28	to	to	ADP
dpc-4547	184	29	patients	patient	NOUN
dpc-4547	184	30	with	with	ADP
dpc-4547	184	31	a	a	DET
dpc-4547	184	32	single	single	ADJ
dpc-4547	184	33	cscc	cscc	NOUN
dpc-4547	185	1	[	[	X
dpc-4547	185	2	77	77	NUM
dpc-4547	185	3	]	]	PUNCT
dpc-4547	185	4	.	.	PUNCT
dpc-4547	186	1	provide	provide	VERB
dpc-4547	186	2	mechanism	mechanism	NOUN
dpc-4547	186	3	of	of	ADP
dpc-4547	186	4	control	control	NOUN
dpc-4547	186	5	for	for	ADP
dpc-4547	186	6	secondary	secondary	ADJ
dpc-4547	186	7	and	and	CCONJ
dpc-4547	186	8	tertiary	tertiary	ADJ
dpc-4547	186	9	prophylaxis	prophylaxis	NOUN
dpc-4547	186	10	.	.	PUNCT
dpc-4547	187	1	in	in	ADP
dpc-4547	187	2	terms	term	NOUN
dpc-4547	187	3	of	of	ADP
dpc-4547	187	4	management	management	NOUN
dpc-4547	187	5	of	of	ADP
dpc-4547	187	6	immunosuppressive	immunosuppressive	ADJ
dpc-4547	187	7	medication	medication	NOUN
dpc-4547	187	8	in	in	ADP
dpc-4547	187	9	stors	stor	NOUN
dpc-4547	187	10	,	,	PUNCT
dpc-4547	187	11	mammalian	mammalian	ADJ
dpc-4547	187	12	target	target	NOUN
dpc-4547	187	13	of	of	ADP
dpc-4547	187	14	rapamycin	rapamycin	NOUN
dpc-4547	187	15	(	(	PUNCT
dpc-4547	187	16	mtor	mtor	NOUN
dpc-4547	187	17	)	)	PUNCT
dpc-4547	187	18	inhibitors	inhibitor	NOUN
dpc-4547	187	19	should	should	AUX
dpc-4547	187	20	be	be	AUX
dpc-4547	187	21	implemented	implement	VERB
dpc-4547	187	22	as	as	ADP
dpc-4547	187	23	the	the	DET
dpc-4547	187	24	preferred	prefer	VERB
dpc-4547	187	25	immunosuppressive	immunosuppressive	ADJ
dpc-4547	187	26	medication	medication	NOUN
dpc-4547	187	27	of	of	ADP
dpc-4547	187	28	choice	choice	NOUN
dpc-4547	187	29	[	[	X
dpc-4547	187	30	65	65	NUM
dpc-4547	187	31	]	]	PUNCT
dpc-4547	187	32	.	.	PUNCT
dpc-4547	188	1	unlike	unlike	ADP
dpc-4547	188	2	immunosuppressive	immunosuppressive	ADJ
dpc-4547	188	3	drugs	drug	NOUN
dpc-4547	188	4	such	such	ADJ
dpc-4547	188	5	as	as	ADP
dpc-4547	188	6	cyclosporine	cyclosporine	NOUN
dpc-4547	188	7	,	,	PUNCT
dpc-4547	188	8	azathioprin	azathioprin	NOUN
dpc-4547	188	9	or	or	CCONJ
dpc-4547	188	10	high	high	ADJ
dpc-4547	188	11	dose	dose	NOUN
dpc-4547	188	12	corticosteroids	corticosteroid	NOUN
dpc-4547	188	13	,	,	PUNCT
dpc-4547	188	14	mtor	mtor	PROPN
dpc-4547	188	15	inhibitors	inhibitor	NOUN
dpc-4547	188	16	prevent	prevent	VERB
dpc-4547	188	17	multiple	multiple	ADJ
dpc-4547	188	18	mechanisms	mechanism	NOUN
dpc-4547	188	19	involved	involve	VERB
dpc-4547	188	20	in	in	ADP
dpc-4547	188	21	carcinogenesis	carcinogenesis	NOUN
dpc-4547	188	22	,	,	PUNCT
dpc-4547	188	23	such	such	ADJ
dpc-4547	188	24	as	as	ADP
dpc-4547	188	25	angiogenesis	angiogenesis	NOUN
dpc-4547	188	26	,	,	PUNCT
dpc-4547	188	27	cell	cell	NOUN
dpc-4547	188	28	expansion	expansion	NOUN
dpc-4547	188	29	and	and	CCONJ
dpc-4547	188	30	cell	cell	NOUN
dpc-4547	188	31	survival	survival	NOUN
dpc-4547	189	1	[	[	X
dpc-4547	189	2	66	66	NUM
dpc-4547	189	3	-	-	SYM
dpc-4547	189	4	68	68	NUM
dpc-4547	189	5	]	]	PUNCT
dpc-4547	189	6	.	.	PUNCT
dpc-4547	190	1	moreover	moreover	ADV
dpc-4547	190	2	,	,	PUNCT
dpc-4547	190	3	mtor	mtor	PROPN
dpc-4547	190	4	inhibitors	inhibitor	NOUN
dpc-4547	190	5	block	block	VERB
dpc-4547	190	6	the	the	DET
dpc-4547	190	7	hpv	hpv	NOUN
dpc-4547	190	8	related	relate	VERB
dpc-4547	190	9	induction	induction	NOUN
dpc-4547	190	10	of	of	ADP
dpc-4547	190	11	mtor	mtor	PROPN
dpc-4547	190	12	pathway	pathway	NOUN
dpc-4547	190	13	and	and	CCONJ
dpc-4547	190	14	therefore	therefore	ADV
dpc-4547	190	15	act	act	VERB
dpc-4547	190	16	as	as	ADP
dpc-4547	190	17	antivirals	antiviral	NOUN
dpc-4547	190	18	,	,	PUNCT
dpc-4547	190	19	by	by	ADP
dpc-4547	190	20	inhibiting	inhibit	VERB
dpc-4547	190	21	growth	growth	NOUN
dpc-4547	190	22	of	of	ADP
dpc-4547	190	23	hpv-16	hpv-16	PROPN
dpc-4547	190	24	-	-	PUNCT
dpc-4547	190	25	immortalised	immortalise	VERB
dpc-4547	190	26	keratinocytes	keratinocyte	NOUN
dpc-4547	190	27	[	[	X
dpc-4547	190	28	66	66	NUM
dpc-4547	190	29	-	-	SYM
dpc-4547	190	30	69	69	NUM
dpc-4547	190	31	]	]	PUNCT
dpc-4547	190	32	.	.	PUNCT
dpc-4547	191	1	other	other	ADJ
dpc-4547	191	2	strategies	strategy	NOUN
dpc-4547	191	3	should	should	AUX
dpc-4547	191	4	include	include	VERB
dpc-4547	191	5	,	,	PUNCT
dpc-4547	191	6	early	early	ADJ
dpc-4547	191	7	treatment	treatment	NOUN
dpc-4547	191	8	of	of	ADP
dpc-4547	191	9	premalignant	premalignant	ADJ
dpc-4547	191	10	and	and	CCONJ
dpc-4547	191	11	malignant	malignant	ADJ
dpc-4547	191	12	lesions	lesion	NOUN
dpc-4547	191	13	,	,	PUNCT
dpc-4547	191	14	by	by	ADP
dpc-4547	191	15	non	non	ADJ
dpc-4547	191	16	-	-	ADJ
dpc-4547	191	17	invasive	invasive	ADJ
dpc-4547	191	18	and	and	CCONJ
dpc-4547	191	19	invasive	invasive	ADJ
dpc-4547	191	20	means	mean	NOUN
dpc-4547	191	21	,	,	PUNCT
dpc-4547	191	22	but	but	CCONJ
dpc-4547	191	23	should	should	AUX
dpc-4547	191	24	also	also	ADV
dpc-4547	191	25	comprise	comprise	VERB
dpc-4547	191	26	prophylactic	prophylactic	ADJ
dpc-4547	191	27	approaches	approach	NOUN
dpc-4547	191	28	,	,	PUNCT
dpc-4547	191	29	such	such	ADJ
dpc-4547	191	30	as	as	ADP
dpc-4547	191	31	photoprotection	photoprotection	NOUN
dpc-4547	191	32	,	,	PUNCT
dpc-4547	191	33	reduction	reduction	NOUN
dpc-4547	191	34	of	of	ADP
dpc-4547	191	35	immunosuppression	immunosuppression	NOUN
dpc-4547	191	36	,	,	PUNCT
dpc-4547	191	37	use	use	NOUN
dpc-4547	191	38	of	of	ADP
dpc-4547	191	39	mtor	mtor	NOUN
dpc-4547	191	40	and	and	CCONJ
dpc-4547	191	41	chemoprophylaxis	chemoprophylaxis	PROPN
dpc-4547	191	42	.	.	PUNCT
dpc-4547	192	1	retinoids	retinoid	NOUN
dpc-4547	192	2	,	,	PUNCT
dpc-4547	192	3	such	such	ADJ
dpc-4547	192	4	as	as	ADP
dpc-4547	192	5	acitretin	acitretin	NOUN
dpc-4547	192	6	,	,	PUNCT
dpc-4547	192	7	a	a	DET
dpc-4547	192	8	synthetic	synthetic	ADJ
dpc-4547	192	9	vitamin	vitamin	NOUN
dpc-4547	192	10	a	a	DET
dpc-4547	192	11	substitute	substitute	NOUN
dpc-4547	192	12	,	,	PUNCT
dpc-4547	192	13	seem	seem	VERB
dpc-4547	192	14	to	to	PART
dpc-4547	192	15	provide	provide	VERB
dpc-4547	192	16	a	a	DET
dpc-4547	192	17	favorable	favorable	ADJ
dpc-4547	192	18	approach	approach	NOUN
dpc-4547	192	19	for	for	ADP
dpc-4547	192	20	prophylaxis	prophylaxis	NOUN
dpc-4547	192	21	of	of	ADP
dpc-4547	192	22	nmsc	nmsc	NOUN
dpc-4547	192	23	in	in	ADP
dpc-4547	192	24	this	this	DET
dpc-4547	192	25	population	population	NOUN
dpc-4547	192	26	,	,	PUNCT
dpc-4547	192	27	due	due	ADP
dpc-4547	192	28	to	to	ADP
dpc-4547	192	29	their	their	PRON
dpc-4547	192	30	positive	positive	ADJ
dpc-4547	192	31	effects	effect	NOUN
dpc-4547	192	32	on	on	ADP
dpc-4547	192	33	cell	cell	NOUN
dpc-4547	192	34	cycle	cycle	NOUN
dpc-4547	192	35	control	control	NOUN
dpc-4547	193	1	[	[	X
dpc-4547	193	2	70	70	NUM
dpc-4547	193	3	]	]	PUNCT
dpc-4547	193	4	.	.	PUNCT
dpc-4547	194	1	these	these	PRON
dpc-4547	194	2	include	include	VERB
dpc-4547	194	3	stimulation	stimulation	NOUN
dpc-4547	194	4	of	of	ADP
dpc-4547	194	5	cellular	cellular	ADJ
dpc-4547	194	6	differentiation	differentiation	NOUN
dpc-4547	194	7	and	and	CCONJ
dpc-4547	194	8	induction	induction	NOUN
dpc-4547	194	9	of	of	ADP
dpc-4547	194	10	apoptosis	apoptosis	NOUN
dpc-4547	194	11	,	,	PUNCT
dpc-4547	194	12	beside	beside	ADP
dpc-4547	194	13	immunomodulatory	immunomodulatory	ADJ
dpc-4547	194	14	aspects	aspect	NOUN
dpc-4547	194	15	,	,	PUNCT
dpc-4547	194	16	cellular	cellular	ADJ
dpc-4547	194	17	proliferation	proliferation	NOUN
dpc-4547	194	18	,	,	PUNCT
dpc-4547	194	19	and	and	CCONJ
dpc-4547	194	20	keratinization	keratinization	NOUN
dpc-4547	194	21	[	[	X
dpc-4547	194	22	70	70	NUM
dpc-4547	194	23	]	]	PUNCT
dpc-4547	194	24	.	.	PUNCT
dpc-4547	195	1	another	another	DET
dpc-4547	195	2	favorable	favorable	ADJ
dpc-4547	195	3	attribute	attribute	NOUN
dpc-4547	195	4	of	of	ADP
dpc-4547	195	5	acitretin	acitretin	NOUN
dpc-4547	195	6	is	be	AUX
dpc-4547	195	7	the	the	DET
dpc-4547	195	8	inhibition	inhibition	NOUN
dpc-4547	195	9	of	of	ADP
dpc-4547	195	10	ornithine	ornithine	ADJ
dpc-4547	195	11	decarboxylase	decarboxylase	NOUN
dpc-4547	195	12	,	,	PUNCT
dpc-4547	195	13	the	the	DET
dpc-4547	195	14	initial	initial	ADJ
dpc-4547	195	15	rate	rate	NOUN
dpc-4547	195	16	-	-	PUNCT
dpc-4547	195	17	limiting	limit	VERB
dpc-4547	195	18	enzyme	enzyme	NOUN
dpc-4547	195	19	in	in	ADP
dpc-4547	195	20	the	the	DET
dpc-4547	195	21	polyamine	polyamine	NOUN
dpc-4547	195	22	biosynthetic	biosynthetic	ADJ
dpc-4547	195	23	pathway	pathway	NOUN
dpc-4547	195	24	,	,	PUNCT
dpc-4547	195	25	being	be	AUX
dpc-4547	195	26	responsible	responsible	ADJ
dpc-4547	195	27	for	for	ADP
dpc-4547	195	28	elevated	elevated	ADJ
dpc-4547	195	29	levels	level	NOUN
dpc-4547	195	30	of	of	ADP
dpc-4547	195	31	polyamines	polyamine	NOUN
dpc-4547	195	32	found	find	VERB
dpc-4547	195	33	in	in	ADP
dpc-4547	195	34	highly	highly	ADV
dpc-4547	195	35	proliferating	proliferate	VERB
dpc-4547	195	36	tumor	tumor	NOUN
dpc-4547	195	37	cells	cell	NOUN
dpc-4547	195	38	[	[	X
dpc-4547	195	39	70	70	NUM
dpc-4547	195	40	,	,	PUNCT
dpc-4547	195	41	71	71	NUM
dpc-4547	195	42	]	]	PUNCT
dpc-4547	195	43	.	.	PUNCT
dpc-4547	196	1	several	several	ADJ
dpc-4547	196	2	studies	study	NOUN
dpc-4547	196	3	report	report	VERB
dpc-4547	196	4	a	a	DET
dpc-4547	196	5	reduction	reduction	NOUN
dpc-4547	196	6	of	of	ADP
dpc-4547	196	7	cscc	cscc	ADJ
dpc-4547	196	8	incidence	incidence	NOUN
dpc-4547	196	9	in	in	ADP
dpc-4547	196	10	cohorts	cohort	NOUN
dpc-4547	196	11	under	under	ADP
dpc-4547	196	12	chemoprophylaxis	chemoprophylaxis	NOUN
dpc-4547	196	13	with	with	ADP
dpc-4547	196	14	acitretin	acitretin	NOUN
dpc-4547	196	15	for	for	ADP
dpc-4547	196	16	at	at	ADV
dpc-4547	196	17	least	least	ADV
dpc-4547	196	18	three	three	NUM
dpc-4547	196	19	to	to	PART
dpc-4547	196	20	five	five	NUM
dpc-4547	196	21	years	year	NOUN
dpc-4547	196	22	and	and	CCONJ
dpc-4547	196	23	report	report	NOUN
dpc-4547	196	24	‘	'	PUNCT
dpc-4547	196	25	rebound	rebound	VERB
dpc-4547	196	26	effect	effect	NOUN
dpc-4547	196	27	’	'	PUNCT
dpc-4547	196	28	with	with	ADP
dpc-4547	196	29	rapid	rapid	ADJ
dpc-4547	196	30	increases	increase	NOUN
dpc-4547	196	31	in	in	ADP
dpc-4547	196	32	cscc	cscc	ADJ
dpc-4547	196	33	incidence	incidence	NOUN
dpc-4547	196	34	after	after	ADP
dpc-4547	196	35	discontinuation	discontinuation	NOUN
dpc-4547	196	36	of	of	ADP
dpc-4547	196	37	acitretin	acitretin	NOUN
dpc-4547	196	38	,	,	PUNCT
dpc-4547	196	39	but	but	CCONJ
dpc-4547	196	40	beneficial	beneficial	ADJ
dpc-4547	196	41	long	long	ADJ
dpc-4547	196	42	-	-	PUNCT
dpc-4547	196	43	term	term	NOUN
dpc-4547	196	44	effects	effect	NOUN
dpc-4547	196	45	are	be	AUX
dpc-4547	196	46	not	not	PART
dpc-4547	196	47	fully	fully	ADV
dpc-4547	196	48	studied	study	VERB
dpc-4547	196	49	to	to	ADP
dpc-4547	196	50	this	this	DET
dpc-4547	196	51	date	date	NOUN
dpc-4547	196	52	[	[	X
dpc-4547	196	53	72	72	NUM
dpc-4547	196	54	-	-	SYM
dpc-4547	196	55	75	75	NUM
dpc-4547	196	56	]	]	PUNCT
dpc-4547	196	57	.	.	PUNCT
dpc-4547	197	1	still	still	ADV
dpc-4547	197	2	the	the	DET
dpc-4547	197	3	named	name	VERB
dpc-4547	197	4	favorable	favorable	ADJ
dpc-4547	197	5	aspects	aspect	NOUN
dpc-4547	197	6	of	of	ADP
dpc-4547	197	7	acitretin	acitretin	NOUN
dpc-4547	197	8	find	find	VERB
dpc-4547	197	9	recognition	recognition	NOUN
dpc-4547	197	10	in	in	ADP
dpc-4547	197	11	a	a	DET
dpc-4547	197	12	consensus	consensus	NOUN
dpc-4547	197	13	-	-	PUNCT
dpc-4547	197	14	based	base	VERB
dpc-4547	197	15	recommendation	recommendation	NOUN
dpc-4547	197	16	on	on	ADP
dpc-4547	197	17	the	the	DET
dpc-4547	197	18	prevention	prevention	NOUN
dpc-4547	197	19	of	of	ADP
dpc-4547	197	20	cscc	cscc	NOUN
dpc-4547	197	21	from	from	ADP
dpc-4547	197	22	the	the	DET
dpc-4547	197	23	year	year	NOUN
dpc-4547	197	24	2021	2021	NUM
dpc-4547	197	25	,	,	PUNCT
dpc-4547	197	26	advocating	advocate	VERB
dpc-4547	197	27	for	for	ADP
dpc-4547	197	28	the	the	DET
dpc-4547	197	29	beneficial	beneficial	ADJ
dpc-4547	197	30	use	use	NOUN
dpc-4547	197	31	of	of	ADP
dpc-4547	197	32	acitretin	acitretin	NOUN
dpc-4547	197	33	as	as	ADP
dpc-4547	197	34	chemoprophylaxis	chemoprophylaxis	NOUN
dpc-4547	197	35	in	in	ADP
dpc-4547	197	36	stors	stor	NOUN
dpc-4547	197	37	,	,	PUNCT
dpc-4547	197	38	who	who	PRON
dpc-4547	197	39	either	either	CCONJ
dpc-4547	197	40	develop	develop	VERB
dpc-4547	197	41	a	a	DET
dpc-4547	197	42	single	single	ADJ
dpc-4547	197	43	high	high	ADJ
dpc-4547	197	44	-	-	PUNCT
dpc-4547	197	45	risk	risk	NOUN
dpc-4547	197	46	cutaneous	cutaneous	ADJ
dpc-4547	197	47	cscc	cscc	NOUN
dpc-4547	197	48	after	after	ADP
dpc-4547	197	49	multiple	multiple	ADJ
dpc-4547	197	50	low	low	ADJ
dpc-4547	197	51	-	-	PUNCT
dpc-4547	197	52	risk	risk	NOUN
dpc-4547	197	53	csccs	csccs	NOUN
dpc-4547	197	54	,	,	PUNCT
dpc-4547	197	55	or	or	CCONJ
dpc-4547	197	56	more	more	ADJ
dpc-4547	197	57	than	than	ADP
dpc-4547	197	58	ten	ten	NUM
dpc-4547	197	59	low	low	ADJ
dpc-4547	197	60	-	-	PUNCT
dpc-4547	197	61	risk	risk	NOUN
dpc-4547	197	62	csccs	csccs	NOUN
dpc-4547	197	63	per	per	ADP
dpc-4547	197	64	year	year	NOUN
dpc-4547	197	65	[	[	X
dpc-4547	197	66	76	76	NUM
dpc-4547	197	67	]	]	PUNCT
dpc-4547	197	68	.	.	PUNCT
dpc-4547	198	1	challenges	challenge	NOUN
dpc-4547	198	2	in	in	ADP
dpc-4547	198	3	ak	ak	PROPN
dpc-4547	198	4	treatment	treatment	NOUN
dpc-4547	198	5	–	–	PUNCT
dpc-4547	198	6	field	field	NOUN
dpc-4547	198	7	cancerization	cancerization	NOUN
dpc-4547	198	8	patients	patient	NOUN
dpc-4547	198	9	suffering	suffer	VERB
dpc-4547	198	10	from	from	ADP
dpc-4547	198	11	actinic	actinic	ADJ
dpc-4547	198	12	fc	fc	PROPN
dpc-4547	198	13	are	be	AUX
dpc-4547	198	14	at	at	ADP
dpc-4547	198	15	the	the	DET
dpc-4547	198	16	highest	high	ADJ
dpc-4547	198	17	risk	risk	NOUN
dpc-4547	198	18	to	to	PART
dpc-4547	198	19	develop	develop	VERB
dpc-4547	198	20	multiple	multiple	ADJ
dpc-4547	198	21	nmsc	nmsc	NOUN
dpc-4547	198	22	during	during	ADP
dpc-4547	198	23	their	their	PRON
dpc-4547	198	24	lifetime	lifetime	NOUN
dpc-4547	198	25	usually	usually	ADV
dpc-4547	198	26	being	be	AUX
dpc-4547	198	27	associated	associate	VERB
dpc-4547	198	28	with	with	ADP
dpc-4547	198	29	poor	poor	ADJ
dpc-4547	198	30	outcomes	outcome	NOUN
dpc-4547	198	31	[	[	X
dpc-4547	198	32	77	77	NUM
dpc-4547	198	33	]	]	PUNCT
dpc-4547	198	34	.	.	PUNCT
dpc-4547	199	1	the	the	DET
dpc-4547	199	2	concept	concept	NOUN
dpc-4547	199	3	of	of	ADP
dpc-4547	199	4	fc	fc	PROPN
dpc-4547	199	5	was	be	AUX
dpc-4547	199	6	first	first	ADV
dpc-4547	199	7	described	describe	VERB
dpc-4547	199	8	in	in	ADP
dpc-4547	199	9	1953	1953	NUM
dpc-4547	199	10	by	by	ADP
dpc-4547	199	11	slaughter	slaughter	NOUN
dpc-4547	199	12	et	et	PROPN
dpc-4547	199	13	al	al	PROPN
dpc-4547	199	14	.	.	PUNCT
dpc-4547	200	1	[	[	X
dpc-4547	200	2	78	78	NUM
dpc-4547	200	3	]	]	PUNCT
dpc-4547	200	4	,	,	PUNCT
dpc-4547	200	5	examining	examine	VERB
dpc-4547	200	6	more	more	ADJ
dpc-4547	200	7	than	than	ADP
dpc-4547	200	8	700	700	NUM
dpc-4547	200	9	tissue	tissue	NOUN
dpc-4547	200	10	samples	sample	NOUN
dpc-4547	200	11	of	of	ADP
dpc-4547	200	12	oropharyngeal	oropharyngeal	ADJ
dpc-4547	200	13	carcinoma	carcinoma	NOUN
dpc-4547	200	14	.	.	PUNCT
dpc-4547	201	1	in	in	ADP
dpc-4547	201	2	a	a	DET
dpc-4547	201	3	predominant	predominant	ADJ
dpc-4547	201	4	number	number	NOUN
dpc-4547	201	5	of	of	ADP
dpc-4547	201	6	the	the	DET
dpc-4547	201	7	reported	report	VERB
dpc-4547	201	8	cases	case	NOUN
dpc-4547	201	9	,	,	PUNCT
dpc-4547	201	10	the	the	DET
dpc-4547	201	11	unsuspicious	unsuspicious	ADJ
dpc-4547	201	12	appearing	appearing	ADJ
dpc-4547	201	13	surrounding	surround	VERB
dpc-4547	201	14	tissue	tissue	NOUN
dpc-4547	201	15	harbored	harbor	VERB
dpc-4547	201	16	pathologically	pathologically	ADV
dpc-4547	201	17	relevant	relevant	ADJ
dpc-4547	201	18	cell	cell	NOUN
dpc-4547	201	19	atypia	atypia	PROPN
dpc-4547	201	20	,	,	PUNCT
dpc-4547	201	21	leading	lead	VERB
dpc-4547	201	22	to	to	ADP
dpc-4547	201	23	a	a	DET
dpc-4547	201	24	substantial	substantial	ADJ
dpc-4547	201	25	number	number	NOUN
dpc-4547	201	26	of	of	ADP
dpc-4547	201	27	second	second	ADJ
dpc-4547	201	28	tumor	tumor	NOUN
dpc-4547	201	29	manifestation	manifestation	NOUN
dpc-4547	201	30	in	in	ADP
dpc-4547	201	31	the	the	DET
dpc-4547	201	32	subsequent	subsequent	ADJ
dpc-4547	201	33	[	[	X
dpc-4547	201	34	78	78	NUM
dpc-4547	201	35	]	]	PUNCT
dpc-4547	201	36	.	.	PUNCT
dpc-4547	202	1	on	on	ADP
dpc-4547	202	2	6	6	NUM
dpc-4547	202	3	review	review	NOUN
dpc-4547	202	4	|	|	ADV
dpc-4547	202	5	dermatol	dermatol	ADJ
dpc-4547	202	6	pract	pract	NOUN
dpc-4547	202	7	concept	concept	NOUN
dpc-4547	202	8	.	.	PUNCT
dpc-4547	203	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	203	2	:	:	PUNCT
dpc-4547	203	3	e2024146s	e2024146s	X
dpc-4547	203	4	beds	bed	NOUN
dpc-4547	203	5	,	,	PUNCT
dpc-4547	203	6	such	such	ADJ
dpc-4547	203	7	as	as	ADP
dpc-4547	203	8	australia	australia	PROPN
dpc-4547	203	9	and	and	CCONJ
dpc-4547	203	10	brazil	brazil	PROPN
dpc-4547	204	1	[	[	X
dpc-4547	204	2	102	102	NUM
dpc-4547	204	3	]	]	PUNCT
dpc-4547	204	4	.	.	PUNCT
dpc-4547	204	5	 	 	SPACE
dpc-4547	204	6	in	in	ADP
dpc-4547	204	7	austria	austria	PROPN
dpc-4547	204	8	,	,	PUNCT
dpc-4547	204	9	belgium	belgium	PROPN
dpc-4547	204	10	,	,	PUNCT
dpc-4547	204	11	france	france	PROPN
dpc-4547	204	12	,	,	PUNCT
dpc-4547	204	13	germany	germany	PROPN
dpc-4547	204	14	,	,	PUNCT
dpc-4547	204	15	portugal	portugal	PROPN
dpc-4547	204	16	,	,	PUNCT
dpc-4547	204	17	spain	spain	PROPN
dpc-4547	204	18	,	,	PUNCT
dpc-4547	204	19	and	and	CCONJ
dpc-4547	204	20	the	the	DET
dpc-4547	204	21	united	united	ADJ
dpc-4547	204	22	kingdom	kingdom	PROPN
dpc-4547	204	23	,	,	PUNCT
dpc-4547	204	24	only	only	ADV
dpc-4547	204	25	bans	ban	NOUN
dpc-4547	204	26	for	for	ADP
dpc-4547	204	27	minors	minor	NOUN
dpc-4547	204	28	under	under	ADP
dpc-4547	204	29	the	the	DET
dpc-4547	204	30	age	age	NOUN
dpc-4547	204	31	of	of	ADP
dpc-4547	204	32	18	18	NUM
dpc-4547	204	33	exist	exist	NOUN
dpc-4547	204	34	[	[	X
dpc-4547	204	35	102	102	NUM
dpc-4547	204	36	]	]	PUNCT
dpc-4547	204	37	.	.	PUNCT
dpc-4547	205	1	data	datum	NOUN
dpc-4547	205	2	from	from	ADP
dpc-4547	205	3	the	the	DET
dpc-4547	205	4	us	us	PROPN
dpc-4547	205	5	shows	show	VERB
dpc-4547	205	6	that	that	SCONJ
dpc-4547	205	7	,	,	PUNCT
dpc-4547	205	8	while	while	SCONJ
dpc-4547	205	9	indoor	indoor	ADJ
dpc-4547	205	10	tanning	tanning	NOUN
dpc-4547	205	11	prevalence	prevalence	NOUN
dpc-4547	205	12	decreased	decrease	VERB
dpc-4547	205	13	significantly	significantly	ADV
dpc-4547	205	14	among	among	ADP
dpc-4547	205	15	all	all	PRON
dpc-4547	205	16	us	us	PROPN
dpc-4547	205	17	adults	adult	NOUN
dpc-4547	205	18	from	from	ADP
dpc-4547	205	19	2007	2007	NUM
dpc-4547	205	20	to	to	ADP
dpc-4547	205	21	2018	2018	NUM
dpc-4547	205	22	(	(	PUNCT
dpc-4547	205	23	10	10	NUM
dpc-4547	205	24	%	%	NOUN
dpc-4547	205	25	vs.	vs.	ADP
dpc-4547	205	26	4	4	NUM
dpc-4547	205	27	%	%	NOUN
dpc-4547	205	28	)	)	PUNCT
dpc-4547	205	29	,	,	PUNCT
dpc-4547	205	30	frequent	frequent	ADJ
dpc-4547	205	31	indoor	indoor	ADJ
dpc-4547	205	32	tanning	tanning	NOUN
dpc-4547	205	33	was	be	AUX
dpc-4547	205	34	still	still	ADV
dpc-4547	205	35	common	common	ADJ
dpc-4547	205	36	in	in	ADP
dpc-4547	205	37	2018	2018	NUM
dpc-4547	205	38	with	with	ADP
dpc-4547	205	39	nearly	nearly	ADV
dpc-4547	205	40	25	25	NUM
dpc-4547	205	41	%	%	NOUN
dpc-4547	205	42	of	of	ADP
dpc-4547	205	43	respondents	respondent	NOUN
dpc-4547	205	44	reporting	report	VERB
dpc-4547	205	45	the	the	DET
dpc-4547	205	46	use	use	NOUN
dpc-4547	205	47	of	of	ADP
dpc-4547	205	48	indoor	indoor	ADJ
dpc-4547	205	49	tanning	tanning	NOUN
dpc-4547	205	50	25	25	NUM
dpc-4547	205	51	times	time	NOUN
dpc-4547	205	52	or	or	CCONJ
dpc-4547	205	53	more	more	ADJ
dpc-4547	205	54	per	per	ADP
dpc-4547	205	55	year	year	NOUN
dpc-4547	205	56	[	[	X
dpc-4547	205	57	103	103	NUM
dpc-4547	205	58	]	]	PUNCT
dpc-4547	205	59	.	.	PUNCT
dpc-4547	206	1	oral	oral	ADJ
dpc-4547	206	2	drugs	drug	NOUN
dpc-4547	206	3	for	for	ADP
dpc-4547	206	4	skin	skin	NOUN
dpc-4547	206	5	cancer	cancer	NOUN
dpc-4547	206	6	prevention	prevention	NOUN
dpc-4547	206	7	beside	beside	ADP
dpc-4547	206	8	topical	topical	ADJ
dpc-4547	206	9	ointment	ointment	NOUN
dpc-4547	206	10	,	,	PUNCT
dpc-4547	206	11	several	several	ADJ
dpc-4547	206	12	systemic	systemic	ADJ
dpc-4547	206	13	agents	agent	NOUN
dpc-4547	206	14	have	have	AUX
dpc-4547	206	15	been	be	AUX
dpc-4547	206	16	investigated	investigate	VERB
dpc-4547	206	17	for	for	ADP
dpc-4547	206	18	its	its	PRON
dpc-4547	206	19	use	use	NOUN
dpc-4547	206	20	and	and	CCONJ
dpc-4547	206	21	effectiveness	effectiveness	NOUN
dpc-4547	206	22	in	in	ADP
dpc-4547	206	23	the	the	DET
dpc-4547	206	24	secondary	secondary	ADJ
dpc-4547	206	25	prevention	prevention	NOUN
dpc-4547	206	26	of	of	ADP
dpc-4547	206	27	ak	ak	PROPN
dpc-4547	206	28	development	development	PROPN
dpc-4547	206	29	.	.	PUNCT
dpc-4547	207	1	chemoprophylaxis	chemoprophylaxis	PROPN
dpc-4547	207	2	of	of	ADP
dpc-4547	207	3	ak	ak	PROPN
dpc-4547	207	4	can	can	AUX
dpc-4547	207	5	be	be	AUX
dpc-4547	207	6	implemented	implement	VERB
dpc-4547	207	7	to	to	PART
dpc-4547	207	8	prevent	prevent	VERB
dpc-4547	207	9	the	the	DET
dpc-4547	207	10	occurrence	occurrence	NOUN
dpc-4547	207	11	or	or	CCONJ
dpc-4547	207	12	reoccurrence	reoccurrence	NOUN
dpc-4547	207	13	of	of	ADP
dpc-4547	207	14	new	new	ADJ
dpc-4547	207	15	ak	ak	PROPN
dpc-4547	207	16	lesions	lesion	NOUN
dpc-4547	207	17	.	.	PUNCT
dpc-4547	208	1	niacinamide	niacinamide	NOUN
dpc-4547	208	2	niacinamide	niacinamide	NOUN
dpc-4547	208	3	is	be	AUX
dpc-4547	208	4	the	the	DET
dpc-4547	208	5	water	water	NOUN
dpc-4547	208	6	-	-	PUNCT
dpc-4547	208	7	soluble	soluble	ADJ
dpc-4547	208	8	derivate	derivate	NOUN
dpc-4547	208	9	of	of	ADP
dpc-4547	208	10	vitamin	vitamin	NOUN
dpc-4547	208	11	b3	b3	PROPN
dpc-4547	208	12	,	,	PUNCT
dpc-4547	208	13	a	a	DET
dpc-4547	208	14	key	key	ADJ
dpc-4547	208	15	-	-	PUNCT
dpc-4547	208	16	coenzyme	coenzyme	NOUN
dpc-4547	208	17	in	in	ADP
dpc-4547	208	18	the	the	DET
dpc-4547	208	19	generation	generation	NOUN
dpc-4547	208	20	of	of	ADP
dpc-4547	208	21	adp	adp	PROPN
dpc-4547	208	22	on	on	ADP
dpc-4547	208	23	cellular	cellular	ADJ
dpc-4547	208	24	level	level	NOUN
dpc-4547	208	25	,	,	PUNCT
dpc-4547	208	26	by	by	ADP
dpc-4547	208	27	its	its	PRON
dpc-4547	208	28	role	role	NOUN
dpc-4547	208	29	for	for	ADP
dpc-4547	208	30	the	the	DET
dpc-4547	208	31	formation	formation	NOUN
dpc-4547	208	32	of	of	ADP
dpc-4547	208	33	nad+	nad+	PROPN
dpc-4547	208	34	complex	complex	ADJ
dpc-4547	208	35	.	.	PUNCT
dpc-4547	209	1	atypical	atypical	ADJ
dpc-4547	209	2	keratinocytes	keratinocyte	NOUN
dpc-4547	209	3	in	in	ADP
dpc-4547	209	4	ak	ak	PROPN
dpc-4547	209	5	are	be	AUX
dpc-4547	209	6	reported	report	VERB
dpc-4547	209	7	to	to	PART
dpc-4547	209	8	produce	produce	VERB
dpc-4547	209	9	significant	significant	ADJ
dpc-4547	209	10	lower	low	ADJ
dpc-4547	209	11	levels	level	NOUN
dpc-4547	209	12	of	of	ADP
dpc-4547	209	13	adp	adp	PROPN
dpc-4547	209	14	,	,	PUNCT
dpc-4547	209	15	which	which	PRON
dpc-4547	209	16	is	be	AUX
dpc-4547	209	17	physiologically	physiologically	ADV
dpc-4547	209	18	required	require	VERB
dpc-4547	209	19	as	as	ADP
dpc-4547	209	20	a	a	DET
dpc-4547	209	21	source	source	NOUN
dpc-4547	209	22	for	for	ADP
dpc-4547	209	23	intracellular	intracellular	ADJ
dpc-4547	209	24	energy	energy	NOUN
dpc-4547	209	25	production	production	NOUN
dpc-4547	209	26	in	in	ADP
dpc-4547	209	27	terms	term	NOUN
dpc-4547	209	28	of	of	ADP
dpc-4547	209	29	providing	provide	VERB
dpc-4547	209	30	functioning	function	VERB
dpc-4547	209	31	dna	dna	PROPN
dpc-4547	209	32	strand	strand	NOUN
dpc-4547	209	33	repair	repair	NOUN
dpc-4547	209	34	mechanism	mechanism	NOUN
dpc-4547	209	35	[	[	X
dpc-4547	209	36	104	104	NUM
dpc-4547	209	37	]	]	PUNCT
dpc-4547	209	38	.	.	PUNCT
dpc-4547	210	1	this	this	DET
dpc-4547	210	2	loss	loss	NOUN
dpc-4547	210	3	of	of	ADP
dpc-4547	210	4	mechanism	mechanism	NOUN
dpc-4547	210	5	is	be	AUX
dpc-4547	210	6	reported	report	VERB
dpc-4547	210	7	to	to	PART
dpc-4547	210	8	reduce	reduce	VERB
dpc-4547	210	9	the	the	DET
dpc-4547	210	10	effectiveness	effectiveness	NOUN
dpc-4547	210	11	of	of	ADP
dpc-4547	210	12	dna	dna	PROPN
dpc-4547	210	13	repair	repair	NOUN
dpc-4547	210	14	and	and	CCONJ
dpc-4547	210	15	promotes	promote	VERB
dpc-4547	210	16	development	development	NOUN
dpc-4547	210	17	of	of	ADP
dpc-4547	210	18	cscc	cscc	NOUN
dpc-4547	211	1	[	[	X
dpc-4547	211	2	105	105	NUM
dpc-4547	211	3	,	,	PUNCT
dpc-4547	211	4	106	106	NUM
dpc-4547	211	5	]	]	PUNCT
dpc-4547	211	6	.	.	PUNCT
dpc-4547	212	1	niacinamide	niacinamide	NOUN
dpc-4547	212	2	also	also	ADV
dpc-4547	212	3	reduces	reduce	VERB
dpc-4547	212	4	uv	uv	NOUN
dpc-4547	212	5	radiation	radiation	NOUN
dpc-4547	212	6	induced	induce	VERB
dpc-4547	212	7	skin	skin	NOUN
dpc-4547	212	8	inflammation	inflammation	NOUN
dpc-4547	212	9	by	by	ADP
dpc-4547	212	10	significant	significant	ADJ
dpc-4547	212	11	downregulation	downregulation	NOUN
dpc-4547	212	12	of	of	ADP
dpc-4547	212	13	il-6	il-6	NOUN
dpc-4547	212	14	,	,	PUNCT
dpc-4547	212	15	il-10	il-10	PRON
dpc-4547	212	16	,	,	PUNCT
dpc-4547	212	17	mcp-1	mcp-1	X
dpc-4547	212	18	and	and	CCONJ
dpc-4547	212	19	tnf	tnf	PROPN
dpc-4547	212	20	-	-	PUNCT
dpc-4547	212	21	α	α	PROPN
dpc-4547	212	22	mrna	mrna	NOUN
dpc-4547	212	23	expression	expression	NOUN
dpc-4547	212	24	,	,	PUNCT
dpc-4547	212	25	in	in	ADP
dpc-4547	212	26	vitro	vitro	X
dpc-4547	212	27	[	[	PUNCT
dpc-4547	212	28	107	107	NUM
dpc-4547	212	29	]	]	PUNCT
dpc-4547	212	30	.	.	PUNCT
dpc-4547	213	1	additionally	additionally	ADV
dpc-4547	213	2	,	,	PUNCT
dpc-4547	213	3	oral	oral	ADJ
dpc-4547	213	4	and	and	CCONJ
dpc-4547	213	5	topical	topical	ADJ
dpc-4547	213	6	nicotinamide	nicotinamide	NOUN
dpc-4547	213	7	have	have	AUX
dpc-4547	213	8	shown	show	VERB
dpc-4547	213	9	to	to	PART
dpc-4547	213	10	be	be	AUX
dpc-4547	213	11	immune	immune	ADJ
dpc-4547	213	12	protective	protective	ADJ
dpc-4547	213	13	against	against	ADP
dpc-4547	213	14	uvbr	uvbr	NOUN
dpc-4547	213	15	and	and	CCONJ
dpc-4547	213	16	uvar	uvar	NOUN
dpc-4547	213	17	[	[	X
dpc-4547	213	18	108	108	NUM
dpc-4547	213	19	,	,	PUNCT
dpc-4547	213	20	109	109	NUM
dpc-4547	213	21	]	]	PUNCT
dpc-4547	213	22	.	.	PUNCT
dpc-4547	214	1	multiple	multiple	ADJ
dpc-4547	214	2	studies	study	NOUN
dpc-4547	214	3	have	have	AUX
dpc-4547	214	4	been	be	AUX
dpc-4547	214	5	conducted	conduct	VERB
dpc-4547	214	6	,	,	PUNCT
dpc-4547	214	7	investing	invest	VERB
dpc-4547	214	8	this	this	DET
dpc-4547	214	9	underlying	underlie	VERB
dpc-4547	214	10	pathway	pathway	NOUN
dpc-4547	214	11	in	in	ADP
dpc-4547	214	12	vitro	vitro	X
dpc-4547	214	13	.	.	PUNCT
dpc-4547	215	1	still	still	ADV
dpc-4547	215	2	clinical	clinical	ADJ
dpc-4547	215	3	studies	study	NOUN
dpc-4547	215	4	additionally	additionally	ADV
dpc-4547	215	5	suggest	suggest	VERB
dpc-4547	215	6	the	the	DET
dpc-4547	215	7	beneficial	beneficial	ADJ
dpc-4547	215	8	use	use	NOUN
dpc-4547	215	9	of	of	ADP
dpc-4547	215	10	niacinamide	niacinamide	NOUN
dpc-4547	215	11	in	in	ADP
dpc-4547	215	12	skin	skin	NOUN
dpc-4547	215	13	cancer	cancer	NOUN
dpc-4547	215	14	prevention	prevention	NOUN
dpc-4547	216	1	[	[	X
dpc-4547	216	2	106	106	NUM
dpc-4547	216	3	,	,	PUNCT
dpc-4547	216	4	109	109	NUM
dpc-4547	216	5	]	]	PUNCT
dpc-4547	216	6	.	.	PUNCT
dpc-4547	217	1	park	park	NOUN
dpc-4547	217	2	et	et	PROPN
dpc-4547	217	3	al	al	PROPN
dpc-4547	217	4	.	.	PUNCT
dpc-4547	218	1	[	[	X
dpc-4547	218	2	104	104	NUM
dpc-4547	218	3	]	]	PUNCT
dpc-4547	218	4	were	be	AUX
dpc-4547	218	5	able	able	ADJ
dpc-4547	218	6	to	to	PART
dpc-4547	218	7	show	show	VERB
dpc-4547	218	8	by	by	ADP
dpc-4547	218	9	microarray	microarray	NOUN
dpc-4547	218	10	studies	study	NOUN
dpc-4547	218	11	on	on	ADP
dpc-4547	218	12	in	in	ADP
dpc-4547	218	13	vivo	vivo	NOUN
dpc-4547	218	14	irradiated	irradiate	VERB
dpc-4547	218	15	human	human	ADJ
dpc-4547	218	16	skin	skin	NOUN
dpc-4547	218	17	,	,	PUNCT
dpc-4547	218	18	that	that	SCONJ
dpc-4547	218	19	uv	uv	NOUN
dpc-4547	218	20	-	-	PUNCT
dpc-4547	218	21	induced	induce	VERB
dpc-4547	218	22	cellular	cellular	ADJ
dpc-4547	218	23	atp	atp	NOUN
dpc-4547	218	24	loss	loss	NOUN
dpc-4547	218	25	was	be	AUX
dpc-4547	218	26	reduced	reduce	VERB
dpc-4547	218	27	by	by	ADP
dpc-4547	218	28	substitution	substitution	NOUN
dpc-4547	218	29	of	of	ADP
dpc-4547	218	30	niacinamide	niacinamide	NOUN
dpc-4547	218	31	but	but	CCONJ
dpc-4547	218	32	did	do	AUX
dpc-4547	218	33	not	not	PART
dpc-4547	218	34	affect	affect	VERB
dpc-4547	218	35	ros	ros	PROPN
dpc-4547	218	36	formation	formation	NOUN
dpc-4547	218	37	or	or	CCONJ
dpc-4547	218	38	keratinocyte	keratinocyte	NOUN
dpc-4547	218	39	apoptosis	apoptosis	NOUN
dpc-4547	218	40	.	.	PUNCT
dpc-4547	219	1	chen	chen	PROPN
dpc-4547	219	2	et	et	PROPN
dpc-4547	219	3	al	al	PROPN
dpc-4547	219	4	.	.	PUNCT
dpc-4547	220	1	[	[	X
dpc-4547	220	2	110	110	NUM
dpc-4547	220	3	]	]	PUNCT
dpc-4547	220	4	were	be	AUX
dpc-4547	220	5	able	able	ADJ
dpc-4547	220	6	to	to	PART
dpc-4547	220	7	show	show	VERB
dpc-4547	220	8	in	in	ADP
dpc-4547	220	9	a	a	DET
dpc-4547	220	10	double	double	ADJ
dpc-4547	220	11	-	-	PUNCT
dpc-4547	220	12	blinded	blind	VERB
dpc-4547	220	13	,	,	PUNCT
dpc-4547	220	14	randomized	randomize	VERB
dpc-4547	220	15	,	,	PUNCT
dpc-4547	220	16	controlled	control	VERB
dpc-4547	220	17	trial	trial	NOUN
dpc-4547	220	18	,	,	PUNCT
dpc-4547	220	19	  	  	SPACE
dpc-4547	220	20	including	include	VERB
dpc-4547	220	21	386	386	NUM
dpc-4547	220	22	immunocompetent	immunocompetent	ADJ
dpc-4547	220	23	australians	australian	NOUN
dpc-4547	220	24	with	with	ADP
dpc-4547	220	25	a	a	DET
dpc-4547	220	26	history	history	NOUN
dpc-4547	220	27	of	of	ADP
dpc-4547	220	28	least	least	ADJ
dpc-4547	220	29	two	two	NUM
dpc-4547	220	30	nmscs	nmsc	NOUN
dpc-4547	220	31	,	,	PUNCT
dpc-4547	220	32	that	that	SCONJ
dpc-4547	220	33	the	the	DET
dpc-4547	220	34	intake	intake	NOUN
dpc-4547	220	35	of	of	ADP
dpc-4547	220	36	500	500	NUM
dpc-4547	220	37	mg	mg	NOUN
dpc-4547	220	38	of	of	ADP
dpc-4547	220	39	niacinamide	niacinamide	NOUN
dpc-4547	220	40	twice	twice	ADV
dpc-4547	220	41	daily	daily	ADV
dpc-4547	220	42	,	,	PUNCT
dpc-4547	220	43	significantly	significantly	ADV
dpc-4547	220	44	lowered	lower	VERB
dpc-4547	220	45	the	the	DET
dpc-4547	220	46	incidence	incidence	NOUN
dpc-4547	220	47	of	of	ADP
dpc-4547	220	48	nmsc	nmsc	NOUN
dpc-4547	220	49	by	by	ADP
dpc-4547	220	50	23	23	NUM
dpc-4547	220	51	%	%	NOUN
dpc-4547	220	52	versus	versus	ADP
dpc-4547	220	53	the	the	DET
dpc-4547	220	54	placebo	placebo	NOUN
dpc-4547	220	55	.	.	PUNCT
dpc-4547	221	1	for	for	ADP
dpc-4547	221	2	cscc	cscc	ADJ
dpc-4547	221	3	,	,	PUNCT
dpc-4547	221	4	a	a	DET
dpc-4547	221	5	reduction	reduction	NOUN
dpc-4547	221	6	by	by	ADP
dpc-4547	221	7	30	30	NUM
dpc-4547	221	8	%	%	NOUN
dpc-4547	221	9	was	be	AUX
dpc-4547	221	10	observed	observe	VERB
dpc-4547	221	11	[	[	X
dpc-4547	221	12	110	110	NUM
dpc-4547	221	13	]	]	PUNCT
dpc-4547	221	14	.	.	PUNCT
dpc-4547	222	1	interestingly	interestingly	ADV
dpc-4547	222	2	also	also	ADV
dpc-4547	222	3	the	the	DET
dpc-4547	222	4	number	number	NOUN
dpc-4547	222	5	of	of	ADP
dpc-4547	222	6	ak	ak	PROPN
dpc-4547	222	7	lesions	lesion	NOUN
dpc-4547	222	8	was	be	AUX
dpc-4547	222	9	significantly	significantly	ADV
dpc-4547	222	10	lower	low	ADJ
dpc-4547	222	11	by	by	ADP
dpc-4547	222	12	13	13	NUM
dpc-4547	222	13	%	%	NOUN
dpc-4547	222	14	after	after	ADP
dpc-4547	222	15	12	12	NUM
dpc-4547	222	16	months	month	NOUN
dpc-4547	222	17	of	of	ADP
dpc-4547	222	18	follow	follow	NOUN
dpc-4547	222	19	-	-	PUNCT
dpc-4547	222	20	up	up	NOUN
dpc-4547	222	21	[	[	X
dpc-4547	222	22	110	110	NUM
dpc-4547	222	23	]	]	PUNCT
dpc-4547	222	24	.	.	PUNCT
dpc-4547	223	1	in	in	ADP
dpc-4547	223	2	a	a	DET
dpc-4547	223	3	recent	recent	ADJ
dpc-4547	223	4	systemic	systemic	ADJ
dpc-4547	223	5	review	review	NOUN
dpc-4547	223	6	conducted	conduct	VERB
dpc-4547	223	7	by	by	ADP
dpc-4547	223	8	mainville	mainville	PROPN
dpc-4547	223	9	et	et	PROPN
dpc-4547	223	10	al	al	PROPN
dpc-4547	223	11	.	.	PUNCT
dpc-4547	224	1	[	[	X
dpc-4547	224	2	111	111	NUM
dpc-4547	224	3	]	]	SYM
dpc-4547	224	4	five	five	NUM
dpc-4547	224	5	trials	trial	NOUN
dpc-4547	224	6	were	be	AUX
dpc-4547	224	7	identified	identify	VERB
dpc-4547	224	8	,	,	PUNCT
dpc-4547	224	9	reporting	report	VERB
dpc-4547	224	10	a	a	DET
dpc-4547	224	11	significant	significant	ADJ
dpc-4547	224	12	reduction	reduction	NOUN
dpc-4547	224	13	for	for	ADP
dpc-4547	224	14	cscc	cscc	ADJ
dpc-4547	224	15	and	and	CCONJ
dpc-4547	224	16	bcc	bcc	PROPN
dpc-4547	224	17	for	for	ADP
dpc-4547	224	18	patients	patient	NOUN
dpc-4547	224	19	with	with	ADP
dpc-4547	224	20	prevention	prevention	NOUN
dpc-4547	224	21	of	of	ADP
dpc-4547	224	22	ak	ak	PROPN
dpc-4547	224	23	and	and	CCONJ
dpc-4547	224	24	cscc	cscc	VERB
dpc-4547	224	25	for	for	ADP
dpc-4547	224	26	the	the	DET
dpc-4547	224	27	us	us	PROPN
dpc-4547	224	28	american	american	ADJ
dpc-4547	224	29	population	population	NOUN
dpc-4547	224	30	,	,	PUNCT
dpc-4547	224	31	trends	trend	NOUN
dpc-4547	224	32	regarding	regard	VERB
dpc-4547	224	33	the	the	DET
dpc-4547	224	34	protective	protective	ADJ
dpc-4547	224	35	behavior	behavior	NOUN
dpc-4547	224	36	of	of	ADP
dpc-4547	224	37	sun	sun	NOUN
dpc-4547	224	38	light	light	ADJ
dpc-4547	224	39	exposure	exposure	NOUN
dpc-4547	224	40	seem	seem	VERB
dpc-4547	224	41	to	to	PART
dpc-4547	224	42	have	have	AUX
dpc-4547	224	43	increased	increase	VERB
dpc-4547	224	44	among	among	ADP
dpc-4547	224	45	adults	adult	NOUN
dpc-4547	224	46	,	,	PUNCT
dpc-4547	224	47	throughout	throughout	ADP
dpc-4547	224	48	2010	2010	NUM
dpc-4547	224	49	to	to	ADP
dpc-4547	224	50	2020	2020	NUM
dpc-4547	225	1	[	[	X
dpc-4547	225	2	86	86	NUM
dpc-4547	225	3	]	]	PUNCT
dpc-4547	225	4	.	.	PUNCT
dpc-4547	226	1	mckenzie	mckenzie	PROPN
dpc-4547	226	2	et	et	PROPN
dpc-4547	226	3	al	al	PROPN
dpc-4547	226	4	.	.	PUNCT
dpc-4547	227	1	[	[	X
dpc-4547	227	2	86	86	NUM
dpc-4547	227	3	]	]	PUNCT
dpc-4547	227	4	reported	report	VERB
dpc-4547	227	5	that	that	SCONJ
dpc-4547	227	6	sun	sun	NOUN
dpc-4547	227	7	-	-	PUNCT
dpc-4547	227	8	protective	protective	ADJ
dpc-4547	227	9	behaviors	behavior	NOUN
dpc-4547	227	10	significantly	significantly	ADV
dpc-4547	227	11	improved	improve	VERB
dpc-4547	227	12	through	through	ADP
dpc-4547	227	13	the	the	DET
dpc-4547	227	14	reported	report	VERB
dpc-4547	227	15	time	time	NOUN
dpc-4547	227	16	period	period	NOUN
dpc-4547	227	17	,	,	PUNCT
dpc-4547	227	18	not	not	PART
dpc-4547	227	19	only	only	ADV
dpc-4547	227	20	for	for	ADP
dpc-4547	227	21	the	the	DET
dpc-4547	227	22	use	use	NOUN
dpc-4547	227	23	of	of	ADP
dpc-4547	227	24	sunscreen	sunscreen	NOUN
dpc-4547	227	25	but	but	CCONJ
dpc-4547	227	26	also	also	ADV
dpc-4547	227	27	in	in	ADP
dpc-4547	227	28	regard	regard	NOUN
dpc-4547	227	29	to	to	ADP
dpc-4547	227	30	seeking	seek	VERB
dpc-4547	227	31	shade	shade	NOUN
dpc-4547	227	32	,	,	PUNCT
dpc-4547	227	33	avoiding	avoid	VERB
dpc-4547	227	34	sun	sun	NOUN
dpc-4547	227	35	and	and	CCONJ
dpc-4547	227	36	sun	sun	NOUN
dpc-4547	227	37	burns	burn	NOUN
dpc-4547	227	38	,	,	PUNCT
dpc-4547	227	39	and	and	CCONJ
dpc-4547	227	40	by	by	ADP
dpc-4547	227	41	wearing	wear	VERB
dpc-4547	227	42	physical	physical	ADJ
dpc-4547	227	43	uv	uv	NOUN
dpc-4547	227	44	-	-	PUNCT
dpc-4547	227	45	light	light	NOUN
dpc-4547	227	46	protection	protection	NOUN
dpc-4547	227	47	,	,	PUNCT
dpc-4547	227	48	such	such	ADJ
dpc-4547	227	49	as	as	ADP
dpc-4547	227	50	long	long	ADV
dpc-4547	227	51	-	-	PUNCT
dpc-4547	227	52	sleeved	sleeve	VERB
dpc-4547	227	53	shirts	shirt	NOUN
dpc-4547	227	54	and	and	CCONJ
dpc-4547	227	55	hats	hat	NOUN
dpc-4547	227	56	.	.	PUNCT
dpc-4547	228	1	in	in	ADP
dpc-4547	228	2	terms	term	NOUN
dpc-4547	228	3	of	of	ADP
dpc-4547	228	4	primary	primary	ADJ
dpc-4547	228	5	prevention	prevention	NOUN
dpc-4547	228	6	of	of	ADP
dpc-4547	228	7	skin	skin	NOUN
dpc-4547	228	8	cancer	cancer	NOUN
dpc-4547	228	9	,	,	PUNCT
dpc-4547	228	10	the	the	DET
dpc-4547	228	11	focus	focus	NOUN
dpc-4547	228	12	lies	lie	VERB
dpc-4547	228	13	on	on	ADP
dpc-4547	228	14	educational	educational	ADJ
dpc-4547	228	15	programs	program	NOUN
dpc-4547	228	16	,	,	PUNCT
dpc-4547	228	17	risk	risk	NOUN
dpc-4547	228	18	assessment	assessment	NOUN
dpc-4547	228	19	models	model	NOUN
dpc-4547	228	20	for	for	ADP
dpc-4547	228	21	individuals	individual	NOUN
dpc-4547	228	22	,	,	PUNCT
dpc-4547	228	23	the	the	DET
dpc-4547	228	24	use	use	NOUN
dpc-4547	228	25	of	of	ADP
dpc-4547	228	26	sunscreen	sunscreen	NOUN
dpc-4547	228	27	and	and	CCONJ
dpc-4547	228	28	legislative	legislative	ADJ
dpc-4547	228	29	regulation	regulation	NOUN
dpc-4547	228	30	[	[	X
dpc-4547	228	31	87	87	NUM
dpc-4547	228	32	]	]	PUNCT
dpc-4547	228	33	.	.	PUNCT
dpc-4547	229	1	as	as	SCONJ
dpc-4547	229	2	80	80	NUM
dpc-4547	229	3	-	-	SYM
dpc-4547	229	4	90	90	NUM
dpc-4547	229	5	%	%	NOUN
dpc-4547	229	6	of	of	ADP
dpc-4547	229	7	skin	skin	NOUN
dpc-4547	229	8	cancer	cancer	NOUN
dpc-4547	229	9	seems	seem	VERB
dpc-4547	229	10	to	to	PART
dpc-4547	229	11	be	be	AUX
dpc-4547	229	12	associated	associate	VERB
dpc-4547	229	13	with	with	ADP
dpc-4547	229	14	exposure	exposure	NOUN
dpc-4547	229	15	to	to	ADP
dpc-4547	229	16	uv	uv	NOUN
dpc-4547	229	17	-	-	PUNCT
dpc-4547	229	18	radiation	radiation	NOUN
dpc-4547	229	19	,	,	PUNCT
dpc-4547	229	20	sun	sun	NOUN
dpc-4547	229	21	protective	protective	ADJ
dpc-4547	229	22	behavior	behavior	NOUN
dpc-4547	229	23	is	be	AUX
dpc-4547	229	24	promoted	promote	VERB
dpc-4547	229	25	and	and	CCONJ
dpc-4547	229	26	appears	appear	VERB
dpc-4547	229	27	to	to	PART
dpc-4547	229	28	be	be	AUX
dpc-4547	229	29	essential	essential	ADJ
dpc-4547	229	30	[	[	X
dpc-4547	229	31	88	88	NUM
dpc-4547	229	32	,	,	PUNCT
dpc-4547	229	33	89	89	NUM
dpc-4547	229	34	]	]	PUNCT
dpc-4547	229	35	.	.	PUNCT
dpc-4547	230	1	educational	educational	ADJ
dpc-4547	230	2	programs	program	NOUN
dpc-4547	230	3	seem	seem	VERB
dpc-4547	230	4	to	to	PART
dpc-4547	230	5	account	account	VERB
dpc-4547	230	6	for	for	ADP
dpc-4547	230	7	the	the	DET
dpc-4547	230	8	most	most	ADV
dpc-4547	230	9	widely	widely	ADV
dpc-4547	230	10	studied	study	VERB
dpc-4547	230	11	primary	primary	ADJ
dpc-4547	230	12	prevention	prevention	NOUN
dpc-4547	230	13	strategy	strategy	NOUN
dpc-4547	230	14	[	[	X
dpc-4547	230	15	87	87	NUM
dpc-4547	230	16	]	]	PUNCT
dpc-4547	230	17	.	.	PUNCT
dpc-4547	231	1	those	those	DET
dpc-4547	231	2	programs	program	NOUN
dpc-4547	231	3	seem	seem	VERB
dpc-4547	231	4	to	to	PART
dpc-4547	231	5	be	be	AUX
dpc-4547	231	6	especially	especially	ADV
dpc-4547	231	7	effective	effective	ADJ
dpc-4547	231	8	in	in	ADP
dpc-4547	231	9	terms	term	NOUN
dpc-4547	231	10	of	of	ADP
dpc-4547	231	11	awareness	awareness	NOUN
dpc-4547	231	12	and	and	CCONJ
dpc-4547	231	13	knowledge	knowledge	NOUN
dpc-4547	231	14	of	of	ADP
dpc-4547	231	15	sun	sun	PROPN
dpc-4547	231	16	protective	protective	ADJ
dpc-4547	231	17	behavior	behavior	NOUN
dpc-4547	231	18	,	,	PUNCT
dpc-4547	231	19	when	when	SCONJ
dpc-4547	231	20	targeting	target	VERB
dpc-4547	231	21	minors	minor	NOUN
dpc-4547	231	22	in	in	ADP
dpc-4547	231	23	primary	primary	ADJ
dpc-4547	231	24	and	and	CCONJ
dpc-4547	231	25	secondary	secondary	ADJ
dpc-4547	231	26	schools	school	NOUN
dpc-4547	231	27	,	,	PUNCT
dpc-4547	231	28	compared	compare	VERB
dpc-4547	231	29	to	to	ADP
dpc-4547	231	30	adults	adult	NOUN
dpc-4547	231	31	[	[	X
dpc-4547	231	32	90	90	NUM
dpc-4547	231	33	,	,	PUNCT
dpc-4547	231	34	91	91	NUM
dpc-4547	231	35	]	]	PUNCT
dpc-4547	231	36	.	.	PUNCT
dpc-4547	232	1	the	the	DET
dpc-4547	232	2	use	use	NOUN
dpc-4547	232	3	of	of	ADP
dpc-4547	232	4	educational	educational	ADJ
dpc-4547	232	5	images	image	NOUN
dpc-4547	232	6	is	be	AUX
dpc-4547	232	7	reported	report	VERB
dpc-4547	232	8	to	to	PART
dpc-4547	232	9	be	be	AUX
dpc-4547	232	10	effective	effective	ADJ
dpc-4547	232	11	in	in	ADP
dpc-4547	232	12	terms	term	NOUN
dpc-4547	232	13	of	of	ADP
dpc-4547	232	14	sun	sun	NOUN
dpc-4547	232	15	protective	protective	ADJ
dpc-4547	232	16	behavior	behavior	NOUN
dpc-4547	232	17	,	,	PUNCT
dpc-4547	232	18	knowledge	knowledge	NOUN
dpc-4547	232	19	and	and	CCONJ
dpc-4547	232	20	for	for	ADP
dpc-4547	232	21	self	self	NOUN
dpc-4547	232	22	-	-	PUNCT
dpc-4547	232	23	examination	examination	NOUN
dpc-4547	232	24	in	in	ADP
dpc-4547	232	25	terms	term	NOUN
dpc-4547	232	26	of	of	ADP
dpc-4547	232	27	melanoma	melanoma	NOUN
dpc-4547	232	28	[	[	PUNCT
dpc-4547	232	29	92	92	NUM
dpc-4547	232	30	-	-	SYM
dpc-4547	232	31	94	94	NUM
dpc-4547	232	32	]	]	PUNCT
dpc-4547	232	33	.	.	PUNCT
dpc-4547	233	1	other	other	ADJ
dpc-4547	233	2	strategies	strategy	NOUN
dpc-4547	233	3	,	,	PUNCT
dpc-4547	233	4	such	such	ADJ
dpc-4547	233	5	as	as	ADP
dpc-4547	233	6	using	use	VERB
dpc-4547	233	7	reminders	reminder	NOUN
dpc-4547	233	8	via	via	ADP
dpc-4547	233	9	text	text	NOUN
dpc-4547	233	10	messages	message	NOUN
dpc-4547	233	11	and	and	CCONJ
dpc-4547	233	12	email	email	NOUN
dpc-4547	233	13	to	to	PART
dpc-4547	233	14	strengthen	strengthen	VERB
dpc-4547	233	15	sun	sun	NOUN
dpc-4547	233	16	protective	protective	ADJ
dpc-4547	233	17	behavior	behavior	NOUN
dpc-4547	233	18	,	,	PUNCT
dpc-4547	233	19	lack	lack	VERB
dpc-4547	233	20	evidence	evidence	NOUN
dpc-4547	233	21	and	and	CCONJ
dpc-4547	233	22	studies	study	NOUN
dpc-4547	233	23	report	report	VERB
dpc-4547	233	24	controversial	controversial	ADJ
dpc-4547	233	25	results	result	NOUN
dpc-4547	233	26	.	.	PUNCT
dpc-4547	234	1	while	while	SCONJ
dpc-4547	234	2	finch	finch	PROPN
dpc-4547	234	3	et	et	PROPN
dpc-4547	234	4	al	al	PROPN
dpc-4547	234	5	.	.	PUNCT
dpc-4547	235	1	[	[	X
dpc-4547	235	2	95	95	NUM
dpc-4547	235	3	]	]	PUNCT
dpc-4547	235	4	found	find	VERB
dpc-4547	235	5	that	that	SCONJ
dpc-4547	235	6	electronic	electronic	ADJ
dpc-4547	235	7	text	text	NOUN
dpc-4547	235	8	reminders	reminder	NOUN
dpc-4547	235	9	lead	lead	VERB
dpc-4547	235	10	to	to	ADP
dpc-4547	235	11	a	a	DET
dpc-4547	235	12	reduction	reduction	NOUN
dpc-4547	235	13	in	in	ADP
dpc-4547	235	14	sunburns	sunburn	NOUN
dpc-4547	235	15	,	,	PUNCT
dpc-4547	235	16	the	the	DET
dpc-4547	235	17	data	datum	NOUN
dpc-4547	235	18	was	be	AUX
dpc-4547	235	19	not	not	PART
dpc-4547	235	20	unambiguous	unambiguous	ADJ
dpc-4547	235	21	to	to	PART
dpc-4547	235	22	interpret	interpret	VERB
dpc-4547	235	23	as	as	SCONJ
dpc-4547	235	24	the	the	DET
dpc-4547	235	25	number	number	NOUN
dpc-4547	235	26	of	of	ADP
dpc-4547	235	27	sunburns	sunburn	NOUN
dpc-4547	235	28	was	be	AUX
dpc-4547	235	29	self	self	NOUN
dpc-4547	235	30	-	-	PUNCT
dpc-4547	235	31	reported	report	VERB
dpc-4547	235	32	.	.	PUNCT
dpc-4547	236	1	other	other	ADJ
dpc-4547	236	2	studies	study	NOUN
dpc-4547	236	3	do	do	AUX
dpc-4547	236	4	not	not	PART
dpc-4547	236	5	report	report	VERB
dpc-4547	236	6	any	any	DET
dpc-4547	236	7	evidence	evidence	NOUN
dpc-4547	236	8	for	for	ADP
dpc-4547	236	9	text	text	NOUN
dpc-4547	236	10	message	message	NOUN
dpc-4547	236	11	reminders	reminder	NOUN
dpc-4547	236	12	[	[	X
dpc-4547	236	13	96	96	NUM
dpc-4547	236	14	]	]	PUNCT
dpc-4547	236	15	.	.	PUNCT
dpc-4547	237	1	beside	beside	ADP
dpc-4547	237	2	schools	school	NOUN
dpc-4547	237	3	,	,	PUNCT
dpc-4547	237	4	the	the	DET
dpc-4547	237	5	occupational	occupational	ADJ
dpc-4547	237	6	setting	setting	NOUN
dpc-4547	237	7	appears	appear	VERB
dpc-4547	237	8	to	to	PART
dpc-4547	237	9	be	be	AUX
dpc-4547	237	10	a	a	DET
dpc-4547	237	11	critical	critical	ADJ
dpc-4547	237	12	targeting	targeting	NOUN
dpc-4547	237	13	point	point	NOUN
dpc-4547	237	14	for	for	ADP
dpc-4547	237	15	the	the	DET
dpc-4547	237	16	implementation	implementation	NOUN
dpc-4547	237	17	of	of	ADP
dpc-4547	237	18	skin	skin	NOUN
dpc-4547	237	19	cancer	cancer	NOUN
dpc-4547	237	20	awareness	awareness	NOUN
dpc-4547	237	21	and	and	CCONJ
dpc-4547	237	22	protection	protection	NOUN
dpc-4547	237	23	,	,	PUNCT
dpc-4547	237	24	as	as	SCONJ
dpc-4547	237	25	behavior	behavior	NOUN
dpc-4547	237	26	towards	towards	ADP
dpc-4547	237	27	uv	uv	NOUN
dpc-4547	237	28	-	-	PUNCT
dpc-4547	237	29	light	light	NOUN
dpc-4547	237	30	exposures	exposure	NOUN
dpc-4547	237	31	differs	differ	VERB
dpc-4547	237	32	tremendously	tremendously	ADV
dpc-4547	237	33	between	between	ADP
dpc-4547	237	34	outdoor	outdoor	ADJ
dpc-4547	237	35	workers	worker	NOUN
dpc-4547	237	36	[	[	X
dpc-4547	237	37	97	97	NUM
dpc-4547	237	38	]	]	PUNCT
dpc-4547	237	39	.	.	PUNCT
dpc-4547	238	1	education	education	NOUN
dpc-4547	238	2	on	on	ADP
dpc-4547	238	3	skin	skin	NOUN
dpc-4547	238	4	cancer	cancer	NOUN
dpc-4547	238	5	prevention	prevention	NOUN
dpc-4547	238	6	at	at	ADP
dpc-4547	238	7	the	the	DET
dpc-4547	238	8	workplace	workplace	NOUN
dpc-4547	238	9	is	be	AUX
dpc-4547	238	10	reported	report	VERB
dpc-4547	238	11	to	to	PART
dpc-4547	238	12	be	be	AUX
dpc-4547	238	13	effective	effective	ADJ
dpc-4547	238	14	in	in	ADP
dpc-4547	238	15	terms	term	NOUN
dpc-4547	238	16	of	of	ADP
dpc-4547	238	17	sun	sun	NOUN
dpc-4547	238	18	protective	protective	ADJ
dpc-4547	238	19	behavior	behavior	NOUN
dpc-4547	238	20	,	,	PUNCT
dpc-4547	238	21	using	use	VERB
dpc-4547	238	22	sunscreen	sunscreen	NOUN
dpc-4547	238	23	to	to	PART
dpc-4547	238	24	reduce	reduce	VERB
dpc-4547	238	25	the	the	DET
dpc-4547	238	26	number	number	NOUN
dpc-4547	238	27	of	of	ADP
dpc-4547	238	28	sunburns	sunburn	NOUN
dpc-4547	238	29	eventually	eventually	ADV
dpc-4547	238	30	[	[	X
dpc-4547	238	31	98	98	NUM
dpc-4547	238	32	,	,	PUNCT
dpc-4547	238	33	99	99	NUM
dpc-4547	238	34	]	]	PUNCT
dpc-4547	238	35	.	.	PUNCT
dpc-4547	239	1	although	although	SCONJ
dpc-4547	239	2	studies	study	NOUN
dpc-4547	239	3	report	report	VERB
dpc-4547	239	4	imprecise	imprecise	ADV
dpc-4547	239	5	results	result	NOUN
dpc-4547	239	6	between	between	ADP
dpc-4547	239	7	the	the	DET
dpc-4547	239	8	use	use	NOUN
dpc-4547	239	9	of	of	ADP
dpc-4547	239	10	sunscreen	sunscreen	NOUN
dpc-4547	239	11	and	and	CCONJ
dpc-4547	239	12	the	the	DET
dpc-4547	239	13	risk	risk	NOUN
dpc-4547	239	14	of	of	ADP
dpc-4547	239	15	developing	develop	VERB
dpc-4547	239	16	melanoma	melanoma	NOUN
dpc-4547	239	17	,	,	PUNCT
dpc-4547	239	18	waldman	waldman	PROPN
dpc-4547	239	19	et	et	PROPN
dpc-4547	239	20	al.[100	al.[100	PROPN
dpc-4547	239	21	]	]	X
dpc-4547	239	22	report	report	VERB
dpc-4547	239	23	the	the	DET
dpc-4547	239	24	beneficial	beneficial	ADJ
dpc-4547	239	25	use	use	NOUN
dpc-4547	239	26	of	of	ADP
dpc-4547	239	27	sunscreen	sunscreen	NOUN
dpc-4547	239	28	to	to	PART
dpc-4547	239	29	reduce	reduce	VERB
dpc-4547	239	30	the	the	DET
dpc-4547	239	31	manifestation	manifestation	NOUN
dpc-4547	239	32	of	of	ADP
dpc-4547	239	33	ak	ak	PROPN
dpc-4547	239	34	,	,	PUNCT
dpc-4547	239	35	scc	scc	PROPN
dpc-4547	239	36	and	and	CCONJ
dpc-4547	239	37	less	less	ADV
dpc-4547	239	38	clear	clear	ADJ
dpc-4547	239	39	also	also	ADV
dpc-4547	239	40	for	for	ADP
dpc-4547	239	41	bcc	bcc	PROPN
dpc-4547	239	42	.	.	PUNCT
dpc-4547	240	1	the	the	DET
dpc-4547	240	2	use	use	NOUN
dpc-4547	240	3	of	of	ADP
dpc-4547	240	4	indoor	indoor	ADJ
dpc-4547	240	5	tanning	tanning	NOUN
dpc-4547	240	6	modalities	modality	NOUN
dpc-4547	240	7	is	be	AUX
dpc-4547	240	8	rightly	rightly	ADV
dpc-4547	240	9	criticized	criticize	VERB
dpc-4547	240	10	to	to	PART
dpc-4547	240	11	promote	promote	VERB
dpc-4547	240	12	skin	skin	NOUN
dpc-4547	240	13	cancer	cancer	NOUN
dpc-4547	240	14	development	development	NOUN
dpc-4547	240	15	.	.	PUNCT
dpc-4547	241	1	a	a	DET
dpc-4547	241	2	large	large	ADJ
dpc-4547	241	3	meta	meta	ADJ
dpc-4547	241	4	-	-	PUNCT
dpc-4547	241	5	analysis	analysis	NOUN
dpc-4547	241	6	conducted	conduct	VERB
dpc-4547	241	7	by	by	ADP
dpc-4547	241	8	wehner	wehner	PROPN
dpc-4547	241	9	et	et	PROPN
dpc-4547	241	10	al	al	PROPN
dpc-4547	241	11	.	.	PUNCT
dpc-4547	242	1	[	[	X
dpc-4547	242	2	101	101	NUM
dpc-4547	242	3	]	]	PUNCT
dpc-4547	242	4	,	,	PUNCT
dpc-4547	242	5	evaluating	evaluate	VERB
dpc-4547	242	6	more	more	ADJ
dpc-4547	242	7	than	than	ADP
dpc-4547	242	8	9000	9000	NUM
dpc-4547	242	9	cases	case	NOUN
dpc-4547	242	10	of	of	ADP
dpc-4547	242	11	skin	skin	NOUN
dpc-4547	242	12	cancer	cancer	NOUN
dpc-4547	242	13	,	,	PUNCT
dpc-4547	242	14	found	find	VERB
dpc-4547	242	15	the	the	DET
dpc-4547	242	16	population	population	NOUN
dpc-4547	242	17	attributable	attributable	ADJ
dpc-4547	242	18	risk	risk	NOUN
dpc-4547	242	19	fraction	fraction	NOUN
dpc-4547	242	20	for	for	ADP
dpc-4547	242	21	cscc	cscc	ADJ
dpc-4547	242	22	to	to	PART
dpc-4547	242	23	be	be	AUX
dpc-4547	242	24	8.2	8.2	NUM
dpc-4547	242	25	%	%	NOUN
dpc-4547	242	26	and	and	CCONJ
dpc-4547	242	27	3.7	3.7	NUM
dpc-4547	242	28	%	%	NOUN
dpc-4547	242	29	for	for	ADP
dpc-4547	242	30	bcc	bcc	PROPN
dpc-4547	242	31	in	in	ADP
dpc-4547	242	32	the	the	DET
dpc-4547	242	33	us	us	PROPN
dpc-4547	242	34	population	population	NOUN
dpc-4547	242	35	.	.	PUNCT
dpc-4547	242	36	 	 	SPACE
dpc-4547	243	1	these	these	DET
dpc-4547	243	2	numbers	number	NOUN
dpc-4547	243	3	are	be	AUX
dpc-4547	243	4	estimated	estimate	VERB
dpc-4547	243	5	to	to	PART
dpc-4547	243	6	account	account	VERB
dpc-4547	243	7	for	for	ADP
dpc-4547	243	8	more	more	ADJ
dpc-4547	243	9	than	than	ADP
dpc-4547	243	10	170	170	NUM
dpc-4547	243	11	000	000	NUM
dpc-4547	243	12	annual	annual	ADJ
dpc-4547	243	13	cases	case	NOUN
dpc-4547	243	14	of	of	ADP
dpc-4547	243	15	nmsc	nmsc	NOUN
dpc-4547	243	16	related	relate	VERB
dpc-4547	243	17	to	to	ADP
dpc-4547	243	18	indoor	indoor	ADJ
dpc-4547	243	19	tanning	tanning	NOUN
dpc-4547	243	20	in	in	ADP
dpc-4547	243	21	the	the	DET
dpc-4547	243	22	us	us	PROPN
dpc-4547	243	23	alone	alone	ADV
dpc-4547	243	24	[	[	X
dpc-4547	243	25	101	101	NUM
dpc-4547	243	26	]	]	PUNCT
dpc-4547	243	27	.	.	PUNCT
dpc-4547	243	28	 	 	SPACE
dpc-4547	244	1	the	the	DET
dpc-4547	244	2	presented	present	VERB
dpc-4547	244	3	numbers	number	NOUN
dpc-4547	244	4	were	be	AUX
dpc-4547	244	5	published	publish	VERB
dpc-4547	244	6	in	in	ADP
dpc-4547	244	7	the	the	DET
dpc-4547	244	8	year	year	NOUN
dpc-4547	244	9	2012	2012	NUM
dpc-4547	244	10	.	.	PUNCT
dpc-4547	245	1	since	since	SCONJ
dpc-4547	245	2	then	then	ADV
dpc-4547	245	3	,	,	PUNCT
dpc-4547	245	4	only	only	ADV
dpc-4547	245	5	a	a	DET
dpc-4547	245	6	handful	handful	NOUN
dpc-4547	245	7	of	of	ADP
dpc-4547	245	8	countries	country	NOUN
dpc-4547	245	9	have	have	AUX
dpc-4547	245	10	implemented	implement	VERB
dpc-4547	245	11	policies	policy	NOUN
dpc-4547	245	12	to	to	PART
dpc-4547	245	13	fully	fully	ADV
dpc-4547	245	14	ban	ban	VERB
dpc-4547	245	15	tanning	tanning	NOUN
dpc-4547	245	16	review	review	NOUN
dpc-4547	245	17	|	|	ADV
dpc-4547	245	18	dermatol	dermatol	ADJ
dpc-4547	245	19	pract	pract	NOUN
dpc-4547	245	20	concept	concept	NOUN
dpc-4547	245	21	.	.	PUNCT
dpc-4547	246	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	246	2	:	:	PUNCT
dpc-4547	246	3	e2024146s	e2024146s	ADV
dpc-4547	246	4	7	7	NUM
dpc-4547	246	5	activator	activator	NOUN
dpc-4547	246	6	of	of	ADP
dpc-4547	246	7	vitamin	vitamin	NOUN
dpc-4547	246	8	d	d	NOUN
dpc-4547	246	9	synthesis	synthesis	NOUN
dpc-4547	246	10	.	.	PUNCT
dpc-4547	247	1	different	different	ADJ
dpc-4547	247	2	hypothesis	hypothesis	NOUN
dpc-4547	247	3	on	on	ADP
dpc-4547	247	4	vitamin	vitamin	NOUN
dpc-4547	247	5	d	d	NOUN
dpc-4547	247	6	levels	level	NOUN
dpc-4547	247	7	related	relate	VERB
dpc-4547	247	8	to	to	ADP
dpc-4547	247	9	skin	skin	NOUN
dpc-4547	247	10	type	type	NOUN
dpc-4547	247	11	exist	exist	NOUN
dpc-4547	247	12	.	.	PUNCT
dpc-4547	248	1	assumptions	assumption	NOUN
dpc-4547	248	2	are	be	AUX
dpc-4547	248	3	made	make	VERB
dpc-4547	248	4	that	that	SCONJ
dpc-4547	248	5	individuals	individual	NOUN
dpc-4547	248	6	with	with	ADP
dpc-4547	248	7	the	the	DET
dpc-4547	248	8	fairest	fair	ADJ
dpc-4547	248	9	phototypes	phototype	NOUN
dpc-4547	248	10	suffer	suffer	VERB
dpc-4547	248	11	from	from	ADP
dpc-4547	248	12	the	the	DET
dpc-4547	248	13	lowest	low	ADJ
dpc-4547	248	14	vitamin	vitamin	NOUN
dpc-4547	248	15	d	d	NOUN
dpc-4547	248	16	levels	level	NOUN
dpc-4547	248	17	due	due	ADP
dpc-4547	248	18	to	to	ADP
dpc-4547	248	19	minimum	minimum	ADJ
dpc-4547	248	20	sun	sun	NOUN
dpc-4547	248	21	exposure	exposure	NOUN
dpc-4547	248	22	,	,	PUNCT
dpc-4547	248	23	given	give	VERB
dpc-4547	248	24	their	their	PRON
dpc-4547	248	25	photosensitivity	photosensitivity	NOUN
dpc-4547	248	26	[	[	X
dpc-4547	248	27	128	128	NUM
dpc-4547	248	28	]	]	PUNCT
dpc-4547	248	29	.	.	PUNCT
dpc-4547	249	1	the	the	DET
dpc-4547	249	2	hypothesis	hypothesis	NOUN
dpc-4547	249	3	for	for	ADP
dpc-4547	249	4	skin	skin	NOUN
dpc-4547	249	5	pigmentation	pigmentation	NOUN
dpc-4547	249	6	evolution	evolution	NOUN
dpc-4547	249	7	proposes	propose	VERB
dpc-4547	249	8	that	that	SCONJ
dpc-4547	249	9	progressive	progressive	ADJ
dpc-4547	249	10	skin	skin	NOUN
dpc-4547	249	11	depigmentation	depigmentation	NOUN
dpc-4547	249	12	was	be	AUX
dpc-4547	249	13	critical	critical	ADJ
dpc-4547	249	14	for	for	SCONJ
dpc-4547	249	15	our	our	PRON
dpc-4547	249	16	ancestors	ancestor	NOUN
dpc-4547	249	17	to	to	PART
dpc-4547	249	18	ensure	ensure	VERB
dpc-4547	249	19	sufficient	sufficient	ADJ
dpc-4547	249	20	vitamin	vitamin	NOUN
dpc-4547	249	21	d	d	NOUN
dpc-4547	249	22	production	production	NOUN
dpc-4547	249	23	through	through	ADP
dpc-4547	249	24	uvbr	uvbr	NOUN
dpc-4547	249	25	,	,	PUNCT
dpc-4547	249	26	when	when	SCONJ
dpc-4547	249	27	migrating	migrate	VERB
dpc-4547	249	28	to	to	ADP
dpc-4547	249	29	areas	area	NOUN
dpc-4547	249	30	with	with	ADP
dpc-4547	249	31	reduced	reduced	ADJ
dpc-4547	249	32	sunlight	sunlight	NOUN
dpc-4547	249	33	[	[	X
dpc-4547	249	34	129	129	NUM
dpc-4547	249	35	]	]	PUNCT
dpc-4547	249	36	.	.	PUNCT
dpc-4547	250	1	although	although	SCONJ
dpc-4547	250	2	fair	fair	ADJ
dpc-4547	250	3	-	-	PUNCT
dpc-4547	250	4	skinned	skin	VERB
dpc-4547	250	5	individuals	individual	NOUN
dpc-4547	250	6	seem	seem	VERB
dpc-4547	250	7	to	to	PART
dpc-4547	250	8	produce	produce	VERB
dpc-4547	250	9	higher	high	ADJ
dpc-4547	250	10	levels	level	NOUN
dpc-4547	250	11	of	of	ADP
dpc-4547	250	12	vitamin	vitamin	NOUN
dpc-4547	250	13	d	d	NOUN
dpc-4547	250	14	,	,	PUNCT
dpc-4547	250	15	they	they	PRON
dpc-4547	250	16	are	be	AUX
dpc-4547	250	17	susceptible	susceptible	ADJ
dpc-4547	250	18	to	to	ADP
dpc-4547	250	19	skin	skin	NOUN
dpc-4547	250	20	cancer	cancer	NOUN
dpc-4547	250	21	due	due	ADP
dpc-4547	250	22	to	to	ADP
dpc-4547	250	23	lower	low	ADJ
dpc-4547	250	24	tanning	tanning	NOUN
dpc-4547	250	25	ability	ability	NOUN
dpc-4547	250	26	and	and	CCONJ
dpc-4547	250	27	greater	great	ADJ
dpc-4547	250	28	sunburn	sunburn	NOUN
dpc-4547	250	29	response	response	NOUN
dpc-4547	250	30	[	[	X
dpc-4547	250	31	130	130	NUM
dpc-4547	250	32	,	,	PUNCT
dpc-4547	250	33	131	131	NUM
dpc-4547	250	34	]	]	PUNCT
dpc-4547	250	35	.	.	PUNCT
dpc-4547	251	1	however	however	ADV
dpc-4547	251	2	,	,	PUNCT
dpc-4547	251	3	bonilla	bonilla	PROPN
dpc-4547	251	4	et	et	PROPN
dpc-4547	251	5	al.[126	al.[126	PROPN
dpc-4547	251	6	]	]	PUNCT
dpc-4547	251	7	found	find	VERB
dpc-4547	251	8	that	that	SCONJ
dpc-4547	251	9	fairer	fair	ADJ
dpc-4547	251	10	-	-	PUNCT
dpc-4547	251	11	skinned	skin	VERB
dpc-4547	251	12	children	child	NOUN
dpc-4547	251	13	with	with	ADP
dpc-4547	251	14	higher	high	ADJ
dpc-4547	251	15	pigmentation	pigmentation	NOUN
dpc-4547	251	16	score	score	NOUN
dpc-4547	251	17	values	value	NOUN
dpc-4547	251	18	had	have	AUX
dpc-4547	251	19	increased	increase	VERB
dpc-4547	251	20	vitamin	vitamin	NOUN
dpc-4547	251	21	d	d	NOUN
dpc-4547	251	22	levels	level	NOUN
dpc-4547	251	23	,	,	PUNCT
dpc-4547	251	24	while	while	SCONJ
dpc-4547	251	25	applying	apply	VERB
dpc-4547	251	26	more	more	ADJ
dpc-4547	251	27	sun	sun	NOUN
dpc-4547	251	28	protective	protective	ADJ
dpc-4547	251	29	measures	measure	NOUN
dpc-4547	251	30	.	.	PUNCT
dpc-4547	252	1	they	they	PRON
dpc-4547	252	2	concluded	conclude	VERB
dpc-4547	252	3	that	that	SCONJ
dpc-4547	252	4	sun	sun	NOUN
dpc-4547	252	5	protection	protection	NOUN
dpc-4547	252	6	does	do	AUX
dpc-4547	252	7	not	not	PART
dpc-4547	252	8	eradicate	eradicate	VERB
dpc-4547	252	9	the	the	DET
dpc-4547	252	10	positive	positive	ADJ
dpc-4547	252	11	effect	effect	NOUN
dpc-4547	252	12	on	on	ADP
dpc-4547	252	13	vitamin	vitamin	NOUN
dpc-4547	252	14	d	d	NOUN
dpc-4547	252	15	production	production	NOUN
dpc-4547	252	16	in	in	ADP
dpc-4547	252	17	less	less	ADJ
dpc-4547	252	18	pigmented	pigmented	ADJ
dpc-4547	252	19	skin	skin	NOUN
dpc-4547	252	20	[	[	X
dpc-4547	252	21	126	126	NUM
dpc-4547	252	22	]	]	PUNCT
dpc-4547	252	23	.	.	PUNCT
dpc-4547	253	1	the	the	DET
dpc-4547	253	2	challenge	challenge	NOUN
dpc-4547	253	3	seems	seem	VERB
dpc-4547	253	4	to	to	PART
dpc-4547	253	5	identify	identify	VERB
dpc-4547	253	6	the	the	DET
dpc-4547	253	7	ideal	ideal	ADJ
dpc-4547	253	8	balance	balance	NOUN
dpc-4547	253	9	between	between	ADP
dpc-4547	253	10	generating	generate	VERB
dpc-4547	253	11	enough	enough	ADJ
dpc-4547	253	12	vitamin	vitamin	NOUN
dpc-4547	253	13	d	d	NOUN
dpc-4547	253	14	while	while	SCONJ
dpc-4547	253	15	limiting	limit	VERB
dpc-4547	253	16	skin	skin	NOUN
dpc-4547	253	17	damage	damage	NOUN
dpc-4547	253	18	caused	cause	VERB
dpc-4547	253	19	by	by	ADP
dpc-4547	253	20	uvbr	uvbr	NOUN
dpc-4547	253	21	,	,	PUNCT
dpc-4547	253	22	but	but	CCONJ
dpc-4547	253	23	to	to	ADP
dpc-4547	253	24	this	this	DET
dpc-4547	253	25	date	date	NOUN
dpc-4547	253	26	no	no	DET
dpc-4547	253	27	data	data	NOUN
dpc-4547	253	28	exists	exist	VERB
dpc-4547	253	29	identifying	identify	VERB
dpc-4547	253	30	the	the	DET
dpc-4547	253	31	optimal	optimal	ADJ
dpc-4547	253	32	dose	dose	NOUN
dpc-4547	253	33	of	of	ADP
dpc-4547	253	34	daily	daily	ADJ
dpc-4547	253	35	vitamin	vitamin	NOUN
dpc-4547	253	36	d	d	X
dpc-4547	253	37	intake	intake	NOUN
dpc-4547	253	38	,	,	PUNCT
dpc-4547	253	39	to	to	PART
dpc-4547	253	40	reduce	reduce	VERB
dpc-4547	253	41	skin	skin	NOUN
dpc-4547	253	42	cancer	cancer	NOUN
dpc-4547	253	43	eventually	eventually	ADV
dpc-4547	253	44	.	.	PUNCT
dpc-4547	254	1	inconsistent	inconsistent	ADJ
dpc-4547	254	2	findings	finding	NOUN
dpc-4547	254	3	exist	exist	VERB
dpc-4547	254	4	regarding	regard	VERB
dpc-4547	254	5	the	the	DET
dpc-4547	254	6	amount	amount	NOUN
dpc-4547	254	7	of	of	ADP
dpc-4547	254	8	sun	sun	NOUN
dpc-4547	254	9	exposure	exposure	NOUN
dpc-4547	254	10	and	and	CCONJ
dpc-4547	254	11	vitamin	vitamin	NOUN
dpc-4547	254	12	d	d	NOUN
dpc-4547	254	13	supplementation	supplementation	NOUN
dpc-4547	254	14	for	for	ADP
dpc-4547	254	15	skin	skin	NOUN
dpc-4547	254	16	cancer	cancer	NOUN
dpc-4547	254	17	prevention	prevention	NOUN
dpc-4547	254	18	[	[	X
dpc-4547	254	19	132	132	NUM
dpc-4547	254	20	]	]	PUNCT
dpc-4547	254	21	.	.	PUNCT
dpc-4547	255	1	yet	yet	ADV
dpc-4547	255	2	,	,	PUNCT
dpc-4547	255	3	several	several	ADJ
dpc-4547	255	4	studies	study	NOUN
dpc-4547	255	5	report	report	VERB
dpc-4547	255	6	,	,	PUNCT
dpc-4547	255	7	25	25	NUM
dpc-4547	255	8	-	-	PUNCT
dpc-4547	255	9	hydroxyvitamin	hydroxyvitamin	NOUN
dpc-4547	255	10	d	d	NOUN
dpc-4547	255	11	(	(	PUNCT
dpc-4547	255	12	25(oh)d	25(oh)d	NOUN
dpc-4547	255	13	)	)	PUNCT
dpc-4547	255	14	,	,	PUNCT
dpc-4547	255	15	the	the	DET
dpc-4547	255	16	circulating	circulate	VERB
dpc-4547	255	17	form	form	NOUN
dpc-4547	255	18	of	of	ADP
dpc-4547	255	19	vitamin	vitamin	NOUN
dpc-4547	255	20	d	d	PROPN
dpc-4547	255	21	,	,	PUNCT
dpc-4547	255	22	being	be	AUX
dpc-4547	255	23	associated	associate	VERB
dpc-4547	255	24	with	with	ADP
dpc-4547	255	25	skin	skin	NOUN
dpc-4547	255	26	cancer	cancer	NOUN
dpc-4547	255	27	development	development	NOUN
dpc-4547	255	28	risk	risk	NOUN
dpc-4547	255	29	and	and	CCONJ
dpc-4547	255	30	therefore	therefore	ADV
dpc-4547	255	31	may	may	AUX
dpc-4547	255	32	function	function	VERB
dpc-4547	255	33	as	as	ADP
dpc-4547	255	34	a	a	DET
dpc-4547	255	35	biomarker	biomarker	NOUN
dpc-4547	255	36	to	to	PART
dpc-4547	255	37	reflect	reflect	VERB
dpc-4547	255	38	longterm	longterm	PROPN
dpc-4547	255	39	sun	sun	NOUN
dpc-4547	255	40	exposure	exposure	NOUN
dpc-4547	255	41	and	and	CCONJ
dpc-4547	255	42	predict	predict	VERB
dpc-4547	255	43	the	the	DET
dpc-4547	255	44	risk	risk	NOUN
dpc-4547	255	45	of	of	ADP
dpc-4547	255	46	nmsc	nmsc	NOUN
dpc-4547	255	47	also	also	ADV
dpc-4547	255	48	in	in	ADP
dpc-4547	255	49	ak	ak	PROPN
dpc-4547	255	50	patients	patient	NOUN
dpc-4547	255	51	[	[	X
dpc-4547	255	52	133	133	NUM
dpc-4547	255	53	-	-	SYM
dpc-4547	255	54	138	138	NUM
dpc-4547	255	55	]	]	PUNCT
dpc-4547	255	56	.	.	PUNCT
dpc-4547	256	1	current	current	ADJ
dpc-4547	256	2	knowledge	knowledge	NOUN
dpc-4547	256	3	on	on	ADP
dpc-4547	256	4	the	the	DET
dpc-4547	256	5	chemoprotective	chemoprotective	ADJ
dpc-4547	256	6	role	role	NOUN
dpc-4547	256	7	of	of	ADP
dpc-4547	256	8	vitamin	vitamin	NOUN
dpc-4547	256	9	d	d	NOUN
dpc-4547	256	10	remains	remain	VERB
dpc-4547	256	11	to	to	PART
dpc-4547	256	12	be	be	AUX
dpc-4547	256	13	discussed	discuss	VERB
dpc-4547	256	14	.	.	PUNCT
dpc-4547	257	1	sutedja	sutedja	PROPN
dpc-4547	257	2	et	et	PROPN
dpc-4547	257	3	al	al	PROPN
dpc-4547	257	4	.	.	PROPN
dpc-4547	257	5	evaluated	evaluate	VERB
dpc-4547	257	6	a	a	DET
dpc-4547	257	7	total	total	NOUN
dpc-4547	257	8	of	of	ADP
dpc-4547	257	9	18	18	NUM
dpc-4547	257	10	studies	study	NOUN
dpc-4547	257	11	on	on	ADP
dpc-4547	257	12	this	this	DET
dpc-4547	257	13	topic	topic	NOUN
dpc-4547	257	14	,	,	PUNCT
dpc-4547	257	15	including	include	VERB
dpc-4547	257	16	11	11	NUM
dpc-4547	257	17	in	in	ADP
dpc-4547	257	18	vivo	vivo	ADJ
dpc-4547	257	19	studies	study	NOUN
dpc-4547	257	20	,	,	PUNCT
dpc-4547	257	21	with	with	SCONJ
dpc-4547	257	22	five	five	NUM
dpc-4547	257	23	of	of	ADP
dpc-4547	257	24	them	they	PRON
dpc-4547	257	25	being	be	AUX
dpc-4547	257	26	either	either	CCONJ
dpc-4547	257	27	randomized	randomize	VERB
dpc-4547	257	28	controlled	control	VERB
dpc-4547	257	29	trials	trial	NOUN
dpc-4547	257	30	or	or	CCONJ
dpc-4547	257	31	interventional	interventional	ADJ
dpc-4547	257	32	studies	study	NOUN
dpc-4547	257	33	[	[	X
dpc-4547	257	34	139	139	NUM
dpc-4547	257	35	]	]	PUNCT
dpc-4547	257	36	.	.	PUNCT
dpc-4547	258	1	evaluating	evaluate	VERB
dpc-4547	258	2	the	the	DET
dpc-4547	258	3	study	study	NOUN
dpc-4547	258	4	of	of	ADP
dpc-4547	258	5	passarelli	passarelli	PROPN
dpc-4547	258	6	et	et	PROPN
dpc-4547	258	7	al	al	PROPN
dpc-4547	258	8	.	.	PROPN
dpc-4547	258	9	,	,	PUNCT
dpc-4547	258	10	the	the	DET
dpc-4547	258	11	oral	oral	ADJ
dpc-4547	258	12	intake	intake	NOUN
dpc-4547	258	13	of	of	ADP
dpc-4547	258	14	1000	1000	NUM
dpc-4547	258	15	iu	iu	NOUN
dpc-4547	258	16	/	/	SYM
dpc-4547	258	17	day	day	NOUN
dpc-4547	258	18	of	of	ADP
dpc-4547	258	19	vitamin	vitamin	NOUN
dpc-4547	258	20	d	d	NOUN
dpc-4547	258	21	alone	alone	ADV
dpc-4547	258	22	or	or	CCONJ
dpc-4547	258	23	in	in	ADP
dpc-4547	258	24	combination	combination	NOUN
dpc-4547	258	25	with	with	ADP
dpc-4547	258	26	calcium	calcium	NOUN
dpc-4547	258	27	was	be	AUX
dpc-4547	258	28	reported	report	VERB
dpc-4547	258	29	to	to	PART
dpc-4547	258	30	be	be	AUX
dpc-4547	258	31	protective	protective	ADJ
dpc-4547	258	32	for	for	ADP
dpc-4547	258	33	cscc	cscc	ADJ
dpc-4547	258	34	development	development	NOUN
dpc-4547	258	35	[	[	X
dpc-4547	258	36	139	139	NUM
dpc-4547	258	37	,	,	PUNCT
dpc-4547	258	38	140	140	NUM
dpc-4547	258	39	]	]	PUNCT
dpc-4547	258	40	.	.	PUNCT
dpc-4547	259	1	rosenberg	rosenberg	PROPN
dpc-4547	259	2	et	et	PROPN
dpc-4547	259	3	al	al	PROPN
dpc-4547	259	4	.	.	PROPN
dpc-4547	259	5	evaluated	evaluate	VERB
dpc-4547	259	6	the	the	DET
dpc-4547	259	7	efficacy	efficacy	NOUN
dpc-4547	259	8	of	of	ADP
dpc-4547	259	9	topical	topical	ADJ
dpc-4547	259	10	application	application	NOUN
dpc-4547	259	11	of	of	ADP
dpc-4547	259	12	5	5	NUM
dpc-4547	259	13	-	-	PUNCT
dpc-4547	259	14	fluorouracil	fluorouracil	NOUN
dpc-4547	259	15	(	(	PUNCT
dpc-4547	259	16	5	5	NUM
dpc-4547	259	17	-	-	PUNCT
dpc-4547	259	18	fu	fu	NOUN
dpc-4547	259	19	)	)	PUNCT
dpc-4547	259	20	in	in	ADP
dpc-4547	259	21	combination	combination	NOUN
dpc-4547	259	22	with	with	ADP
dpc-4547	259	23	calcipotriol	calcipotriol	NOUN
dpc-4547	259	24	0.005	0.005	NUM
dpc-4547	259	25	%	%	NOUN
dpc-4547	259	26	(	(	PUNCT
dpc-4547	259	27	low	low	ADJ
dpc-4547	259	28	-	-	PUNCT
dpc-4547	259	29	calcemic	calcemic	ADJ
dpc-4547	259	30	vitamin	vitamin	NOUN
dpc-4547	259	31	d	d	NOUN
dpc-4547	259	32	analog	analog	NOUN
dpc-4547	259	33	)	)	PUNCT
dpc-4547	259	34	over	over	ADP
dpc-4547	259	35	a	a	DET
dpc-4547	259	36	course	course	NOUN
dpc-4547	259	37	of	of	ADP
dpc-4547	259	38	4	4	NUM
dpc-4547	259	39	days	day	NOUN
dpc-4547	259	40	,	,	PUNCT
dpc-4547	259	41	implemented	implement	VERB
dpc-4547	259	42	as	as	ADP
dpc-4547	259	43	an	an	DET
dpc-4547	259	44	immunotherapy	immunotherapy	NOUN
dpc-4547	259	45	for	for	ADP
dpc-4547	259	46	ak	ak	PROPN
dpc-4547	259	47	on	on	ADP
dpc-4547	259	48	the	the	DET
dpc-4547	259	49	scalp	scalp	NOUN
dpc-4547	259	50	and	and	CCONJ
dpc-4547	259	51	face	face	VERB
dpc-4547	259	52	skin	skin	NOUN
dpc-4547	259	53	to	to	PART
dpc-4547	259	54	prevent	prevent	VERB
dpc-4547	259	55	cscc	cscc	ADJ
dpc-4547	259	56	development	development	NOUN
dpc-4547	259	57	[	[	X
dpc-4547	259	58	141	141	NUM
dpc-4547	259	59	]	]	PUNCT
dpc-4547	259	60	.	.	PUNCT
dpc-4547	260	1	over	over	ADP
dpc-4547	260	2	the	the	DET
dpc-4547	260	3	course	course	NOUN
dpc-4547	260	4	of	of	ADP
dpc-4547	260	5	three	three	NUM
dpc-4547	260	6	years	year	NOUN
dpc-4547	260	7	,	,	PUNCT
dpc-4547	260	8	5	5	NUM
dpc-4547	260	9	-	-	PUNCT
dpc-4547	260	10	fu	fu	NOUN
dpc-4547	260	11	+	+	CCONJ
dpc-4547	260	12	calcipotriol	calcipotriol	NOUN
dpc-4547	260	13	were	be	AUX
dpc-4547	260	14	effective	effective	ADJ
dpc-4547	260	15	in	in	ADP
dpc-4547	260	16	reducing	reduce	VERB
dpc-4547	260	17	the	the	DET
dpc-4547	260	18	incidence	incidence	NOUN
dpc-4547	260	19	of	of	ADP
dpc-4547	260	20	cscc	cscc	NOUN
dpc-4547	260	21	significantly	significantly	ADV
dpc-4547	260	22	,	,	PUNCT
dpc-4547	260	23	compared	compare	VERB
dpc-4547	260	24	to	to	ADP
dpc-4547	260	25	only	only	ADV
dpc-4547	260	26	5	5	NUM
dpc-4547	260	27	-	-	PUNCT
dpc-4547	260	28	fu	fu	NOUN
dpc-4547	260	29	,	,	PUNCT
dpc-4547	260	30	while	while	SCONJ
dpc-4547	260	31	for	for	ADP
dpc-4547	260	32	bcc	bcc	PROPN
dpc-4547	260	33	no	no	DET
dpc-4547	260	34	difference	difference	NOUN
dpc-4547	260	35	was	be	AUX
dpc-4547	260	36	reported	report	VERB
dpc-4547	260	37	[	[	X
dpc-4547	260	38	141	141	NUM
dpc-4547	260	39	]	]	PUNCT
dpc-4547	260	40	.	.	PUNCT
dpc-4547	261	1	rosenberg	rosenberg	PROPN
dpc-4547	261	2	et	et	PROPN
dpc-4547	261	3	al	al	PROPN
dpc-4547	261	4	.	.	PROPN
dpc-4547	261	5	also	also	ADV
dpc-4547	261	6	found	find	VERB
dpc-4547	261	7	that	that	SCONJ
dpc-4547	261	8	the	the	DET
dpc-4547	261	9	treated	treat	VERB
dpc-4547	261	10	skin	skin	NOUN
dpc-4547	261	11	harbored	harbor	VERB
dpc-4547	261	12	significantly	significantly	ADV
dpc-4547	261	13	more	more	ADJ
dpc-4547	261	14	tissue	tissue	NOUN
dpc-4547	261	15	resident	resident	NOUN
dpc-4547	261	16	memory	memory	NOUN
dpc-4547	261	17	t	t	PROPN
dpc-4547	261	18	-	-	PUNCT
dpc-4547	261	19	cells	cell	NOUN
dpc-4547	261	20	compared	compare	VERB
dpc-4547	261	21	to	to	ADP
dpc-4547	261	22	the	the	DET
dpc-4547	261	23	control	control	NOUN
dpc-4547	261	24	(	(	PUNCT
dpc-4547	261	25	5	5	NUM
dpc-4547	261	26	-	-	PUNCT
dpc-4547	261	27	fu	fu	NOUN
dpc-4547	261	28	)	)	PUNCT
dpc-4547	262	1	[	[	X
dpc-4547	262	2	141	141	NUM
dpc-4547	262	3	]	]	PUNCT
dpc-4547	262	4	.	.	PUNCT
dpc-4547	263	1	in	in	ADP
dpc-4547	263	2	analogy	analogy	NOUN
dpc-4547	263	3	,	,	PUNCT
dpc-4547	263	4	cunningham	cunningham	PROPN
dpc-4547	263	5	et	et	PROPN
dpc-4547	263	6	al	al	PROPN
dpc-4547	263	7	.	.	PROPN
dpc-4547	263	8	demonstrated	demonstrate	VERB
dpc-4547	263	9	that	that	SCONJ
dpc-4547	263	10	application	application	NOUN
dpc-4547	263	11	of	of	ADP
dpc-4547	263	12	5	5	NUM
dpc-4547	263	13	-	-	PUNCT
dpc-4547	263	14	fu	fu	NOUN
dpc-4547	263	15	combined	combine	VERB
dpc-4547	263	16	with	with	ADP
dpc-4547	263	17	calcipotriol	calcipotriol	PROPN
dpc-4547	263	18	led	lead	VERB
dpc-4547	263	19	to	to	ADP
dpc-4547	263	20	a	a	DET
dpc-4547	263	21	robust	robust	ADJ
dpc-4547	263	22	and	and	CCONJ
dpc-4547	263	23	sustainable	sustainable	ADJ
dpc-4547	263	24	cd4	cd4	PROPN
dpc-4547	263	25	+	+	PROPN
dpc-4547	263	26	t	t	NOUN
dpc-4547	263	27	-	-	PUNCT
dpc-4547	263	28	cell	cell	NOUN
dpc-4547	263	29	response	response	NOUN
dpc-4547	263	30	against	against	ADP
dpc-4547	263	31	atypical	atypical	ADJ
dpc-4547	263	32	premalignant	premalignant	ADJ
dpc-4547	263	33	keratinocytes	keratinocyte	NOUN
dpc-4547	263	34	in	in	ADP
dpc-4547	263	35	ak	ak	PROPN
dpc-4547	263	36	,	,	PUNCT
dpc-4547	263	37	induced	induce	VERB
dpc-4547	263	38	by	by	ADP
dpc-4547	263	39	upregulation	upregulation	NOUN
dpc-4547	263	40	of	of	ADP
dpc-4547	263	41	thymic	thymic	ADJ
dpc-4547	263	42	untreated	untreated	ADJ
dpc-4547	263	43	ak	ak	PROPN
dpc-4547	263	44	and	and	CCONJ
dpc-4547	263	45	previous	previous	ADJ
dpc-4547	263	46	manifestation	manifestation	NOUN
dpc-4547	263	47	of	of	ADP
dpc-4547	263	48	bcc	bcc	PROPN
dpc-4547	263	49	and	and	CCONJ
dpc-4547	263	50	cscc	cscc	VERB
dpc-4547	264	1	[	[	X
dpc-4547	264	2	110	110	NUM
dpc-4547	264	3	,	,	PUNCT
dpc-4547	264	4	112	112	NUM
dpc-4547	264	5	-	-	SYM
dpc-4547	264	6	115	115	NUM
dpc-4547	264	7	]	]	PUNCT
dpc-4547	264	8	.	.	PUNCT
dpc-4547	265	1	for	for	ADP
dpc-4547	265	2	ak	ak	PROPN
dpc-4547	265	3	,	,	PUNCT
dpc-4547	265	4	the	the	DET
dpc-4547	265	5	current	current	ADJ
dpc-4547	265	6	knowledge	knowledge	NOUN
dpc-4547	265	7	remains	remain	VERB
dpc-4547	265	8	heterogenous	heterogenous	ADJ
dpc-4547	265	9	.	.	PUNCT
dpc-4547	266	1	mainville	mainville	PROPN
dpc-4547	266	2	et	et	PROPN
dpc-4547	266	3	al.[111	al.[111	PROPN
dpc-4547	266	4	]	]	X
dpc-4547	266	5	could	could	AUX
dpc-4547	266	6	not	not	PART
dpc-4547	266	7	identify	identify	VERB
dpc-4547	266	8	a	a	DET
dpc-4547	266	9	beneficial	beneficial	ADJ
dpc-4547	266	10	use	use	NOUN
dpc-4547	266	11	for	for	ADP
dpc-4547	266	12	the	the	DET
dpc-4547	266	13	prevention	prevention	NOUN
dpc-4547	266	14	of	of	ADP
dpc-4547	266	15	ak	ak	PROPN
dpc-4547	266	16	evaluating	evaluate	VERB
dpc-4547	266	17	three	three	NUM
dpc-4547	266	18	trials	trial	NOUN
dpc-4547	266	19	[	[	X
dpc-4547	266	20	110	110	NUM
dpc-4547	266	21	,	,	PUNCT
dpc-4547	266	22	112	112	NUM
dpc-4547	266	23	,	,	PUNCT
dpc-4547	266	24	113	113	NUM
dpc-4547	266	25	]	]	PUNCT
dpc-4547	266	26	.	.	PUNCT
dpc-4547	267	1	although	although	SCONJ
dpc-4547	267	2	,	,	PUNCT
dpc-4547	267	3	the	the	DET
dpc-4547	267	4	level	level	NOUN
dpc-4547	267	5	of	of	ADP
dpc-4547	267	6	evidence	evidence	NOUN
dpc-4547	267	7	for	for	ADP
dpc-4547	267	8	ak	ak	PROPN
dpc-4547	267	9	was	be	AUX
dpc-4547	267	10	estimated	estimate	VERB
dpc-4547	267	11	very	very	ADV
dpc-4547	267	12	low	low	ADJ
dpc-4547	267	13	because	because	SCONJ
dpc-4547	267	14	of	of	ADP
dpc-4547	267	15	study	study	NOUN
dpc-4547	267	16	inconsistency	inconsistency	NOUN
dpc-4547	267	17	and	and	CCONJ
dpc-4547	267	18	imprecision	imprecision	NOUN
dpc-4547	267	19	[	[	X
dpc-4547	267	20	111	111	NUM
dpc-4547	267	21	]	]	PUNCT
dpc-4547	267	22	.	.	PUNCT
dpc-4547	268	1	based	base	VERB
dpc-4547	268	2	on	on	ADP
dpc-4547	268	3	these	these	DET
dpc-4547	268	4	findings	finding	NOUN
dpc-4547	268	5	,	,	PUNCT
dpc-4547	268	6	recent	recent	ADJ
dpc-4547	268	7	recommendations	recommendation	NOUN
dpc-4547	268	8	published	publish	VERB
dpc-4547	268	9	in	in	ADP
dpc-4547	268	10	the	the	DET
dpc-4547	268	11	journal	journal	NOUN
dpc-4547	268	12	of	of	ADP
dpc-4547	268	13	the	the	DET
dpc-4547	268	14	american	american	PROPN
dpc-4547	268	15	academy	academy	PROPN
dpc-4547	268	16	of	of	ADP
dpc-4547	268	17	dermatology	dermatology	NOUN
dpc-4547	268	18	in	in	ADP
dpc-4547	268	19	the	the	DET
dpc-4547	268	20	years	year	NOUN
dpc-4547	268	21	2018	2018	NUM
dpc-4547	268	22	and	and	CCONJ
dpc-4547	268	23	2020	2020	NUM
dpc-4547	268	24	,	,	PUNCT
dpc-4547	268	25	emphasize	emphasize	VERB
dpc-4547	268	26	the	the	DET
dpc-4547	268	27	beneficial	beneficial	ADJ
dpc-4547	268	28	use	use	NOUN
dpc-4547	268	29	of	of	ADP
dpc-4547	268	30	oral	oral	ADJ
dpc-4547	268	31	niacinamide	niacinamide	NOUN
dpc-4547	268	32	500	500	NUM
dpc-4547	268	33	mg	mg	NOUN
dpc-4547	268	34	twice	twice	ADV
dpc-4547	268	35	daily	daily	ADV
dpc-4547	268	36	in	in	ADP
dpc-4547	268	37	patients	patient	NOUN
dpc-4547	268	38	with	with	ADP
dpc-4547	268	39	a	a	DET
dpc-4547	268	40	field	field	NOUN
dpc-4547	268	41	cancerization	cancerization	NOUN
dpc-4547	268	42	or	or	CCONJ
dpc-4547	268	43	more	more	ADJ
dpc-4547	268	44	than	than	ADP
dpc-4547	268	45	one	one	NUM
dpc-4547	268	46	previous	previous	ADJ
dpc-4547	268	47	manifestation	manifestation	NOUN
dpc-4547	268	48	of	of	ADP
dpc-4547	268	49	scc	scc	PROPN
dpc-4547	268	50	[	[	X
dpc-4547	268	51	116	116	NUM
dpc-4547	268	52	,	,	PUNCT
dpc-4547	268	53	117	117	NUM
dpc-4547	268	54	]	]	PUNCT
dpc-4547	268	55	.	.	PUNCT
dpc-4547	269	1	for	for	ADP
dpc-4547	269	2	stors	stor	NOUN
dpc-4547	269	3	the	the	DET
dpc-4547	269	4	use	use	NOUN
dpc-4547	269	5	of	of	ADP
dpc-4547	269	6	niacinamide	niacinamide	NOUN
dpc-4547	269	7	did	do	AUX
dpc-4547	269	8	not	not	PART
dpc-4547	269	9	provide	provide	VERB
dpc-4547	269	10	any	any	DET
dpc-4547	269	11	beneficial	beneficial	ADJ
dpc-4547	269	12	use	use	NOUN
dpc-4547	269	13	over	over	ADP
dpc-4547	269	14	the	the	DET
dpc-4547	269	15	placebo	placebo	NOUN
dpc-4547	269	16	[	[	X
dpc-4547	269	17	118	118	NUM
dpc-4547	269	18	]	]	PUNCT
dpc-4547	269	19	.	.	PUNCT
dpc-4547	270	1	in	in	ADP
dpc-4547	270	2	this	this	DET
dpc-4547	270	3	vulnerable	vulnerable	ADJ
dpc-4547	270	4	group	group	NOUN
dpc-4547	270	5	,	,	PUNCT
dpc-4547	270	6	the	the	DET
dpc-4547	270	7	use	use	NOUN
dpc-4547	270	8	of	of	ADP
dpc-4547	270	9	acitretin	acitretin	NOUN
dpc-4547	270	10	is	be	AUX
dpc-4547	270	11	recommended	recommend	VERB
dpc-4547	270	12	for	for	ADP
dpc-4547	270	13	skin	skin	NOUN
dpc-4547	270	14	cancer	cancer	NOUN
dpc-4547	270	15	prevention	prevention	NOUN
dpc-4547	270	16	[	[	X
dpc-4547	270	17	76	76	NUM
dpc-4547	270	18	]	]	PUNCT
dpc-4547	270	19	,	,	PUNCT
dpc-4547	270	20	see	see	VERB
dpc-4547	270	21	above	above	ADV
dpc-4547	270	22	.	.	PUNCT
dpc-4547	271	1	as	as	SCONJ
dpc-4547	271	2	most	most	ADJ
dpc-4547	271	3	of	of	ADP
dpc-4547	271	4	the	the	DET
dpc-4547	271	5	studies	study	NOUN
dpc-4547	271	6	present	present	VERB
dpc-4547	271	7	results	result	NOUN
dpc-4547	271	8	on	on	ADP
dpc-4547	271	9	tertiary	tertiary	ADJ
dpc-4547	271	10	prophylaxis	prophylaxis	NOUN
dpc-4547	271	11	of	of	ADP
dpc-4547	271	12	skin	skin	NOUN
dpc-4547	271	13	cancer	cancer	NOUN
dpc-4547	271	14	,	,	PUNCT
dpc-4547	271	15	further	further	ADJ
dpc-4547	271	16	studies	study	NOUN
dpc-4547	271	17	should	should	AUX
dpc-4547	271	18	focus	focus	VERB
dpc-4547	271	19	on	on	ADP
dpc-4547	271	20	chemoprevention	chemoprevention	NOUN
dpc-4547	271	21	of	of	ADP
dpc-4547	271	22	ak	ak	PROPN
dpc-4547	271	23	[	[	X
dpc-4547	271	24	111	111	NUM
dpc-4547	271	25	]	]	PUNCT
dpc-4547	271	26	.	.	PUNCT
dpc-4547	272	1	the	the	DET
dpc-4547	272	2	intake	intake	NOUN
dpc-4547	272	3	of	of	ADP
dpc-4547	272	4	niacinamide	niacinamide	NOUN
dpc-4547	272	5	appears	appear	VERB
dpc-4547	272	6	to	to	PART
dpc-4547	272	7	be	be	AUX
dpc-4547	272	8	safe	safe	ADJ
dpc-4547	272	9	and	and	CCONJ
dpc-4547	272	10	well	well	ADV
dpc-4547	272	11	tolerated	tolerate	VERB
dpc-4547	272	12	,	,	PUNCT
dpc-4547	272	13	but	but	CCONJ
dpc-4547	272	14	for	for	ADP
dpc-4547	272	15	high	high	ADJ
dpc-4547	272	16	doses	dose	NOUN
dpc-4547	272	17	exceeding	exceed	VERB
dpc-4547	272	18	3	3	NUM
dpc-4547	272	19	g	g	NOUN
dpc-4547	272	20	/	/	SYM
dpc-4547	272	21	d	d	NOUN
dpc-4547	272	22	reversible	reversible	ADJ
dpc-4547	272	23	hepatotoxicity	hepatotoxicity	NOUN
dpc-4547	272	24	is	be	AUX
dpc-4547	272	25	reported	report	VERB
dpc-4547	272	26	[	[	X
dpc-4547	272	27	110	110	NUM
dpc-4547	272	28	,	,	PUNCT
dpc-4547	272	29	116	116	NUM
dpc-4547	272	30	,	,	PUNCT
dpc-4547	272	31	119	119	NUM
dpc-4547	272	32	,	,	PUNCT
dpc-4547	272	33	120	120	NUM
dpc-4547	272	34	]	]	PUNCT
dpc-4547	272	35	.	.	PUNCT
dpc-4547	273	1	the	the	DET
dpc-4547	273	2	role	role	NOUN
dpc-4547	273	3	of	of	ADP
dpc-4547	273	4	vitamin	vitamin	NOUN
dpc-4547	273	5	d	d	PROPN
dpc-4547	273	6	in	in	ADP
dpc-4547	273	7	ak	ak	PROPN
dpc-4547	273	8	and	and	CCONJ
dpc-4547	273	9	its	its	PRON
dpc-4547	273	10	possible	possible	ADJ
dpc-4547	273	11	preventive	preventive	ADJ
dpc-4547	273	12	use	use	NOUN
dpc-4547	273	13	the	the	DET
dpc-4547	273	14	role	role	NOUN
dpc-4547	273	15	of	of	ADP
dpc-4547	273	16	vitamin	vitamin	NOUN
dpc-4547	273	17	d	d	NOUN
dpc-4547	273	18	in	in	ADP
dpc-4547	273	19	the	the	DET
dpc-4547	273	20	development	development	NOUN
dpc-4547	273	21	of	of	ADP
dpc-4547	273	22	nmsc	nmsc	NOUN
dpc-4547	273	23	is	be	AUX
dpc-4547	273	24	discussed	discuss	VERB
dpc-4547	273	25	controversially	controversially	ADV
dpc-4547	273	26	in	in	ADP
dpc-4547	273	27	the	the	DET
dpc-4547	273	28	available	available	ADJ
dpc-4547	273	29	literature	literature	NOUN
dpc-4547	273	30	and	and	CCONJ
dpc-4547	273	31	is	be	AUX
dpc-4547	273	32	not	not	PART
dpc-4547	273	33	fully	fully	ADV
dpc-4547	273	34	understood	understand	VERB
dpc-4547	273	35	to	to	ADP
dpc-4547	273	36	date	date	NOUN
dpc-4547	273	37	.	.	PUNCT
dpc-4547	274	1	yet	yet	ADV
dpc-4547	274	2	,	,	PUNCT
dpc-4547	274	3	vitamin	vitamin	NOUN
dpc-4547	274	4	d	d	NOUN
dpc-4547	274	5	is	be	AUX
dpc-4547	274	6	attributed	attribute	VERB
dpc-4547	274	7	with	with	ADP
dpc-4547	274	8	skin	skin	NOUN
dpc-4547	274	9	cancer	cancer	NOUN
dpc-4547	274	10	protective	protective	ADJ
dpc-4547	274	11	abilities	ability	NOUN
dpc-4547	274	12	.	.	PUNCT
dpc-4547	275	1	vitamin	vitamin	NOUN
dpc-4547	275	2	d	d	NOUN
dpc-4547	275	3	contributes	contribute	VERB
dpc-4547	275	4	to	to	PART
dpc-4547	275	5	retain	retain	VERB
dpc-4547	275	6	cell	cell	NOUN
dpc-4547	275	7	homeostasis	homeostasis	NOUN
dpc-4547	275	8	,	,	PUNCT
dpc-4547	275	9	by	by	ADP
dpc-4547	275	10	mediating	mediate	VERB
dpc-4547	275	11	and	and	CCONJ
dpc-4547	275	12	promoting	promote	VERB
dpc-4547	275	13	apoptosis	apoptosis	NOUN
dpc-4547	275	14	and	and	CCONJ
dpc-4547	275	15	antiproliferative	antiproliferative	ADJ
dpc-4547	275	16	effects	effect	NOUN
dpc-4547	275	17	in	in	ADP
dpc-4547	275	18	melanocytes	melanocyte	NOUN
dpc-4547	275	19	and	and	CCONJ
dpc-4547	275	20	keratinocytes	keratinocyte	NOUN
dpc-4547	275	21	in	in	ADP
dpc-4547	275	22	vitro	vitro	X
dpc-4547	275	23	[	[	X
dpc-4547	275	24	121	121	NUM
dpc-4547	275	25	]	]	PUNCT
dpc-4547	275	26	.	.	PUNCT
dpc-4547	276	1	moreover	moreover	ADV
dpc-4547	276	2	,	,	PUNCT
dpc-4547	276	3	vitamin	vitamin	NOUN
dpc-4547	276	4	d	d	NOUN
dpc-4547	276	5	acts	act	VERB
dpc-4547	276	6	protective	protective	ADJ
dpc-4547	276	7	in	in	ADP
dpc-4547	276	8	sun	sun	NOUN
dpc-4547	276	9	damaged	damage	VERB
dpc-4547	276	10	skin	skin	NOUN
dpc-4547	276	11	,	,	PUNCT
dpc-4547	276	12	by	by	ADP
dpc-4547	276	13	reducing	reduce	VERB
dpc-4547	276	14	cyclobutene	cyclobutene	NOUN
dpc-4547	276	15	pyrimidine	pyrimidine	NOUN
dpc-4547	276	16	dimers	dimer	NOUN
dpc-4547	276	17	and	and	CCONJ
dpc-4547	276	18	by	by	ADP
dpc-4547	276	19	inducing	induce	VERB
dpc-4547	276	20	the	the	DET
dpc-4547	276	21	formation	formation	NOUN
dpc-4547	276	22	of	of	ADP
dpc-4547	276	23	antioxidants	antioxidant	NOUN
dpc-4547	276	24	such	such	ADJ
dpc-4547	276	25	as	as	ADP
dpc-4547	276	26	metallothionein	metallothionein	ADJ
dpc-4547	276	27	in	in	ADP
dpc-4547	276	28	vitro	vitro	X
dpc-4547	276	29	[	[	PUNCT
dpc-4547	276	30	122	122	NUM
dpc-4547	276	31	-	-	SYM
dpc-4547	276	32	125	125	NUM
dpc-4547	276	33	]	]	PUNCT
dpc-4547	276	34	.	.	PUNCT
dpc-4547	277	1	vitamin	vitamin	NOUN
dpc-4547	277	2	d	d	ADP
dpc-4547	277	3	a	a	DET
dpc-4547	277	4	true	true	ADJ
dpc-4547	277	5	prohormone	prohormone	NOUN
dpc-4547	277	6	comes	come	VERB
dpc-4547	277	7	in	in	ADP
dpc-4547	277	8	two	two	NUM
dpc-4547	277	9	major	major	ADJ
dpc-4547	277	10	configurations	configuration	NOUN
dpc-4547	277	11	,	,	PUNCT
dpc-4547	277	12	namely	namely	ADV
dpc-4547	277	13	cholecalciferol	cholecalciferol	NOUN
dpc-4547	277	14	(	(	PUNCT
dpc-4547	277	15	d3	d3	PROPN
dpc-4547	277	16	)	)	PUNCT
dpc-4547	277	17	and	and	CCONJ
dpc-4547	277	18	ergocalciferol	ergocalciferol	NOUN
dpc-4547	277	19	(	(	PUNCT
dpc-4547	277	20	d2	d2	PROPN
dpc-4547	277	21	)	)	PUNCT
dpc-4547	277	22	.	.	PUNCT
dpc-4547	278	1	both	both	DET
dpc-4547	278	2	forms	form	NOUN
dpc-4547	278	3	can	can	AUX
dpc-4547	278	4	be	be	AUX
dpc-4547	278	5	substituted	substitute	VERB
dpc-4547	278	6	by	by	ADP
dpc-4547	278	7	dietary	dietary	ADJ
dpc-4547	278	8	intake	intake	NOUN
dpc-4547	278	9	while	while	SCONJ
dpc-4547	278	10	the	the	DET
dpc-4547	278	11	larger	large	ADJ
dpc-4547	278	12	amounts	amount	NOUN
dpc-4547	278	13	of	of	ADP
dpc-4547	278	14	vitamin	vitamin	NOUN
dpc-4547	278	15	d3	d3	PROPN
dpc-4547	278	16	are	be	AUX
dpc-4547	278	17	endogenously	endogenously	ADV
dpc-4547	278	18	produced	produce	VERB
dpc-4547	278	19	by	by	ADP
dpc-4547	278	20	photochemical	photochemical	ADJ
dpc-4547	278	21	modification	modification	NOUN
dpc-4547	278	22	of	of	ADP
dpc-4547	278	23	7	7	NUM
dpc-4547	278	24	-	-	PUNCT
dpc-4547	278	25	dehydrocholesterol	dehydrocholesterol	NOUN
dpc-4547	278	26	in	in	ADP
dpc-4547	278	27	the	the	DET
dpc-4547	278	28	skin	skin	NOUN
dpc-4547	278	29	upon	upon	SCONJ
dpc-4547	278	30	uvbr	uvbr	ADJ
dpc-4547	278	31	stimulus	stimulus	NOUN
dpc-4547	279	1	[	[	X
dpc-4547	279	2	121	121	NUM
dpc-4547	279	3	]	]	PUNCT
dpc-4547	279	4	.	.	PUNCT
dpc-4547	280	1	vitamin	vitamin	NOUN
dpc-4547	280	2	d	d	NOUN
dpc-4547	280	3	production	production	NOUN
dpc-4547	280	4	in	in	ADP
dpc-4547	280	5	the	the	DET
dpc-4547	280	6	skin	skin	NOUN
dpc-4547	280	7	largely	largely	ADV
dpc-4547	280	8	depends	depend	VERB
dpc-4547	280	9	on	on	ADP
dpc-4547	280	10	the	the	DET
dpc-4547	280	11	distribution	distribution	NOUN
dpc-4547	280	12	of	of	ADP
dpc-4547	280	13	melanin	melanin	NOUN
dpc-4547	280	14	,	,	PUNCT
dpc-4547	280	15	as	as	SCONJ
dpc-4547	280	16	melanin	melanin	NOUN
dpc-4547	280	17	absorbs	absorb	NOUN
dpc-4547	280	18	and	and	CCONJ
dpc-4547	280	19	scatters	scatter	VERB
dpc-4547	280	20	uvbr	uvbr	PROPN
dpc-4547	280	21	,	,	PUNCT
dpc-4547	280	22	leading	lead	VERB
dpc-4547	280	23	to	to	ADP
dpc-4547	280	24	effective	effective	ADJ
dpc-4547	280	25	conversion	conversion	NOUN
dpc-4547	280	26	of	of	ADP
dpc-4547	280	27	7	7	NUM
dpc-4547	280	28	-	-	PUNCT
dpc-4547	280	29	dehydrocholesterol	dehydrocholesterol	NOUN
dpc-4547	280	30	into	into	ADP
dpc-4547	280	31	vitamin	vitamin	NOUN
dpc-4547	280	32	d	d	NOUN
dpc-4547	280	33	derivates	derivate	NOUN
dpc-4547	280	34	[	[	X
dpc-4547	280	35	126	126	NUM
dpc-4547	280	36	]	]	PUNCT
dpc-4547	280	37	.	.	PUNCT
dpc-4547	281	1	the	the	DET
dpc-4547	281	2	amount	amount	NOUN
dpc-4547	281	3	of	of	ADP
dpc-4547	281	4	endogenous	endogenous	ADJ
dpc-4547	281	5	synthesized	synthesize	VERB
dpc-4547	281	6	vitamin	vitamin	NOUN
dpc-4547	281	7	d3	d3	NOUN
dpc-4547	281	8	also	also	ADV
dpc-4547	281	9	largely	largely	ADV
dpc-4547	281	10	depends	depend	VERB
dpc-4547	281	11	on	on	ADP
dpc-4547	281	12	several	several	ADJ
dpc-4547	281	13	independent	independent	ADJ
dpc-4547	281	14	aspects	aspect	NOUN
dpc-4547	281	15	related	relate	VERB
dpc-4547	281	16	to	to	ADP
dpc-4547	281	17	sun	sun	NOUN
dpc-4547	281	18	exposure	exposure	NOUN
dpc-4547	281	19	,	,	PUNCT
dpc-4547	281	20	such	such	ADJ
dpc-4547	281	21	as	as	ADP
dpc-4547	281	22	cumulative	cumulative	ADJ
dpc-4547	281	23	exposure	exposure	NOUN
dpc-4547	281	24	time	time	NOUN
dpc-4547	281	25	,	,	PUNCT
dpc-4547	281	26	amount	amount	NOUN
dpc-4547	281	27	of	of	ADP
dpc-4547	281	28	sun	sun	NOUN
dpc-4547	281	29	-	-	PUNCT
dpc-4547	281	30	exposed	expose	VERB
dpc-4547	281	31	skin	skin	NOUN
dpc-4547	281	32	,	,	PUNCT
dpc-4547	281	33	age	age	NOUN
dpc-4547	281	34	,	,	PUNCT
dpc-4547	281	35	skin	skin	NOUN
dpc-4547	281	36	phototype	phototype	NOUN
dpc-4547	281	37	and	and	CCONJ
dpc-4547	281	38	body	body	NOUN
dpc-4547	281	39	mass	mass	NOUN
dpc-4547	281	40	index	index	NOUN
dpc-4547	281	41	[	[	X
dpc-4547	281	42	127	127	NUM
dpc-4547	281	43	]	]	PUNCT
dpc-4547	281	44	.	.	PUNCT
dpc-4547	282	1	while	while	SCONJ
dpc-4547	282	2	vitamin	vitamin	NOUN
dpc-4547	282	3	d	d	NOUN
dpc-4547	282	4	is	be	AUX
dpc-4547	282	5	formed	form	VERB
dpc-4547	282	6	by	by	ADP
dpc-4547	282	7	uvbr	uvbr	NOUN
dpc-4547	282	8	stimulus	stimulus	NOUN
dpc-4547	282	9	in	in	ADP
dpc-4547	282	10	the	the	DET
dpc-4547	282	11	skin	skin	NOUN
dpc-4547	282	12	,	,	PUNCT
dpc-4547	282	13	the	the	DET
dpc-4547	282	14	dilemma	dilemma	NOUN
dpc-4547	282	15	in	in	ADP
dpc-4547	282	16	understanding	understand	VERB
dpc-4547	282	17	the	the	DET
dpc-4547	282	18	definite	definite	ADJ
dpc-4547	282	19	role	role	NOUN
dpc-4547	282	20	of	of	ADP
dpc-4547	282	21	vitamin	vitamin	NOUN
dpc-4547	282	22	d	d	NOUN
dpc-4547	282	23	in	in	ADP
dpc-4547	282	24	prevention	prevention	NOUN
dpc-4547	282	25	and	and	CCONJ
dpc-4547	282	26	development	development	NOUN
dpc-4547	282	27	of	of	ADP
dpc-4547	282	28	skin	skin	NOUN
dpc-4547	282	29	cancer	cancer	NOUN
dpc-4547	282	30	lies	lie	VERB
dpc-4547	282	31	in	in	ADP
dpc-4547	282	32	the	the	DET
dpc-4547	282	33	complex	complex	ADJ
dpc-4547	282	34	interplay	interplay	NOUN
dpc-4547	282	35	of	of	ADP
dpc-4547	282	36	uvbr	uvbr	NOUN
dpc-4547	282	37	as	as	ADP
dpc-4547	282	38	a	a	DET
dpc-4547	282	39	key	key	ADJ
dpc-4547	282	40	driver	driver	NOUN
dpc-4547	282	41	of	of	ADP
dpc-4547	282	42	skin	skin	NOUN
dpc-4547	282	43	cancer	cancer	NOUN
dpc-4547	282	44	development	development	NOUN
dpc-4547	282	45	,	,	PUNCT
dpc-4547	282	46	but	but	CCONJ
dpc-4547	282	47	also	also	ADV
dpc-4547	282	48	being	be	AUX
dpc-4547	282	49	the	the	DET
dpc-4547	282	50	8	8	NUM
dpc-4547	282	51	review	review	NOUN
dpc-4547	282	52	|	|	ADV
dpc-4547	282	53	dermatol	dermatol	ADJ
dpc-4547	282	54	pract	pract	NOUN
dpc-4547	282	55	concept	concept	NOUN
dpc-4547	282	56	.	.	PUNCT
dpc-4547	283	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	283	2	:	:	PUNCT
dpc-4547	283	3	e2024146s	e2024146s	PUNCT
dpc-4547	283	4	evidence	evidence	NOUN
dpc-4547	283	5	for	for	ADP
dpc-4547	283	6	screening	screen	VERB
dpc-4547	283	7	reinforces	reinforce	VERB
dpc-4547	283	8	the	the	DET
dpc-4547	283	9	need	need	NOUN
dpc-4547	283	10	for	for	ADP
dpc-4547	283	11	primary	primary	ADJ
dpc-4547	283	12	prevention	prevention	NOUN
dpc-4547	283	13	of	of	ADP
dpc-4547	283	14	nmsc	nmsc	NOUN
dpc-4547	283	15	and	and	CCONJ
dpc-4547	283	16	monitoring	monitoring	NOUN
dpc-4547	283	17	of	of	ADP
dpc-4547	283	18	ak	ak	PROPN
dpc-4547	283	19	appears	appear	VERB
dpc-4547	283	20	to	to	PART
dpc-4547	283	21	be	be	AUX
dpc-4547	283	22	substantial	substantial	ADJ
dpc-4547	283	23	in	in	ADP
dpc-4547	283	24	the	the	DET
dpc-4547	283	25	follow	follow	NOUN
dpc-4547	283	26	-	-	PUNCT
dpc-4547	283	27	up	up	NOUN
dpc-4547	283	28	of	of	ADP
dpc-4547	283	29	ak	ak	PROPN
dpc-4547	283	30	.	.	PROPN
dpc-4547	283	31	especially	especially	ADV
dpc-4547	283	32	,	,	PUNCT
dpc-4547	283	33	patients	patient	NOUN
dpc-4547	283	34	suffering	suffer	VERB
dpc-4547	283	35	from	from	ADP
dpc-4547	283	36	fc	fc	PROPN
dpc-4547	283	37	and/	and/	PROPN
dpc-4547	283	38	or	or	CCONJ
dpc-4547	283	39	immunosuppression	immunosuppression	NOUN
dpc-4547	283	40	are	be	AUX
dpc-4547	283	41	vulnerable	vulnerable	ADJ
dpc-4547	283	42	populations	population	NOUN
dpc-4547	283	43	benefiting	benefit	VERB
dpc-4547	283	44	from	from	ADP
dpc-4547	283	45	close	close	ADJ
dpc-4547	283	46	skin	skin	NOUN
dpc-4547	283	47	cancer	cancer	NOUN
dpc-4547	283	48	screening	screening	NOUN
dpc-4547	283	49	and	and	CCONJ
dpc-4547	283	50	implementation	implementation	NOUN
dpc-4547	283	51	of	of	ADP
dpc-4547	283	52	aggressive	aggressive	ADJ
dpc-4547	283	53	and	and	CCONJ
dpc-4547	283	54	early	early	ADJ
dpc-4547	283	55	adequate	adequate	ADJ
dpc-4547	283	56	therapy	therapy	NOUN
dpc-4547	283	57	[	[	X
dpc-4547	283	58	81	81	NUM
dpc-4547	283	59	,	,	PUNCT
dpc-4547	283	60	116	116	NUM
dpc-4547	283	61	]	]	PUNCT
dpc-4547	283	62	.	.	PUNCT
dpc-4547	284	1	for	for	ADP
dpc-4547	284	2	these	these	DET
dpc-4547	284	3	patients	patient	NOUN
dpc-4547	284	4	,	,	PUNCT
dpc-4547	284	5	acitretin	acitretin	NOUN
dpc-4547	284	6	chemoprophylaxis	chemoprophylaxis	NOUN
dpc-4547	284	7	should	should	AUX
dpc-4547	284	8	be	be	AUX
dpc-4547	284	9	implemented	implement	VERB
dpc-4547	284	10	[	[	X
dpc-4547	284	11	76	76	NUM
dpc-4547	284	12	]	]	PUNCT
dpc-4547	284	13	.	.	PUNCT
dpc-4547	285	1	but	but	CCONJ
dpc-4547	285	2	also	also	ADV
dpc-4547	285	3	,	,	PUNCT
dpc-4547	285	4	when	when	SCONJ
dpc-4547	285	5	ak	ak	PROPN
dpc-4547	285	6	presents	present	VERB
dpc-4547	285	7	therapy	therapy	NOUN
dpc-4547	285	8	refractory	refractory	NOUN
dpc-4547	285	9	and	and	CCONJ
dpc-4547	285	10	additional	additional	ADJ
dpc-4547	285	11	treatment	treatment	NOUN
dpc-4547	285	12	is	be	AUX
dpc-4547	285	13	required	require	VERB
dpc-4547	285	14	the	the	DET
dpc-4547	285	15	risk	risk	NOUN
dpc-4547	285	16	for	for	ADP
dpc-4547	285	17	cscc	cscc	ADJ
dpc-4547	285	18	development	development	NOUN
dpc-4547	285	19	increases	increase	NOUN
dpc-4547	285	20	dramatically	dramatically	ADV
dpc-4547	285	21	up	up	ADP
dpc-4547	285	22	to	to	ADP
dpc-4547	285	23	33.5	33.5	NUM
dpc-4547	285	24	%	%	NOUN
dpc-4547	285	25	for	for	ADP
dpc-4547	285	26	a	a	DET
dpc-4547	285	27	4	4	NUM
dpc-4547	285	28	-	-	PUNCT
dpc-4547	285	29	year	year	NOUN
dpc-4547	285	30	risk	risk	NOUN
dpc-4547	285	31	assessment	assessment	NOUN
dpc-4547	285	32	[	[	X
dpc-4547	285	33	150	150	NUM
dpc-4547	285	34	]	]	PUNCT
dpc-4547	285	35	.	.	PUNCT
dpc-4547	286	1	although	although	SCONJ
dpc-4547	286	2	,	,	PUNCT
dpc-4547	286	3	when	when	SCONJ
dpc-4547	286	4	ak	ak	PROPN
dpc-4547	286	5	is	be	AUX
dpc-4547	286	6	treated	treat	VERB
dpc-4547	286	7	sufficiently	sufficiently	ADV
dpc-4547	286	8	,	,	PUNCT
dpc-4547	286	9	the	the	DET
dpc-4547	286	10	risk	risk	NOUN
dpc-4547	286	11	of	of	ADP
dpc-4547	286	12	cscc	cscc	ADJ
dpc-4547	286	13	occurrence	occurrence	NOUN
dpc-4547	286	14	within	within	ADP
dpc-4547	286	15	the	the	DET
dpc-4547	286	16	field	field	NOUN
dpc-4547	286	17	of	of	ADP
dpc-4547	286	18	treatment	treatment	NOUN
dpc-4547	286	19	is	be	AUX
dpc-4547	286	20	2.2	2.2	NUM
dpc-4547	286	21	to	to	PART
dpc-4547	286	22	5.8	5.8	NUM
dpc-4547	286	23	%	%	NOUN
dpc-4547	286	24	over	over	ADP
dpc-4547	286	25	a	a	DET
dpc-4547	286	26	course	course	NOUN
dpc-4547	286	27	of	of	ADP
dpc-4547	286	28	four	four	NUM
dpc-4547	286	29	years	year	NOUN
dpc-4547	286	30	,	,	PUNCT
dpc-4547	286	31	depending	depend	VERB
dpc-4547	286	32	on	on	ADP
dpc-4547	286	33	the	the	DET
dpc-4547	286	34	topical	topical	ADJ
dpc-4547	286	35	ointment	ointment	NOUN
dpc-4547	286	36	applied	apply	VERB
dpc-4547	286	37	[	[	X
dpc-4547	286	38	150	150	NUM
dpc-4547	286	39	]	]	PUNCT
dpc-4547	286	40	.	.	PUNCT
dpc-4547	287	1	these	these	DET
dpc-4547	287	2	numbers	number	NOUN
dpc-4547	287	3	imply	imply	VERB
dpc-4547	287	4	that	that	SCONJ
dpc-4547	287	5	patients	patient	NOUN
dpc-4547	287	6	may	may	AUX
dpc-4547	287	7	benefit	benefit	VERB
dpc-4547	287	8	from	from	ADP
dpc-4547	287	9	a	a	DET
dpc-4547	287	10	close	close	ADJ
dpc-4547	287	11	follow	follow	NOUN
dpc-4547	287	12	-	-	PUNCT
dpc-4547	287	13	up	up	NOUN
dpc-4547	287	14	for	for	ADP
dpc-4547	287	15	close	close	ADJ
dpc-4547	287	16	ak	ak	NOUN
dpc-4547	287	17	lesion	lesion	NOUN
dpc-4547	287	18	monitoring	monitoring	NOUN
dpc-4547	287	19	.	.	PUNCT
dpc-4547	288	1	this	this	DET
dpc-4547	288	2	assumption	assumption	NOUN
dpc-4547	288	3	may	may	AUX
dpc-4547	288	4	even	even	ADV
dpc-4547	288	5	be	be	AUX
dpc-4547	288	6	validated	validate	VERB
dpc-4547	288	7	as	as	SCONJ
dpc-4547	288	8	studies	study	NOUN
dpc-4547	288	9	suggest	suggest	VERB
dpc-4547	288	10	that	that	SCONJ
dpc-4547	288	11	the	the	DET
dpc-4547	288	12	appliance	appliance	NOUN
dpc-4547	288	13	of	of	ADP
dpc-4547	288	14	topical	topical	ADJ
dpc-4547	288	15	therapy	therapy	NOUN
dpc-4547	288	16	often	often	ADV
dpc-4547	288	17	lacks	lack	VERB
dpc-4547	288	18	adequate	adequate	ADJ
dpc-4547	288	19	implementation	implementation	NOUN
dpc-4547	288	20	by	by	ADP
dpc-4547	288	21	patients	patient	NOUN
dpc-4547	288	22	,	,	PUNCT
dpc-4547	288	23	as	as	SCONJ
dpc-4547	288	24	they	they	PRON
dpc-4547	288	25	are	be	AUX
dpc-4547	288	26	often	often	ADV
dpc-4547	288	27	not	not	PART
dpc-4547	288	28	well	well	ADV
dpc-4547	288	29	informed	informed	ADJ
dpc-4547	288	30	about	about	ADP
dpc-4547	288	31	the	the	DET
dpc-4547	288	32	specific	specific	ADJ
dpc-4547	288	33	topical	topical	ADJ
dpc-4547	288	34	intervention	intervention	NOUN
dpc-4547	288	35	regime	regime	NOUN
dpc-4547	289	1	[	[	X
dpc-4547	289	2	151	151	NUM
dpc-4547	289	3	]	]	PUNCT
dpc-4547	289	4	.	.	PUNCT
dpc-4547	290	1	for	for	ADP
dpc-4547	290	2	a	a	DET
dpc-4547	290	3	cross	cross	ADJ
dpc-4547	290	4	-	-	ADJ
dpc-4547	290	5	sectional	sectional	ADJ
dpc-4547	290	6	cohort	cohort	NOUN
dpc-4547	290	7	of	of	ADP
dpc-4547	290	8	113	113	NUM
dpc-4547	290	9	patients	patient	NOUN
dpc-4547	290	10	,	,	PUNCT
dpc-4547	290	11	koch	koch	PROPN
dpc-4547	290	12	et	et	PROPN
dpc-4547	290	13	al	al	PROPN
dpc-4547	290	14	.[151	.[151	PROPN
dpc-4547	290	15	]	]	PUNCT
dpc-4547	290	16	found	find	VERB
dpc-4547	290	17	a	a	DET
dpc-4547	290	18	concerning	concern	VERB
dpc-4547	290	19	non	non	ADJ
dpc-4547	290	20	-	-	ADJ
dpc-4547	290	21	adherence	adherence	ADJ
dpc-4547	290	22	rate	rate	NOUN
dpc-4547	290	23	of	of	ADP
dpc-4547	290	24	46.9	46.9	NUM
dpc-4547	290	25	%	%	NOUN
dpc-4547	290	26	to	to	ADP
dpc-4547	290	27	the	the	DET
dpc-4547	290	28	implemented	implement	VERB
dpc-4547	290	29	topical	topical	ADJ
dpc-4547	290	30	ak	ak	PROPN
dpc-4547	290	31	treatment	treatment	NOUN
dpc-4547	290	32	.	.	PUNCT
dpc-4547	291	1	only	only	ADV
dpc-4547	291	2	30.9	30.9	NUM
dpc-4547	291	3	%	%	NOUN
dpc-4547	291	4	of	of	ADP
dpc-4547	291	5	the	the	DET
dpc-4547	291	6	patients	patient	NOUN
dpc-4547	291	7	used	use	VERB
dpc-4547	291	8	the	the	DET
dpc-4547	291	9	administered	administer	VERB
dpc-4547	291	10	therapy	therapy	NOUN
dpc-4547	291	11	in	in	ADP
dpc-4547	291	12	accordance	accordance	NOUN
dpc-4547	291	13	with	with	ADP
dpc-4547	291	14	the	the	DET
dpc-4547	291	15	product	product	NOUN
dpc-4547	291	16	characteristics	characteristic	NOUN
dpc-4547	291	17	[	[	X
dpc-4547	291	18	151	151	NUM
dpc-4547	291	19	]	]	PUNCT
dpc-4547	291	20	.	.	PUNCT
dpc-4547	292	1	patients	patient	NOUN
dpc-4547	292	2	,	,	PUNCT
dpc-4547	292	3	who	who	PRON
dpc-4547	292	4	did	do	AUX
dpc-4547	292	5	not	not	PART
dpc-4547	292	6	adhere	adhere	VERB
dpc-4547	292	7	with	with	ADP
dpc-4547	292	8	the	the	DET
dpc-4547	292	9	medical	medical	ADJ
dpc-4547	292	10	product	product	NOUN
dpc-4547	292	11	guidelines	guideline	NOUN
dpc-4547	292	12	were	be	AUX
dpc-4547	292	13	significantly	significantly	ADV
dpc-4547	292	14	less	less	ADV
dpc-4547	292	15	informed	informed	ADJ
dpc-4547	292	16	about	about	ADP
dpc-4547	292	17	the	the	DET
dpc-4547	292	18	product	product	NOUN
dpc-4547	292	19	and	and	CCONJ
dpc-4547	292	20	adjusted	adjust	VERB
dpc-4547	292	21	application	application	NOUN
dpc-4547	292	22	timeframe	timeframe	NOUN
dpc-4547	292	23	and	and	CCONJ
dpc-4547	292	24	therapy	therapy	NOUN
dpc-4547	292	25	frequency	frequency	NOUN
dpc-4547	292	26	independently	independently	ADV
dpc-4547	292	27	[	[	X
dpc-4547	292	28	151	151	NUM
dpc-4547	292	29	]	]	PUNCT
dpc-4547	292	30	.	.	PUNCT
dpc-4547	293	1	recent	recent	ADJ
dpc-4547	293	2	literature	literature	NOUN
dpc-4547	293	3	suggests	suggest	VERB
dpc-4547	293	4	that	that	SCONJ
dpc-4547	293	5	some	some	DET
dpc-4547	293	6	patient	patient	ADJ
dpc-4547	293	7	groups	group	NOUN
dpc-4547	293	8	suffering	suffer	VERB
dpc-4547	293	9	from	from	ADP
dpc-4547	293	10	ak	ak	PROPN
dpc-4547	293	11	are	be	AUX
dpc-4547	293	12	not	not	PART
dpc-4547	293	13	well	well	ADV
dpc-4547	293	14	informed	informed	ADJ
dpc-4547	293	15	about	about	ADP
dpc-4547	293	16	the	the	DET
dpc-4547	293	17	condition	condition	NOUN
dpc-4547	293	18	of	of	ADP
dpc-4547	293	19	ak	ak	PROPN
dpc-4547	293	20	.	.	PROPN
dpc-4547	293	21	elderly	elderly	ADJ
dpc-4547	293	22	patients	patient	NOUN
dpc-4547	293	23	(	(	PUNCT
dpc-4547	293	24	over	over	ADP
dpc-4547	293	25	77	77	NUM
dpc-4547	293	26	years	year	NOUN
dpc-4547	293	27	of	of	ADP
dpc-4547	293	28	age	age	NOUN
dpc-4547	293	29	)	)	PUNCT
dpc-4547	293	30	and	and	CCONJ
dpc-4547	293	31	those	those	PRON
dpc-4547	293	32	suffering	suffer	VERB
dpc-4547	293	33	from	from	ADP
dpc-4547	293	34	more	more	ADJ
dpc-4547	293	35	than	than	ADP
dpc-4547	293	36	seven	seven	NUM
dpc-4547	293	37	lesions	lesion	NOUN
dpc-4547	293	38	were	be	AUX
dpc-4547	293	39	identified	identify	VERB
dpc-4547	293	40	at	at	ADP
dpc-4547	293	41	high	high	ADJ
dpc-4547	293	42	risk	risk	NOUN
dpc-4547	293	43	for	for	ADP
dpc-4547	293	44	not	not	PART
dpc-4547	293	45	seeking	seek	VERB
dpc-4547	293	46	treatment	treatment	NOUN
dpc-4547	293	47	due	due	ADJ
dpc-4547	293	48	to	to	ADP
dpc-4547	293	49	intrinsic	intrinsic	ADJ
dpc-4547	293	50	and	and	CCONJ
dpc-4547	293	51	extrinsic	extrinsic	ADJ
dpc-4547	293	52	motivation	motivation	NOUN
dpc-4547	293	53	deficits	deficit	NOUN
dpc-4547	293	54	[	[	X
dpc-4547	293	55	152	152	NUM
dpc-4547	293	56	]	]	PUNCT
dpc-4547	293	57	.	.	PUNCT
dpc-4547	294	1	but	but	CCONJ
dpc-4547	294	2	also	also	ADV
dpc-4547	294	3	,	,	PUNCT
dpc-4547	294	4	patients	patient	NOUN
dpc-4547	294	5	who	who	PRON
dpc-4547	294	6	never	never	ADV
dpc-4547	294	7	had	have	VERB
dpc-4547	294	8	ak	ak	PROPN
dpc-4547	294	9	related	relate	VERB
dpc-4547	294	10	treatment	treatment	NOUN
dpc-4547	294	11	and	and	CCONJ
dpc-4547	294	12	those	those	PRON
dpc-4547	294	13	suffering	suffer	VERB
dpc-4547	294	14	from	from	ADP
dpc-4547	294	15	only	only	ADV
dpc-4547	294	16	one	one	NUM
dpc-4547	294	17	to	to	PART
dpc-4547	294	18	three	three	NUM
dpc-4547	294	19	ak	ak	PROPN
dpc-4547	294	20	lesions	lesion	NOUN
dpc-4547	294	21	are	be	AUX
dpc-4547	294	22	more	more	ADV
dpc-4547	294	23	likely	likely	ADJ
dpc-4547	294	24	to	to	PART
dpc-4547	294	25	expect	expect	VERB
dpc-4547	294	26	a	a	DET
dpc-4547	294	27	one	one	NUM
dpc-4547	294	28	-	-	PUNCT
dpc-4547	294	29	time	time	NOUN
dpc-4547	294	30	treatment	treatment	NOUN
dpc-4547	294	31	,	,	PUNCT
dpc-4547	294	32	indicating	indicate	VERB
dpc-4547	294	33	that	that	SCONJ
dpc-4547	294	34	they	they	PRON
dpc-4547	294	35	may	may	AUX
dpc-4547	294	36	not	not	PART
dpc-4547	294	37	yet	yet	ADV
dpc-4547	294	38	be	be	AUX
dpc-4547	294	39	aware	aware	ADJ
dpc-4547	294	40	that	that	SCONJ
dpc-4547	294	41	ak	ak	PROPN
dpc-4547	294	42	is	be	AUX
dpc-4547	294	43	considered	consider	VERB
dpc-4547	294	44	a	a	DET
dpc-4547	294	45	chronic	chronic	ADJ
dpc-4547	294	46	condition	condition	NOUN
dpc-4547	294	47	,	,	PUNCT
dpc-4547	294	48	which	which	PRON
dpc-4547	294	49	usually	usually	ADV
dpc-4547	294	50	requires	require	VERB
dpc-4547	294	51	multiple	multiple	ADJ
dpc-4547	294	52	treatment	treatment	NOUN
dpc-4547	294	53	modalities	modality	NOUN
dpc-4547	294	54	and	and	CCONJ
dpc-4547	294	55	lifelong	lifelong	ADJ
dpc-4547	294	56	surveillance	surveillance	NOUN
dpc-4547	295	1	[	[	X
dpc-4547	295	2	152	152	NUM
dpc-4547	295	3	]	]	PUNCT
dpc-4547	295	4	.	.	PUNCT
dpc-4547	296	1	regularly	regularly	ADV
dpc-4547	296	2	patient	patient	ADJ
dpc-4547	296	3	visits	visit	NOUN
dpc-4547	296	4	may	may	AUX
dpc-4547	296	5	be	be	AUX
dpc-4547	296	6	a	a	DET
dpc-4547	296	7	useful	useful	ADJ
dpc-4547	296	8	opportunity	opportunity	NOUN
dpc-4547	296	9	to	to	PART
dpc-4547	296	10	inform	inform	VERB
dpc-4547	296	11	patients	patient	NOUN
dpc-4547	296	12	about	about	ADP
dpc-4547	296	13	ak	ak	PROPN
dpc-4547	296	14	and	and	CCONJ
dpc-4547	296	15	to	to	PART
dpc-4547	296	16	reinforce	reinforce	VERB
dpc-4547	296	17	the	the	DET
dpc-4547	296	18	patients	patient	NOUN
dpc-4547	296	19	’	’	PART
dpc-4547	296	20	therapy	therapy	NOUN
dpc-4547	296	21	adherence	adherence	NOUN
dpc-4547	296	22	as	as	ADP
dpc-4547	296	23	one	one	NUM
dpc-4547	296	24	of	of	ADP
dpc-4547	296	25	the	the	DET
dpc-4547	296	26	main	main	ADJ
dpc-4547	296	27	goals	goal	NOUN
dpc-4547	296	28	in	in	ADP
dpc-4547	296	29	the	the	DET
dpc-4547	296	30	patient	patient	NOUN
dpc-4547	296	31	’s	’s	PART
dpc-4547	296	32	motivation	motivation	NOUN
dpc-4547	296	33	for	for	ADP
dpc-4547	296	34	ak	ak	PROPN
dpc-4547	296	35	treatment	treatment	NOUN
dpc-4547	296	36	is	be	AUX
dpc-4547	296	37	the	the	DET
dpc-4547	296	38	prevention	prevention	NOUN
dpc-4547	296	39	of	of	ADP
dpc-4547	296	40	malignant	malignant	ADJ
dpc-4547	296	41	transformation	transformation	NOUN
dpc-4547	297	1	[	[	X
dpc-4547	297	2	152	152	NUM
dpc-4547	297	3	]	]	PUNCT
dpc-4547	297	4	.	.	PUNCT
dpc-4547	298	1	moreover	moreover	ADV
dpc-4547	298	2	,	,	PUNCT
dpc-4547	298	3	patients	patient	NOUN
dpc-4547	298	4	are	be	AUX
dpc-4547	298	5	strengthened	strengthen	VERB
dpc-4547	298	6	in	in	ADP
dpc-4547	298	7	their	their	PRON
dpc-4547	298	8	will	will	NOUN
dpc-4547	298	9	to	to	PART
dpc-4547	298	10	treat	treat	VERB
dpc-4547	298	11	ak	ak	PROPN
dpc-4547	298	12	,	,	PUNCT
dpc-4547	298	13	when	when	SCONJ
dpc-4547	298	14	it	it	PRON
dpc-4547	298	15	is	be	AUX
dpc-4547	298	16	recommended	recommend	VERB
dpc-4547	298	17	by	by	ADP
dpc-4547	298	18	the	the	DET
dpc-4547	298	19	physician	physician	NOUN
dpc-4547	299	1	[	[	X
dpc-4547	299	2	152	152	NUM
dpc-4547	299	3	]	]	PUNCT
dpc-4547	299	4	.	.	PUNCT
dpc-4547	300	1	however	however	ADV
dpc-4547	300	2	,	,	PUNCT
dpc-4547	300	3	monitoring	monitoring	NOUN
dpc-4547	300	4	of	of	ADP
dpc-4547	300	5	fc	fc	PROPN
dpc-4547	300	6	and	and	CCONJ
dpc-4547	300	7	ak	ak	PROPN
dpc-4547	300	8	only	only	ADV
dpc-4547	300	9	by	by	ADP
dpc-4547	300	10	measuring	measure	VERB
dpc-4547	300	11	lesion	lesion	NOUN
dpc-4547	300	12	counts	count	NOUN
dpc-4547	300	13	can	can	AUX
dpc-4547	300	14	be	be	AUX
dpc-4547	300	15	cumbersome	cumbersome	ADJ
dpc-4547	300	16	and	and	CCONJ
dpc-4547	300	17	studies	study	NOUN
dpc-4547	300	18	have	have	AUX
dpc-4547	300	19	shown	show	VERB
dpc-4547	300	20	that	that	SCONJ
dpc-4547	300	21	this	this	DET
dpc-4547	300	22	approach	approach	NOUN
dpc-4547	300	23	is	be	AUX
dpc-4547	300	24	imprecise	imprecise	ADJ
dpc-4547	300	25	and	and	CCONJ
dpc-4547	300	26	impracticable	impracticable	ADJ
dpc-4547	300	27	,	,	PUNCT
dpc-4547	300	28	due	due	ADP
dpc-4547	300	29	to	to	ADP
dpc-4547	300	30	the	the	DET
dpc-4547	300	31	sometimes	sometimes	ADV
dpc-4547	300	32	-	-	PUNCT
dpc-4547	300	33	difficult	difficult	ADJ
dpc-4547	300	34	identification	identification	NOUN
dpc-4547	300	35	of	of	ADP
dpc-4547	300	36	subclinical	subclinical	ADJ
dpc-4547	300	37	ak	ak	PROPN
dpc-4547	300	38	and	and	CCONJ
dpc-4547	300	39	confluent	confluent	ADJ
dpc-4547	300	40	transition	transition	NOUN
dpc-4547	300	41	of	of	ADP
dpc-4547	300	42	ak	ak	PROPN
dpc-4547	301	1	[	[	X
dpc-4547	301	2	153	153	NUM
dpc-4547	301	3	]	]	PUNCT
dpc-4547	301	4	.	.	PUNCT
dpc-4547	302	1	tools	tool	NOUN
dpc-4547	302	2	such	such	ADJ
dpc-4547	302	3	as	as	ADP
dpc-4547	302	4	the	the	DET
dpc-4547	302	5	actinic	actinic	ADJ
dpc-4547	302	6	keratosis	keratosis	NOUN
dpc-4547	302	7	field	field	NOUN
dpc-4547	302	8	assessment	assessment	NOUN
dpc-4547	302	9	scale	scale	NOUN
dpc-4547	302	10	(	(	PUNCT
dpc-4547	302	11	ak	ak	NOUN
dpc-4547	302	12	-	-	PUNCT
dpc-4547	302	13	fas	fas	NOUN
dpc-4547	302	14	)	)	PUNCT
dpc-4547	302	15	or	or	CCONJ
dpc-4547	302	16	the	the	DET
dpc-4547	302	17	actinic	actinic	ADJ
dpc-4547	302	18	keratosis	keratosis	NOUN
dpc-4547	302	19	stromal	stromal	ADJ
dpc-4547	302	20	lymphopoietin	lymphopoietin	NOUN
dpc-4547	302	21	cytokine	cytokine	NOUN
dpc-4547	302	22	in	in	ADP
dpc-4547	302	23	keratinocytes	keratinocyte	NOUN
dpc-4547	302	24	by	by	ADP
dpc-4547	302	25	calcipotriol	calcipotriol	PROPN
dpc-4547	302	26	,	,	PUNCT
dpc-4547	302	27	which	which	PRON
dpc-4547	302	28	is	be	AUX
dpc-4547	302	29	also	also	ADV
dpc-4547	302	30	reported	report	VERB
dpc-4547	302	31	for	for	ADP
dpc-4547	302	32	treatment	treatment	NOUN
dpc-4547	302	33	of	of	ADP
dpc-4547	302	34	psoriatic	psoriatic	ADJ
dpc-4547	302	35	lesions	lesion	NOUN
dpc-4547	302	36	[	[	X
dpc-4547	302	37	142	142	NUM
dpc-4547	302	38	-	-	SYM
dpc-4547	302	39	144	144	NUM
dpc-4547	302	40	]	]	PUNCT
dpc-4547	302	41	.	.	PUNCT
dpc-4547	303	1	a	a	DET
dpc-4547	303	2	similar	similar	ADJ
dpc-4547	303	3	positive	positive	ADJ
dpc-4547	303	4	effect	effect	NOUN
dpc-4547	303	5	was	be	AUX
dpc-4547	303	6	found	find	VERB
dpc-4547	303	7	for	for	ADP
dpc-4547	303	8	the	the	DET
dpc-4547	303	9	oral	oral	ADJ
dpc-4547	303	10	pretreatment	pretreatment	NOUN
dpc-4547	303	11	of	of	ADP
dpc-4547	303	12	ak	ak	PROPN
dpc-4547	303	13	using	use	VERB
dpc-4547	303	14	vitamin	vitamin	NOUN
dpc-4547	303	15	d3	d3	PROPN
dpc-4547	303	16	10.000	10.000	NUM
dpc-4547	303	17	iu	iu	ADV
dpc-4547	303	18	daily	daily	ADV
dpc-4547	303	19	for	for	ADP
dpc-4547	303	20	5	5	NUM
dpc-4547	303	21	or	or	CCONJ
dpc-4547	303	22	14	14	NUM
dpc-4547	303	23	days	day	NOUN
dpc-4547	303	24	,	,	PUNCT
dpc-4547	303	25	followed	follow	VERB
dpc-4547	303	26	by	by	ADP
dpc-4547	303	27	blue	blue	ADJ
dpc-4547	303	28	light	light	ADJ
dpc-4547	303	29	photodynamic	photodynamic	ADJ
dpc-4547	303	30	therapy	therapy	NOUN
dpc-4547	303	31	(	(	PUNCT
dpc-4547	303	32	30	30	NUM
dpc-4547	303	33	minutes	minute	NOUN
dpc-4547	303	34	;	;	PUNCT
dpc-4547	303	35	20	20	NUM
dpc-4547	303	36	j	j	PROPN
dpc-4547	303	37	/	/	SYM
dpc-4547	303	38	cm2	cm2	NOUN
dpc-4547	303	39	)	)	PUNCT
dpc-4547	304	1	[	[	X
dpc-4547	304	2	145	145	NUM
dpc-4547	304	3	]	]	PUNCT
dpc-4547	304	4	.	.	PUNCT
dpc-4547	305	1	in	in	ADP
dpc-4547	305	2	the	the	DET
dpc-4547	305	3	control	control	NOUN
dpc-4547	305	4	group	group	NOUN
dpc-4547	305	5	with	with	ADP
dpc-4547	305	6	no	no	DET
dpc-4547	305	7	vitamin	vitamin	NOUN
dpc-4547	305	8	d3	d3	PROPN
dpc-4547	305	9	supplementation	supplementation	NOUN
dpc-4547	305	10	,	,	PUNCT
dpc-4547	305	11	individuals	individual	NOUN
dpc-4547	305	12	with	with	ADP
dpc-4547	305	13	25(oh)d	25(oh)d	NOUN
dpc-4547	305	14	deficiency	deficiency	NOUN
dpc-4547	305	15	(	(	PUNCT
dpc-4547	305	16	<	<	X
dpc-4547	305	17	31	31	NUM
dpc-4547	305	18	ng	ng	PROPN
dpc-4547	305	19	/	/	SYM
dpc-4547	305	20	dl	dl	PROPN
dpc-4547	305	21	)	)	PUNCT
dpc-4547	305	22	had	have	VERB
dpc-4547	305	23	a	a	DET
dpc-4547	305	24	clearance	clearance	NOUN
dpc-4547	305	25	rate	rate	NOUN
dpc-4547	305	26	of	of	ADP
dpc-4547	305	27	40.9	40.9	NUM
dpc-4547	305	28	%	%	NOUN
dpc-4547	305	29	±	±	NUM
dpc-4547	305	30	42	42	NUM
dpc-4547	305	31	%	%	NOUN
dpc-4547	305	32	,	,	PUNCT
dpc-4547	305	33	while	while	SCONJ
dpc-4547	305	34	in	in	SCONJ
dpc-4547	305	35	patients	patient	NOUN
dpc-4547	305	36	with	with	ADP
dpc-4547	305	37	normal	normal	ADJ
dpc-4547	305	38	25(oh)d	25(oh)d	NUM
dpc-4547	305	39	levels	level	NOUN
dpc-4547	305	40	a	a	DET
dpc-4547	305	41	clearance	clearance	NOUN
dpc-4547	305	42	was	be	AUX
dpc-4547	305	43	found	find	VERB
dpc-4547	305	44	in	in	ADP
dpc-4547	305	45	62.6	62.6	NUM
dpc-4547	305	46	%	%	NOUN
dpc-4547	305	47	±	±	NUM
dpc-4547	305	48	14.2	14.2	NUM
dpc-4547	305	49	%	%	NOUN
dpc-4547	305	50	of	of	ADP
dpc-4547	305	51	the	the	DET
dpc-4547	305	52	cases	case	NOUN
dpc-4547	305	53	.	.	PUNCT
dpc-4547	306	1	for	for	ADP
dpc-4547	306	2	high	high	ADJ
dpc-4547	306	3	-	-	PUNCT
dpc-4547	306	4	dose	dose	NOUN
dpc-4547	306	5	vitamin	vitamin	NOUN
dpc-4547	306	6	d3	d3	PROPN
dpc-4547	306	7	supplementation	supplementation	NOUN
dpc-4547	306	8	a	a	DET
dpc-4547	306	9	significantly	significantly	ADV
dpc-4547	306	10	improved	improve	VERB
dpc-4547	306	11	lesion	lesion	NOUN
dpc-4547	306	12	clearance	clearance	NOUN
dpc-4547	306	13	was	be	AUX
dpc-4547	306	14	found	find	VERB
dpc-4547	306	15	in	in	ADP
dpc-4547	306	16	72.5	72.5	NUM
dpc-4547	306	17	%	%	NOUN
dpc-4547	306	18	±	±	NUM
dpc-4547	306	19	13.6	13.6	NUM
dpc-4547	306	20	%	%	NOUN
dpc-4547	306	21	cases	case	NOUN
dpc-4547	306	22	[	[	X
dpc-4547	306	23	145	145	NUM
dpc-4547	306	24	]	]	PUNCT
dpc-4547	306	25	.	.	PUNCT
dpc-4547	307	1	discussion	discussion	NOUN
dpc-4547	307	2	–	–	PUNCT
dpc-4547	307	3	management	management	NOUN
dpc-4547	307	4	and	and	CCONJ
dpc-4547	307	5	monitoring	monitoring	NOUN
dpc-4547	307	6	of	of	ADP
dpc-4547	307	7	actinic	actinic	ADJ
dpc-4547	307	8	keratosis	keratosis	NOUN
dpc-4547	307	9	and	and	CCONJ
dpc-4547	307	10	prevention	prevention	NOUN
dpc-4547	307	11	of	of	ADP
dpc-4547	307	12	cscc	cscc	ADJ
dpc-4547	307	13	further	further	ADJ
dpc-4547	307	14	research	research	NOUN
dpc-4547	307	15	is	be	AUX
dpc-4547	307	16	needed	need	VERB
dpc-4547	307	17	to	to	PART
dpc-4547	307	18	fully	fully	ADV
dpc-4547	307	19	understand	understand	VERB
dpc-4547	307	20	the	the	DET
dpc-4547	307	21	effect	effect	NOUN
dpc-4547	307	22	of	of	ADP
dpc-4547	307	23	ak	ak	PROPN
dpc-4547	307	24	treatment	treatment	NOUN
dpc-4547	307	25	on	on	ADP
dpc-4547	307	26	cscc	cscc	ADJ
dpc-4547	307	27	risk	risk	NOUN
dpc-4547	307	28	and	and	CCONJ
dpc-4547	307	29	outcomes	outcome	NOUN
dpc-4547	307	30	of	of	ADP
dpc-4547	307	31	cscc	cscc	NOUN
dpc-4547	307	32	.	.	PUNCT
dpc-4547	308	1	a	a	DET
dpc-4547	308	2	longitudinal	longitudinal	ADJ
dpc-4547	308	3	cohort	cohort	NOUN
dpc-4547	308	4	study	study	NOUN
dpc-4547	308	5	conducted	conduct	VERB
dpc-4547	308	6	by	by	ADP
dpc-4547	308	7	madani	madani	PROPN
dpc-4547	308	8	et	et	PROPN
dpc-4547	308	9	al	al	PROPN
dpc-4547	308	10	.	.	PUNCT
dpc-4547	309	1	[	[	X
dpc-4547	309	2	146	146	NUM
dpc-4547	309	3	]	]	PUNCT
dpc-4547	309	4	evaluated	evaluate	VERB
dpc-4547	309	5	the	the	DET
dpc-4547	309	6	risk	risk	NOUN
dpc-4547	309	7	of	of	ADP
dpc-4547	309	8	cscc	cscc	ADJ
dpc-4547	309	9	development	development	NOUN
dpc-4547	309	10	for	for	ADP
dpc-4547	309	11	more	more	ADJ
dpc-4547	309	12	than	than	ADP
dpc-4547	309	13	200.000	200.000	NUM
dpc-4547	309	14	ak	ak	NOUN
dpc-4547	309	15	patients	patient	NOUN
dpc-4547	309	16	vs.	vs.	ADP
dpc-4547	309	17	a	a	DET
dpc-4547	309	18	control	control	NOUN
dpc-4547	309	19	without	without	ADP
dpc-4547	309	20	ak	ak	PROPN
dpc-4547	309	21	for	for	ADP
dpc-4547	309	22	a	a	DET
dpc-4547	309	23	period	period	NOUN
dpc-4547	309	24	of	of	ADP
dpc-4547	309	25	ten	ten	NUM
dpc-4547	309	26	years	year	NOUN
dpc-4547	309	27	(	(	PUNCT
dpc-4547	309	28	2009	2009	NUM
dpc-4547	309	29	-	-	SYM
dpc-4547	309	30	2020	2020	NUM
dpc-4547	309	31	)	)	PUNCT
dpc-4547	309	32	.	.	PUNCT
dpc-4547	310	1	after	after	ADP
dpc-4547	310	2	ten	ten	NUM
dpc-4547	310	3	years	year	NOUN
dpc-4547	310	4	,	,	PUNCT
dpc-4547	310	5	the	the	DET
dpc-4547	310	6	cumulative	cumulative	ADJ
dpc-4547	310	7	incidence	incidence	NOUN
dpc-4547	310	8	of	of	ADP
dpc-4547	310	9	cscc	cscc	PROPN
dpc-4547	310	10	reached	reach	VERB
dpc-4547	310	11	17.1	17.1	NUM
dpc-4547	310	12	%	%	NOUN
dpc-4547	310	13	for	for	ADP
dpc-4547	310	14	ak	ak	PROPN
dpc-4547	310	15	patients	patient	NOUN
dpc-4547	310	16	vs.	vs.	ADP
dpc-4547	310	17	5.7	5.7	NUM
dpc-4547	310	18	%	%	NOUN
dpc-4547	310	19	  	  	SPACE
dpc-4547	310	20	for	for	ADP
dpc-4547	310	21	the	the	DET
dpc-4547	310	22	control	control	NOUN
dpc-4547	310	23	,	,	PUNCT
dpc-4547	310	24	with	with	ADP
dpc-4547	310	25	the	the	DET
dpc-4547	310	26	number	number	NOUN
dpc-4547	310	27	of	of	ADP
dpc-4547	310	28	ak	ak	PROPN
dpc-4547	310	29	being	be	AUX
dpc-4547	310	30	associated	associate	VERB
dpc-4547	310	31	with	with	ADP
dpc-4547	310	32	the	the	DET
dpc-4547	310	33	incidence	incidence	NOUN
dpc-4547	310	34	of	of	ADP
dpc-4547	310	35	cscc	cscc	NOUN
dpc-4547	310	36	[	[	X
dpc-4547	310	37	146	146	NUM
dpc-4547	310	38	]	]	PUNCT
dpc-4547	310	39	.	.	PUNCT
dpc-4547	311	1	interestingly	interestingly	ADV
dpc-4547	311	2	,	,	PUNCT
dpc-4547	311	3	individuals	individual	NOUN
dpc-4547	311	4	being	be	AUX
dpc-4547	311	5	diagnosed	diagnose	VERB
dpc-4547	311	6	with	with	ADP
dpc-4547	311	7	ak	ak	PROPN
dpc-4547	311	8	under	under	ADP
dpc-4547	311	9	49	49	NUM
dpc-4547	311	10	years	year	NOUN
dpc-4547	311	11	of	of	ADP
dpc-4547	311	12	age	age	NOUN
dpc-4547	311	13	,	,	PUNCT
dpc-4547	311	14	were	be	AUX
dpc-4547	311	15	nearly	nearly	ADV
dpc-4547	311	16	7	7	NUM
dpc-4547	311	17	times	time	NOUN
dpc-4547	311	18	more	more	ADV
dpc-4547	311	19	likely	likely	ADJ
dpc-4547	311	20	to	to	PART
dpc-4547	311	21	be	be	AUX
dpc-4547	311	22	diagnosed	diagnose	VERB
dpc-4547	311	23	with	with	ADP
dpc-4547	311	24	cscc	cscc	ADJ
dpc-4547	311	25	than	than	ADP
dpc-4547	311	26	those	those	PRON
dpc-4547	311	27	without	without	ADP
dpc-4547	311	28	ak	ak	PROPN
dpc-4547	311	29	[	[	X
dpc-4547	311	30	146	146	NUM
dpc-4547	311	31	]	]	PUNCT
dpc-4547	311	32	.	.	PUNCT
dpc-4547	312	1	therefore	therefore	ADV
dpc-4547	312	2	,	,	PUNCT
dpc-4547	312	3	early	early	ADJ
dpc-4547	312	4	detection	detection	NOUN
dpc-4547	312	5	of	of	ADP
dpc-4547	312	6	ak	ak	PROPN
dpc-4547	312	7	may	may	AUX
dpc-4547	312	8	be	be	AUX
dpc-4547	312	9	critical	critical	ADJ
dpc-4547	312	10	,	,	PUNCT
dpc-4547	312	11	but	but	CCONJ
dpc-4547	312	12	the	the	DET
dpc-4547	312	13	role	role	NOUN
dpc-4547	312	14	of	of	ADP
dpc-4547	312	15	screenings	screening	NOUN
dpc-4547	312	16	for	for	ADP
dpc-4547	312	17	nmsc	nmsc	NOUN
dpc-4547	312	18	is	be	AUX
dpc-4547	312	19	not	not	PART
dpc-4547	312	20	well	well	ADV
dpc-4547	312	21	understood	understand	VERB
dpc-4547	312	22	to	to	ADP
dpc-4547	312	23	date	date	NOUN
dpc-4547	312	24	.	.	PUNCT
dpc-4547	313	1	while	while	SCONJ
dpc-4547	313	2	for	for	ADP
dpc-4547	313	3	the	the	DET
dpc-4547	313	4	detection	detection	NOUN
dpc-4547	313	5	of	of	ADP
dpc-4547	313	6	melanoma	melanoma	NOUN
dpc-4547	313	7	,	,	PUNCT
dpc-4547	313	8	schemes	scheme	NOUN
dpc-4547	313	9	such	such	ADJ
dpc-4547	313	10	as	as	ADP
dpc-4547	313	11	the	the	DET
dpc-4547	313	12	“	"	PUNCT
dpc-4547	313	13	abcde	abcde	X
dpc-4547	313	14	”	"	PUNCT
dpc-4547	313	15	rule	rule	NOUN
dpc-4547	313	16	exist	exist	NOUN
dpc-4547	313	17	and	and	CCONJ
dpc-4547	313	18	validation	validation	NOUN
dpc-4547	313	19	data	datum	NOUN
dpc-4547	313	20	in	in	ADP
dpc-4547	313	21	terms	term	NOUN
dpc-4547	313	22	of	of	ADP
dpc-4547	313	23	sensitivity	sensitivity	NOUN
dpc-4547	313	24	and	and	CCONJ
dpc-4547	313	25	specificity	specificity	NOUN
dpc-4547	313	26	is	be	AUX
dpc-4547	313	27	available	available	ADJ
dpc-4547	313	28	,	,	PUNCT
dpc-4547	313	29	the	the	DET
dpc-4547	313	30	detection	detection	NOUN
dpc-4547	313	31	rate	rate	NOUN
dpc-4547	313	32	of	of	ADP
dpc-4547	313	33	nmsc	nmsc	NOUN
dpc-4547	313	34	in	in	ADP
dpc-4547	313	35	skin	skin	NOUN
dpc-4547	313	36	cancer	cancer	NOUN
dpc-4547	313	37	screenings	screening	NOUN
dpc-4547	313	38	is	be	AUX
dpc-4547	313	39	not	not	PART
dpc-4547	313	40	well	well	ADV
dpc-4547	313	41	documented	document	VERB
dpc-4547	313	42	[	[	PUNCT
dpc-4547	313	43	147	147	NUM
dpc-4547	313	44	,	,	PUNCT
dpc-4547	313	45	148	148	NUM
dpc-4547	313	46	]	]	PUNCT
dpc-4547	313	47	.	.	PUNCT
dpc-4547	314	1	often	often	ADV
dpc-4547	314	2	cancer	cancer	NOUN
dpc-4547	314	3	registries	registry	NOUN
dpc-4547	314	4	even	even	ADV
dpc-4547	314	5	lack	lack	VERB
dpc-4547	314	6	reliable	reliable	ADJ
dpc-4547	314	7	epidemiologic	epidemiologic	ADJ
dpc-4547	314	8	data	datum	NOUN
dpc-4547	314	9	,	,	PUNCT
dpc-4547	314	10	because	because	SCONJ
dpc-4547	314	11	nmsc	nmsc	NOUN
dpc-4547	314	12	is	be	AUX
dpc-4547	314	13	common	common	ADJ
dpc-4547	314	14	and	and	CCONJ
dpc-4547	314	15	usually	usually	ADV
dpc-4547	314	16	curable	curable	ADJ
dpc-4547	314	17	and	and	CCONJ
dpc-4547	314	18	is	be	AUX
dpc-4547	314	19	therefore	therefore	ADV
dpc-4547	314	20	not	not	PART
dpc-4547	314	21	monitored	monitor	VERB
dpc-4547	314	22	precisely	precisely	ADV
dpc-4547	314	23	[	[	X
dpc-4547	314	24	147	147	NUM
dpc-4547	314	25	]	]	PUNCT
dpc-4547	314	26	.	.	PUNCT
dpc-4547	315	1	a	a	DET
dpc-4547	315	2	holistic	holistic	ADJ
dpc-4547	315	3	review	review	NOUN
dpc-4547	315	4	conducted	conduct	VERB
dpc-4547	315	5	by	by	ADP
dpc-4547	315	6	henrikson	henrikson	NOUN
dpc-4547	315	7	et	et	PROPN
dpc-4547	315	8	al	al	PROPN
dpc-4547	315	9	.	.	PUNCT
dpc-4547	316	1	[	[	X
dpc-4547	316	2	149	149	NUM
dpc-4547	316	3	]	]	PUNCT
dpc-4547	316	4	found	find	VERB
dpc-4547	316	5	that	that	SCONJ
dpc-4547	316	6	routine	routine	ADJ
dpc-4547	316	7	clinician	clinician	ADJ
dpc-4547	316	8	skin	skin	NOUN
dpc-4547	316	9	examination	examination	NOUN
dpc-4547	316	10	in	in	ADP
dpc-4547	316	11	terms	term	NOUN
dpc-4547	316	12	of	of	ADP
dpc-4547	316	13	skin	skin	NOUN
dpc-4547	316	14	cancer	cancer	NOUN
dpc-4547	316	15	screening	screening	NOUN
dpc-4547	316	16	,	,	PUNCT
dpc-4547	316	17	is	be	AUX
dpc-4547	316	18	not	not	PART
dpc-4547	316	19	associated	associate	VERB
dpc-4547	316	20	with	with	ADP
dpc-4547	316	21	higher	high	ADJ
dpc-4547	316	22	detection	detection	NOUN
dpc-4547	316	23	rates	rate	NOUN
dpc-4547	316	24	of	of	ADP
dpc-4547	316	25	nmsc	nmsc	NOUN
dpc-4547	316	26	,	,	PUNCT
dpc-4547	316	27	skin	skin	NOUN
dpc-4547	316	28	cancer	cancer	NOUN
dpc-4547	316	29	precursor	precursor	NOUN
dpc-4547	316	30	lesions	lesion	NOUN
dpc-4547	316	31	and	and	CCONJ
dpc-4547	316	32	melanoma	melanoma	NOUN
dpc-4547	316	33	compared	compare	VERB
dpc-4547	316	34	to	to	ADP
dpc-4547	316	35	lesion	lesion	NOUN
dpc-4547	316	36	-	-	PUNCT
dpc-4547	316	37	directed	direct	VERB
dpc-4547	316	38	examination	examination	NOUN
dpc-4547	316	39	.	.	PUNCT
dpc-4547	317	1	moreover	moreover	ADV
dpc-4547	317	2	,	,	PUNCT
dpc-4547	317	3	the	the	DET
dpc-4547	317	4	included	include	VERB
dpc-4547	317	5	studies	study	NOUN
dpc-4547	317	6	did	do	AUX
dpc-4547	317	7	not	not	PART
dpc-4547	317	8	report	report	VERB
dpc-4547	317	9	nmsc	nmsc	NOUN
dpc-4547	317	10	mortality	mortality	NOUN
dpc-4547	317	11	by	by	ADP
dpc-4547	317	12	stage	stage	NOUN
dpc-4547	317	13	at	at	ADP
dpc-4547	317	14	detection	detection	NOUN
dpc-4547	317	15	[	[	X
dpc-4547	317	16	149	149	NUM
dpc-4547	317	17	]	]	PUNCT
dpc-4547	317	18	.	.	PUNCT
dpc-4547	318	1	in	in	ADP
dpc-4547	318	2	terms	term	NOUN
dpc-4547	318	3	of	of	ADP
dpc-4547	318	4	harms	harm	NOUN
dpc-4547	318	5	related	relate	VERB
dpc-4547	318	6	to	to	ADP
dpc-4547	318	7	skin	skin	NOUN
dpc-4547	318	8	cancer	cancer	NOUN
dpc-4547	318	9	screenings	screening	NOUN
dpc-4547	318	10	,	,	PUNCT
dpc-4547	318	11	little	little	ADJ
dpc-4547	318	12	evidence	evidence	NOUN
dpc-4547	318	13	exists	exist	VERB
dpc-4547	318	14	for	for	ADP
dpc-4547	318	15	negative	negative	ADJ
dpc-4547	318	16	effects	effect	NOUN
dpc-4547	318	17	on	on	ADP
dpc-4547	318	18	psychological	psychological	ADJ
dpc-4547	318	19	harms	harm	NOUN
dpc-4547	318	20	or	or	CCONJ
dpc-4547	318	21	cosmetic	cosmetic	ADJ
dpc-4547	318	22	concerns	concern	NOUN
dpc-4547	318	23	.	.	PUNCT
dpc-4547	319	1	in	in	ADP
dpc-4547	319	2	a	a	DET
dpc-4547	319	3	german	german	ADJ
dpc-4547	319	4	study	study	NOUN
dpc-4547	319	5	population	population	NOUN
dpc-4547	319	6	7	7	NUM
dpc-4547	319	7	%	%	NOUN
dpc-4547	319	8	of	of	ADP
dpc-4547	319	9	taken	take	VERB
dpc-4547	319	10	shave	shave	NOUN
dpc-4547	319	11	biopsies	biopsy	NOUN
dpc-4547	319	12	were	be	AUX
dpc-4547	319	13	rated	rate	VERB
dpc-4547	319	14	with	with	ADP
dpc-4547	319	15	poor	poor	ADJ
dpc-4547	319	16	cosmetic	cosmetic	ADJ
dpc-4547	319	17	outcome	outcome	NOUN
dpc-4547	319	18	at	at	ADP
dpc-4547	319	19	six	six	NUM
dpc-4547	319	20	months	month	NOUN
dpc-4547	319	21	of	of	ADP
dpc-4547	319	22	follow	follow	NOUN
dpc-4547	319	23	-	-	PUNCT
dpc-4547	319	24	up	up	NOUN
dpc-4547	319	25	and	and	CCONJ
dpc-4547	319	26	after	after	ADP
dpc-4547	319	27	a	a	DET
dpc-4547	319	28	period	period	NOUN
dpc-4547	319	29	of	of	ADP
dpc-4547	319	30	eight	eight	NUM
dpc-4547	319	31	months	month	NOUN
dpc-4547	319	32	after	after	ADP
dpc-4547	319	33	skin	skin	NOUN
dpc-4547	319	34	cancer	cancer	NOUN
dpc-4547	319	35	examination	examination	NOUN
dpc-4547	319	36	,	,	PUNCT
dpc-4547	319	37	the	the	DET
dpc-4547	319	38	patient	patient	NOUN
dpc-4547	319	39	’s	’s	AUX
dpc-4547	319	40	wellbeing	wellbee	VERB
dpc-4547	319	41	in	in	ADP
dpc-4547	319	42	terms	term	NOUN
dpc-4547	319	43	of	of	ADP
dpc-4547	319	44	anxiety	anxiety	NOUN
dpc-4547	319	45	disorders	disorder	NOUN
dpc-4547	319	46	an	an	DET
dpc-4547	319	47	depression	depression	NOUN
dpc-4547	319	48	did	do	AUX
dpc-4547	319	49	not	not	PART
dpc-4547	319	50	differ	differ	VERB
dpc-4547	319	51	significantly	significantly	ADV
dpc-4547	319	52	from	from	ADP
dpc-4547	319	53	the	the	DET
dpc-4547	319	54	normal	normal	ADJ
dpc-4547	319	55	range	range	NOUN
dpc-4547	320	1	[	[	X
dpc-4547	320	2	149	149	NUM
dpc-4547	320	3	]	]	PUNCT
dpc-4547	320	4	.	.	PUNCT
dpc-4547	321	1	the	the	DET
dpc-4547	321	2	insufficient	insufficient	ADJ
dpc-4547	321	3	review	review	NOUN
dpc-4547	321	4	|	|	ADV
dpc-4547	321	5	dermatol	dermatol	ADJ
dpc-4547	321	6	pract	pract	NOUN
dpc-4547	321	7	concept	concept	NOUN
dpc-4547	321	8	.	.	PUNCT
dpc-4547	322	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	322	2	:	:	PUNCT
dpc-4547	322	3	e2024146s	e2024146s	ADV
dpc-4547	322	4	9	9	NUM
dpc-4547	322	5	histological	histological	ADJ
dpc-4547	322	6	sections	section	NOUN
dpc-4547	322	7	with	with	ADP
dpc-4547	322	8	a	a	DET
dpc-4547	322	9	focus	focus	NOUN
dpc-4547	322	10	on	on	ADP
dpc-4547	322	11	keratinocyte	keratinocyte	NOUN
dpc-4547	322	12	morphology	morphology	NOUN
dpc-4547	322	13	and	and	CCONJ
dpc-4547	322	14	epidermis	epidermis	NOUN
dpc-4547	322	15	architecture	architecture	NOUN
dpc-4547	322	16	(	(	PUNCT
dpc-4547	322	17	figure	figure	NOUN
dpc-4547	322	18	1	1	NUM
dpc-4547	322	19	)	)	PUNCT
dpc-4547	323	1	[	[	X
dpc-4547	323	2	1	1	NUM
dpc-4547	323	3	]	]	PUNCT
dpc-4547	323	4	.	.	PUNCT
dpc-4547	324	1	by	by	ADP
dpc-4547	324	2	the	the	DET
dpc-4547	324	3	definition	definition	NOUN
dpc-4547	324	4	of	of	ADP
dpc-4547	324	5	ak	ak	PROPN
dpc-4547	324	6	,	,	PUNCT
dpc-4547	324	7	being	be	AUX
dpc-4547	324	8	an	an	DET
dpc-4547	324	9	intraepidermal	intraepidermal	ADJ
dpc-4547	324	10	neoplasia	neoplasia	NOUN
dpc-4547	324	11	,	,	PUNCT
dpc-4547	324	12	the	the	DET
dpc-4547	324	13	integrity	integrity	NOUN
dpc-4547	324	14	of	of	ADP
dpc-4547	324	15	the	the	DET
dpc-4547	324	16	dej	dej	NOUN
dpc-4547	324	17	must	must	AUX
dpc-4547	324	18	be	be	AUX
dpc-4547	324	19	contained	contain	VERB
dpc-4547	324	20	throughout	throughout	ADP
dpc-4547	324	21	the	the	DET
dpc-4547	324	22	whole	whole	ADJ
dpc-4547	324	23	suspicious	suspicious	ADJ
dpc-4547	324	24	lesion	lesion	NOUN
dpc-4547	324	25	under	under	ADP
dpc-4547	324	26	surveillance	surveillance	NOUN
dpc-4547	324	27	.	.	PUNCT
dpc-4547	325	1	the	the	DET
dpc-4547	325	2	diagnosis	diagnosis	NOUN
dpc-4547	325	3	of	of	ADP
dpc-4547	325	4	ak	ak	PROPN
dpc-4547	325	5	can	can	AUX
dpc-4547	325	6	be	be	AUX
dpc-4547	325	7	made	make	VERB
dpc-4547	325	8	by	by	ADP
dpc-4547	325	9	visualization	visualization	NOUN
dpc-4547	325	10	of	of	ADP
dpc-4547	325	11	hyperand	hyperand	NOUN
dpc-4547	325	12	parakeratosis	parakeratosis	NOUN
dpc-4547	325	13	,	,	PUNCT
dpc-4547	325	14	as	as	ADV
dpc-4547	325	15	well	well	ADV
dpc-4547	325	16	as	as	ADP
dpc-4547	325	17	epidermal	epidermal	ADJ
dpc-4547	325	18	thickening	thickening	NOUN
dpc-4547	325	19	and	and	CCONJ
dpc-4547	325	20	the	the	DET
dpc-4547	325	21	notion	notion	NOUN
dpc-4547	325	22	of	of	ADP
dpc-4547	325	23	atypical	atypical	ADJ
dpc-4547	325	24	,	,	PUNCT
dpc-4547	325	25	basal	basal	NOUN
dpc-4547	325	26	and	and	CCONJ
dpc-4547	325	27	suprabasal	suprabasal	NOUN
dpc-4547	325	28	keratinocytes	keratinocyte	NOUN
dpc-4547	325	29	of	of	ADP
dpc-4547	325	30	heterogenous	heterogenous	ADJ
dpc-4547	325	31	size	size	NOUN
dpc-4547	325	32	.	.	PUNCT
dpc-4547	326	1	also	also	ADV
dpc-4547	326	2	,	,	PUNCT
dpc-4547	326	3	basal	basal	ADJ
dpc-4547	326	4	proliferation	proliferation	NOUN
dpc-4547	326	5	may	may	AUX
dpc-4547	326	6	be	be	AUX
dpc-4547	326	7	present	present	ADJ
dpc-4547	326	8	.	.	PUNCT
dpc-4547	327	1	in	in	ADP
dpc-4547	327	2	the	the	DET
dpc-4547	327	3	papillary	papillary	ADJ
dpc-4547	327	4	dermis	dermis	NOUN
dpc-4547	327	5	dilated	dilate	VERB
dpc-4547	327	6	vessels	vessel	NOUN
dpc-4547	327	7	can	can	AUX
dpc-4547	327	8	be	be	AUX
dpc-4547	327	9	appreciated	appreciate	VERB
dpc-4547	327	10	.	.	PUNCT
dpc-4547	328	1	in	in	ADP
dpc-4547	328	2	contrast	contrast	NOUN
dpc-4547	328	3	,	,	PUNCT
dpc-4547	328	4	for	for	ADP
dpc-4547	328	5	the	the	DET
dpc-4547	328	6	diagnosis	diagnosis	NOUN
dpc-4547	328	7	of	of	ADP
dpc-4547	328	8	sscc	sscc	NOUN
dpc-4547	328	9	,	,	PUNCT
dpc-4547	328	10	the	the	DET
dpc-4547	328	11	most	most	ADV
dpc-4547	328	12	critical	critical	ADJ
dpc-4547	328	13	feature	feature	NOUN
dpc-4547	328	14	which	which	PRON
dpc-4547	328	15	must	must	AUX
dpc-4547	328	16	be	be	AUX
dpc-4547	328	17	noted	note	VERB
dpc-4547	328	18	during	during	ADP
dpc-4547	328	19	lesion	lesion	NOUN
dpc-4547	328	20	imaging	imaging	NOUN
dpc-4547	328	21	is	be	AUX
dpc-4547	328	22	the	the	DET
dpc-4547	328	23	lack	lack	NOUN
dpc-4547	328	24	of	of	ADP
dpc-4547	328	25	dej	dej	PROPN
dpc-4547	328	26	integrity	integrity	NOUN
dpc-4547	328	27	,	,	PUNCT
dpc-4547	328	28	this	this	DET
dpc-4547	328	29	morphological	morphological	ADJ
dpc-4547	328	30	feature	feature	NOUN
dpc-4547	328	31	defines	define	VERB
dpc-4547	328	32	the	the	DET
dpc-4547	328	33	invasiveness	invasiveness	NOUN
dpc-4547	328	34	of	of	ADP
dpc-4547	328	35	this	this	DET
dpc-4547	328	36	tumor	tumor	NOUN
dpc-4547	328	37	in	in	ADP
dpc-4547	328	38	accordance	accordance	NOUN
dpc-4547	328	39	with	with	ADP
dpc-4547	328	40	histology	histology	NOUN
dpc-4547	328	41	.	.	PUNCT
dpc-4547	329	1	other	other	ADJ
dpc-4547	329	2	features	feature	NOUN
dpc-4547	329	3	such	such	ADJ
dpc-4547	329	4	as	as	ADP
dpc-4547	329	5	ulceration	ulceration	NOUN
dpc-4547	329	6	and	and	CCONJ
dpc-4547	329	7	keratin	keratin	NOUN
dpc-4547	329	8	plugs	plug	NOUN
dpc-4547	329	9	may	may	AUX
dpc-4547	329	10	underline	underline	VERB
dpc-4547	329	11	the	the	DET
dpc-4547	329	12	diagnosis	diagnosis	NOUN
dpc-4547	329	13	of	of	ADP
dpc-4547	329	14	sscc	sscc	NOUN
dpc-4547	329	15	[	[	X
dpc-4547	329	16	158	158	NUM
dpc-4547	329	17	-	-	SYM
dpc-4547	329	18	160	160	NUM
dpc-4547	329	19	]	]	PUNCT
dpc-4547	329	20	.	.	PUNCT
dpc-4547	330	1	beside	beside	ADP
dpc-4547	330	2	using	use	VERB
dpc-4547	330	3	non	non	ADJ
dpc-4547	330	4	-	-	ADJ
dpc-4547	330	5	invasive	invasive	ADJ
dpc-4547	330	6	imaging	imaging	NOUN
dpc-4547	330	7	for	for	ADP
dpc-4547	330	8	identifying	identify	VERB
dpc-4547	330	9	ak	ak	PROPN
dpc-4547	330	10	,	,	PUNCT
dpc-4547	330	11	ai	ai	VERB
dpc-4547	330	12	integration	integration	NOUN
dpc-4547	330	13	tools	tool	NOUN
dpc-4547	330	14	are	be	AUX
dpc-4547	330	15	able	able	ADJ
dpc-4547	330	16	to	to	PART
dpc-4547	330	17	characterize	characterize	VERB
dpc-4547	330	18	ak	ak	PROPN
dpc-4547	330	19	by	by	ADP
dpc-4547	330	20	objectifiable	objectifiable	ADJ
dpc-4547	330	21	features	feature	NOUN
dpc-4547	330	22	,	,	PUNCT
dpc-4547	330	23	such	such	ADJ
dpc-4547	330	24	as	as	ADP
dpc-4547	330	25	pro	pro	ADJ
dpc-4547	330	26	score	score	NOUN
dpc-4547	330	27	and	and	CCONJ
dpc-4547	330	28	atypia	atypia	PROPN
dpc-4547	330	29	to	to	PART
dpc-4547	330	30	provide	provide	VERB
dpc-4547	330	31	a	a	DET
dpc-4547	330	32	grading	grading	NOUN
dpc-4547	330	33	to	to	ADP
dpc-4547	330	34	ak	ak	PROPN
dpc-4547	330	35	[	[	X
dpc-4547	330	36	figure	figure	NOUN
dpc-4547	330	37	2	2	NUM
dpc-4547	330	38	)	)	PUNCT
dpc-4547	331	1	[	[	X
dpc-4547	331	2	161	161	NUM
dpc-4547	331	3	-	-	SYM
dpc-4547	331	4	163	163	NUM
dpc-4547	331	5	]	]	PUNCT
dpc-4547	331	6	.	.	PUNCT
dpc-4547	332	1	these	these	DET
dpc-4547	332	2	developments	development	NOUN
dpc-4547	332	3	may	may	AUX
dpc-4547	332	4	resemble	resemble	VERB
dpc-4547	332	5	a	a	DET
dpc-4547	332	6	further	further	ADJ
dpc-4547	332	7	step	step	NOUN
dpc-4547	332	8	to	to	PART
dpc-4547	332	9	provide	provide	VERB
dpc-4547	332	10	an	an	DET
dpc-4547	332	11	effective	effective	ADJ
dpc-4547	332	12	follow	follow	NOUN
dpc-4547	332	13	-	-	PUNCT
dpc-4547	332	14	up	up	NOUN
dpc-4547	332	15	for	for	ADP
dpc-4547	332	16	ak	ak	PROPN
dpc-4547	332	17	,	,	PUNCT
dpc-4547	332	18	which	which	PRON
dpc-4547	332	19	should	should	AUX
dpc-4547	332	20	be	be	AUX
dpc-4547	332	21	non	non	ADJ
dpc-4547	332	22	-	-	ADJ
dpc-4547	332	23	invasive	invasive	ADJ
dpc-4547	332	24	and	and	CCONJ
dpc-4547	332	25	should	should	AUX
dpc-4547	332	26	be	be	AUX
dpc-4547	332	27	able	able	ADJ
dpc-4547	332	28	to	to	PART
dpc-4547	332	29	detect	detect	VERB
dpc-4547	332	30	and	and	CCONJ
dpc-4547	332	31	monitor	monitor	VERB
dpc-4547	332	32	risk	risk	NOUN
dpc-4547	332	33	factors	factor	NOUN
dpc-4547	332	34	in	in	ADP
dpc-4547	332	35	ak	ak	PROPN
dpc-4547	332	36	,	,	PUNCT
dpc-4547	332	37	such	such	ADJ
dpc-4547	332	38	as	as	ADP
dpc-4547	332	39	high	high	ADJ
dpc-4547	332	40	levels	level	NOUN
dpc-4547	332	41	of	of	ADP
dpc-4547	332	42	cell	cell	NOUN
dpc-4547	332	43	atypia	atypia	PROPN
dpc-4547	332	44	and	and	CCONJ
dpc-4547	332	45	basal	basal	PROPN
dpc-4547	332	46	proliferation	proliferation	NOUN
dpc-4547	332	47	,	,	PUNCT
dpc-4547	332	48	in	in	ADP
dpc-4547	332	49	an	an	DET
dpc-4547	332	50	effortless	effortless	ADJ
dpc-4547	332	51	and	and	CCONJ
dpc-4547	332	52	time	time	NOUN
dpc-4547	332	53	sparing	sparing	NOUN
dpc-4547	332	54	manner	manner	NOUN
dpc-4547	332	55	,	,	PUNCT
dpc-4547	332	56	for	for	ADP
dpc-4547	332	57	secondary	secondary	ADJ
dpc-4547	332	58	prevention	prevention	NOUN
dpc-4547	332	59	of	of	ADP
dpc-4547	332	60	cscc	cscc	NOUN
dpc-4547	332	61	.	.	PUNCT
dpc-4547	333	1	moreover	moreover	ADV
dpc-4547	333	2	,	,	PUNCT
dpc-4547	333	3	the	the	DET
dpc-4547	333	4	notion	notion	NOUN
dpc-4547	333	5	of	of	ADP
dpc-4547	333	6	atypia	atypia	PROPN
dpc-4547	333	7	in	in	ADP
dpc-4547	333	8	histopathological	histopathological	ADJ
dpc-4547	333	9	sections	section	NOUN
dpc-4547	333	10	can	can	AUX
dpc-4547	333	11	be	be	AUX
dpc-4547	333	12	very	very	ADV
dpc-4547	333	13	subjective	subjective	ADJ
dpc-4547	333	14	with	with	ADP
dpc-4547	333	15	poor	poor	ADJ
dpc-4547	333	16	inter	inter	ADJ
dpc-4547	333	17	-	-	ADJ
dpc-4547	333	18	rater	rater	ADJ
dpc-4547	333	19	agreement	agreement	NOUN
dpc-4547	333	20	reported	report	VERB
dpc-4547	333	21	in	in	ADP
dpc-4547	333	22	the	the	DET
dpc-4547	333	23	literature	literature	NOUN
dpc-4547	333	24	[	[	X
dpc-4547	333	25	163	163	NUM
dpc-4547	333	26	]	]	PUNCT
dpc-4547	333	27	.	.	PUNCT
dpc-4547	334	1	when	when	SCONJ
dpc-4547	334	2	comparing	compare	VERB
dpc-4547	334	3	the	the	DET
dpc-4547	334	4	automated	automate	VERB
dpc-4547	334	5	atypia	atypia	PROPN
dpc-4547	334	6	scoring	scoring	NOUN
dpc-4547	334	7	algorithm	algorithm	NOUN
dpc-4547	334	8	to	to	ADP
dpc-4547	334	9	the	the	DET
dpc-4547	334	10	experts	expert	NOUN
dpc-4547	334	11	’	’	PART
dpc-4547	334	12	consensus	consensus	NOUN
dpc-4547	334	13	,	,	PUNCT
dpc-4547	334	14	the	the	DET
dpc-4547	334	15	algorithm	algorithm	NOUN
dpc-4547	334	16	outperformed	outperform	VERB
dpc-4547	334	17	for	for	ADP
dpc-4547	334	18	the	the	DET
dpc-4547	334	19	entire	entire	ADJ
dpc-4547	334	20	dataset	dataset	NOUN
dpc-4547	334	21	[	[	X
dpc-4547	334	22	163	163	NUM
dpc-4547	334	23	]	]	PUNCT
dpc-4547	334	24	.	.	PUNCT
dpc-4547	335	1	hence	hence	ADV
dpc-4547	335	2	,	,	PUNCT
dpc-4547	335	3	this	this	DET
dpc-4547	335	4	automated	automate	VERB
dpc-4547	335	5	atypia	atypia	PROPN
dpc-4547	335	6	grading	grade	VERB
dpc-4547	335	7	tool	tool	NOUN
dpc-4547	335	8	may	may	AUX
dpc-4547	335	9	provide	provide	VERB
dpc-4547	335	10	an	an	DET
dpc-4547	335	11	objective	objective	ADJ
dpc-4547	335	12	and	and	CCONJ
dpc-4547	335	13	time	time	NOUN
dpc-4547	335	14	saving	save	VERB
dpc-4547	335	15	alternative	alternative	NOUN
dpc-4547	335	16	to	to	ADP
dpc-4547	335	17	conventional	conventional	ADJ
dpc-4547	335	18	atypia	atypia	PROPN
dpc-4547	335	19	scoring	scoring	NOUN
dpc-4547	335	20	when	when	SCONJ
dpc-4547	335	21	it	it	PRON
dpc-4547	335	22	comes	come	VERB
dpc-4547	335	23	to	to	ADP
dpc-4547	335	24	non	non	ADJ
dpc-4547	335	25	-	-	ADJ
dpc-4547	335	26	invasive	invasive	ADJ
dpc-4547	335	27	ak	ak	NOUN
dpc-4547	335	28	lesion	lesion	NOUN
dpc-4547	335	29	monitoring	monitoring	NOUN
dpc-4547	335	30	.	.	PUNCT
dpc-4547	336	1	moreover	moreover	ADV
dpc-4547	336	2	,	,	PUNCT
dpc-4547	336	3	for	for	ADP
dpc-4547	336	4	clinicians	clinician	NOUN
dpc-4547	336	5	,	,	PUNCT
dpc-4547	336	6	the	the	DET
dpc-4547	336	7	simple	simple	ADJ
dpc-4547	336	8	detection	detection	NOUN
dpc-4547	336	9	of	of	ADP
dpc-4547	336	10	atypia	atypia	PROPN
dpc-4547	336	11	using	use	VERB
dpc-4547	336	12	lc	lc	PROPN
dpc-4547	336	13	-	-	PUNCT
dpc-4547	336	14	oct	oct	PROPN
dpc-4547	336	15	may	may	AUX
dpc-4547	336	16	help	help	VERB
dpc-4547	336	17	to	to	PART
dpc-4547	336	18	distinguish	distinguish	VERB
dpc-4547	336	19	ak	ak	PROPN
dpc-4547	336	20	from	from	ADP
dpc-4547	336	21	other	other	ADJ
dpc-4547	336	22	benign	benign	ADJ
dpc-4547	336	23	skin	skin	NOUN
dpc-4547	336	24	lesions	lesion	NOUN
dpc-4547	336	25	(	(	PUNCT
dpc-4547	336	26	figure	figure	NOUN
dpc-4547	336	27	1	1	NUM
dpc-4547	336	28	)	)	PUNCT
dpc-4547	336	29	.	.	PUNCT
dpc-4547	337	1	previous	previous	ADJ
dpc-4547	337	2	studies	study	NOUN
dpc-4547	337	3	found	find	VERB
dpc-4547	337	4	that	that	SCONJ
dpc-4547	337	5	the	the	DET
dpc-4547	337	6	ai	ai	VERB
dpc-4547	337	7	-	-	PUNCT
dpc-4547	337	8	automated	automate	VERB
dpc-4547	337	9	pro	pro	ADJ
dpc-4547	337	10	score	score	NOUN
dpc-4547	337	11	,	,	PUNCT
dpc-4547	337	12	assessed	assess	VERB
dpc-4547	337	13	by	by	ADP
dpc-4547	337	14	the	the	DET
dpc-4547	337	15	implemented	implement	VERB
dpc-4547	337	16	grading	grade	VERB
dpc-4547	337	17	algorithm	algorithm	NOUN
dpc-4547	337	18	,	,	PUNCT
dpc-4547	337	19	area	area	NOUN
dpc-4547	337	20	and	and	CCONJ
dpc-4547	337	21	severity	severity	NOUN
dpc-4547	337	22	index	index	NOUN
dpc-4547	337	23	(	(	PUNCT
dpc-4547	337	24	akasi	akasi	ADJ
dpc-4547	337	25	)	)	PUNCT
dpc-4547	337	26	have	have	VERB
dpc-4547	337	27	in	in	ADP
dpc-4547	337	28	common	common	ADJ
dpc-4547	337	29	to	to	PART
dpc-4547	337	30	characterize	characterize	VERB
dpc-4547	337	31	and	and	CCONJ
dpc-4547	337	32	objectivize	objectivize	VERB
dpc-4547	337	33	the	the	DET
dpc-4547	337	34	extent	extent	NOUN
dpc-4547	337	35	of	of	ADP
dpc-4547	337	36	ak	ak	PROPN
dpc-4547	337	37	or	or	CCONJ
dpc-4547	337	38	fc	fc	INTJ
dpc-4547	337	39	.	.	PUNCT
dpc-4547	338	1	the	the	DET
dpc-4547	338	2	akasi	akasi	NOUN
dpc-4547	338	3	evaluates	evaluate	VERB
dpc-4547	338	4	the	the	DET
dpc-4547	338	5	percentage	percentage	NOUN
dpc-4547	338	6	of	of	ADP
dpc-4547	338	7	the	the	DET
dpc-4547	338	8	head	head	NOUN
dpc-4547	338	9	area	area	NOUN
dpc-4547	338	10	affected	affect	VERB
dpc-4547	338	11	by	by	ADP
dpc-4547	338	12	ak	ak	PROPN
dpc-4547	338	13	and	and	CCONJ
dpc-4547	338	14	graded	grade	VERB
dpc-4547	338	15	by	by	ADP
dpc-4547	338	16	the	the	DET
dpc-4547	338	17	severities	severity	NOUN
dpc-4547	338	18	of	of	ADP
dpc-4547	338	19	distribution	distribution	NOUN
dpc-4547	338	20	,	,	PUNCT
dpc-4547	338	21	erythema	erythema	ADJ
dpc-4547	338	22	and	and	CCONJ
dpc-4547	338	23	thickness	thickness	NOUN
dpc-4547	338	24	and	and	CCONJ
dpc-4547	338	25	higher	high	ADJ
dpc-4547	338	26	scores	score	NOUN
dpc-4547	338	27	are	be	AUX
dpc-4547	338	28	associated	associate	VERB
dpc-4547	338	29	with	with	ADP
dpc-4547	338	30	the	the	DET
dpc-4547	338	31	incidence	incidence	NOUN
dpc-4547	338	32	of	of	ADP
dpc-4547	338	33	scc	scc	NOUN
dpc-4547	338	34	according	accord	VERB
dpc-4547	338	35	to	to	ADP
dpc-4547	338	36	schmitz	schmitz	PROPN
dpc-4547	338	37	et	et	PROPN
dpc-4547	338	38	al	al	PROPN
dpc-4547	338	39	.	.	PUNCT
dpc-4547	339	1	[	[	X
dpc-4547	339	2	154	154	NUM
dpc-4547	339	3	]	]	PUNCT
dpc-4547	339	4	.	.	PUNCT
dpc-4547	340	1	another	another	DET
dpc-4547	340	2	tool	tool	NOUN
dpc-4547	340	3	for	for	ADP
dpc-4547	340	4	the	the	DET
dpc-4547	340	5	evaluation	evaluation	NOUN
dpc-4547	340	6	of	of	ADP
dpc-4547	340	7	sun	sun	NOUN
dpc-4547	340	8	damaged	damage	VERB
dpc-4547	340	9	skin	skin	NOUN
dpc-4547	340	10	regarding	regard	VERB
dpc-4547	340	11	the	the	DET
dpc-4547	340	12	extent	extent	NOUN
dpc-4547	340	13	of	of	ADP
dpc-4547	340	14	ak	ak	PROPN
dpc-4547	340	15	and	and	CCONJ
dpc-4547	340	16	fc	fc	PROPN
dpc-4547	340	17	located	locate	VERB
dpc-4547	340	18	at	at	ADP
dpc-4547	340	19	the	the	DET
dpc-4547	340	20	face	face	NOUN
dpc-4547	340	21	and	and	CCONJ
dpc-4547	340	22	scalp	scalp	NOUN
dpc-4547	340	23	area	area	NOUN
dpc-4547	340	24	is	be	AUX
dpc-4547	340	25	the	the	DET
dpc-4547	340	26	ak	ak	PROPN
dpc-4547	340	27	-	-	PUNCT
dpc-4547	340	28	fas	fas	PROPN
dpc-4547	340	29	scale	scale	NOUN
dpc-4547	340	30	[	[	X
dpc-4547	340	31	155	155	NUM
dpc-4547	340	32	]	]	SYM
dpc-4547	340	33	.	.	PUNCT
dpc-4547	341	1	ak	ak	PROPN
dpc-4547	341	2	-	-	PUNCT
dpc-4547	341	3	fas	fas	PROPN
dpc-4547	341	4	takes	take	VERB
dpc-4547	341	5	total	total	ADJ
dpc-4547	341	6	affected	affect	VERB
dpc-4547	341	7	skin	skin	NOUN
dpc-4547	341	8	area	area	NOUN
dpc-4547	341	9	,	,	PUNCT
dpc-4547	341	10	hyperkeratosis	hyperkeratosis	NOUN
dpc-4547	341	11	and	and	CCONJ
dpc-4547	341	12	aspects	aspect	NOUN
dpc-4547	341	13	of	of	ADP
dpc-4547	341	14	sun	sun	NOUN
dpc-4547	341	15	damage	damage	NOUN
dpc-4547	341	16	into	into	ADP
dpc-4547	341	17	account	account	NOUN
dpc-4547	341	18	,	,	PUNCT
dpc-4547	341	19	but	but	CCONJ
dpc-4547	341	20	was	be	AUX
dpc-4547	341	21	also	also	ADV
dpc-4547	341	22	evaluated	evaluate	VERB
dpc-4547	341	23	from	from	ADP
dpc-4547	341	24	standardized	standardized	ADJ
dpc-4547	341	25	clinical	clinical	ADJ
dpc-4547	341	26	photographs	photograph	NOUN
dpc-4547	341	27	so	so	ADV
dpc-4547	341	28	far	far	ADV
dpc-4547	341	29	and	and	CCONJ
dpc-4547	341	30	was	be	AUX
dpc-4547	341	31	not	not	PART
dpc-4547	341	32	tested	test	VERB
dpc-4547	341	33	in	in	ADP
dpc-4547	341	34	the	the	DET
dpc-4547	341	35	clinical	clinical	ADJ
dpc-4547	341	36	setting	setting	NOUN
dpc-4547	341	37	[	[	X
dpc-4547	341	38	155	155	NUM
dpc-4547	341	39	]	]	PUNCT
dpc-4547	341	40	.	.	PUNCT
dpc-4547	342	1	willenbrink	willenbrink	PROPN
dpc-4547	342	2	et	et	PROPN
dpc-4547	342	3	al.[81	al.[81	PROPN
dpc-4547	342	4	]	]	PUNCT
dpc-4547	342	5	concluded	conclude	VERB
dpc-4547	342	6	that	that	SCONJ
dpc-4547	342	7	both	both	DET
dpc-4547	342	8	grading	grade	VERB
dpc-4547	342	9	systems	system	NOUN
dpc-4547	342	10	(	(	PUNCT
dpc-4547	342	11	akasi	akasi	NOUN
dpc-4547	342	12	and	and	CCONJ
dpc-4547	342	13	ak	ak	PROPN
dpc-4547	342	14	-	-	PUNCT
dpc-4547	342	15	fas	fas	NOUN
dpc-4547	342	16	)	)	PUNCT
dpc-4547	342	17	are	be	AUX
dpc-4547	342	18	partly	partly	ADV
dpc-4547	342	19	impractical	impractical	ADJ
dpc-4547	342	20	in	in	ADP
dpc-4547	342	21	the	the	DET
dpc-4547	342	22	clinical	clinical	ADJ
dpc-4547	342	23	setting	setting	NOUN
dpc-4547	342	24	,	,	PUNCT
dpc-4547	342	25	because	because	SCONJ
dpc-4547	342	26	the	the	DET
dpc-4547	342	27	assessment	assessment	NOUN
dpc-4547	342	28	is	be	AUX
dpc-4547	342	29	time	time	NOUN
dpc-4547	342	30	-	-	PUNCT
dpc-4547	342	31	consuming	consume	VERB
dpc-4547	342	32	and	and	CCONJ
dpc-4547	342	33	laborious	laborious	ADJ
dpc-4547	342	34	.	.	PUNCT
dpc-4547	343	1	another	another	DET
dpc-4547	343	2	disadvantage	disadvantage	NOUN
dpc-4547	343	3	of	of	ADP
dpc-4547	343	4	both	both	DET
dpc-4547	343	5	scoring	scoring	NOUN
dpc-4547	343	6	systems	system	NOUN
dpc-4547	343	7	may	may	AUX
dpc-4547	343	8	be	be	AUX
dpc-4547	343	9	the	the	DET
dpc-4547	343	10	neglection	neglection	NOUN
dpc-4547	343	11	of	of	ADP
dpc-4547	343	12	in	in	ADP
dpc-4547	343	13	situ	situ	ADJ
dpc-4547	343	14	cscc	cscc	NOUN
dpc-4547	343	15	and	and	CCONJ
dpc-4547	343	16	invasive	invasive	ADJ
dpc-4547	343	17	cscc	cscc	NOUN
dpc-4547	343	18	within	within	ADP
dpc-4547	343	19	the	the	DET
dpc-4547	343	20	sun	sun	NOUN
dpc-4547	343	21	damaged	damage	VERB
dpc-4547	343	22	area	area	NOUN
dpc-4547	343	23	[	[	X
dpc-4547	343	24	81	81	NUM
dpc-4547	343	25	]	]	PUNCT
dpc-4547	343	26	.	.	PUNCT
dpc-4547	344	1	therefore	therefore	ADV
dpc-4547	344	2	willenbrink	willenbrink	VERB
dpc-4547	344	3	et	et	PROPN
dpc-4547	344	4	al.[81	al.[81	PROPN
dpc-4547	344	5	]	]	PUNCT
dpc-4547	344	6	assumed	assume	VERB
dpc-4547	344	7	that	that	SCONJ
dpc-4547	344	8	those	those	DET
dpc-4547	344	9	assessment	assessment	NOUN
dpc-4547	344	10	tools	tool	NOUN
dpc-4547	344	11	are	be	AUX
dpc-4547	344	12	prone	prone	ADJ
dpc-4547	344	13	to	to	PART
dpc-4547	344	14	fail	fail	VERB
dpc-4547	344	15	for	for	ADP
dpc-4547	344	16	risk	risk	NOUN
dpc-4547	344	17	stratification	stratification	NOUN
dpc-4547	344	18	towards	towards	ADP
dpc-4547	344	19	scc	scc	ADJ
dpc-4547	344	20	progression	progression	NOUN
dpc-4547	344	21	,	,	PUNCT
dpc-4547	344	22	as	as	SCONJ
dpc-4547	344	23	both	both	DET
dpc-4547	344	24	tools	tool	NOUN
dpc-4547	344	25	were	be	AUX
dpc-4547	344	26	not	not	PART
dpc-4547	344	27	validated	validate	VERB
dpc-4547	344	28	in	in	ADP
dpc-4547	344	29	large	large	ADJ
dpc-4547	344	30	prospective	prospective	ADJ
dpc-4547	344	31	study	study	NOUN
dpc-4547	344	32	cohorts	cohort	NOUN
dpc-4547	344	33	.	.	PUNCT
dpc-4547	345	1	when	when	SCONJ
dpc-4547	345	2	ak	ak	PROPN
dpc-4547	345	3	is	be	AUX
dpc-4547	345	4	present	present	ADJ
dpc-4547	345	5	on	on	ADP
dpc-4547	345	6	the	the	DET
dpc-4547	345	7	skin	skin	NOUN
dpc-4547	345	8	,	,	PUNCT
dpc-4547	345	9	non	non	ADJ
dpc-4547	345	10	-	-	ADJ
dpc-4547	345	11	invasive	invasive	ADJ
dpc-4547	345	12	imaging	imaging	NOUN
dpc-4547	345	13	techniques	technique	NOUN
dpc-4547	345	14	may	may	AUX
dpc-4547	345	15	provide	provide	VERB
dpc-4547	345	16	a	a	DET
dpc-4547	345	17	substantial	substantial	ADJ
dpc-4547	345	18	benefit	benefit	NOUN
dpc-4547	345	19	for	for	ADP
dpc-4547	345	20	risk	risk	NOUN
dpc-4547	345	21	assessment	assessment	NOUN
dpc-4547	345	22	and	and	CCONJ
dpc-4547	345	23	monitoring	monitoring	NOUN
dpc-4547	345	24	of	of	ADP
dpc-4547	345	25	ak	ak	PROPN
dpc-4547	345	26	.	.	PROPN
dpc-4547	345	27	using	use	VERB
dpc-4547	345	28	skin	skin	NOUN
dpc-4547	345	29	imaging	imaging	NOUN
dpc-4547	345	30	techniques	technique	NOUN
dpc-4547	345	31	allows	allow	VERB
dpc-4547	345	32	non	non	ADJ
dpc-4547	345	33	-	-	ADJ
dpc-4547	345	34	invasive	invasive	ADJ
dpc-4547	345	35	assessment	assessment	NOUN
dpc-4547	345	36	of	of	ADP
dpc-4547	345	37	independent	independent	ADJ
dpc-4547	345	38	risk	risk	NOUN
dpc-4547	345	39	factors	factor	NOUN
dpc-4547	345	40	in	in	ADP
dpc-4547	345	41	ak	ak	PROPN
dpc-4547	345	42	such	such	ADJ
dpc-4547	345	43	as	as	ADP
dpc-4547	345	44	pro	pro	ADJ
dpc-4547	345	45	score	score	NOUN
dpc-4547	345	46	and	and	CCONJ
dpc-4547	345	47	atypia	atypia	PROPN
dpc-4547	345	48	score	score	NOUN
dpc-4547	345	49	.	.	PUNCT
dpc-4547	346	1	since	since	SCONJ
dpc-4547	346	2	the	the	DET
dpc-4547	346	3	introduction	introduction	NOUN
dpc-4547	346	4	of	of	ADP
dpc-4547	346	5	line	line	NOUN
dpc-4547	346	6	-	-	PUNCT
dpc-4547	346	7	field	field	NOUN
dpc-4547	346	8	confocal	confocal	ADJ
dpc-4547	346	9	optical	optical	ADJ
dpc-4547	346	10	coherence	coherence	NOUN
dpc-4547	346	11	tomography	tomography	NOUN
dpc-4547	346	12	(	(	PUNCT
dpc-4547	346	13	lc	lc	PROPN
dpc-4547	346	14	-	-	PUNCT
dpc-4547	346	15	oct	oct	NOUN
dpc-4547	346	16	)	)	PUNCT
dpc-4547	346	17	to	to	ADP
dpc-4547	346	18	the	the	DET
dpc-4547	346	19	field	field	NOUN
dpc-4547	346	20	of	of	ADP
dpc-4547	346	21	dermatology	dermatology	NOUN
dpc-4547	346	22	,	,	PUNCT
dpc-4547	346	23	numerous	numerous	ADJ
dpc-4547	346	24	studies	study	NOUN
dpc-4547	346	25	investigated	investigate	VERB
dpc-4547	346	26	its	its	PRON
dpc-4547	346	27	use	use	NOUN
dpc-4547	346	28	in	in	ADP
dpc-4547	346	29	clinical	clinical	ADJ
dpc-4547	346	30	dermatology	dermatology	NOUN
dpc-4547	346	31	to	to	PART
dpc-4547	346	32	visualize	visualize	VERB
dpc-4547	346	33	benign	benign	ADJ
dpc-4547	346	34	and	and	CCONJ
dpc-4547	346	35	malignant	malignant	ADJ
dpc-4547	346	36	skin	skin	NOUN
dpc-4547	346	37	lesions	lesion	NOUN
dpc-4547	346	38	.	.	PUNCT
dpc-4547	347	1	lc	lc	PROPN
dpc-4547	347	2	-	-	PUNCT
dpc-4547	347	3	oct	oct	NOUN
dpc-4547	347	4	images	image	NOUN
dpc-4547	347	5	were	be	AUX
dpc-4547	347	6	found	find	VERB
dpc-4547	347	7	to	to	PART
dpc-4547	347	8	strongly	strongly	ADV
dpc-4547	347	9	correlate	correlate	VERB
dpc-4547	347	10	with	with	ADP
dpc-4547	347	11	conventional	conventional	ADJ
dpc-4547	347	12	histopathological	histopathological	ADJ
dpc-4547	347	13	images	image	NOUN
dpc-4547	347	14	[	[	X
dpc-4547	347	15	156	156	NUM
dpc-4547	347	16	]	]	PUNCT
dpc-4547	347	17	.	.	PUNCT
dpc-4547	348	1	further	far	ADV
dpc-4547	348	2	,	,	PUNCT
dpc-4547	348	3	ruini	ruini	PROPN
dpc-4547	348	4	et	et	PROPN
dpc-4547	348	5	al	al	PROPN
dpc-4547	348	6	.	.	PROPN
dpc-4547	348	7	found	find	VERB
dpc-4547	348	8	that	that	SCONJ
dpc-4547	348	9	non	non	ADJ
dpc-4547	348	10	-	-	ADJ
dpc-4547	348	11	invasive	invasive	ADJ
dpc-4547	348	12	real	real	ADJ
dpc-4547	348	13	-	-	PUNCT
dpc-4547	348	14	time	time	NOUN
dpc-4547	348	15	evaluation	evaluation	NOUN
dpc-4547	348	16	of	of	ADP
dpc-4547	348	17	the	the	DET
dpc-4547	348	18	dermo	dermo	NOUN
dpc-4547	348	19	-	-	PUNCT
dpc-4547	348	20	epidermal	epidermal	ADJ
dpc-4547	348	21	junction	junction	NOUN
dpc-4547	348	22	(	(	PUNCT
dpc-4547	348	23	dej	dej	PROPN
dpc-4547	348	24	)	)	PUNCT
dpc-4547	348	25	and	and	CCONJ
dpc-4547	348	26	subsequent	subsequent	ADJ
dpc-4547	348	27	pro	pro	ADJ
dpc-4547	348	28	score	score	NOUN
dpc-4547	348	29	quantification	quantification	NOUN
dpc-4547	348	30	is	be	AUX
dpc-4547	348	31	possible	possible	ADJ
dpc-4547	348	32	,	,	PUNCT
dpc-4547	348	33	using	use	VERB
dpc-4547	348	34	lc	lc	NOUN
dpc-4547	348	35	-	-	PUNCT
dpc-4547	348	36	oct	oct	NOUN
dpc-4547	349	1	[	[	X
dpc-4547	349	2	157	157	NUM
dpc-4547	349	3	,	,	PUNCT
dpc-4547	349	4	158	158	NUM
dpc-4547	349	5	]	]	PUNCT
dpc-4547	349	6	.	.	PUNCT
dpc-4547	350	1	the	the	DET
dpc-4547	350	2	non	non	ADJ
dpc-4547	350	3	-	-	ADJ
dpc-4547	350	4	invasive	invasive	ADJ
dpc-4547	350	5	diagnosis	diagnosis	NOUN
dpc-4547	350	6	of	of	ADP
dpc-4547	350	7	ak	ak	PROPN
dpc-4547	350	8	,	,	PUNCT
dpc-4547	350	9	using	use	VERB
dpc-4547	350	10	lc	lc	PROPN
dpc-4547	350	11	-	-	PUNCT
dpc-4547	350	12	oct	oct	PROPN
dpc-4547	350	13	,	,	PUNCT
dpc-4547	350	14	can	can	AUX
dpc-4547	350	15	be	be	AUX
dpc-4547	350	16	made	make	VERB
dpc-4547	350	17	in	in	ADP
dpc-4547	350	18	analogy	analogy	NOUN
dpc-4547	350	19	to	to	ADP
dpc-4547	350	20	ak	ak	PROPN
dpc-4547	350	21	features	feature	NOUN
dpc-4547	350	22	in	in	ADP
dpc-4547	350	23	figure	figure	NOUN
dpc-4547	350	24	1	1	NUM
dpc-4547	350	25	.	.	PUNCT
dpc-4547	351	1	diagnosis	diagnosis	NOUN
dpc-4547	351	2	of	of	ADP
dpc-4547	351	3	ak	ak	PROPN
dpc-4547	351	4	using	use	VERB
dpc-4547	351	5	lc	lc	PROPN
dpc-4547	351	6	-	-	PUNCT
dpc-4547	351	7	oct	oct	PROPN
dpc-4547	351	8	.	.	PROPN
dpc-4547	351	9	ak	ak	PROPN
dpc-4547	351	10	lesion	lesion	NOUN
dpc-4547	351	11	on	on	ADP
dpc-4547	351	12	the	the	DET
dpc-4547	351	13	forehead	forehead	NOUN
dpc-4547	351	14	of	of	ADP
dpc-4547	351	15	a	a	DET
dpc-4547	351	16	patient	patient	NOUN
dpc-4547	351	17	.	.	PUNCT
dpc-4547	352	1	stratum	stratum	PROPN
dpc-4547	352	2	corneum	corneum	PROPN
dpc-4547	352	3	(	(	PUNCT
dpc-4547	352	4	sc	sc	PROPN
dpc-4547	352	5	)	)	PUNCT
dpc-4547	352	6	presents	present	VERB
dpc-4547	352	7	hyper-/parakeratosis	hyper-/parakeratosis	X
dpc-4547	352	8	(	(	PUNCT
dpc-4547	352	9	white	white	ADJ
dpc-4547	352	10	arrows	arrow	NOUN
dpc-4547	352	11	)	)	PUNCT
dpc-4547	352	12	,	,	PUNCT
dpc-4547	352	13	while	while	SCONJ
dpc-4547	352	14	the	the	DET
dpc-4547	352	15	epidermis	epidermis	NOUN
dpc-4547	352	16	harbors	harbor	VERB
dpc-4547	352	17	keratinocytes	keratinocyte	NOUN
dpc-4547	352	18	which	which	PRON
dpc-4547	352	19	are	be	AUX
dpc-4547	352	20	heterogenous	heterogenous	ADJ
dpc-4547	352	21	in	in	ADP
dpc-4547	352	22	size	size	NOUN
dpc-4547	352	23	(	(	PUNCT
dpc-4547	352	24	white	white	PROPN
dpc-4547	352	25	circle	circle	PROPN
dpc-4547	352	26	)	)	PUNCT
dpc-4547	352	27	.	.	PUNCT
dpc-4547	353	1	the	the	DET
dpc-4547	353	2	epidermis	epidermis	NOUN
dpc-4547	353	3	shows	show	VERB
dpc-4547	353	4	beginning	begin	VERB
dpc-4547	353	5	basal	basal	ADJ
dpc-4547	353	6	proliferation	proliferation	NOUN
dpc-4547	353	7	(	(	PUNCT
dpc-4547	353	8	white	white	ADJ
dpc-4547	353	9	asterisk	asterisk	NOUN
dpc-4547	353	10	)	)	PUNCT
dpc-4547	353	11	,	,	PUNCT
dpc-4547	353	12	so	so	CCONJ
dpc-4547	353	13	pro	pro	ADJ
dpc-4547	353	14	ii	ii	PROPN
dpc-4547	353	15	can	can	AUX
dpc-4547	353	16	be	be	AUX
dpc-4547	353	17	assumed	assume	VERB
dpc-4547	353	18	.	.	PUNCT
dpc-4547	354	1	in	in	ADP
dpc-4547	354	2	the	the	DET
dpc-4547	354	3	papillary	papillary	ADJ
dpc-4547	354	4	dermis	dermis	NOUN
dpc-4547	354	5	dilated	dilate	VERB
dpc-4547	354	6	vessels	vessel	NOUN
dpc-4547	354	7	are	be	AUX
dpc-4547	354	8	present	present	ADJ
dpc-4547	354	9	.	.	PUNCT
dpc-4547	355	1	based	base	VERB
dpc-4547	355	2	on	on	ADP
dpc-4547	355	3	the	the	DET
dpc-4547	355	4	named	name	VERB
dpc-4547	355	5	features	feature	VERB
dpc-4547	355	6	the	the	DET
dpc-4547	355	7	clinician	clinician	NOUN
dpc-4547	355	8	can	can	AUX
dpc-4547	355	9	be	be	AUX
dpc-4547	355	10	guided	guide	VERB
dpc-4547	355	11	in	in	ADP
dpc-4547	355	12	making	make	VERB
dpc-4547	355	13	the	the	DET
dpc-4547	355	14	diagnosis	diagnosis	NOUN
dpc-4547	355	15	of	of	ADP
dpc-4547	355	16	ak	ak	PROPN
dpc-4547	355	17	using	use	VERB
dpc-4547	355	18	lc	lc	PROPN
dpc-4547	355	19	-	-	PUNCT
dpc-4547	355	20	oct	oct	PROPN
dpc-4547	355	21	.	.	PROPN
dpc-4547	356	1	(	(	PUNCT
dpc-4547	356	2	lc	lc	PROPN
dpc-4547	356	3	-	-	PUNCT
dpc-4547	356	4	oct	oct	NOUN
dpc-4547	356	5	,	,	PUNCT
dpc-4547	356	6	deeplive	deeplive	ADJ
dpc-4547	356	7	™	™	NOUN
dpc-4547	356	8	,	,	PUNCT
dpc-4547	356	9	damae	damae	VERB
dpc-4547	356	10	medical	medical	ADJ
dpc-4547	356	11	,	,	PUNCT
dpc-4547	356	12	paris	paris	PROPN
dpc-4547	356	13	,	,	PUNCT
dpc-4547	356	14	france	france	PROPN
dpc-4547	356	15	;	;	PUNCT
dpc-4547	356	16	image	image	NOUN
dpc-4547	356	17	size	size	NOUN
dpc-4547	356	18	:	:	PUNCT
dpc-4547	356	19	1.2	1.2	NUM
dpc-4547	356	20	x	x	SYM
dpc-4547	356	21	0.5	0.5	NUM
dpc-4547	356	22	mm2	mm2	NOUN
dpc-4547	356	23	,	,	PUNCT
dpc-4547	356	24	lateral	lateral	ADJ
dpc-4547	356	25	and	and	CCONJ
dpc-4547	356	26	axial	axial	ADJ
dpc-4547	356	27	resolution	resolution	NOUN
dpc-4547	356	28	:	:	PUNCT
dpc-4547	356	29	1.1	1.1	NUM
dpc-4547	356	30	x	x	SYM
dpc-4547	356	31	1.3	1.3	NUM
dpc-4547	356	32	µm	µm	NUM
dpc-4547	356	33	)	)	PUNCT
dpc-4547	356	34	.	.	PUNCT
dpc-4547	357	1	10	10	NUM
dpc-4547	357	2	review	review	NOUN
dpc-4547	357	3	|	|	ADV
dpc-4547	357	4	dermatol	dermatol	ADJ
dpc-4547	357	5	pract	pract	NOUN
dpc-4547	357	6	concept	concept	NOUN
dpc-4547	357	7	.	.	PUNCT
dpc-4547	358	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	358	2	:	:	PUNCT
dpc-4547	358	3	e2024146s	e2024146s	ADV
dpc-4547	358	4	as	as	SCONJ
dpc-4547	358	5	presence	presence	NOUN
dpc-4547	358	6	of	of	ADP
dpc-4547	358	7	atypia	atypia	PROPN
dpc-4547	358	8	and	and	CCONJ
dpc-4547	358	9	therefore	therefore	ADV
dpc-4547	358	10	should	should	AUX
dpc-4547	358	11	be	be	AUX
dpc-4547	358	12	used	use	VERB
dpc-4547	358	13	as	as	ADP
dpc-4547	358	14	an	an	DET
dpc-4547	358	15	automated	automate	VERB
dpc-4547	358	16	tool	tool	NOUN
dpc-4547	358	17	for	for	ADP
dpc-4547	358	18	therapy	therapy	NOUN
dpc-4547	358	19	monitoring	monitoring	NOUN
dpc-4547	358	20	of	of	ADP
dpc-4547	358	21	ak	ak	PROPN
dpc-4547	358	22	,	,	PUNCT
dpc-4547	358	23	as	as	SCONJ
dpc-4547	358	24	suggested	suggest	VERB
dpc-4547	358	25	by	by	ADP
dpc-4547	358	26	fishman	fishman	PROPN
dpc-4547	358	27	et	et	PROPN
dpc-4547	358	28	al	al	PROPN
dpc-4547	358	29	.	.	PUNCT
dpc-4547	359	1	[	[	X
dpc-4547	359	2	163	163	NUM
dpc-4547	359	3	]	]	PUNCT
dpc-4547	359	4	.	.	PUNCT
dpc-4547	360	1	the	the	DET
dpc-4547	360	2	treatment	treatment	NOUN
dpc-4547	360	3	and	and	CCONJ
dpc-4547	360	4	monitoring	monitoring	NOUN
dpc-4547	360	5	of	of	ADP
dpc-4547	360	6	ak	ak	PROPN
dpc-4547	360	7	remains	remain	VERB
dpc-4547	360	8	a	a	DET
dpc-4547	360	9	laborious	laborious	ADJ
dpc-4547	360	10	task	task	NOUN
dpc-4547	360	11	.	.	PUNCT
dpc-4547	361	1	the	the	DET
dpc-4547	361	2	primary	primary	ADJ
dpc-4547	361	3	goal	goal	NOUN
dpc-4547	361	4	needs	need	VERB
dpc-4547	361	5	to	to	PART
dpc-4547	361	6	be	be	AUX
dpc-4547	361	7	prevention	prevention	NOUN
dpc-4547	361	8	or	or	CCONJ
dpc-4547	361	9	at	at	ADP
dpc-4547	361	10	least	least	ADJ
dpc-4547	361	11	the	the	DET
dpc-4547	361	12	early	early	ADJ
dpc-4547	361	13	detection	detection	NOUN
dpc-4547	361	14	of	of	ADP
dpc-4547	361	15	cscc	cscc	NOUN
dpc-4547	361	16	.	.	PUNCT
dpc-4547	362	1	a	a	DET
dpc-4547	362	2	follow	follow	NOUN
dpc-4547	362	3	-	-	PUNCT
dpc-4547	362	4	up	up	NOUN
dpc-4547	362	5	for	for	ADP
dpc-4547	362	6	ak	ak	PROPN
dpc-4547	362	7	may	may	AUX
dpc-4547	362	8	be	be	AUX
dpc-4547	362	9	helpful	helpful	ADJ
dpc-4547	362	10	to	to	PART
dpc-4547	362	11	strengthen	strengthen	VERB
dpc-4547	362	12	patient	patient	ADJ
dpc-4547	362	13	adherence	adherence	NOUN
dpc-4547	362	14	to	to	ADP
dpc-4547	362	15	therapy	therapy	NOUN
dpc-4547	362	16	and	and	CCONJ
dpc-4547	362	17	lc	lc	PROPN
dpc-4547	362	18	-	-	PUNCT
dpc-4547	362	19	oct	oct	PROPN
dpc-4547	362	20	may	may	AUX
dpc-4547	362	21	add	add	VERB
dpc-4547	362	22	value	value	NOUN
dpc-4547	362	23	to	to	ADP
dpc-4547	362	24	a	a	DET
dpc-4547	362	25	non	non	ADJ
dpc-4547	362	26	-	-	ADJ
dpc-4547	362	27	invasive	invasive	ADJ
dpc-4547	362	28	follow	follow	NOUN
dpc-4547	362	29	-	-	PUNCT
dpc-4547	362	30	up	up	NOUN
dpc-4547	362	31	for	for	ADP
dpc-4547	362	32	ak	ak	PROPN
dpc-4547	362	33	by	by	ADP
dpc-4547	362	34	visualization	visualization	NOUN
dpc-4547	362	35	of	of	ADP
dpc-4547	362	36	epidermal	epidermal	ADJ
dpc-4547	362	37	recovery	recovery	NOUN
dpc-4547	362	38	processes	process	NOUN
dpc-4547	362	39	and	and	CCONJ
dpc-4547	362	40	the	the	DET
dpc-4547	362	41	evaluation	evaluation	NOUN
dpc-4547	362	42	of	of	ADP
dpc-4547	362	43	its	its	PRON
dpc-4547	362	44	objective	objective	ADJ
dpc-4547	362	45	parameters	parameter	NOUN
dpc-4547	362	46	such	such	ADJ
dpc-4547	362	47	as	as	ADP
dpc-4547	362	48	sc	sc	NOUN
dpc-4547	362	49	/	/	SYM
dpc-4547	362	50	epidermal	epidermal	ADJ
dpc-4547	362	51	thickness	thickness	NOUN
dpc-4547	362	52	,	,	PUNCT
dpc-4547	362	53	dej	dej	PROPN
dpc-4547	362	54	undulation	undulation	NOUN
dpc-4547	362	55	(	(	PUNCT
dpc-4547	362	56	pro	pro	ADJ
dpc-4547	362	57	score	score	NOUN
dpc-4547	362	58	)	)	PUNCT
dpc-4547	362	59	and	and	CCONJ
dpc-4547	362	60	keratinocyte	keratinocyte	PROPN
dpc-4547	362	61	atypia	atypia	PROPN
dpc-4547	362	62	.	.	PUNCT
dpc-4547	363	1	this	this	PRON
dpc-4547	363	2	allows	allow	VERB
dpc-4547	363	3	a	a	DET
dpc-4547	363	4	more	more	ADV
dpc-4547	363	5	comprehensive	comprehensive	ADJ
dpc-4547	363	6	follow	follow	NOUN
dpc-4547	363	7	-	-	PUNCT
dpc-4547	363	8	up	up	NOUN
dpc-4547	363	9	of	of	ADP
dpc-4547	363	10	ak	ak	PROPN
dpc-4547	363	11	rather	rather	ADV
dpc-4547	363	12	than	than	ADP
dpc-4547	363	13	considering	consider	VERB
dpc-4547	363	14	clinical	clinical	ADJ
dpc-4547	363	15	lesion	lesion	NOUN
dpc-4547	363	16	aspects	aspect	NOUN
dpc-4547	363	17	only	only	ADV
dpc-4547	363	18	.	.	PUNCT
dpc-4547	364	1	moreover	moreover	ADV
dpc-4547	364	2	,	,	PUNCT
dpc-4547	364	3	lesions	lesion	NOUN
dpc-4547	364	4	non	non	ADJ
dpc-4547	364	5	-	-	ADJ
dpc-4547	364	6	responding	respond	VERB
dpc-4547	364	7	to	to	ADP
dpc-4547	364	8	the	the	DET
dpc-4547	364	9	implemented	implement	VERB
dpc-4547	364	10	therapy	therapy	NOUN
dpc-4547	364	11	can	can	AUX
dpc-4547	364	12	be	be	AUX
dpc-4547	364	13	identified	identify	VERB
dpc-4547	364	14	and	and	CCONJ
dpc-4547	364	15	can	can	AUX
dpc-4547	364	16	subsequently	subsequently	ADV
dpc-4547	364	17	be	be	AUX
dpc-4547	364	18	referred	refer	VERB
dpc-4547	364	19	to	to	ADP
dpc-4547	364	20	an	an	DET
dpc-4547	364	21	adequate	adequate	ADJ
dpc-4547	364	22	treatment	treatment	NOUN
dpc-4547	364	23	regime	regime	NOUN
dpc-4547	364	24	early	early	ADV
dpc-4547	364	25	on	on	ADV
dpc-4547	364	26	.	.	PUNCT
dpc-4547	365	1	short	short	ADJ
dpc-4547	365	2	summary	summary	PROPN
dpc-4547	365	3	•	•	PROPN
dpc-4547	365	4	ak	ak	PROPN
dpc-4547	365	5	are	be	AUX
dpc-4547	365	6	considered	consider	VERB
dpc-4547	365	7	a	a	DET
dpc-4547	365	8	chronic	chronic	ADJ
dpc-4547	365	9	skin	skin	NOUN
dpc-4547	365	10	disease	disease	NOUN
dpc-4547	365	11	and	and	CCONJ
dpc-4547	365	12	reflect	reflect	VERB
dpc-4547	365	13	longterm	longterm	ADJ
dpc-4547	365	14	exposure	exposure	NOUN
dpc-4547	365	15	to	to	ADP
dpc-4547	365	16	uv	uv	NOUN
dpc-4547	365	17	radiation	radiation	NOUN
dpc-4547	365	18	,	,	PUNCT
dpc-4547	365	19	coming	come	VERB
dpc-4547	365	20	with	with	ADP
dpc-4547	365	21	an	an	DET
dpc-4547	365	22	individual	individual	ADJ
dpc-4547	365	23	susceptibility	susceptibility	NOUN
dpc-4547	365	24	for	for	ADP
dpc-4547	365	25	skin	skin	NOUN
dpc-4547	365	26	cancer	cancer	NOUN
dpc-4547	365	27	manifestation	manifestation	NOUN
dpc-4547	365	28	.	.	PUNCT
dpc-4547	366	1	•	•	NOUN
dpc-4547	366	2	risk	risk	NOUN
dpc-4547	366	3	factors	factor	NOUN
dpc-4547	366	4	in	in	ADP
dpc-4547	366	5	ak	ak	PROPN
dpc-4547	366	6	for	for	ADP
dpc-4547	366	7	development	development	NOUN
dpc-4547	366	8	of	of	ADP
dpc-4547	366	9	cscc	cscc	PROPN
dpc-4547	366	10	are	be	AUX
dpc-4547	366	11	not	not	PART
dpc-4547	366	12	fully	fully	ADV
dpc-4547	366	13	understood	understand	VERB
dpc-4547	366	14	,	,	PUNCT
dpc-4547	366	15	but	but	CCONJ
dpc-4547	366	16	studies	study	NOUN
dpc-4547	366	17	suggest	suggest	VERB
dpc-4547	366	18	that	that	SCONJ
dpc-4547	366	19	atypia	atypia	PROPN
dpc-4547	366	20	and	and	CCONJ
dpc-4547	366	21	basal	basal	PROPN
dpc-4547	366	22	proliferation	proliferation	NOUN
dpc-4547	366	23	in	in	ADP
dpc-4547	366	24	ak	ak	PROPN
dpc-4547	366	25	play	play	VERB
dpc-4547	366	26	a	a	DET
dpc-4547	366	27	pivotal	pivotal	ADJ
dpc-4547	366	28	role	role	NOUN
dpc-4547	366	29	for	for	ADP
dpc-4547	366	30	malignant	malignant	ADJ
dpc-4547	366	31	transformation	transformation	NOUN
dpc-4547	366	32	.	.	PUNCT
dpc-4547	367	1	•	•	NOUN
dpc-4547	367	2	skin	skin	NOUN
dpc-4547	367	3	imaging	imaging	NOUN
dpc-4547	367	4	can	can	AUX
dpc-4547	367	5	help	help	VERB
dpc-4547	367	6	to	to	PART
dpc-4547	367	7	facilitate	facilitate	VERB
dpc-4547	367	8	individual	individual	ADJ
dpc-4547	367	9	risk	risk	NOUN
dpc-4547	367	10	assessment	assessment	NOUN
dpc-4547	367	11	of	of	ADP
dpc-4547	367	12	ak	ak	PROPN
dpc-4547	367	13	lesions	lesion	NOUN
dpc-4547	367	14	by	by	ADP
dpc-4547	367	15	non	non	ADJ
dpc-4547	367	16	-	-	ADJ
dpc-4547	367	17	invasive	invasive	ADJ
dpc-4547	367	18	visualization	visualization	NOUN
dpc-4547	367	19	of	of	ADP
dpc-4547	367	20	atypia	atypia	PROPN
dpc-4547	367	21	and	and	CCONJ
dpc-4547	367	22	basal	basal	PROPN
dpc-4547	367	23	proliferation	proliferation	NOUN
dpc-4547	367	24	.	.	PUNCT
dpc-4547	368	1	correlates	correlate	VERB
dpc-4547	368	2	well	well	ADV
dpc-4547	368	3	with	with	ADP
dpc-4547	368	4	the	the	DET
dpc-4547	368	5	experts	expert	NOUN
dpc-4547	368	6	’	’	PART
dpc-4547	368	7	consensus	consensus	NOUN
dpc-4547	368	8	[	[	X
dpc-4547	368	9	161	161	NUM
dpc-4547	368	10	]	]	PUNCT
dpc-4547	368	11	.	.	PUNCT
dpc-4547	369	1	also	also	ADV
dpc-4547	369	2	,	,	PUNCT
dpc-4547	369	3	2d	2d	NUM
dpc-4547	369	4	imaging	imaging	NOUN
dpc-4547	369	5	allows	allow	VERB
dpc-4547	369	6	visualization	visualization	NOUN
dpc-4547	369	7	of	of	ADP
dpc-4547	369	8	the	the	DET
dpc-4547	369	9	pro	pro	ADJ
dpc-4547	369	10	score	score	NOUN
dpc-4547	369	11	in	in	ADP
dpc-4547	369	12	accordance	accordance	NOUN
dpc-4547	369	13	with	with	ADP
dpc-4547	369	14	histology	histology	NOUN
dpc-4547	369	15	[	[	X
dpc-4547	369	16	157	157	NUM
dpc-4547	369	17	]	]	PUNCT
dpc-4547	369	18	.	.	PUNCT
dpc-4547	370	1	still	still	ADV
dpc-4547	370	2	,	,	PUNCT
dpc-4547	370	3	2d	2d	NUM
dpc-4547	370	4	vertical	vertical	ADJ
dpc-4547	370	5	section	section	NOUN
dpc-4547	370	6	imaging	imaging	NOUN
dpc-4547	370	7	of	of	ADP
dpc-4547	370	8	ak	ak	PROPN
dpc-4547	370	9	only	only	ADV
dpc-4547	370	10	allows	allow	VERB
dpc-4547	370	11	a	a	DET
dpc-4547	370	12	very	very	ADV
dpc-4547	370	13	limited	limited	ADJ
dpc-4547	370	14	glimpse	glimpse	NOUN
dpc-4547	370	15	under	under	ADP
dpc-4547	370	16	the	the	DET
dpc-4547	370	17	lesions	lesion	NOUN
dpc-4547	370	18	’	'	PUNCT
dpc-4547	370	19	surface	surface	NOUN
dpc-4547	370	20	under	under	ADP
dpc-4547	370	21	the	the	DET
dpc-4547	370	22	assumption	assumption	NOUN
dpc-4547	370	23	that	that	SCONJ
dpc-4547	370	24	single	single	ADJ
dpc-4547	370	25	ak	ak	PROPN
dpc-4547	370	26	lesions	lesion	NOUN
dpc-4547	370	27	comprise	comprise	VERB
dpc-4547	370	28	heterogenous	heterogenous	ADJ
dpc-4547	370	29	patterns	pattern	NOUN
dpc-4547	370	30	of	of	ADP
dpc-4547	370	31	basal	basal	ADJ
dpc-4547	370	32	proliferation	proliferation	NOUN
dpc-4547	370	33	.	.	PUNCT
dpc-4547	371	1	this	this	DET
dpc-4547	371	2	fact	fact	NOUN
dpc-4547	371	3	resembles	resemble	VERB
dpc-4547	371	4	the	the	DET
dpc-4547	371	5	possible	possible	ADJ
dpc-4547	371	6	additional	additional	ADJ
dpc-4547	371	7	value	value	NOUN
dpc-4547	371	8	of	of	ADP
dpc-4547	371	9	automated	automate	VERB
dpc-4547	371	10	3d	3d	NUM
dpc-4547	371	11	visualization	visualization	NOUN
dpc-4547	371	12	allowing	allow	VERB
dpc-4547	371	13	a	a	DET
dpc-4547	371	14	much	much	ADV
dpc-4547	371	15	broader	broad	ADJ
dpc-4547	371	16	lesion	lesion	NOUN
dpc-4547	371	17	imaging	imaging	NOUN
dpc-4547	371	18	and	and	CCONJ
dpc-4547	371	19	therefore	therefore	ADV
dpc-4547	371	20	describe	describe	VERB
dpc-4547	371	21	the	the	DET
dpc-4547	371	22	dej	dej	PROPN
dpc-4547	371	23	undulation	undulation	NOUN
dpc-4547	371	24	not	not	PART
dpc-4547	371	25	just	just	ADV
dpc-4547	371	26	by	by	ADP
dpc-4547	371	27	a	a	DET
dpc-4547	371	28	single	single	ADJ
dpc-4547	371	29	vertical	vertical	ADJ
dpc-4547	371	30	section	section	NOUN
dpc-4547	371	31	,	,	PUNCT
dpc-4547	371	32	so	so	SCONJ
dpc-4547	371	33	that	that	SCONJ
dpc-4547	371	34	the	the	DET
dpc-4547	371	35	computed	compute	VERB
dpc-4547	371	36	dej	dej	PROPN
dpc-4547	371	37	undulation	undulation	PROPN
dpc-4547	371	38	index	index	NOUN
dpc-4547	371	39	allows	allow	VERB
dpc-4547	371	40	a	a	DET
dpc-4547	371	41	broader	broad	ADJ
dpc-4547	371	42	understanding	understanding	NOUN
dpc-4547	371	43	for	for	ADP
dpc-4547	371	44	basal	basal	ADJ
dpc-4547	371	45	growth	growth	NOUN
dpc-4547	371	46	patterns	pattern	NOUN
dpc-4547	371	47	in	in	ADP
dpc-4547	371	48	ak	ak	PROPN
dpc-4547	371	49	.	.	PROPN
dpc-4547	371	50	for	for	ADP
dpc-4547	371	51	a	a	DET
dpc-4547	371	52	cohort	cohort	NOUN
dpc-4547	371	53	with	with	ADP
dpc-4547	371	54	24	24	NUM
dpc-4547	371	55	ak	ak	PROPN
dpc-4547	371	56	lesions	lesion	NOUN
dpc-4547	371	57	under	under	ADP
dpc-4547	371	58	treatment	treatment	NOUN
dpc-4547	371	59	with	with	ADP
dpc-4547	371	60	tirbanibulin	tirbanibulin	PROPN
dpc-4547	371	61	1	1	NUM
dpc-4547	371	62	%	%	NOUN
dpc-4547	371	63	,	,	PUNCT
dpc-4547	371	64	thamm	thamm	PROPN
dpc-4547	371	65	et	et	PROPN
dpc-4547	371	66	al.[164	al.[164	NOUN
dpc-4547	371	67	]	]	PUNCT
dpc-4547	371	68	were	be	AUX
dpc-4547	371	69	able	able	ADJ
dpc-4547	371	70	to	to	PART
dpc-4547	371	71	provide	provide	VERB
dpc-4547	371	72	a	a	DET
dpc-4547	371	73	holistic	holistic	ADJ
dpc-4547	371	74	follow	follow	NOUN
dpc-4547	371	75	-	-	PUNCT
dpc-4547	371	76	up	up	NOUN
dpc-4547	371	77	for	for	ADP
dpc-4547	371	78	ak	ak	PROPN
dpc-4547	371	79	over	over	ADP
dpc-4547	371	80	90	90	NUM
dpc-4547	371	81	days	day	NOUN
dpc-4547	371	82	,	,	PUNCT
dpc-4547	371	83	using	use	VERB
dpc-4547	371	84	lc	lc	PROPN
dpc-4547	371	85	-	-	PUNCT
dpc-4547	371	86	oct	oct	PROPN
dpc-4547	371	87	(	(	PUNCT
dpc-4547	371	88	reference	reference	NOUN
dpc-4547	371	89	)	)	PUNCT
dpc-4547	371	90	.	.	PUNCT
dpc-4547	372	1	by	by	ADP
dpc-4547	372	2	non	non	ADJ
dpc-4547	372	3	-	-	ADJ
dpc-4547	372	4	invasive	invasive	ADJ
dpc-4547	372	5	imaging	imaging	NOUN
dpc-4547	372	6	it	it	PRON
dpc-4547	372	7	was	be	AUX
dpc-4547	372	8	possible	possible	ADJ
dpc-4547	372	9	to	to	PART
dpc-4547	372	10	show	show	VERB
dpc-4547	372	11	that	that	PRON
dpc-4547	372	12	keratinocyte	keratinocyte	PROPN
dpc-4547	372	13	atypia	atypia	PROPN
dpc-4547	372	14	decreased	decrease	VERB
dpc-4547	372	15	significantly	significantly	ADV
dpc-4547	372	16	over	over	ADP
dpc-4547	372	17	all	all	DET
dpc-4547	372	18	cases	case	NOUN
dpc-4547	372	19	after	after	ADP
dpc-4547	372	20	the	the	DET
dpc-4547	372	21	treatment	treatment	NOUN
dpc-4547	372	22	during	during	ADP
dpc-4547	372	23	the	the	DET
dpc-4547	372	24	follow	follow	NOUN
dpc-4547	372	25	-	-	PUNCT
dpc-4547	372	26	up	up	NOUN
dpc-4547	372	27	.	.	PUNCT
dpc-4547	373	1	interestingly	interestingly	ADV
dpc-4547	373	2	,	,	PUNCT
dpc-4547	373	3	for	for	ADP
dpc-4547	373	4	a	a	DET
dpc-4547	373	5	single	single	ADJ
dpc-4547	373	6	lesion	lesion	NOUN
dpc-4547	373	7	a	a	DET
dpc-4547	373	8	slight	slight	ADJ
dpc-4547	373	9	worsening	worsen	VERB
dpc-4547	373	10	in	in	ADP
dpc-4547	373	11	dermoscopic	dermoscopic	ADJ
dpc-4547	373	12	strawberry	strawberry	NOUN
dpc-4547	373	13	pattern	pattern	NOUN
dpc-4547	373	14	was	be	AUX
dpc-4547	373	15	clinically	clinically	ADV
dpc-4547	373	16	noticed	notice	VERB
dpc-4547	373	17	during	during	ADP
dpc-4547	373	18	the	the	DET
dpc-4547	373	19	follow	follow	NOUN
dpc-4547	373	20	-	-	PUNCT
dpc-4547	373	21	up	up	NOUN
dpc-4547	373	22	.	.	PUNCT
dpc-4547	374	1	in	in	ADP
dpc-4547	374	2	lcoct	lcoct	PROPN
dpc-4547	374	3	imaging	image	VERB
dpc-4547	374	4	the	the	DET
dpc-4547	374	5	persistence	persistence	NOUN
dpc-4547	374	6	of	of	ADP
dpc-4547	374	7	atypia	atypia	PROPN
dpc-4547	374	8	was	be	AUX
dpc-4547	374	9	observed	observe	VERB
dpc-4547	374	10	accordingly	accordingly	ADV
dpc-4547	374	11	at	at	ADP
dpc-4547	374	12	the	the	DET
dpc-4547	374	13	end	end	NOUN
dpc-4547	374	14	of	of	ADP
dpc-4547	374	15	the	the	DET
dpc-4547	374	16	follow	follow	NOUN
dpc-4547	374	17	-	-	PUNCT
dpc-4547	374	18	up	up	NOUN
dpc-4547	374	19	and	and	CCONJ
dpc-4547	374	20	an	an	DET
dpc-4547	374	21	inadequate	inadequate	ADJ
dpc-4547	374	22	therapy	therapy	NOUN
dpc-4547	374	23	response	response	NOUN
dpc-4547	374	24	was	be	AUX
dpc-4547	374	25	therefore	therefore	ADV
dpc-4547	374	26	assumed	assume	VERB
dpc-4547	374	27	.	.	PUNCT
dpc-4547	375	1	by	by	ADP
dpc-4547	375	2	the	the	DET
dpc-4547	375	3	means	mean	NOUN
dpc-4547	375	4	of	of	ADP
dpc-4547	375	5	non	non	ADJ
dpc-4547	375	6	-	-	ADJ
dpc-4547	375	7	invasive	invasive	ADJ
dpc-4547	375	8	imaging	imaging	NOUN
dpc-4547	375	9	this	this	DET
dpc-4547	375	10	lesion	lesion	NOUN
dpc-4547	375	11	was	be	AUX
dpc-4547	375	12	identified	identify	VERB
dpc-4547	375	13	as	as	ADP
dpc-4547	375	14	therapy	therapy	NOUN
dpc-4547	375	15	non	non	NOUN
dpc-4547	375	16	-	-	NOUN
dpc-4547	375	17	responder	responder	NOUN
dpc-4547	375	18	,	,	PUNCT
dpc-4547	375	19	while	while	SCONJ
dpc-4547	375	20	clinically	clinically	ADV
dpc-4547	375	21	therapy	therapy	NOUN
dpc-4547	375	22	associated	associate	VERB
dpc-4547	375	23	inflammation	inflammation	NOUN
dpc-4547	375	24	and	and	CCONJ
dpc-4547	375	25	lesion	lesion	NOUN
dpc-4547	375	26	clearing	clearing	NOUN
dpc-4547	375	27	was	be	AUX
dpc-4547	375	28	assumed	assume	VERB
dpc-4547	375	29	over	over	ADP
dpc-4547	375	30	the	the	DET
dpc-4547	375	31	follow	follow	NOUN
dpc-4547	375	32	-	-	PUNCT
dpc-4547	375	33	up	up	NOUN
dpc-4547	375	34	to	to	ADP
dpc-4547	375	35	some	some	DET
dpc-4547	375	36	extent	extent	NOUN
dpc-4547	375	37	.	.	PUNCT
dpc-4547	376	1	these	these	DET
dpc-4547	376	2	findings	finding	NOUN
dpc-4547	376	3	highlight	highlight	VERB
dpc-4547	376	4	the	the	DET
dpc-4547	376	5	additional	additional	ADJ
dpc-4547	376	6	valuable	valuable	ADJ
dpc-4547	376	7	input	input	NOUN
dpc-4547	376	8	of	of	ADP
dpc-4547	376	9	non	non	ADJ
dpc-4547	376	10	-	-	ADJ
dpc-4547	376	11	invasive	invasive	ADJ
dpc-4547	376	12	imaging	imaging	NOUN
dpc-4547	376	13	as	as	SCONJ
dpc-4547	376	14	it	it	PRON
dpc-4547	376	15	allows	allow	VERB
dpc-4547	376	16	to	to	PART
dpc-4547	376	17	underline	underline	VERB
dpc-4547	376	18	the	the	DET
dpc-4547	376	19	clinical	clinical	ADJ
dpc-4547	376	20	assumption	assumption	NOUN
dpc-4547	376	21	of	of	ADP
dpc-4547	376	22	therapy	therapy	NOUN
dpc-4547	376	23	refractory	refractory	NOUN
dpc-4547	376	24	by	by	ADP
dpc-4547	376	25	objective	objective	ADJ
dpc-4547	376	26	parameters	parameter	NOUN
dpc-4547	376	27	such	such	ADJ
dpc-4547	376	28	figure	figure	NOUN
dpc-4547	376	29	2	2	NUM
dpc-4547	376	30	.	.	PUNCT
dpc-4547	376	31	ai	ai	AUX
dpc-4547	376	32	-	-	PUNCT
dpc-4547	376	33	generated	generate	VERB
dpc-4547	376	34	evaluation	evaluation	NOUN
dpc-4547	376	35	of	of	ADP
dpc-4547	376	36	ak	ak	PROPN
dpc-4547	376	37	features	feature	NOUN
dpc-4547	376	38	in	in	ADP
dpc-4547	376	39	lc	lc	PROPN
dpc-4547	376	40	-	-	PUNCT
dpc-4547	376	41	oct	oct	PROPN
dpc-4547	376	42	.	.	PROPN
dpc-4547	376	43	ak	ak	PROPN
dpc-4547	376	44	lesion	lesion	NOUN
dpc-4547	376	45	on	on	ADP
dpc-4547	376	46	the	the	DET
dpc-4547	376	47	forehead	forehead	NOUN
dpc-4547	376	48	of	of	ADP
dpc-4547	376	49	a	a	DET
dpc-4547	376	50	patient	patient	NOUN
dpc-4547	376	51	.	.	PUNCT
dpc-4547	377	1	white	white	ADJ
dpc-4547	377	2	arrows	arrow	NOUN
dpc-4547	377	3	show	show	VERB
dpc-4547	377	4	the	the	DET
dpc-4547	377	5	surface	surface	NOUN
dpc-4547	377	6	of	of	ADP
dpc-4547	377	7	stratum	stratum	PROPN
dpc-4547	377	8	corneum	corneum	NOUN
dpc-4547	377	9	(	(	PUNCT
dpc-4547	377	10	sc	sc	PROPN
dpc-4547	377	11	)	)	PUNCT
dpc-4547	377	12	and	and	CCONJ
dpc-4547	377	13	the	the	DET
dpc-4547	377	14	viable	viable	ADJ
dpc-4547	377	15	epidermis	epidermis	NOUN
dpc-4547	377	16	(	(	PUNCT
dpc-4547	377	17	ve	ve	NOUN
dpc-4547	377	18	)	)	PUNCT
dpc-4547	377	19	detected	detect	VERB
dpc-4547	377	20	by	by	ADP
dpc-4547	377	21	the	the	DET
dpc-4547	377	22	skin	skin	NOUN
dpc-4547	377	23	segmentation	segmentation	NOUN
dpc-4547	377	24	algorithm	algorithm	NOUN
dpc-4547	377	25	.	.	PUNCT
dpc-4547	378	1	the	the	DET
dpc-4547	378	2	red	red	ADJ
dpc-4547	378	3	arrow	arrow	NOUN
dpc-4547	378	4	shows	show	VERB
dpc-4547	378	5	the	the	DET
dpc-4547	378	6	detected	detect	VERB
dpc-4547	378	7	intact	intact	ADJ
dpc-4547	378	8	dej	dej	NOUN
dpc-4547	378	9	.	.	PUNCT
dpc-4547	379	1	epidermal	epidermal	ADJ
dpc-4547	379	2	protrusions	protrusion	NOUN
dpc-4547	379	3	are	be	AUX
dpc-4547	379	4	found	find	VERB
dpc-4547	379	5	and	and	CCONJ
dpc-4547	379	6	indicated	indicate	VERB
dpc-4547	379	7	by	by	ADP
dpc-4547	379	8	the	the	DET
dpc-4547	379	9	white	white	PROPN
dpc-4547	379	10	circle	circle	PROPN
dpc-4547	379	11	.	.	PUNCT
dpc-4547	380	1	keratinocytes	keratinocyte	NOUN
dpc-4547	380	2	colored	color	VERB
dpc-4547	380	3	in	in	ADP
dpc-4547	380	4	red	red	ADJ
dpc-4547	380	5	show	show	PROPN
dpc-4547	380	6	high	high	ADJ
dpc-4547	380	7	atypia	atypia	PROPN
dpc-4547	380	8	within	within	ADP
dpc-4547	380	9	the	the	DET
dpc-4547	380	10	epidermis	epidermis	NOUN
dpc-4547	380	11	.	.	PUNCT
dpc-4547	381	1	the	the	DET
dpc-4547	381	2	following	follow	VERB
dpc-4547	381	3	parameters	parameter	NOUN
dpc-4547	381	4	were	be	AUX
dpc-4547	381	5	detected	detect	VERB
dpc-4547	381	6	by	by	ADP
dpc-4547	381	7	the	the	DET
dpc-4547	381	8	implemented	implement	VERB
dpc-4547	381	9	algorithms	algorithm	NOUN
dpc-4547	381	10	:	:	PUNCT
dpc-4547	381	11	sc	sc	PROPN
dpc-4547	381	12	thickness	thickness	NOUN
dpc-4547	381	13	:	:	PUNCT
dpc-4547	381	14	24.2	24.2	NUM
dpc-4547	381	15	µm	µm	NOUN
dpc-4547	381	16	,	,	PUNCT
dpc-4547	381	17	ve	ve	VERB
dpc-4547	381	18	thickness	thickness	NOUN
dpc-4547	381	19	:	:	PUNCT
dpc-4547	381	20	108.7	108.7	NUM
dpc-4547	381	21	µm	µm	NOUN
dpc-4547	381	22	,	,	PUNCT
dpc-4547	381	23	dej	dej	PROPN
dpc-4547	381	24	undulation	undulation	NOUN
dpc-4547	381	25	:	:	PUNCT
dpc-4547	381	26	33	33	NUM
dpc-4547	381	27	%	%	NOUN
dpc-4547	381	28	,	,	PUNCT
dpc-4547	381	29	kn	kn	PROPN
dpc-4547	381	30	atypia	atypia	PROPN
dpc-4547	381	31	:	:	PUNCT
dpc-4547	382	1	0.61	0.61	NUM
dpc-4547	382	2	.	.	PUNCT
dpc-4547	383	1	from	from	ADP
dpc-4547	383	2	this	this	DET
dpc-4547	383	3	ak	ak	PROPN
dpc-4547	383	4	lesion	lesion	NOUN
dpc-4547	383	5	,	,	PUNCT
dpc-4547	383	6	prevalence	prevalence	NOUN
dpc-4547	383	7	of	of	ADP
dpc-4547	383	8	atypia	atypia	PROPN
dpc-4547	383	9	in	in	ADP
dpc-4547	383	10	2/3	2/3	NUM
dpc-4547	383	11	of	of	ADP
dpc-4547	383	12	the	the	DET
dpc-4547	383	13	epidermal	epidermal	ADJ
dpc-4547	383	14	layer	layer	NOUN
dpc-4547	383	15	and	and	CCONJ
dpc-4547	383	16	pro	pro	ADJ
dpc-4547	383	17	ii	ii	PROPN
dpc-4547	383	18	can	can	AUX
dpc-4547	383	19	be	be	AUX
dpc-4547	383	20	assumed	assume	VERB
dpc-4547	383	21	(	(	PUNCT
dpc-4547	383	22	sc=	sc=	ADJ
dpc-4547	383	23	stratum	stratum	PROPN
dpc-4547	383	24	corneum	corneum	NOUN
dpc-4547	383	25	,	,	PUNCT
dpc-4547	383	26	ve=	ve=	ADJ
dpc-4547	383	27	viable	viable	ADJ
dpc-4547	383	28	epidermis	epidermis	NOUN
dpc-4547	383	29	,	,	PUNCT
dpc-4547	383	30	kn=	kn=	PROPN
dpc-4547	383	31	keratinocyte	keratinocyte	NOUN
dpc-4547	383	32	nuclei	nuclei	PROPN
dpc-4547	383	33	,	,	PUNCT
dpc-4547	383	34	dej=	dej=	PROPN
dpc-4547	383	35	dermo	dermo	NOUN
dpc-4547	383	36	-	-	PUNCT
dpc-4547	383	37	epidermal	epidermal	ADJ
dpc-4547	383	38	junction	junction	NOUN
dpc-4547	383	39	;	;	PUNCT
dpc-4547	383	40	lc	lc	PROPN
dpc-4547	383	41	-	-	PUNCT
dpc-4547	383	42	oct	oct	NOUN
dpc-4547	383	43	,	,	PUNCT
dpc-4547	383	44	deeplive	deeplive	ADJ
dpc-4547	383	45	™	™	NOUN
dpc-4547	383	46	,	,	PUNCT
dpc-4547	383	47	damae	damae	VERB
dpc-4547	383	48	medical	medical	ADJ
dpc-4547	383	49	,	,	PUNCT
dpc-4547	383	50	paris	paris	PROPN
dpc-4547	383	51	,	,	PUNCT
dpc-4547	383	52	france	france	PROPN
dpc-4547	383	53	)	)	PUNCT
dpc-4547	383	54	.	.	PUNCT
dpc-4547	384	1	review	review	VERB
dpc-4547	384	2	|	|	ADV
dpc-4547	384	3	dermatol	dermatol	ADJ
dpc-4547	384	4	pract	pract	NOUN
dpc-4547	384	5	concept	concept	NOUN
dpc-4547	384	6	.	.	PUNCT
dpc-4547	385	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	385	2	:	:	PUNCT
dpc-4547	385	3	e2024146s	e2024146s	ADV
dpc-4547	385	4	11	11	NUM
dpc-4547	385	5	13	13	NUM
dpc-4547	385	6	.	.	PUNCT
dpc-4547	386	1	weinstock	weinstock	PROPN
dpc-4547	386	2	ma	ma	PROPN
dpc-4547	386	3	,	,	PUNCT
dpc-4547	386	4	lee	lee	PROPN
dpc-4547	386	5	kc	kc	PROPN
dpc-4547	386	6	,	,	PUNCT
dpc-4547	386	7	chren	chren	PROPN
dpc-4547	386	8	mm	mm	PROPN
dpc-4547	386	9	,	,	PUNCT
dpc-4547	386	10	marcolivio	marcolivio	NOUN
dpc-4547	386	11	k	k	PROPN
dpc-4547	386	12	,	,	PUNCT
dpc-4547	386	13	group	group	PROPN
dpc-4547	386	14	vt	vt	PROPN
dpc-4547	386	15	.	.	PROPN
dpc-4547	386	16	quality	quality	NOUN
dpc-4547	386	17	of	of	ADP
dpc-4547	386	18	life	life	NOUN
dpc-4547	386	19	in	in	ADP
dpc-4547	386	20	the	the	DET
dpc-4547	386	21	actinic	actinic	ADJ
dpc-4547	386	22	neoplasia	neoplasia	NOUN
dpc-4547	386	23	syndrome	syndrome	NOUN
dpc-4547	386	24	:	:	PUNCT
dpc-4547	386	25	the	the	DET
dpc-4547	386	26	va	va	PROPN
dpc-4547	386	27	topical	topical	ADJ
dpc-4547	386	28	tretinoin	tretinoin	PROPN
dpc-4547	386	29	chemoprevention	chemoprevention	PROPN
dpc-4547	386	30	(	(	PUNCT
dpc-4547	386	31	vattc	vattc	NOUN
dpc-4547	386	32	)	)	PUNCT
dpc-4547	386	33	trial	trial	NOUN
dpc-4547	386	34	.	.	PUNCT
dpc-4547	387	1	j	j	PROPN
dpc-4547	387	2	am	be	AUX
dpc-4547	387	3	acad	acad	ADJ
dpc-4547	387	4	dermatol	dermatol	NOUN
dpc-4547	387	5	.	.	PUNCT
dpc-4547	388	1	2009;61(2):207	2009;61(2):207	NOUN
dpc-4547	388	2	-	-	SYM
dpc-4547	388	3	15	15	NUM
dpc-4547	388	4	.	.	PUNCT
dpc-4547	388	5	14	14	NUM
dpc-4547	388	6	.	.	PUNCT
dpc-4547	389	1	tennvall	tennvall	PROPN
dpc-4547	389	2	gr	gr	PROPN
dpc-4547	389	3	,	,	PUNCT
dpc-4547	389	4	norlin	norlin	PROPN
dpc-4547	389	5	jm	jm	PROPN
dpc-4547	389	6	,	,	PUNCT
dpc-4547	389	7	malmberg	malmberg	PROPN
dpc-4547	389	8	i	i	PROPN
dpc-4547	389	9	,	,	PUNCT
dpc-4547	389	10	erlendsson	erlendsson	PROPN
dpc-4547	389	11	am	be	AUX
dpc-4547	389	12	,	,	PUNCT
dpc-4547	389	13	haedersdal	haedersdal	ADJ
dpc-4547	389	14	m.	m.	NOUN
dpc-4547	389	15	health	health	NOUN
dpc-4547	389	16	related	relate	VERB
dpc-4547	389	17	quality	quality	NOUN
dpc-4547	389	18	of	of	ADP
dpc-4547	389	19	life	life	NOUN
dpc-4547	389	20	in	in	ADP
dpc-4547	389	21	patients	patient	NOUN
dpc-4547	389	22	with	with	ADP
dpc-4547	389	23	actinic	actinic	ADJ
dpc-4547	389	24	keratosis	keratosis	NOUN
dpc-4547	389	25	--	--	PUNCT
dpc-4547	389	26	an	an	DET
dpc-4547	389	27	observational	observational	ADJ
dpc-4547	389	28	study	study	NOUN
dpc-4547	389	29	of	of	ADP
dpc-4547	389	30	patients	patient	NOUN
dpc-4547	389	31	treated	treat	VERB
dpc-4547	389	32	in	in	ADP
dpc-4547	389	33	dermatology	dermatology	NOUN
dpc-4547	389	34	specialist	specialist	NOUN
dpc-4547	389	35	care	care	VERB
dpc-4547	389	36	in	in	ADP
dpc-4547	389	37	denmark	denmark	PROPN
dpc-4547	389	38	.	.	PUNCT
dpc-4547	390	1	health	health	PROPN
dpc-4547	390	2	qual	qual	PROPN
dpc-4547	390	3	life	life	NOUN
dpc-4547	390	4	outcomes	outcome	NOUN
dpc-4547	390	5	.	.	PUNCT
dpc-4547	391	1	2015;13:111	2015;13:111	NOUN
dpc-4547	391	2	.	.	PUNCT
dpc-4547	392	1	15	15	NUM
dpc-4547	392	2	.	.	PUNCT
dpc-4547	393	1	miller	miller	PROPN
dpc-4547	394	1	i	i	PRON
dpc-4547	394	2	m	m	PROPN
dpc-4547	394	3	,	,	PUNCT
dpc-4547	394	4	vinding	vinde	VERB
dpc-4547	394	5	g	g	NOUN
dpc-4547	394	6	,	,	PUNCT
dpc-4547	394	7	zarchi	zarchi	PROPN
dpc-4547	394	8	k	k	X
dpc-4547	394	9	,	,	PUNCT
dpc-4547	394	10	esmann	esmann	PROPN
dpc-4547	394	11	s	s	PART
dpc-4547	394	12	,	,	PUNCT
dpc-4547	394	13	murrell	murrell	PROPN
dpc-4547	394	14	df	df	PROPN
dpc-4547	394	15	,	,	PUNCT
dpc-4547	394	16	jemec	jemec	VERB
dpc-4547	394	17	gb	gb	ADP
dpc-4547	394	18	.	.	PUNCT
dpc-4547	394	19	differences	difference	NOUN
dpc-4547	394	20	in	in	ADP
dpc-4547	394	21	disease	disease	NOUN
dpc-4547	394	22	-	-	PUNCT
dpc-4547	394	23	specific	specific	ADJ
dpc-4547	394	24	quality	quality	NOUN
dpc-4547	394	25	of	of	ADP
dpc-4547	394	26	life	life	NOUN
dpc-4547	394	27	in	in	ADP
dpc-4547	394	28	patients	patient	NOUN
dpc-4547	394	29	with	with	ADP
dpc-4547	394	30	actinic	actinic	ADJ
dpc-4547	394	31	keratosis	keratosis	NOUN
dpc-4547	394	32	in	in	ADP
dpc-4547	394	33	australia	australia	PROPN
dpc-4547	394	34	and	and	CCONJ
dpc-4547	394	35	denmark	denmark	NOUN
dpc-4547	394	36	.	.	PUNCT
dpc-4547	395	1	acta	acta	PROPN
dpc-4547	395	2	dermatovenerol	dermatovenerol	PROPN
dpc-4547	395	3	croat	croat	PROPN
dpc-4547	395	4	.	.	PUNCT
dpc-4547	396	1	2016;24(1):25	2016;24(1):25	X
dpc-4547	396	2	-	-	SYM
dpc-4547	396	3	8	8	NUM
dpc-4547	396	4	.	.	NUM
dpc-4547	397	1	16	16	NUM
dpc-4547	397	2	.	.	PUNCT
dpc-4547	398	1	lee	lee	PROPN
dpc-4547	398	2	k	k	PROPN
dpc-4547	398	3	,	,	PUNCT
dpc-4547	398	4	weinstock	weinstock	ADJ
dpc-4547	398	5	m.	m.	NOUN
dpc-4547	398	6	prospective	prospective	ADJ
dpc-4547	398	7	quality	quality	NOUN
dpc-4547	398	8	of	of	ADP
dpc-4547	398	9	life	life	NOUN
dpc-4547	398	10	impact	impact	NOUN
dpc-4547	398	11	of	of	ADP
dpc-4547	398	12	actinic	actinic	ADJ
dpc-4547	398	13	keratoses	keratose	NOUN
dpc-4547	398	14	:	:	PUNCT
dpc-4547	398	15	observations	observation	NOUN
dpc-4547	398	16	from	from	ADP
dpc-4547	398	17	the	the	DET
dpc-4547	398	18	veterans	veteran	NOUN
dpc-4547	398	19	affairs	affairs	PROPN
dpc-4547	398	20	topical	topical	ADJ
dpc-4547	398	21	tretinoin	tretinoin	PROPN
dpc-4547	398	22	chemoprevention	chemoprevention	NOUN
dpc-4547	398	23	trial	trial	NOUN
dpc-4547	398	24	.	.	PUNCT
dpc-4547	399	1	acta	acta	PROPN
dpc-4547	399	2	derm	derm	PROPN
dpc-4547	399	3	venereol	venereol	NOUN
dpc-4547	399	4	.	.	PUNCT
dpc-4547	400	1	2011;91(1	2011;91(1	NUM
dpc-4547	400	2	):	):	PUNCT
dpc-4547	400	3	101	101	NUM
dpc-4547	400	4	-	-	SYM
dpc-4547	400	5	2	2	NUM
dpc-4547	400	6	.	.	NUM
dpc-4547	400	7	17	17	NUM
dpc-4547	400	8	.	.	PUNCT
dpc-4547	401	1	vis	vis	X
dpc-4547	401	2	k	k	X
dpc-4547	401	3	,	,	PUNCT
dpc-4547	401	4	waalboer	waalboer	NOUN
dpc-4547	401	5	-	-	PUNCT
dpc-4547	401	6	spuij	spuij	NOUN
dpc-4547	401	7	r	r	NOUN
dpc-4547	401	8	,	,	PUNCT
dpc-4547	401	9	snels	snel	NOUN
dpc-4547	401	10	d	d	PROPN
dpc-4547	401	11	,	,	PUNCT
dpc-4547	401	12	hollestein	hollestein	PROPN
dpc-4547	401	13	lm	lm	PROPN
dpc-4547	401	14	.	.	PROPN
dpc-4547	401	15	validity	validity	NOUN
dpc-4547	401	16	and	and	CCONJ
dpc-4547	401	17	reliability	reliability	NOUN
dpc-4547	401	18	of	of	ADP
dpc-4547	401	19	the	the	DET
dpc-4547	401	20	dutch	dutch	ADJ
dpc-4547	401	21	adaptation	adaptation	NOUN
dpc-4547	401	22	of	of	ADP
dpc-4547	401	23	the	the	DET
dpc-4547	401	24	actinic	actinic	ADJ
dpc-4547	401	25	keratosis	keratosis	NOUN
dpc-4547	401	26	quality	quality	NOUN
dpc-4547	401	27	of	of	ADP
dpc-4547	401	28	life	life	NOUN
dpc-4547	401	29	questionnaire	questionnaire	NOUN
dpc-4547	401	30	(	(	PUNCT
dpc-4547	401	31	akqol	akqol	ADJ
dpc-4547	401	32	)	)	PUNCT
dpc-4547	401	33	.	.	PUNCT
dpc-4547	402	1	dermatology	dermatology	NOUN
dpc-4547	402	2	.	.	PUNCT
dpc-4547	403	1	2018	2018	NUM
dpc-4547	403	2	;	;	PUNCT
dpc-4547	403	3	234(1	234(1	NUM
dpc-4547	403	4	-	-	SYM
dpc-4547	403	5	2):60	2):60	NUM
dpc-4547	403	6	-	-	SYM
dpc-4547	403	7	5	5	NUM
dpc-4547	403	8	.	.	NOUN
dpc-4547	403	9	18	18	NUM
dpc-4547	403	10	.	.	PUNCT
dpc-4547	404	1	philipp	philipp	PROPN
dpc-4547	404	2	-	-	PUNCT
dpc-4547	404	3	dormston	dormston	PROPN
dpc-4547	404	4	wg	wg	PROPN
dpc-4547	404	5	,	,	PUNCT
dpc-4547	404	6	muller	muller	PROPN
dpc-4547	404	7	k	k	PROPN
dpc-4547	404	8	,	,	PUNCT
dpc-4547	404	9	novak	novak	PROPN
dpc-4547	404	10	b	b	PROPN
dpc-4547	404	11	,	,	PUNCT
dpc-4547	404	12	stromer	stromer	PROPN
dpc-4547	404	13	k	k	PROPN
dpc-4547	404	14	,	,	PUNCT
dpc-4547	404	15	termeer	termeer	NOUN
dpc-4547	404	16	c	c	NOUN
dpc-4547	404	17	,	,	PUNCT
dpc-4547	404	18	hammann	hammann	X
dpc-4547	404	19	u	u	NOUN
dpc-4547	404	20	,	,	PUNCT
dpc-4547	404	21	et	et	PROPN
dpc-4547	404	22	al	al	PROPN
dpc-4547	404	23	.	.	PUNCT
dpc-4547	405	1	patient	patient	NOUN
dpc-4547	405	2	-	-	PUNCT
dpc-4547	405	3	reported	report	VERB
dpc-4547	405	4	health	health	NOUN
dpc-4547	405	5	outcomes	outcome	NOUN
dpc-4547	405	6	in	in	ADP
dpc-4547	405	7	patients	patient	NOUN
dpc-4547	405	8	with	with	ADP
dpc-4547	405	9	non	non	ADJ
dpc-4547	405	10	-	-	ADJ
dpc-4547	405	11	melanoma	melanoma	ADJ
dpc-4547	405	12	skin	skin	NOUN
dpc-4547	405	13	cancer	cancer	NOUN
dpc-4547	405	14	and	and	CCONJ
dpc-4547	405	15	actinic	actinic	ADJ
dpc-4547	405	16	keratosis	keratosis	NOUN
dpc-4547	405	17	:	:	PUNCT
dpc-4547	405	18	results	result	NOUN
dpc-4547	405	19	from	from	ADP
dpc-4547	405	20	a	a	DET
dpc-4547	405	21	large	large	ADJ
dpc-4547	405	22	-	-	PUNCT
dpc-4547	405	23	scale	scale	NOUN
dpc-4547	405	24	observational	observational	ADJ
dpc-4547	405	25	study	study	NOUN
dpc-4547	405	26	analysing	analysing	NOUN
dpc-4547	405	27	effects	effect	NOUN
dpc-4547	405	28	of	of	ADP
dpc-4547	405	29	diagnoses	diagnosis	NOUN
dpc-4547	405	30	and	and	CCONJ
dpc-4547	405	31	disease	disease	NOUN
dpc-4547	405	32	progression	progression	NOUN
dpc-4547	405	33	.	.	PUNCT
dpc-4547	406	1	j	j	PROPN
dpc-4547	406	2	eur	eur	PROPN
dpc-4547	406	3	acad	acad	PROPN
dpc-4547	406	4	dermatol	dermatol	NOUN
dpc-4547	406	5	venereol	venereol	NOUN
dpc-4547	406	6	.	.	PUNCT
dpc-4547	407	1	2018;32(7):1138	2018;32(7):1138	PROPN
dpc-4547	407	2	-	-	SYM
dpc-4547	407	3	46	46	NUM
dpc-4547	407	4	.	.	PUNCT
dpc-4547	407	5	19	19	NUM
dpc-4547	407	6	.	.	PUNCT
dpc-4547	408	1	longo	longo	PROPN
dpc-4547	408	2	i	i	PRON
dpc-4547	408	3	,	,	PUNCT
dpc-4547	408	4	serra	serra	PROPN
dpc-4547	408	5	-	-	PUNCT
dpc-4547	408	6	guillen	guillen	PROPN
dpc-4547	408	7	c.	c.	PROPN
dpc-4547	408	8	quality	quality	NOUN
dpc-4547	408	9	of	of	ADP
dpc-4547	408	10	life	life	NOUN
dpc-4547	408	11	,	,	PUNCT
dpc-4547	408	12	behaviour	behaviour	NOUN
dpc-4547	408	13	and	and	CCONJ
dpc-4547	408	14	attitudes	attitude	NOUN
dpc-4547	408	15	towards	towards	ADP
dpc-4547	408	16	actinic	actinic	ADJ
dpc-4547	408	17	keratosis	keratosis	NOUN
dpc-4547	408	18	in	in	ADP
dpc-4547	408	19	spain	spain	PROPN
dpc-4547	408	20	:	:	PUNCT
dpc-4547	408	21	the	the	DET
dpc-4547	408	22	piqa	piqa	NOUN
dpc-4547	408	23	study	study	NOUN
dpc-4547	408	24	.	.	PUNCT
dpc-4547	409	1	actas	actas	PROPN
dpc-4547	409	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-4547	409	3	(	(	PUNCT
dpc-4547	409	4	engl	engl	PROPN
dpc-4547	409	5	ed	ed	NOUN
dpc-4547	409	6	)	)	PUNCT
dpc-4547	409	7	.	.	PUNCT
dpc-4547	410	1	2018;109(4):331	2018;109(4):331	X
dpc-4547	410	2	-	-	SYM
dpc-4547	410	3	9	9	NUM
dpc-4547	410	4	.	.	NOUN
dpc-4547	410	5	20	20	NUM
dpc-4547	410	6	.	.	PUNCT
dpc-4547	411	1	schmitt	schmitt	PROPN
dpc-4547	411	2	j	j	NOUN
dpc-4547	411	3	,	,	PUNCT
dpc-4547	411	4	seidler	seidler	NOUN
dpc-4547	411	5	a	a	NOUN
dpc-4547	411	6	,	,	PUNCT
dpc-4547	411	7	diepgen	diepgen	PROPN
dpc-4547	411	8	tl	tl	PROPN
dpc-4547	411	9	,	,	PUNCT
dpc-4547	411	10	bauer	bauer	PROPN
dpc-4547	411	11	a.	a.	PROPN
dpc-4547	411	12	occupational	occupational	PROPN
dpc-4547	411	13	ultraviolet	ultraviolet	ADJ
dpc-4547	411	14	light	light	ADJ
dpc-4547	411	15	exposure	exposure	NOUN
dpc-4547	411	16	increases	increase	VERB
dpc-4547	411	17	the	the	DET
dpc-4547	411	18	risk	risk	NOUN
dpc-4547	411	19	for	for	ADP
dpc-4547	411	20	the	the	DET
dpc-4547	411	21	development	development	NOUN
dpc-4547	411	22	of	of	ADP
dpc-4547	411	23	cutaneous	cutaneous	ADJ
dpc-4547	411	24	squamous	squamous	ADJ
dpc-4547	411	25	cell	cell	NOUN
dpc-4547	411	26	carcinoma	carcinoma	NOUN
dpc-4547	411	27	:	:	PUNCT
dpc-4547	411	28	a	a	DET
dpc-4547	411	29	systematic	systematic	ADJ
dpc-4547	411	30	review	review	NOUN
dpc-4547	411	31	and	and	CCONJ
dpc-4547	411	32	meta	meta	ADJ
dpc-4547	411	33	-	-	PUNCT
dpc-4547	411	34	analysis	analysis	NOUN
dpc-4547	411	35	.	.	PUNCT
dpc-4547	412	1	br	br	PROPN
dpc-4547	412	2	j	j	PROPN
dpc-4547	412	3	dermatol	dermatol	NOUN
dpc-4547	412	4	.	.	PUNCT
dpc-4547	413	1	2011;164(2):291	2011;164(2):291	NUM
dpc-4547	413	2	-	-	SYM
dpc-4547	413	3	307	307	NUM
dpc-4547	413	4	.	.	PUNCT
dpc-4547	414	1	21	21	NUM
dpc-4547	414	2	.	.	PUNCT
dpc-4547	415	1	ziegler	ziegler	PROPN
dpc-4547	415	2	a	a	PROPN
dpc-4547	415	3	,	,	PUNCT
dpc-4547	415	4	jonason	jonason	NOUN
dpc-4547	415	5	as	as	ADP
dpc-4547	415	6	,	,	PUNCT
dpc-4547	415	7	leffell	leffell	PROPN
dpc-4547	415	8	dj	dj	PROPN
dpc-4547	415	9	,	,	PUNCT
dpc-4547	415	10	et	et	PROPN
dpc-4547	415	11	al	al	PROPN
dpc-4547	415	12	.	.	PROPN
dpc-4547	415	13	sunburn	sunburn	NOUN
dpc-4547	415	14	and	and	CCONJ
dpc-4547	415	15	p53	p53	NOUN
dpc-4547	415	16	in	in	ADP
dpc-4547	415	17	the	the	DET
dpc-4547	415	18	onset	onset	NOUN
dpc-4547	415	19	of	of	ADP
dpc-4547	415	20	skin	skin	NOUN
dpc-4547	415	21	cancer	cancer	NOUN
dpc-4547	415	22	.	.	PUNCT
dpc-4547	416	1	nature	nature	NOUN
dpc-4547	416	2	.	.	PUNCT
dpc-4547	417	1	1994;372(6508):773	1994;372(6508):773	NUM
dpc-4547	417	2	-	-	SYM
dpc-4547	417	3	6	6	NUM
dpc-4547	417	4	.	.	NOUN
dpc-4547	418	1	22	22	NUM
dpc-4547	418	2	.	.	PUNCT
dpc-4547	419	1	ziegler	ziegler	PROPN
dpc-4547	419	2	a	a	PROPN
dpc-4547	419	3	,	,	PUNCT
dpc-4547	419	4	jonason	jonason	PROPN
dpc-4547	419	5	a	a	NOUN
dpc-4547	419	6	,	,	PUNCT
dpc-4547	419	7	simon	simon	PROPN
dpc-4547	419	8	j	j	PROPN
dpc-4547	419	9	,	,	PUNCT
dpc-4547	419	10	leffell	leffell	PROPN
dpc-4547	419	11	d	d	NOUN
dpc-4547	419	12	,	,	PUNCT
dpc-4547	419	13	brash	brash	ADJ
dpc-4547	419	14	de	de	X
dpc-4547	419	15	.	.	PROPN
dpc-4547	419	16	tumor	tumor	PROPN
dpc-4547	419	17	suppressor	suppressor	NOUN
dpc-4547	419	18	gene	gene	NOUN
dpc-4547	419	19	mutations	mutation	NOUN
dpc-4547	419	20	and	and	CCONJ
dpc-4547	419	21	photocarcinogenesis	photocarcinogenesis	NOUN
dpc-4547	419	22	.	.	PUNCT
dpc-4547	420	1	photochem	photochem	PROPN
dpc-4547	420	2	photobiol	photobiol	NOUN
dpc-4547	420	3	.	.	PUNCT
dpc-4547	421	1	1996;63(4):432	1996;63(4):432	NUM
dpc-4547	421	2	-	-	SYM
dpc-4547	421	3	5	5	NUM
dpc-4547	421	4	.	.	NOUN
dpc-4547	421	5	23	23	NUM
dpc-4547	421	6	.	.	PUNCT
dpc-4547	422	1	yoshizumi	yoshizumi	PROPN
dpc-4547	422	2	m	m	PROPN
dpc-4547	422	3	,	,	PUNCT
dpc-4547	422	4	nakamura	nakamura	PROPN
dpc-4547	422	5	t	t	PROPN
dpc-4547	422	6	,	,	PUNCT
dpc-4547	422	7	kato	kato	PROPN
dpc-4547	422	8	m	m	PROPN
dpc-4547	422	9	,	,	PUNCT
dpc-4547	422	10	et	et	PROPN
dpc-4547	422	11	al	al	PROPN
dpc-4547	422	12	.	.	PROPN
dpc-4547	422	13	release	release	NOUN
dpc-4547	422	14	of	of	ADP
dpc-4547	422	15	cytokines/	cytokines/	NUM
dpc-4547	422	16	chemokines	chemokine	NOUN
dpc-4547	422	17	and	and	CCONJ
dpc-4547	422	18	cell	cell	NOUN
dpc-4547	422	19	death	death	NOUN
dpc-4547	422	20	in	in	ADP
dpc-4547	422	21	uvb	uvb	ADJ
dpc-4547	422	22	-	-	ADJ
dpc-4547	422	23	irradiated	irradiate	VERB
dpc-4547	422	24	human	human	ADJ
dpc-4547	422	25	keratinocytes	keratinocyte	NOUN
dpc-4547	422	26	,	,	PUNCT
dpc-4547	422	27	hacat	hacat	PROPN
dpc-4547	422	28	.	.	PUNCT
dpc-4547	423	1	cell	cell	NOUN
dpc-4547	423	2	biol	biol	PROPN
dpc-4547	423	3	int	int	NOUN
dpc-4547	423	4	.	.	PUNCT
dpc-4547	424	1	2008;32(11):1405	2008;32(11):1405	NUM
dpc-4547	424	2	-	-	SYM
dpc-4547	424	3	11	11	NUM
dpc-4547	424	4	.	.	X
dpc-4547	425	1	24	24	NUM
dpc-4547	425	2	.	.	PUNCT
dpc-4547	425	3	yarosh	yarosh	PROPN
dpc-4547	426	1	db	db	PROPN
dpc-4547	426	2	.	.	PROPN
dpc-4547	426	3	dna	dna	PROPN
dpc-4547	426	4	repair	repair	NOUN
dpc-4547	426	5	,	,	PUNCT
dpc-4547	426	6	immunosuppression	immunosuppression	NOUN
dpc-4547	426	7	,	,	PUNCT
dpc-4547	426	8	and	and	CCONJ
dpc-4547	426	9	skin	skin	NOUN
dpc-4547	426	10	cancer	cancer	NOUN
dpc-4547	426	11	.	.	PUNCT
dpc-4547	427	1	cutis	cutis	NOUN
dpc-4547	427	2	.	.	PUNCT
dpc-4547	428	1	2004;74(5	2004;74(5	NUM
dpc-4547	428	2	suppl):10	suppl):10	PROPN
dpc-4547	428	3	-	-	PUNCT
dpc-4547	428	4	3	3	NUM
dpc-4547	428	5	.	.	NUM
dpc-4547	428	6	25	25	NUM
dpc-4547	428	7	.	.	PUNCT
dpc-4547	429	1	meyskens	meyskens	PROPN
dpc-4547	429	2	fl	fl	PROPN
dpc-4547	429	3	,	,	PUNCT
dpc-4547	429	4	jr	jr	PROPN
dpc-4547	429	5	.	.	PROPN
dpc-4547	429	6	,	,	PUNCT
dpc-4547	429	7	farmer	farmer	NOUN
dpc-4547	429	8	p	p	NOUN
dpc-4547	429	9	,	,	PUNCT
dpc-4547	429	10	fruehauf	fruehauf	PROPN
dpc-4547	429	11	jp	jp	PROPN
dpc-4547	429	12	.	.	PUNCT
dpc-4547	430	1	redox	redox	ADJ
dpc-4547	430	2	regulation	regulation	NOUN
dpc-4547	430	3	in	in	ADP
dpc-4547	430	4	human	human	ADJ
dpc-4547	430	5	melanocytes	melanocyte	NOUN
dpc-4547	430	6	and	and	CCONJ
dpc-4547	430	7	melanoma	melanoma	NOUN
dpc-4547	430	8	.	.	PUNCT
dpc-4547	431	1	pigment	pigment	NOUN
dpc-4547	431	2	cell	cell	NOUN
dpc-4547	431	3	res	re	NOUN
dpc-4547	431	4	.	.	PUNCT
dpc-4547	432	1	2001	2001	NUM
dpc-4547	432	2	;	;	PUNCT
dpc-4547	432	3	14(3):148	14(3):148	NUM
dpc-4547	432	4	-	-	SYM
dpc-4547	432	5	54	54	NUM
dpc-4547	432	6	.	.	NUM
dpc-4547	433	1	26	26	NUM
dpc-4547	433	2	.	.	PUNCT
dpc-4547	433	3	agar	agar	NOUN
dpc-4547	433	4	ns	ns	PROPN
dpc-4547	433	5	,	,	PUNCT
dpc-4547	433	6	halliday	halliday	PROPN
dpc-4547	433	7	gm	gm	PROPN
dpc-4547	433	8	,	,	PUNCT
dpc-4547	433	9	barnetson	barnetson	NOUN
dpc-4547	433	10	rs	rs	NOUN
dpc-4547	433	11	,	,	PUNCT
dpc-4547	433	12	ananthaswamy	ananthaswamy	VERB
dpc-4547	433	13	hn	hn	PROPN
dpc-4547	433	14	,	,	PUNCT
dpc-4547	433	15	wheeler	wheeler	NOUN
dpc-4547	433	16	m	m	PROPN
dpc-4547	433	17	,	,	PUNCT
dpc-4547	433	18	jones	jones	PROPN
dpc-4547	433	19	am	be	AUX
dpc-4547	433	20	.	.	PUNCT
dpc-4547	434	1	the	the	DET
dpc-4547	434	2	basal	basal	ADJ
dpc-4547	434	3	layer	layer	NOUN
dpc-4547	434	4	in	in	ADP
dpc-4547	434	5	human	human	ADJ
dpc-4547	434	6	squamous	squamous	ADJ
dpc-4547	434	7	tumors	tumor	NOUN
dpc-4547	434	8	harbors	harbor	VERB
dpc-4547	434	9	more	more	ADJ
dpc-4547	434	10	uva	uva	NOUN
dpc-4547	434	11	than	than	ADP
dpc-4547	434	12	uvb	uvb	ADJ
dpc-4547	434	13	fingerprint	fingerprint	NOUN
dpc-4547	434	14	mutations	mutation	NOUN
dpc-4547	434	15	:	:	PUNCT
dpc-4547	434	16	a	a	DET
dpc-4547	434	17	role	role	NOUN
dpc-4547	434	18	for	for	ADP
dpc-4547	434	19	uva	uva	PROPN
dpc-4547	434	20	in	in	ADP
dpc-4547	434	21	human	human	ADJ
dpc-4547	434	22	skin	skin	NOUN
dpc-4547	434	23	carcinogenesis	carcinogenesis	NOUN
dpc-4547	434	24	.	.	PUNCT
dpc-4547	435	1	proc	proc	PROPN
dpc-4547	435	2	natl	natl	PROPN
dpc-4547	435	3	acad	acad	PROPN
dpc-4547	435	4	sci	sci	PROPN
dpc-4547	435	5	u	u	PROPN
dpc-4547	435	6	s	s	NOUN
dpc-4547	435	7	a.	a.	NOUN
dpc-4547	435	8	2004;101(14):4954	2004;101(14):4954	NUM
dpc-4547	435	9	-	-	SYM
dpc-4547	435	10	9	9	NUM
dpc-4547	435	11	.	.	NOUN
dpc-4547	435	12	27	27	NUM
dpc-4547	435	13	.	.	PUNCT
dpc-4547	436	1	queille	queille	PROPN
dpc-4547	436	2	s	s	PROPN
dpc-4547	436	3	,	,	PUNCT
dpc-4547	436	4	luron	luron	PROPN
dpc-4547	436	5	l	l	NOUN
dpc-4547	436	6	,	,	PUNCT
dpc-4547	436	7	spatz	spatz	PROPN
dpc-4547	436	8	a	a	PROPN
dpc-4547	436	9	,	,	PUNCT
dpc-4547	436	10	et	et	PROPN
dpc-4547	436	11	al	al	PROPN
dpc-4547	436	12	.	.	PUNCT
dpc-4547	437	1	analysis	analysis	NOUN
dpc-4547	437	2	of	of	ADP
dpc-4547	437	3	skin	skin	NOUN
dpc-4547	437	4	cancer	cancer	NOUN
dpc-4547	437	5	risk	risk	NOUN
dpc-4547	437	6	factors	factor	NOUN
dpc-4547	437	7	in	in	ADP
dpc-4547	437	8	immunosuppressed	immunosuppressed	ADJ
dpc-4547	437	9	renal	renal	ADJ
dpc-4547	437	10	transplant	transplant	NOUN
dpc-4547	437	11	patients	patient	NOUN
dpc-4547	437	12	shows	show	VERB
dpc-4547	437	13	high	high	ADJ
dpc-4547	437	14	levels	level	NOUN
dpc-4547	437	15	of	of	ADP
dpc-4547	437	16	uv	uv	NOUN
dpc-4547	437	17	-	-	PUNCT
dpc-4547	437	18	specific	specific	ADJ
dpc-4547	437	19	tandem	tandem	NOUN
dpc-4547	437	20	cc	cc	NOUN
dpc-4547	437	21	to	to	ADP
dpc-4547	437	22	tt	tt	PROPN
dpc-4547	437	23	mutations	mutation	NOUN
dpc-4547	437	24	of	of	ADP
dpc-4547	437	25	the	the	DET
dpc-4547	437	26	p53	p53	NOUN
dpc-4547	437	27	gene	gene	NOUN
dpc-4547	437	28	.	.	PUNCT
dpc-4547	438	1	carcinogenesis	carcinogenesis	NOUN
dpc-4547	438	2	.	.	PUNCT
dpc-4547	439	1	2007;28(3):724	2007;28(3):724	NUM
dpc-4547	439	2	-	-	SYM
dpc-4547	439	3	31	31	NUM
dpc-4547	439	4	.	.	PUNCT
dpc-4547	440	1	28	28	NUM
dpc-4547	440	2	.	.	PUNCT
dpc-4547	441	1	heerfordt	heerfordt	PROPN
dpc-4547	441	2	i	i	PRON
dpc-4547	441	3	m	m	PROPN
dpc-4547	441	4	,	,	PUNCT
dpc-4547	441	5	nissen	nissen	PROPN
dpc-4547	441	6	cv	cv	PROPN
dpc-4547	441	7	,	,	PUNCT
dpc-4547	441	8	poulsen	poulsen	VERB
dpc-4547	441	9	t	t	PROPN
dpc-4547	441	10	,	,	PUNCT
dpc-4547	441	11	philipsen	philipsen	PROPN
dpc-4547	441	12	pa	pa	PROPN
dpc-4547	441	13	,	,	PUNCT
dpc-4547	441	14	wulf	wulf	PROPN
dpc-4547	441	15	hc	hc	PROPN
dpc-4547	441	16	.	.	PROPN
dpc-4547	441	17	thickness	thickness	NOUN
dpc-4547	441	18	of	of	ADP
dpc-4547	441	19	actinic	actinic	ADJ
dpc-4547	441	20	keratosis	keratosis	NOUN
dpc-4547	441	21	does	do	AUX
dpc-4547	441	22	not	not	PART
dpc-4547	441	23	predict	predict	VERB
dpc-4547	441	24	dysplasia	dysplasia	NOUN
dpc-4547	441	25	severity	severity	NOUN
dpc-4547	441	26	or	or	CCONJ
dpc-4547	441	27	p53	p53	NOUN
dpc-4547	441	28	expression	expression	NOUN
dpc-4547	441	29	.	.	PUNCT
dpc-4547	442	1	sci	sci	PROPN
dpc-4547	442	2	rep	rep	PROPN
dpc-4547	442	3	.	.	PROPN
dpc-4547	442	4	2016;6:33952	2016;6:33952	NOUN
dpc-4547	442	5	.	.	PUNCT
dpc-4547	443	1	29	29	NUM
dpc-4547	443	2	.	.	PUNCT
dpc-4547	444	1	kuchel	kuchel	PROPN
dpc-4547	444	2	jm	jm	PROPN
dpc-4547	444	3	,	,	PUNCT
dpc-4547	444	4	barnetson	barnetson	NOUN
dpc-4547	444	5	rs	rs	PROPN
dpc-4547	444	6	,	,	PUNCT
dpc-4547	444	7	halliday	halliday	PROPN
dpc-4547	444	8	gm	gm	PROPN
dpc-4547	444	9	.	.	PUNCT
dpc-4547	445	1	cyclobutane	cyclobutane	PROPN
dpc-4547	445	2	pyrimidine	pyrimidine	NOUN
dpc-4547	445	3	dimer	dimer	NOUN
dpc-4547	445	4	formation	formation	NOUN
dpc-4547	445	5	is	be	AUX
dpc-4547	445	6	a	a	DET
dpc-4547	445	7	molecular	molecular	ADJ
dpc-4547	445	8	trigger	trigger	NOUN
dpc-4547	445	9	for	for	ADP
dpc-4547	445	10	solar	solar	NOUN
dpc-4547	445	11	-	-	PUNCT
dpc-4547	445	12	simulated	simulate	VERB
dpc-4547	445	13	•	•	NOUN
dpc-4547	445	14	guidelines	guideline	NOUN
dpc-4547	445	15	suggest	suggest	AUX
dpc-4547	445	16	treating	treat	VERB
dpc-4547	445	17	every	every	DET
dpc-4547	445	18	single	single	ADJ
dpc-4547	445	19	ak	ak	PROPN
dpc-4547	445	20	lesion	lesion	NOUN
dpc-4547	445	21	independently	independently	ADV
dpc-4547	445	22	from	from	ADP
dpc-4547	445	23	severity	severity	NOUN
dpc-4547	445	24	of	of	ADP
dpc-4547	445	25	clinical	clinical	ADJ
dpc-4547	445	26	appearance	appearance	NOUN
dpc-4547	445	27	.	.	PUNCT
dpc-4547	446	1	patients	patient	NOUN
dpc-4547	446	2	with	with	ADP
dpc-4547	446	3	ak	ak	PROPN
dpc-4547	446	4	may	may	AUX
dpc-4547	446	5	benefit	benefit	VERB
dpc-4547	446	6	from	from	ADP
dpc-4547	446	7	a	a	DET
dpc-4547	446	8	close	close	ADJ
dpc-4547	446	9	follow	follow	NOUN
dpc-4547	446	10	-	-	PUNCT
dpc-4547	446	11	up	up	NOUN
dpc-4547	446	12	to	to	PART
dpc-4547	446	13	strengthen	strengthen	VERB
dpc-4547	446	14	therapy	therapy	NOUN
dpc-4547	446	15	adherence	adherence	NOUN
dpc-4547	446	16	.	.	PUNCT
dpc-4547	447	1	•	•	NUM
dpc-4547	447	2	patients	patient	NOUN
dpc-4547	447	3	with	with	ADP
dpc-4547	447	4	ak	ak	PROPN
dpc-4547	447	5	and	and	CCONJ
dpc-4547	447	6	field	field	NOUN
dpc-4547	447	7	cancerization	cancerization	NOUN
dpc-4547	447	8	and/	and/	NOUN
dpc-4547	447	9	or	or	CCONJ
dpc-4547	447	10	immunosuppression	immunosuppression	NOUN
dpc-4547	447	11	are	be	AUX
dpc-4547	447	12	highly	highly	ADV
dpc-4547	447	13	vulnerable	vulnerable	ADJ
dpc-4547	447	14	subgroups	subgroup	NOUN
dpc-4547	447	15	who	who	PRON
dpc-4547	447	16	benefit	benefit	VERB
dpc-4547	447	17	from	from	ADP
dpc-4547	447	18	close	close	ADJ
dpc-4547	447	19	skin	skin	NOUN
dpc-4547	447	20	cancer	cancer	NOUN
dpc-4547	447	21	screening	screening	NOUN
dpc-4547	447	22	,	,	PUNCT
dpc-4547	447	23	early	early	ADV
dpc-4547	447	24	adequate	adequate	ADJ
dpc-4547	447	25	treatment	treatment	NOUN
dpc-4547	447	26	,	,	PUNCT
dpc-4547	447	27	and	and	CCONJ
dpc-4547	447	28	chemoprevention	chemoprevention	NOUN
dpc-4547	447	29	.	.	PUNCT
dpc-4547	448	1	•	•	NOUN
dpc-4547	448	2	skin	skin	NOUN
dpc-4547	448	3	cancer	cancer	NOUN
dpc-4547	448	4	prevention	prevention	NOUN
dpc-4547	448	5	is	be	AUX
dpc-4547	448	6	substantial	substantial	ADJ
dpc-4547	448	7	.	.	PUNCT
dpc-4547	449	1	primary	primary	ADJ
dpc-4547	449	2	prevention	prevention	NOUN
dpc-4547	449	3	should	should	AUX
dpc-4547	449	4	include	include	VERB
dpc-4547	449	5	chemical	chemical	NOUN
dpc-4547	449	6	and	and	CCONJ
dpc-4547	449	7	physical	physical	ADJ
dpc-4547	449	8	uv	uv	NOUN
dpc-4547	449	9	-	-	PUNCT
dpc-4547	449	10	light	light	NOUN
dpc-4547	449	11	protection	protection	NOUN
dpc-4547	449	12	and	and	CCONJ
dpc-4547	449	13	avoidance	avoidance	NOUN
dpc-4547	449	14	of	of	ADP
dpc-4547	449	15	indoor	indoor	ADJ
dpc-4547	449	16	tanning	tanning	NOUN
dpc-4547	449	17	.	.	PUNCT
dpc-4547	450	1	secondary	secondary	ADJ
dpc-4547	450	2	prevention	prevention	NOUN
dpc-4547	450	3	is	be	AUX
dpc-4547	450	4	essential	essential	ADJ
dpc-4547	450	5	in	in	ADP
dpc-4547	450	6	high	high	ADJ
dpc-4547	450	7	-	-	PUNCT
dpc-4547	450	8	risk	risk	NOUN
dpc-4547	450	9	populations	population	NOUN
dpc-4547	450	10	,	,	PUNCT
dpc-4547	450	11	such	such	ADJ
dpc-4547	450	12	as	as	ADP
dpc-4547	450	13	fair	fair	ADJ
dpc-4547	450	14	skin	skin	NOUN
dpc-4547	450	15	type	type	NOUN
dpc-4547	450	16	elderly	elderly	ADJ
dpc-4547	450	17	men	man	NOUN
dpc-4547	450	18	and	and	CCONJ
dpc-4547	450	19	stors	stor	NOUN
dpc-4547	450	20	.	.	PUNCT
dpc-4547	451	1	tertiary	tertiary	ADJ
dpc-4547	451	2	prevention	prevention	NOUN
dpc-4547	451	3	should	should	AUX
dpc-4547	451	4	comprise	comprise	VERB
dpc-4547	451	5	adequate	adequate	ADJ
dpc-4547	451	6	treatment	treatment	NOUN
dpc-4547	451	7	strategies	strategy	NOUN
dpc-4547	451	8	to	to	PART
dpc-4547	451	9	prevent	prevent	VERB
dpc-4547	451	10	therapy	therapy	NOUN
dpc-4547	451	11	resistance	resistance	NOUN
dpc-4547	451	12	,	,	PUNCT
dpc-4547	451	13	reoccurrence	reoccurrence	NOUN
dpc-4547	451	14	and	and	CCONJ
dpc-4547	451	15	cscc	cscc	ADJ
dpc-4547	451	16	development	development	NOUN
dpc-4547	451	17	,	,	PUNCT
dpc-4547	451	18	especially	especially	ADV
dpc-4547	451	19	when	when	SCONJ
dpc-4547	451	20	field	field	NOUN
dpc-4547	451	21	cancerization	cancerization	NOUN
dpc-4547	451	22	and	and	CCONJ
dpc-4547	451	23	immunosuppression	immunosuppression	NOUN
dpc-4547	451	24	are	be	AUX
dpc-4547	451	25	present	present	ADJ
dpc-4547	451	26	.	.	PUNCT
dpc-4547	452	1	references	reference	NOUN
dpc-4547	452	2	1	1	NUM
dpc-4547	452	3	.	.	PUNCT
dpc-4547	452	4	thamm	thamm	PROPN
dpc-4547	452	5	jr	jr	PROPN
dpc-4547	452	6	,	,	PUNCT
dpc-4547	452	7	welzel	welzel	PROPN
dpc-4547	452	8	j	j	PROPN
dpc-4547	452	9	,	,	PUNCT
dpc-4547	452	10	schuh	schuh	PROPN
dpc-4547	452	11	s.	s.	PROPN
dpc-4547	452	12	diagnosis	diagnosis	PROPN
dpc-4547	452	13	and	and	CCONJ
dpc-4547	452	14	therapy	therapy	NOUN
dpc-4547	452	15	of	of	ADP
dpc-4547	452	16	actinic	actinic	ADJ
dpc-4547	452	17	keratosis	keratosis	NOUN
dpc-4547	452	18	.	.	PUNCT
dpc-4547	453	1	j	j	PROPN
dpc-4547	453	2	dtsch	dtsch	PROPN
dpc-4547	453	3	dermatol	dermatol	NOUN
dpc-4547	453	4	ges	ge	NOUN
dpc-4547	453	5	.	.	PROPN
dpc-4547	453	6	2024	2024	NUM
dpc-4547	453	7	.	.	PUNCT
dpc-4547	454	1	2	2	X
dpc-4547	454	2	.	.	X
dpc-4547	454	3	yaldiz	yaldiz	PROPN
dpc-4547	454	4	m.	m.	NOUN
dpc-4547	454	5	prevalence	prevalence	NOUN
dpc-4547	454	6	of	of	ADP
dpc-4547	454	7	actinic	actinic	ADJ
dpc-4547	454	8	keratosis	keratosis	NOUN
dpc-4547	454	9	in	in	ADP
dpc-4547	454	10	patients	patient	NOUN
dpc-4547	454	11	attending	attend	VERB
dpc-4547	454	12	the	the	DET
dpc-4547	454	13	dermatology	dermatology	NOUN
dpc-4547	454	14	outpatient	outpatient	NOUN
dpc-4547	454	15	clinic	clinic	NOUN
dpc-4547	454	16	.	.	PUNCT
dpc-4547	455	1	medicine	medicine	NOUN
dpc-4547	455	2	(	(	PUNCT
dpc-4547	455	3	baltimore	baltimore	PROPN
dpc-4547	455	4	)	)	PUNCT
dpc-4547	455	5	.	.	PUNCT
dpc-4547	456	1	2019;98(28):e16465	2019;98(28):e16465	ADJ
dpc-4547	456	2	.	.	PUNCT
dpc-4547	457	1	3	3	X
dpc-4547	457	2	.	.	X
dpc-4547	457	3	schafer	schafer	PROPN
dpc-4547	457	4	i	i	PROPN
dpc-4547	457	5	,	,	PUNCT
dpc-4547	457	6	reusch	reusch	PROPN
dpc-4547	457	7	m	m	PROPN
dpc-4547	457	8	,	,	PUNCT
dpc-4547	457	9	siebert	siebert	PROPN
dpc-4547	457	10	j	j	PROPN
dpc-4547	457	11	,	,	PUNCT
dpc-4547	457	12	spehr	spehr	PROPN
dpc-4547	457	13	c	c	PROPN
dpc-4547	457	14	,	,	PUNCT
dpc-4547	457	15	augustin	augustin	PROPN
dpc-4547	457	16	m.	m.	PROPN
dpc-4547	457	17	health	health	PROPN
dpc-4547	457	18	care	care	PROPN
dpc-4547	457	19	characteristics	characteristic	NOUN
dpc-4547	457	20	of	of	ADP
dpc-4547	457	21	basal	basal	ADJ
dpc-4547	457	22	cell	cell	NOUN
dpc-4547	457	23	carcinoma	carcinoma	NOUN
dpc-4547	457	24	in	in	ADP
dpc-4547	457	25	germany	germany	PROPN
dpc-4547	457	26	:	:	PUNCT
dpc-4547	457	27	the	the	DET
dpc-4547	457	28	role	role	NOUN
dpc-4547	457	29	of	of	ADP
dpc-4547	457	30	insurance	insurance	NOUN
dpc-4547	457	31	status	status	NOUN
dpc-4547	457	32	and	and	CCONJ
dpc-4547	457	33	socio	socio	NOUN
dpc-4547	457	34	-	-	ADJ
dpc-4547	457	35	demographic	demographic	ADJ
dpc-4547	457	36	factors	factor	NOUN
dpc-4547	457	37	.	.	PUNCT
dpc-4547	458	1	j	j	NOUN
dpc-4547	458	2	dtsch	dtsch	PROPN
dpc-4547	458	3	dermatol	dermatol	NOUN
dpc-4547	458	4	ges	ge	NOUN
dpc-4547	458	5	.	.	PROPN
dpc-4547	458	6	2014;12(9):803	2014;12(9):803	PROPN
dpc-4547	458	7	-	-	PUNCT
dpc-4547	458	8	11	11	NUM
dpc-4547	458	9	.	.	PUNCT
dpc-4547	458	10	4	4	X
dpc-4547	458	11	.	.	X
dpc-4547	458	12	foote	foote	PROPN
dpc-4547	458	13	ja	ja	PROPN
dpc-4547	458	14	,	,	PUNCT
dpc-4547	458	15	harris	harris	PROPN
dpc-4547	458	16	rb	rb	PROPN
dpc-4547	458	17	,	,	PUNCT
dpc-4547	458	18	giuliano	giuliano	PROPN
dpc-4547	458	19	ar	ar	PROPN
dpc-4547	458	20	,	,	PUNCT
dpc-4547	458	21	et	et	PROPN
dpc-4547	458	22	al	al	PROPN
dpc-4547	458	23	.	.	PUNCT
dpc-4547	458	24	predictors	predictor	NOUN
dpc-4547	458	25	for	for	ADP
dpc-4547	458	26	cutaneous	cutaneous	ADJ
dpc-4547	458	27	basaland	basaland	NOUN
dpc-4547	458	28	squamous	squamous	ADJ
dpc-4547	458	29	-	-	PUNCT
dpc-4547	458	30	cell	cell	NOUN
dpc-4547	458	31	carcinoma	carcinoma	NOUN
dpc-4547	458	32	among	among	ADP
dpc-4547	458	33	actinically	actinically	ADV
dpc-4547	458	34	damaged	damage	VERB
dpc-4547	458	35	adults	adult	NOUN
dpc-4547	458	36	.	.	PUNCT
dpc-4547	459	1	int	int	NOUN
dpc-4547	459	2	j	j	PROPN
dpc-4547	459	3	cancer	cancer	NOUN
dpc-4547	459	4	.	.	PUNCT
dpc-4547	460	1	2001;95(1):7	2001;95(1):7	NUM
dpc-4547	460	2	-	-	SYM
dpc-4547	460	3	11	11	NUM
dpc-4547	460	4	.	.	PUNCT
dpc-4547	461	1	5	5	NUM
dpc-4547	461	2	.	.	NOUN
dpc-4547	461	3	marks	marks	PROPN
dpc-4547	461	4	r	r	NOUN
dpc-4547	461	5	,	,	PUNCT
dpc-4547	461	6	rennie	rennie	PROPN
dpc-4547	461	7	g	g	PROPN
dpc-4547	461	8	,	,	PUNCT
dpc-4547	461	9	selwood	selwood	NOUN
dpc-4547	461	10	ts	ts	PROPN
dpc-4547	461	11	.	.	PUNCT
dpc-4547	461	12	malignant	malignant	ADJ
dpc-4547	461	13	transformation	transformation	NOUN
dpc-4547	461	14	of	of	ADP
dpc-4547	461	15	solar	solar	ADJ
dpc-4547	461	16	keratoses	keratose	NOUN
dpc-4547	461	17	to	to	ADP
dpc-4547	461	18	squamous	squamous	ADJ
dpc-4547	461	19	cell	cell	NOUN
dpc-4547	461	20	carcinoma	carcinoma	NOUN
dpc-4547	461	21	.	.	PUNCT
dpc-4547	462	1	lancet	lancet	PROPN
dpc-4547	462	2	.	.	PUNCT
dpc-4547	463	1	1988	1988	NUM
dpc-4547	463	2	;	;	PUNCT
dpc-4547	463	3	1(8589):795	1(8589):795	NUM
dpc-4547	463	4	-	-	SYM
dpc-4547	463	5	7	7	NUM
dpc-4547	463	6	.	.	NOUN
dpc-4547	463	7	6	6	NUM
dpc-4547	463	8	.	.	PUNCT
dpc-4547	463	9	quaedvlieg	quaedvlieg	PROPN
dpc-4547	463	10	pj	pj	PROPN
dpc-4547	463	11	,	,	PUNCT
dpc-4547	463	12	tirsi	tirsi	NOUN
dpc-4547	463	13	e	e	NOUN
dpc-4547	463	14	,	,	PUNCT
dpc-4547	463	15	thissen	thissen	VERB
dpc-4547	463	16	mr	mr	PROPN
dpc-4547	463	17	,	,	PUNCT
dpc-4547	463	18	krekels	krekels	PROPN
dpc-4547	463	19	ga	ga	PROPN
dpc-4547	463	20	.	.	PROPN
dpc-4547	463	21	actinic	actinic	ADJ
dpc-4547	463	22	keratosis	keratosis	NOUN
dpc-4547	463	23	:	:	PUNCT
dpc-4547	464	1	how	how	SCONJ
dpc-4547	464	2	to	to	PART
dpc-4547	464	3	differentiate	differentiate	VERB
dpc-4547	464	4	the	the	DET
dpc-4547	464	5	good	good	NOUN
dpc-4547	464	6	from	from	ADP
dpc-4547	464	7	the	the	DET
dpc-4547	464	8	bad	bad	ADJ
dpc-4547	464	9	ones	one	NOUN
dpc-4547	464	10	?	?	PUNCT
dpc-4547	465	1	eur	eur	PROPN
dpc-4547	465	2	j	j	PROPN
dpc-4547	465	3	dermatol	dermatol	NOUN
dpc-4547	465	4	.	.	PUNCT
dpc-4547	466	1	2006;16(4):335	2006;16(4):335	NUM
dpc-4547	466	2	-	-	SYM
dpc-4547	466	3	9	9	NUM
dpc-4547	466	4	.	.	NOUN
dpc-4547	466	5	7	7	NUM
dpc-4547	466	6	.	.	PUNCT
dpc-4547	466	7	steeb	steeb	PROPN
dpc-4547	466	8	t	t	PROPN
dpc-4547	466	9	,	,	PUNCT
dpc-4547	466	10	wessely	wessely	ADV
dpc-4547	466	11	a	a	PRON
dpc-4547	466	12	,	,	PUNCT
dpc-4547	466	13	petzold	petzold	NOUN
dpc-4547	466	14	a	a	PRON
dpc-4547	466	15	,	,	PUNCT
dpc-4547	466	16	et	et	PROPN
dpc-4547	466	17	al	al	PROPN
dpc-4547	466	18	.	.	PUNCT
dpc-4547	466	19	long	long	ADJ
dpc-4547	466	20	-	-	PUNCT
dpc-4547	466	21	term	term	NOUN
dpc-4547	466	22	recurrence	recurrence	NOUN
dpc-4547	466	23	rates	rate	NOUN
dpc-4547	466	24	of	of	ADP
dpc-4547	466	25	actinic	actinic	ADJ
dpc-4547	466	26	keratosis	keratosis	NOUN
dpc-4547	466	27	:	:	PUNCT
dpc-4547	466	28	a	a	DET
dpc-4547	466	29	systematic	systematic	ADJ
dpc-4547	466	30	review	review	NOUN
dpc-4547	466	31	and	and	CCONJ
dpc-4547	466	32	pooled	pool	VERB
dpc-4547	466	33	analysis	analysis	NOUN
dpc-4547	466	34	of	of	ADP
dpc-4547	466	35	randomized	randomized	ADJ
dpc-4547	466	36	controlled	control	VERB
dpc-4547	466	37	trials	trial	NOUN
dpc-4547	466	38	.	.	PUNCT
dpc-4547	467	1	j	j	PROPN
dpc-4547	467	2	am	be	AUX
dpc-4547	467	3	acad	acad	ADJ
dpc-4547	467	4	dermatol	dermatol	NOUN
dpc-4547	467	5	.	.	PUNCT
dpc-4547	468	1	2022	2022	NUM
dpc-4547	468	2	;	;	PUNCT
dpc-4547	468	3	86(5):1116	86(5):1116	NUM
dpc-4547	468	4	-	-	SYM
dpc-4547	468	5	9	9	NUM
dpc-4547	468	6	.	.	NOUN
dpc-4547	468	7	8	8	NUM
dpc-4547	468	8	.	.	PUNCT
dpc-4547	469	1	lim	lim	PROPN
dpc-4547	469	2	hw	hw	PROPN
dpc-4547	469	3	,	,	PUNCT
dpc-4547	469	4	collins	collins	PROPN
dpc-4547	469	5	sab	sab	PROPN
dpc-4547	469	6	,	,	PUNCT
dpc-4547	469	7	resneck	resneck	NOUN
dpc-4547	469	8	js	js	PROPN
dpc-4547	469	9	,	,	PUNCT
dpc-4547	469	10	jr	jr	PROPN
dpc-4547	469	11	.	.	PROPN
dpc-4547	469	12	,	,	PUNCT
dpc-4547	469	13	et	et	PROPN
dpc-4547	469	14	al	al	PROPN
dpc-4547	469	15	.	.	PUNCT
dpc-4547	470	1	the	the	DET
dpc-4547	470	2	burden	burden	NOUN
dpc-4547	470	3	of	of	ADP
dpc-4547	470	4	skin	skin	NOUN
dpc-4547	470	5	disease	disease	NOUN
dpc-4547	470	6	in	in	ADP
dpc-4547	470	7	the	the	DET
dpc-4547	470	8	united	united	PROPN
dpc-4547	470	9	states	states	PROPN
dpc-4547	470	10	.	.	PUNCT
dpc-4547	471	1	j	j	PROPN
dpc-4547	471	2	am	be	AUX
dpc-4547	471	3	acad	acad	ADJ
dpc-4547	471	4	dermatol	dermatol	NOUN
dpc-4547	471	5	.	.	PUNCT
dpc-4547	472	1	2017;76(5	2017;76(5	NUM
dpc-4547	472	2	):	):	PUNCT
dpc-4547	472	3	958	958	NUM
dpc-4547	472	4	-	-	SYM
dpc-4547	472	5	72	72	NUM
dpc-4547	472	6	e2	e2	NOUN
dpc-4547	472	7	.	.	PUNCT
dpc-4547	473	1	9	9	NUM
dpc-4547	473	2	.	.	X
dpc-4547	473	3	kirby	kirby	PROPN
dpc-4547	473	4	js	js	PROPN
dpc-4547	473	5	,	,	PUNCT
dpc-4547	473	6	gregory	gregory	PROPN
dpc-4547	473	7	t	t	PROPN
dpc-4547	473	8	,	,	PUNCT
dpc-4547	473	9	liu	liu	PROPN
dpc-4547	473	10	g	g	PROPN
dpc-4547	473	11	,	,	PUNCT
dpc-4547	473	12	leslie	leslie	PROPN
dpc-4547	473	13	dl	dl	PROPN
dpc-4547	473	14	,	,	PUNCT
dpc-4547	473	15	miller	miller	PROPN
dpc-4547	473	16	jj	jj	PROPN
dpc-4547	473	17	.	.	PROPN
dpc-4547	473	18	variation	variation	NOUN
dpc-4547	473	19	in	in	ADP
dpc-4547	473	20	the	the	DET
dpc-4547	473	21	cost	cost	NOUN
dpc-4547	473	22	of	of	ADP
dpc-4547	473	23	managing	manage	VERB
dpc-4547	473	24	actinic	actinic	ADJ
dpc-4547	473	25	keratosis	keratosis	NOUN
dpc-4547	473	26	.	.	PUNCT
dpc-4547	474	1	jama	jama	PROPN
dpc-4547	474	2	dermatol	dermatol	NOUN
dpc-4547	474	3	.	.	PUNCT
dpc-4547	475	1	2017;153(4):264	2017;153(4):264	NUM
dpc-4547	475	2	-	-	SYM
dpc-4547	475	3	9	9	NUM
dpc-4547	475	4	.	.	NOUN
dpc-4547	475	5	10	10	NUM
dpc-4547	475	6	.	.	PUNCT
dpc-4547	476	1	housman	housman	PROPN
dpc-4547	476	2	ts	ts	PROPN
dpc-4547	476	3	,	,	PUNCT
dpc-4547	476	4	feldman	feldman	PROPN
dpc-4547	476	5	sr	sr	PROPN
dpc-4547	476	6	,	,	PUNCT
dpc-4547	476	7	williford	williford	PROPN
dpc-4547	476	8	pm	pm	PROPN
dpc-4547	476	9	,	,	PUNCT
dpc-4547	476	10	et	et	PROPN
dpc-4547	476	11	al	al	PROPN
dpc-4547	476	12	.	.	PROPN
dpc-4547	477	1	skin	skin	NOUN
dpc-4547	477	2	cancer	cancer	NOUN
dpc-4547	477	3	is	be	AUX
dpc-4547	477	4	among	among	ADP
dpc-4547	477	5	the	the	DET
dpc-4547	477	6	most	most	ADV
dpc-4547	477	7	costly	costly	ADJ
dpc-4547	477	8	of	of	ADP
dpc-4547	477	9	all	all	DET
dpc-4547	477	10	cancers	cancer	NOUN
dpc-4547	477	11	to	to	PART
dpc-4547	477	12	treat	treat	VERB
dpc-4547	477	13	for	for	ADP
dpc-4547	477	14	the	the	DET
dpc-4547	477	15	medicare	medicare	PROPN
dpc-4547	477	16	population	population	NOUN
dpc-4547	477	17	.	.	PUNCT
dpc-4547	478	1	j	j	PROPN
dpc-4547	478	2	am	be	AUX
dpc-4547	478	3	acad	acad	ADJ
dpc-4547	478	4	dermatol	dermatol	NOUN
dpc-4547	478	5	.	.	PUNCT
dpc-4547	479	1	2003;48(3):425	2003;48(3):425	NUM
dpc-4547	479	2	-	-	SYM
dpc-4547	479	3	9	9	NUM
dpc-4547	479	4	.	.	NOUN
dpc-4547	479	5	11	11	NUM
dpc-4547	479	6	.	.	PUNCT
dpc-4547	480	1	heppt	heppt	ADJ
dpc-4547	480	2	mv	mv	PROPN
dpc-4547	480	3	,	,	PUNCT
dpc-4547	480	4	leiter	leiter	PROPN
dpc-4547	480	5	u	u	PROPN
dpc-4547	480	6	,	,	PUNCT
dpc-4547	480	7	steeb	steeb	PROPN
dpc-4547	480	8	t	t	PROPN
dpc-4547	480	9	,	,	PUNCT
dpc-4547	480	10	et	et	PROPN
dpc-4547	480	11	al	al	PROPN
dpc-4547	480	12	.	.	PUNCT
dpc-4547	481	1	s3	s3	PROPN
dpc-4547	481	2	guideline	guideline	NOUN
dpc-4547	481	3	for	for	ADP
dpc-4547	481	4	actinic	actinic	ADJ
dpc-4547	481	5	keratosis	keratosis	NOUN
dpc-4547	481	6	and	and	CCONJ
dpc-4547	481	7	cutaneous	cutaneous	ADJ
dpc-4547	481	8	squamous	squamous	ADJ
dpc-4547	481	9	cell	cell	NOUN
dpc-4547	481	10	carcinoma	carcinoma	NOUN
dpc-4547	481	11	short	short	ADJ
dpc-4547	481	12	version	version	NOUN
dpc-4547	481	13	,	,	PUNCT
dpc-4547	481	14	part	part	NOUN
dpc-4547	481	15	1	1	NUM
dpc-4547	481	16	:	:	PUNCT
dpc-4547	481	17	diagnosis	diagnosis	NOUN
dpc-4547	481	18	,	,	PUNCT
dpc-4547	481	19	interventions	intervention	NOUN
dpc-4547	481	20	for	for	ADP
dpc-4547	481	21	actinic	actinic	ADJ
dpc-4547	481	22	keratoses	keratose	NOUN
dpc-4547	481	23	,	,	PUNCT
dpc-4547	481	24	care	care	NOUN
dpc-4547	481	25	structures	structure	NOUN
dpc-4547	481	26	and	and	CCONJ
dpc-4547	481	27	quality	quality	NOUN
dpc-4547	481	28	-	-	PUNCT
dpc-4547	481	29	of	of	ADP
dpc-4547	481	30	-	-	PUNCT
dpc-4547	481	31	care	care	NOUN
dpc-4547	481	32	indicators	indicator	NOUN
dpc-4547	481	33	.	.	PUNCT
dpc-4547	482	1	j	j	PROPN
dpc-4547	482	2	dtsch	dtsch	PROPN
dpc-4547	482	3	dermatol	dermatol	NOUN
dpc-4547	482	4	ges	ge	NOUN
dpc-4547	482	5	.	.	PROPN
dpc-4547	482	6	2020;18(3	2020;18(3	NUM
dpc-4547	482	7	):	):	PUNCT
dpc-4547	482	8	275	275	NUM
dpc-4547	482	9	-	-	SYM
dpc-4547	482	10	94	94	NUM
dpc-4547	482	11	.	.	PUNCT
dpc-4547	482	12	12	12	NUM
dpc-4547	482	13	.	.	PUNCT
dpc-4547	483	1	leiter	leiter	PROPN
dpc-4547	483	2	u	u	PROPN
dpc-4547	483	3	,	,	PUNCT
dpc-4547	483	4	keim	keim	PROPN
dpc-4547	483	5	u	u	PROPN
dpc-4547	483	6	,	,	PUNCT
dpc-4547	483	7	eigentler	eigentler	PROPN
dpc-4547	483	8	t	t	PROPN
dpc-4547	483	9	,	,	PUNCT
dpc-4547	483	10	katalinic	katalinic	VERB
dpc-4547	483	11	a	a	DET
dpc-4547	483	12	,	,	PUNCT
dpc-4547	483	13	holleczek	holleczek	PROPN
dpc-4547	483	14	b	b	NOUN
dpc-4547	483	15	,	,	PUNCT
dpc-4547	483	16	martus	martus	X
dpc-4547	483	17	p	p	NOUN
dpc-4547	483	18	,	,	PUNCT
dpc-4547	483	19	garbe	garbe	ADJ
dpc-4547	483	20	c.	c.	PROPN
dpc-4547	483	21	incidence	incidence	PROPN
dpc-4547	483	22	,	,	PUNCT
dpc-4547	483	23	mortality	mortality	NOUN
dpc-4547	483	24	,	,	PUNCT
dpc-4547	483	25	and	and	CCONJ
dpc-4547	483	26	trends	trend	NOUN
dpc-4547	483	27	of	of	ADP
dpc-4547	483	28	nonmelanoma	nonmelanoma	ADJ
dpc-4547	483	29	skin	skin	NOUN
dpc-4547	483	30	cancer	cancer	NOUN
dpc-4547	483	31	in	in	ADP
dpc-4547	483	32	germany	germany	PROPN
dpc-4547	483	33	.	.	PUNCT
dpc-4547	484	1	j	j	PROPN
dpc-4547	484	2	invest	invest	VERB
dpc-4547	484	3	dermatol	dermatol	NOUN
dpc-4547	484	4	.	.	PUNCT
dpc-4547	485	1	2017;137(9):1860	2017;137(9):1860	NUM
dpc-4547	485	2	-	-	SYM
dpc-4547	485	3	7	7	NUM
dpc-4547	485	4	.	.	NOUN
dpc-4547	485	5	12	12	NUM
dpc-4547	485	6	review	review	NOUN
dpc-4547	485	7	|	|	ADV
dpc-4547	485	8	dermatol	dermatol	ADJ
dpc-4547	485	9	pract	pract	NOUN
dpc-4547	485	10	concept	concept	NOUN
dpc-4547	485	11	.	.	PUNCT
dpc-4547	486	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	486	2	:	:	PUNCT
dpc-4547	486	3	e2024146s	e2024146s	ADV
dpc-4547	486	4	46	46	NUM
dpc-4547	486	5	.	.	PUNCT
dpc-4547	487	1	lindelof	lindelof	PROPN
dpc-4547	487	2	b	b	PROPN
dpc-4547	487	3	,	,	PUNCT
dpc-4547	487	4	sigurgeirsson	sigurgeirsson	NOUN
dpc-4547	487	5	b	b	NOUN
dpc-4547	487	6	,	,	PUNCT
dpc-4547	487	7	gabel	gabel	NOUN
dpc-4547	487	8	h	h	NOUN
dpc-4547	487	9	,	,	PUNCT
dpc-4547	487	10	stern	stern	ADJ
dpc-4547	487	11	rs	rs	NOUN
dpc-4547	487	12	.	.	PUNCT
dpc-4547	488	1	incidence	incidence	NOUN
dpc-4547	488	2	of	of	ADP
dpc-4547	488	3	skin	skin	NOUN
dpc-4547	488	4	cancer	cancer	NOUN
dpc-4547	488	5	in	in	ADP
dpc-4547	488	6	5356	5356	NUM
dpc-4547	488	7	patients	patient	NOUN
dpc-4547	488	8	following	follow	VERB
dpc-4547	488	9	organ	organ	NOUN
dpc-4547	488	10	transplantation	transplantation	NOUN
dpc-4547	488	11	.	.	PUNCT
dpc-4547	489	1	br	br	PROPN
dpc-4547	489	2	j	j	PROPN
dpc-4547	489	3	dermatol	dermatol	NOUN
dpc-4547	489	4	.	.	PUNCT
dpc-4547	490	1	2000;143(3):513	2000;143(3):513	NUM
dpc-4547	490	2	-	-	SYM
dpc-4547	490	3	9	9	NUM
dpc-4547	490	4	.	.	X
dpc-4547	491	1	47	47	NUM
dpc-4547	491	2	.	.	PUNCT
dpc-4547	492	1	euvrard	euvrard	PROPN
dpc-4547	492	2	s	s	PROPN
dpc-4547	492	3	,	,	PUNCT
dpc-4547	492	4	kanitakis	kanitakis	PROPN
dpc-4547	492	5	j	j	PROPN
dpc-4547	492	6	,	,	PUNCT
dpc-4547	492	7	pouteil	pouteil	ADJ
dpc-4547	492	8	-	-	PUNCT
dpc-4547	492	9	noble	noble	ADJ
dpc-4547	492	10	c	c	NOUN
dpc-4547	492	11	,	,	PUNCT
dpc-4547	492	12	dureau	dureau	PROPN
dpc-4547	492	13	g	g	PROPN
dpc-4547	492	14	,	,	PUNCT
dpc-4547	492	15	et	et	PROPN
dpc-4547	492	16	al	al	PROPN
dpc-4547	492	17	.	.	PROPN
dpc-4547	493	1	comparative	comparative	ADJ
dpc-4547	493	2	epidemiologic	epidemiologic	ADJ
dpc-4547	493	3	study	study	NOUN
dpc-4547	493	4	of	of	ADP
dpc-4547	493	5	premalignant	premalignant	ADJ
dpc-4547	493	6	and	and	CCONJ
dpc-4547	493	7	malignant	malignant	ADJ
dpc-4547	493	8	epithelial	epithelial	ADJ
dpc-4547	493	9	cutaneous	cutaneous	ADJ
dpc-4547	493	10	lesions	lesion	NOUN
dpc-4547	493	11	developing	develop	VERB
dpc-4547	493	12	after	after	ADP
dpc-4547	493	13	kidney	kidney	NOUN
dpc-4547	493	14	and	and	CCONJ
dpc-4547	493	15	heart	heart	NOUN
dpc-4547	493	16	transplantation	transplantation	NOUN
dpc-4547	493	17	.	.	PUNCT
dpc-4547	494	1	j	j	PROPN
dpc-4547	494	2	am	be	AUX
dpc-4547	494	3	acad	acad	ADJ
dpc-4547	494	4	dermatol	dermatol	NOUN
dpc-4547	494	5	.	.	PUNCT
dpc-4547	495	1	1995;33(2	1995;33(2	NUM
dpc-4547	495	2	pt	pt	NOUN
dpc-4547	495	3	1):222	1):222	NUM
dpc-4547	495	4	-	-	PUNCT
dpc-4547	495	5	9	9	NUM
dpc-4547	495	6	.	.	NUM
dpc-4547	495	7	48	48	NUM
dpc-4547	495	8	.	.	PUNCT
dpc-4547	496	1	marcil	marcil	PROPN
dpc-4547	496	2	i	i	PRON
dpc-4547	496	3	,	,	PUNCT
dpc-4547	496	4	stern	stern	ADJ
dpc-4547	496	5	rs	rs	NOUN
dpc-4547	496	6	.	.	PUNCT
dpc-4547	497	1	risk	risk	NOUN
dpc-4547	497	2	of	of	ADP
dpc-4547	497	3	developing	develop	VERB
dpc-4547	497	4	a	a	DET
dpc-4547	497	5	subsequent	subsequent	ADJ
dpc-4547	497	6	nonmelanoma	nonmelanoma	ADJ
dpc-4547	497	7	skin	skin	NOUN
dpc-4547	497	8	cancer	cancer	NOUN
dpc-4547	497	9	in	in	ADP
dpc-4547	497	10	patients	patient	NOUN
dpc-4547	497	11	with	with	ADP
dpc-4547	497	12	a	a	DET
dpc-4547	497	13	history	history	NOUN
dpc-4547	497	14	of	of	ADP
dpc-4547	497	15	nonmelanoma	nonmelanoma	ADJ
dpc-4547	497	16	skin	skin	NOUN
dpc-4547	497	17	cancer	cancer	NOUN
dpc-4547	497	18	:	:	PUNCT
dpc-4547	497	19	a	a	DET
dpc-4547	497	20	critical	critical	ADJ
dpc-4547	497	21	review	review	NOUN
dpc-4547	497	22	of	of	ADP
dpc-4547	497	23	the	the	DET
dpc-4547	497	24	literature	literature	NOUN
dpc-4547	497	25	and	and	CCONJ
dpc-4547	497	26	meta	meta	ADJ
dpc-4547	497	27	-	-	PUNCT
dpc-4547	497	28	analysis	analysis	NOUN
dpc-4547	497	29	.	.	PUNCT
dpc-4547	498	1	arch	arch	ADJ
dpc-4547	498	2	dermatol	dermatol	NOUN
dpc-4547	498	3	.	.	PUNCT
dpc-4547	499	1	2000;136(12):1524	2000;136(12):1524	NUM
dpc-4547	499	2	-	-	SYM
dpc-4547	499	3	30	30	NUM
dpc-4547	499	4	.	.	PUNCT
dpc-4547	499	5	49	49	NUM
dpc-4547	499	6	.	.	PUNCT
dpc-4547	500	1	harwood	harwood	NOUN
dpc-4547	500	2	ca	ca	PROPN
dpc-4547	500	3	,	,	PUNCT
dpc-4547	500	4	mesher	mesher	NOUN
dpc-4547	500	5	d	d	PROPN
dpc-4547	500	6	,	,	PUNCT
dpc-4547	500	7	mcgregor	mcgregor	PROPN
dpc-4547	500	8	jm	jm	PROPN
dpc-4547	500	9	,	,	PUNCT
dpc-4547	500	10	et	et	PROPN
dpc-4547	500	11	al	al	PROPN
dpc-4547	500	12	.	.	PUNCT
dpc-4547	501	1	a	a	DET
dpc-4547	501	2	surveillance	surveillance	NOUN
dpc-4547	501	3	model	model	NOUN
dpc-4547	501	4	for	for	ADP
dpc-4547	501	5	skin	skin	NOUN
dpc-4547	501	6	cancer	cancer	NOUN
dpc-4547	501	7	in	in	ADP
dpc-4547	501	8	organ	organ	NOUN
dpc-4547	501	9	transplant	transplant	NOUN
dpc-4547	501	10	recipients	recipient	NOUN
dpc-4547	501	11	:	:	PUNCT
dpc-4547	501	12	a	a	DET
dpc-4547	501	13	22	22	NUM
dpc-4547	501	14	-	-	PUNCT
dpc-4547	501	15	year	year	NOUN
dpc-4547	501	16	prospective	prospective	ADJ
dpc-4547	501	17	study	study	NOUN
dpc-4547	501	18	in	in	ADP
dpc-4547	501	19	an	an	DET
dpc-4547	501	20	ethnically	ethnically	ADV
dpc-4547	501	21	diverse	diverse	ADJ
dpc-4547	501	22	population	population	NOUN
dpc-4547	501	23	.	.	PUNCT
dpc-4547	502	1	am	be	AUX
dpc-4547	502	2	j	j	PROPN
dpc-4547	502	3	transplant	transplant	NOUN
dpc-4547	502	4	.	.	PUNCT
dpc-4547	503	1	2013;13(1):119	2013;13(1):119	NUM
dpc-4547	503	2	-	-	SYM
dpc-4547	503	3	29	29	NUM
dpc-4547	503	4	.	.	PUNCT
dpc-4547	504	1	50	50	NUM
dpc-4547	504	2	.	.	PUNCT
dpc-4547	505	1	wallingford	wallingford	PROPN
dpc-4547	505	2	sc	sc	PROPN
dpc-4547	505	3	,	,	PUNCT
dpc-4547	505	4	russell	russell	PROPN
dpc-4547	505	5	sa	sa	PROPN
dpc-4547	505	6	,	,	PUNCT
dpc-4547	505	7	vail	vail	PROPN
dpc-4547	505	8	a	a	PRON
dpc-4547	505	9	,	,	PUNCT
dpc-4547	505	10	proby	proby	ADJ
dpc-4547	505	11	cm	cm	NOUN
dpc-4547	505	12	,	,	PUNCT
dpc-4547	505	13	lear	lear	PROPN
dpc-4547	505	14	jt	jt	PROPN
dpc-4547	505	15	,	,	PUNCT
dpc-4547	505	16	green	green	PROPN
dpc-4547	505	17	ac	ac	PROPN
dpc-4547	505	18	.	.	PUNCT
dpc-4547	505	19	actinic	actinic	ADJ
dpc-4547	505	20	keratoses	keratose	NOUN
dpc-4547	505	21	,	,	PUNCT
dpc-4547	505	22	actinic	actinic	ADJ
dpc-4547	505	23	field	field	NOUN
dpc-4547	505	24	change	change	NOUN
dpc-4547	505	25	and	and	CCONJ
dpc-4547	505	26	associations	association	NOUN
dpc-4547	505	27	with	with	ADP
dpc-4547	505	28	squamous	squamous	ADJ
dpc-4547	505	29	cell	cell	NOUN
dpc-4547	505	30	carcinoma	carcinoma	NOUN
dpc-4547	505	31	in	in	ADP
dpc-4547	505	32	renal	renal	ADJ
dpc-4547	505	33	transplant	transplant	NOUN
dpc-4547	505	34	recipients	recipient	NOUN
dpc-4547	505	35	in	in	ADP
dpc-4547	505	36	manchester	manchester	PROPN
dpc-4547	505	37	,	,	PUNCT
dpc-4547	505	38	uk	uk	PROPN
dpc-4547	505	39	.	.	PROPN
dpc-4547	505	40	acta	acta	PROPN
dpc-4547	505	41	derm	derm	PROPN
dpc-4547	505	42	venereol	venereol	NOUN
dpc-4547	505	43	.	.	PUNCT
dpc-4547	506	1	2015;95(7):830	2015;95(7):830	NOUN
dpc-4547	506	2	-	-	SYM
dpc-4547	506	3	4	4	NUM
dpc-4547	506	4	.	.	NUM
dpc-4547	506	5	51	51	NUM
dpc-4547	506	6	.	.	PUNCT
dpc-4547	507	1	ferrandiz	ferrandiz	PROPN
dpc-4547	507	2	c	c	X
dpc-4547	507	3	,	,	PUNCT
dpc-4547	507	4	fuente	fuente	PROPN
dpc-4547	507	5	mj	mj	PROPN
dpc-4547	507	6	,	,	PUNCT
dpc-4547	507	7	ribera	ribera	PROPN
dpc-4547	507	8	m	m	PROPN
dpc-4547	507	9	,	,	PUNCT
dpc-4547	507	10	bielsa	bielsa	VERB
dpc-4547	507	11	i	i	PRON
dpc-4547	507	12	,	,	PUNCT
dpc-4547	507	13	fernandez	fernandez	PROPN
dpc-4547	507	14	mt	mt	PROPN
dpc-4547	507	15	,	,	PUNCT
dpc-4547	507	16	lauzurica	lauzurica	PROPN
dpc-4547	507	17	r	r	PROPN
dpc-4547	507	18	,	,	PUNCT
dpc-4547	507	19	roca	roca	PROPN
dpc-4547	507	20	j.	j.	PROPN
dpc-4547	507	21	epidermal	epidermal	ADJ
dpc-4547	507	22	dysplasia	dysplasia	NOUN
dpc-4547	507	23	and	and	CCONJ
dpc-4547	507	24	neoplasia	neoplasia	NOUN
dpc-4547	507	25	in	in	ADP
dpc-4547	507	26	kidney	kidney	NOUN
dpc-4547	507	27	transplant	transplant	NOUN
dpc-4547	507	28	recipients	recipient	NOUN
dpc-4547	507	29	.	.	PUNCT
dpc-4547	508	1	j	j	PROPN
dpc-4547	508	2	am	be	AUX
dpc-4547	508	3	acad	acad	ADJ
dpc-4547	508	4	dermatol	dermatol	NOUN
dpc-4547	508	5	.	.	PUNCT
dpc-4547	509	1	1995;33(4):590	1995;33(4):590	NUM
dpc-4547	509	2	-	-	SYM
dpc-4547	509	3	6	6	NUM
dpc-4547	509	4	.	.	NOUN
dpc-4547	509	5	52	52	NUM
dpc-4547	509	6	.	.	PUNCT
dpc-4547	509	7	friman	friman	PROPN
dpc-4547	509	8	tk	tk	PROPN
dpc-4547	509	9	,	,	PUNCT
dpc-4547	509	10	jaamaa	jaamaa	PROPN
dpc-4547	509	11	-	-	PUNCT
dpc-4547	509	12	holmberg	holmberg	PROPN
dpc-4547	509	13	s	s	PROPN
dpc-4547	509	14	,	,	PUNCT
dpc-4547	509	15	aberg	aberg	ADV
dpc-4547	509	16	f	f	X
dpc-4547	509	17	,	,	PUNCT
dpc-4547	509	18	et	et	PROPN
dpc-4547	509	19	al	al	PROPN
dpc-4547	509	20	.	.	PUNCT
dpc-4547	510	1	cancer	cancer	NOUN
dpc-4547	510	2	risk	risk	NOUN
dpc-4547	510	3	and	and	CCONJ
dpc-4547	510	4	mortality	mortality	NOUN
dpc-4547	510	5	after	after	ADP
dpc-4547	510	6	solid	solid	ADJ
dpc-4547	510	7	organ	organ	NOUN
dpc-4547	510	8	transplantation	transplantation	NOUN
dpc-4547	510	9	:	:	PUNCT
dpc-4547	510	10	a	a	DET
dpc-4547	510	11	population	population	NOUN
dpc-4547	510	12	-	-	PUNCT
dpc-4547	510	13	based	base	VERB
dpc-4547	510	14	30	30	NUM
dpc-4547	510	15	-	-	PUNCT
dpc-4547	510	16	year	year	NOUN
dpc-4547	510	17	cohort	cohort	NOUN
dpc-4547	510	18	study	study	NOUN
dpc-4547	510	19	in	in	ADP
dpc-4547	510	20	finland	finland	PROPN
dpc-4547	510	21	.	.	PUNCT
dpc-4547	511	1	int	int	PROPN
dpc-4547	511	2	j	j	PROPN
dpc-4547	511	3	cancer	cancer	NOUN
dpc-4547	511	4	.	.	PUNCT
dpc-4547	512	1	2022;150(11	2022;150(11	NUM
dpc-4547	512	2	):	):	PUNCT
dpc-4547	512	3	1779	1779	NUM
dpc-4547	512	4	-	-	SYM
dpc-4547	512	5	91	91	NUM
dpc-4547	512	6	.	.	PUNCT
dpc-4547	513	1	53	53	NUM
dpc-4547	513	2	.	.	PUNCT
dpc-4547	514	1	rosales	rosales	PROPN
dpc-4547	514	2	bm	bm	PROPN
dpc-4547	514	3	,	,	PUNCT
dpc-4547	514	4	de	de	PROPN
dpc-4547	514	5	la	la	X
dpc-4547	514	6	mata	mata	PROPN
dpc-4547	514	7	n	n	CCONJ
dpc-4547	514	8	,	,	PUNCT
dpc-4547	514	9	vajdic	vajdic	ADJ
dpc-4547	514	10	cm	cm	NOUN
dpc-4547	514	11	,	,	PUNCT
dpc-4547	514	12	kelly	kelly	PROPN
dpc-4547	514	13	pj	pj	PROPN
dpc-4547	514	14	,	,	PUNCT
dpc-4547	514	15	wyburn	wyburn	VERB
dpc-4547	514	16	k	k	PROPN
dpc-4547	514	17	,	,	PUNCT
dpc-4547	514	18	webster	webster	PROPN
dpc-4547	514	19	ac	ac	PROPN
dpc-4547	514	20	.	.	PUNCT
dpc-4547	515	1	cancer	cancer	NOUN
dpc-4547	515	2	mortality	mortality	NOUN
dpc-4547	515	3	in	in	ADP
dpc-4547	515	4	kidney	kidney	NOUN
dpc-4547	515	5	transplant	transplant	NOUN
dpc-4547	515	6	recipients	recipient	NOUN
dpc-4547	515	7	:	:	PUNCT
dpc-4547	515	8	an	an	DET
dpc-4547	515	9	australian	australian	ADJ
dpc-4547	515	10	and	and	CCONJ
dpc-4547	515	11	new	new	PROPN
dpc-4547	515	12	zealand	zealand	PROPN
dpc-4547	515	13	population	population	NOUN
dpc-4547	515	14	-	-	PUNCT
dpc-4547	515	15	based	base	VERB
dpc-4547	515	16	cohort	cohort	NOUN
dpc-4547	515	17	study	study	NOUN
dpc-4547	515	18	,	,	PUNCT
dpc-4547	515	19	1980	1980	NUM
dpc-4547	515	20	-	-	SYM
dpc-4547	515	21	2013	2013	NUM
dpc-4547	515	22	.	.	PUNCT
dpc-4547	516	1	int	int	NOUN
dpc-4547	516	2	j	j	PROPN
dpc-4547	516	3	cancer	cancer	NOUN
dpc-4547	516	4	.	.	PUNCT
dpc-4547	517	1	2020;146(10):2703	2020;146(10):2703	NUM
dpc-4547	517	2	-	-	SYM
dpc-4547	517	3	11	11	NUM
dpc-4547	517	4	.	.	PUNCT
dpc-4547	518	1	54	54	NUM
dpc-4547	518	2	.	.	PUNCT
dpc-4547	519	1	garrett	garrett	PROPN
dpc-4547	519	2	gl	gl	PROPN
dpc-4547	519	3	,	,	PUNCT
dpc-4547	519	4	lowenstein	lowenstein	PROPN
dpc-4547	519	5	se	se	PROPN
dpc-4547	519	6	,	,	PUNCT
dpc-4547	519	7	singer	singer	NOUN
dpc-4547	519	8	jp	jp	NOUN
dpc-4547	519	9	,	,	PUNCT
dpc-4547	519	10	he	he	PRON
dpc-4547	519	11	sy	sy	VERB
dpc-4547	519	12	,	,	PUNCT
dpc-4547	519	13	arron	arron	PROPN
dpc-4547	519	14	st	st	PROPN
dpc-4547	519	15	.	.	PROPN
dpc-4547	519	16	trends	trend	NOUN
dpc-4547	519	17	of	of	ADP
dpc-4547	519	18	skin	skin	NOUN
dpc-4547	519	19	cancer	cancer	NOUN
dpc-4547	519	20	mortality	mortality	NOUN
dpc-4547	519	21	after	after	ADP
dpc-4547	519	22	transplantation	transplantation	NOUN
dpc-4547	519	23	in	in	ADP
dpc-4547	519	24	the	the	DET
dpc-4547	519	25	united	united	PROPN
dpc-4547	519	26	states	states	PROPN
dpc-4547	519	27	:	:	PUNCT
dpc-4547	519	28	1987	1987	NUM
dpc-4547	519	29	to	to	ADP
dpc-4547	519	30	2013	2013	NUM
dpc-4547	519	31	.	.	PUNCT
dpc-4547	520	1	j	j	PROPN
dpc-4547	520	2	am	be	AUX
dpc-4547	520	3	acad	acad	ADJ
dpc-4547	520	4	dermatol	dermatol	NOUN
dpc-4547	520	5	.	.	PUNCT
dpc-4547	521	1	2016;75(1):106	2016;75(1):106	NUM
dpc-4547	521	2	-	-	PUNCT
dpc-4547	521	3	12	12	NUM
dpc-4547	521	4	.	.	PUNCT
dpc-4547	522	1	55	55	NUM
dpc-4547	522	2	.	.	PUNCT
dpc-4547	523	1	euvrard	euvrard	PROPN
dpc-4547	523	2	s	s	PROPN
dpc-4547	523	3	,	,	PUNCT
dpc-4547	523	4	kanitakis	kanitakis	PROPN
dpc-4547	523	5	j	j	PROPN
dpc-4547	523	6	,	,	PUNCT
dpc-4547	523	7	claudy	claudy	ADJ
dpc-4547	523	8	a.	a.	NOUN
dpc-4547	523	9	skin	skin	NOUN
dpc-4547	523	10	cancers	cancer	NOUN
dpc-4547	523	11	after	after	ADP
dpc-4547	523	12	organ	organ	NOUN
dpc-4547	523	13	transplantation	transplantation	NOUN
dpc-4547	523	14	.	.	PUNCT
dpc-4547	524	1	n	n	CCONJ
dpc-4547	524	2	engl	engl	PROPN
dpc-4547	524	3	j	j	PROPN
dpc-4547	524	4	med	med	PROPN
dpc-4547	524	5	.	.	PUNCT
dpc-4547	525	1	2003;348(17):1681	2003;348(17):1681	NUM
dpc-4547	525	2	-	-	SYM
dpc-4547	525	3	91	91	NUM
dpc-4547	525	4	.	.	PUNCT
dpc-4547	526	1	56	56	NUM
dpc-4547	526	2	.	.	PUNCT
dpc-4547	527	1	berg	berg	PROPN
dpc-4547	527	2	d	d	PROPN
dpc-4547	527	3	,	,	PUNCT
dpc-4547	527	4	otley	otley	PROPN
dpc-4547	527	5	cc	cc	PROPN
dpc-4547	527	6	.	.	PROPN
dpc-4547	527	7	skin	skin	NOUN
dpc-4547	527	8	cancer	cancer	NOUN
dpc-4547	527	9	in	in	ADP
dpc-4547	527	10	organ	organ	NOUN
dpc-4547	527	11	transplant	transplant	NOUN
dpc-4547	527	12	recipients	recipient	NOUN
dpc-4547	527	13	:	:	PUNCT
dpc-4547	527	14	epidemiology	epidemiology	NOUN
dpc-4547	527	15	,	,	PUNCT
dpc-4547	527	16	pathogenesis	pathogenesis	NOUN
dpc-4547	527	17	,	,	PUNCT
dpc-4547	527	18	and	and	CCONJ
dpc-4547	527	19	management	management	NOUN
dpc-4547	527	20	.	.	PUNCT
dpc-4547	528	1	j	j	PROPN
dpc-4547	528	2	am	be	AUX
dpc-4547	528	3	acad	acad	ADJ
dpc-4547	528	4	dermatol	dermatol	NOUN
dpc-4547	528	5	.	.	PUNCT
dpc-4547	529	1	2002;47(1):1	2002;47(1):1	NOUN
dpc-4547	529	2	-	-	SYM
dpc-4547	529	3	17	17	NUM
dpc-4547	529	4	;	;	PUNCT
dpc-4547	529	5	quiz	quiz	NOUN
dpc-4547	529	6	8	8	NUM
dpc-4547	529	7	-	-	SYM
dpc-4547	529	8	20	20	NUM
dpc-4547	529	9	.	.	PUNCT
dpc-4547	529	10	57	57	NUM
dpc-4547	529	11	.	.	PUNCT
dpc-4547	530	1	thompson	thompson	PROPN
dpc-4547	530	2	ak	ak	PROPN
dpc-4547	530	3	,	,	PUNCT
dpc-4547	530	4	kelley	kelley	PROPN
dpc-4547	530	5	bf	bf	PROPN
dpc-4547	530	6	,	,	PUNCT
dpc-4547	530	7	prokop	prokop	PROPN
dpc-4547	530	8	lj	lj	PROPN
dpc-4547	530	9	,	,	PUNCT
dpc-4547	530	10	murad	murad	PROPN
dpc-4547	530	11	mh	mh	PROPN
dpc-4547	530	12	,	,	PUNCT
dpc-4547	530	13	baum	baum	PROPN
dpc-4547	530	14	cl	cl	PROPN
dpc-4547	530	15	.	.	PUNCT
dpc-4547	531	1	risk	risk	NOUN
dpc-4547	531	2	factors	factor	NOUN
dpc-4547	531	3	for	for	ADP
dpc-4547	531	4	cutaneous	cutaneous	ADJ
dpc-4547	531	5	squamous	squamous	ADJ
dpc-4547	531	6	cell	cell	NOUN
dpc-4547	531	7	carcinoma	carcinoma	NOUN
dpc-4547	531	8	recurrence	recurrence	NOUN
dpc-4547	531	9	,	,	PUNCT
dpc-4547	531	10	metastasis	metastasis	NOUN
dpc-4547	531	11	,	,	PUNCT
dpc-4547	531	12	and	and	CCONJ
dpc-4547	531	13	disease	disease	NOUN
dpc-4547	531	14	-	-	PUNCT
dpc-4547	531	15	specific	specific	ADJ
dpc-4547	531	16	death	death	NOUN
dpc-4547	531	17	:	:	PUNCT
dpc-4547	531	18	a	a	DET
dpc-4547	531	19	systematic	systematic	ADJ
dpc-4547	531	20	review	review	NOUN
dpc-4547	531	21	and	and	CCONJ
dpc-4547	531	22	meta	meta	ADJ
dpc-4547	531	23	-	-	PUNCT
dpc-4547	531	24	analysis	analysis	NOUN
dpc-4547	531	25	.	.	PUNCT
dpc-4547	532	1	jama	jama	PROPN
dpc-4547	532	2	dermatol	dermatol	NOUN
dpc-4547	532	3	.	.	PUNCT
dpc-4547	533	1	2016;152(4):419	2016;152(4):419	NUM
dpc-4547	533	2	-	-	SYM
dpc-4547	533	3	28	28	NUM
dpc-4547	533	4	.	.	PUNCT
dpc-4547	534	1	58	58	NUM
dpc-4547	534	2	.	.	PUNCT
dpc-4547	535	1	greene	greene	PROPN
dpc-4547	535	2	mh	mh	PROPN
dpc-4547	535	3	,	,	PUNCT
dpc-4547	535	4	hoover	hoover	PROPN
dpc-4547	535	5	rn	rn	PROPN
dpc-4547	535	6	,	,	PUNCT
dpc-4547	535	7	fraumeni	fraumeni	PROPN
dpc-4547	535	8	jf	jf	PROPN
dpc-4547	535	9	,	,	PUNCT
dpc-4547	535	10	jr	jr	PROPN
dpc-4547	535	11	.	.	PROPN
dpc-4547	535	12	subsequent	subsequent	ADJ
dpc-4547	535	13	cancer	cancer	NOUN
dpc-4547	535	14	in	in	ADP
dpc-4547	535	15	patients	patient	NOUN
dpc-4547	535	16	with	with	ADP
dpc-4547	535	17	chronic	chronic	ADJ
dpc-4547	535	18	lymphocytic	lymphocytic	ADJ
dpc-4547	535	19	leukemia	leukemia	NOUN
dpc-4547	535	20	—	—	PUNCT
dpc-4547	535	21	a	a	DET
dpc-4547	535	22	possible	possible	ADJ
dpc-4547	535	23	immunologic	immunologic	ADJ
dpc-4547	535	24	mechanism	mechanism	NOUN
dpc-4547	535	25	.	.	PUNCT
dpc-4547	536	1	j	j	PROPN
dpc-4547	536	2	natl	natl	PROPN
dpc-4547	536	3	cancer	cancer	PROPN
dpc-4547	536	4	inst	inst	PROPN
dpc-4547	536	5	.	.	PUNCT
dpc-4547	537	1	1978;61(2):337	1978;61(2):337	NUM
dpc-4547	537	2	-	-	SYM
dpc-4547	537	3	40	40	NUM
dpc-4547	537	4	.	.	PUNCT
dpc-4547	538	1	59	59	NUM
dpc-4547	538	2	.	.	PUNCT
dpc-4547	538	3	adami	adami	PROPN
dpc-4547	538	4	j	j	PROPN
dpc-4547	538	5	,	,	PUNCT
dpc-4547	538	6	frisch	frisch	VERB
dpc-4547	538	7	m	m	PROPN
dpc-4547	538	8	,	,	PUNCT
dpc-4547	538	9	yuen	yuen	PROPN
dpc-4547	538	10	j	j	PROPN
dpc-4547	538	11	,	,	PUNCT
dpc-4547	538	12	glimelius	glimelius	NOUN
dpc-4547	538	13	b	b	NOUN
dpc-4547	538	14	,	,	PUNCT
dpc-4547	538	15	melbye	melbye	ADJ
dpc-4547	538	16	m.	m.	NOUN
dpc-4547	538	17	evidence	evidence	NOUN
dpc-4547	538	18	of	of	ADP
dpc-4547	538	19	an	an	DET
dpc-4547	538	20	association	association	NOUN
dpc-4547	538	21	between	between	ADP
dpc-4547	538	22	non	non	ADJ
dpc-4547	538	23	-	-	ADJ
dpc-4547	538	24	hodgkin	hodgkin	ADJ
dpc-4547	538	25	’s	’s	PART
dpc-4547	538	26	lymphoma	lymphoma	NOUN
dpc-4547	538	27	and	and	CCONJ
dpc-4547	538	28	skin	skin	NOUN
dpc-4547	538	29	cancer	cancer	NOUN
dpc-4547	538	30	.	.	PUNCT
dpc-4547	539	1	bmj	bmj	PROPN
dpc-4547	539	2	.	.	PUNCT
dpc-4547	539	3	1995;310(6993):1491	1995;310(6993):1491	NUM
dpc-4547	539	4	-	-	SYM
dpc-4547	539	5	5	5	NUM
dpc-4547	539	6	.	.	NOUN
dpc-4547	539	7	60	60	NUM
dpc-4547	539	8	.	.	PUNCT
dpc-4547	540	1	levi	levi	PROPN
dpc-4547	540	2	f	f	PROPN
dpc-4547	540	3	,	,	PUNCT
dpc-4547	540	4	randimbison	randimbison	NOUN
dpc-4547	540	5	l	l	NOUN
dpc-4547	540	6	,	,	PUNCT
dpc-4547	540	7	te	te	PROPN
dpc-4547	540	8	vc	vc	PROPN
dpc-4547	540	9	,	,	PUNCT
dpc-4547	540	10	la	la	PROPN
dpc-4547	540	11	vecchia	vecchia	PROPN
dpc-4547	540	12	c.	c.	PROPN
dpc-4547	540	13	non	non	PROPN
dpc-4547	540	14	-	-	PROPN
dpc-4547	540	15	hodgkin	hodgkin	ADJ
dpc-4547	540	16	’s	’s	PART
dpc-4547	540	17	lymphomas	lymphoma	NOUN
dpc-4547	540	18	,	,	PUNCT
dpc-4547	540	19	chronic	chronic	ADJ
dpc-4547	540	20	lymphocytic	lymphocytic	ADJ
dpc-4547	540	21	leukaemias	leukaemia	NOUN
dpc-4547	540	22	and	and	CCONJ
dpc-4547	540	23	skin	skin	NOUN
dpc-4547	540	24	cancers	cancer	NOUN
dpc-4547	540	25	.	.	PUNCT
dpc-4547	541	1	br	br	PROPN
dpc-4547	541	2	j	j	PROPN
dpc-4547	541	3	cancer	cancer	NOUN
dpc-4547	541	4	.	.	PUNCT
dpc-4547	542	1	1996;74(11):1847	1996;74(11):1847	X
dpc-4547	542	2	-	-	SYM
dpc-4547	542	3	50	50	NUM
dpc-4547	542	4	.	.	PUNCT
dpc-4547	543	1	61	61	NUM
dpc-4547	543	2	.	.	PUNCT
dpc-4547	544	1	royle	royle	PROPN
dpc-4547	544	2	ja	ja	PROPN
dpc-4547	544	3	,	,	PUNCT
dpc-4547	544	4	baade	baade	PROPN
dpc-4547	544	5	pd	pd	PROPN
dpc-4547	544	6	,	,	PUNCT
dpc-4547	544	7	joske	joske	PROPN
dpc-4547	544	8	d	d	PROPN
dpc-4547	544	9	,	,	PUNCT
dpc-4547	544	10	girschik	girschik	PROPN
dpc-4547	544	11	j	j	PROPN
dpc-4547	544	12	,	,	PUNCT
dpc-4547	544	13	fritschi	fritschi	PROPN
dpc-4547	544	14	l.	l.	PROPN
dpc-4547	544	15	second	second	ADJ
dpc-4547	544	16	cancer	cancer	NOUN
dpc-4547	544	17	incidence	incidence	NOUN
dpc-4547	544	18	and	and	CCONJ
dpc-4547	544	19	cancer	cancer	NOUN
dpc-4547	544	20	mortality	mortality	NOUN
dpc-4547	544	21	among	among	ADP
dpc-4547	544	22	chronic	chronic	ADJ
dpc-4547	544	23	lymphocytic	lymphocytic	ADJ
dpc-4547	544	24	leukaemia	leukaemia	NOUN
dpc-4547	544	25	patients	patient	NOUN
dpc-4547	544	26	:	:	PUNCT
dpc-4547	544	27	a	a	DET
dpc-4547	544	28	population	population	NOUN
dpc-4547	544	29	-	-	PUNCT
dpc-4547	544	30	based	base	VERB
dpc-4547	544	31	study	study	NOUN
dpc-4547	544	32	.	.	PUNCT
dpc-4547	545	1	br	br	PROPN
dpc-4547	545	2	j	j	PROPN
dpc-4547	545	3	cancer	cancer	NOUN
dpc-4547	545	4	.	.	PUNCT
dpc-4547	546	1	2011;105(7):1076	2011;105(7):1076	NUM
dpc-4547	546	2	-	-	SYM
dpc-4547	546	3	81	81	NUM
dpc-4547	546	4	.	.	PUNCT
dpc-4547	547	1	62	62	NUM
dpc-4547	547	2	.	.	PUNCT
dpc-4547	548	1	velez	velez	PROPN
dpc-4547	548	2	nf	nf	PROPN
dpc-4547	548	3	,	,	PUNCT
dpc-4547	548	4	karia	karia	PROPN
dpc-4547	548	5	ps	ps	PROPN
dpc-4547	548	6	,	,	PUNCT
dpc-4547	548	7	vartanov	vartanov	PROPN
dpc-4547	548	8	ar	ar	PROPN
dpc-4547	548	9	,	,	PUNCT
dpc-4547	548	10	davids	davids	PROPN
dpc-4547	548	11	ms	ms	PROPN
dpc-4547	548	12	,	,	PUNCT
dpc-4547	548	13	brown	brown	PROPN
dpc-4547	548	14	jr	jr	PROPN
dpc-4547	548	15	,	,	PUNCT
dpc-4547	548	16	schmults	schmults	PROPN
dpc-4547	548	17	cd	cd	PROPN
dpc-4547	548	18	.	.	PROPN
dpc-4547	548	19	association	association	PROPN
dpc-4547	548	20	of	of	ADP
dpc-4547	548	21	advanced	advanced	ADJ
dpc-4547	548	22	leukemic	leukemic	ADJ
dpc-4547	548	23	stage	stage	NOUN
dpc-4547	548	24	and	and	CCONJ
dpc-4547	548	25	skin	skin	NOUN
dpc-4547	548	26	cancer	cancer	NOUN
dpc-4547	548	27	tumor	tumor	NOUN
dpc-4547	548	28	stage	stage	NOUN
dpc-4547	548	29	with	with	ADP
dpc-4547	548	30	poor	poor	ADJ
dpc-4547	548	31	skin	skin	NOUN
dpc-4547	548	32	cancer	cancer	NOUN
dpc-4547	548	33	outcomes	outcome	NOUN
dpc-4547	548	34	in	in	ADP
dpc-4547	548	35	patients	patient	NOUN
dpc-4547	548	36	with	with	ADP
dpc-4547	548	37	chronic	chronic	ADJ
dpc-4547	548	38	lymphocytic	lymphocytic	ADJ
dpc-4547	548	39	leukemia	leukemia	NOUN
dpc-4547	548	40	.	.	PUNCT
dpc-4547	549	1	jama	jama	PROPN
dpc-4547	549	2	dermatol	dermatol	NOUN
dpc-4547	549	3	.	.	PUNCT
dpc-4547	550	1	2014	2014	NUM
dpc-4547	550	2	;	;	PUNCT
dpc-4547	550	3	150(3):280	150(3):280	NUM
dpc-4547	550	4	-	-	SYM
dpc-4547	550	5	7	7	NUM
dpc-4547	550	6	.	.	PUNCT
dpc-4547	551	1	ultraviolet	ultraviolet	ADJ
dpc-4547	551	2	radiation	radiation	NOUN
dpc-4547	551	3	-	-	PUNCT
dpc-4547	551	4	induced	induce	VERB
dpc-4547	551	5	suppression	suppression	NOUN
dpc-4547	551	6	of	of	ADP
dpc-4547	551	7	memory	memory	NOUN
dpc-4547	551	8	immunity	immunity	NOUN
dpc-4547	551	9	in	in	ADP
dpc-4547	551	10	humans	human	NOUN
dpc-4547	551	11	.	.	PUNCT
dpc-4547	552	1	photochem	photochem	PROPN
dpc-4547	552	2	photobiol	photobiol	PROPN
dpc-4547	552	3	sci	sci	PROPN
dpc-4547	552	4	.	.	PUNCT
dpc-4547	553	1	2005;4(8):577	2005;4(8):577	NUM
dpc-4547	553	2	-	-	SYM
dpc-4547	553	3	82	82	NUM
dpc-4547	553	4	.	.	PUNCT
dpc-4547	553	5	30	30	NUM
dpc-4547	553	6	.	.	PUNCT
dpc-4547	554	1	halliday	halliday	PROPN
dpc-4547	554	2	gm	gm	PROPN
dpc-4547	554	3	,	,	PUNCT
dpc-4547	554	4	byrne	byrne	PROPN
dpc-4547	554	5	sn	sn	PROPN
dpc-4547	554	6	,	,	PUNCT
dpc-4547	554	7	kuchel	kuchel	PROPN
dpc-4547	554	8	jm	jm	PROPN
dpc-4547	554	9	,	,	PUNCT
dpc-4547	554	10	poon	poon	NOUN
dpc-4547	554	11	ts	ts	NOUN
dpc-4547	554	12	,	,	PUNCT
dpc-4547	554	13	barnetson	barnetson	NOUN
dpc-4547	554	14	rs	rs	NOUN
dpc-4547	554	15	.	.	PUNCT
dpc-4547	555	1	the	the	DET
dpc-4547	555	2	suppression	suppression	NOUN
dpc-4547	555	3	of	of	ADP
dpc-4547	555	4	immunity	immunity	NOUN
dpc-4547	555	5	by	by	ADP
dpc-4547	555	6	ultraviolet	ultraviolet	ADJ
dpc-4547	555	7	radiation	radiation	NOUN
dpc-4547	555	8	:	:	PUNCT
dpc-4547	555	9	uva	uva	PROPN
dpc-4547	555	10	,	,	PUNCT
dpc-4547	555	11	nitric	nitric	ADJ
dpc-4547	555	12	oxide	oxide	NOUN
dpc-4547	555	13	and	and	CCONJ
dpc-4547	555	14	dna	dna	NOUN
dpc-4547	555	15	damage	damage	NOUN
dpc-4547	555	16	.	.	PUNCT
dpc-4547	556	1	photochem	photochem	PROPN
dpc-4547	556	2	photobiol	photobiol	PROPN
dpc-4547	556	3	sci	sci	PROPN
dpc-4547	556	4	.	.	PROPN
dpc-4547	556	5	2004	2004	NUM
dpc-4547	556	6	;	;	PUNCT
dpc-4547	556	7	3(8):736	3(8):736	NUM
dpc-4547	556	8	-	-	SYM
dpc-4547	556	9	40	40	NUM
dpc-4547	556	10	.	.	PUNCT
dpc-4547	557	1	31	31	NUM
dpc-4547	557	2	.	.	PUNCT
dpc-4547	558	1	kramata	kramata	PROPN
dpc-4547	558	2	p	p	NOUN
dpc-4547	558	3	,	,	PUNCT
dpc-4547	558	4	lu	lu	PROPN
dpc-4547	558	5	yp	yp	PROPN
dpc-4547	558	6	,	,	PUNCT
dpc-4547	558	7	lou	lou	PROPN
dpc-4547	558	8	yr	yr	PROPN
dpc-4547	558	9	,	,	PUNCT
dpc-4547	558	10	singh	singh	PROPN
dpc-4547	558	11	rn	rn	PROPN
dpc-4547	558	12	,	,	PUNCT
dpc-4547	558	13	kwon	kwon	VERB
dpc-4547	558	14	sm	sm	PROPN
dpc-4547	558	15	,	,	PUNCT
dpc-4547	558	16	conney	conney	NOUN
dpc-4547	558	17	ah	ah	INTJ
dpc-4547	558	18	.	.	PUNCT
dpc-4547	559	1	patches	patch	NOUN
dpc-4547	559	2	of	of	ADP
dpc-4547	559	3	mutant	mutant	ADJ
dpc-4547	559	4	p53	p53	NOUN
dpc-4547	559	5	-	-	PUNCT
dpc-4547	559	6	immunoreactive	immunoreactive	ADJ
dpc-4547	559	7	epidermal	epidermal	ADJ
dpc-4547	559	8	cells	cell	NOUN
dpc-4547	559	9	induced	induce	VERB
dpc-4547	559	10	by	by	ADP
dpc-4547	559	11	chronic	chronic	ADJ
dpc-4547	559	12	uvb	uvb	ADJ
dpc-4547	559	13	irradiation	irradiation	NOUN
dpc-4547	559	14	harbor	harbor	VERB
dpc-4547	559	15	the	the	DET
dpc-4547	559	16	same	same	ADJ
dpc-4547	559	17	p53	p53	NOUN
dpc-4547	559	18	mutations	mutation	NOUN
dpc-4547	559	19	as	as	ADP
dpc-4547	559	20	squamous	squamous	ADJ
dpc-4547	559	21	cell	cell	NOUN
dpc-4547	559	22	carcinomas	carcinoma	NOUN
dpc-4547	559	23	in	in	ADP
dpc-4547	559	24	the	the	DET
dpc-4547	559	25	skin	skin	NOUN
dpc-4547	559	26	of	of	ADP
dpc-4547	559	27	hairless	hairless	NOUN
dpc-4547	559	28	skh-1	skh-1	PUNCT
dpc-4547	559	29	mice	mouse	NOUN
dpc-4547	559	30	.	.	PUNCT
dpc-4547	560	1	cancer	cancer	NOUN
dpc-4547	560	2	res	re	NOUN
dpc-4547	560	3	.	.	PUNCT
dpc-4547	561	1	2005;65(9):3577	2005;65(9):3577	NUM
dpc-4547	561	2	-	-	PUNCT
dpc-4547	561	3	85	85	NUM
dpc-4547	561	4	.	.	PUNCT
dpc-4547	561	5	32	32	NUM
dpc-4547	561	6	.	.	PUNCT
dpc-4547	562	1	schmitz	schmitz	PROPN
dpc-4547	562	2	l	l	PROPN
dpc-4547	562	3	,	,	PUNCT
dpc-4547	562	4	oster	oster	NOUN
dpc-4547	562	5	-	-	PUNCT
dpc-4547	562	6	schmidt	schmidt	PROPN
dpc-4547	562	7	c	c	PROPN
dpc-4547	562	8	,	,	PUNCT
dpc-4547	562	9	stockfleth	stockfleth	PROPN
dpc-4547	562	10	e.	e.	PROPN
dpc-4547	562	11	nonmelanoma	nonmelanoma	PROPN
dpc-4547	562	12	skin	skin	NOUN
dpc-4547	562	13	cancer	cancer	NOUN
dpc-4547	562	14	from	from	ADP
dpc-4547	562	15	actinic	actinic	ADJ
dpc-4547	562	16	keratosis	keratosis	NOUN
dpc-4547	562	17	to	to	ADP
dpc-4547	562	18	cutaneous	cutaneous	ADJ
dpc-4547	562	19	squamous	squamous	ADJ
dpc-4547	562	20	cell	cell	NOUN
dpc-4547	562	21	carcinoma	carcinoma	NOUN
dpc-4547	562	22	.	.	PUNCT
dpc-4547	563	1	j	j	PROPN
dpc-4547	563	2	dtsch	dtsch	PROPN
dpc-4547	563	3	dermatol	dermatol	NOUN
dpc-4547	563	4	ges	ge	NOUN
dpc-4547	563	5	.	.	PROPN
dpc-4547	563	6	2018;16(8):1002	2018;16(8):1002	NUM
dpc-4547	563	7	-	-	SYM
dpc-4547	563	8	13	13	NUM
dpc-4547	563	9	.	.	PUNCT
dpc-4547	564	1	33	33	NUM
dpc-4547	564	2	.	.	PUNCT
dpc-4547	565	1	lee	lee	PROPN
dpc-4547	565	2	cs	cs	PROPN
dpc-4547	565	3	,	,	PUNCT
dpc-4547	565	4	bhaduri	bhaduri	PROPN
dpc-4547	565	5	a	a	PROPN
dpc-4547	565	6	,	,	PUNCT
dpc-4547	565	7	mah	mah	X
dpc-4547	565	8	a	a	PRON
dpc-4547	565	9	,	,	PUNCT
dpc-4547	565	10	et	et	PROPN
dpc-4547	565	11	al	al	PROPN
dpc-4547	565	12	.	.	PROPN
dpc-4547	565	13	recurrent	recurrent	ADJ
dpc-4547	565	14	point	point	NOUN
dpc-4547	565	15	mutations	mutation	NOUN
dpc-4547	565	16	in	in	ADP
dpc-4547	565	17	the	the	DET
dpc-4547	565	18	kinetochore	kinetochore	PROPN
dpc-4547	565	19	gene	gene	NOUN
dpc-4547	565	20	knstrn	knstrn	NOUN
dpc-4547	565	21	in	in	ADP
dpc-4547	565	22	cutaneous	cutaneous	ADJ
dpc-4547	565	23	squamous	squamous	ADJ
dpc-4547	565	24	cell	cell	NOUN
dpc-4547	565	25	carcinoma	carcinoma	NOUN
dpc-4547	565	26	.	.	PUNCT
dpc-4547	566	1	nat	nat	PROPN
dpc-4547	566	2	genet	genet	PROPN
dpc-4547	566	3	.	.	PUNCT
dpc-4547	567	1	2014;46(10):1060	2014;46(10):1060	NUM
dpc-4547	567	2	-	-	SYM
dpc-4547	567	3	2	2	NUM
dpc-4547	567	4	.	.	NOUN
dpc-4547	567	5	34	34	NUM
dpc-4547	567	6	.	.	PUNCT
dpc-4547	568	1	rowert	rowert	PROPN
dpc-4547	568	2	-	-	PUNCT
dpc-4547	568	3	huber	huber	PROPN
dpc-4547	568	4	j	j	PROPN
dpc-4547	568	5	,	,	PUNCT
dpc-4547	568	6	patel	patel	PROPN
dpc-4547	568	7	mj	mj	PROPN
dpc-4547	568	8	,	,	PUNCT
dpc-4547	568	9	forschner	forschner	PROPN
dpc-4547	568	10	t	t	PROPN
dpc-4547	568	11	,	,	PUNCT
dpc-4547	568	12	et	et	PROPN
dpc-4547	568	13	al	al	PROPN
dpc-4547	568	14	.	.	PROPN
dpc-4547	568	15	actinic	actinic	ADJ
dpc-4547	568	16	keratosis	keratosis	NOUN
dpc-4547	568	17	is	be	AUX
dpc-4547	568	18	an	an	DET
dpc-4547	568	19	early	early	ADJ
dpc-4547	568	20	in	in	ADP
dpc-4547	568	21	situ	situ	ADJ
dpc-4547	568	22	squamous	squamous	ADJ
dpc-4547	568	23	cell	cell	NOUN
dpc-4547	568	24	carcinoma	carcinoma	NOUN
dpc-4547	568	25	:	:	PUNCT
dpc-4547	568	26	a	a	DET
dpc-4547	568	27	proposal	proposal	NOUN
dpc-4547	568	28	for	for	ADP
dpc-4547	568	29	reclassification	reclassification	NOUN
dpc-4547	568	30	.	.	PUNCT
dpc-4547	569	1	br	br	PROPN
dpc-4547	569	2	j	j	PROPN
dpc-4547	569	3	dermatol	dermatol	NOUN
dpc-4547	569	4	.	.	PUNCT
dpc-4547	570	1	2007;156	2007;156	NUM
dpc-4547	570	2	suppl	suppl	ADJ
dpc-4547	570	3	3:8	3:8	NUM
dpc-4547	570	4	-	-	SYM
dpc-4547	570	5	12	12	NUM
dpc-4547	570	6	.	.	PUNCT
dpc-4547	570	7	35	35	NUM
dpc-4547	570	8	.	.	PUNCT
dpc-4547	571	1	ajila	ajila	NOUN
dpc-4547	571	2	v	v	PROPN
dpc-4547	571	3	,	,	PUNCT
dpc-4547	571	4	shetty	shetty	PROPN
dpc-4547	571	5	h	h	PROPN
dpc-4547	571	6	,	,	PUNCT
dpc-4547	571	7	babu	babu	PROPN
dpc-4547	571	8	s	s	PROPN
dpc-4547	571	9	,	,	PUNCT
dpc-4547	571	10	shetty	shetty	PROPN
dpc-4547	571	11	v	v	PROPN
dpc-4547	571	12	,	,	PUNCT
dpc-4547	571	13	hegde	hegde	PROPN
dpc-4547	571	14	s.	s.	PROPN
dpc-4547	571	15	human	human	PROPN
dpc-4547	571	16	papilloma	papilloma	PROPN
dpc-4547	571	17	virus	virus	NOUN
dpc-4547	571	18	associated	associate	VERB
dpc-4547	571	19	squamous	squamous	ADJ
dpc-4547	571	20	cell	cell	NOUN
dpc-4547	571	21	carcinoma	carcinoma	NOUN
dpc-4547	571	22	of	of	ADP
dpc-4547	571	23	the	the	DET
dpc-4547	571	24	head	head	NOUN
dpc-4547	571	25	and	and	CCONJ
dpc-4547	571	26	neck	neck	NOUN
dpc-4547	571	27	.	.	PUNCT
dpc-4547	572	1	j	j	PROPN
dpc-4547	572	2	sex	sex	PROPN
dpc-4547	572	3	transm	transm	PROPN
dpc-4547	572	4	dis	dis	PROPN
dpc-4547	572	5	.	.	PUNCT
dpc-4547	573	1	2015;2015:791024	2015;2015:791024	NUM
dpc-4547	573	2	.	.	PROPN
dpc-4547	573	3	36	36	NUM
dpc-4547	573	4	.	.	PUNCT
dpc-4547	573	5	fernandez	fernandez	PROPN
dpc-4547	573	6	-	-	PUNCT
dpc-4547	573	7	figueras	figueras	PROPN
dpc-4547	573	8	mt	mt	PROPN
dpc-4547	573	9	,	,	PUNCT
dpc-4547	573	10	carrato	carrato	PROPN
dpc-4547	573	11	c	c	PROPN
dpc-4547	573	12	,	,	PUNCT
dpc-4547	573	13	saenz	saenz	PROPN
dpc-4547	573	14	x	x	PROPN
dpc-4547	573	15	,	,	PUNCT
dpc-4547	573	16	et	et	PROPN
dpc-4547	573	17	al	al	PROPN
dpc-4547	573	18	.	.	PROPN
dpc-4547	573	19	actinic	actinic	ADJ
dpc-4547	573	20	keratosis	keratosis	NOUN
dpc-4547	573	21	with	with	ADP
dpc-4547	573	22	atypical	atypical	ADJ
dpc-4547	573	23	basal	basal	NOUN
dpc-4547	573	24	cells	cell	NOUN
dpc-4547	573	25	(	(	PUNCT
dpc-4547	573	26	ak	ak	PROPN
dpc-4547	573	27	i	i	PROPN
dpc-4547	573	28	)	)	PUNCT
dpc-4547	573	29	is	be	AUX
dpc-4547	573	30	the	the	DET
dpc-4547	573	31	most	most	ADV
dpc-4547	573	32	common	common	ADJ
dpc-4547	573	33	lesion	lesion	NOUN
dpc-4547	573	34	associated	associate	VERB
dpc-4547	573	35	with	with	ADP
dpc-4547	573	36	invasive	invasive	ADJ
dpc-4547	573	37	squamous	squamous	ADJ
dpc-4547	573	38	cell	cell	NOUN
dpc-4547	573	39	carcinoma	carcinoma	NOUN
dpc-4547	573	40	of	of	ADP
dpc-4547	573	41	the	the	DET
dpc-4547	573	42	skin	skin	NOUN
dpc-4547	573	43	.	.	PUNCT
dpc-4547	574	1	j	j	PROPN
dpc-4547	574	2	eur	eur	PROPN
dpc-4547	574	3	acad	acad	PROPN
dpc-4547	574	4	dermatol	dermatol	NOUN
dpc-4547	574	5	venereol	venereol	NOUN
dpc-4547	574	6	.	.	PUNCT
dpc-4547	575	1	2015;29(5):991	2015;29(5):991	NUM
dpc-4547	575	2	-	-	SYM
dpc-4547	575	3	7	7	NUM
dpc-4547	575	4	.	.	NOUN
dpc-4547	575	5	37	37	NUM
dpc-4547	575	6	.	.	PUNCT
dpc-4547	576	1	schmitz	schmitz	PROPN
dpc-4547	576	2	l	l	PROPN
dpc-4547	576	3	,	,	PUNCT
dpc-4547	576	4	gambichler	gambichler	PROPN
dpc-4547	576	5	t	t	PROPN
dpc-4547	576	6	,	,	PUNCT
dpc-4547	576	7	gupta	gupta	PROPN
dpc-4547	576	8	g	g	PROPN
dpc-4547	576	9	,	,	PUNCT
dpc-4547	576	10	et	et	PROPN
dpc-4547	576	11	al	al	PROPN
dpc-4547	576	12	.	.	PROPN
dpc-4547	576	13	actinic	actinic	ADJ
dpc-4547	576	14	keratoses	keratose	NOUN
dpc-4547	576	15	show	show	VERB
dpc-4547	576	16	variable	variable	ADJ
dpc-4547	576	17	histological	histological	ADJ
dpc-4547	576	18	basal	basal	NOUN
dpc-4547	576	19	growth	growth	NOUN
dpc-4547	576	20	patterns	pattern	VERB
dpc-4547	576	21	a	a	DET
dpc-4547	576	22	proposed	propose	VERB
dpc-4547	576	23	classification	classification	NOUN
dpc-4547	576	24	adjustment	adjustment	NOUN
dpc-4547	576	25	.	.	PUNCT
dpc-4547	577	1	j	j	PROPN
dpc-4547	577	2	eur	eur	PROPN
dpc-4547	577	3	acad	acad	PROPN
dpc-4547	577	4	dermatol	dermatol	NOUN
dpc-4547	577	5	venereol	venereol	NOUN
dpc-4547	577	6	.	.	PUNCT
dpc-4547	578	1	2018;32(5	2018;32(5	NOUN
dpc-4547	578	2	):	):	PUNCT
dpc-4547	578	3	745	745	NUM
dpc-4547	578	4	-	-	SYM
dpc-4547	578	5	51	51	NUM
dpc-4547	578	6	.	.	PUNCT
dpc-4547	579	1	38	38	NUM
dpc-4547	579	2	.	.	PUNCT
dpc-4547	580	1	schmitz	schmitz	PROPN
dpc-4547	580	2	l	l	PROPN
dpc-4547	580	3	,	,	PUNCT
dpc-4547	580	4	gambichler	gambichler	PROPN
dpc-4547	580	5	t	t	PROPN
dpc-4547	580	6	,	,	PUNCT
dpc-4547	580	7	kost	kost	PROPN
dpc-4547	580	8	c	c	PROPN
dpc-4547	580	9	,	,	PUNCT
dpc-4547	580	10	et	et	PROPN
dpc-4547	580	11	al	al	PROPN
dpc-4547	580	12	.	.	PUNCT
dpc-4547	581	1	cutaneous	cutaneous	ADJ
dpc-4547	581	2	squamous	squamous	ADJ
dpc-4547	581	3	cell	cell	NOUN
dpc-4547	581	4	carcinomas	carcinoma	NOUN
dpc-4547	581	5	are	be	AUX
dpc-4547	581	6	associated	associate	VERB
dpc-4547	581	7	with	with	ADP
dpc-4547	581	8	basal	basal	ADJ
dpc-4547	581	9	proliferating	proliferate	VERB
dpc-4547	581	10	actinic	actinic	ADJ
dpc-4547	581	11	keratoses	keratose	NOUN
dpc-4547	581	12	.	.	PUNCT
dpc-4547	582	1	br	br	PROPN
dpc-4547	582	2	j	j	PROPN
dpc-4547	582	3	dermatol	dermatol	NOUN
dpc-4547	582	4	.	.	PUNCT
dpc-4547	583	1	2019;180(4):916	2019;180(4):916	NUM
dpc-4547	583	2	-	-	SYM
dpc-4547	583	3	21	21	NUM
dpc-4547	583	4	.	.	PUNCT
dpc-4547	584	1	39	39	NUM
dpc-4547	584	2	.	.	PUNCT
dpc-4547	585	1	schmitz	schmitz	PROPN
dpc-4547	585	2	l	l	PROPN
dpc-4547	585	3	,	,	PUNCT
dpc-4547	585	4	kahl	kahl	PROPN
dpc-4547	585	5	p	p	PROPN
dpc-4547	585	6	,	,	PUNCT
dpc-4547	585	7	majores	majore	NOUN
dpc-4547	585	8	m	m	PROPN
dpc-4547	585	9	,	,	PUNCT
dpc-4547	585	10	bierhoff	bierhoff	ADJ
dpc-4547	585	11	e	e	PROPN
dpc-4547	585	12	,	,	PUNCT
dpc-4547	585	13	stockfleth	stockfleth	PROPN
dpc-4547	585	14	e	e	PROPN
dpc-4547	585	15	,	,	PUNCT
dpc-4547	585	16	dirschka	dirschka	ADJ
dpc-4547	585	17	t.	t.	PROPN
dpc-4547	585	18	actinic	actinic	ADJ
dpc-4547	585	19	keratosis	keratosis	NOUN
dpc-4547	585	20	:	:	PUNCT
dpc-4547	585	21	correlation	correlation	NOUN
dpc-4547	585	22	between	between	ADP
dpc-4547	585	23	clinical	clinical	ADJ
dpc-4547	585	24	and	and	CCONJ
dpc-4547	585	25	histological	histological	ADJ
dpc-4547	585	26	classification	classification	NOUN
dpc-4547	585	27	systems	system	NOUN
dpc-4547	585	28	.	.	PUNCT
dpc-4547	586	1	j	j	PROPN
dpc-4547	586	2	eur	eur	PROPN
dpc-4547	586	3	acad	acad	PROPN
dpc-4547	586	4	dermatol	dermatol	NOUN
dpc-4547	586	5	venereol	venereol	NOUN
dpc-4547	586	6	.	.	PUNCT
dpc-4547	587	1	2016;30(8):1303	2016;30(8):1303	NUM
dpc-4547	587	2	-	-	SYM
dpc-4547	587	3	7	7	NUM
dpc-4547	587	4	.	.	NUM
dpc-4547	587	5	40	40	NUM
dpc-4547	587	6	.	.	PUNCT
dpc-4547	588	1	bakshi	bakshi	PROPN
dpc-4547	588	2	a	a	PROPN
dpc-4547	588	3	,	,	PUNCT
dpc-4547	588	4	shafi	shafi	PROPN
dpc-4547	588	5	r	r	PROPN
dpc-4547	588	6	,	,	PUNCT
dpc-4547	588	7	nelson	nelson	PROPN
dpc-4547	588	8	j	j	PROPN
dpc-4547	588	9	,	,	PUNCT
dpc-4547	588	10	et	et	PROPN
dpc-4547	588	11	al	al	PROPN
dpc-4547	588	12	.	.	PUNCT
dpc-4547	589	1	the	the	DET
dpc-4547	589	2	clinical	clinical	ADJ
dpc-4547	589	3	course	course	NOUN
dpc-4547	589	4	of	of	ADP
dpc-4547	589	5	actinic	actinic	ADJ
dpc-4547	589	6	keratosis	keratosis	NOUN
dpc-4547	589	7	correlates	correlate	VERB
dpc-4547	589	8	with	with	ADP
dpc-4547	589	9	underlying	underlie	VERB
dpc-4547	589	10	molecular	molecular	ADJ
dpc-4547	589	11	mechanisms	mechanism	NOUN
dpc-4547	589	12	.	.	PUNCT
dpc-4547	590	1	br	br	PROPN
dpc-4547	590	2	j	j	PROPN
dpc-4547	590	3	dermatol	dermatol	NOUN
dpc-4547	590	4	.	.	PUNCT
dpc-4547	591	1	2020;182(4):995	2020;182(4):995	NUM
dpc-4547	591	2	-	-	SYM
dpc-4547	591	3	1002	1002	NUM
dpc-4547	591	4	.	.	PUNCT
dpc-4547	592	1	41	41	NUM
dpc-4547	592	2	.	.	PUNCT
dpc-4547	593	1	schmitz	schmitz	PROPN
dpc-4547	593	2	l	l	PROPN
dpc-4547	593	3	,	,	PUNCT
dpc-4547	593	4	brehmer	brehmer	PROPN
dpc-4547	593	5	a	a	NOUN
dpc-4547	593	6	,	,	PUNCT
dpc-4547	593	7	falkenberg	falkenberg	PROPN
dpc-4547	593	8	c	c	NOUN
dpc-4547	593	9	,	,	PUNCT
dpc-4547	593	10	et	et	PROPN
dpc-4547	593	11	al	al	PROPN
dpc-4547	593	12	.	.	PUNCT
dpc-4547	594	1	treatmentresistant	treatmentresistant	PROPN
dpc-4547	594	2	actinic	actinic	ADJ
dpc-4547	594	3	keratoses	keratose	NOUN
dpc-4547	594	4	are	be	AUX
dpc-4547	594	5	characterized	characterize	VERB
dpc-4547	594	6	by	by	ADP
dpc-4547	594	7	distinct	distinct	ADJ
dpc-4547	594	8	clinical	clinical	ADJ
dpc-4547	594	9	and	and	CCONJ
dpc-4547	594	10	histological	histological	ADJ
dpc-4547	594	11	features	feature	NOUN
dpc-4547	594	12	.	.	PUNCT
dpc-4547	595	1	ital	ital	PROPN
dpc-4547	595	2	j	j	PROPN
dpc-4547	595	3	dermatol	dermatol	PROPN
dpc-4547	595	4	venerol	venerol	PROPN
dpc-4547	595	5	.	.	PUNCT
dpc-4547	596	1	2021;156(2	2021;156(2	ADV
dpc-4547	596	2	):	):	PUNCT
dpc-4547	596	3	213	213	NUM
dpc-4547	596	4	-	-	SYM
dpc-4547	596	5	9	9	NUM
dpc-4547	596	6	.	.	NUM
dpc-4547	596	7	42	42	NUM
dpc-4547	596	8	.	.	PUNCT
dpc-4547	597	1	warszawik	warszawik	PROPN
dpc-4547	597	2	-	-	PUNCT
dpc-4547	597	3	hendzel	hendzel	PROPN
dpc-4547	597	4	o	o	NOUN
dpc-4547	597	5	,	,	PUNCT
dpc-4547	597	6	olszewska	olszewska	PROPN
dpc-4547	597	7	m	m	PROPN
dpc-4547	597	8	,	,	PUNCT
dpc-4547	597	9	rakowska	rakowska	NOUN
dpc-4547	597	10	a	a	PRON
dpc-4547	597	11	,	,	PUNCT
dpc-4547	597	12	sikora	sikora	PROPN
dpc-4547	597	13	m	m	PROPN
dpc-4547	597	14	,	,	PUNCT
dpc-4547	597	15	hendzel	hendzel	ADJ
dpc-4547	597	16	p	p	X
dpc-4547	597	17	,	,	PUNCT
dpc-4547	597	18	rudnicka	rudnicka	NOUN
dpc-4547	597	19	l.	l.	PROPN
dpc-4547	597	20	cardiovascular	cardiovascular	ADJ
dpc-4547	597	21	drug	drug	NOUN
dpc-4547	597	22	use	use	NOUN
dpc-4547	597	23	and	and	CCONJ
dpc-4547	597	24	risk	risk	NOUN
dpc-4547	597	25	of	of	ADP
dpc-4547	597	26	actinic	actinic	ADJ
dpc-4547	597	27	keratosis	keratosis	NOUN
dpc-4547	597	28	:	:	PUNCT
dpc-4547	597	29	a	a	DET
dpc-4547	597	30	case	case	NOUN
dpc-4547	597	31	-	-	PUNCT
dpc-4547	597	32	control	control	NOUN
dpc-4547	597	33	study	study	NOUN
dpc-4547	597	34	.	.	PUNCT
dpc-4547	598	1	dermatol	dermatol	NOUN
dpc-4547	598	2	ther	ther	ADV
dpc-4547	598	3	(	(	PUNCT
dpc-4547	598	4	heidelb	heidelb	NOUN
dpc-4547	598	5	)	)	PUNCT
dpc-4547	598	6	.	.	PUNCT
dpc-4547	599	1	2020;10(4):735	2020;10(4):735	NUM
dpc-4547	599	2	-	-	SYM
dpc-4547	599	3	43	43	NUM
dpc-4547	599	4	.	.	PUNCT
dpc-4547	600	1	43	43	NUM
dpc-4547	600	2	.	.	PUNCT
dpc-4547	601	1	sechi	sechi	PROPN
dpc-4547	601	2	a	a	PROPN
dpc-4547	601	3	,	,	PUNCT
dpc-4547	601	4	di	di	NOUN
dpc-4547	601	5	altobrando	altobrando	NOUN
dpc-4547	601	6	a	a	PRON
dpc-4547	601	7	,	,	PUNCT
dpc-4547	601	8	cerciello	cerciello	ADJ
dpc-4547	601	9	e	e	NOUN
dpc-4547	601	10	,	,	PUNCT
dpc-4547	601	11	maietti	maietti	NOUN
dpc-4547	601	12	e	e	NOUN
dpc-4547	601	13	,	,	PUNCT
dpc-4547	601	14	patrizi	patrizi	NOUN
dpc-4547	601	15	a	a	PRON
dpc-4547	601	16	,	,	PUNCT
dpc-4547	601	17	savoia	savoia	PROPN
dpc-4547	601	18	f.	f.	PROPN
dpc-4547	601	19	drug	drug	PROPN
dpc-4547	601	20	intake	intake	PROPN
dpc-4547	601	21	and	and	CCONJ
dpc-4547	601	22	actinic	actinic	ADJ
dpc-4547	601	23	keratosis	keratosis	NOUN
dpc-4547	601	24	:	:	PUNCT
dpc-4547	601	25	a	a	DET
dpc-4547	601	26	case	case	NOUN
dpc-4547	601	27	-	-	PUNCT
dpc-4547	601	28	control	control	NOUN
dpc-4547	601	29	study	study	NOUN
dpc-4547	601	30	.	.	PUNCT
dpc-4547	602	1	dermatol	dermatol	NOUN
dpc-4547	602	2	pract	pract	PROPN
dpc-4547	602	3	concept	concept	NOUN
dpc-4547	602	4	.	.	PUNCT
dpc-4547	603	1	2021;11(2):e2021031	2021;11(2):e2021031	NUM
dpc-4547	603	2	.	.	NOUN
dpc-4547	604	1	44	44	NUM
dpc-4547	604	2	.	.	PUNCT
dpc-4547	605	1	iannacone	iannacone	PROPN
dpc-4547	605	2	mr	mr	PROPN
dpc-4547	605	3	,	,	PUNCT
dpc-4547	605	4	sinnya	sinnya	VERB
dpc-4547	605	5	s	s	PROPN
dpc-4547	605	6	,	,	PUNCT
dpc-4547	605	7	pandeya	pandeya	PROPN
dpc-4547	605	8	n	n	CCONJ
dpc-4547	605	9	,	,	PUNCT
dpc-4547	605	10	et	et	PROPN
dpc-4547	605	11	al	al	PROPN
dpc-4547	605	12	.	.	PUNCT
dpc-4547	606	1	prevalence	prevalence	NOUN
dpc-4547	606	2	of	of	ADP
dpc-4547	606	3	skin	skin	NOUN
dpc-4547	606	4	cancer	cancer	NOUN
dpc-4547	606	5	and	and	CCONJ
dpc-4547	606	6	related	relate	VERB
dpc-4547	606	7	skin	skin	NOUN
dpc-4547	606	8	tumors	tumor	NOUN
dpc-4547	606	9	in	in	ADP
dpc-4547	606	10	high	high	ADJ
dpc-4547	606	11	-	-	PUNCT
dpc-4547	606	12	risk	risk	NOUN
dpc-4547	606	13	kidney	kidney	NOUN
dpc-4547	606	14	and	and	CCONJ
dpc-4547	606	15	liver	liver	NOUN
dpc-4547	606	16	transplant	transplant	NOUN
dpc-4547	606	17	recipients	recipient	NOUN
dpc-4547	606	18	in	in	ADP
dpc-4547	606	19	queensland	queensland	PROPN
dpc-4547	606	20	,	,	PUNCT
dpc-4547	606	21	australia	australia	PROPN
dpc-4547	606	22	.	.	PUNCT
dpc-4547	607	1	j	j	PROPN
dpc-4547	607	2	invest	invest	VERB
dpc-4547	607	3	dermatol	dermatol	NOUN
dpc-4547	607	4	.	.	PUNCT
dpc-4547	608	1	2016;136(7):1382	2016;136(7):1382	NUM
dpc-4547	608	2	-	-	SYM
dpc-4547	608	3	6	6	NUM
dpc-4547	608	4	.	.	NOUN
dpc-4547	608	5	45	45	NUM
dpc-4547	608	6	.	.	PUNCT
dpc-4547	609	1	jiyad	jiyad	PROPN
dpc-4547	609	2	z	z	PROPN
dpc-4547	609	3	,	,	PUNCT
dpc-4547	609	4	o’rourke	o’rourke	NOUN
dpc-4547	609	5	p	p	X
dpc-4547	609	6	,	,	PUNCT
dpc-4547	609	7	soyer	soyer	PROPN
dpc-4547	609	8	hp	hp	PROPN
dpc-4547	609	9	,	,	PUNCT
dpc-4547	609	10	green	green	PROPN
dpc-4547	609	11	ac	ac	PROPN
dpc-4547	609	12	.	.	PROPN
dpc-4547	610	1	actinic	actinic	ADJ
dpc-4547	610	2	keratosis	keratosis	NOUN
dpc-4547	610	3	related	relate	VERB
dpc-4547	610	4	signs	sign	NOUN
dpc-4547	610	5	predictive	predictive	ADJ
dpc-4547	610	6	of	of	ADP
dpc-4547	610	7	squamous	squamous	ADJ
dpc-4547	610	8	cell	cell	NOUN
dpc-4547	610	9	carcinoma	carcinoma	NOUN
dpc-4547	610	10	in	in	ADP
dpc-4547	610	11	renal	renal	ADJ
dpc-4547	610	12	transplant	transplant	NOUN
dpc-4547	610	13	recipients	recipient	NOUN
dpc-4547	610	14	:	:	PUNCT
dpc-4547	610	15	a	a	DET
dpc-4547	610	16	nested	nested	ADJ
dpc-4547	610	17	case	case	NOUN
dpc-4547	610	18	-	-	PUNCT
dpc-4547	610	19	control	control	NOUN
dpc-4547	610	20	study	study	NOUN
dpc-4547	610	21	.	.	PUNCT
dpc-4547	611	1	br	br	PROPN
dpc-4547	611	2	j	j	PROPN
dpc-4547	611	3	dermatol	dermatol	NOUN
dpc-4547	611	4	.	.	PUNCT
dpc-4547	612	1	2017;176(4):965	2017;176(4):965	NUM
dpc-4547	612	2	-	-	SYM
dpc-4547	612	3	70	70	NUM
dpc-4547	612	4	.	.	PUNCT
dpc-4547	613	1	review	review	VERB
dpc-4547	613	2	|	|	ADV
dpc-4547	613	3	dermatol	dermatol	ADJ
dpc-4547	613	4	pract	pract	NOUN
dpc-4547	613	5	concept	concept	NOUN
dpc-4547	613	6	.	.	PUNCT
dpc-4547	614	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	614	2	:	:	PUNCT
dpc-4547	614	3	e2024146s	e2024146s	ADV
dpc-4547	614	4	13	13	NUM
dpc-4547	614	5	79	79	NUM
dpc-4547	614	6	.	.	PUNCT
dpc-4547	615	1	braakhuis	braakhuis	PROPN
dpc-4547	615	2	bj	bj	PROPN
dpc-4547	615	3	,	,	PUNCT
dpc-4547	615	4	tabor	tabor	PROPN
dpc-4547	615	5	mp	mp	PROPN
dpc-4547	615	6	,	,	PUNCT
dpc-4547	615	7	kummer	kummer	PROPN
dpc-4547	615	8	ja	ja	PROPN
dpc-4547	615	9	,	,	PUNCT
dpc-4547	615	10	leemans	leemans	PROPN
dpc-4547	615	11	cr	cr	PROPN
dpc-4547	615	12	,	,	PUNCT
dpc-4547	615	13	brakenhoff	brakenhoff	PROPN
dpc-4547	615	14	rh	rh	PROPN
dpc-4547	615	15	.	.	PUNCT
dpc-4547	616	1	a	a	DET
dpc-4547	616	2	genetic	genetic	ADJ
dpc-4547	616	3	explanation	explanation	NOUN
dpc-4547	616	4	of	of	ADP
dpc-4547	616	5	slaughter	slaughter	NOUN
dpc-4547	616	6	’s	’s	PART
dpc-4547	616	7	concept	concept	NOUN
dpc-4547	616	8	of	of	ADP
dpc-4547	616	9	field	field	NOUN
dpc-4547	616	10	cancerization	cancerization	NOUN
dpc-4547	616	11	:	:	PUNCT
dpc-4547	616	12	evidence	evidence	NOUN
dpc-4547	616	13	and	and	CCONJ
dpc-4547	616	14	clinical	clinical	ADJ
dpc-4547	616	15	implications	implication	NOUN
dpc-4547	616	16	.	.	PUNCT
dpc-4547	617	1	cancer	cancer	NOUN
dpc-4547	617	2	res	re	NOUN
dpc-4547	617	3	.	.	PUNCT
dpc-4547	618	1	2003;63(8):1727	2003;63(8):1727	NUM
dpc-4547	618	2	-	-	SYM
dpc-4547	618	3	30	30	NUM
dpc-4547	618	4	.	.	PUNCT
dpc-4547	619	1	80	80	NUM
dpc-4547	619	2	.	.	PUNCT
dpc-4547	620	1	figueras	figueras	PROPN
dpc-4547	620	2	nart	nart	PROPN
dpc-4547	620	3	i	i	PRON
dpc-4547	620	4	,	,	PUNCT
dpc-4547	620	5	cerio	cerio	PROPN
dpc-4547	620	6	r	r	PROPN
dpc-4547	620	7	,	,	PUNCT
dpc-4547	620	8	dirschka	dirschka	PROPN
dpc-4547	620	9	t	t	PROPN
dpc-4547	620	10	,	,	PUNCT
dpc-4547	620	11	et	et	PROPN
dpc-4547	620	12	al	al	PROPN
dpc-4547	620	13	.	.	PUNCT
dpc-4547	620	14	defining	define	VERB
dpc-4547	620	15	the	the	DET
dpc-4547	620	16	actinic	actinic	ADJ
dpc-4547	620	17	keratosis	keratosis	NOUN
dpc-4547	620	18	field	field	NOUN
dpc-4547	620	19	:	:	PUNCT
dpc-4547	620	20	a	a	DET
dpc-4547	620	21	literature	literature	NOUN
dpc-4547	620	22	review	review	NOUN
dpc-4547	620	23	and	and	CCONJ
dpc-4547	620	24	discussion	discussion	NOUN
dpc-4547	620	25	.	.	PUNCT
dpc-4547	621	1	j	j	PROPN
dpc-4547	621	2	eur	eur	PROPN
dpc-4547	621	3	acad	acad	PROPN
dpc-4547	621	4	dermatol	dermatol	NOUN
dpc-4547	621	5	venereol	venereol	NOUN
dpc-4547	621	6	.	.	PUNCT
dpc-4547	622	1	2018;32(4):544	2018;32(4):544	NUM
dpc-4547	622	2	-	-	SYM
dpc-4547	622	3	63	63	NUM
dpc-4547	622	4	.	.	PUNCT
dpc-4547	622	5	81	81	NUM
dpc-4547	622	6	.	.	PUNCT
dpc-4547	623	1	willenbrink	willenbrink	PROPN
dpc-4547	623	2	tj	tj	PROPN
dpc-4547	623	3	,	,	PUNCT
dpc-4547	623	4	ruiz	ruiz	NOUN
dpc-4547	623	5	es	es	PROPN
dpc-4547	623	6	,	,	PUNCT
dpc-4547	623	7	cornejo	cornejo	PROPN
dpc-4547	623	8	cm	cm	PROPN
dpc-4547	623	9	,	,	PUNCT
dpc-4547	623	10	schmults	schmults	PROPN
dpc-4547	623	11	cd	cd	PROPN
dpc-4547	623	12	,	,	PUNCT
dpc-4547	623	13	arron	arron	PROPN
dpc-4547	623	14	st	st	PROPN
dpc-4547	623	15	,	,	PUNCT
dpc-4547	623	16	jambusaria	jambusaria	PROPN
dpc-4547	623	17	-	-	PUNCT
dpc-4547	623	18	pahlajani	pahlajani	ADJ
dpc-4547	623	19	a.	a.	NOUN
dpc-4547	623	20	field	field	NOUN
dpc-4547	623	21	cancerization	cancerization	NOUN
dpc-4547	623	22	:	:	PUNCT
dpc-4547	624	1	definition	definition	NOUN
dpc-4547	624	2	,	,	PUNCT
dpc-4547	624	3	epidemiology	epidemiology	NOUN
dpc-4547	624	4	,	,	PUNCT
dpc-4547	624	5	risk	risk	NOUN
dpc-4547	624	6	factors	factor	NOUN
dpc-4547	624	7	,	,	PUNCT
dpc-4547	624	8	and	and	CCONJ
dpc-4547	624	9	outcomes	outcome	NOUN
dpc-4547	624	10	.	.	PUNCT
dpc-4547	625	1	j	j	PROPN
dpc-4547	625	2	am	be	AUX
dpc-4547	625	3	acad	acad	ADJ
dpc-4547	625	4	dermatol	dermatol	NOUN
dpc-4547	625	5	.	.	PUNCT
dpc-4547	626	1	2020;83(3):709	2020;83(3):709	NUM
dpc-4547	626	2	-	-	PUNCT
dpc-4547	626	3	17	17	NUM
dpc-4547	626	4	.	.	PUNCT
dpc-4547	627	1	82	82	NUM
dpc-4547	627	2	.	.	PUNCT
dpc-4547	628	1	xiong	xiong	PROPN
dpc-4547	629	1	my	my	PRON
dpc-4547	629	2	,	,	PUNCT
dpc-4547	629	3	rizzo	rizzo	PROPN
dpc-4547	629	4	ae	ae	PROPN
dpc-4547	629	5	,	,	PUNCT
dpc-4547	629	6	cohen	cohen	PROPN
dpc-4547	629	7	ts	ts	PROPN
dpc-4547	629	8	,	,	PUNCT
dpc-4547	629	9	et	et	PROPN
dpc-4547	629	10	al	al	PROPN
dpc-4547	629	11	.	.	PUNCT
dpc-4547	629	12	predictors	predictor	NOUN
dpc-4547	629	13	of	of	ADP
dpc-4547	629	14	squamous	squamous	ADJ
dpc-4547	629	15	cell	cell	NOUN
dpc-4547	629	16	carcinoma	carcinoma	NOUN
dpc-4547	629	17	in	in	ADP
dpc-4547	629	18	high	high	ADJ
dpc-4547	629	19	-	-	PUNCT
dpc-4547	629	20	risk	risk	NOUN
dpc-4547	629	21	patients	patient	NOUN
dpc-4547	629	22	in	in	ADP
dpc-4547	629	23	the	the	DET
dpc-4547	629	24	vattc	vattc	NOUN
dpc-4547	629	25	trial	trial	NOUN
dpc-4547	629	26	.	.	PUNCT
dpc-4547	630	1	j	j	PROPN
dpc-4547	630	2	invest	invest	VERB
dpc-4547	630	3	dermatol	dermatol	NOUN
dpc-4547	630	4	.	.	PUNCT
dpc-4547	631	1	2013;133(6):1521	2013;133(6):1521	NUM
dpc-4547	631	2	-	-	SYM
dpc-4547	631	3	32	32	NUM
dpc-4547	631	4	.	.	PUNCT
dpc-4547	632	1	83	83	NUM
dpc-4547	632	2	.	.	PUNCT
dpc-4547	633	1	schaefer	schaefer	PROPN
dpc-4547	633	2	i	i	PROPN
dpc-4547	633	3	,	,	PUNCT
dpc-4547	633	4	augustin	augustin	PROPN
dpc-4547	633	5	m	m	PROPN
dpc-4547	633	6	,	,	PUNCT
dpc-4547	633	7	spehr	spehr	PROPN
dpc-4547	633	8	c	c	PROPN
dpc-4547	633	9	,	,	PUNCT
dpc-4547	633	10	reusch	reusch	PROPN
dpc-4547	633	11	m	m	PROPN
dpc-4547	633	12	,	,	PUNCT
dpc-4547	633	13	kornek	kornek	ADJ
dpc-4547	633	14	t.	t.	NOUN
dpc-4547	633	15	prevalence	prevalence	NOUN
dpc-4547	633	16	and	and	CCONJ
dpc-4547	633	17	risk	risk	NOUN
dpc-4547	633	18	factors	factor	NOUN
dpc-4547	633	19	of	of	ADP
dpc-4547	633	20	actinic	actinic	ADJ
dpc-4547	633	21	keratoses	keratose	NOUN
dpc-4547	633	22	in	in	ADP
dpc-4547	633	23	germany	germany	PROPN
dpc-4547	633	24	–	–	PUNCT
dpc-4547	633	25	analysis	analysis	NOUN
dpc-4547	633	26	of	of	ADP
dpc-4547	633	27	multisource	multisource	ADJ
dpc-4547	633	28	data	datum	NOUN
dpc-4547	633	29	.	.	PUNCT
dpc-4547	634	1	j	j	PROPN
dpc-4547	634	2	eur	eur	PROPN
dpc-4547	634	3	acad	acad	PROPN
dpc-4547	634	4	dermatol	dermatol	NOUN
dpc-4547	634	5	venereol	venereol	NOUN
dpc-4547	634	6	.	.	PUNCT
dpc-4547	635	1	2014;28(3):309	2014;28(3):309	NUM
dpc-4547	635	2	-	-	SYM
dpc-4547	635	3	13	13	NUM
dpc-4547	635	4	.	.	PUNCT
dpc-4547	635	5	84	84	NUM
dpc-4547	635	6	.	.	PUNCT
dpc-4547	636	1	hensen	hensen	PROPN
dpc-4547	636	2	p	p	PROPN
dpc-4547	636	3	,	,	PUNCT
dpc-4547	636	4	muller	muller	NOUN
dpc-4547	636	5	ml	ml	PROPN
dpc-4547	636	6	,	,	PUNCT
dpc-4547	636	7	haschemi	haschemi	ADV
dpc-4547	636	8	r	r	NOUN
dpc-4547	636	9	,	,	PUNCT
dpc-4547	636	10	et	et	PROPN
dpc-4547	636	11	al	al	PROPN
dpc-4547	636	12	.	.	PUNCT
dpc-4547	636	13	predisposing	predispose	VERB
dpc-4547	636	14	factors	factor	NOUN
dpc-4547	636	15	of	of	ADP
dpc-4547	636	16	actinic	actinic	ADJ
dpc-4547	636	17	keratosis	keratosis	NOUN
dpc-4547	636	18	in	in	ADP
dpc-4547	636	19	a	a	DET
dpc-4547	636	20	north	north	NOUN
dpc-4547	636	21	-	-	PUNCT
dpc-4547	636	22	west	west	ADJ
dpc-4547	636	23	german	german	ADJ
dpc-4547	636	24	population	population	NOUN
dpc-4547	636	25	.	.	PUNCT
dpc-4547	637	1	eur	eur	PROPN
dpc-4547	637	2	j	j	PROPN
dpc-4547	637	3	dermatol	dermatol	NOUN
dpc-4547	637	4	.	.	PUNCT
dpc-4547	638	1	2009;19(4):345	2009;19(4):345	NUM
dpc-4547	638	2	-	-	SYM
dpc-4547	638	3	54	54	NUM
dpc-4547	638	4	.	.	PUNCT
dpc-4547	638	5	85	85	NUM
dpc-4547	638	6	.	.	PUNCT
dpc-4547	639	1	flohil	flohil	PROPN
dpc-4547	639	2	sc	sc	PROPN
dpc-4547	639	3	,	,	PUNCT
dpc-4547	639	4	van	van	PROPN
dpc-4547	639	5	der	der	PROPN
dpc-4547	639	6	leest	leest	PROPN
dpc-4547	639	7	rj	rj	PROPN
dpc-4547	639	8	,	,	PUNCT
dpc-4547	639	9	dowlatshahi	dowlatshahi	PROPN
dpc-4547	639	10	ea	ea	NUM
dpc-4547	639	11	,	,	PUNCT
dpc-4547	639	12	hofman	hofman	PROPN
dpc-4547	639	13	a	a	DET
dpc-4547	639	14	,	,	PUNCT
dpc-4547	639	15	de	de	PROPN
dpc-4547	639	16	vries	vries	PROPN
dpc-4547	639	17	e	e	PROPN
dpc-4547	639	18	,	,	PUNCT
dpc-4547	639	19	nijsten	nijsten	ADJ
dpc-4547	639	20	t.	t.	ADJ
dpc-4547	639	21	prevalence	prevalence	NOUN
dpc-4547	639	22	of	of	ADP
dpc-4547	639	23	actinic	actinic	ADJ
dpc-4547	639	24	keratosis	keratosis	NOUN
dpc-4547	639	25	and	and	CCONJ
dpc-4547	639	26	its	its	PRON
dpc-4547	639	27	risk	risk	NOUN
dpc-4547	639	28	factors	factor	NOUN
dpc-4547	639	29	in	in	ADP
dpc-4547	639	30	the	the	DET
dpc-4547	639	31	general	general	ADJ
dpc-4547	639	32	population	population	NOUN
dpc-4547	639	33	:	:	PUNCT
dpc-4547	639	34	the	the	DET
dpc-4547	639	35	rotterdam	rotterdam	PROPN
dpc-4547	639	36	study	study	NOUN
dpc-4547	639	37	.	.	PUNCT
dpc-4547	640	1	j	j	PROPN
dpc-4547	640	2	invest	invest	VERB
dpc-4547	640	3	dermatol	dermatol	NOUN
dpc-4547	640	4	.	.	PUNCT
dpc-4547	641	1	2013;133(8):1971	2013;133(8):1971	NUM
dpc-4547	641	2	-	-	SYM
dpc-4547	641	3	8	8	NUM
dpc-4547	641	4	.	.	NOUN
dpc-4547	642	1	86	86	NUM
dpc-4547	642	2	.	.	PUNCT
dpc-4547	643	1	mckenzie	mckenzie	PROPN
dpc-4547	643	2	c	c	PROPN
dpc-4547	643	3	,	,	PUNCT
dpc-4547	643	4	nahm	nahm	PROPN
dpc-4547	643	5	wj	wj	PROPN
dpc-4547	643	6	,	,	PUNCT
dpc-4547	643	7	kearney	kearney	PROPN
dpc-4547	643	8	ca	ca	PROPN
dpc-4547	643	9	,	,	PUNCT
dpc-4547	643	10	zampella	zampella	PROPN
dpc-4547	643	11	jg	jg	PROPN
dpc-4547	643	12	.	.	PUNCT
dpc-4547	644	1	sun	sun	PROPN
dpc-4547	644	2	protective	protective	ADJ
dpc-4547	644	3	behaviors	behavior	NOUN
dpc-4547	644	4	and	and	CCONJ
dpc-4547	644	5	sunburn	sunburn	NOUN
dpc-4547	644	6	among	among	ADP
dpc-4547	644	7	us	us	PROPN
dpc-4547	644	8	adults	adult	NOUN
dpc-4547	644	9	.	.	PUNCT
dpc-4547	645	1	arch	arch	ADJ
dpc-4547	645	2	dermatol	dermatol	NOUN
dpc-4547	645	3	res	re	NOUN
dpc-4547	645	4	.	.	PUNCT
dpc-4547	646	1	2023;315(6):1665	2023;315(6):1665	NUM
dpc-4547	646	2	-	-	SYM
dpc-4547	646	3	74	74	NUM
dpc-4547	646	4	.	.	PUNCT
dpc-4547	647	1	87	87	NUM
dpc-4547	647	2	.	.	PUNCT
dpc-4547	648	1	alonso	alonso	PROPN
dpc-4547	648	2	-	-	PUNCT
dpc-4547	648	3	belmonte	belmonte	PROPN
dpc-4547	648	4	c	c	PROPN
dpc-4547	648	5	,	,	PUNCT
dpc-4547	648	6	montero	montero	PROPN
dpc-4547	648	7	-	-	PUNCT
dpc-4547	648	8	vilchez	vilchez	PROPN
dpc-4547	648	9	t	t	PROPN
dpc-4547	648	10	,	,	PUNCT
dpc-4547	648	11	arias	arias	PROPN
dpc-4547	648	12	-	-	PUNCT
dpc-4547	648	13	santiago	santiago	PROPN
dpc-4547	648	14	s	s	PROPN
dpc-4547	648	15	,	,	PUNCT
dpc-4547	648	16	buendia	buendia	PROPN
dpc-4547	648	17	-	-	PUNCT
dpc-4547	648	18	eisman	eisman	PROPN
dpc-4547	648	19	a.	a.	PROPN
dpc-4547	648	20	current	current	PROPN
dpc-4547	648	21	state	state	NOUN
dpc-4547	648	22	of	of	ADP
dpc-4547	648	23	skin	skin	NOUN
dpc-4547	648	24	cancer	cancer	NOUN
dpc-4547	648	25	prevention	prevention	NOUN
dpc-4547	648	26	:	:	PUNCT
dpc-4547	648	27	a	a	DET
dpc-4547	648	28	systematic	systematic	ADJ
dpc-4547	648	29	review	review	NOUN
dpc-4547	648	30	.	.	PUNCT
dpc-4547	649	1	actas	actas	PROPN
dpc-4547	649	2	dermosifiliogr	dermosifiliogr	NOUN
dpc-4547	649	3	.	.	PUNCT
dpc-4547	650	1	2022;113(8):781	2022;113(8):781	X
dpc-4547	650	2	-	-	SYM
dpc-4547	650	3	91	91	NUM
dpc-4547	650	4	.	.	PUNCT
dpc-4547	651	1	88	88	NUM
dpc-4547	651	2	.	.	PUNCT
dpc-4547	652	1	koh	koh	PROPN
dpc-4547	652	2	hk	hk	PROPN
dpc-4547	652	3	,	,	PUNCT
dpc-4547	652	4	geller	geller	PROPN
dpc-4547	652	5	ac	ac	PROPN
dpc-4547	652	6	,	,	PUNCT
dpc-4547	652	7	miller	miller	PROPN
dpc-4547	652	8	dr	dr	PROPN
dpc-4547	652	9	,	,	PUNCT
dpc-4547	652	10	grossbart	grossbart	NOUN
dpc-4547	652	11	ta	ta	PROPN
dpc-4547	652	12	,	,	PUNCT
dpc-4547	652	13	lew	lew	PROPN
dpc-4547	652	14	ra	ra	PROPN
dpc-4547	652	15	.	.	PROPN
dpc-4547	652	16	prevention	prevention	PROPN
dpc-4547	652	17	and	and	CCONJ
dpc-4547	652	18	early	early	ADJ
dpc-4547	652	19	detection	detection	NOUN
dpc-4547	652	20	strategies	strategy	NOUN
dpc-4547	652	21	for	for	ADP
dpc-4547	652	22	melanoma	melanoma	NOUN
dpc-4547	652	23	and	and	CCONJ
dpc-4547	652	24	skin	skin	NOUN
dpc-4547	652	25	cancer	cancer	NOUN
dpc-4547	652	26	.	.	PUNCT
dpc-4547	653	1	current	current	ADJ
dpc-4547	653	2	status	status	NOUN
dpc-4547	653	3	.	.	PUNCT
dpc-4547	654	1	arch	arch	ADJ
dpc-4547	654	2	dermatol	dermatol	NOUN
dpc-4547	654	3	.	.	PUNCT
dpc-4547	655	1	1996;132(4):436	1996;132(4):436	NUM
dpc-4547	655	2	-	-	SYM
dpc-4547	655	3	43	43	NUM
dpc-4547	655	4	.	.	PUNCT
dpc-4547	655	5	89	89	NUM
dpc-4547	655	6	.	.	PUNCT
dpc-4547	656	1	parkin	parkin	PROPN
dpc-4547	656	2	dm	dm	PROPN
dpc-4547	656	3	,	,	PUNCT
dpc-4547	656	4	mesher	mesher	NOUN
dpc-4547	656	5	d	d	NOUN
dpc-4547	656	6	,	,	PUNCT
dpc-4547	657	1	sasieni	sasieni	ADJ
dpc-4547	657	2	p.	p.	NOUN
dpc-4547	657	3	13	13	NUM
dpc-4547	657	4	.	.	PUNCT
dpc-4547	658	1	cancers	cancer	NOUN
dpc-4547	658	2	attributable	attributable	ADJ
dpc-4547	658	3	to	to	ADP
dpc-4547	658	4	solar	solar	ADJ
dpc-4547	658	5	(	(	PUNCT
dpc-4547	658	6	ultraviolet	ultraviolet	NOUN
dpc-4547	658	7	)	)	PUNCT
dpc-4547	658	8	radiation	radiation	NOUN
dpc-4547	658	9	exposure	exposure	NOUN
dpc-4547	658	10	in	in	ADP
dpc-4547	658	11	the	the	DET
dpc-4547	658	12	uk	uk	PROPN
dpc-4547	658	13	in	in	ADP
dpc-4547	658	14	2010	2010	NUM
dpc-4547	658	15	.	.	PUNCT
dpc-4547	659	1	br	br	PROPN
dpc-4547	659	2	j	j	PROPN
dpc-4547	659	3	cancer	cancer	NOUN
dpc-4547	659	4	.	.	PUNCT
dpc-4547	660	1	2011;105	2011;105	NUM
dpc-4547	661	1	suppl	suppl	ADJ
dpc-4547	661	2	2(suppl	2(suppl	PROPN
dpc-4547	661	3	2):s66	2):s66	NUM
dpc-4547	661	4	-	-	SYM
dpc-4547	661	5	9	9	NUM
dpc-4547	661	6	.	.	NOUN
dpc-4547	661	7	90	90	NUM
dpc-4547	661	8	.	.	PUNCT
dpc-4547	662	1	reyes	reyes	PROPN
dpc-4547	662	2	-	-	PUNCT
dpc-4547	662	3	marcelino	marcelino	PROPN
dpc-4547	662	4	g	g	PROPN
dpc-4547	662	5	,	,	PUNCT
dpc-4547	662	6	wang	wang	PROPN
dpc-4547	662	7	r	r	PROPN
dpc-4547	662	8	,	,	PUNCT
dpc-4547	662	9	gultekin	gultekin	PROPN
dpc-4547	662	10	s	s	PROPN
dpc-4547	662	11	,	,	PUNCT
dpc-4547	662	12	et	et	PROPN
dpc-4547	662	13	al	al	PROPN
dpc-4547	662	14	.	.	PUNCT
dpc-4547	663	1	school	school	NOUN
dpc-4547	663	2	-	-	PUNCT
dpc-4547	663	3	based	base	VERB
dpc-4547	663	4	interventions	intervention	NOUN
dpc-4547	663	5	to	to	PART
dpc-4547	663	6	improve	improve	VERB
dpc-4547	663	7	sun	sun	NOUN
dpc-4547	663	8	-	-	PUNCT
dpc-4547	663	9	safe	safe	ADJ
dpc-4547	663	10	knowledge	knowledge	NOUN
dpc-4547	663	11	,	,	PUNCT
dpc-4547	663	12	attitudes	attitude	NOUN
dpc-4547	663	13	and	and	CCONJ
dpc-4547	663	14	behaviors	behavior	NOUN
dpc-4547	663	15	in	in	ADP
dpc-4547	663	16	childhood	childhood	NOUN
dpc-4547	663	17	and	and	CCONJ
dpc-4547	663	18	adolescence	adolescence	NOUN
dpc-4547	663	19	:	:	PUNCT
dpc-4547	663	20	a	a	DET
dpc-4547	663	21	systematic	systematic	ADJ
dpc-4547	663	22	review	review	NOUN
dpc-4547	663	23	.	.	PUNCT
dpc-4547	664	1	prev	prev	PROPN
dpc-4547	664	2	med	med	PROPN
dpc-4547	664	3	.	.	PUNCT
dpc-4547	665	1	2021;146:106459	2021;146:106459	X
dpc-4547	665	2	.	.	PUNCT
dpc-4547	666	1	91	91	NUM
dpc-4547	666	2	.	.	PUNCT
dpc-4547	667	1	thoonen	thoonen	X
dpc-4547	668	1	k	k	PROPN
dpc-4547	668	2	,	,	PUNCT
dpc-4547	668	3	osch	osch	PROPN
dpc-4547	668	4	lv	lv	PROPN
dpc-4547	668	5	,	,	PUNCT
dpc-4547	668	6	vries	vries	PROPN
dpc-4547	668	7	h	h	PROPN
dpc-4547	668	8	,	,	PUNCT
dpc-4547	668	9	jongen	jongen	PROPN
dpc-4547	668	10	s	s	PROPN
dpc-4547	668	11	,	,	PUNCT
dpc-4547	668	12	schneider	schneider	PROPN
dpc-4547	668	13	f.	f.	PROPN
dpc-4547	668	14	are	be	AUX
dpc-4547	668	15	environmental	environmental	ADJ
dpc-4547	668	16	interventions	intervention	NOUN
dpc-4547	668	17	targeting	target	VERB
dpc-4547	668	18	skin	skin	NOUN
dpc-4547	668	19	cancer	cancer	NOUN
dpc-4547	668	20	prevention	prevention	NOUN
dpc-4547	668	21	among	among	ADP
dpc-4547	668	22	children	child	NOUN
dpc-4547	668	23	and	and	CCONJ
dpc-4547	668	24	adolescents	adolescent	NOUN
dpc-4547	668	25	effective	effective	ADJ
dpc-4547	668	26	?	?	PUNCT
dpc-4547	669	1	a	a	DET
dpc-4547	669	2	systematic	systematic	ADJ
dpc-4547	669	3	review	review	NOUN
dpc-4547	669	4	.	.	PUNCT
dpc-4547	670	1	int	int	PROPN
dpc-4547	671	1	j	j	PROPN
dpc-4547	671	2	environ	environ	PROPN
dpc-4547	671	3	res	re	VERB
dpc-4547	671	4	public	public	ADJ
dpc-4547	671	5	health	health	NOUN
dpc-4547	671	6	.	.	PUNCT
dpc-4547	672	1	2020;17(2	2020;17(2	NUM
dpc-4547	672	2	)	)	PUNCT
dpc-4547	672	3	.	.	PUNCT
dpc-4547	673	1	92	92	NUM
dpc-4547	673	2	.	.	PUNCT
dpc-4547	674	1	mcwhirter	mcwhirter	PROPN
dpc-4547	674	2	je	je	PROPN
dpc-4547	674	3	,	,	PUNCT
dpc-4547	674	4	hoffman	hoffman	PROPN
dpc-4547	674	5	-	-	PUNCT
dpc-4547	674	6	goetz	goetz	PROPN
dpc-4547	674	7	l.	l.	PROPN
dpc-4547	674	8	visual	visual	ADJ
dpc-4547	674	9	images	image	NOUN
dpc-4547	674	10	for	for	ADP
dpc-4547	674	11	skin	skin	NOUN
dpc-4547	674	12	cancer	cancer	NOUN
dpc-4547	674	13	prevention	prevention	NOUN
dpc-4547	674	14	:	:	PUNCT
dpc-4547	674	15	a	a	DET
dpc-4547	674	16	systematic	systematic	ADJ
dpc-4547	674	17	review	review	NOUN
dpc-4547	674	18	of	of	ADP
dpc-4547	674	19	qualitative	qualitative	ADJ
dpc-4547	674	20	studies	study	NOUN
dpc-4547	674	21	.	.	PUNCT
dpc-4547	675	1	j	j	PROPN
dpc-4547	675	2	cancer	cancer	NOUN
dpc-4547	675	3	educ	educ	PROPN
dpc-4547	675	4	.	.	PUNCT
dpc-4547	676	1	2012;27(2):202	2012;27(2):202	NUM
dpc-4547	676	2	-	-	SYM
dpc-4547	676	3	16	16	NUM
dpc-4547	676	4	.	.	PUNCT
dpc-4547	677	1	93	93	NUM
dpc-4547	677	2	.	.	PUNCT
dpc-4547	678	1	mcwhirter	mcwhirter	PROPN
dpc-4547	678	2	je	je	PROPN
dpc-4547	678	3	,	,	PUNCT
dpc-4547	678	4	hoffman	hoffman	PROPN
dpc-4547	678	5	-	-	PUNCT
dpc-4547	678	6	goetz	goetz	PROPN
dpc-4547	678	7	l.	l.	PROPN
dpc-4547	678	8	visual	visual	ADJ
dpc-4547	678	9	images	image	NOUN
dpc-4547	678	10	for	for	ADP
dpc-4547	678	11	patient	patient	ADJ
dpc-4547	678	12	skin	skin	NOUN
dpc-4547	678	13	self	self	NOUN
dpc-4547	678	14	-	-	PUNCT
dpc-4547	678	15	examination	examination	NOUN
dpc-4547	678	16	and	and	CCONJ
dpc-4547	678	17	melanoma	melanoma	NOUN
dpc-4547	678	18	detection	detection	NOUN
dpc-4547	678	19	:	:	PUNCT
dpc-4547	678	20	a	a	DET
dpc-4547	678	21	systematic	systematic	ADJ
dpc-4547	678	22	review	review	NOUN
dpc-4547	678	23	of	of	ADP
dpc-4547	678	24	published	publish	VERB
dpc-4547	678	25	studies	study	NOUN
dpc-4547	678	26	.	.	PUNCT
dpc-4547	679	1	j	j	PROPN
dpc-4547	679	2	am	be	AUX
dpc-4547	679	3	acad	acad	ADJ
dpc-4547	679	4	dermatol	dermatol	NOUN
dpc-4547	679	5	.	.	PUNCT
dpc-4547	680	1	2013;69(1):47	2013;69(1):47	NUM
dpc-4547	680	2	-	-	SYM
dpc-4547	680	3	55	55	NUM
dpc-4547	680	4	.	.	PUNCT
dpc-4547	681	1	94	94	NUM
dpc-4547	681	2	.	.	PUNCT
dpc-4547	682	1	mcwhirter	mcwhirter	PROPN
dpc-4547	682	2	je	je	PROPN
dpc-4547	682	3	,	,	PUNCT
dpc-4547	682	4	hoffman	hoffman	PROPN
dpc-4547	682	5	-	-	PUNCT
dpc-4547	682	6	goetz	goetz	PROPN
dpc-4547	682	7	l.	l.	PROPN
dpc-4547	682	8	systematic	systematic	PROPN
dpc-4547	682	9	review	review	PROPN
dpc-4547	682	10	of	of	ADP
dpc-4547	682	11	population	population	NOUN
dpc-4547	682	12	-	-	PUNCT
dpc-4547	682	13	based	base	VERB
dpc-4547	682	14	studies	study	NOUN
dpc-4547	682	15	on	on	ADP
dpc-4547	682	16	the	the	DET
dpc-4547	682	17	impact	impact	NOUN
dpc-4547	682	18	of	of	ADP
dpc-4547	682	19	images	image	NOUN
dpc-4547	682	20	on	on	ADP
dpc-4547	682	21	uv	uv	NOUN
dpc-4547	682	22	attitudes	attitude	NOUN
dpc-4547	682	23	and	and	CCONJ
dpc-4547	682	24	behaviours	behaviour	NOUN
dpc-4547	682	25	.	.	PUNCT
dpc-4547	683	1	health	health	NOUN
dpc-4547	683	2	promot	promot	PROPN
dpc-4547	683	3	int	int	NOUN
dpc-4547	683	4	.	.	PUNCT
dpc-4547	684	1	2015;30(2):397	2015;30(2):397	NUM
dpc-4547	684	2	-	-	SYM
dpc-4547	684	3	410	410	NUM
dpc-4547	684	4	.	.	PUNCT
dpc-4547	684	5	95	95	NUM
dpc-4547	684	6	.	.	PUNCT
dpc-4547	685	1	finch	finch	PROPN
dpc-4547	685	2	l	l	PROPN
dpc-4547	685	3	,	,	PUNCT
dpc-4547	685	4	janda	janda	PROPN
dpc-4547	685	5	m	m	PROPN
dpc-4547	685	6	,	,	PUNCT
dpc-4547	685	7	loescher	loescher	PROPN
dpc-4547	685	8	lj	lj	PROPN
dpc-4547	685	9	,	,	PUNCT
dpc-4547	685	10	hacker	hacker	PROPN
dpc-4547	685	11	e.	e.	PROPN
dpc-4547	685	12	can	can	AUX
dpc-4547	685	13	skin	skin	VERB
dpc-4547	685	14	cancer	cancer	NOUN
dpc-4547	685	15	prevention	prevention	NOUN
dpc-4547	685	16	be	be	AUX
dpc-4547	685	17	improved	improve	VERB
dpc-4547	685	18	through	through	ADP
dpc-4547	685	19	mobile	mobile	ADJ
dpc-4547	685	20	technology	technology	NOUN
dpc-4547	685	21	interventions	intervention	NOUN
dpc-4547	685	22	?	?	PUNCT
dpc-4547	686	1	a	a	DET
dpc-4547	686	2	systematic	systematic	ADJ
dpc-4547	686	3	review	review	NOUN
dpc-4547	686	4	.	.	PUNCT
dpc-4547	687	1	prev	prev	PROPN
dpc-4547	687	2	med	med	PROPN
dpc-4547	687	3	.	.	PUNCT
dpc-4547	688	1	2016;90:121	2016;90:121	NUM
dpc-4547	688	2	-	-	SYM
dpc-4547	688	3	32	32	NUM
dpc-4547	688	4	.	.	PUNCT
dpc-4547	689	1	96	96	NUM
dpc-4547	689	2	.	.	PUNCT
dpc-4547	689	3	chambergo	chambergo	NOUN
dpc-4547	689	4	-	-	PUNCT
dpc-4547	689	5	michilot	michilot	PROPN
dpc-4547	689	6	d	d	NOUN
dpc-4547	689	7	,	,	PUNCT
dpc-4547	689	8	tellez	tellez	PROPN
dpc-4547	689	9	wa	wa	PROPN
dpc-4547	689	10	,	,	PUNCT
dpc-4547	689	11	becerra	becerra	PROPN
dpc-4547	689	12	-	-	PUNCT
dpc-4547	689	13	chauca	chauca	PROPN
dpc-4547	689	14	n	n	CCONJ
dpc-4547	689	15	,	,	PUNCT
dpc-4547	689	16	zafra	zafra	PROPN
dpc-4547	689	17	-	-	PUNCT
dpc-4547	689	18	tanaka	tanaka	PROPN
dpc-4547	689	19	jh	jh	PROPN
dpc-4547	689	20	,	,	PUNCT
dpc-4547	689	21	taype	taype	NOUN
dpc-4547	689	22	-	-	PUNCT
dpc-4547	689	23	rondan	rondan	NOUN
dpc-4547	689	24	a.	a.	NOUN
dpc-4547	689	25	text	text	NOUN
dpc-4547	689	26	message	message	NOUN
dpc-4547	689	27	reminders	reminder	NOUN
dpc-4547	689	28	for	for	ADP
dpc-4547	689	29	improving	improve	VERB
dpc-4547	689	30	sun	sun	NOUN
dpc-4547	689	31	protection	protection	NOUN
dpc-4547	689	32	habits	habit	NOUN
dpc-4547	689	33	:	:	PUNCT
dpc-4547	689	34	a	a	DET
dpc-4547	689	35	systematic	systematic	ADJ
dpc-4547	689	36	review	review	NOUN
dpc-4547	689	37	.	.	PUNCT
dpc-4547	690	1	plos	plos	PROPN
dpc-4547	690	2	one	one	NUM
dpc-4547	690	3	.	.	PUNCT
dpc-4547	691	1	2020;15(5):e0233220	2020;15(5):e0233220	X
dpc-4547	691	2	.	.	NOUN
dpc-4547	691	3	63	63	NUM
dpc-4547	691	4	.	.	PUNCT
dpc-4547	692	1	brewer	brewer	PROPN
dpc-4547	692	2	jd	jd	PROPN
dpc-4547	692	3	,	,	PUNCT
dpc-4547	692	4	shanafelt	shanafelt	ADJ
dpc-4547	692	5	td	td	PROPN
dpc-4547	692	6	,	,	PUNCT
dpc-4547	692	7	khezri	khezri	PROPN
dpc-4547	692	8	f	f	PROPN
dpc-4547	692	9	,	,	PUNCT
dpc-4547	692	10	et	et	PROPN
dpc-4547	692	11	al	al	PROPN
dpc-4547	692	12	.	.	PROPN
dpc-4547	692	13	increased	increase	VERB
dpc-4547	692	14	incidence	incidence	NOUN
dpc-4547	692	15	and	and	CCONJ
dpc-4547	692	16	recurrence	recurrence	NOUN
dpc-4547	692	17	rates	rate	NOUN
dpc-4547	692	18	of	of	ADP
dpc-4547	692	19	nonmelanoma	nonmelanoma	ADJ
dpc-4547	692	20	skin	skin	NOUN
dpc-4547	692	21	cancer	cancer	NOUN
dpc-4547	692	22	in	in	ADP
dpc-4547	692	23	patients	patient	NOUN
dpc-4547	692	24	with	with	ADP
dpc-4547	692	25	non	non	ADJ
dpc-4547	692	26	-	-	ADJ
dpc-4547	692	27	hodgkin	hodgkin	ADJ
dpc-4547	692	28	lymphoma	lymphoma	NOUN
dpc-4547	692	29	:	:	PUNCT
dpc-4547	692	30	a	a	DET
dpc-4547	692	31	rochester	rochester	PROPN
dpc-4547	692	32	epidemiology	epidemiology	NOUN
dpc-4547	692	33	project	project	NOUN
dpc-4547	692	34	population	population	NOUN
dpc-4547	692	35	-	-	PUNCT
dpc-4547	692	36	based	base	VERB
dpc-4547	692	37	study	study	NOUN
dpc-4547	692	38	in	in	ADP
dpc-4547	692	39	minnesota	minnesota	PROPN
dpc-4547	692	40	.	.	PUNCT
dpc-4547	693	1	j	j	PROPN
dpc-4547	693	2	am	be	AUX
dpc-4547	693	3	acad	acad	ADJ
dpc-4547	693	4	dermatol	dermatol	NOUN
dpc-4547	693	5	.	.	PUNCT
dpc-4547	694	1	2015;72(2):302	2015;72(2):302	NUM
dpc-4547	694	2	-	-	SYM
dpc-4547	694	3	9	9	NUM
dpc-4547	694	4	.	.	NOUN
dpc-4547	694	5	64	64	NUM
dpc-4547	694	6	.	.	PUNCT
dpc-4547	695	1	mehrany	mehrany	VERB
dpc-4547	695	2	k	k	NOUN
dpc-4547	695	3	,	,	PUNCT
dpc-4547	695	4	weenig	weenig	PROPN
dpc-4547	695	5	rh	rh	PROPN
dpc-4547	695	6	,	,	PUNCT
dpc-4547	695	7	lee	lee	PROPN
dpc-4547	695	8	kk	kk	PROPN
dpc-4547	695	9	,	,	PUNCT
dpc-4547	695	10	pittelkow	pittelkow	PROPN
dpc-4547	695	11	mr	mr	PROPN
dpc-4547	695	12	,	,	PUNCT
dpc-4547	695	13	otley	otley	PROPN
dpc-4547	695	14	cc	cc	PROPN
dpc-4547	695	15	.	.	PROPN
dpc-4547	695	16	increased	increase	VERB
dpc-4547	695	17	metastasis	metastasis	NOUN
dpc-4547	695	18	and	and	CCONJ
dpc-4547	695	19	mortality	mortality	NOUN
dpc-4547	695	20	from	from	ADP
dpc-4547	695	21	cutaneous	cutaneous	ADJ
dpc-4547	695	22	squamous	squamous	ADJ
dpc-4547	695	23	cell	cell	NOUN
dpc-4547	695	24	carcinoma	carcinoma	NOUN
dpc-4547	695	25	in	in	ADP
dpc-4547	695	26	patients	patient	NOUN
dpc-4547	695	27	with	with	ADP
dpc-4547	695	28	chronic	chronic	ADJ
dpc-4547	695	29	lymphocytic	lymphocytic	ADJ
dpc-4547	695	30	leukemia	leukemia	NOUN
dpc-4547	695	31	.	.	PUNCT
dpc-4547	696	1	j	j	PROPN
dpc-4547	696	2	am	be	AUX
dpc-4547	696	3	acad	acad	ADJ
dpc-4547	696	4	dermatol	dermatol	NOUN
dpc-4547	696	5	.	.	PUNCT
dpc-4547	697	1	2005;53(6):1067	2005;53(6):1067	NUM
dpc-4547	697	2	-	-	SYM
dpc-4547	697	3	71	71	NUM
dpc-4547	697	4	.	.	PUNCT
dpc-4547	697	5	65	65	NUM
dpc-4547	697	6	.	.	PUNCT
dpc-4547	698	1	perez	perez	PROPN
dpc-4547	698	2	hc	hc	PROPN
dpc-4547	698	3	,	,	PUNCT
dpc-4547	698	4	benavides	benavides	PROPN
dpc-4547	698	5	x	x	PROPN
dpc-4547	698	6	,	,	PUNCT
dpc-4547	698	7	perez	perez	PROPN
dpc-4547	698	8	js	js	PROPN
dpc-4547	698	9	,	,	PUNCT
dpc-4547	698	10	et	et	PROPN
dpc-4547	698	11	al	al	PROPN
dpc-4547	698	12	.	.	PUNCT
dpc-4547	698	13	basic	basic	ADJ
dpc-4547	698	14	aspects	aspect	NOUN
dpc-4547	698	15	of	of	ADP
dpc-4547	698	16	the	the	DET
dpc-4547	698	17	pathogenesis	pathogenesis	NOUN
dpc-4547	698	18	and	and	CCONJ
dpc-4547	698	19	prevention	prevention	NOUN
dpc-4547	698	20	of	of	ADP
dpc-4547	698	21	non	non	ADJ
dpc-4547	698	22	-	-	ADJ
dpc-4547	698	23	melanoma	melanoma	ADJ
dpc-4547	698	24	skin	skin	NOUN
dpc-4547	698	25	cancer	cancer	NOUN
dpc-4547	698	26	in	in	ADP
dpc-4547	698	27	solid	solid	ADJ
dpc-4547	698	28	organ	organ	NOUN
dpc-4547	698	29	transplant	transplant	NOUN
dpc-4547	698	30	recipients	recipient	NOUN
dpc-4547	698	31	:	:	PUNCT
dpc-4547	698	32	a	a	DET
dpc-4547	698	33	review	review	NOUN
dpc-4547	698	34	.	.	PUNCT
dpc-4547	699	1	int	int	NOUN
dpc-4547	699	2	j	j	PROPN
dpc-4547	699	3	dermatol	dermatol	NOUN
dpc-4547	699	4	.	.	PUNCT
dpc-4547	700	1	2017;56(4):370	2017;56(4):370	NUM
dpc-4547	700	2	-	-	SYM
dpc-4547	700	3	8	8	NUM
dpc-4547	700	4	.	.	PUNCT
dpc-4547	701	1	66	66	NUM
dpc-4547	701	2	.	.	PUNCT
dpc-4547	702	1	euvrard	euvrard	PROPN
dpc-4547	702	2	s	s	PROPN
dpc-4547	702	3	,	,	PUNCT
dpc-4547	702	4	morelon	morelon	PROPN
dpc-4547	702	5	e	e	NOUN
dpc-4547	702	6	,	,	PUNCT
dpc-4547	702	7	rostaing	rostae	VERB
dpc-4547	702	8	l	l	NOUN
dpc-4547	702	9	,	,	PUNCT
dpc-4547	702	10	et	et	PROPN
dpc-4547	702	11	al	al	PROPN
dpc-4547	702	12	.	.	PROPN
dpc-4547	702	13	sirolimus	sirolimus	PROPN
dpc-4547	702	14	and	and	CCONJ
dpc-4547	702	15	secondary	secondary	ADJ
dpc-4547	702	16	skin	skin	NOUN
dpc-4547	702	17	-	-	PUNCT
dpc-4547	702	18	cancer	cancer	NOUN
dpc-4547	702	19	prevention	prevention	NOUN
dpc-4547	702	20	in	in	ADP
dpc-4547	702	21	kidney	kidney	NOUN
dpc-4547	702	22	transplantation	transplantation	NOUN
dpc-4547	702	23	.	.	PUNCT
dpc-4547	703	1	n	n	CCONJ
dpc-4547	703	2	engl	engl	PROPN
dpc-4547	703	3	j	j	PROPN
dpc-4547	703	4	med	med	PROPN
dpc-4547	703	5	.	.	PUNCT
dpc-4547	704	1	2012;367(4):329	2012;367(4):329	NUM
dpc-4547	704	2	-	-	SYM
dpc-4547	704	3	39	39	NUM
dpc-4547	704	4	.	.	PUNCT
dpc-4547	705	1	67	67	NUM
dpc-4547	705	2	.	.	PUNCT
dpc-4547	706	1	salgo	salgo	PROPN
dpc-4547	706	2	r	r	PROPN
dpc-4547	706	3	,	,	PUNCT
dpc-4547	706	4	gossmann	gossmann	PROPN
dpc-4547	706	5	j	j	PROPN
dpc-4547	706	6	,	,	PUNCT
dpc-4547	706	7	schofer	schofer	VERB
dpc-4547	706	8	h	h	NOUN
dpc-4547	706	9	,	,	PUNCT
dpc-4547	706	10	et	et	PROPN
dpc-4547	706	11	al	al	PROPN
dpc-4547	706	12	.	.	PROPN
dpc-4547	706	13	switch	switch	PROPN
dpc-4547	706	14	to	to	ADP
dpc-4547	706	15	a	a	DET
dpc-4547	706	16	sirolimus	sirolimus	NOUN
dpc-4547	706	17	-	-	PUNCT
dpc-4547	706	18	based	base	VERB
dpc-4547	706	19	immunosuppression	immunosuppression	NOUN
dpc-4547	706	20	in	in	ADP
dpc-4547	706	21	long	long	ADJ
dpc-4547	706	22	-	-	PUNCT
dpc-4547	706	23	term	term	NOUN
dpc-4547	706	24	renal	renal	ADJ
dpc-4547	706	25	transplant	transplant	NOUN
dpc-4547	706	26	recipients	recipient	NOUN
dpc-4547	706	27	:	:	PUNCT
dpc-4547	706	28	reduced	reduce	VERB
dpc-4547	706	29	rate	rate	NOUN
dpc-4547	706	30	of	of	ADP
dpc-4547	706	31	(	(	PUNCT
dpc-4547	706	32	pre-)malignancies	pre-)malignancie	NOUN
dpc-4547	706	33	and	and	CCONJ
dpc-4547	706	34	nonmelanoma	nonmelanoma	ADJ
dpc-4547	706	35	skin	skin	NOUN
dpc-4547	706	36	cancer	cancer	NOUN
dpc-4547	706	37	in	in	ADP
dpc-4547	706	38	a	a	DET
dpc-4547	706	39	prospective	prospective	ADJ
dpc-4547	706	40	,	,	PUNCT
dpc-4547	706	41	randomized	randomize	VERB
dpc-4547	706	42	,	,	PUNCT
dpc-4547	706	43	assessor	assessor	NOUN
dpc-4547	706	44	-	-	PUNCT
dpc-4547	706	45	blinded	blind	VERB
dpc-4547	706	46	,	,	PUNCT
dpc-4547	706	47	controlled	control	VERB
dpc-4547	706	48	clinical	clinical	ADJ
dpc-4547	706	49	trial	trial	NOUN
dpc-4547	706	50	.	.	PUNCT
dpc-4547	707	1	am	be	AUX
dpc-4547	707	2	j	j	PROPN
dpc-4547	707	3	transplant	transplant	NOUN
dpc-4547	707	4	.	.	PUNCT
dpc-4547	708	1	2010;10(6):1385	2010;10(6):1385	NUM
dpc-4547	708	2	-	-	SYM
dpc-4547	708	3	93	93	NUM
dpc-4547	708	4	.	.	PUNCT
dpc-4547	709	1	68	68	NUM
dpc-4547	709	2	.	.	PUNCT
dpc-4547	710	1	campistol	campistol	PROPN
dpc-4547	710	2	jm	jm	PROPN
dpc-4547	710	3	,	,	PUNCT
dpc-4547	710	4	eris	eris	PROPN
dpc-4547	710	5	j	j	PROPN
dpc-4547	710	6	,	,	PUNCT
dpc-4547	710	7	oberbauer	oberbauer	NOUN
dpc-4547	710	8	r	r	NOUN
dpc-4547	710	9	,	,	PUNCT
dpc-4547	710	10	et	et	PROPN
dpc-4547	710	11	al	al	PROPN
dpc-4547	710	12	.	.	PROPN
dpc-4547	711	1	sirolimus	sirolimus	PROPN
dpc-4547	711	2	therapy	therapy	NOUN
dpc-4547	711	3	after	after	SCONJ
dpc-4547	711	4	early	early	ADJ
dpc-4547	711	5	cyclosporine	cyclosporine	NOUN
dpc-4547	711	6	withdrawal	withdrawal	NOUN
dpc-4547	711	7	reduces	reduce	VERB
dpc-4547	711	8	the	the	DET
dpc-4547	711	9	risk	risk	NOUN
dpc-4547	711	10	for	for	ADP
dpc-4547	711	11	cancer	cancer	NOUN
dpc-4547	711	12	in	in	ADP
dpc-4547	711	13	adult	adult	NOUN
dpc-4547	711	14	renal	renal	ADJ
dpc-4547	711	15	transplantation	transplantation	NOUN
dpc-4547	711	16	.	.	PUNCT
dpc-4547	712	1	j	j	PROPN
dpc-4547	712	2	am	be	AUX
dpc-4547	712	3	soc	soc	NOUN
dpc-4547	712	4	nephrol	nephrol	NOUN
dpc-4547	712	5	.	.	PUNCT
dpc-4547	713	1	2006;17(2):581	2006;17(2):581	NUM
dpc-4547	713	2	-	-	SYM
dpc-4547	713	3	9	9	NUM
dpc-4547	713	4	.	.	NUM
dpc-4547	713	5	69	69	NUM
dpc-4547	713	6	.	.	PUNCT
dpc-4547	714	1	harwood	harwood	NOUN
dpc-4547	714	2	ca	can	AUX
dpc-4547	714	3	,	,	PUNCT
dpc-4547	714	4	surentheran	surentheran	VERB
dpc-4547	714	5	t	t	PROPN
dpc-4547	714	6	,	,	PUNCT
dpc-4547	714	7	mcgregor	mcgregor	PROPN
dpc-4547	714	8	jm	jm	PROPN
dpc-4547	714	9	,	,	PUNCT
dpc-4547	714	10	et	et	PROPN
dpc-4547	714	11	al	al	PROPN
dpc-4547	714	12	.	.	PROPN
dpc-4547	715	1	human	human	ADJ
dpc-4547	715	2	papillomavirus	papillomavirus	NOUN
dpc-4547	715	3	infection	infection	NOUN
dpc-4547	715	4	and	and	CCONJ
dpc-4547	715	5	non	non	ADJ
dpc-4547	715	6	-	-	ADJ
dpc-4547	715	7	melanoma	melanoma	ADJ
dpc-4547	715	8	skin	skin	NOUN
dpc-4547	715	9	cancer	cancer	NOUN
dpc-4547	715	10	in	in	ADP
dpc-4547	715	11	immunosuppressed	immunosuppressed	ADJ
dpc-4547	715	12	and	and	CCONJ
dpc-4547	715	13	immunocompetent	immunocompetent	ADJ
dpc-4547	715	14	individuals	individual	NOUN
dpc-4547	715	15	.	.	PUNCT
dpc-4547	716	1	j	j	PROPN
dpc-4547	716	2	med	med	PROPN
dpc-4547	716	3	virol	virol	NOUN
dpc-4547	716	4	.	.	PUNCT
dpc-4547	717	1	2000;61(3):289	2000;61(3):289	NUM
dpc-4547	717	2	-	-	SYM
dpc-4547	717	3	97	97	NUM
dpc-4547	717	4	.	.	PUNCT
dpc-4547	718	1	70	70	NUM
dpc-4547	718	2	.	.	PUNCT
dpc-4547	719	1	lens	lens	PROPN
dpc-4547	719	2	m	m	PROPN
dpc-4547	719	3	,	,	PUNCT
dpc-4547	719	4	medenica	medenica	PROPN
dpc-4547	719	5	l.	l.	PROPN
dpc-4547	719	6	systemic	systemic	ADJ
dpc-4547	719	7	retinoids	retinoid	NOUN
dpc-4547	719	8	in	in	ADP
dpc-4547	719	9	chemoprevention	chemoprevention	NOUN
dpc-4547	719	10	of	of	ADP
dpc-4547	719	11	non	non	ADJ
dpc-4547	719	12	-	-	ADJ
dpc-4547	719	13	melanoma	melanoma	ADJ
dpc-4547	719	14	skin	skin	NOUN
dpc-4547	719	15	cancer	cancer	NOUN
dpc-4547	719	16	.	.	PUNCT
dpc-4547	720	1	expert	expert	NOUN
dpc-4547	720	2	opin	opin	NOUN
dpc-4547	720	3	pharmacother	pharmacother	NOUN
dpc-4547	720	4	.	.	PUNCT
dpc-4547	721	1	2008;9(8):1363	2008;9(8):1363	NUM
dpc-4547	721	2	-	-	SYM
dpc-4547	721	3	74	74	NUM
dpc-4547	721	4	.	.	PUNCT
dpc-4547	722	1	71	71	NUM
dpc-4547	722	2	.	.	PUNCT
dpc-4547	723	1	somani	somani	PROPN
dpc-4547	723	2	rr	rr	PROPN
dpc-4547	723	3	,	,	PUNCT
dpc-4547	723	4	rai	rai	PROPN
dpc-4547	723	5	pr	pr	PROPN
dpc-4547	723	6	,	,	PUNCT
dpc-4547	723	7	kandpile	kandpile	ADJ
dpc-4547	723	8	ps	ps	PROPN
dpc-4547	723	9	.	.	PROPN
dpc-4547	723	10	ornithine	ornithine	PROPN
dpc-4547	723	11	decarboxylase	decarboxylase	NOUN
dpc-4547	723	12	inhibition	inhibition	NOUN
dpc-4547	723	13	:	:	PUNCT
dpc-4547	723	14	a	a	DET
dpc-4547	723	15	strategy	strategy	NOUN
dpc-4547	723	16	to	to	PART
dpc-4547	723	17	combat	combat	VERB
dpc-4547	723	18	various	various	ADJ
dpc-4547	723	19	diseases	disease	NOUN
dpc-4547	723	20	.	.	PUNCT
dpc-4547	724	1	mini	mini	PROPN
dpc-4547	724	2	rev	rev	PROPN
dpc-4547	724	3	med	med	PROPN
dpc-4547	724	4	chem	chem	NOUN
dpc-4547	724	5	.	.	PUNCT
dpc-4547	725	1	2018;18(12):1008	2018;18(12):1008	NUM
dpc-4547	725	2	-	-	SYM
dpc-4547	725	3	21	21	NUM
dpc-4547	725	4	.	.	PUNCT
dpc-4547	726	1	72	72	NUM
dpc-4547	726	2	.	.	PUNCT
dpc-4547	727	1	allnutt	allnutt	PROPN
dpc-4547	727	2	kj	kj	PROPN
dpc-4547	727	3	,	,	PUNCT
dpc-4547	727	4	vogrin	vogrin	PROPN
dpc-4547	727	5	s	s	PROPN
dpc-4547	727	6	,	,	PUNCT
dpc-4547	727	7	li	li	PROPN
dpc-4547	727	8	j	j	PROPN
dpc-4547	727	9	,	,	PUNCT
dpc-4547	727	10	et	et	PROPN
dpc-4547	727	11	al	al	PROPN
dpc-4547	727	12	.	.	PUNCT
dpc-4547	728	1	a	a	DET
dpc-4547	728	2	long	long	ADJ
dpc-4547	728	3	-	-	PUNCT
dpc-4547	728	4	term	term	NOUN
dpc-4547	728	5	cohort	cohort	NOUN
dpc-4547	728	6	study	study	NOUN
dpc-4547	728	7	of	of	ADP
dpc-4547	728	8	acitretin	acitretin	NOUN
dpc-4547	728	9	for	for	ADP
dpc-4547	728	10	prevention	prevention	NOUN
dpc-4547	728	11	of	of	ADP
dpc-4547	728	12	keratinocyte	keratinocyte	NOUN
dpc-4547	728	13	carcinoma	carcinoma	NOUN
dpc-4547	728	14	in	in	ADP
dpc-4547	728	15	solid	solid	ADJ
dpc-4547	728	16	organ	organ	NOUN
dpc-4547	728	17	transplant	transplant	NOUN
dpc-4547	728	18	recipients	recipient	NOUN
dpc-4547	728	19	.	.	PUNCT
dpc-4547	729	1	australas	australas	PROPN
dpc-4547	729	2	j	j	PROPN
dpc-4547	729	3	dermatol	dermatol	NOUN
dpc-4547	729	4	.	.	PUNCT
dpc-4547	730	1	2022;63(2):e121	2022;63(2):e121	NOUN
dpc-4547	730	2	-	-	PUNCT
dpc-4547	730	3	e6	e6	NOUN
dpc-4547	730	4	.	.	PUNCT
dpc-4547	731	1	73	73	NUM
dpc-4547	731	2	.	.	PUNCT
dpc-4547	732	1	bavinck	bavinck	PROPN
dpc-4547	732	2	jn	jn	PROPN
dpc-4547	732	3	,	,	PUNCT
dpc-4547	732	4	tieben	tieben	PROPN
dpc-4547	732	5	lm	lm	PROPN
dpc-4547	732	6	,	,	PUNCT
dpc-4547	732	7	van	van	PROPN
dpc-4547	732	8	der	der	PROPN
dpc-4547	732	9	woude	woude	VERB
dpc-4547	732	10	fj	fj	PROPN
dpc-4547	732	11	,	,	PUNCT
dpc-4547	732	12	et	et	PROPN
dpc-4547	732	13	al	al	PROPN
dpc-4547	732	14	.	.	PROPN
dpc-4547	732	15	prevention	prevention	PROPN
dpc-4547	732	16	of	of	ADP
dpc-4547	732	17	skin	skin	NOUN
dpc-4547	732	18	cancer	cancer	NOUN
dpc-4547	732	19	and	and	CCONJ
dpc-4547	732	20	reduction	reduction	NOUN
dpc-4547	732	21	of	of	ADP
dpc-4547	732	22	keratotic	keratotic	ADJ
dpc-4547	732	23	skin	skin	NOUN
dpc-4547	732	24	lesions	lesion	NOUN
dpc-4547	732	25	during	during	ADP
dpc-4547	732	26	acitretin	acitretin	NOUN
dpc-4547	732	27	therapy	therapy	NOUN
dpc-4547	732	28	in	in	ADP
dpc-4547	732	29	renal	renal	ADJ
dpc-4547	732	30	transplant	transplant	NOUN
dpc-4547	732	31	recipients	recipient	NOUN
dpc-4547	732	32	:	:	PUNCT
dpc-4547	732	33	a	a	DET
dpc-4547	732	34	double	double	ADJ
dpc-4547	732	35	-	-	PUNCT
dpc-4547	732	36	blind	blind	ADJ
dpc-4547	732	37	,	,	PUNCT
dpc-4547	732	38	placebo	placebo	NOUN
dpc-4547	732	39	controlled	control	VERB
dpc-4547	732	40	study	study	NOUN
dpc-4547	732	41	.	.	PUNCT
dpc-4547	733	1	j	j	PROPN
dpc-4547	733	2	clin	clin	PROPN
dpc-4547	733	3	oncol	oncol	PROPN
dpc-4547	733	4	.	.	PUNCT
dpc-4547	734	1	1995;13(8):1933	1995;13(8):1933	NUM
dpc-4547	734	2	-	-	SYM
dpc-4547	734	3	8	8	NUM
dpc-4547	734	4	.	.	X
dpc-4547	734	5	74	74	NUM
dpc-4547	734	6	.	.	PUNCT
dpc-4547	735	1	george	george	PROPN
dpc-4547	735	2	r	r	PROPN
dpc-4547	735	3	,	,	PUNCT
dpc-4547	735	4	weightman	weightman	ADJ
dpc-4547	735	5	w	w	PROPN
dpc-4547	735	6	,	,	PUNCT
dpc-4547	735	7	russ	russ	PROPN
dpc-4547	735	8	gr	gr	PROPN
dpc-4547	735	9	,	,	PUNCT
dpc-4547	735	10	bannister	bannister	PROPN
dpc-4547	735	11	km	km	PROPN
dpc-4547	735	12	,	,	PUNCT
dpc-4547	735	13	mathew	mathew	PROPN
dpc-4547	735	14	th	th	PROPN
dpc-4547	735	15	.	.	PUNCT
dpc-4547	735	16	acitretin	acitretin	PROPN
dpc-4547	735	17	for	for	ADP
dpc-4547	735	18	chemoprevention	chemoprevention	NOUN
dpc-4547	735	19	of	of	ADP
dpc-4547	735	20	non	non	ADJ
dpc-4547	735	21	-	-	ADJ
dpc-4547	735	22	melanoma	melanoma	ADJ
dpc-4547	735	23	skin	skin	NOUN
dpc-4547	735	24	cancers	cancer	NOUN
dpc-4547	735	25	in	in	ADP
dpc-4547	735	26	renal	renal	ADJ
dpc-4547	735	27	transplant	transplant	NOUN
dpc-4547	735	28	recipients	recipient	NOUN
dpc-4547	735	29	.	.	PUNCT
dpc-4547	736	1	australas	australas	PROPN
dpc-4547	736	2	j	j	PROPN
dpc-4547	736	3	dermatol	dermatol	NOUN
dpc-4547	736	4	.	.	PUNCT
dpc-4547	737	1	2002	2002	NUM
dpc-4547	737	2	;	;	PUNCT
dpc-4547	737	3	43(4):269	43(4):269	PROPN
dpc-4547	737	4	-	-	PUNCT
dpc-4547	737	5	73	73	NUM
dpc-4547	737	6	.	.	PUNCT
dpc-4547	738	1	75	75	NUM
dpc-4547	738	2	.	.	PUNCT
dpc-4547	739	1	harwood	harwood	PROPN
dpc-4547	739	2	ca	ca	PROPN
dpc-4547	739	3	,	,	PUNCT
dpc-4547	739	4	leedham	leedham	NOUN
dpc-4547	739	5	-	-	PUNCT
dpc-4547	739	6	green	green	PROPN
dpc-4547	739	7	m	m	PROPN
dpc-4547	739	8	,	,	PUNCT
dpc-4547	739	9	leigh	leigh	PROPN
dpc-4547	739	10	i	i	PROPN
dpc-4547	739	11	m	m	PROPN
dpc-4547	739	12	,	,	PUNCT
dpc-4547	739	13	proby	proby	ADJ
dpc-4547	739	14	cm	cm	NOUN
dpc-4547	739	15	.	.	PUNCT
dpc-4547	740	1	lowdose	lowdose	ADJ
dpc-4547	740	2	retinoids	retinoid	NOUN
dpc-4547	740	3	in	in	ADP
dpc-4547	740	4	the	the	DET
dpc-4547	740	5	prevention	prevention	NOUN
dpc-4547	740	6	of	of	ADP
dpc-4547	740	7	cutaneous	cutaneous	ADJ
dpc-4547	740	8	squamous	squamous	ADJ
dpc-4547	740	9	cell	cell	NOUN
dpc-4547	740	10	carcinomas	carcinoma	NOUN
dpc-4547	740	11	in	in	ADP
dpc-4547	740	12	organ	organ	NOUN
dpc-4547	740	13	transplant	transplant	NOUN
dpc-4547	740	14	recipients	recipient	NOUN
dpc-4547	740	15	:	:	PUNCT
dpc-4547	740	16	a	a	DET
dpc-4547	740	17	16	16	NUM
dpc-4547	740	18	-	-	PUNCT
dpc-4547	740	19	year	year	NOUN
dpc-4547	740	20	retrospective	retrospective	ADJ
dpc-4547	740	21	study	study	NOUN
dpc-4547	740	22	.	.	PUNCT
dpc-4547	741	1	arch	arch	ADJ
dpc-4547	741	2	dermatol	dermatol	NOUN
dpc-4547	741	3	.	.	PUNCT
dpc-4547	742	1	2005;141(4):456	2005;141(4):456	NUM
dpc-4547	742	2	-	-	SYM
dpc-4547	742	3	64	64	NUM
dpc-4547	742	4	.	.	PUNCT
dpc-4547	743	1	76	76	NUM
dpc-4547	743	2	.	.	PUNCT
dpc-4547	744	1	massey	massey	PROPN
dpc-4547	744	2	pr	pr	PROPN
dpc-4547	744	3	,	,	PUNCT
dpc-4547	744	4	schmults	schmults	PROPN
dpc-4547	744	5	cd	cd	PROPN
dpc-4547	744	6	,	,	PUNCT
dpc-4547	744	7	li	li	PROPN
dpc-4547	744	8	sj	sj	PROPN
dpc-4547	744	9	,	,	PUNCT
dpc-4547	744	10	et	et	PROPN
dpc-4547	744	11	al	al	PROPN
dpc-4547	744	12	.	.	PUNCT
dpc-4547	745	1	consensus	consensus	NOUN
dpc-4547	745	2	-	-	PUNCT
dpc-4547	745	3	based	base	VERB
dpc-4547	745	4	recommendations	recommendation	NOUN
dpc-4547	745	5	on	on	ADP
dpc-4547	745	6	the	the	DET
dpc-4547	745	7	prevention	prevention	NOUN
dpc-4547	745	8	of	of	ADP
dpc-4547	745	9	squamous	squamous	ADJ
dpc-4547	745	10	cell	cell	NOUN
dpc-4547	745	11	carcinoma	carcinoma	NOUN
dpc-4547	745	12	in	in	ADP
dpc-4547	745	13	solid	solid	ADJ
dpc-4547	745	14	organ	organ	NOUN
dpc-4547	745	15	transplant	transplant	NOUN
dpc-4547	745	16	recipients	recipient	NOUN
dpc-4547	745	17	:	:	PUNCT
dpc-4547	745	18	a	a	DET
dpc-4547	745	19	delphi	delphi	ADJ
dpc-4547	745	20	consensus	consensus	NOUN
dpc-4547	745	21	statement	statement	NOUN
dpc-4547	745	22	.	.	PUNCT
dpc-4547	746	1	jama	jama	PROPN
dpc-4547	746	2	dermatol	dermatol	NOUN
dpc-4547	746	3	.	.	PUNCT
dpc-4547	747	1	2021;157(10):1219	2021;157(10):1219	NUM
dpc-4547	747	2	-	-	SYM
dpc-4547	747	3	26	26	NUM
dpc-4547	747	4	.	.	PUNCT
dpc-4547	748	1	77	77	NUM
dpc-4547	748	2	.	.	PUNCT
dpc-4547	749	1	levine	levine	PROPN
dpc-4547	749	2	de	de	PROPN
dpc-4547	749	3	,	,	PUNCT
dpc-4547	749	4	karia	karia	PROPN
dpc-4547	749	5	ps	ps	PROPN
dpc-4547	749	6	,	,	PUNCT
dpc-4547	749	7	schmults	schmults	PROPN
dpc-4547	749	8	cd	cd	PROPN
dpc-4547	749	9	.	.	PUNCT
dpc-4547	750	1	outcomes	outcome	NOUN
dpc-4547	750	2	of	of	ADP
dpc-4547	750	3	patients	patient	NOUN
dpc-4547	750	4	with	with	ADP
dpc-4547	750	5	multiple	multiple	ADJ
dpc-4547	750	6	cutaneous	cutaneous	ADJ
dpc-4547	750	7	squamous	squamous	ADJ
dpc-4547	750	8	cell	cell	NOUN
dpc-4547	750	9	carcinomas	carcinoma	NOUN
dpc-4547	750	10	:	:	PUNCT
dpc-4547	750	11	a	a	DET
dpc-4547	750	12	10	10	NUM
dpc-4547	750	13	-	-	PUNCT
dpc-4547	750	14	year	year	NOUN
dpc-4547	750	15	single	single	ADJ
dpc-4547	750	16	-	-	PUNCT
dpc-4547	750	17	institution	institution	NOUN
dpc-4547	750	18	cohort	cohort	NOUN
dpc-4547	750	19	study	study	NOUN
dpc-4547	750	20	.	.	PUNCT
dpc-4547	751	1	jama	jama	PROPN
dpc-4547	751	2	dermatol	dermatol	NOUN
dpc-4547	751	3	.	.	PUNCT
dpc-4547	752	1	2015	2015	NUM
dpc-4547	752	2	;	;	PUNCT
dpc-4547	753	1	151(11):1220	151(11):1220	PROPN
dpc-4547	753	2	-	-	SYM
dpc-4547	753	3	5	5	NUM
dpc-4547	753	4	.	.	NOUN
dpc-4547	753	5	78	78	NUM
dpc-4547	753	6	.	.	PUNCT
dpc-4547	754	1	slaughter	slaughter	PROPN
dpc-4547	754	2	dp	dp	PROPN
dpc-4547	754	3	,	,	PUNCT
dpc-4547	754	4	southwick	southwick	PROPN
dpc-4547	754	5	hw	hw	PROPN
dpc-4547	754	6	,	,	PUNCT
dpc-4547	754	7	smejkal	smejkal	PROPN
dpc-4547	754	8	w.	w.	PROPN
dpc-4547	754	9	field	field	PROPN
dpc-4547	754	10	cancerization	cancerization	NOUN
dpc-4547	754	11	in	in	ADP
dpc-4547	754	12	oral	oral	ADJ
dpc-4547	754	13	stratified	stratified	ADJ
dpc-4547	754	14	squamous	squamous	ADJ
dpc-4547	754	15	epithelium	epithelium	NOUN
dpc-4547	754	16	;	;	PUNCT
dpc-4547	754	17	clinical	clinical	ADJ
dpc-4547	754	18	implications	implication	NOUN
dpc-4547	754	19	of	of	ADP
dpc-4547	754	20	multicentric	multicentric	ADJ
dpc-4547	754	21	origin	origin	NOUN
dpc-4547	754	22	.	.	PUNCT
dpc-4547	755	1	cancer	cancer	NOUN
dpc-4547	755	2	.	.	PUNCT
dpc-4547	756	1	1953;6(5):963	1953;6(5):963	NUM
dpc-4547	756	2	-	-	SYM
dpc-4547	756	3	8	8	NUM
dpc-4547	756	4	.	.	X
dpc-4547	757	1	14	14	NUM
dpc-4547	757	2	review	review	NOUN
dpc-4547	757	3	|	|	ADV
dpc-4547	757	4	dermatol	dermatol	ADJ
dpc-4547	757	5	pract	pract	NOUN
dpc-4547	757	6	concept	concept	NOUN
dpc-4547	757	7	.	.	PUNCT
dpc-4547	758	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	758	2	:	:	PUNCT
dpc-4547	758	3	e2024146s	e2024146s	ADV
dpc-4547	758	4	113	113	NUM
dpc-4547	758	5	.	.	PUNCT
dpc-4547	759	1	surjana	surjana	PROPN
dpc-4547	759	2	d	d	PROPN
dpc-4547	759	3	,	,	PUNCT
dpc-4547	759	4	halliday	halliday	PROPN
dpc-4547	759	5	gm	gm	PROPN
dpc-4547	759	6	,	,	PUNCT
dpc-4547	759	7	martin	martin	PROPN
dpc-4547	759	8	aj	aj	PROPN
dpc-4547	759	9	,	,	PUNCT
dpc-4547	759	10	moloney	moloney	PROPN
dpc-4547	759	11	fj	fj	PROPN
dpc-4547	759	12	,	,	PUNCT
dpc-4547	759	13	damian	damian	PROPN
dpc-4547	759	14	dl	dl	PROPN
dpc-4547	759	15	.	.	PROPN
dpc-4547	759	16	oral	oral	ADJ
dpc-4547	759	17	nicotinamide	nicotinamide	NOUN
dpc-4547	759	18	reduces	reduce	VERB
dpc-4547	759	19	actinic	actinic	ADJ
dpc-4547	759	20	keratoses	keratose	NOUN
dpc-4547	759	21	in	in	ADP
dpc-4547	759	22	phase	phase	NOUN
dpc-4547	759	23	ii	ii	PROPN
dpc-4547	759	24	double	double	ADV
dpc-4547	759	25	-	-	PUNCT
dpc-4547	759	26	blinded	blind	VERB
dpc-4547	759	27	randomized	randomize	VERB
dpc-4547	759	28	controlled	control	VERB
dpc-4547	759	29	trials	trial	NOUN
dpc-4547	759	30	.	.	PUNCT
dpc-4547	760	1	j	j	PROPN
dpc-4547	760	2	invest	invest	VERB
dpc-4547	760	3	dermatol	dermatol	NOUN
dpc-4547	760	4	.	.	PUNCT
dpc-4547	761	1	2012;132(5):1497	2012;132(5):1497	NUM
dpc-4547	761	2	-	-	SYM
dpc-4547	761	3	500	500	NUM
dpc-4547	761	4	.	.	PUNCT
dpc-4547	762	1	114	114	NUM
dpc-4547	762	2	.	.	PUNCT
dpc-4547	763	1	drago	drago	PROPN
dpc-4547	763	2	f	f	PROPN
dpc-4547	763	3	,	,	PUNCT
dpc-4547	763	4	ciccarese	ciccarese	VERB
dpc-4547	763	5	g	g	PROPN
dpc-4547	763	6	,	,	PUNCT
dpc-4547	763	7	cogorno	cogorno	PROPN
dpc-4547	763	8	l	l	PROPN
dpc-4547	763	9	,	,	PUNCT
dpc-4547	763	10	calvi	calvi	NOUN
dpc-4547	763	11	c	c	NOUN
dpc-4547	763	12	,	,	PUNCT
dpc-4547	763	13	marsano	marsano	PROPN
dpc-4547	763	14	la	la	X
dpc-4547	763	15	,	,	PUNCT
dpc-4547	763	16	parodi	parodi	PROPN
dpc-4547	763	17	a.	a.	NOUN
dpc-4547	763	18	prevention	prevention	NOUN
dpc-4547	763	19	of	of	ADP
dpc-4547	763	20	non	non	ADJ
dpc-4547	763	21	-	-	ADJ
dpc-4547	763	22	melanoma	melanoma	ADJ
dpc-4547	763	23	skin	skin	NOUN
dpc-4547	763	24	cancers	cancer	NOUN
dpc-4547	763	25	with	with	ADP
dpc-4547	763	26	nicotinamide	nicotinamide	NOUN
dpc-4547	763	27	in	in	ADP
dpc-4547	763	28	transplant	transplant	NOUN
dpc-4547	763	29	recipients	recipient	NOUN
dpc-4547	763	30	:	:	PUNCT
dpc-4547	763	31	a	a	DET
dpc-4547	763	32	case	case	NOUN
dpc-4547	763	33	-	-	PUNCT
dpc-4547	763	34	control	control	NOUN
dpc-4547	763	35	study	study	NOUN
dpc-4547	763	36	.	.	PUNCT
dpc-4547	764	1	eur	eur	PROPN
dpc-4547	764	2	j	j	PROPN
dpc-4547	764	3	dermatol	dermatol	NOUN
dpc-4547	764	4	.	.	PUNCT
dpc-4547	765	1	2017;27(4):382	2017;27(4):382	NUM
dpc-4547	765	2	-	-	SYM
dpc-4547	765	3	5	5	NUM
dpc-4547	765	4	.	.	NOUN
dpc-4547	765	5	115	115	NUM
dpc-4547	765	6	.	.	PUNCT
dpc-4547	766	1	chen	chen	PROPN
dpc-4547	766	2	ac	ac	PROPN
dpc-4547	766	3	,	,	PUNCT
dpc-4547	766	4	martin	martin	PROPN
dpc-4547	766	5	aj	aj	PROPN
dpc-4547	766	6	,	,	PUNCT
dpc-4547	766	7	dalziell	dalziell	PROPN
dpc-4547	766	8	ra	ra	PROPN
dpc-4547	766	9	,	,	PUNCT
dpc-4547	766	10	et	et	PROPN
dpc-4547	766	11	al	al	PROPN
dpc-4547	766	12	.	.	PUNCT
dpc-4547	767	1	a	a	DET
dpc-4547	767	2	phase	phase	NOUN
dpc-4547	767	3	ii	ii	NOUN
dpc-4547	767	4	randomized	randomize	VERB
dpc-4547	767	5	controlled	control	VERB
dpc-4547	767	6	trial	trial	NOUN
dpc-4547	767	7	of	of	ADP
dpc-4547	767	8	nicotinamide	nicotinamide	NOUN
dpc-4547	767	9	for	for	ADP
dpc-4547	767	10	skin	skin	NOUN
dpc-4547	767	11	cancer	cancer	NOUN
dpc-4547	767	12	chemoprevention	chemoprevention	NOUN
dpc-4547	767	13	in	in	ADP
dpc-4547	767	14	renal	renal	ADJ
dpc-4547	767	15	transplant	transplant	NOUN
dpc-4547	767	16	recipients	recipient	NOUN
dpc-4547	767	17	.	.	PUNCT
dpc-4547	768	1	br	br	PROPN
dpc-4547	768	2	j	j	PROPN
dpc-4547	768	3	dermatol	dermatol	NOUN
dpc-4547	768	4	.	.	PUNCT
dpc-4547	769	1	2016	2016	NUM
dpc-4547	769	2	;	;	PUNCT
dpc-4547	769	3	175(5):1073	175(5):1073	PROPN
dpc-4547	769	4	-	-	SYM
dpc-4547	769	5	5	5	NUM
dpc-4547	769	6	.	.	NOUN
dpc-4547	769	7	116	116	NUM
dpc-4547	769	8	.	.	PUNCT
dpc-4547	770	1	cornejo	cornejo	PROPN
dpc-4547	770	2	cm	cm	PROPN
dpc-4547	770	3	,	,	PUNCT
dpc-4547	770	4	jambusaria	jambusaria	NOUN
dpc-4547	770	5	-	-	PUNCT
dpc-4547	770	6	pahlajani	pahlajani	PROPN
dpc-4547	770	7	a	a	DET
dpc-4547	770	8	,	,	PUNCT
dpc-4547	770	9	willenbrink	willenbrink	PROPN
dpc-4547	770	10	tj	tj	PROPN
dpc-4547	770	11	,	,	PUNCT
dpc-4547	770	12	schmults	schmults	PROPN
dpc-4547	770	13	cd	cd	PROPN
dpc-4547	770	14	,	,	PUNCT
dpc-4547	770	15	arron	arron	PROPN
dpc-4547	770	16	st	st	PROPN
dpc-4547	770	17	,	,	PUNCT
dpc-4547	770	18	ruiz	ruiz	NOUN
dpc-4547	770	19	es	es	PROPN
dpc-4547	770	20	.	.	PROPN
dpc-4547	770	21	field	field	NOUN
dpc-4547	770	22	cancerization	cancerization	NOUN
dpc-4547	770	23	:	:	PUNCT
dpc-4547	770	24	treatment	treatment	NOUN
dpc-4547	770	25	.	.	PUNCT
dpc-4547	771	1	j	j	PROPN
dpc-4547	771	2	am	be	AUX
dpc-4547	771	3	acad	acad	ADJ
dpc-4547	771	4	dermatol	dermatol	NOUN
dpc-4547	771	5	.	.	PUNCT
dpc-4547	772	1	2020;83(3):719	2020;83(3):719	PROPN
dpc-4547	772	2	-	-	SYM
dpc-4547	772	3	30	30	NUM
dpc-4547	772	4	.	.	PUNCT
dpc-4547	772	5	117	117	NUM
dpc-4547	772	6	.	.	PUNCT
dpc-4547	773	1	que	que	PROPN
dpc-4547	773	2	skt	skt	PROPN
dpc-4547	773	3	,	,	PUNCT
dpc-4547	773	4	zwald	zwald	NOUN
dpc-4547	773	5	fo	fo	PROPN
dpc-4547	773	6	,	,	PUNCT
dpc-4547	773	7	schmults	schmult	NOUN
dpc-4547	773	8	cd	cd	PROPN
dpc-4547	773	9	.	.	PUNCT
dpc-4547	774	1	cutaneous	cutaneous	ADJ
dpc-4547	774	2	squamous	squamous	ADJ
dpc-4547	774	3	cell	cell	NOUN
dpc-4547	774	4	carcinoma	carcinoma	NOUN
dpc-4547	774	5	:	:	PUNCT
dpc-4547	774	6	management	management	NOUN
dpc-4547	774	7	of	of	ADP
dpc-4547	774	8	advanced	advanced	ADJ
dpc-4547	774	9	and	and	CCONJ
dpc-4547	774	10	high	high	ADJ
dpc-4547	774	11	-	-	PUNCT
dpc-4547	774	12	stage	stage	NOUN
dpc-4547	774	13	tumors	tumor	NOUN
dpc-4547	774	14	.	.	PUNCT
dpc-4547	775	1	j	j	PROPN
dpc-4547	775	2	am	be	AUX
dpc-4547	775	3	acad	acad	ADJ
dpc-4547	775	4	dermatol	dermatol	NOUN
dpc-4547	775	5	.	.	PUNCT
dpc-4547	776	1	2018;78(2):249	2018;78(2):249	NUM
dpc-4547	776	2	-	-	SYM
dpc-4547	776	3	61	61	NUM
dpc-4547	776	4	.	.	PUNCT
dpc-4547	776	5	118	118	NUM
dpc-4547	776	6	.	.	PUNCT
dpc-4547	777	1	chung	chung	PROPN
dpc-4547	777	2	eym	eym	PROPN
dpc-4547	777	3	,	,	PUNCT
dpc-4547	777	4	palmer	palmer	PROPN
dpc-4547	777	5	sc	sc	PROPN
dpc-4547	777	6	,	,	PUNCT
dpc-4547	777	7	strippoli	strippoli	PROPN
dpc-4547	777	8	gfm	gfm	PROPN
dpc-4547	777	9	.	.	PUNCT
dpc-4547	778	1	interventions	intervention	NOUN
dpc-4547	778	2	to	to	PART
dpc-4547	778	3	prevent	prevent	VERB
dpc-4547	778	4	nonmelanoma	nonmelanoma	ADJ
dpc-4547	778	5	skin	skin	NOUN
dpc-4547	778	6	cancers	cancer	NOUN
dpc-4547	778	7	in	in	ADP
dpc-4547	778	8	recipients	recipient	NOUN
dpc-4547	778	9	of	of	ADP
dpc-4547	778	10	a	a	DET
dpc-4547	778	11	solid	solid	ADJ
dpc-4547	778	12	organ	organ	NOUN
dpc-4547	778	13	transplant	transplant	NOUN
dpc-4547	778	14	:	:	PUNCT
dpc-4547	778	15	systematic	systematic	ADJ
dpc-4547	778	16	review	review	NOUN
dpc-4547	778	17	of	of	ADP
dpc-4547	778	18	randomized	randomized	ADJ
dpc-4547	778	19	controlled	control	VERB
dpc-4547	778	20	trials	trial	NOUN
dpc-4547	778	21	.	.	PUNCT
dpc-4547	779	1	transplantation	transplantation	NOUN
dpc-4547	779	2	.	.	PUNCT
dpc-4547	780	1	2019;103(6):1206	2019;103(6):1206	NUM
dpc-4547	780	2	-	-	SYM
dpc-4547	780	3	15	15	NUM
dpc-4547	780	4	.	.	PUNCT
dpc-4547	781	1	119	119	NUM
dpc-4547	781	2	.	.	PUNCT
dpc-4547	782	1	knip	knip	PROPN
dpc-4547	782	2	m	m	PROPN
dpc-4547	782	3	,	,	PUNCT
dpc-4547	782	4	douek	douek	VERB
dpc-4547	782	5	if	if	SCONJ
dpc-4547	782	6	,	,	PUNCT
dpc-4547	782	7	moore	moore	PROPN
dpc-4547	782	8	wp	wp	PROPN
dpc-4547	782	9	,	,	PUNCT
dpc-4547	782	10	et	et	PROPN
dpc-4547	782	11	al	al	PROPN
dpc-4547	782	12	.	.	PROPN
dpc-4547	782	13	safety	safety	NOUN
dpc-4547	782	14	of	of	ADP
dpc-4547	782	15	high	high	ADJ
dpc-4547	782	16	-	-	PUNCT
dpc-4547	782	17	dose	dose	NOUN
dpc-4547	782	18	nicotinamide	nicotinamide	NOUN
dpc-4547	782	19	:	:	PUNCT
dpc-4547	782	20	a	a	DET
dpc-4547	782	21	review	review	NOUN
dpc-4547	782	22	.	.	PUNCT
dpc-4547	783	1	diabetologia	diabetologia	NOUN
dpc-4547	783	2	.	.	PUNCT
dpc-4547	784	1	2000;43(11):1337	2000;43(11):1337	NUM
dpc-4547	784	2	-	-	SYM
dpc-4547	784	3	45	45	NUM
dpc-4547	784	4	.	.	PUNCT
dpc-4547	785	1	120	120	NUM
dpc-4547	785	2	.	.	PUNCT
dpc-4547	786	1	gale	gale	PROPN
dpc-4547	786	2	ea	ea	PROPN
dpc-4547	786	3	,	,	PUNCT
dpc-4547	786	4	bingley	bingley	PROPN
dpc-4547	786	5	pj	pj	PROPN
dpc-4547	786	6	,	,	PUNCT
dpc-4547	786	7	emmett	emmett	PROPN
dpc-4547	786	8	cl	cl	PROPN
dpc-4547	786	9	,	,	PUNCT
dpc-4547	786	10	collier	collier	PROPN
dpc-4547	786	11	t	t	PROPN
dpc-4547	786	12	,	,	PUNCT
dpc-4547	786	13	european	european	ADJ
dpc-4547	786	14	nicotinamide	nicotinamide	NOUN
dpc-4547	786	15	diabetes	diabetes	NOUN
dpc-4547	786	16	intervention	intervention	NOUN
dpc-4547	786	17	trial	trial	NOUN
dpc-4547	786	18	g.	g.	PROPN
dpc-4547	786	19	european	european	PROPN
dpc-4547	786	20	nicotinamide	nicotinamide	NOUN
dpc-4547	786	21	diabetes	diabetes	NOUN
dpc-4547	786	22	intervention	intervention	NOUN
dpc-4547	786	23	trial	trial	NOUN
dpc-4547	786	24	(	(	PUNCT
dpc-4547	786	25	endit	endit	NOUN
dpc-4547	786	26	):	):	PUNCT
dpc-4547	786	27	a	a	DET
dpc-4547	786	28	randomised	randomised	ADJ
dpc-4547	786	29	controlled	control	VERB
dpc-4547	786	30	trial	trial	NOUN
dpc-4547	786	31	of	of	ADP
dpc-4547	786	32	intervention	intervention	NOUN
dpc-4547	786	33	before	before	ADP
dpc-4547	786	34	the	the	DET
dpc-4547	786	35	onset	onset	NOUN
dpc-4547	786	36	of	of	ADP
dpc-4547	786	37	type	type	NOUN
dpc-4547	786	38	1	1	NUM
dpc-4547	786	39	diabetes	diabetes	NOUN
dpc-4547	786	40	.	.	PUNCT
dpc-4547	787	1	lancet	lancet	PROPN
dpc-4547	787	2	.	.	PUNCT
dpc-4547	788	1	2004;363(9413):925	2004;363(9413):925	NUM
dpc-4547	788	2	-	-	SYM
dpc-4547	788	3	31	31	NUM
dpc-4547	788	4	.	.	PUNCT
dpc-4547	789	1	121	121	NUM
dpc-4547	789	2	.	.	PUNCT
dpc-4547	790	1	martin	martin	PROPN
dpc-4547	790	2	-	-	PUNCT
dpc-4547	790	3	gorgojo	gorgojo	PROPN
dpc-4547	790	4	a	a	PRON
dpc-4547	790	5	,	,	PUNCT
dpc-4547	790	6	gilaberte	gilaberte	PROPN
dpc-4547	790	7	y	y	PROPN
dpc-4547	790	8	,	,	PUNCT
dpc-4547	790	9	nagore	nagore	PROPN
dpc-4547	790	10	e.	e.	PROPN
dpc-4547	790	11	vitamin	vitamin	PROPN
dpc-4547	790	12	d	d	PROPN
dpc-4547	790	13	and	and	CCONJ
dpc-4547	790	14	skin	skin	NOUN
dpc-4547	790	15	cancer	cancer	NOUN
dpc-4547	790	16	:	:	PUNCT
dpc-4547	790	17	an	an	DET
dpc-4547	790	18	epidemiological	epidemiological	ADJ
dpc-4547	790	19	,	,	PUNCT
dpc-4547	790	20	patient	patient	NOUN
dpc-4547	790	21	-	-	PUNCT
dpc-4547	790	22	centered	center	VERB
dpc-4547	790	23	update	update	NOUN
dpc-4547	790	24	and	and	CCONJ
dpc-4547	790	25	review	review	NOUN
dpc-4547	790	26	.	.	PUNCT
dpc-4547	791	1	nutrients	nutrient	NOUN
dpc-4547	791	2	.	.	PUNCT
dpc-4547	792	1	2021;13(12	2021;13(12	NUM
dpc-4547	792	2	)	)	PUNCT
dpc-4547	792	3	.	.	PUNCT
dpc-4547	793	1	122	122	NUM
dpc-4547	793	2	.	.	X
dpc-4547	793	3	tang	tang	PROPN
dpc-4547	794	1	jy	jy	PROPN
dpc-4547	794	2	,	,	PUNCT
dpc-4547	794	3	fu	fu	PROPN
dpc-4547	794	4	t	t	PROPN
dpc-4547	794	5	,	,	PUNCT
dpc-4547	794	6	lau	lau	PROPN
dpc-4547	794	7	c	c	X
dpc-4547	794	8	,	,	PUNCT
dpc-4547	794	9	oh	oh	INTJ
dpc-4547	794	10	dh	dh	NOUN
dpc-4547	794	11	,	,	PUNCT
dpc-4547	794	12	bikle	bikle	NOUN
dpc-4547	794	13	dd	dd	NOUN
dpc-4547	794	14	,	,	PUNCT
dpc-4547	794	15	asgari	asgari	PROPN
dpc-4547	794	16	mm	mm	PROPN
dpc-4547	794	17	.	.	PUNCT
dpc-4547	795	1	vitamin	vitamin	NOUN
dpc-4547	795	2	d	d	NOUN
dpc-4547	795	3	in	in	ADP
dpc-4547	795	4	cutaneous	cutaneous	ADJ
dpc-4547	795	5	carcinogenesis	carcinogenesis	NOUN
dpc-4547	795	6	:	:	PUNCT
dpc-4547	795	7	part	part	PROPN
dpc-4547	795	8	ii	ii	PROPN
dpc-4547	795	9	.	.	PUNCT
dpc-4547	796	1	j	j	PROPN
dpc-4547	796	2	am	be	AUX
dpc-4547	796	3	acad	acad	ADJ
dpc-4547	796	4	dermatol	dermatol	NOUN
dpc-4547	796	5	.	.	PUNCT
dpc-4547	797	1	2012;67(5):817	2012;67(5):817	NUM
dpc-4547	797	2	e1	e1	NOUN
dpc-4547	797	3	-	-	PUNCT
dpc-4547	797	4	11	11	NUM
dpc-4547	797	5	;	;	PUNCT
dpc-4547	797	6	quiz	quiz	NOUN
dpc-4547	797	7	27	27	NUM
dpc-4547	797	8	-	-	SYM
dpc-4547	797	9	8	8	NUM
dpc-4547	797	10	.	.	PUNCT
dpc-4547	797	11	123	123	NUM
dpc-4547	797	12	.	.	PUNCT
dpc-4547	798	1	dixon	dixon	PROPN
dpc-4547	798	2	km	km	PROPN
dpc-4547	798	3	,	,	PUNCT
dpc-4547	798	4	deo	deo	NOUN
dpc-4547	798	5	ss	ss	PROPN
dpc-4547	798	6	,	,	PUNCT
dpc-4547	798	7	wong	wong	PROPN
dpc-4547	798	8	g	g	PROPN
dpc-4547	798	9	,	,	PUNCT
dpc-4547	798	10	et	et	PROPN
dpc-4547	798	11	al	al	PROPN
dpc-4547	798	12	.	.	PROPN
dpc-4547	798	13	skin	skin	PROPN
dpc-4547	798	14	cancer	cancer	NOUN
dpc-4547	798	15	prevention	prevention	NOUN
dpc-4547	798	16	:	:	PUNCT
dpc-4547	798	17	a	a	DET
dpc-4547	798	18	possible	possible	ADJ
dpc-4547	798	19	role	role	NOUN
dpc-4547	798	20	of	of	ADP
dpc-4547	798	21	1,25dihydroxyvitamin	1,25dihydroxyvitamin	NUM
dpc-4547	798	22	d3	d3	PROPN
dpc-4547	798	23	and	and	CCONJ
dpc-4547	798	24	its	its	PRON
dpc-4547	798	25	analogs	analog	NOUN
dpc-4547	798	26	.	.	PUNCT
dpc-4547	799	1	j	j	PROPN
dpc-4547	799	2	steroid	steroid	PROPN
dpc-4547	799	3	biochem	biochem	PROPN
dpc-4547	799	4	mol	mol	ADP
dpc-4547	799	5	biol	biol	PROPN
dpc-4547	799	6	.	.	PUNCT
dpc-4547	800	1	2005;97(1	2005;97(1	NUM
dpc-4547	800	2	-	-	PUNCT
dpc-4547	800	3	2):137	2):137	NUM
dpc-4547	800	4	-	-	PUNCT
dpc-4547	800	5	43	43	NUM
dpc-4547	800	6	.	.	PUNCT
dpc-4547	801	1	124	124	NUM
dpc-4547	801	2	.	.	PUNCT
dpc-4547	802	1	hanada	hanada	PROPN
dpc-4547	802	2	k	k	NOUN
dpc-4547	802	3	,	,	PUNCT
dpc-4547	802	4	sawamura	sawamura	NOUN
dpc-4547	802	5	d	d	PROPN
dpc-4547	802	6	,	,	PUNCT
dpc-4547	802	7	nakano	nakano	PROPN
dpc-4547	802	8	h	h	NOUN
dpc-4547	802	9	,	,	PUNCT
dpc-4547	802	10	hashimoto	hashimoto	NOUN
dpc-4547	802	11	i.	i.	NOUN
dpc-4547	802	12	possible	possible	ADJ
dpc-4547	802	13	role	role	NOUN
dpc-4547	802	14	of	of	ADP
dpc-4547	802	15	1,25	1,25	NUM
dpc-4547	802	16	-	-	PUNCT
dpc-4547	802	17	dihydroxyvitamin	dihydroxyvitamin	ADJ
dpc-4547	802	18	d3	d3	PROPN
dpc-4547	802	19	-	-	PUNCT
dpc-4547	802	20	induced	induce	VERB
dpc-4547	802	21	metallothionein	metallothionein	ADV
dpc-4547	802	22	in	in	ADP
dpc-4547	802	23	photoprotection	photoprotection	NOUN
dpc-4547	802	24	against	against	ADP
dpc-4547	802	25	uvb	uvb	ADJ
dpc-4547	802	26	injury	injury	NOUN
dpc-4547	802	27	in	in	ADP
dpc-4547	802	28	mouse	mouse	NOUN
dpc-4547	802	29	skin	skin	NOUN
dpc-4547	802	30	and	and	CCONJ
dpc-4547	802	31	cultured	cultured	ADJ
dpc-4547	802	32	rat	rat	NOUN
dpc-4547	802	33	keratinocytes	keratinocyte	NOUN
dpc-4547	802	34	.	.	PUNCT
dpc-4547	803	1	j	j	PROPN
dpc-4547	803	2	dermatol	dermatol	NOUN
dpc-4547	803	3	sci	sci	PROPN
dpc-4547	803	4	.	.	PUNCT
dpc-4547	804	1	1995;9(3):203	1995;9(3):203	NUM
dpc-4547	804	2	-	-	SYM
dpc-4547	804	3	8	8	NUM
dpc-4547	804	4	.	.	NUM
dpc-4547	805	1	125	125	NUM
dpc-4547	805	2	.	.	PUNCT
dpc-4547	806	1	lee	lee	PROPN
dpc-4547	806	2	j	j	PROPN
dpc-4547	806	3	,	,	PUNCT
dpc-4547	806	4	youn	youn	PROPN
dpc-4547	806	5	ji	ji	PROPN
dpc-4547	806	6	.	.	PUNCT
dpc-4547	807	1	the	the	DET
dpc-4547	807	2	photoprotective	photoprotective	ADJ
dpc-4547	807	3	effect	effect	NOUN
dpc-4547	807	4	of	of	ADP
dpc-4547	807	5	1,25dihydroxyvitamin	1,25dihydroxyvitamin	NUM
dpc-4547	807	6	d3	d3	PROPN
dpc-4547	807	7	on	on	ADP
dpc-4547	807	8	ultraviolet	ultraviolet	ADJ
dpc-4547	807	9	light	light	PROPN
dpc-4547	807	10	b	b	NOUN
dpc-4547	807	11	-	-	PUNCT
dpc-4547	807	12	induced	induced	ADJ
dpc-4547	807	13	damage	damage	NOUN
dpc-4547	807	14	in	in	ADP
dpc-4547	807	15	keratinocyte	keratinocyte	NOUN
dpc-4547	807	16	and	and	CCONJ
dpc-4547	807	17	its	its	PRON
dpc-4547	807	18	mechanism	mechanism	NOUN
dpc-4547	807	19	of	of	ADP
dpc-4547	807	20	action	action	NOUN
dpc-4547	807	21	.	.	PUNCT
dpc-4547	808	1	j	j	PROPN
dpc-4547	808	2	dermatol	dermatol	NOUN
dpc-4547	808	3	sci	sci	PROPN
dpc-4547	808	4	.	.	PUNCT
dpc-4547	809	1	1998;18(1):11	1998;18(1):11	NUM
dpc-4547	809	2	-	-	SYM
dpc-4547	809	3	8	8	NUM
dpc-4547	809	4	.	.	PUNCT
dpc-4547	810	1	126	126	NUM
dpc-4547	810	2	.	.	PUNCT
dpc-4547	811	1	bonilla	bonilla	PROPN
dpc-4547	811	2	c	c	PROPN
dpc-4547	811	3	,	,	PUNCT
dpc-4547	811	4	ness	ness	PROPN
dpc-4547	811	5	ar	ar	PROPN
dpc-4547	811	6	,	,	PUNCT
dpc-4547	811	7	wills	will	NOUN
dpc-4547	811	8	ak	ak	PROPN
dpc-4547	811	9	,	,	PUNCT
dpc-4547	811	10	lawlor	lawlor	PROPN
dpc-4547	811	11	da	da	PROPN
dpc-4547	811	12	,	,	PUNCT
dpc-4547	811	13	lewis	lewis	PROPN
dpc-4547	811	14	sj	sj	PROPN
dpc-4547	811	15	,	,	PUNCT
dpc-4547	811	16	davey	davey	PROPN
dpc-4547	811	17	smith	smith	PROPN
dpc-4547	811	18	g.	g.	PROPN
dpc-4547	811	19	skin	skin	PROPN
dpc-4547	811	20	pigmentation	pigmentation	NOUN
dpc-4547	811	21	,	,	PUNCT
dpc-4547	811	22	sun	sun	NOUN
dpc-4547	811	23	exposure	exposure	NOUN
dpc-4547	811	24	and	and	CCONJ
dpc-4547	811	25	vitamin	vitamin	NOUN
dpc-4547	811	26	d	d	PROPN
dpc-4547	811	27	levels	level	NOUN
dpc-4547	811	28	in	in	ADP
dpc-4547	811	29	children	child	NOUN
dpc-4547	811	30	of	of	ADP
dpc-4547	811	31	the	the	DET
dpc-4547	811	32	avon	avon	PROPN
dpc-4547	811	33	longitudinal	longitudinal	ADJ
dpc-4547	811	34	study	study	NOUN
dpc-4547	811	35	of	of	ADP
dpc-4547	811	36	parents	parent	NOUN
dpc-4547	811	37	and	and	CCONJ
dpc-4547	811	38	children	child	NOUN
dpc-4547	811	39	.	.	PUNCT
dpc-4547	812	1	bmc	bmc	ADJ
dpc-4547	812	2	public	public	ADJ
dpc-4547	812	3	health	health	NOUN
dpc-4547	812	4	.	.	PUNCT
dpc-4547	813	1	2014;14:597	2014;14:597	NUM
dpc-4547	813	2	.	.	PUNCT
dpc-4547	814	1	127	127	NUM
dpc-4547	814	2	.	.	PUNCT
dpc-4547	815	1	de	de	PROPN
dpc-4547	815	2	giorgi	giorgi	PROPN
dpc-4547	815	3	v	v	PROPN
dpc-4547	815	4	,	,	PUNCT
dpc-4547	815	5	gori	gori	PROPN
dpc-4547	815	6	a	a	X
dpc-4547	815	7	,	,	PUNCT
dpc-4547	815	8	grazzini	grazzini	PROPN
dpc-4547	815	9	m	m	PROPN
dpc-4547	815	10	,	,	PUNCT
dpc-4547	815	11	et	et	PROPN
dpc-4547	815	12	al	al	PROPN
dpc-4547	815	13	.	.	PUNCT
dpc-4547	816	1	epidemiology	epidemiology	NOUN
dpc-4547	816	2	of	of	ADP
dpc-4547	816	3	melanoma	melanoma	NOUN
dpc-4547	816	4	:	:	PUNCT
dpc-4547	816	5	is	be	AUX
dpc-4547	816	6	it	it	PRON
dpc-4547	816	7	still	still	ADV
dpc-4547	816	8	epidemic	epidemic	ADJ
dpc-4547	816	9	?	?	PUNCT
dpc-4547	817	1	what	what	PRON
dpc-4547	817	2	is	be	AUX
dpc-4547	817	3	the	the	DET
dpc-4547	817	4	role	role	NOUN
dpc-4547	817	5	of	of	ADP
dpc-4547	817	6	the	the	DET
dpc-4547	817	7	sun	sun	NOUN
dpc-4547	817	8	,	,	PUNCT
dpc-4547	817	9	sunbeds	sunbed	NOUN
dpc-4547	817	10	,	,	PUNCT
dpc-4547	817	11	vit	vit	NOUN
dpc-4547	817	12	d	d	PROPN
dpc-4547	817	13	,	,	PUNCT
dpc-4547	817	14	betablocks	betablock	NOUN
dpc-4547	817	15	,	,	PUNCT
dpc-4547	817	16	and	and	CCONJ
dpc-4547	817	17	others	other	NOUN
dpc-4547	817	18	?	?	PUNCT
dpc-4547	818	1	dermatol	dermatol	NOUN
dpc-4547	818	2	ther	ther	ADV
dpc-4547	818	3	.	.	PUNCT
dpc-4547	819	1	2012;25(5):392	2012;25(5):392	NUM
dpc-4547	819	2	-	-	SYM
dpc-4547	819	3	6	6	NUM
dpc-4547	819	4	.	.	NOUN
dpc-4547	819	5	128	128	NUM
dpc-4547	819	6	.	.	PUNCT
dpc-4547	820	1	bataille	bataille	PROPN
dpc-4547	820	2	v.	v.	ADP
dpc-4547	820	3	sun	sun	PROPN
dpc-4547	820	4	exposure	exposure	NOUN
dpc-4547	820	5	,	,	PUNCT
dpc-4547	820	6	sunbeds	sunbed	NOUN
dpc-4547	820	7	and	and	CCONJ
dpc-4547	820	8	sunscreens	sunscreen	NOUN
dpc-4547	820	9	and	and	CCONJ
dpc-4547	820	10	melanoma	melanoma	NOUN
dpc-4547	820	11	.	.	PUNCT
dpc-4547	821	1	what	what	PRON
dpc-4547	821	2	are	be	AUX
dpc-4547	821	3	the	the	DET
dpc-4547	821	4	controversies	controversy	NOUN
dpc-4547	821	5	?	?	PUNCT
dpc-4547	822	1	curr	curr	PROPN
dpc-4547	822	2	oncol	oncol	PROPN
dpc-4547	822	3	rep	rep	PROPN
dpc-4547	822	4	.	.	PROPN
dpc-4547	823	1	2013;15(6	2013;15(6	NUM
dpc-4547	823	2	):	):	PUNCT
dpc-4547	823	3	526	526	NUM
dpc-4547	823	4	-	-	SYM
dpc-4547	823	5	32	32	NUM
dpc-4547	823	6	.	.	PUNCT
dpc-4547	824	1	129	129	NUM
dpc-4547	824	2	.	.	PUNCT
dpc-4547	825	1	jablonski	jablonski	PROPN
dpc-4547	825	2	ng	ng	PROPN
dpc-4547	825	3	.	.	PUNCT
dpc-4547	826	1	the	the	DET
dpc-4547	826	2	evolution	evolution	NOUN
dpc-4547	826	3	of	of	ADP
dpc-4547	826	4	human	human	ADJ
dpc-4547	826	5	skin	skin	NOUN
dpc-4547	826	6	pigmentation	pigmentation	NOUN
dpc-4547	826	7	involved	involve	VERB
dpc-4547	826	8	the	the	DET
dpc-4547	826	9	interactions	interaction	NOUN
dpc-4547	826	10	of	of	ADP
dpc-4547	826	11	genetic	genetic	ADJ
dpc-4547	826	12	,	,	PUNCT
dpc-4547	826	13	environmental	environmental	ADJ
dpc-4547	826	14	,	,	PUNCT
dpc-4547	826	15	and	and	CCONJ
dpc-4547	826	16	cultural	cultural	ADJ
dpc-4547	826	17	variables	variable	NOUN
dpc-4547	826	18	.	.	PUNCT
dpc-4547	827	1	pigment	pigment	ADJ
dpc-4547	827	2	cell	cell	NOUN
dpc-4547	827	3	melanoma	melanoma	NOUN
dpc-4547	827	4	res	re	NOUN
dpc-4547	827	5	.	.	PUNCT
dpc-4547	828	1	2021;34(4):707	2021;34(4):707	NUM
dpc-4547	828	2	-	-	SYM
dpc-4547	828	3	29	29	NUM
dpc-4547	828	4	.	.	PUNCT
dpc-4547	828	5	130	130	NUM
dpc-4547	828	6	.	.	PUNCT
dpc-4547	829	1	wagner	wagner	PROPN
dpc-4547	829	2	jk	jk	PROPN
dpc-4547	829	3	,	,	PUNCT
dpc-4547	829	4	parra	parra	PROPN
dpc-4547	829	5	ej	ej	PROPN
dpc-4547	829	6	,	,	PUNCT
dpc-4547	829	7	h	h	PROPN
dpc-4547	829	8	ln	ln	ADJ
dpc-4547	829	9	,	,	PUNCT
dpc-4547	829	10	jovel	jovel	NOUN
dpc-4547	829	11	c	c	PROPN
dpc-4547	829	12	,	,	PUNCT
dpc-4547	829	13	shriver	shriver	PROPN
dpc-4547	829	14	md	md	PROPN
dpc-4547	829	15	.	.	PROPN
dpc-4547	829	16	skin	skin	NOUN
dpc-4547	829	17	responses	response	NOUN
dpc-4547	829	18	to	to	ADP
dpc-4547	829	19	ultraviolet	ultraviolet	ADJ
dpc-4547	829	20	radiation	radiation	NOUN
dpc-4547	829	21	:	:	PUNCT
dpc-4547	829	22	effects	effect	NOUN
dpc-4547	829	23	of	of	ADP
dpc-4547	829	24	constitutive	constitutive	ADJ
dpc-4547	829	25	pigmentation	pigmentation	NOUN
dpc-4547	829	26	,	,	PUNCT
dpc-4547	829	27	sex	sex	NOUN
dpc-4547	829	28	,	,	PUNCT
dpc-4547	829	29	and	and	CCONJ
dpc-4547	829	30	ancestry	ancestry	NOUN
dpc-4547	829	31	.	.	PUNCT
dpc-4547	830	1	pigment	pigment	NOUN
dpc-4547	830	2	cell	cell	NOUN
dpc-4547	830	3	res	re	NOUN
dpc-4547	830	4	.	.	PUNCT
dpc-4547	831	1	2002;15(5):385	2002;15(5):385	NUM
dpc-4547	831	2	-	-	SYM
dpc-4547	831	3	90	90	NUM
dpc-4547	831	4	.	.	PUNCT
dpc-4547	832	1	97	97	NUM
dpc-4547	832	2	.	.	PUNCT
dpc-4547	833	1	ziehfreund	ziehfreund	PROPN
dpc-4547	833	2	s	s	PROPN
dpc-4547	833	3	,	,	PUNCT
dpc-4547	833	4	schuster	schuster	PROPN
dpc-4547	833	5	b	b	PROPN
dpc-4547	833	6	,	,	PUNCT
dpc-4547	833	7	zink	zink	NOUN
dpc-4547	833	8	a.	a.	NOUN
dpc-4547	833	9	primary	primary	PROPN
dpc-4547	833	10	prevention	prevention	NOUN
dpc-4547	833	11	of	of	ADP
dpc-4547	833	12	keratinocyte	keratinocyte	NOUN
dpc-4547	833	13	carcinoma	carcinoma	NOUN
dpc-4547	833	14	among	among	ADP
dpc-4547	833	15	outdoor	outdoor	ADJ
dpc-4547	833	16	workers	worker	NOUN
dpc-4547	833	17	,	,	PUNCT
dpc-4547	833	18	the	the	DET
dpc-4547	833	19	general	general	ADJ
dpc-4547	833	20	population	population	NOUN
dpc-4547	833	21	and	and	CCONJ
dpc-4547	833	22	medical	medical	ADJ
dpc-4547	833	23	professionals	professional	NOUN
dpc-4547	833	24	:	:	PUNCT
dpc-4547	833	25	a	a	DET
dpc-4547	833	26	systematic	systematic	ADJ
dpc-4547	833	27	review	review	NOUN
dpc-4547	833	28	updated	update	VERB
dpc-4547	833	29	for	for	ADP
dpc-4547	833	30	2019	2019	NUM
dpc-4547	833	31	.	.	PUNCT
dpc-4547	834	1	j	j	PROPN
dpc-4547	834	2	eur	eur	PROPN
dpc-4547	834	3	acad	acad	PROPN
dpc-4547	834	4	dermatol	dermatol	NOUN
dpc-4547	834	5	venereol	venereol	NOUN
dpc-4547	834	6	.	.	PUNCT
dpc-4547	835	1	2019;33(8):1477	2019;33(8):1477	NUM
dpc-4547	835	2	-	-	SYM
dpc-4547	835	3	95	95	NUM
dpc-4547	835	4	.	.	PUNCT
dpc-4547	836	1	98	98	NUM
dpc-4547	836	2	.	.	PUNCT
dpc-4547	837	1	reinau	reinau	PROPN
dpc-4547	837	2	d	d	PROPN
dpc-4547	837	3	,	,	PUNCT
dpc-4547	837	4	weiss	weiss	PROPN
dpc-4547	837	5	m	m	PROPN
dpc-4547	837	6	,	,	PUNCT
dpc-4547	837	7	meier	meier	PROPN
dpc-4547	837	8	cr	cr	PROPN
dpc-4547	837	9	,	,	PUNCT
dpc-4547	837	10	diepgen	diepgen	PROPN
dpc-4547	837	11	tl	tl	PROPN
dpc-4547	837	12	,	,	PUNCT
dpc-4547	837	13	surber	surber	PROPN
dpc-4547	837	14	c.	c.	PROPN
dpc-4547	837	15	outdoor	outdoor	PROPN
dpc-4547	837	16	workers	worker	NOUN
dpc-4547	837	17	’	'	PUNCT
dpc-4547	837	18	sun	sun	NOUN
dpc-4547	837	19	-	-	PUNCT
dpc-4547	837	20	related	relate	VERB
dpc-4547	837	21	knowledge	knowledge	NOUN
dpc-4547	837	22	,	,	PUNCT
dpc-4547	837	23	attitudes	attitude	NOUN
dpc-4547	837	24	and	and	CCONJ
dpc-4547	837	25	protective	protective	ADJ
dpc-4547	837	26	behaviours	behaviour	NOUN
dpc-4547	837	27	:	:	PUNCT
dpc-4547	837	28	a	a	DET
dpc-4547	837	29	systematic	systematic	ADJ
dpc-4547	837	30	review	review	NOUN
dpc-4547	837	31	of	of	ADP
dpc-4547	837	32	cross	cross	ADJ
dpc-4547	837	33	-	-	ADJ
dpc-4547	837	34	sectional	sectional	ADJ
dpc-4547	837	35	and	and	CCONJ
dpc-4547	837	36	interventional	interventional	ADJ
dpc-4547	837	37	studies	study	NOUN
dpc-4547	837	38	.	.	PUNCT
dpc-4547	838	1	br	br	PROPN
dpc-4547	838	2	j	j	PROPN
dpc-4547	838	3	dermatol	dermatol	NOUN
dpc-4547	838	4	.	.	PUNCT
dpc-4547	839	1	2013;168(5):928	2013;168(5):928	NUM
dpc-4547	839	2	-	-	SYM
dpc-4547	839	3	40	40	NUM
dpc-4547	839	4	.	.	PUNCT
dpc-4547	840	1	99	99	NUM
dpc-4547	840	2	.	.	PUNCT
dpc-4547	841	1	horsham	horsham	PROPN
dpc-4547	841	2	c	c	PROPN
dpc-4547	841	3	,	,	PUNCT
dpc-4547	841	4	auster	auster	PROPN
dpc-4547	841	5	j	j	PROPN
dpc-4547	841	6	,	,	PUNCT
dpc-4547	841	7	sendall	sendall	PROPN
dpc-4547	841	8	mc	mc	PROPN
dpc-4547	841	9	,	,	PUNCT
dpc-4547	841	10	et	et	PROPN
dpc-4547	841	11	al	al	PROPN
dpc-4547	841	12	.	.	PUNCT
dpc-4547	841	13	interventions	intervention	NOUN
dpc-4547	841	14	to	to	PART
dpc-4547	841	15	decrease	decrease	VERB
dpc-4547	841	16	skin	skin	NOUN
dpc-4547	841	17	cancer	cancer	NOUN
dpc-4547	841	18	risk	risk	NOUN
dpc-4547	841	19	in	in	ADP
dpc-4547	841	20	outdoor	outdoor	ADJ
dpc-4547	841	21	workers	worker	NOUN
dpc-4547	841	22	:	:	PUNCT
dpc-4547	841	23	update	update	NOUN
dpc-4547	841	24	to	to	ADP
dpc-4547	841	25	a	a	DET
dpc-4547	841	26	2007	2007	NUM
dpc-4547	841	27	systematic	systematic	ADJ
dpc-4547	841	28	review	review	NOUN
dpc-4547	841	29	.	.	PUNCT
dpc-4547	842	1	bmc	bmc	ADJ
dpc-4547	842	2	res	re	NOUN
dpc-4547	842	3	notes	note	NOUN
dpc-4547	842	4	.	.	PUNCT
dpc-4547	843	1	2014;7:10	2014;7:10	PROPN
dpc-4547	843	2	.	.	PUNCT
dpc-4547	844	1	100	100	NUM
dpc-4547	844	2	.	.	PUNCT
dpc-4547	845	1	waldman	waldman	PROPN
dpc-4547	845	2	ra	ra	PROPN
dpc-4547	845	3	,	,	PUNCT
dpc-4547	845	4	grant	grant	NOUN
dpc-4547	845	5	-	-	PUNCT
dpc-4547	845	6	kels	kel	NOUN
dpc-4547	845	7	jm	jm	PROPN
dpc-4547	845	8	.	.	PUNCT
dpc-4547	846	1	the	the	DET
dpc-4547	846	2	role	role	NOUN
dpc-4547	846	3	of	of	ADP
dpc-4547	846	4	sunscreen	sunscreen	NOUN
dpc-4547	846	5	in	in	ADP
dpc-4547	846	6	the	the	DET
dpc-4547	846	7	prevention	prevention	NOUN
dpc-4547	846	8	of	of	ADP
dpc-4547	846	9	cutaneous	cutaneous	ADJ
dpc-4547	846	10	melanoma	melanoma	NOUN
dpc-4547	846	11	and	and	CCONJ
dpc-4547	846	12	nonmelanoma	nonmelanoma	ADJ
dpc-4547	846	13	skin	skin	NOUN
dpc-4547	846	14	cancer	cancer	NOUN
dpc-4547	846	15	.	.	PUNCT
dpc-4547	847	1	j	j	PROPN
dpc-4547	847	2	am	be	AUX
dpc-4547	847	3	acad	acad	ADJ
dpc-4547	847	4	dermatol	dermatol	NOUN
dpc-4547	847	5	.	.	PUNCT
dpc-4547	848	1	2019;80(2):574	2019;80(2):574	NUM
dpc-4547	848	2	-	-	PUNCT
dpc-4547	848	3	6	6	NUM
dpc-4547	848	4	e1	e1	NOUN
dpc-4547	848	5	.	.	PUNCT
dpc-4547	849	1	101	101	NUM
dpc-4547	849	2	.	.	PUNCT
dpc-4547	850	1	wehner	wehner	PROPN
dpc-4547	850	2	mr	mr	PROPN
dpc-4547	850	3	,	,	PUNCT
dpc-4547	850	4	shive	shive	PROPN
dpc-4547	850	5	ml	ml	PROPN
dpc-4547	850	6	,	,	PUNCT
dpc-4547	850	7	chren	chren	PROPN
dpc-4547	850	8	mm	mm	PROPN
dpc-4547	850	9	,	,	PUNCT
dpc-4547	850	10	han	han	PROPN
dpc-4547	850	11	j	j	PROPN
dpc-4547	850	12	,	,	PUNCT
dpc-4547	850	13	qureshi	qureshi	PROPN
dpc-4547	850	14	aa	aa	PROPN
dpc-4547	850	15	,	,	PUNCT
dpc-4547	850	16	linos	linos	PROPN
dpc-4547	850	17	e.	e.	PROPN
dpc-4547	850	18	indoor	indoor	PROPN
dpc-4547	850	19	tanning	tanning	PROPN
dpc-4547	850	20	and	and	CCONJ
dpc-4547	850	21	non	non	ADJ
dpc-4547	850	22	-	-	ADJ
dpc-4547	850	23	melanoma	melanoma	ADJ
dpc-4547	850	24	skin	skin	NOUN
dpc-4547	850	25	cancer	cancer	NOUN
dpc-4547	850	26	:	:	PUNCT
dpc-4547	850	27	systematic	systematic	ADJ
dpc-4547	850	28	review	review	NOUN
dpc-4547	850	29	and	and	CCONJ
dpc-4547	850	30	meta	meta	ADJ
dpc-4547	850	31	-	-	PUNCT
dpc-4547	850	32	analysis	analysis	NOUN
dpc-4547	850	33	.	.	PUNCT
dpc-4547	851	1	bmj	bmj	PROPN
dpc-4547	851	2	.	.	PUNCT
dpc-4547	852	1	2012;345	2012;345	NUM
dpc-4547	852	2	:	:	PUNCT
dpc-4547	853	1	e5909	e5909	INTJ
dpc-4547	853	2	.	.	PROPN
dpc-4547	854	1	102	102	NUM
dpc-4547	854	2	.	.	X
dpc-4547	855	1	eskander	eskander	NOUN
dpc-4547	855	2	a	a	NOUN
dpc-4547	855	3	,	,	PUNCT
dpc-4547	855	4	marqueen	marqueen	ADJ
dpc-4547	855	5	ke	ke	PROPN
dpc-4547	855	6	,	,	PUNCT
dpc-4547	855	7	edwards	edwards	PROPN
dpc-4547	855	8	ha	ha	INTJ
dpc-4547	855	9	,	,	PUNCT
dpc-4547	855	10	et	et	PROPN
dpc-4547	855	11	al	al	PROPN
dpc-4547	855	12	.	.	PUNCT
dpc-4547	856	1	to	to	PART
dpc-4547	856	2	ban	ban	VERB
dpc-4547	856	3	or	or	CCONJ
dpc-4547	856	4	not	not	PART
dpc-4547	856	5	to	to	PART
dpc-4547	856	6	ban	ban	VERB
dpc-4547	856	7	tanning	tanning	NOUN
dpc-4547	856	8	bed	bed	NOUN
dpc-4547	856	9	use	use	NOUN
dpc-4547	856	10	for	for	ADP
dpc-4547	856	11	minors	minor	NOUN
dpc-4547	856	12	:	:	PUNCT
dpc-4547	856	13	a	a	DET
dpc-4547	856	14	cost	cost	NOUN
dpc-4547	856	15	-	-	PUNCT
dpc-4547	856	16	effectiveness	effectiveness	NOUN
dpc-4547	856	17	analysis	analysis	NOUN
dpc-4547	856	18	from	from	ADP
dpc-4547	856	19	multiple	multiple	ADJ
dpc-4547	856	20	us	us	PROPN
dpc-4547	856	21	perspectives	perspective	NOUN
dpc-4547	856	22	for	for	ADP
dpc-4547	856	23	invasive	invasive	ADJ
dpc-4547	856	24	melanoma	melanoma	NOUN
dpc-4547	856	25	.	.	PUNCT
dpc-4547	857	1	cancer	cancer	NOUN
dpc-4547	857	2	.	.	PUNCT
dpc-4547	858	1	2021;127(13):2333	2021;127(13):2333	PROPN
dpc-4547	858	2	-	-	PUNCT
dpc-4547	858	3	41	41	NUM
dpc-4547	858	4	.	.	PUNCT
dpc-4547	858	5	103	103	NUM
dpc-4547	858	6	.	.	PUNCT
dpc-4547	859	1	bowers	bowers	PROPN
dpc-4547	859	2	jm	jm	PROPN
dpc-4547	859	3	,	,	PUNCT
dpc-4547	859	4	geller	geller	PROPN
dpc-4547	859	5	ac	ac	PROPN
dpc-4547	859	6	,	,	PUNCT
dpc-4547	859	7	schofield	schofield	PROPN
dpc-4547	859	8	e	e	PROPN
dpc-4547	859	9	,	,	PUNCT
dpc-4547	859	10	li	li	PROPN
dpc-4547	859	11	y	y	PROPN
dpc-4547	859	12	,	,	PUNCT
dpc-4547	859	13	hay	hay	PROPN
dpc-4547	859	14	jl	jl	PROPN
dpc-4547	859	15	.	.	PUNCT
dpc-4547	859	16	indoor	indoor	ADJ
dpc-4547	859	17	tanning	tanning	NOUN
dpc-4547	859	18	trends	trend	NOUN
dpc-4547	859	19	among	among	ADP
dpc-4547	859	20	us	us	PROPN
dpc-4547	859	21	adults	adult	NOUN
dpc-4547	859	22	,	,	PUNCT
dpc-4547	859	23	2007	2007	NUM
dpc-4547	859	24	-	-	SYM
dpc-4547	859	25	2018	2018	NUM
dpc-4547	859	26	.	.	PUNCT
dpc-4547	859	27	am	be	AUX
dpc-4547	859	28	j	j	PROPN
dpc-4547	859	29	public	public	ADJ
dpc-4547	859	30	health	health	NOUN
dpc-4547	859	31	.	.	PUNCT
dpc-4547	860	1	2020;110(6):823	2020;110(6):823	NUM
dpc-4547	860	2	-	-	SYM
dpc-4547	860	3	8	8	NUM
dpc-4547	860	4	.	.	X
dpc-4547	860	5	104	104	NUM
dpc-4547	860	6	.	.	PUNCT
dpc-4547	861	1	park	park	PROPN
dpc-4547	861	2	j	j	PROPN
dpc-4547	861	3	,	,	PUNCT
dpc-4547	861	4	halliday	halliday	PROPN
dpc-4547	861	5	gm	gm	PROPN
dpc-4547	861	6	,	,	PUNCT
dpc-4547	861	7	surjana	surjana	PROPN
dpc-4547	861	8	d	d	PROPN
dpc-4547	861	9	,	,	PUNCT
dpc-4547	861	10	damian	damian	PROPN
dpc-4547	861	11	dl	dl	PROPN
dpc-4547	861	12	.	.	PROPN
dpc-4547	861	13	nicotinamide	nicotinamide	NOUN
dpc-4547	861	14	prevents	prevent	VERB
dpc-4547	861	15	ultraviolet	ultraviolet	ADJ
dpc-4547	861	16	radiation	radiation	NOUN
dpc-4547	861	17	-	-	PUNCT
dpc-4547	861	18	induced	induce	VERB
dpc-4547	861	19	cellular	cellular	ADJ
dpc-4547	861	20	energy	energy	NOUN
dpc-4547	861	21	loss	loss	NOUN
dpc-4547	861	22	.	.	PUNCT
dpc-4547	862	1	photochem	photochem	PROPN
dpc-4547	862	2	photobiol	photobiol	NOUN
dpc-4547	862	3	.	.	PUNCT
dpc-4547	863	1	2010;86(4):942	2010;86(4):942	NUM
dpc-4547	863	2	-	-	SYM
dpc-4547	863	3	8	8	NUM
dpc-4547	863	4	.	.	PUNCT
dpc-4547	863	5	105	105	NUM
dpc-4547	863	6	.	.	PUNCT
dpc-4547	864	1	surjana	surjana	PROPN
dpc-4547	864	2	d	d	PROPN
dpc-4547	864	3	,	,	PUNCT
dpc-4547	864	4	halliday	halliday	PROPN
dpc-4547	864	5	gm	gm	PROPN
dpc-4547	864	6	,	,	PUNCT
dpc-4547	864	7	damian	damian	PROPN
dpc-4547	864	8	dl	dl	PROPN
dpc-4547	864	9	.	.	PROPN
dpc-4547	864	10	nicotinamide	nicotinamide	NOUN
dpc-4547	864	11	enhances	enhance	VERB
dpc-4547	864	12	repair	repair	NOUN
dpc-4547	864	13	of	of	ADP
dpc-4547	864	14	ultraviolet	ultraviolet	ADJ
dpc-4547	864	15	radiation	radiation	NOUN
dpc-4547	864	16	-	-	PUNCT
dpc-4547	864	17	induced	induce	VERB
dpc-4547	864	18	dna	dna	NOUN
dpc-4547	864	19	damage	damage	NOUN
dpc-4547	864	20	in	in	ADP
dpc-4547	864	21	human	human	ADJ
dpc-4547	864	22	keratinocytes	keratinocyte	NOUN
dpc-4547	864	23	and	and	CCONJ
dpc-4547	864	24	ex	ex	PRON
dpc-4547	864	25	vivo	vivo	ADJ
dpc-4547	864	26	skin	skin	NOUN
dpc-4547	864	27	.	.	PUNCT
dpc-4547	865	1	carcinogenesis	carcinogenesis	NOUN
dpc-4547	865	2	.	.	PUNCT
dpc-4547	866	1	2013	2013	NUM
dpc-4547	866	2	;	;	PUNCT
dpc-4547	866	3	34(5):1144	34(5):1144	NUM
dpc-4547	866	4	-	-	SYM
dpc-4547	866	5	9	9	NUM
dpc-4547	866	6	.	.	NOUN
dpc-4547	866	7	106	106	NUM
dpc-4547	866	8	.	.	PUNCT
dpc-4547	867	1	damian	damian	PROPN
dpc-4547	867	2	dl	dl	PROPN
dpc-4547	867	3	,	,	PUNCT
dpc-4547	867	4	patterson	patterson	PROPN
dpc-4547	867	5	cr	cr	PROPN
dpc-4547	867	6	,	,	PUNCT
dpc-4547	867	7	stapelberg	stapelberg	PROPN
dpc-4547	867	8	m	m	PROPN
dpc-4547	867	9	,	,	PUNCT
dpc-4547	867	10	park	park	PROPN
dpc-4547	867	11	j	j	PROPN
dpc-4547	867	12	,	,	PUNCT
dpc-4547	867	13	barnetson	barnetson	NOUN
dpc-4547	867	14	rs	rs	PROPN
dpc-4547	867	15	,	,	PUNCT
dpc-4547	867	16	halliday	halliday	PROPN
dpc-4547	867	17	gm	gm	PROPN
dpc-4547	867	18	.	.	PUNCT
dpc-4547	868	1	uv	uv	NOUN
dpc-4547	868	2	radiation	radiation	NOUN
dpc-4547	868	3	-	-	PUNCT
dpc-4547	868	4	induced	induce	VERB
dpc-4547	868	5	immunosuppression	immunosuppression	NOUN
dpc-4547	868	6	is	be	AUX
dpc-4547	868	7	greater	great	ADJ
dpc-4547	868	8	in	in	ADP
dpc-4547	868	9	men	man	NOUN
dpc-4547	868	10	and	and	CCONJ
dpc-4547	868	11	prevented	prevent	VERB
dpc-4547	868	12	by	by	ADP
dpc-4547	868	13	topical	topical	ADJ
dpc-4547	868	14	nicotinamide	nicotinamide	NOUN
dpc-4547	868	15	.	.	PUNCT
dpc-4547	869	1	j	j	PROPN
dpc-4547	869	2	invest	invest	VERB
dpc-4547	869	3	dermatol	dermatol	NOUN
dpc-4547	869	4	.	.	PUNCT
dpc-4547	870	1	2008;128(2):447	2008;128(2):447	NUM
dpc-4547	870	2	-	-	SYM
dpc-4547	870	3	54	54	NUM
dpc-4547	870	4	.	.	PUNCT
dpc-4547	871	1	107	107	NUM
dpc-4547	871	2	.	.	PUNCT
dpc-4547	872	1	monfrecola	monfrecola	PROPN
dpc-4547	872	2	g	g	PROPN
dpc-4547	872	3	,	,	PUNCT
dpc-4547	872	4	gaudiello	gaudiello	PROPN
dpc-4547	872	5	f	f	PROPN
dpc-4547	872	6	,	,	PUNCT
dpc-4547	872	7	cirillo	cirillo	PROPN
dpc-4547	872	8	t	t	PROPN
dpc-4547	872	9	,	,	PUNCT
dpc-4547	872	10	fabbrocini	fabbrocini	NOUN
dpc-4547	872	11	g	g	NOUN
dpc-4547	872	12	,	,	PUNCT
dpc-4547	872	13	balato	balato	NOUN
dpc-4547	872	14	a	a	DET
dpc-4547	872	15	,	,	PUNCT
dpc-4547	872	16	lembo	lembo	PROPN
dpc-4547	872	17	s.	s.	PROPN
dpc-4547	872	18	nicotinamide	nicotinamide	PROPN
dpc-4547	872	19	downregulates	downregulate	NOUN
dpc-4547	872	20	gene	gene	NOUN
dpc-4547	872	21	expression	expression	NOUN
dpc-4547	872	22	of	of	ADP
dpc-4547	872	23	interleukin-6	interleukin-6	PROPN
dpc-4547	872	24	,	,	PUNCT
dpc-4547	872	25	interleukin-10	interleukin-10	PROPN
dpc-4547	872	26	,	,	PUNCT
dpc-4547	872	27	monocyte	monocyte	NOUN
dpc-4547	872	28	chemoattractant	chemoattractant	PROPN
dpc-4547	872	29	protein-1	protein-1	PROPN
dpc-4547	872	30	,	,	PUNCT
dpc-4547	872	31	and	and	CCONJ
dpc-4547	872	32	tumour	tumour	NOUN
dpc-4547	872	33	necrosis	necrosis	NOUN
dpc-4547	872	34	factor	factor	NOUN
dpc-4547	872	35	-	-	PUNCT
dpc-4547	872	36	alpha	alpha	NOUN
dpc-4547	872	37	gene	gene	NOUN
dpc-4547	872	38	expression	expression	NOUN
dpc-4547	872	39	in	in	ADP
dpc-4547	872	40	hacat	hacat	PROPN
dpc-4547	872	41	keratinocytes	keratinocyte	NOUN
dpc-4547	872	42	after	after	ADP
dpc-4547	872	43	ultraviolet	ultraviolet	PROPN
dpc-4547	872	44	b	b	PROPN
dpc-4547	872	45	irradiation	irradiation	NOUN
dpc-4547	872	46	.	.	PUNCT
dpc-4547	873	1	clin	clin	PROPN
dpc-4547	873	2	exp	exp	NOUN
dpc-4547	873	3	dermatol	dermatol	NOUN
dpc-4547	873	4	.	.	PUNCT
dpc-4547	874	1	2013;38(2):185	2013;38(2):185	NUM
dpc-4547	874	2	-	-	SYM
dpc-4547	874	3	8	8	NUM
dpc-4547	874	4	.	.	NUM
dpc-4547	874	5	108	108	NUM
dpc-4547	874	6	.	.	PUNCT
dpc-4547	875	1	sivapirabu	sivapirabu	PROPN
dpc-4547	875	2	g	g	PROPN
dpc-4547	875	3	,	,	PUNCT
dpc-4547	875	4	yiasemides	yiasemide	NOUN
dpc-4547	875	5	e	e	NOUN
dpc-4547	875	6	,	,	PUNCT
dpc-4547	875	7	halliday	halliday	PROPN
dpc-4547	875	8	gm	gm	PROPN
dpc-4547	875	9	,	,	PUNCT
dpc-4547	875	10	park	park	PROPN
dpc-4547	875	11	j	j	PROPN
dpc-4547	875	12	,	,	PUNCT
dpc-4547	875	13	damian	damian	PROPN
dpc-4547	875	14	dl	dl	PROPN
dpc-4547	875	15	.	.	PROPN
dpc-4547	875	16	topical	topical	ADJ
dpc-4547	875	17	nicotinamide	nicotinamide	NOUN
dpc-4547	875	18	modulates	modulate	NOUN
dpc-4547	875	19	cellular	cellular	ADJ
dpc-4547	875	20	energy	energy	NOUN
dpc-4547	875	21	metabolism	metabolism	NOUN
dpc-4547	875	22	and	and	CCONJ
dpc-4547	875	23	provides	provide	VERB
dpc-4547	875	24	broad	broad	ADJ
dpc-4547	875	25	-	-	PUNCT
dpc-4547	875	26	spectrum	spectrum	NOUN
dpc-4547	875	27	protection	protection	NOUN
dpc-4547	875	28	against	against	ADP
dpc-4547	875	29	ultraviolet	ultraviolet	ADJ
dpc-4547	875	30	radiation	radiation	NOUN
dpc-4547	875	31	-	-	PUNCT
dpc-4547	875	32	induced	induce	VERB
dpc-4547	875	33	immunosuppression	immunosuppression	NOUN
dpc-4547	875	34	in	in	ADP
dpc-4547	875	35	humans	human	NOUN
dpc-4547	875	36	.	.	PUNCT
dpc-4547	876	1	br	br	PROPN
dpc-4547	876	2	j	j	PROPN
dpc-4547	876	3	dermatol	dermatol	NOUN
dpc-4547	876	4	.	.	PUNCT
dpc-4547	877	1	2009;161(6):1357	2009;161(6):1357	NUM
dpc-4547	877	2	-	-	SYM
dpc-4547	877	3	64	64	NUM
dpc-4547	877	4	.	.	PUNCT
dpc-4547	878	1	109	109	NUM
dpc-4547	878	2	.	.	PUNCT
dpc-4547	878	3	yiasemides	yiasemides	PROPN
dpc-4547	878	4	e	e	NOUN
dpc-4547	878	5	,	,	PUNCT
dpc-4547	878	6	sivapirabu	sivapirabu	NOUN
dpc-4547	878	7	g	g	PROPN
dpc-4547	878	8	,	,	PUNCT
dpc-4547	878	9	halliday	halliday	PROPN
dpc-4547	878	10	gm	gm	PROPN
dpc-4547	878	11	,	,	PUNCT
dpc-4547	878	12	park	park	PROPN
dpc-4547	878	13	j	j	PROPN
dpc-4547	878	14	,	,	PUNCT
dpc-4547	878	15	damian	damian	PROPN
dpc-4547	878	16	dl	dl	PROPN
dpc-4547	878	17	.	.	PROPN
dpc-4547	878	18	oral	oral	ADJ
dpc-4547	878	19	nicotinamide	nicotinamide	NOUN
dpc-4547	878	20	protects	protect	NOUN
dpc-4547	878	21	against	against	ADP
dpc-4547	878	22	ultraviolet	ultraviolet	ADJ
dpc-4547	878	23	radiation	radiation	NOUN
dpc-4547	878	24	-	-	PUNCT
dpc-4547	878	25	induced	induce	VERB
dpc-4547	878	26	immunosuppression	immunosuppression	NOUN
dpc-4547	878	27	in	in	ADP
dpc-4547	878	28	humans	human	NOUN
dpc-4547	878	29	.	.	PUNCT
dpc-4547	879	1	carcinogenesis	carcinogenesis	NOUN
dpc-4547	879	2	.	.	PUNCT
dpc-4547	880	1	2009;30(1	2009;30(1	NUM
dpc-4547	880	2	):	):	PUNCT
dpc-4547	880	3	101	101	NUM
dpc-4547	880	4	-	-	SYM
dpc-4547	880	5	5	5	NUM
dpc-4547	880	6	.	.	NOUN
dpc-4547	880	7	110	110	NUM
dpc-4547	880	8	.	.	PUNCT
dpc-4547	881	1	chen	chen	PROPN
dpc-4547	881	2	ac	ac	PROPN
dpc-4547	881	3	,	,	PUNCT
dpc-4547	881	4	martin	martin	PROPN
dpc-4547	881	5	aj	aj	PROPN
dpc-4547	881	6	,	,	PUNCT
dpc-4547	881	7	choy	choy	NOUN
dpc-4547	881	8	b	b	PROPN
dpc-4547	881	9	,	,	PUNCT
dpc-4547	881	10	et	et	PROPN
dpc-4547	881	11	al	al	PROPN
dpc-4547	881	12	.	.	PUNCT
dpc-4547	882	1	a	a	DET
dpc-4547	882	2	phase	phase	NOUN
dpc-4547	882	3	3	3	NUM
dpc-4547	882	4	randomized	randomize	VERB
dpc-4547	882	5	trial	trial	NOUN
dpc-4547	882	6	of	of	ADP
dpc-4547	882	7	nicotinamide	nicotinamide	NOUN
dpc-4547	882	8	for	for	ADP
dpc-4547	882	9	skin	skin	NOUN
dpc-4547	882	10	-	-	PUNCT
dpc-4547	882	11	cancer	cancer	NOUN
dpc-4547	882	12	chemoprevention	chemoprevention	NOUN
dpc-4547	882	13	.	.	PUNCT
dpc-4547	883	1	n	n	PROPN
dpc-4547	883	2	engl	engl	PROPN
dpc-4547	883	3	j	j	PROPN
dpc-4547	883	4	med	med	PROPN
dpc-4547	883	5	.	.	PUNCT
dpc-4547	884	1	2015;373(17):1618	2015;373(17):1618	NUM
dpc-4547	884	2	-	-	SYM
dpc-4547	884	3	26	26	NUM
dpc-4547	884	4	.	.	NOUN
dpc-4547	884	5	111	111	NUM
dpc-4547	884	6	.	.	PUNCT
dpc-4547	885	1	mainville	mainville	PROPN
dpc-4547	885	2	l	l	NOUN
dpc-4547	885	3	,	,	PUNCT
dpc-4547	885	4	smilga	smilga	ADJ
dpc-4547	885	5	as	as	SCONJ
dpc-4547	885	6	,	,	PUNCT
dpc-4547	885	7	fortin	fortin	PROPN
dpc-4547	885	8	pr	pr	PROPN
dpc-4547	885	9	.	.	PUNCT
dpc-4547	885	10	effect	effect	NOUN
dpc-4547	885	11	of	of	ADP
dpc-4547	885	12	nicotinamide	nicotinamide	NOUN
dpc-4547	885	13	in	in	ADP
dpc-4547	885	14	skin	skin	NOUN
dpc-4547	885	15	cancer	cancer	NOUN
dpc-4547	885	16	and	and	CCONJ
dpc-4547	885	17	actinic	actinic	ADJ
dpc-4547	885	18	keratoses	keratose	NOUN
dpc-4547	885	19	chemoprophylaxis	chemoprophylaxis	ADJ
dpc-4547	885	20	,	,	PUNCT
dpc-4547	885	21	and	and	CCONJ
dpc-4547	885	22	adverse	adverse	ADJ
dpc-4547	885	23	effects	effect	NOUN
dpc-4547	885	24	related	relate	VERB
dpc-4547	885	25	to	to	ADP
dpc-4547	885	26	nicotinamide	nicotinamide	NOUN
dpc-4547	885	27	:	:	PUNCT
dpc-4547	885	28	a	a	DET
dpc-4547	885	29	systematic	systematic	ADJ
dpc-4547	885	30	review	review	NOUN
dpc-4547	885	31	and	and	CCONJ
dpc-4547	885	32	meta	meta	ADJ
dpc-4547	885	33	-	-	PUNCT
dpc-4547	885	34	analysis	analysis	NOUN
dpc-4547	885	35	.	.	PUNCT
dpc-4547	886	1	j	j	PROPN
dpc-4547	886	2	cutan	cutan	PROPN
dpc-4547	886	3	med	med	ADJ
dpc-4547	886	4	surg	surg	NOUN
dpc-4547	886	5	.	.	PUNCT
dpc-4547	887	1	2022;26(3):297	2022;26(3):297	PROPN
dpc-4547	887	2	-	-	PUNCT
dpc-4547	887	3	308	308	NUM
dpc-4547	887	4	.	.	PUNCT
dpc-4547	888	1	112	112	NUM
dpc-4547	888	2	.	.	PUNCT
dpc-4547	889	1	moloney	moloney	PROPN
dpc-4547	889	2	f	f	PROPN
dpc-4547	889	3	,	,	PUNCT
dpc-4547	889	4	vestergaard	vestergaard	PROPN
dpc-4547	889	5	m	m	PROPN
dpc-4547	889	6	,	,	PUNCT
dpc-4547	889	7	radojkovic	radojkovic	PROPN
dpc-4547	889	8	b	b	PROPN
dpc-4547	889	9	,	,	PUNCT
dpc-4547	889	10	damian	damian	PROPN
dpc-4547	889	11	d.	d.	PROPN
dpc-4547	889	12	randomized	randomize	VERB
dpc-4547	889	13	,	,	PUNCT
dpc-4547	889	14	double	double	ADJ
dpc-4547	889	15	-	-	PUNCT
dpc-4547	889	16	blinded	blind	VERB
dpc-4547	889	17	,	,	PUNCT
dpc-4547	889	18	placebo	placebo	NOUN
dpc-4547	889	19	controlled	control	VERB
dpc-4547	889	20	study	study	NOUN
dpc-4547	889	21	to	to	PART
dpc-4547	889	22	assess	assess	VERB
dpc-4547	889	23	the	the	DET
dpc-4547	889	24	effect	effect	NOUN
dpc-4547	889	25	of	of	ADP
dpc-4547	889	26	topical	topical	ADJ
dpc-4547	889	27	1	1	NUM
dpc-4547	889	28	%	%	NOUN
dpc-4547	889	29	nicotinamide	nicotinamide	NOUN
dpc-4547	889	30	on	on	ADP
dpc-4547	889	31	actinic	actinic	ADJ
dpc-4547	889	32	keratoses	keratose	NOUN
dpc-4547	889	33	.	.	PUNCT
dpc-4547	890	1	br	br	PROPN
dpc-4547	890	2	j	j	PROPN
dpc-4547	890	3	dermatol	dermatol	NOUN
dpc-4547	890	4	.	.	PUNCT
dpc-4547	891	1	2010;162(5):1138	2010;162(5):1138	NUM
dpc-4547	891	2	-	-	SYM
dpc-4547	891	3	9	9	NUM
dpc-4547	891	4	.	.	X
dpc-4547	891	5	review	review	NOUN
dpc-4547	891	6	|	|	ADV
dpc-4547	891	7	dermatol	dermatol	ADJ
dpc-4547	891	8	pract	pract	NOUN
dpc-4547	891	9	concept	concept	NOUN
dpc-4547	891	10	.	.	PUNCT
dpc-4547	892	1	2024;14(3)s1	2024;14(3)s1	NOUN
dpc-4547	892	2	:	:	PUNCT
dpc-4547	892	3	e2024146s	e2024146s	ADV
dpc-4547	892	4	15	15	NUM
dpc-4547	892	5	149	149	NUM
dpc-4547	892	6	.	.	PUNCT
dpc-4547	893	1	henrikson	henrikson	PROPN
dpc-4547	893	2	nb	nb	PROPN
dpc-4547	893	3	,	,	PUNCT
dpc-4547	893	4	ivlev	ivlev	PROPN
dpc-4547	893	5	i	i	PRON
dpc-4547	893	6	,	,	PUNCT
dpc-4547	893	7	blasi	blasi	PROPN
dpc-4547	893	8	pr	pr	NOUN
dpc-4547	893	9	,	,	PUNCT
dpc-4547	893	10	et	et	PROPN
dpc-4547	893	11	al	al	PROPN
dpc-4547	893	12	.	.	PUNCT
dpc-4547	893	13	  	  	SPACE
dpc-4547	893	14	screening	screen	VERB
dpc-4547	893	15	for	for	ADP
dpc-4547	893	16	skin	skin	NOUN
dpc-4547	893	17	cancer	cancer	NOUN
dpc-4547	893	18	:	:	PUNCT
dpc-4547	893	19	an	an	DET
dpc-4547	893	20	evidence	evidence	NOUN
dpc-4547	893	21	update	update	NOUN
dpc-4547	893	22	for	for	ADP
dpc-4547	893	23	the	the	DET
dpc-4547	893	24	u.s	u.s	PROPN
dpc-4547	893	25	.	.	PROPN
dpc-4547	893	26	preventive	preventive	ADJ
dpc-4547	893	27	services	service	NOUN
dpc-4547	893	28	task	task	NOUN
dpc-4547	893	29	force	force	NOUN
dpc-4547	893	30	.	.	PUNCT
dpc-4547	894	1	rockville	rockville	PROPN
dpc-4547	894	2	(	(	PUNCT
dpc-4547	894	3	md	md	PROPN
dpc-4547	894	4	):	):	PUNCT
dpc-4547	894	5	agency	agency	PROPN
dpc-4547	894	6	for	for	ADP
dpc-4547	894	7	healthcare	healthcare	PROPN
dpc-4547	894	8	research	research	NOUN
dpc-4547	894	9	and	and	CCONJ
dpc-4547	894	10	quality	quality	NOUN
dpc-4547	894	11	(	(	PUNCT
dpc-4547	894	12	us	us	PROPN
dpc-4547	894	13	)	)	PUNCT
dpc-4547	894	14	;	;	PUNCT
dpc-4547	894	15	april	april	PROPN
dpc-4547	894	16	2023	2023	NUM
dpc-4547	894	17	.	.	PUNCT
dpc-4547	895	1	150	150	NUM
dpc-4547	895	2	.	.	PUNCT
dpc-4547	896	1	ahmady	ahmady	PROPN
dpc-4547	896	2	s	s	PROPN
dpc-4547	896	3	,	,	PUNCT
dpc-4547	896	4	jansen	jansen	PROPN
dpc-4547	896	5	mhe	mhe	PROPN
dpc-4547	896	6	,	,	PUNCT
dpc-4547	896	7	nelemans	nelemans	PROPN
dpc-4547	896	8	pj	pj	PROPN
dpc-4547	896	9	,	,	PUNCT
dpc-4547	896	10	et	et	PROPN
dpc-4547	896	11	al	al	PROPN
dpc-4547	896	12	.	.	PROPN
dpc-4547	897	1	risk	risk	NOUN
dpc-4547	897	2	of	of	ADP
dpc-4547	897	3	invasive	invasive	ADJ
dpc-4547	897	4	cutaneous	cutaneous	ADJ
dpc-4547	897	5	squamous	squamous	ADJ
dpc-4547	897	6	cell	cell	NOUN
dpc-4547	897	7	carcinoma	carcinoma	NOUN
dpc-4547	897	8	after	after	ADP
dpc-4547	897	9	different	different	ADJ
dpc-4547	897	10	treatments	treatment	NOUN
dpc-4547	897	11	for	for	ADP
dpc-4547	897	12	actinic	actinic	ADJ
dpc-4547	897	13	keratosis	keratosis	NOUN
dpc-4547	897	14	:	:	PUNCT
dpc-4547	897	15	a	a	DET
dpc-4547	897	16	secondary	secondary	ADJ
dpc-4547	897	17	analysis	analysis	NOUN
dpc-4547	897	18	of	of	ADP
dpc-4547	897	19	a	a	DET
dpc-4547	897	20	randomized	randomized	ADJ
dpc-4547	897	21	clinical	clinical	ADJ
dpc-4547	897	22	trial	trial	NOUN
dpc-4547	897	23	.	.	PUNCT
dpc-4547	898	1	jama	jama	PROPN
dpc-4547	898	2	dermatol	dermatol	NOUN
dpc-4547	898	3	.	.	PUNCT
dpc-4547	899	1	2022;158(6):634	2022;158(6):634	NUM
dpc-4547	899	2	-	-	PROPN
dpc-4547	899	3	40	40	NUM
dpc-4547	899	4	.	.	PUNCT
dpc-4547	900	1	151	151	NUM
dpc-4547	900	2	.	.	PUNCT
dpc-4547	901	1	koch	koch	PROPN
dpc-4547	901	2	eat	eat	PROPN
dpc-4547	901	3	,	,	PUNCT
dpc-4547	901	4	steeb	steeb	PROPN
dpc-4547	901	5	t	t	PROPN
dpc-4547	901	6	,	,	PUNCT
dpc-4547	901	7	bender	bender	NOUN
dpc-4547	901	8	-	-	PUNCT
dpc-4547	901	9	sabelkampf	sabelkampf	NOUN
dpc-4547	901	10	s	s	PART
dpc-4547	901	11	,	,	PUNCT
dpc-4547	901	12	et	et	PROPN
dpc-4547	901	13	al	al	PROPN
dpc-4547	901	14	.	.	PUNCT
dpc-4547	902	1	poor	poor	ADJ
dpc-4547	902	2	adherence	adherence	NOUN
dpc-4547	902	3	to	to	ADP
dpc-4547	902	4	self	self	NOUN
dpc-4547	902	5	-	-	PUNCT
dpc-4547	902	6	applied	apply	VERB
dpc-4547	902	7	topical	topical	ADJ
dpc-4547	902	8	drug	drug	NOUN
dpc-4547	902	9	treatment	treatment	NOUN
dpc-4547	902	10	is	be	AUX
dpc-4547	902	11	a	a	DET
dpc-4547	902	12	common	common	ADJ
dpc-4547	902	13	source	source	NOUN
dpc-4547	902	14	of	of	ADP
dpc-4547	902	15	low	low	ADJ
dpc-4547	902	16	lesion	lesion	NOUN
dpc-4547	902	17	clearance	clearance	NOUN
dpc-4547	902	18	in	in	ADP
dpc-4547	902	19	patients	patient	NOUN
dpc-4547	902	20	with	with	ADP
dpc-4547	902	21	actinic	actinic	ADJ
dpc-4547	902	22	keratosis	keratosis	NOUN
dpc-4547	902	23	-	-	PUNCT
dpc-4547	902	24	a	a	DET
dpc-4547	902	25	cross	cross	ADJ
dpc-4547	902	26	-	-	ADJ
dpc-4547	902	27	sectional	sectional	ADJ
dpc-4547	902	28	study	study	NOUN
dpc-4547	902	29	.	.	PUNCT
dpc-4547	903	1	j	j	PROPN
dpc-4547	903	2	clin	clin	PROPN
dpc-4547	903	3	med	med	PROPN
dpc-4547	903	4	.	.	PUNCT
dpc-4547	903	5	2023;12(11	2023;12(11	NUM
dpc-4547	903	6	)	)	PUNCT
dpc-4547	903	7	.	.	PUNCT
dpc-4547	904	1	152	152	NUM
dpc-4547	904	2	.	.	PUNCT
dpc-4547	905	1	steeb	steeb	PROPN
dpc-4547	905	2	t	t	PROPN
dpc-4547	905	3	,	,	PUNCT
dpc-4547	905	4	wessely	wessely	ADV
dpc-4547	905	5	a	a	PRON
dpc-4547	905	6	,	,	PUNCT
dpc-4547	906	1	von	von	PROPN
dpc-4547	906	2	bubnoff	bubnoff	PROPN
dpc-4547	906	3	d	d	PROPN
dpc-4547	906	4	,	,	PUNCT
dpc-4547	906	5	et	et	PROPN
dpc-4547	906	6	al	al	PROPN
dpc-4547	906	7	.	.	PUNCT
dpc-4547	907	1	treatment	treatment	NOUN
dpc-4547	907	2	motivations	motivation	NOUN
dpc-4547	907	3	and	and	CCONJ
dpc-4547	907	4	expectations	expectation	NOUN
dpc-4547	907	5	in	in	ADP
dpc-4547	907	6	patients	patient	NOUN
dpc-4547	907	7	with	with	ADP
dpc-4547	907	8	actinic	actinic	ADJ
dpc-4547	907	9	keratosis	keratosis	NOUN
dpc-4547	907	10	:	:	PUNCT
dpc-4547	907	11	a	a	DET
dpc-4547	907	12	german	german	ADJ
dpc-4547	907	13	-	-	PUNCT
dpc-4547	907	14	wide	wide	ADJ
dpc-4547	907	15	multicenter	multicenter	NOUN
dpc-4547	907	16	,	,	PUNCT
dpc-4547	907	17	cross	cross	ADJ
dpc-4547	907	18	-	-	ADJ
dpc-4547	907	19	sectional	sectional	ADJ
dpc-4547	907	20	trial	trial	NOUN
dpc-4547	907	21	.	.	PUNCT
dpc-4547	908	1	j	j	PROPN
dpc-4547	908	2	clin	clin	PROPN
dpc-4547	908	3	med	me	VERB
dpc-4547	908	4	.	.	PUNCT
dpc-4547	909	1	2020;9(5	2020;9(5	NUM
dpc-4547	909	2	)	)	PUNCT
dpc-4547	909	3	.	.	PUNCT
dpc-4547	910	1	153	153	NUM
dpc-4547	910	2	.	.	PUNCT
dpc-4547	910	3	weinstock	weinstock	PROPN
dpc-4547	910	4	ma	ma	PROPN
dpc-4547	910	5	,	,	PUNCT
dpc-4547	910	6	bingham	bingham	PROPN
dpc-4547	910	7	sf	sf	PROPN
dpc-4547	910	8	,	,	PUNCT
dpc-4547	910	9	cole	cole	PROPN
dpc-4547	910	10	gw	gw	PROPN
dpc-4547	910	11	,	,	PUNCT
dpc-4547	910	12	et	et	PROPN
dpc-4547	910	13	al	al	PROPN
dpc-4547	910	14	.	.	PUNCT
dpc-4547	911	1	reliability	reliability	NOUN
dpc-4547	911	2	of	of	ADP
dpc-4547	911	3	counting	count	VERB
dpc-4547	911	4	actinic	actinic	ADJ
dpc-4547	911	5	keratoses	keratose	NOUN
dpc-4547	911	6	before	before	ADV
dpc-4547	911	7	and	and	CCONJ
dpc-4547	911	8	after	after	ADP
dpc-4547	911	9	brief	brief	ADJ
dpc-4547	911	10	consensus	consensus	NOUN
dpc-4547	911	11	discussion	discussion	NOUN
dpc-4547	911	12	:	:	PUNCT
dpc-4547	911	13	the	the	DET
dpc-4547	911	14	va	va	PROPN
dpc-4547	911	15	topical	topical	ADJ
dpc-4547	911	16	tretinoin	tretinoin	PROPN
dpc-4547	911	17	chemoprevention	chemoprevention	PROPN
dpc-4547	911	18	(	(	PUNCT
dpc-4547	911	19	vattc	vattc	NOUN
dpc-4547	911	20	)	)	PUNCT
dpc-4547	911	21	trial	trial	NOUN
dpc-4547	911	22	.	.	PUNCT
dpc-4547	912	1	arch	arch	ADJ
dpc-4547	912	2	dermatol	dermatol	NOUN
dpc-4547	912	3	.	.	PUNCT
dpc-4547	913	1	2001;137(8):1055	2001;137(8):1055	NUM
dpc-4547	913	2	-	-	SYM
dpc-4547	913	3	8	8	NUM
dpc-4547	913	4	.	.	PUNCT
dpc-4547	914	1	154	154	NUM
dpc-4547	914	2	.	.	PUNCT
dpc-4547	915	1	schmitz	schmitz	PROPN
dpc-4547	915	2	l	l	PROPN
dpc-4547	915	3	,	,	PUNCT
dpc-4547	915	4	gambichler	gambichler	PROPN
dpc-4547	915	5	t	t	PROPN
dpc-4547	915	6	,	,	PUNCT
dpc-4547	915	7	gupta	gupta	PROPN
dpc-4547	915	8	g	g	PROPN
dpc-4547	915	9	,	,	PUNCT
dpc-4547	915	10	stucker	stucker	NOUN
dpc-4547	915	11	m	m	PROPN
dpc-4547	915	12	,	,	PUNCT
dpc-4547	915	13	dirschka	dirschka	ADJ
dpc-4547	915	14	t.	t.	PROPN
dpc-4547	915	15	actinic	actinic	ADJ
dpc-4547	915	16	keratosis	keratosis	NOUN
dpc-4547	915	17	area	area	NOUN
dpc-4547	915	18	and	and	CCONJ
dpc-4547	915	19	severity	severity	NOUN
dpc-4547	915	20	index	index	NOUN
dpc-4547	915	21	(	(	PUNCT
dpc-4547	915	22	akasi	akasi	ADJ
dpc-4547	915	23	)	)	PUNCT
dpc-4547	915	24	is	be	AUX
dpc-4547	915	25	associated	associate	VERB
dpc-4547	915	26	with	with	ADP
dpc-4547	915	27	the	the	DET
dpc-4547	915	28	incidence	incidence	NOUN
dpc-4547	915	29	of	of	ADP
dpc-4547	915	30	squamous	squamous	ADJ
dpc-4547	915	31	cell	cell	NOUN
dpc-4547	915	32	carcinoma	carcinoma	NOUN
dpc-4547	915	33	.	.	PUNCT
dpc-4547	916	1	j	j	PROPN
dpc-4547	916	2	eur	eur	PROPN
dpc-4547	916	3	acad	acad	PROPN
dpc-4547	916	4	dermatol	dermatol	NOUN
dpc-4547	916	5	venereol	venereol	NOUN
dpc-4547	916	6	.	.	PUNCT
dpc-4547	917	1	2018;32(5):752	2018;32(5):752	NUM
dpc-4547	917	2	-	-	SYM
dpc-4547	917	3	6	6	NUM
dpc-4547	917	4	.	.	NOUN
dpc-4547	917	5	155	155	NUM
dpc-4547	917	6	.	.	PUNCT
dpc-4547	918	1	dreno	dreno	PROPN
dpc-4547	918	2	b	b	NOUN
dpc-4547	918	3	,	,	PUNCT
dpc-4547	918	4	cerio	cerio	PROPN
dpc-4547	918	5	r	r	PROPN
dpc-4547	918	6	,	,	PUNCT
dpc-4547	918	7	dirschka	dirschka	PROPN
dpc-4547	918	8	t	t	PROPN
dpc-4547	918	9	,	,	PUNCT
dpc-4547	918	10	et	et	PROPN
dpc-4547	918	11	al	al	PROPN
dpc-4547	918	12	.	.	PUNCT
dpc-4547	919	1	a	a	DET
dpc-4547	919	2	novel	novel	ADJ
dpc-4547	919	3	actinic	actinic	ADJ
dpc-4547	919	4	keratosis	keratosis	NOUN
dpc-4547	919	5	field	field	NOUN
dpc-4547	919	6	assessment	assessment	NOUN
dpc-4547	919	7	scale	scale	NOUN
dpc-4547	919	8	for	for	ADP
dpc-4547	919	9	grading	grade	VERB
dpc-4547	919	10	actinic	actinic	ADJ
dpc-4547	919	11	keratosis	keratosis	NOUN
dpc-4547	919	12	disease	disease	NOUN
dpc-4547	919	13	severity	severity	NOUN
dpc-4547	919	14	.	.	PUNCT
dpc-4547	920	1	acta	acta	PROPN
dpc-4547	920	2	derm	derm	PROPN
dpc-4547	920	3	venereol	venereol	NOUN
dpc-4547	920	4	.	.	PUNCT
dpc-4547	921	1	2017;97(9):1108	2017;97(9):1108	NUM
dpc-4547	921	2	-	-	SYM
dpc-4547	921	3	13	13	NUM
dpc-4547	921	4	.	.	PUNCT
dpc-4547	921	5	156	156	NUM
dpc-4547	921	6	.	.	PUNCT
dpc-4547	922	1	dubois	dubois	PROPN
dpc-4547	922	2	a	a	PRON
dpc-4547	922	3	,	,	PUNCT
dpc-4547	922	4	levecq	levecq	NOUN
dpc-4547	922	5	o	o	NOUN
dpc-4547	922	6	,	,	PUNCT
dpc-4547	922	7	azimani	azimani	PROPN
dpc-4547	922	8	h	h	PROPN
dpc-4547	922	9	,	,	PUNCT
dpc-4547	922	10	et	et	PROPN
dpc-4547	922	11	al	al	PROPN
dpc-4547	922	12	.	.	PROPN
dpc-4547	922	13	line	line	NOUN
dpc-4547	922	14	-	-	PUNCT
dpc-4547	922	15	field	field	NOUN
dpc-4547	922	16	confocal	confocal	ADJ
dpc-4547	922	17	optical	optical	ADJ
dpc-4547	922	18	coherence	coherence	NOUN
dpc-4547	922	19	tomography	tomography	NOUN
dpc-4547	922	20	for	for	ADP
dpc-4547	922	21	high	high	ADJ
dpc-4547	922	22	-	-	PUNCT
dpc-4547	922	23	resolution	resolution	NOUN
dpc-4547	922	24	noninvasive	noninvasive	ADJ
dpc-4547	922	25	imaging	imaging	NOUN
dpc-4547	922	26	of	of	ADP
dpc-4547	922	27	skin	skin	NOUN
dpc-4547	922	28	tumors	tumor	NOUN
dpc-4547	922	29	.	.	PUNCT
dpc-4547	923	1	j	j	PROPN
dpc-4547	923	2	biomed	biome	VERB
dpc-4547	923	3	opt	opt	PROPN
dpc-4547	923	4	.	.	PUNCT
dpc-4547	924	1	2018;23(10):1	2018;23(10):1	NUM
dpc-4547	924	2	-	-	SYM
dpc-4547	924	3	9	9	NUM
dpc-4547	924	4	.	.	NUM
dpc-4547	924	5	157	157	NUM
dpc-4547	924	6	.	.	PUNCT
dpc-4547	925	1	ruini	ruini	PROPN
dpc-4547	925	2	c	c	PROPN
dpc-4547	925	3	,	,	PUNCT
dpc-4547	925	4	schuh	schuh	PROPN
dpc-4547	925	5	s	s	PROPN
dpc-4547	925	6	,	,	PUNCT
dpc-4547	925	7	gust	gust	PROPN
dpc-4547	925	8	c	c	NOUN
dpc-4547	925	9	,	,	PUNCT
dpc-4547	925	10	et	et	PROPN
dpc-4547	925	11	al	al	PROPN
dpc-4547	925	12	.	.	PROPN
dpc-4547	926	1	in	in	ADP
dpc-4547	926	2	-	-	PUNCT
dpc-4547	926	3	vivo	vivo	ADJ
dpc-4547	926	4	lc	lc	PROPN
dpc-4547	926	5	-	-	PUNCT
dpc-4547	926	6	oct	oct	NOUN
dpc-4547	926	7	evaluation	evaluation	NOUN
dpc-4547	926	8	of	of	ADP
dpc-4547	926	9	the	the	DET
dpc-4547	926	10	downward	downward	ADJ
dpc-4547	926	11	proliferation	proliferation	NOUN
dpc-4547	926	12	pattern	pattern	NOUN
dpc-4547	926	13	of	of	ADP
dpc-4547	926	14	keratinocytes	keratinocyte	NOUN
dpc-4547	926	15	in	in	ADP
dpc-4547	926	16	actinic	actinic	ADJ
dpc-4547	926	17	keratosis	keratosis	NOUN
dpc-4547	926	18	in	in	ADP
dpc-4547	926	19	comparison	comparison	NOUN
dpc-4547	926	20	with	with	ADP
dpc-4547	926	21	histology	histology	NOUN
dpc-4547	926	22	:	:	PUNCT
dpc-4547	926	23	first	first	ADJ
dpc-4547	926	24	impressions	impression	NOUN
dpc-4547	926	25	from	from	ADP
dpc-4547	926	26	a	a	DET
dpc-4547	926	27	pilot	pilot	NOUN
dpc-4547	926	28	study	study	NOUN
dpc-4547	926	29	.	.	PUNCT
dpc-4547	927	1	cancers	cancer	NOUN
dpc-4547	927	2	(	(	PUNCT
dpc-4547	927	3	basel	basel	PROPN
dpc-4547	927	4	)	)	PUNCT
dpc-4547	927	5	.	.	PUNCT
dpc-4547	928	1	2021;13(12	2021;13(12	NUM
dpc-4547	928	2	)	)	PUNCT
dpc-4547	928	3	.	.	PUNCT
dpc-4547	929	1	158	158	X
dpc-4547	929	2	.	.	PUNCT
dpc-4547	930	1	ruini	ruini	PROPN
dpc-4547	930	2	c	c	PROPN
dpc-4547	930	3	,	,	PUNCT
dpc-4547	930	4	schuh	schuh	PROPN
dpc-4547	930	5	s	s	PROPN
dpc-4547	930	6	,	,	PUNCT
dpc-4547	930	7	gust	gust	PROPN
dpc-4547	930	8	c	c	NOUN
dpc-4547	930	9	,	,	PUNCT
dpc-4547	930	10	et	et	PROPN
dpc-4547	930	11	al	al	PROPN
dpc-4547	930	12	.	.	PROPN
dpc-4547	930	13	line	line	NOUN
dpc-4547	930	14	-	-	PUNCT
dpc-4547	930	15	field	field	NOUN
dpc-4547	930	16	confocal	confocal	ADJ
dpc-4547	930	17	optical	optical	ADJ
dpc-4547	930	18	coherence	coherence	NOUN
dpc-4547	930	19	tomography	tomography	NOUN
dpc-4547	930	20	for	for	ADP
dpc-4547	930	21	the	the	DET
dpc-4547	930	22	in	in	ADP
dpc-4547	930	23	vivo	vivo	ADJ
dpc-4547	930	24	real	real	ADJ
dpc-4547	930	25	-	-	PUNCT
dpc-4547	930	26	time	time	NOUN
dpc-4547	930	27	diagnosis	diagnosis	NOUN
dpc-4547	930	28	of	of	ADP
dpc-4547	930	29	different	different	ADJ
dpc-4547	930	30	stages	stage	NOUN
dpc-4547	930	31	of	of	ADP
dpc-4547	930	32	keratinocyte	keratinocyte	NOUN
dpc-4547	930	33	skin	skin	NOUN
dpc-4547	930	34	cancer	cancer	NOUN
dpc-4547	930	35	:	:	PUNCT
dpc-4547	930	36	a	a	DET
dpc-4547	930	37	preliminary	preliminary	ADJ
dpc-4547	930	38	study	study	NOUN
dpc-4547	930	39	.	.	PUNCT
dpc-4547	931	1	j	j	PROPN
dpc-4547	931	2	eur	eur	PROPN
dpc-4547	931	3	acad	acad	PROPN
dpc-4547	931	4	dermatol	dermatol	NOUN
dpc-4547	931	5	venereol	venereol	NOUN
dpc-4547	931	6	.	.	PUNCT
dpc-4547	932	1	2021;35(12):2388	2021;35(12):2388	NUM
dpc-4547	932	2	-	-	SYM
dpc-4547	932	3	97	97	NUM
dpc-4547	932	4	.	.	NOUN
dpc-4547	932	5	159	159	NUM
dpc-4547	932	6	.	.	PUNCT
dpc-4547	933	1	cinotti	cinotti	PROPN
dpc-4547	933	2	e	e	PROPN
dpc-4547	933	3	,	,	PUNCT
dpc-4547	933	4	bertello	bertello	PROPN
dpc-4547	933	5	m	m	PROPN
dpc-4547	933	6	,	,	PUNCT
dpc-4547	933	7	cartocci	cartocci	VERB
dpc-4547	933	8	a	a	PRON
dpc-4547	933	9	,	,	PUNCT
dpc-4547	933	10	et	et	PROPN
dpc-4547	933	11	al	al	PROPN
dpc-4547	933	12	.	.	PROPN
dpc-4547	933	13	comparison	comparison	NOUN
dpc-4547	933	14	of	of	ADP
dpc-4547	933	15	reflectance	reflectance	NOUN
dpc-4547	933	16	confocal	confocal	ADJ
dpc-4547	933	17	microscopy	microscopy	NOUN
dpc-4547	933	18	and	and	CCONJ
dpc-4547	933	19	line	line	NOUN
dpc-4547	933	20	-	-	PUNCT
dpc-4547	933	21	field	field	NOUN
dpc-4547	933	22	optical	optical	ADJ
dpc-4547	933	23	coherence	coherence	NOUN
dpc-4547	933	24	tomography	tomography	NOUN
dpc-4547	933	25	for	for	ADP
dpc-4547	933	26	the	the	DET
dpc-4547	933	27	identification	identification	NOUN
dpc-4547	933	28	of	of	ADP
dpc-4547	933	29	keratinocyte	keratinocyte	NOUN
dpc-4547	933	30	skin	skin	NOUN
dpc-4547	933	31	tumours	tumour	NOUN
dpc-4547	933	32	.	.	PUNCT
dpc-4547	934	1	skin	skin	NOUN
dpc-4547	934	2	res	re	NOUN
dpc-4547	934	3	technol	technol	NOUN
dpc-4547	934	4	.	.	PUNCT
dpc-4547	935	1	2023;29(1):e13215	2023;29(1):e13215	NUM
dpc-4547	935	2	.	.	NOUN
dpc-4547	935	3	160	160	NUM
dpc-4547	935	4	.	.	PUNCT
dpc-4547	936	1	lenoir	lenoir	PROPN
dpc-4547	936	2	c	c	PROPN
dpc-4547	936	3	,	,	PUNCT
dpc-4547	936	4	cinotti	cinotti	NOUN
dpc-4547	936	5	e	e	NOUN
dpc-4547	936	6	,	,	PUNCT
dpc-4547	936	7	tognetti	tognetti	PROPN
dpc-4547	936	8	l	l	NOUN
dpc-4547	936	9	,	,	PUNCT
dpc-4547	936	10	et	et	PROPN
dpc-4547	936	11	al	al	PROPN
dpc-4547	936	12	.	.	PROPN
dpc-4547	936	13	line	line	NOUN
dpc-4547	936	14	-	-	PUNCT
dpc-4547	936	15	field	field	NOUN
dpc-4547	936	16	confocal	confocal	ADJ
dpc-4547	936	17	optical	optical	ADJ
dpc-4547	936	18	coherence	coherence	NOUN
dpc-4547	936	19	tomography	tomography	NOUN
dpc-4547	936	20	of	of	ADP
dpc-4547	936	21	actinic	actinic	ADJ
dpc-4547	936	22	keratosis	keratosis	NOUN
dpc-4547	936	23	:	:	PUNCT
dpc-4547	936	24	a	a	DET
dpc-4547	936	25	case	case	NOUN
dpc-4547	936	26	series	series	NOUN
dpc-4547	936	27	.	.	PUNCT
dpc-4547	937	1	j	j	PROPN
dpc-4547	937	2	eur	eur	PROPN
dpc-4547	937	3	acad	acad	PROPN
dpc-4547	937	4	dermatol	dermatol	NOUN
dpc-4547	937	5	venereol	venereol	NOUN
dpc-4547	937	6	.	.	PUNCT
dpc-4547	938	1	2021;35(12):e900	2021;35(12):e900	X
dpc-4547	938	2	-	-	PUNCT
dpc-4547	938	3	e2	e2	NOUN
dpc-4547	938	4	.	.	PUNCT
dpc-4547	939	1	161	161	NUM
dpc-4547	939	2	.	.	PUNCT
dpc-4547	940	1	daxenberger	daxenberger	NOUN
dpc-4547	940	2	f	f	NOUN
dpc-4547	940	3	,	,	PUNCT
dpc-4547	940	4	deussing	deusse	VERB
dpc-4547	940	5	m	m	PRON
dpc-4547	940	6	,	,	PUNCT
dpc-4547	940	7	eijkenboom	eijkenboom	PROPN
dpc-4547	940	8	q	q	PROPN
dpc-4547	940	9	,	,	PUNCT
dpc-4547	940	10	et	et	PROPN
dpc-4547	940	11	al	al	PROPN
dpc-4547	940	12	.	.	PROPN
dpc-4547	940	13	innovation	innovation	NOUN
dpc-4547	940	14	in	in	ADP
dpc-4547	940	15	actinic	actinic	ADJ
dpc-4547	940	16	keratosis	keratosis	NOUN
dpc-4547	940	17	assessment	assessment	NOUN
dpc-4547	940	18	:	:	PUNCT
dpc-4547	940	19	artificial	artificial	ADJ
dpc-4547	940	20	intelligence	intelligence	NOUN
dpc-4547	940	21	-	-	PUNCT
dpc-4547	940	22	based	base	VERB
dpc-4547	940	23	approach	approach	NOUN
dpc-4547	940	24	to	to	ADP
dpc-4547	940	25	lc	lc	PROPN
dpc-4547	940	26	-	-	PUNCT
dpc-4547	940	27	oct	oct	NOUN
dpc-4547	940	28	pro	pro	ADJ
dpc-4547	940	29	score	score	NOUN
dpc-4547	940	30	evaluation	evaluation	NOUN
dpc-4547	940	31	.	.	PUNCT
dpc-4547	941	1	cancers	cancer	NOUN
dpc-4547	941	2	(	(	PUNCT
dpc-4547	941	3	basel	basel	PROPN
dpc-4547	941	4	)	)	PUNCT
dpc-4547	941	5	.	.	PUNCT
dpc-4547	942	1	2023;15(18	2023;15(18	NUM
dpc-4547	942	2	)	)	PUNCT
dpc-4547	942	3	.	.	PUNCT
dpc-4547	943	1	162	162	NUM
dpc-4547	943	2	.	.	PUNCT
dpc-4547	944	1	thamm	thamm	PROPN
dpc-4547	944	2	jr	jr	PROPN
dpc-4547	944	3	,	,	PUNCT
dpc-4547	944	4	daxenberger	daxenberger	NOUN
dpc-4547	944	5	f	f	PROPN
dpc-4547	944	6	,	,	PUNCT
dpc-4547	944	7	viel	viel	PROPN
dpc-4547	944	8	t	t	PROPN
dpc-4547	944	9	,	,	PUNCT
dpc-4547	944	10	et	et	PROPN
dpc-4547	944	11	al	al	PROPN
dpc-4547	944	12	.	.	PUNCT
dpc-4547	944	13	artificial	artificial	ADJ
dpc-4547	944	14	intelligence	intelligence	NOUN
dpc-4547	944	15	-	-	PUNCT
dpc-4547	944	16	based	base	VERB
dpc-4547	944	17	pro	pro	ADJ
dpc-4547	944	18	score	score	NOUN
dpc-4547	944	19	assessment	assessment	NOUN
dpc-4547	944	20	in	in	ADP
dpc-4547	944	21	actinic	actinic	ADJ
dpc-4547	944	22	keratoses	keratose	NOUN
dpc-4547	944	23	from	from	ADP
dpc-4547	944	24	lc	lc	NOUN
dpc-4547	944	25	-	-	PUNCT
dpc-4547	944	26	oct	oct	NOUN
dpc-4547	944	27	imaging	imaging	NOUN
dpc-4547	944	28	using	use	VERB
dpc-4547	944	29	convolutional	convolutional	ADJ
dpc-4547	944	30	neural	neural	ADJ
dpc-4547	944	31	networks	network	NOUN
dpc-4547	944	32	.	.	PUNCT
dpc-4547	945	1	j	j	PROPN
dpc-4547	945	2	dtsch	dtsch	PROPN
dpc-4547	945	3	dermatol	dermatol	NOUN
dpc-4547	945	4	ges	ge	NOUN
dpc-4547	945	5	.	.	PROPN
dpc-4547	945	6	2023;21(11):1359	2023;21(11):1359	NUM
dpc-4547	945	7	-	-	SYM
dpc-4547	945	8	66	66	NUM
dpc-4547	945	9	.	.	PUNCT
dpc-4547	945	10	163	163	NUM
dpc-4547	945	11	.	.	PUNCT
dpc-4547	946	1	fischman	fischman	PROPN
dpc-4547	946	2	s	s	PROPN
dpc-4547	946	3	,	,	PUNCT
dpc-4547	946	4	pérez	pérez	NOUN
dpc-4547	946	5	-	-	PUNCT
dpc-4547	946	6	anker	anker	PROPN
dpc-4547	946	7	j	j	PROPN
dpc-4547	946	8	,	,	PUNCT
dpc-4547	946	9	tognetti	tognetti	PROPN
dpc-4547	946	10	l	l	PROPN
dpc-4547	946	11	,	,	PUNCT
dpc-4547	946	12	et	et	PROPN
dpc-4547	946	13	al	al	PROPN
dpc-4547	946	14	.	.	PUNCT
dpc-4547	947	1	non	non	ADJ
dpc-4547	947	2	-	-	ADJ
dpc-4547	947	3	invasive	invasive	ADJ
dpc-4547	947	4	scoring	scoring	NOUN
dpc-4547	947	5	of	of	ADP
dpc-4547	947	6	cellular	cellular	ADJ
dpc-4547	947	7	atypia	atypia	PROPN
dpc-4547	947	8	in	in	ADP
dpc-4547	947	9	keratinocyte	keratinocyte	NOUN
dpc-4547	947	10	cancers	cancer	NOUN
dpc-4547	947	11	in	in	ADP
dpc-4547	947	12	3d	3d	PROPN
dpc-4547	947	13	lc	lc	PROPN
dpc-4547	947	14	-	-	PUNCT
dpc-4547	947	15	oct	oct	NOUN
dpc-4547	947	16	images	image	NOUN
dpc-4547	947	17	using	use	VERB
dpc-4547	947	18	deep	deep	ADJ
dpc-4547	947	19	learning	learning	NOUN
dpc-4547	947	20	.	.	PUNCT
dpc-4547	948	1	sci	sci	PROPN
dpc-4547	948	2	rep	rep	PROPN
dpc-4547	948	3	.	.	PROPN
dpc-4547	948	4	2022;12(1):481	2022;12(1):481	NUM
dpc-4547	948	5	.	.	NOUN
dpc-4547	949	1	164	164	NUM
dpc-4547	949	2	.	.	PUNCT
dpc-4547	950	1	thamm	thamm	PROPN
dpc-4547	950	2	j	j	PROPN
dpc-4547	950	3	,	,	PUNCT
dpc-4547	950	4	welzel	welzel	PROPN
dpc-4547	950	5	j	j	PROPN
dpc-4547	950	6	,	,	PUNCT
dpc-4547	950	7	schuh	schuh	PROPN
dpc-4547	950	8	s.	s.	PROPN
dpc-4547	950	9	ai	ai	AUX
dpc-4547	950	10	-	-	PUNCT
dpc-4547	950	11	based	base	VERB
dpc-4547	950	12	and	and	CCONJ
dpc-4547	950	13	lc	lc	NOUN
dpc-4547	950	14	-	-	PUNCT
dpc-4547	950	15	octguided	octguide	VERB
dpc-4547	950	16	follow	follow	NOUN
dpc-4547	950	17	-	-	PUNCT
dpc-4547	950	18	up	up	NOUN
dpc-4547	950	19	of	of	ADP
dpc-4547	950	20	actinic	actinic	ADJ
dpc-4547	950	21	keratoses	keratose	NOUN
dpc-4547	950	22	under	under	ADP
dpc-4547	950	23	treatment	treatment	NOUN
dpc-4547	950	24	with	with	ADP
dpc-4547	950	25	tirbanibulin	tirbanibulin	PROPN
dpc-4547	950	26	1	1	NUM
dpc-4547	950	27	%	%	NOUN
dpc-4547	950	28	.	.	PUNCT
dpc-4547	951	1	submitted	submit	VERB
dpc-4547	951	2	to	to	ADP
dpc-4547	951	3	jeadv	jeadv	NOUN
dpc-4547	951	4	and	and	CCONJ
dpc-4547	951	5	currently	currently	ADV
dpc-4547	951	6	under	under	ADP
dpc-4547	951	7	review	review	NOUN
dpc-4547	951	8	.	.	PUNCT
dpc-4547	952	1	131	131	NUM
dpc-4547	952	2	.	.	PUNCT
dpc-4547	952	3	sturm	sturm	PROPN
dpc-4547	952	4	ra	ra	PROPN
dpc-4547	952	5	.	.	PUNCT
dpc-4547	953	1	skin	skin	NOUN
dpc-4547	953	2	colour	colour	NOUN
dpc-4547	953	3	and	and	CCONJ
dpc-4547	953	4	skin	skin	NOUN
dpc-4547	953	5	cancer	cancer	NOUN
dpc-4547	953	6	mc1r	mc1r	PROPN
dpc-4547	953	7	,	,	PUNCT
dpc-4547	953	8	the	the	DET
dpc-4547	953	9	genetic	genetic	ADJ
dpc-4547	953	10	link	link	NOUN
dpc-4547	953	11	.	.	PUNCT
dpc-4547	954	1	melanoma	melanoma	NOUN
dpc-4547	954	2	res	re	NOUN
dpc-4547	954	3	.	.	PUNCT
dpc-4547	955	1	2002;12(5):405	2002;12(5):405	NUM
dpc-4547	955	2	-	-	SYM
dpc-4547	955	3	16	16	NUM
dpc-4547	955	4	.	.	PUNCT
dpc-4547	956	1	132	132	NUM
dpc-4547	956	2	.	.	PUNCT
dpc-4547	956	3	burns	burn	VERB
dpc-4547	956	4	em	em	PRON
dpc-4547	956	5	,	,	PUNCT
dpc-4547	956	6	elmets	elmet	NOUN
dpc-4547	956	7	ca	can	AUX
dpc-4547	956	8	,	,	PUNCT
dpc-4547	956	9	yusuf	yusuf	PROPN
dpc-4547	956	10	n.	n.	PROPN
dpc-4547	956	11	vitamin	vitamin	PROPN
dpc-4547	956	12	d	d	NOUN
dpc-4547	956	13	and	and	CCONJ
dpc-4547	956	14	skin	skin	NOUN
dpc-4547	956	15	cancer	cancer	NOUN
dpc-4547	956	16	.	.	PUNCT
dpc-4547	957	1	photochem	photochem	PROPN
dpc-4547	957	2	photobiol	photobiol	PROPN
dpc-4547	957	3	.	.	PUNCT
dpc-4547	958	1	2015;91(1):201	2015;91(1):201	NUM
dpc-4547	958	2	-	-	SYM
dpc-4547	958	3	9	9	NUM
dpc-4547	958	4	.	.	NUM
dpc-4547	958	5	133	133	NUM
dpc-4547	958	6	.	.	PUNCT
dpc-4547	959	1	liang	liang	PROPN
dpc-4547	959	2	g	g	PROPN
dpc-4547	959	3	,	,	PUNCT
dpc-4547	959	4	nan	nan	PROPN
dpc-4547	959	5	h	h	PROPN
dpc-4547	959	6	,	,	PUNCT
dpc-4547	959	7	qureshi	qureshi	PROPN
dpc-4547	959	8	aa	aa	PROPN
dpc-4547	959	9	,	,	PUNCT
dpc-4547	959	10	han	han	PROPN
dpc-4547	959	11	j.	j.	PROPN
dpc-4547	959	12	pre	pre	PROPN
dpc-4547	959	13	-	-	ADJ
dpc-4547	959	14	diagnostic	diagnostic	ADJ
dpc-4547	959	15	plasma	plasma	NOUN
dpc-4547	959	16	25	25	NUM
dpc-4547	959	17	-	-	PUNCT
dpc-4547	959	18	hydroxyvitamin	hydroxyvitamin	NOUN
dpc-4547	959	19	d	d	NOUN
dpc-4547	959	20	levels	level	NOUN
dpc-4547	959	21	and	and	CCONJ
dpc-4547	959	22	risk	risk	NOUN
dpc-4547	959	23	of	of	ADP
dpc-4547	959	24	non	non	ADJ
dpc-4547	959	25	-	-	ADJ
dpc-4547	959	26	melanoma	melanoma	ADJ
dpc-4547	959	27	skin	skin	NOUN
dpc-4547	959	28	cancer	cancer	NOUN
dpc-4547	959	29	in	in	ADP
dpc-4547	959	30	women	woman	NOUN
dpc-4547	959	31	.	.	PUNCT
dpc-4547	960	1	plos	plos	PROPN
dpc-4547	960	2	one	one	NUM
dpc-4547	960	3	.	.	PUNCT
dpc-4547	961	1	2012;7(4):e35211	2012;7(4):e35211	NUM
dpc-4547	961	2	.	.	PUNCT
dpc-4547	962	1	134	134	NUM
dpc-4547	962	2	.	.	PUNCT
dpc-4547	963	1	van	van	PROPN
dpc-4547	963	2	der	der	PROPN
dpc-4547	963	3	pols	pol	NOUN
dpc-4547	963	4	jc	jc	PROPN
dpc-4547	963	5	,	,	PUNCT
dpc-4547	963	6	russell	russell	PROPN
dpc-4547	963	7	a	a	PROPN
dpc-4547	963	8	,	,	PUNCT
dpc-4547	963	9	bauer	bauer	PROPN
dpc-4547	963	10	u	u	PROPN
dpc-4547	963	11	,	,	PUNCT
dpc-4547	963	12	neale	neale	PROPN
dpc-4547	963	13	re	re	PROPN
dpc-4547	963	14	,	,	PUNCT
dpc-4547	963	15	kimlin	kimlin	PROPN
dpc-4547	963	16	mg	mg	PROPN
dpc-4547	963	17	,	,	PUNCT
dpc-4547	963	18	green	green	PROPN
dpc-4547	963	19	ac	ac	PROPN
dpc-4547	963	20	.	.	PUNCT
dpc-4547	964	1	vitamin	vitamin	NOUN
dpc-4547	964	2	d	d	NOUN
dpc-4547	964	3	status	status	NOUN
dpc-4547	964	4	and	and	CCONJ
dpc-4547	964	5	skin	skin	NOUN
dpc-4547	964	6	cancer	cancer	NOUN
dpc-4547	964	7	risk	risk	NOUN
dpc-4547	964	8	independent	independent	ADJ
dpc-4547	964	9	of	of	ADP
dpc-4547	964	10	time	time	NOUN
dpc-4547	964	11	outdoors	outdoor	NOUN
dpc-4547	964	12	:	:	PUNCT
dpc-4547	964	13	11	11	NUM
dpc-4547	964	14	-	-	PUNCT
dpc-4547	964	15	year	year	NOUN
dpc-4547	964	16	prospective	prospective	ADJ
dpc-4547	964	17	study	study	NOUN
dpc-4547	964	18	in	in	ADP
dpc-4547	964	19	an	an	DET
dpc-4547	964	20	australian	australian	ADJ
dpc-4547	964	21	community	community	NOUN
dpc-4547	964	22	.	.	PUNCT
dpc-4547	965	1	j	j	PROPN
dpc-4547	965	2	invest	invest	VERB
dpc-4547	965	3	dermatol	dermatol	NOUN
dpc-4547	965	4	.	.	PUNCT
dpc-4547	966	1	2013;133(3):637	2013;133(3):637	NUM
dpc-4547	966	2	-	-	SYM
dpc-4547	966	3	41	41	NUM
dpc-4547	966	4	.	.	PUNCT
dpc-4547	967	1	135	135	NUM
dpc-4547	967	2	.	.	PUNCT
dpc-4547	967	3	nemazannikova	nemazannikova	PROPN
dpc-4547	967	4	n	n	SYM
dpc-4547	967	5	,	,	PUNCT
dpc-4547	967	6	antonas	antonas	PROPN
dpc-4547	967	7	k	k	PROPN
dpc-4547	967	8	,	,	PUNCT
dpc-4547	967	9	dass	dass	PROPN
dpc-4547	967	10	cr	cr	PROPN
dpc-4547	967	11	.	.	PUNCT
dpc-4547	968	1	role	role	NOUN
dpc-4547	968	2	of	of	ADP
dpc-4547	968	3	vitamin	vitamin	NOUN
dpc-4547	968	4	d	d	NOUN
dpc-4547	968	5	metabolism	metabolism	NOUN
dpc-4547	968	6	in	in	ADP
dpc-4547	968	7	cutaneous	cutaneous	ADJ
dpc-4547	968	8	tumour	tumour	NOUN
dpc-4547	968	9	formation	formation	NOUN
dpc-4547	968	10	and	and	CCONJ
dpc-4547	968	11	progression	progression	NOUN
dpc-4547	968	12	.	.	PUNCT
dpc-4547	969	1	j	j	PROPN
dpc-4547	969	2	pharm	pharm	PROPN
dpc-4547	969	3	pharmacol	pharmacol	PROPN
dpc-4547	969	4	.	.	PUNCT
dpc-4547	970	1	2013;65(1):2	2013;65(1):2	NUM
dpc-4547	970	2	-	-	SYM
dpc-4547	970	3	10	10	NUM
dpc-4547	970	4	.	.	PUNCT
dpc-4547	971	1	136	136	NUM
dpc-4547	971	2	.	.	PUNCT
dpc-4547	972	1	afzal	afzal	PROPN
dpc-4547	972	2	s	s	PROPN
dpc-4547	972	3	,	,	PUNCT
dpc-4547	972	4	nordestgaard	nordestgaard	PROPN
dpc-4547	972	5	bg	bg	PROPN
dpc-4547	972	6	,	,	PUNCT
dpc-4547	972	7	bojesen	bojesen	X
dpc-4547	972	8	se	se	PROPN
dpc-4547	972	9	.	.	PUNCT
dpc-4547	973	1	plasma	plasma	VERB
dpc-4547	973	2	25hydroxyvitamin	25hydroxyvitamin	PROPN
dpc-4547	973	3	d	d	NOUN
dpc-4547	973	4	and	and	CCONJ
dpc-4547	973	5	risk	risk	NOUN
dpc-4547	973	6	of	of	ADP
dpc-4547	973	7	non	non	ADJ
dpc-4547	973	8	-	-	ADJ
dpc-4547	973	9	melanoma	melanoma	ADJ
dpc-4547	973	10	and	and	CCONJ
dpc-4547	973	11	melanoma	melanoma	NOUN
dpc-4547	973	12	skin	skin	NOUN
dpc-4547	973	13	cancer	cancer	NOUN
dpc-4547	973	14	:	:	PUNCT
dpc-4547	973	15	a	a	DET
dpc-4547	973	16	prospective	prospective	ADJ
dpc-4547	973	17	cohort	cohort	NOUN
dpc-4547	973	18	study	study	NOUN
dpc-4547	973	19	.	.	PUNCT
dpc-4547	974	1	j	j	PROPN
dpc-4547	974	2	invest	invest	VERB
dpc-4547	974	3	dermatol	dermatol	NOUN
dpc-4547	974	4	.	.	PUNCT
dpc-4547	975	1	2013;133(3):629	2013;133(3):629	NUM
dpc-4547	975	2	-	-	SYM
dpc-4547	975	3	36	36	NUM
dpc-4547	975	4	.	.	PUNCT
dpc-4547	975	5	137	137	NUM
dpc-4547	975	6	.	.	PUNCT
dpc-4547	975	7	tang	tang	PROPN
dpc-4547	976	1	jy	jy	PROPN
dpc-4547	976	2	,	,	PUNCT
dpc-4547	976	3	parimi	parimi	PROPN
dpc-4547	976	4	n	n	CCONJ
dpc-4547	976	5	,	,	PUNCT
dpc-4547	976	6	wu	wu	PROPN
dpc-4547	976	7	a	a	PROPN
dpc-4547	976	8	,	,	PUNCT
dpc-4547	976	9	et	et	PROPN
dpc-4547	976	10	al	al	PROPN
dpc-4547	976	11	.	.	PROPN
dpc-4547	976	12	inverse	inverse	PROPN
dpc-4547	976	13	association	association	NOUN
dpc-4547	976	14	between	between	ADP
dpc-4547	976	15	serum	serum	NOUN
dpc-4547	976	16	25(oh	25(oh	NOUN
dpc-4547	976	17	)	)	PUNCT
dpc-4547	976	18	vitamin	vitamin	NOUN
dpc-4547	976	19	d	d	NOUN
dpc-4547	976	20	levels	level	NOUN
dpc-4547	976	21	and	and	CCONJ
dpc-4547	976	22	non	non	ADJ
dpc-4547	976	23	-	-	ADJ
dpc-4547	976	24	melanoma	melanoma	ADJ
dpc-4547	976	25	skin	skin	NOUN
dpc-4547	976	26	cancer	cancer	NOUN
dpc-4547	976	27	in	in	ADP
dpc-4547	976	28	elderly	elderly	ADJ
dpc-4547	976	29	men	man	NOUN
dpc-4547	976	30	.	.	PUNCT
dpc-4547	977	1	cancer	cancer	NOUN
dpc-4547	977	2	causes	cause	VERB
dpc-4547	977	3	control	control	NOUN
dpc-4547	977	4	.	.	PUNCT
dpc-4547	978	1	2010;21(3):387	2010;21(3):387	NUM
dpc-4547	978	2	-	-	PUNCT
dpc-4547	978	3	91	91	NUM
dpc-4547	978	4	.	.	PUNCT
dpc-4547	978	5	138	138	NUM
dpc-4547	978	6	.	.	PUNCT
dpc-4547	979	1	cerman	cerman	PROPN
dpc-4547	979	2	aa	aa	PROPN
dpc-4547	979	3	,	,	PUNCT
dpc-4547	979	4	karabay	karabay	PROPN
dpc-4547	979	5	ea	ea	PROPN
dpc-4547	979	6	,	,	PUNCT
dpc-4547	979	7	altunay	altunay	PROPN
dpc-4547	979	8	ik	ik	PROPN
dpc-4547	979	9	,	,	PUNCT
dpc-4547	979	10	cesur	cesur	PROPN
dpc-4547	979	11	sk	sk	PROPN
dpc-4547	979	12	.	.	PROPN
dpc-4547	979	13	vitamin	vitamin	PROPN
dpc-4547	979	14	d	d	PROPN
dpc-4547	979	15	levels	level	NOUN
dpc-4547	979	16	in	in	ADP
dpc-4547	979	17	actinic	actinic	ADJ
dpc-4547	979	18	keratosis	keratosis	NOUN
dpc-4547	979	19	:	:	PUNCT
dpc-4547	979	20	a	a	DET
dpc-4547	979	21	preliminary	preliminary	ADJ
dpc-4547	979	22	study	study	NOUN
dpc-4547	979	23	.	.	PUNCT
dpc-4547	980	1	an	an	DET
dpc-4547	980	2	bras	bras	NOUN
dpc-4547	980	3	dermatol	dermatol	NOUN
dpc-4547	980	4	.	.	PUNCT
dpc-4547	981	1	2018;93(4):535	2018;93(4):535	NUM
dpc-4547	981	2	-	-	SYM
dpc-4547	981	3	8	8	NUM
dpc-4547	981	4	.	.	NOUN
dpc-4547	981	5	139	139	NUM
dpc-4547	981	6	.	.	PUNCT
dpc-4547	982	1	sutedja	sutedja	PROPN
dpc-4547	982	2	ek	ek	PROPN
dpc-4547	982	3	,	,	PUNCT
dpc-4547	982	4	arianto	arianto	ADP
dpc-4547	982	5	tr	tr	VERB
dpc-4547	982	6	,	,	PUNCT
dpc-4547	982	7	lesmana	lesmana	PROPN
dpc-4547	982	8	r	r	NOUN
dpc-4547	982	9	,	,	PUNCT
dpc-4547	982	10	suwarsa	suwarsa	NOUN
dpc-4547	982	11	o	o	NOUN
dpc-4547	982	12	,	,	PUNCT
dpc-4547	982	13	setiabudiawan	setiabudiawan	PROPN
dpc-4547	982	14	b.	b.	PROPN
dpc-4547	983	1	the	the	DET
dpc-4547	983	2	chemoprotective	chemoprotective	ADJ
dpc-4547	983	3	role	role	NOUN
dpc-4547	983	4	of	of	ADP
dpc-4547	983	5	vitamin	vitamin	NOUN
dpc-4547	983	6	d	d	NOUN
dpc-4547	983	7	in	in	ADP
dpc-4547	983	8	skin	skin	NOUN
dpc-4547	983	9	cancer	cancer	NOUN
dpc-4547	983	10	:	:	PUNCT
dpc-4547	983	11	a	a	DET
dpc-4547	983	12	systematic	systematic	ADJ
dpc-4547	983	13	review	review	NOUN
dpc-4547	983	14	.	.	PUNCT
dpc-4547	984	1	cancer	cancer	NOUN
dpc-4547	984	2	manag	manag	PROPN
dpc-4547	984	3	res	re	NOUN
dpc-4547	984	4	.	.	PUNCT
dpc-4547	985	1	2022;14:3551	2022;14:3551	NUM
dpc-4547	985	2	-	-	SYM
dpc-4547	985	3	65	65	NUM
dpc-4547	985	4	.	.	PUNCT
dpc-4547	986	1	140	140	NUM
dpc-4547	986	2	.	.	X
dpc-4547	986	3	passarelli	passarelli	PROPN
dpc-4547	986	4	mn	mn	PROPN
dpc-4547	986	5	,	,	PUNCT
dpc-4547	986	6	karagas	karagas	PROPN
dpc-4547	986	7	mr	mr	PROPN
dpc-4547	986	8	,	,	PUNCT
dpc-4547	986	9	mott	mott	PROPN
dpc-4547	986	10	la	la	PROPN
dpc-4547	986	11	,	,	PUNCT
dpc-4547	986	12	rees	rees	PROPN
dpc-4547	986	13	jr	jr	PROPN
dpc-4547	986	14	,	,	PUNCT
dpc-4547	986	15	barry	barry	PROPN
dpc-4547	986	16	el	el	PROPN
dpc-4547	986	17	,	,	PUNCT
dpc-4547	986	18	baron	baron	PROPN
dpc-4547	986	19	ja	ja	PROPN
dpc-4547	986	20	.	.	PUNCT
dpc-4547	987	1	risk	risk	NOUN
dpc-4547	987	2	of	of	ADP
dpc-4547	987	3	keratinocyte	keratinocyte	NOUN
dpc-4547	987	4	carcinomas	carcinoma	NOUN
dpc-4547	987	5	with	with	ADP
dpc-4547	987	6	vitamin	vitamin	NOUN
dpc-4547	987	7	d	d	NOUN
dpc-4547	987	8	and	and	CCONJ
dpc-4547	987	9	calcium	calcium	NOUN
dpc-4547	987	10	supplementation	supplementation	NOUN
dpc-4547	987	11	:	:	PUNCT
dpc-4547	987	12	a	a	DET
dpc-4547	987	13	secondary	secondary	ADJ
dpc-4547	987	14	analysis	analysis	NOUN
dpc-4547	987	15	of	of	ADP
dpc-4547	987	16	a	a	DET
dpc-4547	987	17	randomized	randomized	ADJ
dpc-4547	987	18	clinical	clinical	ADJ
dpc-4547	987	19	trial	trial	NOUN
dpc-4547	987	20	.	.	PUNCT
dpc-4547	988	1	am	be	AUX
dpc-4547	988	2	j	j	PROPN
dpc-4547	988	3	clin	clin	PROPN
dpc-4547	988	4	nutr	nutr	PROPN
dpc-4547	988	5	.	.	PUNCT
dpc-4547	989	1	2020;112(6):1532	2020;112(6):1532	NUM
dpc-4547	989	2	-	-	SYM
dpc-4547	989	3	9	9	NUM
dpc-4547	989	4	.	.	NOUN
dpc-4547	989	5	141	141	NUM
dpc-4547	989	6	.	.	PUNCT
dpc-4547	990	1	rosenberg	rosenberg	PROPN
dpc-4547	990	2	ar	ar	PROPN
dpc-4547	990	3	,	,	PUNCT
dpc-4547	990	4	tabacchi	tabacchi	PROPN
dpc-4547	990	5	m	m	PROPN
dpc-4547	990	6	,	,	PUNCT
dpc-4547	990	7	ngo	ngo	PROPN
dpc-4547	990	8	kh	kh	PROPN
dpc-4547	990	9	,	,	PUNCT
dpc-4547	990	10	et	et	PROPN
dpc-4547	990	11	al	al	PROPN
dpc-4547	990	12	.	.	PROPN
dpc-4547	990	13	skin	skin	NOUN
dpc-4547	990	14	cancer	cancer	NOUN
dpc-4547	990	15	precursor	precursor	NOUN
dpc-4547	990	16	immunotherapy	immunotherapy	NOUN
dpc-4547	990	17	for	for	ADP
dpc-4547	990	18	squamous	squamous	ADJ
dpc-4547	990	19	cell	cell	NOUN
dpc-4547	990	20	carcinoma	carcinoma	NOUN
dpc-4547	990	21	prevention	prevention	NOUN
dpc-4547	990	22	.	.	PUNCT
dpc-4547	991	1	jci	jci	PROPN
dpc-4547	991	2	insight	insight	PROPN
dpc-4547	991	3	.	.	PUNCT
dpc-4547	992	1	2019;4(6	2019;4(6	NUM
dpc-4547	992	2	)	)	PUNCT
dpc-4547	992	3	.	.	PUNCT
dpc-4547	993	1	142	142	NUM
dpc-4547	993	2	.	.	PUNCT
dpc-4547	994	1	cunningham	cunningham	PROPN
dpc-4547	994	2	tj	tj	PROPN
dpc-4547	994	3	,	,	PUNCT
dpc-4547	994	4	tabacchi	tabacchi	PROPN
dpc-4547	994	5	m	m	PROPN
dpc-4547	994	6	,	,	PUNCT
dpc-4547	994	7	eliane	eliane	NOUN
dpc-4547	994	8	jp	jp	NOUN
dpc-4547	994	9	,	,	PUNCT
dpc-4547	994	10	et	et	PROPN
dpc-4547	994	11	al	al	PROPN
dpc-4547	994	12	.	.	PROPN
dpc-4547	994	13	randomized	randomize	VERB
dpc-4547	994	14	trial	trial	NOUN
dpc-4547	994	15	of	of	ADP
dpc-4547	994	16	calcipotriol	calcipotriol	NOUN
dpc-4547	994	17	combined	combine	VERB
dpc-4547	994	18	with	with	ADP
dpc-4547	994	19	5	5	NUM
dpc-4547	994	20	-	-	PUNCT
dpc-4547	994	21	fluorouracil	fluorouracil	NOUN
dpc-4547	994	22	for	for	ADP
dpc-4547	994	23	skin	skin	NOUN
dpc-4547	994	24	cancer	cancer	NOUN
dpc-4547	994	25	precursor	precursor	NOUN
dpc-4547	994	26	immunotherapy	immunotherapy	NOUN
dpc-4547	994	27	.	.	PUNCT
dpc-4547	995	1	j	j	PROPN
dpc-4547	995	2	clin	clin	PROPN
dpc-4547	995	3	invest	invest	PROPN
dpc-4547	995	4	.	.	PUNCT
dpc-4547	996	1	2017;127(1):106	2017;127(1):106	NUM
dpc-4547	996	2	-	-	SYM
dpc-4547	996	3	16	16	NUM
dpc-4547	996	4	.	.	PUNCT
dpc-4547	997	1	143	143	NUM
dpc-4547	997	2	.	.	PUNCT
dpc-4547	998	1	li	li	PROPN
dpc-4547	998	2	m	m	PROPN
dpc-4547	998	3	,	,	PUNCT
dpc-4547	998	4	hener	hener	PROPN
dpc-4547	998	5	p	p	PROPN
dpc-4547	998	6	,	,	PUNCT
dpc-4547	998	7	zhang	zhang	PROPN
dpc-4547	998	8	z	z	PROPN
dpc-4547	998	9	,	,	PUNCT
dpc-4547	998	10	kato	kato	PROPN
dpc-4547	998	11	s	s	PROPN
dpc-4547	998	12	,	,	PUNCT
dpc-4547	998	13	metzger	metzger	PROPN
dpc-4547	998	14	d	d	PROPN
dpc-4547	998	15	,	,	PUNCT
dpc-4547	998	16	chambon	chambon	NOUN
dpc-4547	998	17	p.	p.	NOUN
dpc-4547	998	18	topical	topical	ADJ
dpc-4547	998	19	vitamin	vitamin	NOUN
dpc-4547	998	20	d3	d3	PROPN
dpc-4547	998	21	and	and	CCONJ
dpc-4547	998	22	low	low	ADJ
dpc-4547	998	23	-	-	PUNCT
dpc-4547	998	24	calcemic	calcemic	ADJ
dpc-4547	998	25	analogs	analog	NOUN
dpc-4547	998	26	induce	induce	VERB
dpc-4547	998	27	thymic	thymic	ADJ
dpc-4547	998	28	stromal	stromal	ADJ
dpc-4547	998	29	lymphopoietin	lymphopoietin	NOUN
dpc-4547	998	30	in	in	ADP
dpc-4547	998	31	mouse	mouse	NOUN
dpc-4547	998	32	keratinocytes	keratinocyte	NOUN
dpc-4547	998	33	and	and	CCONJ
dpc-4547	998	34	trigger	trigger	VERB
dpc-4547	998	35	an	an	DET
dpc-4547	998	36	atopic	atopic	NOUN
dpc-4547	998	37	dermatitis	dermatitis	NOUN
dpc-4547	998	38	.	.	PUNCT
dpc-4547	999	1	proc	proc	PROPN
dpc-4547	999	2	natl	natl	PROPN
dpc-4547	999	3	acad	acad	PROPN
dpc-4547	999	4	sci	sci	PROPN
dpc-4547	999	5	u	u	PROPN
dpc-4547	999	6	s	s	NOUN
dpc-4547	999	7	a.	a.	NOUN
dpc-4547	999	8	2006;103(31):11736	2006;103(31):11736	NUM
dpc-4547	999	9	-	-	SYM
dpc-4547	999	10	41	41	NUM
dpc-4547	999	11	.	.	PUNCT
dpc-4547	1000	1	144	144	NUM
dpc-4547	1000	2	.	.	PUNCT
dpc-4547	1001	1	sato	sato	PROPN
dpc-4547	1001	2	-	-	PUNCT
dpc-4547	1001	3	deguchi	deguchi	PROPN
dpc-4547	1001	4	e	e	PROPN
dpc-4547	1001	5	,	,	PUNCT
dpc-4547	1001	6	imafuku	imafuku	PROPN
dpc-4547	1001	7	s	s	PROPN
dpc-4547	1001	8	,	,	PUNCT
dpc-4547	1001	9	chou	chou	PROPN
dpc-4547	1001	10	b	b	PROPN
dpc-4547	1001	11	,	,	PUNCT
dpc-4547	1001	12	ishii	ishii	PROPN
dpc-4547	1001	13	k	k	PROPN
dpc-4547	1001	14	,	,	PUNCT
dpc-4547	1001	15	hiromatsu	hiromatsu	PROPN
dpc-4547	1001	16	k	k	PROPN
dpc-4547	1001	17	,	,	PUNCT
dpc-4547	1001	18	nakayama	nakayama	PROPN
dpc-4547	1001	19	j.	j.	PROPN
dpc-4547	1001	20	topical	topical	ADJ
dpc-4547	1001	21	vitamin	vitamin	PROPN
dpc-4547	1001	22	d(3	d(3	PROPN
dpc-4547	1001	23	)	)	PUNCT
dpc-4547	1001	24	analogues	analogue	NOUN
dpc-4547	1001	25	induce	induce	VERB
dpc-4547	1001	26	thymic	thymic	ADJ
dpc-4547	1001	27	stromal	stromal	ADJ
dpc-4547	1001	28	lymphopoietin	lymphopoietin	NOUN
dpc-4547	1001	29	and	and	CCONJ
dpc-4547	1001	30	cathelicidin	cathelicidin	VERB
dpc-4547	1001	31	in	in	ADP
dpc-4547	1001	32	psoriatic	psoriatic	ADJ
dpc-4547	1001	33	skin	skin	NOUN
dpc-4547	1001	34	lesions	lesion	NOUN
dpc-4547	1001	35	.	.	PUNCT
dpc-4547	1002	1	br	br	PROPN
dpc-4547	1002	2	j	j	PROPN
dpc-4547	1002	3	dermatol	dermatol	NOUN
dpc-4547	1002	4	.	.	PUNCT
dpc-4547	1003	1	2012;167(1):77	2012;167(1):77	NUM
dpc-4547	1003	2	-	-	SYM
dpc-4547	1003	3	84	84	NUM
dpc-4547	1003	4	.	.	PUNCT
dpc-4547	1004	1	145	145	NUM
dpc-4547	1004	2	.	.	PUNCT
dpc-4547	1005	1	bullock	bullock	PROPN
dpc-4547	1005	2	ta	ta	PROPN
dpc-4547	1005	3	,	,	PUNCT
dpc-4547	1005	4	negrey	negrey	PROPN
dpc-4547	1005	5	j	j	PROPN
dpc-4547	1005	6	,	,	PUNCT
dpc-4547	1005	7	hu	hu	PROPN
dpc-4547	1005	8	b	b	PROPN
dpc-4547	1005	9	,	,	PUNCT
dpc-4547	1005	10	warren	warren	PROPN
dpc-4547	1005	11	cb	cb	PROPN
dpc-4547	1005	12	,	,	PUNCT
dpc-4547	1005	13	hasan	hasan	PROPN
dpc-4547	1005	14	t	t	PROPN
dpc-4547	1005	15	,	,	PUNCT
dpc-4547	1005	16	maytin	maytin	NOUN
dpc-4547	1005	17	ev	ev	ADP
dpc-4547	1005	18	.	.	PUNCT
dpc-4547	1005	19	significant	significant	ADJ
dpc-4547	1005	20	improvement	improvement	NOUN
dpc-4547	1005	21	of	of	ADP
dpc-4547	1005	22	facial	facial	ADJ
dpc-4547	1005	23	actinic	actinic	ADJ
dpc-4547	1005	24	keratoses	keratose	NOUN
dpc-4547	1005	25	after	after	ADP
dpc-4547	1005	26	blue	blue	ADJ
dpc-4547	1005	27	light	light	ADJ
dpc-4547	1005	28	photodynamic	photodynamic	ADJ
dpc-4547	1005	29	therapy	therapy	NOUN
dpc-4547	1005	30	with	with	ADP
dpc-4547	1005	31	oral	oral	ADJ
dpc-4547	1005	32	vitamin	vitamin	NOUN
dpc-4547	1005	33	d	d	NOUN
dpc-4547	1005	34	pretreatment	pretreatment	NOUN
dpc-4547	1005	35	:	:	PUNCT
dpc-4547	1005	36	an	an	DET
dpc-4547	1005	37	interventional	interventional	ADJ
dpc-4547	1005	38	cohort	cohort	NOUN
dpc-4547	1005	39	-	-	PUNCT
dpc-4547	1005	40	controlled	control	VERB
dpc-4547	1005	41	trial	trial	NOUN
dpc-4547	1005	42	.	.	PUNCT
dpc-4547	1006	1	j	j	PROPN
dpc-4547	1006	2	am	be	AUX
dpc-4547	1006	3	acad	acad	ADJ
dpc-4547	1006	4	dermatol	dermatol	NOUN
dpc-4547	1006	5	.	.	PUNCT
dpc-4547	1007	1	2022;87(1):80	2022;87(1):80	X
dpc-4547	1007	2	-	-	SYM
dpc-4547	1007	3	6	6	NUM
dpc-4547	1007	4	.	.	NOUN
dpc-4547	1007	5	146	146	NUM
dpc-4547	1007	6	.	.	PUNCT
dpc-4547	1008	1	madani	madani	PROPN
dpc-4547	1008	2	s	s	PROPN
dpc-4547	1008	3	,	,	PUNCT
dpc-4547	1008	4	marwaha	marwaha	NOUN
dpc-4547	1008	5	s	s	PART
dpc-4547	1008	6	,	,	PUNCT
dpc-4547	1008	7	dusendang	dusendang	PROPN
dpc-4547	1008	8	jr	jr	PROPN
dpc-4547	1008	9	,	,	PUNCT
dpc-4547	1008	10	et	et	PROPN
dpc-4547	1008	11	al	al	PROPN
dpc-4547	1008	12	.	.	PROPN
dpc-4547	1008	13	ten	ten	NUM
dpc-4547	1008	14	-	-	PUNCT
dpc-4547	1008	15	year	year	NOUN
dpc-4547	1008	16	follow	follow	NOUN
dpc-4547	1008	17	-	-	PUNCT
dpc-4547	1008	18	up	up	NOUN
dpc-4547	1008	19	of	of	ADP
dpc-4547	1008	20	persons	person	NOUN
dpc-4547	1008	21	with	with	ADP
dpc-4547	1008	22	sun	sun	NOUN
dpc-4547	1008	23	-	-	PUNCT
dpc-4547	1008	24	damaged	damage	VERB
dpc-4547	1008	25	skin	skin	NOUN
dpc-4547	1008	26	associated	associate	VERB
dpc-4547	1008	27	with	with	ADP
dpc-4547	1008	28	subsequent	subsequent	ADJ
dpc-4547	1008	29	development	development	NOUN
dpc-4547	1008	30	of	of	ADP
dpc-4547	1008	31	cutaneous	cutaneous	ADJ
dpc-4547	1008	32	squamous	squamous	ADJ
dpc-4547	1008	33	cell	cell	NOUN
dpc-4547	1008	34	carcinoma	carcinoma	NOUN
dpc-4547	1008	35	.	.	PUNCT
dpc-4547	1009	1	jama	jama	PROPN
dpc-4547	1009	2	dermatol	dermatol	NOUN
dpc-4547	1009	3	.	.	PUNCT
dpc-4547	1010	1	2021;157(5):559	2021;157(5):559	NUM
dpc-4547	1010	2	-	-	SYM
dpc-4547	1010	3	65	65	NUM
dpc-4547	1010	4	.	.	PUNCT
dpc-4547	1011	1	147	147	NUM
dpc-4547	1011	2	.	.	PUNCT
dpc-4547	1012	1	force	force	PROPN
dpc-4547	1012	2	uspst	uspst	PROPN
dpc-4547	1012	3	,	,	PUNCT
dpc-4547	1012	4	mangione	mangione	PROPN
dpc-4547	1012	5	cm	cm	PROPN
dpc-4547	1012	6	,	,	PUNCT
dpc-4547	1012	7	barry	barry	PROPN
dpc-4547	1012	8	mj	mj	PROPN
dpc-4547	1012	9	,	,	PUNCT
dpc-4547	1012	10	et	et	PROPN
dpc-4547	1012	11	al	al	PROPN
dpc-4547	1012	12	.	.	PUNCT
dpc-4547	1012	13	screening	screen	VERB
dpc-4547	1012	14	for	for	ADP
dpc-4547	1012	15	skin	skin	NOUN
dpc-4547	1012	16	cancer	cancer	NOUN
dpc-4547	1012	17	:	:	PUNCT
dpc-4547	1012	18	us	us	PROPN
dpc-4547	1012	19	preventive	preventive	ADJ
dpc-4547	1012	20	services	service	NOUN
dpc-4547	1012	21	task	task	PROPN
dpc-4547	1012	22	force	force	PROPN
dpc-4547	1012	23	recommendation	recommendation	NOUN
dpc-4547	1012	24	statement	statement	NOUN
dpc-4547	1012	25	.	.	PUNCT
dpc-4547	1013	1	jama	jama	PROPN
dpc-4547	1013	2	.	.	PUNCT
dpc-4547	1014	1	2023;329(15):1290	2023;329(15):1290	NUM
dpc-4547	1014	2	-	-	SYM
dpc-4547	1014	3	5	5	NUM
dpc-4547	1014	4	.	.	NOUN
dpc-4547	1014	5	148	148	NUM
dpc-4547	1014	6	.	.	PUNCT
dpc-4547	1015	1	garbe	garbe	PROPN
dpc-4547	1015	2	c	c	PROPN
dpc-4547	1015	3	,	,	PUNCT
dpc-4547	1015	4	augustin	augustin	PROPN
dpc-4547	1015	5	m	m	PROPN
dpc-4547	1015	6	,	,	PUNCT
dpc-4547	1015	7	augustin	augustin	PROPN
dpc-4547	1015	8	j	j	PROPN
dpc-4547	1015	9	,	,	PUNCT
dpc-4547	1015	10	et	et	PROPN
dpc-4547	1015	11	al	al	PROPN
dpc-4547	1015	12	.	.	PUNCT
dpc-4547	1015	13	evaluation	evaluation	NOUN
dpc-4547	1015	14	of	of	ADP
dpc-4547	1015	15	skin	skin	NOUN
dpc-4547	1015	16	cancer	cancer	NOUN
dpc-4547	1015	17	screening	screening	NOUN
dpc-4547	1015	18	in	in	ADP
dpc-4547	1015	19	germany	germany	PROPN
dpc-4547	1015	20	participation	participation	NOUN
dpc-4547	1015	21	,	,	PUNCT
dpc-4547	1015	22	tumor	tumor	NOUN
dpc-4547	1015	23	detection	detection	NOUN
dpc-4547	1015	24	and	and	CCONJ
dpc-4547	1015	25	interval	interval	NOUN
dpc-4547	1015	26	tumors	tumor	NOUN
dpc-4547	1015	27	based	base	VERB
dpc-4547	1015	28	on	on	ADP
dpc-4547	1015	29	shi	shi	PROPN
dpc-4547	1015	30	data	data	PROPN
dpc-4547	1015	31	.	.	PUNCT
dpc-4547	1016	1	j	j	PROPN
dpc-4547	1016	2	dtsch	dtsch	PROPN
dpc-4547	1016	3	dermatol	dermatol	NOUN
dpc-4547	1016	4	ges	ge	NOUN
dpc-4547	1016	5	.	.	PUNCT
dpc-4547	1017	1	2023;21	2023;21	NUM
dpc-4547	1017	2	suppl	suppl	ADJ
dpc-4547	1017	3	5:3	5:3	NUM
dpc-4547	1017	4	-	-	SYM
dpc-4547	1017	5	11	11	NUM
dpc-4547	1017	6	.	.	PUNCT